Allele.name	Allele.primaryIdentifier	Allele.symbol	Allele.publications.pubMedId	Allele.projectCollection
1-acylglycerol-3-phosphate O-acyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432492	Agpat3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
1-acylglycerol-3-phosphate O-acyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432492	Agpat3<tm1a(EUCOMM)Wtsi>	28578315	EUCOMM
1-acylglycerol-3-phosphate O-acyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432492	Agpat3<tm1a(EUCOMM)Wtsi>	28578316	EUCOMM
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362437	Agpat4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637031	Agpat4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
2,3-bisphosphoglycerate mutase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363424	Bpgm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2',3'-cyclic nucleotide 3' phosphodiesterase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433004	Cnp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
2',3'-cyclic nucleotide 3' phosphodiesterase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434123	Cnp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
24-dehydrocholesterol reductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431942	Dhcr24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
24-dehydrocholesterol reductase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434331	Dhcr24<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
2,4-dienoyl CoA reductase 1, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433543	Decr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
2,4-dienoyl CoA reductase 1, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434263	Decr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
2-4-dienoyl-Coenzyme A reductase 2, peroxisomal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460423	Decr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
2-4-dienoyl-Coenzyme A reductase 2, peroxisomal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460427	Decr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
2'-5' oligoadenylate synthetase 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820095	Oas1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820174	Oas1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362444	Oas1e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362348	Oas1e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364835	Oas1g<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362795	Oas1g<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1G; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363868	Oas1g<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1G; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4455455	Oas1g<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1G; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4455595	Oas1g<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 1G; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4455595	Oas1g<tm3e(KOMP)Wtsi>	27626380	KOMP-CSD
2'-5' oligoadenylate synthetase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362367	Oas3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363341	Oas3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2'-5' oligoadenylate synthetase-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431962	Oasl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
2'-deoxynucleoside 5'-phosphate N-hydrolase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419148	Dnph1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2'-deoxynucleoside 5'-phosphate N-hydrolase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419999	Dnph1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2'-deoxynucleoside 5'-phosphate N-hydrolase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472978	Dnph1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
2-hydroxyacyl-CoA lyase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362181	Hacl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2-hydroxyacyl-CoA lyase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362181	Hacl1<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
2-hydroxyacyl-CoA lyase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548710	Hacl1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
2-hydroxyacyl-CoA lyase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362999	Hacl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362420	Ogfod1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362420	Ogfod1<tm1a(KOMP)Wtsi>	24550447	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5607135	Ogfod1<tm1c(KOMP)Wtsi>	24550447	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5607136	Ogfod1<tm1d(KOMP)Wtsi>	24550447	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365223	Ogfod1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362986	Ogfod1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4362970	Ogfod1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307111	Ogfod2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364925	Ogfod3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548515	Ogfod3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
2-oxoglutarate and iron-dependent oxygenase domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364579	Ogfod3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
2-phosphoxylose phosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362699	Pxylp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
3-hydroxy-3-methylglutaryl-Coenzyme A reductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364935	Hmgcr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
3-hydroxy-3-methylglutaryl-Coenzyme A reductase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364674	Hmgcr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847703	Hmgcs2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319895	Hmgcs2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
3-hydroxyanthranilate 3,4-dioxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432202	Haao<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
3-hydroxyanthranilate 3,4-dioxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432202	Haao<tm1a(KOMP)Wtsi>	27754481	KOMP-CSD
3-hydroxybutyrate dehydrogenase, type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432883	Bdh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
3-hydroxybutyrate dehydrogenase, type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431876	Bdh1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
3-hydroxybutyrate dehydrogenase, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433163	Bdh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
3-hydroxybutyrate dehydrogenase, type 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434125	Bdh2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
3-hydroxyisobutyrate dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014686	Hibadh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
3-hydroxyisobutyrate dehydrogenase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637002	Hibadh<tm1b(EUCOMM)Wtsi>	26398943	EUCOMM
3-hydroxyisobutyrate dehydrogenase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637002	Hibadh<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286181	Hmgcll1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426556	Hmgcll1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
3-ketodihydrosphingosine reductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944357	Kdsr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
3-ketodihydrosphingosine reductase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944336	Kdsr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
3-oxoacid CoA transferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364940	Oxct1<tm1a(KOMP)Wtsi>	21209089	KOMP-CSD
3-oxoacid CoA transferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364940	Oxct1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
3-oxoacid CoA transferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364940	Oxct1<tm1a(KOMP)Wtsi>	23233542	KOMP-CSD
3-oxoacid CoA transferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364940	Oxct1<tm1a(KOMP)Wtsi>	25353003	KOMP-CSD
3-oxoacid CoA transferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365227	Oxct1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
3'-phosphoadenosine 5'-phosphosulfate synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286398	Papss2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
3'-phosphoadenosine 5'-phosphosulfate synthase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296209	Papss2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
3-phosphoglycerate dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362757	Phgdh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
3-phosphoglycerate dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364189	Phgdh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
3-phosphoinositide dependent protein kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944580	Pdpk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
3-phosphoinositide dependent protein kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432507	Pdpk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
4-hydroxy-2-oxoglutarate aldolase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363251	Hoga1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
4-hydroxy-2-oxoglutarate aldolase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419886	Hoga1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
4-hydroxy-2-oxoglutarate aldolase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419886	Hoga1<tm2a(KOMP)Wtsi>	26428388	KOMP-CSD
4-hydroxy-2-oxoglutarate aldolase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419736	Hoga1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
4-hydroxyphenylpyruvic acid dioxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473070	Hpd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
4short chain dehydrogenase/reductase family 9C, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881074	Sdr9c7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
4short chain dehydrogenase/reductase family 9C, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881078	Sdr9c7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
5, 10-methenyltetrahydrofolate synthetase-like; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548911	Mthfsl<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
5, 10-methenyltetrahydrofolate synthetase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419786	Mthfs<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
5'-3' exoribonuclease 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296130	Xrn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
5'-3' exoribonuclease 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296118	Xrn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
5',3'-nucleotidase, cytosolic; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419398	Nt5c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
5',3'-nucleotidase, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433639	Nt5m<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
5',3'-nucleotidase, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431922	Nt5m<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
5',3'-nucleotidase, mitochondrial; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472811	Nt5m<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
5-azacytidine induced gene 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842791	Azi2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
5-hydroxytryptamine (serotonin) receptor 1A; targeted mutation 1.1, Velocigene	MGI:5445924	Htr1a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 1A; targeted mutation 1.1, Velocigene	MGI:5445924	Htr1a<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 1B; targeted mutation 1.1, Velocigene	MGI:5463939	Htr1b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 1D; targeted mutation 1.1, Velocigene	MGI:5529062	Htr1d<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 1D; targeted mutation 1.1, Velocigene	MGI:5529062	Htr1d<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 1F; targeted mutation 1.1, Velocigene	MGI:5520176	Htr1f<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432543	Htr2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
5-hydroxytryptamine (serotonin) receptor 2B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5550591	Htr2b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
5-hydroxytryptamine (serotonin) receptor 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432082	Htr2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
5-hydroxytryptamine (serotonin) receptor 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052491	Htr3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
5-hydroxytryptamine (serotonin) receptor 3B; targeted mutation 1.1, Velocigene	MGI:5445922	Htr3b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 3B; targeted mutation 1.1, Velocigene	MGI:5445922	Htr3b<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
5-hydroxytryptamine (serotonin) receptor 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364274	Htr7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
5-hydroxytryptamine (serotonin) receptor 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498765	Htr7<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
5-hydroxytryptamine (serotonin) receptor 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498765	Htr7<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
5-hydroxytryptamine (serotonin) receptor 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841249	Htr7<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
5-hydroxytryptamine (serotonin) receptor 7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841432	Htr7<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
5-methyltetrahydrofolate-homocysteine methyltransferase reductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000404	Mtrr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
5'-nucleotidase, cytosolic IA; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841112	Nt5c1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
5'-nucleotidase, cytosolic IA; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841137	Nt5c1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
5'-nucleotidase, cytosolic IB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948619	Nt5c1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
5'-nucleotidase, cytosolic IB; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635258	Nt5c1b<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
5'-nucleotidase, cytosolic IB; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007968	Nt5c1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
5'-nucleotidase, cytosolic II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432536	Nt5c2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
5'-nucleotidase, cytosolic II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433513	Nt5c2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
5'-nucleotidase, cytosolic II; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511925	Nt5c2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
5'-nucleotidase, cytosolic II; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511898	Nt5c2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
5'-nucleotidase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944377	Nt5dc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
5'-nucleotidase domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419353	Nt5dc2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
5'-nucleotidase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433307	Nt5dc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
5' nucleotidase, ecto; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841170	Nt5e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
5-oxoprolinase (ATP-hydrolysing); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363400	Oplah<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
5-oxoprolinase (ATP-hydrolysing); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364406	Oplah<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
5-phosphohydroxy-L-lysine phospholyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431628	Phykpl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
5-phosphohydroxy-L-lysine phospholyase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434281	Phykpl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
5-phosphohydroxy-L-lysine phospholyase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456760	Phykpl<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
5-phosphohydroxy-L-lysine phospholyase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456765	Phykpl<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944400	Pfkfb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548378	Pfkfb1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946688	Pfkfb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364491	Pfkfb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605741	Pfkfb2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364707	Pfkfb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441922	Pfkfb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441985	Pfkfb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362852	Pfkfb4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362852	Pfkfb4<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548881	Pfkfb4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363315	Pfkfb4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
6-phosphogluconolactonase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305612	Pgls<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
6-pyruvoyl-tetrahydropterin synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944538	Pts<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
6-pyruvoyl-tetrahydropterin synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944507	Pts<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
8-oxoguanine DNA-glycosylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432999	Ogg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
8-oxoguanine DNA-glycosylase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433477	Ogg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aarF domain containing kinase 2; targeted mutation 1.1, Velocigene	MGI:5529498	Adck2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Abelson helper integration site 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434378	Ahi1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Abelson helper integration site 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434344	Ahi1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451450	Abhd13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
abhydrolase domain containing 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451693	Abhd13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
abhydrolase domain containing 14A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441620	Abhd14a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 14A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842383	Abhd14a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 14b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452768	Abhd14b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 14b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452761	Abhd14b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 14b; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473099	Abhd14b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452667	Abhd15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
abhydrolase domain containing 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452710	Abhd15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
abhydrolase domain containing 16A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820220	Abhd16a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 16A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820220	Abhd16a<tm1a(EUCOMM)Wtsi>	25580854	EUCOMM
abhydrolase domain containing 16A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820391	Abhd16a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 17A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013744	Abhd17a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
abhydrolase domain containing 17C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431699	Abhd17c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 17C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306489	Abhd17c<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 17C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441859	Abhd17c<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944547	Abhd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944511	Abhd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433524	Abhd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434210	Abhd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364049	Abhd5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
abhydrolase domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364049	Abhd5<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
abhydrolase domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364049	Abhd5<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
abhydrolase domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365194	Abhd5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
abhydrolase domain containing 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4458703	Abhd6<tm1a(EUCOMM)Hmgu>	24814481	EUCOMM
abhydrolase domain containing 6; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4458703	Abhd6<tm1a(EUCOMM)Hmgu>	26997277	EUCOMM
abhydrolase domain containing 6; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5907201	Abhd6<tm1c(EUCOMM)Hmgu>	24814481	EUCOMM
abhydrolase domain containing 6; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5907201	Abhd6<tm1c(EUCOMM)Hmgu>	26909310	EUCOMM
abhydrolase domain containing 6; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5907201	Abhd6<tm1c(EUCOMM)Hmgu>	27783937	EUCOMM
abhydrolase domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452819	Abhd8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abhydrolase domain containing 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5612824	Abhd8<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
abhydrolase domain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452810	Abhd8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ABI gene family, member 3 (NESH) binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140435	Abi3bp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ABI gene family, member 3 (NESH) binding protein; targeted mutation 1e.1, Mouse Biology Program, UCDavis	MGI:5605816	Abi3bp<tm1e.1(KOMP)Mbp>	27626380	KOMP-CSD
ABI gene family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363968	Abi3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ABI gene family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362259	Abi3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
abl-interactor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452812	Abi1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abl-interactor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452813	Abi1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abl-interactor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842424	Abi2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
abl-interactor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842547	Abi2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
abnormal spindle microtubule assembly; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362345	Aspm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
abnormal spindle microtubule assembly; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362345	Aspm<tm1a(KOMP)Wtsi>	26450969	KOMP-CSD
abnormal spindle microtubule assembly; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362770	Aspm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase, transferase B, alpha 1-3-galactosyltransferase); targeted mutation 1.1, Velocigene	MGI:5548732	Abo<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ABRA C-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944364	Abracl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ABRA C-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944406	Abracl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acetyl-Coenzyme A acetyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008775	Acat2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acetyl-Coenzyme A acetyltransferase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548912	Acat2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
acetyl-Coenzyme A acetyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363558	Acat3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acetyl-Coenzyme A acyltransferase 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451483	Acaa1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acetyl-Coenzyme A acyltransferase 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451444	Acaa1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acetyl-Coenzyme A carboxylase alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008774	Acaca<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acetyl-Coenzyme A carboxylase beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452757	Acacb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acetyl-Coenzyme A carboxylase beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452814	Acacb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
achaete-scute family bHLH transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427121	Ascl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451414	Anp32e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451429	Anp32e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acidic residue methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433265	Armt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acidic residue methyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434052	Armt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acid phosphatase 2, lysosomal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431704	Acp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acid phosphatase 2, lysosomal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432220	Acp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acid phosphatase 7, tartrate resistant; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363037	Acp7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acid phosphatase 7, tartrate resistant; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362418	Acp7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acid phosphatase, prostate; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364649	Acpp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 4; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:5293878	Asic4<tm1a(KOMP)Mbp>	28461138	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303095	Asic4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 4; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5583077	Asic4<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427123	Asic4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363801	Asic5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847709	Asic5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847709	Asic5<tm2a(KOMP)Wtsi>	24663811	KOMP-CSD
acid-sensing (proton-gated) ion channel family member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847711	Asic5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
acireductone dioxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432367	Adi1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acireductone dioxygenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431668	Adi1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aconitate decarboxylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362443	Acod1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aconitate decarboxylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362443	Acod1<tm1a(KOMP)Wtsi>	27189937	KOMP-CSD
aconitate decarboxylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362443	Acod1<tm1a(KOMP)Wtsi>	27374498	KOMP-CSD
aconitate decarboxylase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362417	Acod1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acrosin prepropeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841115	Acr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acrosin prepropeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841037	Acr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
actin, alpha 2, smooth muscle, aorta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432773	Acta2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin, alpha 2, smooth muscle, aorta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432085	Acta2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin-binding LIM protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511982	Ablim2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
actin-binding LIM protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511956	Ablim2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
actin filament associated protein 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842406	Afap1l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin filament associated protein 1-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842527	Afap1l1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
actin filament associated protein 1-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4842620	Afap1l1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
actin filament associated protein 1-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362354	Afap1l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
actin filament associated protein 1-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548752	Afap1l2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
actin filament associated protein 1-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363842	Afap1l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
actin filament associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432637	Afap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin filament associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434004	Afap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actinin, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362572	Actn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
actinin, alpha 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364271	Actn1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
actinin, alpha 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473220	Actn1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
actinin, alpha 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5473205	Actn1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
actinin alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434322	Actn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actinin alpha 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434364	Actn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actinin alpha 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441842	Actn4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actinin alpha 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441783	Actn4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin-like 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473172	Actl10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin-like 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472747	Actl10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin-like 6B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432669	Actl6b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin-like 6B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434164	Actl6b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin-related protein 2/3 complex inhibitor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842572	Arpin<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin-related protein 2/3 complex inhibitor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842686	Arpin<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431990	Arpc1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433499	Arpc1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431851	Arpc1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431851	Arpc1b<tm1a(EUCOMM)Wtsi>	25340873	EUCOMM
actin related protein 2/3 complex, subunit 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431851	Arpc1b<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
actin related protein 2/3 complex, subunit 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432819	Arpc1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431694	Arpc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431694	Arpc2<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431694	Arpc2<tm1a(EUCOMM)Wtsi>	25543281	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431694	Arpc2<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431694	Arpc2<tm1a(EUCOMM)Wtsi>	27385014	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431694	Arpc2<tm1a(EUCOMM)Wtsi>	28867487	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5819114	Arpc2<tm1c(EUCOMM)Wtsi>	27385014	EUCOMM
actin related protein 2/3 complex, subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434020	Arpc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842449	Arpc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842814	Arpc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433308	Arpc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433308	Arpc4<tm1a(EUCOMM)Wtsi>	29113991	EUCOMM
actin related protein 2/3 complex, subunit 4; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111539	Arpc4<tm1c(EUCOMM)Wtsi>	29113991	EUCOMM
actin related protein 2/3 complex, subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431826	Arpc5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
actin related protein 2/3 complex, subunit 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434333	Arpc5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
activated leukocyte cell adhesion molecule; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364350	Alcam<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
activating signal cointegrator 1 complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008937	Ascc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
activating signal cointegrator 1 complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008937	Ascc2<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
activating signal cointegrator 1 complex subunit 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548657	Ascc2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
activating signal cointegrator 1 complex subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950257	Ascc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
activating transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364015	Atf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
activating transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364852	Atf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
activating transcription factor 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840692	Atf3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
activating transcription factor 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5636919	Atf3<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
activating transcription factor 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840690	Atf3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
activating transcription factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419672	Atf5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
activating transcription factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419313	Atf5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
activating transcription factor 5; targeted mutation 1, Velocigene	MGI:4399238	Atf5<tm1(KOMP)Vlcg>	24120133	KOMP-Regeneron
activating transcription factor 5; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511926	Atf5<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
activating transcription factor 5; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511899	Atf5<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
activating transcription factor 6 beta; targeted mutation 1.1, Velocigene	MGI:5548360	Atf6b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
activating transcription factor 6 beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940802	Atf6b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
activating transcription factor 6 beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940796	Atf6b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
active BCR-related gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364825	Abr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
active BCR-related gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363333	Abr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
activin A receptor, type 1B; targeted mutation 1.1, Velocigene	MGI:5548443	Acvr1b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
activin A receptor, type 1; targeted mutation 1.1, Velocigene	MGI:5548914	Acvr1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
activin receptor IIA; targeted mutation 1.1, Velocigene	MGI:5548333	Acvr2a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
activin receptor IIB; targeted mutation 1.1, Velocigene	MGI:5548915	Acvr2b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
activity-dependent neuroprotective protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050866	Adnp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase bubblegum family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432785	Acsbg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase bubblegum family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433606	Acsbg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase family member 2; targeted mutation 1.1, Velocigene	MGI:5554927	Acsf2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
acyl-CoA synthetase family member 2; targeted mutation 1.1, Velocigene	MGI:5554927	Acsf2<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
acyl-CoA synthetase family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365154	Acsf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363156	Acsf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase long-chain family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434365	Acsl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase long-chain family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431605	Acsl4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase long-chain family member 5; targeted mutation 1.1, Velocigene	MGI:5548610	Acsl5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
acyl-CoA synthetase long-chain family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293896	Acsl6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase long-chain family member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362856	Acsl6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase medium-chain family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319887	Acsm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase medium-chain family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319871	Acsm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase medium-chain family member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319872	Acsm1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase medium-chain family member 2; targeted mutation 1.1, Velocigene	MGI:5554928	Acsm2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
acyl-CoA synthetase medium-chain family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941566	Acsm2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase medium-chain family member 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050914	Acsm2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase medium-chain family member 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050986	Acsm2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase medium-chain family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362499	Acsm4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase medium-chain family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362576	Acsm4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA synthetase short-chain family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441709	Acss1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase short-chain family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441965	Acss1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase short-chain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842432	Acss2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase short-chain family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842408	Acss2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA synthetase short-chain family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287805	Acss3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432293	Acot11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA thioesterase 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456061	Acot11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA thioesterase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364961	Acot12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294015	Acot12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434369	Acot13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA thioesterase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362942	Acot4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548768	Acot4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
acyl-CoA thioesterase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364287	Acot4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364061	Acot5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363576	Acot5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362231	Acot6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362231	Acot6<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
acyl-CoA thioesterase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363456	Acot6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA thioesterase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433052	Acot8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA thioesterase 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433855	Acot8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-CoA wax alcohol acyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286170	Awat1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA wax alcohol acyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363486	Awat2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA wax alcohol acyltransferase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820168	Awat2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-CoA wax alcohol acyltransferase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820116	Awat2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-coenzyme A amino acid N-acyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052399	Acnat1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-Coenzyme A binding domain containing 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548778	Acbd3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
acyl-Coenzyme A binding domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842354	Acbd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A binding domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842499	Acbd5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A binding domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432820	Acbd6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A binding domain containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432262	Acbd6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A dehydrogenase family, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842615	Acad12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A dehydrogenase family, member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842520	Acad12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A dehydrogenase family, member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841124	Acad8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-Coenzyme A dehydrogenase family, member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841419	Acad8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-Coenzyme A dehydrogenase family, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944332	Acad9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-Coenzyme A dehydrogenase family, member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944419	Acad9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-Coenzyme A oxidase 1, palmitoyl; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456796	Acox1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A oxidase 1, palmitoyl; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456812	Acox1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
acyl-Coenzyme A oxidase 2, branched chain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362160	Acox2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
acyl-Coenzyme A oxidase 2, branched chain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363319	Acox2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADAM-like, decysin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426623	Adamdec1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADAMTS-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362645	Adamtsl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADAMTS-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362645	Adamtsl2<tm1a(KOMP)Wtsi>	25762570	KOMP-CSD
ADAMTS-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5696789	Adamtsl2<tm1b(KOMP)Wtsi>	25762570	KOMP-CSD
ADAMTS-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364750	Adamtsl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADAMTS-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364813	Adamtsl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADAMTS-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426653	Adamtsl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADAMTS-like 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472933	Adamtsl3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ADAMTS-like 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472791	Adamtsl3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor protein complex AP-1, beta 1 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456817	Ap1b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor protein complex AP-1, gamma 2 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433518	Ap1g2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor protein complex AP-1, gamma 2 subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441810	Ap1g2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor protein complex AP-1, gamma 2 subunit; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441764	Ap1g2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor protein complex AP-1, sigma 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434473	Ap1s1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362456	Appl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363155	Appl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363019	Appl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363488	Appl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex 1, sigma 2 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432123	Ap1s2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex 1, sigma 2 subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432233	Ap1s2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex 1, sigma 2 subunit; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433234	Ap1s2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex 2, alpha 1 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842636	Ap2a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex 2, alpha 1 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842349	Ap2a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex 2, alpha 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888954	Ap2a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex 2, alpha 2 subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548327	Ap2a2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
adaptor-related protein complex 2, beta 1 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362150	Ap2b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex 2, beta 1 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364757	Ap2b1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex 3, beta 1 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452666	Ap3b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex 3, beta 1 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452654	Ap3b1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex 3, sigma 1 subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548436	Ap3s1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
adaptor-related protein complex 3, sigma 2 subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548435	Ap3s2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
adaptor-related protein complex 5, zeta 1 subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4460281	Ap5z1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex 5, zeta 1 subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4460281	Ap5z1<tm1(KOMP)Wtsi>	27626380	KOMP-CSD
adaptor-related protein complex AP-1, sigma 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434503	Ap1s3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex AP-4, beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842459	Ap4b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362509	Ap4e1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362509	Ap4e1<tm1a(KOMP)Wtsi>	23870131	KOMP-CSD
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362509	Ap4e1<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548434	Ap4e1<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548434	Ap4e1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548434	Ap4e1<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548434	Ap4e1<tm1b(KOMP)Wtsi>	29180427	KOMP-CSD
adaptor-related protein complex AP-4, epsilon 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365269	Ap4e1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adaptor-related protein complex AP-4, mu 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014709	Ap4m1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex AP-4, mu 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636962	Ap4m1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
adaptor-related protein complex AP-4, mu 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432153	Ap4m1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex AP-4, mu 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433219	Ap4m1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
adaptor-related protein complex AP-4, sigma 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419139	Ap4s1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
additional sex combs like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431878	Asxl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
additional sex combs like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431878	Asxl1<tm1a(EUCOMM)Wtsi>	22876197	EUCOMM
additional sex combs like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431878	Asxl1<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
additional sex combs like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431878	Asxl1<tm1a(EUCOMM)Wtsi>	24860998	EUCOMM
additional sex combs like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431878	Asxl1<tm1a(EUCOMM)Wtsi>	26385183	EUCOMM
additional sex combs like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431878	Asxl1<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
additional sex combs like 3, transcriptional regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432972	Asxl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
additional sex combs like 3, transcriptional regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434226	Asxl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adducin 1 (alpha); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014699	Add1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adducin 2 (beta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841152	Add2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adducin 2 (beta); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841180	Add2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adducin 3 (gamma); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820317	Add3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adducin 3 (gamma); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820215	Add3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adenomatosis polyposis coli 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363112	Apc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenomatosis polyposis coli 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362615	Apc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenomatosis polyposis coli down-regulated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841073	Apcdd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenomatosis polyposis coli down-regulated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841229	Apcdd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenomatosis polyposis coli; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363356	Apc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine A1 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307109	Adora1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine A1 receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5634953	Adora1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine A2a receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941999	Adora2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine A2a receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941983	Adora2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine A2b receptor; targeted mutation 1.1, Velocigene	MGI:5445790	Adora2b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
adenosine A2b receptor; targeted mutation 1.1, Velocigene	MGI:5445790	Adora2b<tm1.1(KOMP)Vlcg>	28238550	KOMP-Regeneron
adenosine A2b receptor; targeted mutation 1.1, Velocigene	MGI:5445790	Adora2b<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
adenosine A3 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841250	Adora3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine A3 receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5447053	Adora3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine A3 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841235	Adora3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine deaminase domain containing 1 (testis specific); endonuclease-mediated mutation 1, Jackson	MGI:5616653	Adad1<em1(IMPC)J>	28700664	IMPC
adenosine deaminase domain containing 1 (testis specific); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009567	Adad1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine deaminase domain containing 1 (testis specific); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293910	Adad1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine deaminase domain containing 1 (testis specific); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294024	Adad1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine deaminase domain containing 1 (testis specific); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294018	Adad1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine deaminase domain containing 2; endonuclease-mediated mutation 1, Jackson	MGI:5565206	Adad2<em1(IMPC)J>	28700664	IMPC
adenosine deaminase domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4460275	Adad2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine deaminase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302350	Adal<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenosine deaminase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302323	Adal<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adenosine deaminase, RNA-specific, B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431902	Adarb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenosine deaminase, RNA-specific, B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433673	Adarb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adenosine deaminase, RNA-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432463	Adar<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenosine deaminase, RNA-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432463	Adar<tm1a(EUCOMM)Wtsi>	28395340	EUCOMM
adenosine deaminase, RNA-specific; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474756	Adar<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
adenosine deaminase, RNA-specific; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474756	Adar<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
adenosine deaminase, RNA-specific; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6100937	Adar<tm1c(EUCOMM)Wtsi>	28395340	EUCOMM
adenosine deaminase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050169	Ada<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine deaminase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427148	Ada<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine monophosphate deaminase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362729	Ampd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine monophosphate deaminase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362729	Ampd1<tm1a(KOMP)Wtsi>	27775065	KOMP-CSD
adenosine monophosphate deaminase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548917	Ampd1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
adenosine monophosphate deaminase 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5905188	Ampd1<tm1c(KOMP)Wtsi>	27775065	KOMP-CSD
adenosine monophosphate deaminase 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5905189	Ampd1<tm1d(KOMP)Wtsi>	27775065	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362154	Ampd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362836	Ampd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364610	Ampd3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364610	Ampd3<tm2a(KOMP)Wtsi>	23911318	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364610	Ampd3<tm2a(KOMP)Wtsi>	24066180	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364610	Ampd3<tm2a(KOMP)Wtsi>	26398943	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364610	Ampd3<tm2a(KOMP)Wtsi>	28746349	KOMP-CSD
adenosine monophosphate deaminase 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363194	Ampd3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441907	Adcy1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenylate cyclase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441952	Adcy1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adenylate cyclase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451651	Adcy2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451354	Adcy2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451497	Adcy2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451571	Adcy2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432916	Adcy3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenylate cyclase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433944	Adcy3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adenylate cyclase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419395	Adcy4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419617	Adcy4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4843829	Adcy5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451241	Adcy8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433478	Adcy9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenylate cyclase 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636912	Adcy9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
adenylate cyclase 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636912	Adcy9<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
adenylate cyclase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432454	Adcy9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adenylate cyclase activating polypeptide 1 receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362874	Adcyap1r1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate cyclase activating polypeptide 1 receptor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5550590	Adcyap1r1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
adenylate cyclase activating polypeptide 1 receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363172	Adcyap1r1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate kinase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419556	Ak1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
adenylate kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432311	Ak4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenylate kinase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432320	Ak4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adenylosuccinate lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364902	Adsl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adenylosuccinate lyase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548339	Adsl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
adenylosuccinate synthetase, non muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432087	Adss<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adenylosuccinate synthetase, non muscle; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434253	Adss<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adherens junction associated protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5502312	Ajap1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
adhesion G protein-coupled receptor A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842588	Adgra3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842685	Adgra3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006735	Adgrb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor B1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5006776	Adgrb1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor B1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5006776	Adgrb1<tm2a(EUCOMM)Wtsi>	23912999	EUCOMM
adhesion G protein-coupled receptor B1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5006778	Adgrb1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor B2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5616366	Adgrb2<tm1b(KOMP)Mbp>	28894906	KOMP-CSD
adhesion G protein-coupled receptor D1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432831	Adgrd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor D1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548892	Adgrd1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
adhesion G protein-coupled receptor D1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433504	Adgrd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor E1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419950	Adgre1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor F1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362398	Adgrf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor F1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362398	Adgrf1<tm1a(KOMP)Wtsi>	27759003	KOMP-CSD
adhesion G protein-coupled receptor F4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451613	Adgrf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor F4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451512	Adgrf4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor F4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473224	Adgrf4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor F5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296538	Adgrf5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor F5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513786	Adgrf5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
adhesion G protein-coupled receptor F5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296527	Adgrf5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor G2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362735	Adgrg2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor G2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452648	Adgrg2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor G4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427169	Adgrg4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor G5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842796	Adgrg5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor G5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842522	Adgrg5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor G6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947837	Adgrg6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor G7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841015	Adgrg7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adhesion G protein-coupled receptor L3; targeted mutation 1.1, Velocigene	MGI:5603353	Adgrl3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
adhesion G protein-coupled receptor L3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014720	Adgrl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor L4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302348	Adgrl4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor L4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302316	Adgrl4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion G protein-coupled receptor V1; targeted mutation 1.1, Velocigene	MGI:5695890	Adgrv1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
adhesion molecule with Ig like domain 3; targeted mutation 1.1, Velocigene	MGI:5548832	Amigo3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
adhesion molecule with Ig like domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473196	Amigo3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
adhesion molecule with Ig like domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472770	Amigo3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
adipocyte plasma membrane associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363051	Apmap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adipocyte plasma membrane associated protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5427195	Apmap<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
adipocyte plasma membrane associated protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5427153	Apmap<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
adipogenin; targeted mutation 1.1, Velocigene	MGI:5548852	Adig<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
adipogenin; targeted mutation 1, Velocigene	MGI:4460531	Adig<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
adiponectin, C1Q and collagen domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363630	Adipoq<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
adiponectin, C1Q and collagen domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363190	Adipoq<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adiponectin receptor 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692722	Adipor1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
a disintegrin and metallopeptidase domain 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434074	Adam17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin and metallopeptidase domain 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434074	Adam17<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
a disintegrin and metallopeptidase domain 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434199	Adam17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin and metallopeptidase domain 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458641	Adam18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin and metallopeptidase domain 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820033	Adam21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin and metallopeptidase domain 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820103	Adam21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin and metallopeptidase domain 23; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636978	Adam23<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
a disintegrin and metallopeptidase domain 26A (testase 3); targeted mutation 1.1, Velocigene	MGI:5569036	Adam26a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
a disintegrin and metallopeptidase domain 26A (testase 3); targeted mutation 1, Velocigene	MGI:4399381	Adam26a<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
a disintegrin and metallopeptidase domain 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842707	Adam28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin and metallopeptidase domain 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293959	Adam32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin and metallopeptidase domain 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441716	Adam33<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin and metallopeptidase domain 3 (cyritestin); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364424	Adam3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin and metallopeptidase domain 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432111	Adam5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin and metallopeptidase domain 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319901	Adam7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin and metallopeptidase domain 8; targeted mutation 1.1, Velocigene	MGI:5696878	Adam8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431859	Adamts13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548873	Adamts13<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432983	Adamts13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951094	Adamts14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15; targeted mutation 1.1, Velocigene	MGI:5569072	Adamts15<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305677	Adamts16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362561	Adamts17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363616	Adamts17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18; targeted mutation 1.1, Velocigene	MGI:5548810	Adamts18<tm1.1(KOMP)Vlcg>	25770910	KOMP-Regeneron
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18; targeted mutation 1.1, Velocigene	MGI:5548810	Adamts18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000415	Adamts18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472961	Adamts19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511153	Adamts19<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5512014	Adamts19<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5527601	Adamts19<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364946	Adamts20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841315	Adamts3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841315	Adamts3<tm1a(KOMP)Wtsi>	27159393	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841315	Adamts3<tm1a(KOMP)Wtsi>	28213441	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5585728	Adamts3<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840930	Adamts3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426651	Adamts6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363113	Adamts7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363113	Adamts7<tm1a(KOMP)Wtsi>	25712206	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363113	Adamts7<tm1a(KOMP)Wtsi>	25712208	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363113	Adamts7<tm1a(KOMP)Wtsi>	25770910	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363113	Adamts7<tm1a(KOMP)Wtsi>	25843683	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365059	Adamts7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432698	Adamts8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433533	Adamts8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841048	Adamts9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841045	Adamts9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-dependent glucokinase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840602	Adpgk<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-dependent glucokinase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840694	Adpgk<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842694	Arf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842743	Arf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5529068	Arf2<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5529068	Arf2<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
ADP-ribosylation factor 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419724	Arf2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5614714	Arf3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ADP-ribosylation factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458477	Arf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458603	Arf4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362594	Arf5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362459	Arf5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor GTPase activating protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5008029	Arfgap1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor GTPase activating protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050940	Arfgap1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842653	Arfip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor interacting protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548677	Arfip2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ADP-ribosylation factor interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842435	Arfip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 10; targeted mutation 1.1, Velocigene	MGI:5548718	Arl10<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ADP-ribosylation factor-like 10; targeted mutation 1, Velocigene	MGI:4452866	Arl10<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
ADP-ribosylation factor-like 13A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364818	Arl13a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor-like 13A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5529959	Arl13a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor-like 13B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433340	Arl13b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 13B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433340	Arl13b<tm1a(EUCOMM)Wtsi>	27153923	EUCOMM
ADP-ribosylation factor-like 13B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5907220	Arl13b<tm1c(EUCOMM)Wtsi>	27153923	EUCOMM
ADP-ribosylation factor-like 13B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433080	Arl13b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 14 effector protein-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433679	Arl14epl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 14 effector protein-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441976	Arl14epl<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 14 effector protein-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4442004	Arl14epl<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842768	Arl15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842583	Arl15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363159	Arl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364857	Arl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosylation factor-like 4D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432430	Arl4d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 5C; targeted mutation 1.1, Velocigene	MGI:5558161	Arl5c<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ADP-ribosylation factor-like 6 interacting protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014688	Arl6ip5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 6 interacting protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434058	Arl6ip5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosylation factor-like 8B; targeted mutation 1.1, Mammalian Functional Genomics Centre	MGI:5766134	Arl8b<tm1.1(NCOM)Mfgc>	27626380	null
ADP-ribosylation factor-like 9; targeted mutation 1.1, Velocigene	MGI:5572029	Arl9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ADP-ribosylhydrolase like 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365136	Adprhl1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434084	Art1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ADP-ribosyltransferase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363180	Art4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosyltransferase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362657	Art4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosyltransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307113	Art5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ADP-ribosyltransferase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5308284	Art5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
adrenergic receptor, alpha 2a; targeted mutation 1.1, Velocigene	MGI:5695965	Adra2a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
adrenergic receptor, beta 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419883	Adrb3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
adrenomedullin 2; targeted mutation 1.1, Velocigene	MGI:5695957	Adm2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
adrenomedullin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4881073	Adm<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
advillin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432693	Avil<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
advillin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433241	Avil<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
AE binding protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362728	Aebp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
AE binding protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362625	Aebp2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
AF4/FMR2 family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434291	Aff3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
afadin, adherens junction formation factor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434791	Afdn<tm1a(EUCOMM)Hmgu>	25100583	EUCOMM
afadin, adherens junction formation factor; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5607284	Afdn<tm1c(EUCOMM)Hmgu>	25100583	EUCOMM
afamin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455621	Afm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
afamin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455480	Afm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
AFG3-like AAA ATPase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432482	Afg3l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AFG3-like AAA ATPase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433036	Afg3l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aftiphilin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419979	Aftph<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aftiphilin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419669	Aftph<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
agmatine ureohydrolase (agmatinase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362575	Agmat<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
agmatine ureohydrolase (agmatinase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363252	Agmat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
AHA1, activator of heat shock protein ATPase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434221	Ahsa2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AHA1, activator of heat shock protein ATPase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548571	Ahsa2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
AHNAK nucleoprotein (desmoyokin); targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5636950	Ahnak<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
AhpC/TSA antioxidant enzyme domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433035	Aaed1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AhpC/TSA antioxidant enzyme domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433680	Aaed1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ajuba LIM protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424643	Ajuba<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
A kinase (PRKA) anchor protein 10; targeted mutation 1.1, Velocigene	MGI:5574598	Akap10<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
A kinase (PRKA) anchor protein 11; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5503137	Akap11<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
A kinase (PRKA) anchor protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453720	Akap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
A kinase (PRKA) anchor protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453776	Akap2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
A kinase (PRKA) anchor protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363832	Akap5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
A kinase (PRKA) anchor protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364358	Akap5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
A kinase (PRKA) anchor protein 8-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419259	Akap8l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
A kinase (PRKA) anchor protein 8-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420115	Akap8l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362642	Akap9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362642	Akap9<tm1a(KOMP)Wtsi>	23608191	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362642	Akap9<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362642	Akap9<tm1a(KOMP)Wtsi>	26680259	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362642	Akap9<tm1a(KOMP)Wtsi>	26687990	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5516002	Akap9<tm1b(KOMP)Wtsi>	23608191	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5796314	Akap9<tm1c(KOMP)Wtsi>	26680259	KOMP-CSD
A kinase (PRKA) anchor protein (yotiao) 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363691	Akap9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
A kinase (PRKA) interacting protein 1; targeted mutation 1.1, Velocigene	MGI:5565609	Akip1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
A kinase (PRKA) interacting protein 1; targeted mutation 1.1, Velocigene	MGI:5565609	Akip1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
A kinase (PRKA) interacting protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419414	Akip1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
AKT1 substrate 1 (proline-rich); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431959	Akt1s1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AKT1 substrate 1 (proline-rich); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434185	Akt1s1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alanine and arginine rich domain containing protein; targeted mutation 1.1, Velocigene	MGI:5569071	Aard<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
alanine and arginine rich domain containing protein; targeted mutation 1, Velocigene	MGI:4452871	Aard<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
alanine-glyoxylate aminotransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881954	Agxt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
alanine-glyoxylate aminotransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881965	Agxt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
alanyl-tRNA synthetase 2, mitochondrial; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419134	Aars2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
alcohol dehydrogenase 4 (class II), pi polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426644	Adh4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
alcohol dehydrogenase 4 (class II), pi polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426603	Adh4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
alcohol dehydrogenase 5 (class III), chi polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432854	Adh5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alcohol dehydrogenase 5 (class III), chi polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548916	Adh5<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
alcohol dehydrogenase 5 (class III), chi polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548916	Adh5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
alcohol dehydrogenase 5 (class III), chi polypeptide; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433749	Adh5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
alcohol dehydrogenase 6A (class V); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362616	Adh6a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
alcohol dehydrogenase 6A (class V); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365205	Adh6a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
alcohol dehydrogenase, iron containing, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085356	Adhfe1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 16 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432547	Aldh16a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 16 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432547	Aldh16a1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
aldehyde dehydrogenase 16 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432547	Aldh16a1<tm1a(EUCOMM)Wtsi>	28254523	EUCOMM
aldehyde dehydrogenase 18 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363671	Aldh18a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 18 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363671	Aldh18a1<tm1a(KOMP)Wtsi>	25340873	KOMP-CSD
aldehyde dehydrogenase 18 family, member A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364131	Aldh18a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 1 family, member B1; targeted mutation 1.1, Velocigene	MGI:5792875	Aldh1b1<tm1.1(KOMP)Vlcg>	26518685	KOMP-Regeneron
aldehyde dehydrogenase 1 family, member B1; targeted mutation 1, Velocigene	MGI:3813109	Aldh1b1<tm1(KOMP)Vlcg>	26518685	KOMP-Regeneron
aldehyde dehydrogenase 1 family, member B1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840594	Aldh1b1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 1 family, member B1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840594	Aldh1b1<tm2a(EUCOMM)Wtsi>	28026023	EUCOMM
aldehyde dehydrogenase 1 family, member B1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840645	Aldh1b1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 1 family, member L1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364886	Aldh1l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 1 family, member L1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548445	Aldh1l1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
aldehyde dehydrogenase 1 family, member L1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365026	Aldh1l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 1 family, member L2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362727	Aldh1l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 1 family, member L2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451238	Aldh1l2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 1 family, member L2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451568	Aldh1l2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431566	Aldh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431566	Aldh2<tm1a(EUCOMM)Wtsi>	21734703	EUCOMM
aldehyde dehydrogenase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431566	Aldh2<tm1a(EUCOMM)Wtsi>	22922648	EUCOMM
aldehyde dehydrogenase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431566	Aldh2<tm1a(EUCOMM)Wtsi>	25155611	EUCOMM
aldehyde dehydrogenase 2, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432754	Aldh2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 3 family, member B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003007	Aldh3b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 3 family, member B1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548549	Aldh3b1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
aldehyde dehydrogenase 3 family, member B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003024	Aldh3b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 4 family, member A1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840583	Aldh4a1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 4 family, member A1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840617	Aldh4a1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase 8 family, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364900	Aldh8a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 9, subfamily A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287798	Aldh9a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase 9, subfamily A1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572027	Aldh9a1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
aldehyde dehydrogenase 9, subfamily A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427147	Aldh9a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase family 1, subfamily A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365144	Aldh1a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase family 1, subfamily A3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5634954	Aldh1a3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase family 1, subfamily A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364790	Aldh1a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase family 1, subfamily A7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362658	Aldh1a7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde dehydrogenase family 3, subfamily A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842540	Aldh3a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase family 3, subfamily A1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548482	Aldh3a1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
aldehyde dehydrogenase family 3, subfamily A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432633	Aldh3a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase family 3, subfamily A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432633	Aldh3a2<tm1a(EUCOMM)Wtsi>	27053112	EUCOMM
aldehyde dehydrogenase family 3, subfamily A2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5803882	Aldh3a2<tm1b(EUCOMM)Wtsi>	27053112	EUCOMM
aldehyde dehydrogenase family 3, subfamily A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434102	Aldh3a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase family 6, subfamily A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842398	Aldh6a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde dehydrogenase family 6, subfamily A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842700	Aldh6a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aldehyde oxidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363389	Aox1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldehyde oxidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363135	Aox1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldhehyde dehydrogenase family 5, subfamily A1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4881069	Aldh5a1<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
aldo-keto reductase family 1, member A1 (aldehyde reductase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432614	Akr1a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldo-keto reductase family 1, member A1 (aldehyde reductase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434323	Akr1a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aldo-keto reductase family 1, member B10 (aldose reductase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431601	Akr1b10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aldo-keto reductase family 1, member B3 (aldose reductase); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362571	Akr1b3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member B8; targeted mutation 1.1, Velocigene	MGI:5523271	Akr1b8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
aldo-keto reductase family 1, member B8; targeted mutation 1.1, Velocigene	MGI:5523271	Akr1b8<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
aldo-keto reductase family 1, member C12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000324	Akr1c12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C12; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692634	Akr1c12<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
aldo-keto reductase family 1, member C12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426567	Akr1c12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362909	Akr1c13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364670	Akr1c13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950952	Akr1c20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950970	Akr1c20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462596	Akr1c21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462612	Akr1c21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420111	Akr1c6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member C-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426625	Akr1cl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldo-keto reductase family 1, member D1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938580	Akr1d1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aldo-keto reductase family 1, member D1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511929	Akr1d1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
aldo-keto reductase family 1, member D1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511900	Akr1d1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
aldo-keto reductase family 1, member E1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363105	Akr1e1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aldolase A, fructose-bisphosphate; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419797	Aldoa<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
aldolase B, fructose-bisphosphate; targeted mutation 1, Velocigene	MGI:4951216	Aldob<tm1(KOMP)Vlcg>	25637246	KOMP-Regeneron
aldolase B, fructose-bisphosphate; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5085473	Aldob<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
aldolase B, fructose-bisphosphate; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050968	Aldob<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
aldolase C, fructose-bisphosphate; targeted mutation 1.1, Velocigene	MGI:5548322	Aldoc<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
aldolase C, fructose-bisphosphate; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441803	Aldoc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aldolase C, fructose-bisphosphate; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441615	Aldoc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alkaline ceramidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432648	Acer1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alkaline ceramidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432648	Acer1<tm1a(EUCOMM)Wtsi>	27126290	EUCOMM
alkaline ceramidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433346	Acer1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alkaline ceramidase 1; targeted mutation 1, Velocigene	MGI:5085811	Acer1<tm1(KOMP)Vlcg>	29056331	KOMP-Regeneron
alkaline phosphatase, liver/bone/kidney; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432241	Alpl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alkaline phosphatase, liver/bone/kidney; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431963	Alpl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alkB homolog 4, lysine demethylase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840618	Alkbh4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
alkB homolog 4, lysine demethylase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840660	Alkbh4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
alkB homolog 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364500	Alkbh7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
alkB homolog 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365058	Alkbh7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
alkylglycerol monooxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431788	Agmo<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alkylglycerol monooxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433360	Agmo<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alkylglycerone phosphate synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363032	Agps<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
alkylglycerone phosphate synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363032	Agps<tm1a(KOMP)Wtsi>	25197626	KOMP-CSD
allantoicase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364304	Allc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
allantoicase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362177	Allc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
allograft inflammatory factor 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432419	Aif1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
allograft inflammatory factor 1-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548618	Aif1l<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
allograft inflammatory factor 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432281	Aif1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
allograft inflammatory factor 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5613637	Aif1<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
allograft inflammatory factor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419468	Aif1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
alpha 1,3-galactosyltransferase 2 (isoglobotriaosylceramide synthase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000411	A3galt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alpha 1,3-galactosyltransferase 2 (isoglobotriaosylceramide synthase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000417	A3galt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alpha-2-glycoprotein 1, zinc; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051013	Azgp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alpha-2-glycoprotein 1, zinc; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085470	Azgp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alpha-2-HS-glycoprotein; targeted mutation 1.1, Velocigene	MGI:5548370	Ahsg<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
alpha-2-macroglobulin; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766179	A2m<tm1b(NCOM)Mfgc>	27626380	NorCOMM
alpha fetoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842350	Afp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alpha fetoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842599	Afp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419601	Naglu<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419924	Naglu<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
alpha tubulin acetyltransferase 1; targeted mutation 1, Velocigene	MGI:4453011	Atat1<tm1(KOMP)Vlcg>	23720746	KOMP-Regeneron
alpha tubulin acetyltransferase 1; targeted mutation 1, Velocigene	MGI:4453011	Atat1<tm1(KOMP)Vlcg>	24743598	KOMP-Regeneron
ALS2 C-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362593	Als2cl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ALS2 C-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364663	Als2cl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
alsin Rho guanine nucleotide exchange factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431693	Als2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
alsin Rho guanine nucleotide exchange factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432847	Als2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
alveolar soft part sarcoma chromosome region, candidate 1 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458494	Aspscr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
alveolar soft part sarcoma chromosome region, candidate 1 (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458532	Aspscr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
alveolar soft part sarcoma chromosome region, candidate 1 (human); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458501	Aspscr1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
alveolar soft part sarcoma chromosome region, candidate 1 (human); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4458655	Aspscr1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ALX homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365178	Alx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ALX homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296139	Alx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ALX homeobox 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847710	Alx1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ALX homeobox 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847681	Alx1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
amelogenin, X-linked; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947838	Amelx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
amelogenin, X-linked; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944544	Amelx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
amine oxidase, copper-containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548670	Aoc1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820370	Aimp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820384	Aimp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451335	Aimp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451362	Aimp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aminoadipate-semialdehyde synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431552	Aass<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aminoadipate-semialdehyde synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432723	Aass<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aminolevulinate, delta-, dehydratase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432278	Alad<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aminolevulinate, delta-, dehydratase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433615	Alad<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aminolevulinate, delta-, dehydratase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456011	Alad<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
aminolevulinate, delta-, dehydratase; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456826	Alad<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
aminomethyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293975	Amt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aminomethyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820066	Amt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aminopeptidase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364323	Npepl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aminopeptidase-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452679	Npepl1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
aminopeptidase-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452713	Npepl1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
aminopeptidase puromycin sensitive; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365172	Npepps<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aminopeptidase puromycin sensitive; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364075	Npepps<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aminopeptidase puromycin sensitive; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5141831	Npepps<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
amnionless; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419637	Amn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
amnionless; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419661	Amn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
amphiregulin; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:5299794	Areg<tm2a(EUCOMM)Hmgu>	26317471	EUCOMM
amphiregulin; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5637197	Areg<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
amplified in osteosarcoma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939774	Os9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
amplified in osteosarcoma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939770	Os9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
amylase 1, salivary; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363965	Amy1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
amylo-1,6-glucosidase, 4-alpha-glucanotransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432988	Agl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
amylo-1,6-glucosidase, 4-alpha-glucanotransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432988	Agl<tm1a(EUCOMM)Wtsi>	24613482	EUCOMM
amylo-1,6-glucosidase, 4-alpha-glucanotransferase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548686	Agl<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
amylo-1,6-glucosidase, 4-alpha-glucanotransferase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548686	Agl<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
amylo-1,6-glucosidase, 4-alpha-glucanotransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432126	Agl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
amyloid beta (A4) precursor-like protein 2; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5572038	Aplp2<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
amyloid beta (A4) precursor protein-binding, family A, member 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431453	Apba3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947757	Apbb1ip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008797	Apbb1ip<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein; targeted mutation 1, Velocigene	MGI:5085540	Apbb1ip<tm1(KOMP)Vlcg>	25336629	KOMP-Regeneron
amyloid beta (A4) precursor protein-binding, family B, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428469	Apbb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
amyloid beta (A4) precursor protein-binding, family B, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293997	Apbb3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
amyloid beta (A4) precursor protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008790	App<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
amyloid beta precursor protein (cytoplasmic tail) binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307092	Appbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anaphase promoting complex subunit 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419548	Anapc11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anaphase promoting complex subunit 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419627	Anapc11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
anaphase promoting complex subunit 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432218	Anapc13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anaphase promoting complex subunit 13; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472704	Anapc13<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
anaphase promoting complex subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434153	Anapc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anaphase promoting complex subunit 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548397	Anapc4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
anaphase promoting complex subunit 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434115	Anapc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
anaphase prompoting complex C subunit 15; targeted mutation 1.1, Velocigene	MGI:5561049	Anapc15<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
anaphase prompoting complex C subunit 15; targeted mutation 1.1, Velocigene	MGI:5561049	Anapc15<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
anaplastic lymphoma kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842352	Alk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anaplastic lymphoma kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842869	Alk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
androgen dependent TFPI regulating protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426569	Adtrp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
androgen-induced 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364922	Aig1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
androgen-induced 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426658	Aig1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
androglobin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881957	Adgb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
androglobin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880988	Adgb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
angel homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849430	Angel1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
angel homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849421	Angel1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
angel homolog 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511149	Angel1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
angel homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431868	Angel2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
angel homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432727	Angel2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
angel homolog 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433409	Angel2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
angio-associated migratory protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364285	Aamp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
angio-associated migratory protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362560	Aamp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
angio-associated migratory protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472795	Aamp<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
angiogenin, ribonuclease A family, member 6; targeted mutation 1.1, Velocigene	MGI:5695964	Ang6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
angiogenin, ribonuclease, RNase A family, 5; targeted mutation 1.1, Velocigene	MGI:5695966	Ang<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
angiomotin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433551	Amotl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
angiomotin-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431934	Amotl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
angiopoietin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458533	Angpt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458621	Angpt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365215	Angpt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294000	Angpt2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947758	Angpt4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456028	Angptl1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
angiopoietin-like 1; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5302292	Angptl1<tm4a(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin-like 1; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:5302279	Angptl1<tm4e(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin-like 1; targeted mutation 5e, Wellcome Trust Sanger Institute	MGI:5444895	Angptl1<tm5e(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin-like 1; targeted mutation 6e, Wellcome Trust Sanger Institute	MGI:5444989	Angptl1<tm6e(EUCOMM)Wtsi>	21677750	EUCOMM
angiopoietin-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364692	Angptl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294014	Angptl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin-like 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5287774	Angptl3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
angiopoietin-like 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637000	Angptl4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
angiopoietin-like 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944554	Angptl7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
angiopoietin-like 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944502	Angptl7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
angiopoietin-like 8; targeted mutation 1, Velocigene	MGI:5292942	Angptl8<tm1(KOMP)Vlcg>	24043787	KOMP-Regeneron
angiopoietin-like 8; targeted mutation 1, Velocigene	MGI:5292942	Angptl8<tm1(KOMP)Vlcg>	25417115	KOMP-Regeneron
angiopoietin-like 8; targeted mutation 1, Velocigene	MGI:5292942	Angptl8<tm1(KOMP)Vlcg>	25954050	KOMP-Regeneron
angiopoietin-like 8; targeted mutation 1, Velocigene	MGI:5292942	Angptl8<tm1(KOMP)Vlcg>	28413163	KOMP-Regeneron
angiopoietin-like 8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419653	Angptl8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008786	Ace<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820112	Ace2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
angiotensin II receptor, type 1a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842866	Agtr1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
angiotensin II receptor, type 1a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842776	Agtr1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
angiotensin II receptor, type 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364361	Agtr1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
angiotensin II receptor, type 1b; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293921	Agtr1b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
angiotensin II receptor, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433535	Agtr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
angiotensin II receptor, type 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431800	Agtr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
anillin, actin binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453758	Anln<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anillin, actin binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453734	Anln<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin 1, erythroid; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363862	Ank1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin 1, erythroid; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362347	Ank1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and BTB (POZ) domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451397	Abtb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and death domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951111	Ankdd1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and EF-hand domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503349	Ankef1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin-repeat and fibronectin type III domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442053	Ankfn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin-repeat and fibronectin type III domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842888	Ankfn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin-repeat and fibronectin type III domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293990	Ankfn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and KH domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847680	Ankhd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and KH domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847678	Ankhd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and LEM domain containing 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5827621	Ankle1<tm1.1(KOMP)Wtsi>	27010503	KOMP-CSD
ankyrin repeat and LEM domain containing 1; targeted mutation 1.2, Wellcome Trust Sanger Institute	MGI:5827623	Ankle1<tm1.2(KOMP)Wtsi>	27010503	KOMP-CSD
ankyrin repeat and LEM domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363814	Ankle1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and LEM domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363814	Ankle1<tm1(KOMP)Wtsi>	27010503	KOMP-CSD
ankyrin repeat and SAM domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455545	Anks1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SAM domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456662	Anks1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365015	Asb10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451492	Asb10<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 10; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5463965	Asb10<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 10; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5463965	Asb10<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
ankyrin repeat and SOCS box-containing 10; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5463965	Asb10<tm2b(KOMP)Wtsi>	28700664	KOMP-CSD
ankyrin repeat and SOCS box-containing 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451422	Asb10<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427150	Asb11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951110	Asb12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and SOCS box-containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363819	Asb13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364548	Asb13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820155	Asb14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820123	Asb14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 14; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299600	Asb14<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 14; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299524	Asb14<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880920	Asb15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548697	Asb15<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ankyrin repeat and SOCS box-containing 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880947	Asb15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 17; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050969	Asb17<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and SOCS box-containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365275	Asb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427246	Asb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431432	Asb2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431507	Asb2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840680	Asb3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and SOCS box-containing 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840703	Asb3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and SOCS box-containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286203	Asb4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427187	Asb6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427140	Asb6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289808	Asb7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293902	Asb7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419366	Asb8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364403	Asb9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363290	Asb9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and SOCS box-containing 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364793	Asb9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820106	Anks1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820106	Anks1b<tm1a(KOMP)Wtsi>	28115237	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 1B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5896631	Anks1b<tm1b(KOMP)Wtsi>	28115237	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 1B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299569	Anks1b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 1B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299507	Anks1b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433440	Anks4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and sterile alpha motif domain containing 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433582	Anks4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and sterile alpha motif domain containing 4B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433863	Anks4b<tm2a(EUCOMM)Wtsi>	19525957	EUCOMM
ankyrin repeat and sterile alpha motif domain containing 4B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433863	Anks4b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and sterile alpha motif domain containing 4B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434287	Anks4b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and sterile alpha motif domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363754	Anks6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637085	Anks6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ankyrin repeat and sterile alpha motif domain containing 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637085	Anks6<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
ankyrin repeat and zinc finger domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432452	Ankzf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat and zinc finger domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433465	Ankzf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842657	Ankrd11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548681	Ankrd11<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ankyrin repeat domain 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842638	Ankrd11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432195	Ankrd12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 13a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362608	Ankrd13a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 13a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363187	Ankrd13a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 13b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363045	Ankrd13b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 13b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364387	Ankrd13b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 13c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426669	Ankrd13c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 13 family, member D; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503344	Ankrd13d<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 1 (cardiac muscle); targeted mutation 1.1, Velocigene	MGI:5569943	Ankrd1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ankyrin repeat domain 1 (cardiac muscle); targeted mutation 1, Velocigene	MGI:3808333	Ankrd1<tm1(KOMP)Vlcg>	24470489	KOMP-Regeneron
ankyrin repeat domain 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432058	Ankrd24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433204	Ankrd24<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452658	Ankrd26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 26; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452642	Ankrd26<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 27 (VPS9 domain); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5612827	Ankrd27<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ankyrin repeat domain 34A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420014	Ankrd34a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 34A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419123	Ankrd34a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 34B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362736	Ankrd34b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 34C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363900	Ankrd34c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 34C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319827	Ankrd34c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 34C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319878	Ankrd34c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 34C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319848	Ankrd34c<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306500	Ankrd36<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301396	Ankrd36<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451484	Ankrd39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302357	Ankrd40<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 40; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306496	Ankrd40<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 40; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302366	Ankrd40<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364873	Ankrd42<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 42; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362553	Ankrd42<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 42; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299566	Ankrd42<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 53; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419936	Ankrd53<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433117	Ankrd54<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 54; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433032	Ankrd54<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ankyrin repeat domain 60; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841434	Ankrd60<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 60; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841405	Ankrd60<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 65; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419461	Ankrd65<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 6; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548763	Ankrd6<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
ankyrin repeat domain 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419782	Ankrd6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454176	Ankrd7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948628	Ankrd7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ankyrin repeat domain 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419197	Ankrd9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
annexin A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363865	Anxa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
annexin A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362436	Anxa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
annexin A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452775	Anxa2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
annexin A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452766	Anxa2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
annexin A3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5617787	Anxa3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
annexin A5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433845	Anxa5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
annexin A6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432672	Anxa6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
annexin A6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432672	Anxa6<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
annexin A6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433257	Anxa6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
annexin A9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441796	Anxa9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
annexin A9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548668	Anxa9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
anoctamin 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820361	Ano10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anoctamin 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820349	Ano10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
anoctamin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364805	Ano2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anoctamin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363417	Ano2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
anoctamin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052417	Ano3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anoctamin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887637	Ano5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anterior gradient 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434412	Agr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anterior gradient 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432879	Agr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
anterior gradient 2; targeted mutation 1, Velocigene	MGI:5051097	Agr2<tm1(KOMP)Vlcg>	25666625	KOMP-Regeneron
anterior gradient 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841472	Agr3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anterior gradient 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426573	Agr3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
anthrax toxin receptor 1; targeted mutation 1, Velocigene	MGI:3797843	Antxr1<tm1(KOMP)Vlcg>	25572963	KOMP-Regeneron
anthrax toxin receptor 1; targeted mutation 1, Velocigene	MGI:3797843	Antxr1<tm1(KOMP)Vlcg>	28011198	KOMP-Regeneron
anthrax toxin receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944574	Antxr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anthrax toxin receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944560	Antxr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
antigen identified by monoclonal antibody Ki 67; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461730	Mki67<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
antigen identified by monoclonal antibody Ki 67; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461744	Mki67<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
antigen identified by monoclonal antibody Ki 67; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820284	Mki67<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
anti-Mullerian hormone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286384	Amh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
anti-Mullerian hormone; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299877	Amh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
antioxidant 1 copper chaperone; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4950169	Atox1<tm1a(EUCOMM)Hmgu>	27666810	EUCOMM
antioxidant 1 copper chaperone; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5812238	Atox1<tm1c(EUCOMM)Hmgu>	27666810	EUCOMM
anti-silencing function 1A histone chaperone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944371	Asf1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anti-silencing function 1A histone chaperone; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471306	Asf1a<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
anti-silencing function 1A histone chaperone; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471306	Asf1a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
anti-silencing function 1A histone chaperone; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471306	Asf1a<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
anti-silencing function 1B histone chaperone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362737	Asf1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
anti-silencing function 1B histone chaperone; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364804	Asf1b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
antizyme inhibitor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431784	Azin1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
antizyme inhibitor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433193	Azin1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
antizyme inhibitor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433759	Azin2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
antizyme inhibitor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434387	Azin2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
APAF1 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441695	Apip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
APAF1 interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637096	Apip<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
APAF1 interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441843	Apip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
APC membrane recruitment 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841091	Amer1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
apelin receptor; targeted mutation 1.1, Velocigene	MGI:5569042	Aplnr<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
apelin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419227	Apln<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apelin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5603348	Apln<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
apelin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419931	Apln<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apelin; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511924	Apln<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
aph1 homolog B, gamma secretase subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363687	Aph1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aph1 homolog B, gamma secretase subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362269	Aph1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aph1 homolog C, gamma secretase subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458639	Aph1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aph1 homolog C, gamma secretase subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548561	Aph1c<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
aph1 homolog C, gamma secretase subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458635	Aph1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
APOBEC1 complementation factor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4950222	A1cf<tm1a(EUCOMM)Hmgu>	28069890	EUCOMM
APOBEC1 complementation factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5523232	A1cf<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
APOBEC1 complementation factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5523232	A1cf<tm1b(EUCOMM)Hmgu>	28069890	EUCOMM
APOBEC1 complementation factor; transgene insertion 1, Jeffery D Molkentin	MGI:3050453	A1cf<Tg(Myh6-cre/Esr1*)1Jmk>	26175717	null
apolipoprotein A-II; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431398	Apoa2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein A-I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433654	Apoa1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293950	Apobec3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451252	Apob<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451499	Apob<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein C-IV; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5613668	Apoc4<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
apolipoprotein E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420123	Apoe<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419324	Apoe<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein F; targeted mutation 1.1, Velocigene	MGI:5560008	Apof<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
apolipoprotein F; targeted mutation 1, Velocigene	MGI:3800154	Apof<tm1(KOMP)Vlcg>	22363685	KOMP-Regeneron
apolipoprotein F; targeted mutation 1, Velocigene	MGI:3800154	Apof<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
apolipoprotein H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432031	Apoh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
apolipoprotein L 10A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840620	Apol10a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
apolipoprotein L 10A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840627	Apol10a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
apolipoprotein L 10B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841227	Apol10b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 10B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841274	Apol10b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 7a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419740	Apol7a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 7a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419268	Apol7a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 7b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451452	Apol7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 7b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451642	Apol7b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 7e; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050154	Apol7e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887598	Apol8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887595	Apol8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 9b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362987	Apol9b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 9b; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5287779	Apol9b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein L 9b; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293901	Apol9b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein O-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364721	Apool<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein O-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426674	Apool<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein O; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052398	Apoo<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apolipoprotein O; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637032	Apoo<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
apolipoprotein O; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637032	Apoo<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
apolipoprotein O; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5295575	Apoo<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apoptosis antagonizing transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052407	Aatf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apoptosis antagonizing transcription factor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286178	Aatf<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
apoptosis-associated tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939710	Aatk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apoptosis-associated tyrosine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950961	Aatk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apoptosis inhibitor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362827	Api5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apoptotic chromatin condensation inducer 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364030	Acin1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apoptotic chromatin condensation inducer 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363239	Acin1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apoptotic peptidase activating factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363131	Apaf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apoptotic peptidase activating factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365081	Apaf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
apoptotic peptidase activating factor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319877	Apaf1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
apoptotic peptidase activating factor 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363770	Apaf1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
apoptotic peptidase activating factor 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5296530	Apaf1<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
apurinic/apyrimidinic endonuclease 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431417	Apex1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
apurinic/apyrimidinic endonuclease 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941509	Apex2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
apurinic/apyrimidinic endonuclease 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947769	Apex2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aquaporin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441703	Aqp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aquaporin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441853	Aqp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aquaporin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840639	Aqp3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
aquaporin 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5636956	Aqp3<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
aquaporin 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840590	Aqp3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
aquaporin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009572	Aqp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aquaporin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009556	Aqp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aquaporin 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636970	Aqp6<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
aquaporin 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820226	Aqp8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aquaporin 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820318	Aqp8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aquaporin 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363991	Aqp9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aquaporin 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362413	Aqp9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aquaporin 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4362985	Aqp9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
aquarius; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942016	Aqr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aquarius; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942040	Aqr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 12-lipoxygenase, 12R type; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951137	Alox12b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arachidonate 12-lipoxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419718	Alox12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 12-lipoxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419489	Alox12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 15-lipoxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364252	Alox15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 5-lipoxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319844	Alox5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 5-lipoxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362684	Alox5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 5-lipoxygenase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419923	Alox5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 8-lipoxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362187	Alox8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate 8-lipoxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362634	Alox8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate lipoxygenase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363547	Aloxe3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate lipoxygenase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363414	Aloxe3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate lipoxygenase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365047	Aloxe3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate lipoxygenase 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5426663	Aloxe3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
arachidonate lipoxygenase, epidermal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441885	Alox12e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arachidonate lipoxygenase, epidermal; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548415	Alox12e<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
arachidonate lipoxygenase, epidermal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451983	Alox12e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Araf proto-oncogene, serine/threonine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820296	Araf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
archaelysin family metallopeptidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363967	Amz1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
archaelysin family metallopeptidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364948	Amz1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
archaelysin family metallopeptidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451481	Amz2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
archaelysin family metallopeptidase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451419	Amz2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1; targeted mutation 1.1, Velocigene	MGI:5585643	Acap1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ArfGAP with dual PH domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944490	Adap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with dual PH domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944489	Adap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with dual PH domains 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5512013	Adap1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with FG repeats 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461703	Agfg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with FG repeats 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461678	Agfg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820274	Agap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419987	Agap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419639	Agap2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293961	Agap3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293919	Agap3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433293	Arap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433293	Arap1<tm1a(EUCOMM)Wtsi>	26275310	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433293	Arap1<tm1a(EUCOMM)Wtsi>	26839965	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433293	Arap1<tm1a(EUCOMM)Wtsi>	28132686	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548590	Arap1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5692696	Arap1<tm1c(EUCOMM)Wtsi>	28132686	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432103	Arap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451962	Arap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452022	Arap2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527598	Arap2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419832	Arap3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419647	Arap3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with SH3 domain, ankyrin repeat and PH domain1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458471	Asap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ArfGAP with SH3 domain, ankyrin repeat and PH domain1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458581	Asap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arginine glutamic acid dipeptide (RE) repeats; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296215	Rere<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arginine vasopressin-induced 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548586	Avpi1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
arginine vasopressin receptor 1B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512002	Avpr1b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
arginine vasopressin receptor 1B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511970	Avpr1b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
arginine vasopressin receptor 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419874	Avpr2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
arginine vasopressin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431847	Avp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arginine vasopressin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637198	Avp<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
arginyl aminopeptidase (aminopeptidase B); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433971	Rnpep<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arginyl aminopeptidase (aminopeptidase B); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441692	Rnpep<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
arginyl aminopeptidase (aminopeptidase B); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441767	Rnpep<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
arginyl-tRNA synthetase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432770	Rars2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arginyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432394	Rars<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arginyl-tRNA synthetase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432261	Rars<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
argonaute RISC catalytic subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362358	Ago1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
argonaute RISC catalytic subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363253	Ago1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
argonaute RISC catalytic subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880894	Ago3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ariadne RBR E3 ubiquitin protein ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362497	Arih1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ariadne RBR E3 ubiquitin protein ligase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362956	Arih1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aristaless-like homeobox 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362131	Alx3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aristaless-like homeobox 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364463	Alx3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
armadillo repeat containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433886	Armc10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
armadillo repeat containing 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433593	Armc10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
armadillo repeat containing 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887624	Armc12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
armadillo repeat containing 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887619	Armc12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
armadillo repeat containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050964	Armc3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
armadillo repeat containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942137	Armc5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
armadillo repeat containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432478	Armc6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
armadillo repeat containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433569	Armc6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
armadillo repeat containing 7; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548858	Armc7<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
armadillo repeat containing 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419537	Armc7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
armadillo repeat gene deleted in velocardiofacial syndrome; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433370	Arvcf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
armadillo repeat gene deleted in velocardiofacial syndrome; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432634	Arvcf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ARP10 actin-related protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888926	Actr10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ARP10 actin-related protein 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888920	Actr10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ARP1 actin-related protein 1A, centractin alpha; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050933	Actr1a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ARP1 actin-related protein 1A, centractin alpha; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473223	Actr1a<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
ARP1 actin-related protein 1A, centractin alpha; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5473208	Actr1a<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
ARP1 actin-related protein 1B, centractin beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433105	Actr1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ARP1 actin-related protein 1B, centractin beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432358	Actr1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ARP2 actin-related protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939701	Actr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ARP2 actin-related protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939717	Actr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ARP5 actin-related protein 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050905	Actr5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ARP6 actin-related protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434280	Actr6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ARP6 actin-related protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432557	Actr6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ARP8 actin-related protein 8; targeted mutation 1.1, Velocigene	MGI:5554924	Actr8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
arrestin 3, retinal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362458	Arr3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arrestin 3, retinal; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841364	Arr3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
arrestin 3, retinal; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841078	Arr3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
arrestin, beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841004	Arrb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arrestin, beta 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5477806	Arrb1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
arrestin, beta 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5477806	Arrb1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
arrestin, beta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841324	Arrb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arrestin, beta 2; targeted mutation 1.1, Velocigene	MGI:5445919	Arrb2<tm1.1(KOMP)Vlcg>	27452469	KOMP-Regeneron
arrestin, beta 2; targeted mutation 1.1, Velocigene	MGI:5445919	Arrb2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
arrestin, beta 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949380	Arrb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arrestin, beta 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949376	Arrb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arrestin domain containing 1; targeted mutation 1.1, Velocigene	MGI:5445677	Arrdc1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
arrestin domain containing 1; targeted mutation 1.1, Velocigene	MGI:5445677	Arrdc1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
arrestin domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433793	Arrdc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arrestin domain containing 1; targeted mutation 1, Velocigene	MGI:5051234	Arrdc1<tm1(KOMP)Vlcg>	27462458	KOMP-Regeneron
arrestin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432114	Arrdc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arrestin domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432449	Arrdc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arrestin domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427226	Arrdc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arrestin domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302298	Arrdc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arrestin domain containing 4; targeted mutation 1, Velocigene	MGI:5286528	Arrdc4<tm1(KOMP)Vlcg>	27462458	KOMP-Regeneron
arrestin domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433019	Arrdc5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arrestin domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432060	Arrdc5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ARV1 homolog, fatty acid homeostasis modulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286407	Arv1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ARV1 homolog, fatty acid homeostasis modulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296216	Arv1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arylacetamide deacetylase like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363175	Aadacl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arylacetamide deacetylase like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841388	Aadacl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arylacetamide deacetylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008773	Aadac<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arylalkylamine N-acetyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456740	Aanat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arylalkylamine N-acetyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456835	Aanat<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
arylformamidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432070	Afmid<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
arylformamidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432070	Afmid<tm1a(EUCOMM)Wtsi>	26432886	EUCOMM
arylformamidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548841	Afmid<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
arylformamidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548841	Afmid<tm1b(EUCOMM)Wtsi>	26432886	EUCOMM
arylformamidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548841	Afmid<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
arylformamidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434360	Afmid<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aryl-hydrocarbon receptor-interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433801	Aip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aryl-hydrocarbon receptor-interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434083	Aip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aryl-hydrocarbon receptor-interacting protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473112	Aip<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
aryl hydrocarbon receptor nuclear translocator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014600	Arnt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aryl hydrocarbon receptor nuclear translocator-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362493	Arntl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aryl hydrocarbon receptor nuclear translocator-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362493	Arntl2<tm1a(KOMP)Wtsi>	27671790	KOMP-CSD
aryl hydrocarbon receptor nuclear translocator-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364032	Arntl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
aryl hydrocarbon receptor nuclear translocator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942156	Arnt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aryl-hydrocarbon receptor repressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363633	Ahrr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aryl-hydrocarbon receptor repressor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5443922	Ahrr<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
aryl-hydrocarbon receptor repressor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5443922	Ahrr<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
arylsulfatase G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362292	Arsg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arylsulfatase G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363227	Arsg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arylsulfatase i; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364037	Arsi<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arylsulfatase i; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362442	Arsi<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
arylsulfatase J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305621	Arsj<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arylsulfatase K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841100	Arsk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
arylsulfatase K; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446134	Arsk<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
arylsulfatase K; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446134	Arsk<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
arylsulfatase K; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446134	Arsk<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
ASH2 like histone lysine methyltransferase complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433734	Ash2l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asialoglycoprotein receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948642	Asgr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparaginase like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849412	Asrgl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparaginase like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457581	Asrgl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
asparaginase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419918	Aspg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
asparaginase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419437	Aspg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
asparagine-linked glycosylation 10B (alpha-1,2-glucosyltransferase); targeted mutation 1.1, Velocigene	MGI:5548751	Alg10b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
asparagine-linked glycosylation 11 (alpha-1,2-mannosyltransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433124	Alg11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine-linked glycosylation 12 (alpha-1,6-mannosyltransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456018	Alg12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine-linked glycosylation 12 (alpha-1,6-mannosyltransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456022	Alg12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine-linked glycosylation 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841293	Alg13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
asparagine-linked glycosylation 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841285	Alg13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
asparagine-linked glycosylation 1 (beta-1,4-mannosyltransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420073	Alg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
asparagine-linked glycosylation 1 (beta-1,4-mannosyltransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420001	Alg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
asparagine-linked glycosylation 2 (alpha-1,3-mannosyltransferase); targeted mutation 1.1, Velocigene	MGI:5523411	Alg2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
asparagine-linked glycosylation 3 (alpha-1,3-mannosyltransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842605	Alg3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine-linked glycosylation 3 (alpha-1,3-mannosyltransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842439	Alg3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine-linked glycosylation 8 (alpha-1,3-glucosyltransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433843	Alg8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433154	Alg9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432889	Alg9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441742	Asns<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparagine synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441742	Asns<tm1a(EUCOMM)Wtsi>	24139043	EUCOMM
asparagine synthetase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441830	Asns<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
asparaginyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432022	Nars<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asparaginyl-tRNA synthetase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432658	Nars<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aspartate dehydrogenase domain containing; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299554	Aspdh<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
aspartoacylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434258	Aspa<tm1a(EUCOMM)Wtsi>	21625469	EUCOMM
aspartoacylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434258	Aspa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aspartoacylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434258	Aspa<tm1a(EUCOMM)Wtsi>	24826990	EUCOMM
aspartoacylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434258	Aspa<tm1a(EUCOMM)Wtsi>	29116375	EUCOMM
aspartoacylase; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5008602	Aspa<tm1c(EUCOMM)Wtsi>	21625469	EUCOMM
aspartoacylase; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5008602	Aspa<tm1c(EUCOMM)Wtsi>	29116375	EUCOMM
aspartoacylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433652	Aspa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
aspartoacylase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456758	Aspa<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
aspartoacylase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456854	Aspa<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
aspartyl aminopeptidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050992	Dnpep<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
aspartyl-tRNA synthetase 2 (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362200	Dars2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
aspartyl-tRNA synthetase 2 (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362200	Dars2<tm1a(KOMP)Wtsi>	24606902	KOMP-CSD
aspartyl-tRNA synthetase 2 (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362200	Dars2<tm1a(KOMP)Wtsi>	27154400	KOMP-CSD
aspartyl-tRNA synthetase 2 (mitochondrial); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5629584	Dars2<tm1b(KOMP)Wtsi>	24606902	KOMP-CSD
aspartyl-tRNA synthetase 2 (mitochondrial); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364963	Dars2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
asporin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548526	Aspn<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
astacin-like metalloendopeptidase (M12 family); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433329	Astl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
asteroid homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364811	Aste1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
asteroid homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364637	Aste1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
asteroid homolog 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364778	Aste1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
asteroid homolog 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365164	Aste1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
astrotactin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5544982	Astn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ataxia telangiectasia and Rad3 related; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944356	Atr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ataxia telangiectasia and Rad3 related; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471285	Atr<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
ataxia telangiectasia and Rad3 related; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471285	Atr<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ataxia telangiectasia mutated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441835	Atm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ataxin 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942022	Atxn10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ataxin 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636994	Atxn10<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ataxin 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942036	Atxn10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ataxin 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473219	Atxn10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ataxin 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5473204	Atxn10<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ataxin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362415	Atxn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ataxin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363791	Atxn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ataxin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363482	Atxn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ataxin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364366	Atxn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ataxin 7-like 3; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548884	Atxn7l3<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
ataxin 7-like 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364787	Atxn7l3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ataxin 7-like 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364787	Atxn7l3<tm1(KOMP)Wtsi>	25228644	KOMP-CSD
AT hook containing transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842566	Ahctf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AT hook containing transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842533	Ahctf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
AT hook, DNA binding motif, containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419100	Ahdc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
atlastin GTPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433918	Atl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
atlastin GTPase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431898	Atl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
atonal bHLH transcription factor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511995	Atoh1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434463	Atp8a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Ca++-sequestering; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294975	Atp2c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692558	Atp2a1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4942050	Atp2a2<tm1a(EUCOMM)Hmgu>	29131158	EUCOMM
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548918	Atp2a2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATPase, Ca++ transporting, plasma membrane 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008748	Atp2b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Ca++ transporting, plasma membrane 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008748	Atp2b1<tm1a(KOMP)Wtsi>	28827723	KOMP-CSD
ATPase, Ca++ transporting, plasma membrane 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605735	Atp2b1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ATPase, Ca++ transporting, plasma membrane 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115548	Atp2b1<tm1c(KOMP)Wtsi>	28827723	KOMP-CSD
ATPase, Ca++ transporting, plasma membrane 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842514	Atp2b2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Ca++ transporting, plasma membrane 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842554	Atp2b2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Ca++ transporting, plasma membrane 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364155	Atp2b3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Ca++ transporting, plasma membrane 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364223	Atp2b3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Ca++ transporting, plasma membrane 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299578	Atp2b3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Ca++ transporting, plasma membrane 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432663	Atp2b4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Ca++ transporting, plasma membrane 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432475	Atp2b4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Ca++ transporting, ubiquitous; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840972	Atp2a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Ca++ transporting, ubiquitous; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841138	Atp2a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class I, type 8B, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458841	Atp8b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, class I, type 8B, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458853	Atp8b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, class I, type 8B, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419232	Atp8b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class I, type 8B, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419288	Atp8b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class I, type 8B, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293973	Atp8b4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class I, type 8B, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293934	Atp8b4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class I, type 8B, member 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296104	Atp8b4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class VI, type 11A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363953	Atp11a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class VI, type 11A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363953	Atp11a<tm1a(KOMP)Wtsi>	27996060	KOMP-CSD
ATPase, class V, type 10A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841407	Atp10a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, class V, type 10B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455958	Atp10b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, class V, type 10B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456044	Atp10b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Cu++ transporting, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432331	Atp7a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Cu++ transporting, alpha polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433437	Atp7a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Cu++ transporting, alpha polypeptide; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473100	Atp7a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Cu++ transporting, alpha polypeptide; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472896	Atp7a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Cu++ transporting, beta polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454062	Atp7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase family, AAA domain containing 2B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548831	Atad2b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATPase family, AAA domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432934	Atad2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase family, AAA domain containing 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364878	Atad3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase family, AAA domain containing 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363440	Atad3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase family, AAA domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296533	Atad5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+/K+ exchanging, beta polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455540	Atp4b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+/K+ exchanging, beta polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455620	Atp4b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+/K+ exchanging, gastric, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363058	Atp4a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+/K+ exchanging, gastric, alpha polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362670	Atp4a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal accessory protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5430968	Atp6ap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal accessory protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430963	Atp6ap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V0 subunit A1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513745	Atp6v0a1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATPase, H+ transporting, lysosomal V0 subunit A4; targeted mutation 1, Velocigene	MGI:5051197	Atp6v0a4<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ATPase, H+ transporting, lysosomal V0 subunit B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302351	Atp6v0b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, H+ transporting, lysosomal V0 subunit B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302324	Atp6v0b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, H+ transporting, lysosomal V1 subunit A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511981	Atp6v1a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, H+ transporting, lysosomal V1 subunit A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511954	Atp6v1a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, H+ transporting, lysosomal V1 subunit B1; targeted mutation 1, Velocigene	MGI:3847520	Atp6v1b1<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
ATPase, H+ transporting, lysosomal V1 subunit B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363588	Atp6v1b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit B2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513747	Atp6v1b2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit C2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432744	Atp6v1c2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, H+ transporting, lysosomal V1 subunit C2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434229	Atp6v1c2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, H+ transporting, lysosomal V1 subunit D; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513749	Atp6v1d<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATPase, H+ transporting, lysosomal V1 subunit E1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887583	Atp6v1e1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit E1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887635	Atp6v1e1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419360	Atp6v1f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419629	Atp6v1f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit F; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473010	Atp6v1f<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, H+ transporting, lysosomal V1 subunit G1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296124	Atp6v1g1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit G1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427128	Atp6v1g1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit G2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419109	Atp6v1g2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit G3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319821	Atp6v1g3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit G3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319799	Atp6v1g3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, H+ transporting, lysosomal V1 subunit G3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319869	Atp6v1g3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase inhibitory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433166	Atpif1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase inhibitory factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433279	Atpif1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Na+/K+ transporting, alpha 3 polypeptide; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692876	Atp1a3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATPase, Na+/K+ transporting, alpha 4 polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880927	Atp1a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Na+/K+ transporting, alpha 4 polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5694169	Atp1a4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ATPase, Na+/K+ transporting, alpha 4 polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880955	Atp1a4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, Na+/K+ transporting, beta 1 polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950258	Atp1b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Na+/K+ transporting, beta 1 polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940797	Atp1b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Na+/K+ transporting, beta 2 polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433480	Atp1b2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, Na+/K+ transporting, beta 2 polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432929	Atp1b2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase, (Na+)/K+ transporting, beta 4 polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362882	Atp1b4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase, (Na+)/K+ transporting, beta 4 polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364101	Atp1b4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATPase type 13A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433545	Atp13a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATPase type 13A5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365005	Atp13a5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432965	Abca13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 13; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5603352	Abca13<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434414	Abca13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 14; targeted mutation 1.1, Mammalian Functional Genomics Centre	MGI:5766135	Abca14<tm1.1(NCOM)Mfgc>	27626380	NorCOMM
ATP-binding cassette, sub-family A (ABC1), member 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364768	Abca15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364698	Abca15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880961	Abca16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880993	Abca16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434142	Abca17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432803	Abca17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548975	Abca1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451500	Abca2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451495	Abca2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441732	Abca4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441732	Abca4<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441820	Abca4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842548	Abca5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842487	Abca5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364782	Abca6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451246	Abca6<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 6; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5513737	Abca6<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 8a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426660	Abca8a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family A (ABC1), member 8b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432962	Abca8b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 8b; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548477	Abca8b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ATP-binding cassette, sub-family A (ABC1), member 8b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432470	Abca8b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family B (MDR/TAP), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432342	Abcb10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family B (MDR/TAP), member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433724	Abcb10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family B (MDR/TAP), member 11; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548476	Abcb11<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATP-binding cassette, sub-family B (MDR/TAP), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052394	Abcb4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family B (MDR/TAP), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362220	Abcb6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family B (MDR/TAP), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363653	Abcb6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family B (MDR/TAP), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441786	Abcb8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family B (MDR/TAP), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441651	Abcb8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family B (MDR/TAP), member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419349	Abcb9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family B (MDR/TAP), member 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513738	Abcb9<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ATP-binding cassette, sub-family B (MDR/TAP), member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419825	Abcb9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family B (MDR/TAP), member 9; targeted mutation 1, Velocigene	MGI:3847525	Abcb9<tm1(KOMP)Vlcg>	27335633	KOMP-Regeneron
ATP-binding cassette, sub-family B (MDR/TAP), member 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473069	Abcb9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family C (CFTR/MRP), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363899	Abcc10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365143	Abcc10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365253	Abcc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364965	Abcc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4947743	Abcc2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548478	Abcc2<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426619	Abcc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426552	Abcc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family C (CFTR/MRP), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842843	Abcc6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family C (CFTR/MRP), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842678	Abcc6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family D (ALD), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433571	Abcd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family D (ALD), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433571	Abcd1<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
ATP-binding cassette, sub-family D (ALD), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433116	Abcd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family D (ALD), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294967	Abcd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family D (ALD), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299505	Abcd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family D (ALD), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364270	Abcd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family D (ALD), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362718	Abcd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family F (GCN20), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842542	Abcf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family F (GCN20), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842544	Abcf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP-binding cassette, sub-family F (GCN20), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419565	Abcf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family F (GCN20), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419348	Abcf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP-binding cassette, sub-family F (GCN20), member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473028	Abcf3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP binding cassette subfamily G member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050958	Abcg1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP binding cassette subfamily G member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050983	Abcg1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP binding cassette subfamily G member 2 (Junior blood group); targeted mutation 1.1, Velocigene	MGI:5505632	Abcg2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ATP binding cassette subfamily G member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294026	Abcg3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP binding cassette subfamily G member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294022	Abcg3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP binding cassette subfamily G member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362568	Abcg8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP citrate lyase; targeted mutation 1, Velocigene	MGI:5085526	Acly<tm1(KOMP)Vlcg>	27760311	KOMP-Regeneron
ATP/GTP binding protein-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442049	Agbl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP/GTP binding protein-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441857	Agbl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431782	Atp5f1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432618	Atp5f1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419513	Atp5g1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419646	Atp5g1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9); targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5588276	Atp5g2<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820043	Atp5g3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820133	Atp5g3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636982	Atp5l<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432141	Atp5a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432141	Atp5a1<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432141	Atp5a1<tm1a(EUCOMM)Wtsi>	25526730	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432141	Atp5a1<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432076	Atp5a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513743	Atp5b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842692	Atp5e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636990	Atp5e<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842865	Atp5e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432975	Atp5c1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434303	Atp5c1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit E; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882009	Atp5k<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
ATP synthase mitochondrial F1 complex assembly factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296106	Atpaf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP synthase mitochondrial F1 complex assembly factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294005	Atpaf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ATP synthase mitochondrial F1 complex assembly factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362266	Atpaf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATP synthase mitochondrial F1 complex assembly factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364336	Atpaf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 1A (SWI-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362765	Arid1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 1A (SWI-like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363179	Arid1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 1B (SWI-like); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435087	Arid1b<tm1a(EUCOMM)Hmgu>	29184203	EUCOMM
AT rich interactive domain 1B (SWI-like); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5771994	Arid1b<tm1b(EUCOMM)Hmgu>	29184203	EUCOMM
AT rich interactive domain 1B (SWI-like); targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6115546	Arid1b<tm1c(EUCOMM)Hmgu>	29184203	EUCOMM
AT rich interactive domain 2 (ARID, RFX-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433303	Arid2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AT rich interactive domain 2 (ARID, RFX-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433303	Arid2<tm1a(EUCOMM)Wtsi>	25299188	EUCOMM
AT rich interactive domain 3A (BRIGHT-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364761	Arid3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 3A (BRIGHT-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364761	Arid3a<tm1a(KOMP)Wtsi>	29114251	KOMP-CSD
AT rich interactive domain 3A (BRIGHT-like); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5448531	Arid3a<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 3A (BRIGHT-like); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5448531	Arid3a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
AT rich interactive domain 3A (BRIGHT-like); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115543	Arid3a<tm1c(KOMP)Wtsi>	29114251	KOMP-CSD
AT rich interactive domain 3A (BRIGHT-like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364099	Arid3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 3B (BRIGHT-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451239	Arid3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 3B (BRIGHT-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451239	Arid3b<tm1a(KOMP)Wtsi>	27537840	KOMP-CSD
AT rich interactive domain 3B (BRIGHT-like); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5812005	Arid3b<tm1c(KOMP)Wtsi>	27537840	KOMP-CSD
AT rich interactive domain 3B (BRIGHT-like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451640	Arid3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 3C (BRIGHT-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364724	Arid3c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 3C (BRIGHT-like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419945	Arid3c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
AT rich interactive domain 4A (RBP1-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432398	Arid4a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AT rich interactive domain 4A (RBP1-like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433278	Arid4a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
AT rich interactive domain 4B (RBP1-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441740	Arid4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
AT rich interactive domain 4B (RBP1-like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442054	Arid4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
AT rich interactive domain 5B (MRF1-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008750	Arid5b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATR interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420066	Atrip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ATR interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5473356	Atrip<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
ATR interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5473356	Atrip<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ATR interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5473356	Atrip<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
ATR interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419260	Atrip<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
atrophin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433256	Atn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
atrophin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548352	Atn1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
atrophin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432786	Atn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ATRX, chromatin remodeler; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441677	Atrx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ATRX, chromatin remodeler; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442013	Atrx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
atypical chemokine receptor 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5085477	Ackr3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
atypical chemokine receptor 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5692583	Ackr3<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
atypical chemokine receptor 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840610	Ackr3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
AU RNA binding protein/enoyl-coenzyme A hydratase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840672	Auh<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
AU RNA binding protein/enoyl-coenzyme A hydratase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840696	Auh<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
autocrine motility factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362704	Amfr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
autocrine motility factor receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364002	Amfr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
autophagy/beclin 1 regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842665	Ambra1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy/beclin 1 regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842706	Ambra1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441693	Atg10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441993	Atg10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451998	Atg10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452822	Atg10<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432181	Atg16l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432181	Atg16l1<tm1a(EUCOMM)Wtsi>	23973919	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432181	Atg16l1<tm1a(EUCOMM)Wtsi>	24821797	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432181	Atg16l1<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	22520467	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	23954160	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	23973919	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	25308334	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	25816775	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	26910010	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	26929451	EUCOMM
autophagy related 16-like 1 (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	28694387	EUCOMM
autophagy related 16-like 2 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433064	Atg16l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 16-like 2 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433064	Atg16l2<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
autophagy related 16-like 2 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432083	Atg16l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548550	Atg3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
autophagy related 4C, cysteine peptidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455960	Atg4c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 9A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473107	Atg9a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
autophagy related 9B; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5569076	Atg9b<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
axin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363820	Axin1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
axin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820042	Axin1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
axin 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820137	Axin1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
axin 1; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:5511884	Axin1<tm4e(EUCOMM)Wtsi>	21677750	EUCOMM
axin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841043	Axin2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
axin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299495	Axin2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
axonemal dynein light chain domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299611	Axdnd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
B9 protein domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432284	B9d1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B9 protein domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432284	B9d1<tm1a(EUCOMM)Wtsi>	21763481	EUCOMM
B9 protein domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432284	B9d1<tm1a(EUCOMM)Wtsi>	22179047	EUCOMM
B9 protein domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432284	B9d1<tm1a(EUCOMM)Wtsi>	25869670	EUCOMM
B9 protein domain 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5301331	B9d1<tm1c(EUCOMM)Wtsi>	21763481	EUCOMM
B9 protein domain 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5301331	B9d1<tm1c(EUCOMM)Wtsi>	25869670	EUCOMM
B9 protein domain 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5301332	B9d1<tm1d(EUCOMM)Wtsi>	21763481	EUCOMM
B9 protein domain 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5301332	B9d1<tm1d(EUCOMM)Wtsi>	22179047	EUCOMM
B9 protein domain 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5301332	B9d1<tm1d(EUCOMM)Wtsi>	25869670	EUCOMM
B9 protein domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441794	B9d2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B9 protein domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442029	B9d2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bactericidal permeablility increasing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842642	Bpi<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
baculoviral IAP repeat-containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434002	Birc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
baculoviral IAP repeat-containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434484	Birc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BAH domain and coiled-coil containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431461	Bahcc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
BAI1-associated protein 2-like 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435406	Baiap2l2<tm1a(EUCOMM)Hmgu>	27626380	EUCOMM
BAI1-associated protein 2-like 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548844	Baiap2l2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Bardet-Biedl syndrome 10 (human); targeted mutation 1.1, Velocigene	MGI:5515782	Bbs10<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Bardet-Biedl syndrome 4 (human); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5554915	Bbs4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Bardet-Biedl syndrome 5 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433255	Bbs5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Bardet-Biedl syndrome 5 (human); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548622	Bbs5<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
Bardet-Biedl syndrome 5 (human); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548622	Bbs5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
Bardet-Biedl syndrome 7 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951097	Bbs7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Bardet-Biedl syndrome 7 (human); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554939	Bbs7<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
Bardet-Biedl syndrome 7 (human); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554939	Bbs7<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
Bardet-Biedl syndrome 7 (human); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554939	Bbs7<tm1b(EUCOMM)Wtsi>	28700664	EUCOMM
Bardet-Biedl syndrome 9 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841206	Bbs9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Bardet-Biedl syndrome 9 (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841086	Bbs9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BarH like homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427188	Barhl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BarH like homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427141	Barhl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BarH-like homeobox 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548392	Barx2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
barttin CLCNK type accessory beta subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286263	Bsnd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
barttin CLCNK type accessory beta subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294025	Bsnd<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
basal body orientation factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364440	Bbof1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
basal body orientation factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364299	Bbof1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
base methyltransferase of 25S rRNA 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842490	Bmt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
basic helix-loop-helix domain containing, class B9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840641	Bhlhb9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
basic helix-loop-helix domain containing, class B9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840571	Bhlhb9<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
basic helix-loop-helix family, member e40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362482	Bhlhe40<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
basic, immunoglobulin-like variable motif containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296109	Bivm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
basic, immunoglobulin-like variable motif containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294017	Bivm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
basic leucine zipper and W2 domains 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5463964	Bzw2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
basic leucine zipper and W2 domains 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5463964	Bzw2<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
basic leucine zipper nuclear factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441856	Blzf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
basic transcription factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842802	Btf3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
basic transcription factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842328	Btf3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
basonuclin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419750	Bnc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
basonuclin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420045	Bnc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
basonuclin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5293986	Bnc1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
basonuclin 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293979	Bnc1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
basonuclin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362307	Bnc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
basonuclin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362600	Bnc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bassoon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847857	Bsn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bassoon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847864	Bsn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
B-box and SPRY domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432968	Bspry<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B-box and SPRY domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434373	Bspry<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
B cell CLL/lymphoma 11A (zinc finger protein); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453793	Bcl11a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B cell CLL/lymphoma 11A (zinc finger protein); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453733	Bcl11a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
B cell CLL/lymphoma 6, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433508	Bcl6b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B cell CLL/lymphoma 6, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431576	Bcl6b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
B cell CLL/lymphoma 7A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461688	Bcl7a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B cell CLL/lymphoma 7B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433174	Bcl7b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B cell CLL/lymphoma 7B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431673	Bcl7b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
B cell leukemia/lymphoma 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460467	Bcl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B cell leukemia/lymphoma 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460523	Bcl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
B cell leukemia/lymphoma 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947822	Bcl6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B cell receptor associated protein 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820041	Bcap29<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
B cell receptor associated protein 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820045	Bcap29<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
B cell receptor associated protein 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432267	Bcap31<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B cell scaffold protein with ankyrin repeats 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880884	Bank1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
B cell translocation gene 1, anti-proliferative, pseudogene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364175	Btg1-ps2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
B cell translocation gene 1, anti-proliferative, pseudogene 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426654	Btg1-ps2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
B cell translocation gene 2, anti-proliferative; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5472170	Btg2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
B cell translocation gene 2, anti-proliferative; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5472170	Btg2<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
BCL2/adenovirus E1B interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363370	Bnip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BCL2/adenovirus E1B interacting protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299602	Bnip1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
BCL2/adenovirus E1B interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432551	Bnip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2/adenovirus E1B interacting protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636917	Bnip2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
BCL2/adenovirus E1B interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434046	Bnip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2/adenovirus E1B interacting protein 3-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432687	Bnip3l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2-associated agonist of cell death; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5286311	Bad<tm1a(EUCOMM)Hmgu>	29368690	EUCOMM
BCL2-associated agonist of cell death; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6115633	Bad<tm1c(EUCOMM)Hmgu>	29368690	EUCOMM
BCL2-associated athanogene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434347	Bag2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2-associated athanogene 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436101	Bag3<tm1a(EUCOMM)Hmgu>	28737513	EUCOMM
BCL2-associated athanogene 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548479	Bag3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
BCL2-associated athanogene 3; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5760384	Bag3<tm1c(EUCOMM)Hmgu>	28737513	EUCOMM
BCL2-associated athanogene 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431594	Bag4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2-associated athanogene 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294974	Bag5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BCL2-associated athanogene 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299544	Bag5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BCL2-associated transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461748	Bclaf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2-associated transcription factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520175	Bclaf1<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2-associated transcription factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520175	Bclaf1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
BCL2-associated transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461680	Bclaf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2-associated X protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842290	Bax<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BCL2 binding component 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296103	Bbc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BCL2 binding component 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419747	Bbc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BCL2-like 11 (apoptosis facilitator); targeted mutation 6.1, Philippe Bouillet	MGI:5562690	Bcl2l11<tm6.1Boui>	28552963	null
BCL2 modifying factor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419589	Bmf<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
BCL2-related ovarian killer; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605768	Bok<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
BCL6 co-repressor-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420044	Bcorl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BCL6 co-repressor-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419831	Bcorl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BCL6 co-repressor-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299591	Bcorl1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
BCL6 interacting corepressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433483	Bcor<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BCL6 interacting corepressor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431908	Bcor<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BCL6 interacting corepressor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455952	Bcor<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
BCL6 interacting corepressor; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455967	Bcor<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
beaded filament structural protein 1, in lens-CP94; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432272	Bfsp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
beaded filament structural protein 1, in lens-CP94; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431849	Bfsp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
beclin 1, autophagy related; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362198	Becn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
beclin 1, autophagy related; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364992	Becn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BEN domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362277	Bend5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BEN domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363932	Bend5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BEN domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431614	Bend7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BEN domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434192	Bend7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Bet1 golgi vesicular membrane trafficking protein like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451273	Bet1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427233	B3gat1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4453735	B3gat2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4453756	B3gat2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
beta-1,4-glucuronyltransferase 1; targeted mutation 1, Velocigene	MGI:4399423	B4gat1<tm1(KOMP)Vlcg>	23217742	KOMP-Regeneron
beta-1,4-N-acetyl-galactosaminyl transferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434237	B4galnt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
beta-1,4-N-acetyl-galactosaminyl transferase 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419658	B4galnt4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
beta-2 microglobulin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820252	B2m<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
beta-3-glucosyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820079	B3glct<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
beta-3-glucosyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820131	B3glct<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
beta-carotene oxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363707	Bco1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
beta-carotene oxygenase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364894	Bco2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
beta-carotene oxygenase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364481	Bco2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
betaine-homocysteine methyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364020	Bhmt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
betaine-homocysteine methyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364154	Bhmt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
betaine-homocysteine methyltransferase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5582429	Bhmt<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
betaine-homocysteine methyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887708	Bhmt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
beta-site APP-cleaving enzyme 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949365	Bace2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
beta-site APP-cleaving enzyme 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949361	Bace2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
beta-transducin repeat containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419962	Btrc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
beta-transducin repeat containing protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548441	Btrc<tm1b(KOMP)Wtsi>	25849460	KOMP-CSD
beta-transducin repeat containing protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548441	Btrc<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
beta-transducin repeat containing protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419973	Btrc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BH3 interacting domain death agonist; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432228	Bid<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BH3 interacting domain death agonist; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433514	Bid<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BICD cargo adaptor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419515	Bicd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
BICD cargo adaptor 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419480	Bicd2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
BICD family like cargo adaptor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840580	Bicdl1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
BICD family like cargo adaptor 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5603351	Bicdl1<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
BICD family like cargo adaptor 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840693	Bicdl1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
bile acid-Coenzyme A: amino acid N-acyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427134	Baat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
biliverdin reductase A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436528	Blvra<tm1a(EUCOMM)Hmgu>	27738106	EUCOMM
biliverdin reductase A; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5816874	Blvra<tm1c(EUCOMM)Hmgu>	27738106	EUCOMM
biliverdin reductase B (flavin reductase (NADPH)); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419545	Blvrb<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
biliverdin reductase B (flavin reductase (NADPH)); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419545	Blvrb<tm1(KOMP)Wtsi>	27626380	KOMP-CSD
binder of sperm protein homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461697	Bsph2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
binder of sperm protein homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461761	Bsph2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
biogenesis of lysosomal organelles complex-1, subunit 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434990	Bloc1s1<tm1a(EUCOMM)Hmgu>	24356961	EUCOMM
biogenesis of lysosomal organelles complex-1, subunit 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434990	Bloc1s1<tm1a(EUCOMM)Hmgu>	28900165	EUCOMM
biogenesis of lysosomal organelles complex-1, subunit 2; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5490495	Bloc1s2<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
biogenesis of lysosomal organelles complex-1, subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299528	Bloc1s3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
biogenesis of lysosomal organelles complex-1, subunit 5, muted; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944567	Bloc1s5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
biorientation of chromosomes in cell division 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363946	Bod1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
biorientation of chromosomes in cell division 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319862	Bod1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
biorientation of chromosomes in cell division 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319908	Bod1<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364249	Boc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548758	Boc<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364011	Boc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bisphosphate 3'-nucleotidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434391	Bpnt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bladder cancer associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364515	Blcap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bladder cancer associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364153	Blcap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bladder cancer associated protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299612	Blcap<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
bladder cancer associated protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299533	Blcap<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
bleomycin hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364845	Blmh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bleomycin hydrolase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362878	Blmh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BLOC-1 related complex subunit 6; targeted mutation 1.1, Velocigene	MGI:5750742	Borcs6<tm1.1(KOMP)Vlcg>	28877454	KOMP-Regeneron
BLOC-1 related complex subunit 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433500	Borcs8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BLOC-1 related complex subunit 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434206	Borcs8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
blood vessel epicardial substance; targeted mutation 1.1, Velocigene	MGI:5583059	Bves<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Bloom syndrome, RecQ like helicase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820328	Blm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
B lymphoid kinase; targeted mutation 1.1, Velocigene	MGI:5695967	Blk<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
B lymphoid kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881088	Blk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BMP and activin membrane-bound inhibitor; targeted mutation 1.1, Velocigene	MGI:5569047	Bambi<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
BMS1, ribosome biogenesis factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548836	Bms1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
BMX non-receptor tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433142	Bmx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BMX non-receptor tyrosine kinase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548403	Bmx<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
bobby sox HMG box containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432372	Bbx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bobby sox HMG box containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432372	Bbx<tm1a(EUCOMM)Wtsi>	22876197	EUCOMM
bobby sox HMG box containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432372	Bbx<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
bobby sox HMG box containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434231	Bbx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bolA-like 2 (E. coli); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419429	Bola2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
bolA-like 2 (E. coli); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419429	Bola2<tm1(KOMP)Wtsi>	27626380	KOMP-CSD
bolA-like 3 (E. coli); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842419	Bola3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bombesin-like receptor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364495	Brs3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bombesin-like receptor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363441	Brs3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bone marrow stromal cell antigen 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938518	Bst1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bone marrow stromal cell antigen 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938530	Bst1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bone morphogenetic protein 10; targeted mutation 3b, Helmholtz Zentrum Muenchen GmbH	MGI:5694168	Bmp10<tm3b(EUCOMM)Hmgu>	27626380	EUCOMM
bone morphogenetic protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847700	Bmp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bone morphogenetic protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847706	Bmp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bone morphogenetic protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302322	Bmp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302370	Bmp2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008061	Bmp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein 3; targeted mutation 1, Velocigene	MGI:4881251	Bmp3<tm1(KOMP)Vlcg>	22074949	KOMP-Regeneron
bone morphogenetic protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433110	Bmp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434353	Bmp5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286378	Bmp7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein 8b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433585	Bmp8b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein 8b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432679	Bmp8b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bone morphogenetic protein receptor, type 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451277	Bmpr1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bone morphogenetic protein receptor, type 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451641	Bmpr1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bone morphogenetic protein/retinoic acid inducible neural specific 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427245	Brinp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
bone morphogenic protein/retinoic acid inducible neural-specific 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951113	Brinp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bora, aurora kinase A activator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460422	Bora<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bora, aurora kinase A activator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460502	Bora<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bora, aurora kinase A activator; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4461667	Bora<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
boule homolog, RNA binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841165	Boll<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family A, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842881	Bpifa1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BPI fold containing family A, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842758	Bpifa1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BPI fold containing family A, member 1; targeted mutation 1, Velocigene	MGI:3847456	Bpifa1<tm1(KOMP)Vlcg>	21514430	KOMP-Regeneron
BPI fold containing family A, member 1; targeted mutation 1, Velocigene	MGI:3847456	Bpifa1<tm1(KOMP)Vlcg>	22499853	KOMP-Regeneron
BPI fold containing family A, member 2; targeted mutation 1, Velocigene	MGI:4881181	Bpifa2<tm1(KOMP)Vlcg>	28775000	KOMP-Regeneron
BPI fold containing family A, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363898	Bpifa3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family A, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362552	Bpifa3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family A, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006740	Bpifa6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family A, member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006737	Bpifa6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family B, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880889	Bpifb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family B, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880889	Bpifb1<tm1a(KOMP)Wtsi>	28851744	KOMP-CSD
BPI fold containing family B, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5583068	Bpifb1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
BPI fold containing family B, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948644	Bpifb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BPI fold containing family B, member 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548851	Bpifb3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
BPI fold containing family B, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365147	Bpifb4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family B, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364192	Bpifb5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family B, member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4843822	Bpifb5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family B, member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4843845	Bpifb5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
BPI fold containing family B, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938572	Bpifb6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BPI fold containing family B, member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938590	Bpifb6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
brachyury, T-box transcription factor T; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419219	T<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
brachyury, T-box transcription factor T; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419422	T<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Braf transforming gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820236	Braf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Braf transforming gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820369	Braf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
brain abundant, membrane attached signal protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432221	Basp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
brain abundant, membrane attached signal protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5009663	Basp1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
brain abundant, membrane attached signal protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5014702	Basp1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
brain and acute leukemia, cytoplasmic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456024	Baalc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
brain and acute leukemia, cytoplasmic; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456067	Baalc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
brain-enriched guanylate kinase-associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460489	Begain<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
brain-enriched guanylate kinase-associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460501	Begain<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
brain expressed X-linked 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419819	Bex3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
brain glycogen phosphorylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362274	Pygb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
brain glycogen phosphorylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363277	Pygb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
brain glycogen phosphorylase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363287	Pygb<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
brain glycogen phosphorylase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4362555	Pygb<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
brain glycogen phosphorylase; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4362705	Pygb<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
brain glycogen phosphorylase; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4363763	Pygb<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
brain-specific angiogenesis inhibitor 1-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419375	Baiap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
brain-specific angiogenesis inhibitor 1-associated protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605808	Baiap2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
brain-specific angiogenesis inhibitor 1-associated protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419218	Baiap2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
brain specific homeobox; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363233	Bsx<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
brain specific homeobox; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364207	Bsx<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
branched chain aminotransferase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842446	Bcat2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
branched chain aminotransferase 2, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842335	Bcat2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
branched chain ketoacid dehydrogenase kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441616	Bckdk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
branched chain ketoacid dehydrogenase kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441616	Bckdk<tm1a(EUCOMM)Wtsi>	28051178	EUCOMM
branched chain ketoacid dehydrogenase kinase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:6105931	Bckdk<tm1b(EUCOMM)Wtsi>	28051178	EUCOMM
branched chain ketoacid dehydrogenase kinase; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6105928	Bckdk<tm1c(EUCOMM)Wtsi>	28051178	EUCOMM
branched chain ketoacid dehydrogenase kinase; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6105928	Bckdk<tm1c(EUCOMM)Wtsi>	28719620	EUCOMM
branched chain ketoacid dehydrogenase kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441964	Bckdk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BRCA1 A complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840956	Abraxas1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BRCA1 A complex subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841469	Abraxas1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Brca1 associated protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436674	Bap1<tm1a(EUCOMM)Hmgu>	26437366	EUCOMM
Brca1 associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939771	Bap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Brca1 associated protein 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5774999	Bap1<tm1c(EUCOMM)Hmgu>	26437366	EUCOMM
Brca1 associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939766	Bap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Brca1 associated protein 1; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:4452731	Bap1<tm2a(EUCOMM)Hmgu>	25359211	EUCOMM
Brca1 associated protein 1; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:4452731	Bap1<tm2a(EUCOMM)Hmgu>	28473526	EUCOMM
BRCA1 associated RING domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939693	Bard1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BRCA1 associated RING domain 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5464325	Bard1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
BRCA1 associated RING domain 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5464318	Bard1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
BRCA1/BRCA2-containing complex, subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364012	Brcc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BRCA1/BRCA2-containing complex, subunit 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5427124	Brcc3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
breakpoint cluster region; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419256	Bcr<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
breast cancer 1, early onset; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4946680	Brca1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
breast cancer anti-estrogen resistance 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432468	Bcar3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
breast cancer anti-estrogen resistance 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433854	Bcar3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
breast cancer metastasis-suppressor 1; targeted mutation 1.1, Velocigene	MGI:5529063	Brms1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
breast cancer metastasis-suppressor 1; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050951	Brms1<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
breast carcinoma amplified sequence 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432084	Bcas1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
breast carcinoma amplified sequence 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433177	Bcas1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5532965	Brf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BRF2, RNA polymerase III transcription initiation factor 50kDa subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820374	Brf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BRF2, RNA polymerase III transcription initiation factor 50kDa subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820237	Brf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Bri3 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949348	Bri3bp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Bri3 binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949344	Bri3bp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BRISC and BRCA1 A complex member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432635	Babam2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BRISC and BRCA1 A complex member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432635	Babam2<tm1a(EUCOMM)Wtsi>	26740569	EUCOMM
BRISC and BRCA1 A complex member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432635	Babam2<tm1a(EUCOMM)Wtsi>	27001068	EUCOMM
BRISC and BRCA1 A complex member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432635	Babam2<tm1a(EUCOMM)Wtsi>	28333135	EUCOMM
BRISC complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431611	Abraxas2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BRISC complex subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434466	Abraxas2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bromo adjacent homology domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293974	Bahd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bromo adjacent homology domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294011	Bahd1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
bromo adjacent homology domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294004	Bahd1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
bromo adjacent homology domain containing 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5294013	Bahd1<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
bromodomain adjacent to zinc finger domain 1A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513751	Baz1a<tm1b(EUCOMM)Hmgu>	27328812	EUCOMM
bromodomain adjacent to zinc finger domain 1A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513751	Baz1a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
bromodomain adjacent to zinc finger domain, 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362304	Baz1b<tm1a(KOMP)Wtsi>	20799038	KOMP-CSD
bromodomain adjacent to zinc finger domain, 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362304	Baz1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bromodomain adjacent to zinc finger domain, 1B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363543	Baz1b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
bromodomain adjacent to zinc finger domain, 1B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363543	Baz1b<tm2a(KOMP)Wtsi>	25979708	KOMP-CSD
bromodomain adjacent to zinc finger domain, 1B; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5432207	Baz1b<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
bromodomain and PHD finger containing, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433631	Brpf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433631	Brpf1<tm1a(EUCOMM)Wtsi>	24646517	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5705128	Brpf1<tm1b(EUCOMM)Wtsi>	24646517	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5705131	Brpf1<tm1c(EUCOMM)Wtsi>	24646517	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5705131	Brpf1<tm1c(EUCOMM)Wtsi>	25568313	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5705131	Brpf1<tm1c(EUCOMM)Wtsi>	25757017	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5705131	Brpf1<tm1c(EUCOMM)Wtsi>	25773539	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5705131	Brpf1<tm1c(EUCOMM)Wtsi>	27500495	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5705131	Brpf1<tm1c(EUCOMM)Wtsi>	27939640	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5705132	Brpf1<tm1d(EUCOMM)Wtsi>	24646517	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5705132	Brpf1<tm1d(EUCOMM)Wtsi>	25773539	EUCOMM
bromodomain and PHD finger containing, 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5705132	Brpf1<tm1d(EUCOMM)Wtsi>	27939640	EUCOMM
bromodomain and PHD finger containing, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432544	Brpf3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain and WD repeat domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289804	Brwd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
bromodomain and WD repeat domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431896	Brwd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain and WD repeat domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434177	Brwd3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432065	Brd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433231	Brd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5003018	Brd2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432416	Brd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456062	Brd3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5426681	Brd3<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5426680	Brd3<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441798	Brd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433736	Brd7<tm1a(EUCOMM)Wtsi>	20799038	EUCOMM
bromodomain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433736	Brd7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842893	Brd7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842893	Brd7<tm2a(EUCOMM)Wtsi>	27444544	EUCOMM
bromodomain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433628	Brd8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433628	Brd8<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
bromodomain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433976	Brd8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain containing 8; targeted mutation 1, William C Skarnes	MGI:5903502	Brd8<tm1Wcs>	28981838	null
bromodomain, testis-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455954	Brdt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
bromodomain, testis-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455954	Brdt<tm1a(EUCOMM)Wtsi>	22922464	EUCOMM
bromodomain, testis-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455954	Brdt<tm1a(EUCOMM)Wtsi>	26994494	EUCOMM
bromodomain, testis-specific; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455968	Brdt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BR serine/threonine kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363730	Brsk2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BR serine/threonine kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362252	Brsk2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BR serine/threonine kinase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299613	Brsk2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
BR serine/threonine kinase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299536	Brsk2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
BSD domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363151	Bsdc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BTB and CNC homology 1, basic leucine zipper transcription factor 1; targeted mutation 1.1, Velocigene	MGI:5471267	Bach1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
BTB and CNC homology, basic leucine zipper transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882014	Bach2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BTB and CNC homology, basic leucine zipper transcription factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882029	Bach2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BTB domain containing 35, family member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473144	Btbd35f7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441636	Btbd11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441636	Btbd11<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
BTB (POZ) domain containing 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452007	Btbd11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 16; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5581735	Btbd16<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
BTB (POZ) domain containing 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5464323	Btbd17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BTB (POZ) domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419700	Btbd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
BTB (POZ) domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419302	Btbd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BTB (POZ) domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433152	Btbd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432206	Btbd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842410	Btbd7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842330	Btbd7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842263	Btbd9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BTB (POZ) domain containing 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548584	Btbd9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
BTB (POZ) domain containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842868	Btbd9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
BTG3 associated nuclear protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364201	Banp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
BTG3 associated nuclear protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419430	Banp<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
BTG3 associated nuclear protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419263	Banp<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
BUD13 homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842696	Bud13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
BUD31 homolog; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419355	Bud31<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426649	Bbox1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5561563	Bbox1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5426650	Bbox1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
butyrophilin-like 1; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548723	Btnl1<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
butyrophilin-like 4; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:5014557	Btnl4<tm1(KOMP)Mbp>	27641500	KOMP-CSD
butyrophilin-like 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000318	Btnl9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
butyrophilin-like 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006745	Btnl9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
butyrophilin, subfamily 1, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433044	Btn1a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
butyrophilin, subfamily 1, member A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433353	Btn1a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
butyrylcholinesterase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842430	Bche<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
butyrylcholinesterase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842780	Bche<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
bystin-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050921	Bysl<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
bystin-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050931	Bysl<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
C1GALT1-specific chaperone 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419482	C1galt1c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C1GALT1-specific chaperone 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419217	C1galt1c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C1GALT1-specific chaperone 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472996	C1galt1c1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
C1q and tumor necrosis factor related 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008055	C1qtnf12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C1q and tumor necrosis factor related protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365155	C1qtnf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419335	C1qtnf2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548580	C1qtnf2<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
C1q and tumor necrosis factor related protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4420104	C1qtnf2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940756	C1qtnf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940777	C1qtnf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473094	C1qtnf3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
C1q and tumor necrosis factor related protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140432	C1qtnf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455488	C1qtnf4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 5; targeted mutation 1.1, Velocigene	MGI:5443923	C1qtnf5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
C1q and tumor necrosis factor related protein 5; targeted mutation 1.1, Velocigene	MGI:5443923	C1qtnf5<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
C1q and tumor necrosis factor related protein 5; targeted mutation 1, Velocigene	MGI:4460570	C1qtnf5<tm1(KOMP)Vlcg>	27143553	KOMP-Regeneron
C1q and tumor necrosis factor related protein 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050840	C1qtnf5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432223	C1qtnf6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C1q and tumor necrosis factor related protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433326	C1qtnf6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C1q and tumor necrosis factor related protein 7; targeted mutation 1.1, Velocigene	MGI:5548693	C1qtnf7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
C1q and tumor necrosis factor related protein 7; targeted mutation 1, Velocigene	MGI:4452854	C1qtnf7<tm1(KOMP)Vlcg>	28223291	KOMP-Regeneron
C1q and tumor necrosis factor related protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427239	C1qtnf9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427228	C1qtnf9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C1q and tumor necrosis factor related protein 9; targeted mutation 1, Velocigene	MGI:4415477	C1qtnf9<tm1(KOMP)Vlcg>	24473438	KOMP-Regeneron
C1q and tumor necrosis factor related protein 9; targeted mutation 1, Velocigene	MGI:4415477	C1qtnf9<tm1(KOMP)Vlcg>	25870106	KOMP-Regeneron
C2 calcium-dependent domain containing 2-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431533	C2cd2l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C2 calcium-dependent domain containing 2-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431832	C2cd2l<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
C2 calcium-dependent domain containing 2-like; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4441707	C2cd2l<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
C2 calcium-dependent domain containing 2-like; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4441846	C2cd2l<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
C2 calcium-dependent domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842681	C2cd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C2 calcium-dependent domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842249	C2cd3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C2 calcium-dependent domain containing 4C; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456628	C2cd4c<tm1(KOMP)Mbp>	27349930	KOMP-CSD
C2 calcium dependent domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364769	C2cd6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C2 calcium dependent domain containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362218	C2cd6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C2 calcium dependent domain containing 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319846	C2cd6<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
C2 calcium dependent domain containing 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319859	C2cd6<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
C2 calcium dependent domain containing 6; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319858	C2cd6<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
cache domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364372	Cachd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007980	Cdh10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5007987	Cdh10<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 10; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548371	Cdh10<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
cadherin 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5007991	Cdh10<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 10; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5007990	Cdh10<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451391	Cdh12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451247	Cdh12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 13; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5612831	Cdh13<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cadherin 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419977	Cdh16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419898	Cdh16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009648	Cdh17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009650	Cdh17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364471	Cdh18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363144	Cdh18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 19, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432826	Cdh19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 19, type 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433752	Cdh19<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432805	Cdh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432805	Cdh1<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
cadherin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433186	Cdh1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841259	Cdh20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451432	Cdh20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452772	Cdh22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452805	Cdh22<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 23 (otocadherin); age related hearing loss 1	MGI:3028349	Cdh23<ahl>	22138310	null
cadherin 23 (otocadherin); CBA/CaJ	MGI:5009808	Cdh23<CBA/CaJ>	22138310	null
cadherin 23 (otocadherin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434223	Cdh23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 23 (otocadherin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433439	Cdh23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 23 (otocadherin); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527600	Cdh23<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433942	Cdh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433958	Cdh2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432963	Cdh4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432963	Cdh4<tm1a(EUCOMM)Wtsi>	27151949	EUCOMM
cadherin 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5571352	Cdh4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cadherin 4; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806242	Cdh4<tm1c(EUCOMM)Wtsi>	27151949	EUCOMM
cadherin 7, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008807	Cdh7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451240	Cdh8<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 8; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451689	Cdh8<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420137	Cdh9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420137	Cdh9<tm1a(KOMP)Wtsi>	25126785	KOMP-CSD
cadherin 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420137	Cdh9<tm1a(KOMP)Wtsi>	28957665	KOMP-CSD
cadherin 9; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5688872	Cdh9<tm1c(KOMP)Wtsi>	25126785	KOMP-CSD
cadherin 9; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5688872	Cdh9<tm1c(KOMP)Wtsi>	27565351	KOMP-CSD
cadherin 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5285712	Cdh9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin, EGF LAG seven-pass G-type receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842351	Celsr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin, EGF LAG seven-pass G-type receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842813	Celsr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin-like 26; targeted mutation 1.1, Velocigene	MGI:5695960	Cdh26<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cadherin-like 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942041	Cdh26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cadherin-like and PC-esterase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455991	Cped1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cadherin-related family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880901	Cdhr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcineurin-like EF hand protein 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5565261	Chp2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
calcineurin-like EF hand protein 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5565261	Chp2<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
calcineurin-like phosphoesterase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433321	Cpped1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcineurin-like phosphoesterase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433782	Cpped1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcitonin gene-related peptide-receptor component protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433157	Crcp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcitonin gene-related peptide-receptor component protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433853	Crcp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcitonin receptor-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364389	Calcrl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcitonin receptor-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365176	Calcrl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcitonin receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364662	Calcr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcitonin-related polypeptide, beta; targeted mutation 1.1, Velocigene	MGI:5696919	Calcb<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
calcium activated nucleotidase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5612825	Cant1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
calcium and integrin binding family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432101	Cib2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium and integrin binding family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432101	Cib2<tm1a(EUCOMM)Wtsi>	24239741	EUCOMM
calcium and integrin binding family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432101	Cib2<tm1a(EUCOMM)Wtsi>	28031293	EUCOMM
calcium and integrin binding family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432101	Cib2<tm1a(EUCOMM)Wtsi>	28663585	EUCOMM
calcium and integrin binding family member 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548707	Cib2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
calcium and integrin binding family member 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548707	Cib2<tm1b(EUCOMM)Wtsi>	28663585	EUCOMM
calcium and integrin binding family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433800	Cib2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium binding and coiled coil domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362152	Calcoco1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium binding and coiled-coil domain 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419466	Calcoco2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
calcium binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441861	Cabp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441861	Cabp1<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
calcium binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548480	Cabp1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
calcium binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441614	Cabp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium binding protein 39-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433220	Cab39l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium binding protein 39-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637018	Cab39l<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
calcium binding protein 39-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432472	Cab39l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium binding protein 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433949	Cab39<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium binding protein 39; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432056	Cab39<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium binding protein 4; targeted mutation 1.1, Velocigene	MGI:5577270	Cabp4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
calcium binding protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362424	Cabp5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium binding protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364869	Cabp5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium binding protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419264	Cabp7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium binding protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419678	Cabp7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472975	Cabp7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium/calmodulin-dependent protein kinase ID; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434410	Camk1d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium/calmodulin-dependent protein kinase ID; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432612	Camk1d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium/calmodulin-dependent protein kinase I gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364394	Camk1g<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium/calmodulin-dependent protein kinase II alpha; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363193	Camk2a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
calcium/calmodulin-dependent protein kinase II, delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363948	Camk2d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium/calmodulin-dependent protein kinase II, delta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319873	Camk2d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium/calmodulin-dependent protein kinase II, delta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319837	Camk2d<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium/calmodulin-dependent protein kinase II gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842292	Camk2g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium/calmodulin-dependent protein kinase II gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842668	Camk2g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium/calmodulin-dependent protein kinase I; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5574594	Camk1<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
calcium channel flower domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941986	Cacfd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel flower domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941994	Cacfd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, alpha 1I subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014569	Cacna1i<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, alpha 1I subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548772	Cacna1i<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
calcium channel, voltage-dependent, alpha 1I subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140418	Cacna1i<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, alpha2/delta subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5473215	Cacna2d1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium channel, voltage-dependent, alpha 2/delta subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363324	Cacna2d2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, alpha 2/delta subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363711	Cacna2d2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, alpha2/delta subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942021	Cacna2d3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, alpha2/delta subunit 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5477798	Cacna2d3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, alpha2/delta subunit 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5477798	Cacna2d3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
calcium channel, voltage-dependent, alpha2/delta subunit 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5477798	Cacna2d3<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
calcium channel, voltage-dependent, alpha2/delta subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942024	Cacna2d3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, beta 1 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842879	Cacnb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium channel, voltage-dependent, gamma subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362223	Cacng1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, gamma subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364129	Cacng1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, gamma subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944410	Cacng4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, L type, alpha 1C subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842754	Cacna1c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium channel, voltage-dependent, L type, alpha 1C subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842621	Cacna1c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium channel, voltage-dependent, L type, alpha 1S subunit; targeted mutation 1.1, Velocigene	MGI:5494476	Cacna1s<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
calcium channel, voltage-dependent, L type, alpha 1S subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842553	Cacna1s<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium channel, voltage-dependent, L type, alpha 1S subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842651	Cacna1s<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcium channel, voltage-dependent, N type, alpha 1B subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363249	Cacna1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium channel, voltage-dependent, N type, alpha 1B subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572039	Cacna1b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
calcium channel, voltage-dependent, T type, alpha 1G subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938568	Cacna1g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcium channel, voltage-dependent, T type, alpha 1H subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362554	Cacna1h<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium homeostasis endoplasmic reticulum protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503341	Cherp<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium modulating ligand; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363919	Caml<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium modulating ligand; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362505	Caml<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium release activated channel regulator 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365201	Cracr2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calcium release activated channel regulator 2B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050855	Cracr2b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
calcium response factor; targeted mutation 1.1, Velocigene	MGI:5529500	Carf<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
calcyclin binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441768	Cacybp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcyclin binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441831	Cacybp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcyphosine-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944498	Capsl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calcyphosine-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944575	Capsl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calcyphosphine 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006744	Caps2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
caldesmon 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296540	Cald1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
caldesmon 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296528	Cald1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calmin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432753	Clmn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calmin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513754	Clmn<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
calmin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431712	Clmn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938578	Calm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938597	Calm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365075	Calm3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calmodulin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362690	Calm3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calmodulin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5293964	Calm3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
calmodulin 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293926	Calm3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
calmodulin binding transcription activator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433245	Camta2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin binding transcription activator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433261	Camta2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473151	Calml3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472729	Calml3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin-like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432608	Calml4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin-like 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441639	Calml4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin-lysine N-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820305	Camkmt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin-lysine N-methyltransferase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637069	Camkmt<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
calmodulin-lysine N-methyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820388	Camkmt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin regulated spectrin-associated protein family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431915	Camsap3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calmodulin regulated spectrin-associated protein family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431915	Camsap3<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
calmodulin regulated spectrin-associated protein family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432008	Camsap3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calneuron 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944402	Caln1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calnexin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888933	Canx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calnexin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888936	Canx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calpain 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842347	Capn10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calpain 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432998	Capn11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calpain 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433341	Capn11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calpain 12; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605772	Capn12<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
calpain 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460516	Capn13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calpain 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460460	Capn13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
calpain 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940773	Capn6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calpain 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941503	Capn6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calpain 8; targeted mutation 1.1, Velocigene	MGI:5695951	Capn8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
calpain 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013733	Capn9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calpastatin; targeted mutation 1.1, Velocigene	MGI:5488495	Cast<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
calpastatin; targeted mutation 1.1, Velocigene	MGI:5488495	Cast<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
calponin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363816	Cnn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calponin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364756	Cnn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calreticulin 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419130	Calr3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
calreticulin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008777	Calr4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calsequestrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431740	Casq1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
calsequestrin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692603	Casq1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
calsequestrin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362192	Casq2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
calsequestrin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548421	Casq2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
calsequestrin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362519	Casq2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
calsyntenin 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548714	Clstn1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
calsyntenin 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548773	Clstn3<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
calsyntenin 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548773	Clstn3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cAMP responsive element binding protein 3-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842254	Creb3l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cAMP responsive element binding protein 3-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842311	Creb3l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cAMP responsive element binding protein 3-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842311	Creb3l1<tm1e(EUCOMM)Wtsi>	24721909	EUCOMM
cAMP responsive element binding protein 3-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365170	Creb3l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cAMP responsive element binding protein 3-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362359	Creb3l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cAMP responsive element binding protein 3; targeted mutation 1.1, Velocigene	MGI:5603360	Creb3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cAMP responsive element binding protein-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434456	Crebl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cAMP responsive element binding protein-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433756	Crebl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cancer susceptibility candidate 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441941	Casc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cancer susceptibility candidate 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302318	Casc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cancer susceptibility candidate 3; targeted mutation 1.1, Velocigene	MGI:5548776	Casc3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cancer susceptibility candidate 3; targeted mutation 1, Velocigene	MGI:4452843	Casc3<tm1(KOMP)Vlcg>	27780844	KOMP-Regeneron
cancer susceptibility candidate 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451954	Casc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cancer susceptibility candidate 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451967	Casc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cancer susceptibility candidate 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458827	Casc4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cancer susceptibility candidate 4; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637147	Casc4<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
cancer susceptibility candidate 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4458837	Casc4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cancer/testis antigen 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841140	Ctag2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cancer/testis antigen 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841160	Ctag2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cannabinoid receptor 1 (brain); targeted mutation 1.1, Velocigene	MGI:5582419	Cnr1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
canopy FGF signaling regulator 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419843	Cnpy1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
canopy FGF signaling regulator 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419813	Cnpy2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431970	Cap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431970	Cap2<tm1a(EUCOMM)Wtsi>	26616005	EUCOMM
CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692670	Cap2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806472	Cap2<tm1c(EUCOMM)Wtsi>	26616005	EUCOMM
CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5776537	Cap2<tm1e(EUCOMM)Wtsi>	22945801	EUCOMM
CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5776537	Cap2<tm1e(EUCOMM)Wtsi>	26925136	EUCOMM
CAP, adenylate cyclase-associated protein, 2 (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5776537	Cap2<tm1e(EUCOMM)Wtsi>	27507934	EUCOMM
CAP-GLY domain containing linker protein family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868028	Clip4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CAP-GLY domain containing linker protein family, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868037	Clip4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
capicua transcriptional repressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364599	Cic<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
capicua transcriptional repressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364599	Cic<tm1a(KOMP)Wtsi>	28288114	KOMP-CSD
capicua transcriptional repressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364599	Cic<tm1a(KOMP)Wtsi>	28855737	KOMP-CSD
capicua transcriptional repressor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5903087	Cic<tm1b(KOMP)Wtsi>	28288114	KOMP-CSD
capicua transcriptional repressor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5903084	Cic<tm1c(KOMP)Wtsi>	28288114	KOMP-CSD
capicua transcriptional repressor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5903084	Cic<tm1c(KOMP)Wtsi>	28855737	KOMP-CSD
capicua transcriptional repressor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363212	Cic<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
capicua transcriptional repressor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364213	Cic<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
capicua transcriptional repressor; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364319	Cic<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
capping protein (actin filament) muscle Z-line, alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880887	Capza2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
capping protein (actin filament) muscle Z-line, alpha 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880978	Capza2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
capping protein (actin filament) muscle Z-line, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432323	Capzb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
capping protein (actin filament) muscle Z-line, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432323	Capzb<tm1a(EUCOMM)Wtsi>	28899994	EUCOMM
capping protein (actin filament) muscle Z-line, beta; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925338	Capzb<tm1c(EUCOMM)Wtsi>	28899994	EUCOMM
capping protein regulator and myosin 1 linker 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362921	Carmil1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
capping protein regulator and myosin 1 linker 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362921	Carmil1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
capping protein regulator and myosin 1 linker 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299654	Carmil1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
capping protein regulator and myosin 1 linker 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299603	Carmil1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
capping protein regulator and myosin 1 linker 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299525	Carmil1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
capping protein regulator and myosin 1 linker 2; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4462559	Carmil2<tm1a(KOMP)Mbp>	23793062	KOMP-CSD
caprin family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432518	Caprin2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
caprin family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434454	Caprin2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
caprin family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434168	Caprin2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
caprin family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434168	Caprin2<tm2a(EUCOMM)Wtsi>	26177727	EUCOMM
caprin family member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434184	Caprin2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362428	Cad<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362943	Cad<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949357	Chst1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951100	Chst1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1; targeted mutation 1, Velocigene	MGI:4415360	Chst1<tm1(KOMP)Vlcg>	23254996	KOMP-Regeneron
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1; targeted mutation 1, Velocigene	MGI:4415360	Chst1<tm1(KOMP)Vlcg>	23880769	KOMP-Regeneron
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1; targeted mutation 1, Velocigene	MGI:4415360	Chst1<tm1(KOMP)Vlcg>	26362733	KOMP-Regeneron
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548572	Chst8<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432310	Chst5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637102	Chst5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433610	Chst5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carbohydrate sulfotransferase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841075	Chst10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carbohydrate sulfotransferase 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363643	Chst11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carbohydrate sulfotransferase 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363643	Chst11<tm1a(KOMP)Wtsi>	27996060	KOMP-CSD
carbohydrate sulfotransferase 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363064	Chst11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947832	Car10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carbonic anhydrase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363015	Car12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841038	Car13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841399	Car13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 2; targeted mutation 1, Velocigene	MGI:3808366	Car2<tm1(KOMP)Vlcg>	25143453	KOMP-Regeneron
carbonic anhydrase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433993	Car4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carbonic anhydrase 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548394	Car4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
carbonic anhydrase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434150	Car4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carbonic anhydrase 5b, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442014	Car5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carbonic anhydrase 5b, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442022	Car5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carbonic anhydrase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365055	Car7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498767	Car7<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498767	Car7<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
carbonic anhydrase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362399	Car7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363794	Car9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carbonic anhydrase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363042	Car9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carbonyl reductase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364710	Cbr1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
carbonyl reductase 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432467	Cbr4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxyesterase 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820169	Ces2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxyesterase 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820144	Ces2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxyesterase 2B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299547	Ces2b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455600	Ces1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455596	Ces1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472912	Ces1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxylesterase 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013755	Ces1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 1E; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050956	Ces1e<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxylesterase 1F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293948	Ces1f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 1F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085350	Ces1f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 1G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427242	Ces1g<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938552	Ces2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carboxylesterase 2E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008041	Ces2e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxylesterase 2F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841427	Ces2f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 2F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841279	Ces2f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 2G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841392	Ces2g<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940744	Ces3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941496	Ces3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxylesterase 4A; targeted mutation 1.1, Velocigene	MGI:5520174	Ces4a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
carboxylesterase 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140495	Ces4a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxyl ester lipase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842663	Cel<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxyl ester lipase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842873	Cel<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carboxymethylenebutenolidase-like (Pseudomonas); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286220	Cmbl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxymethylenebutenolidase-like (Pseudomonas); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637042	Cmbl<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
carboxymethylenebutenolidase-like (Pseudomonas); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426581	Cmbl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A1, pancreatic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363726	Cpa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A1, pancreatic; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364906	Cpa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A2, pancreatic; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548904	Cpa2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
carboxypeptidase A3, mast cell; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849429	Cpa3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxypeptidase A4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363491	Cpa4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363119	Cpa5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362478	Cpa5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364883	Cpa6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451507	Cpa6<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase A6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451609	Cpa6<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase B1 (tissue); targeted mutation 1.1, Velocigene	MGI:5605652	Cpb1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
carboxypeptidase B1 (tissue); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050925	Cpb1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
carboxypeptidase E; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548328	Cpe<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
carboxypeptidase N, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013731	Cpn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase N, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5661930	Cpn1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase N, polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363775	Cpn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase N, polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362346	Cpn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase N, polypeptide 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455581	Cpn2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase N, polypeptide 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455571	Cpn2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase X 2 (M14 family); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455572	Cpxm2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase Z; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451393	Cpz<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carboxypeptidase Z; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451595	Cpz<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5529964	Ceacam10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carcinoembryonic antigen-related cell adhesion molecule 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433728	Ceacam10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carcinoembryonic antigen-related cell adhesion molecule 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441925	Ceacam10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
carcinoembryonic antigen-related cell adhesion molecule 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441822	Ceacam10<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
carcinoembryonic antigen-related cell adhesion molecule 16; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5517676	Ceacam16<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 16; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5517676	Ceacam16<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 16; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5517676	Ceacam16<tm1.1(KOMP)Wtsi>	28700664	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 16; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363974	Ceacam16<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 16; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363974	Ceacam16<tm1(KOMP)Wtsi>	25080593	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441706	Ceacam18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carcinoembryonic antigen-related cell adhesion molecule 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441948	Ceacam18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carcinoembryonic antigen-related cell adhesion molecule 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939741	Ceacam19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939730	Ceacam19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363342	Ceacam3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carcinoembryonic antigen-related cell adhesion molecule 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363723	Ceacam3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cardiolipin synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432552	Crls1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cardiolipin synthase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431879	Crls1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cardiotrophin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362391	Ctf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cardiotrophin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362425	Ctf2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cardiotrophin 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364544	Ctf2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cardiotrophin 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473063	Ctf2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
cardiotrophin-like cytokine factor 1; targeted mutation 1.1, Velocigene	MGI:5548715	Clcf1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cardiotrophin-like cytokine factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849404	Clcf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carnitine palmitoyltransferase 1c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888923	Cpt1c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
carnitine palmitoyltransferase 1c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888930	Cpt1c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
carnitine palmitoyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362863	Cpt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carnitine palmitoyltransferase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636913	Cpt2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
carnitine palmitoyltransferase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636913	Cpt2<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
carnitine palmitoyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364538	Cpt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carnosine N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364669	Carnmt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carnosine N-methyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362235	Carnmt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
carnosine synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451355	Carns1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
carnosine synthase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451618	Carns1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cartilage associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442008	Crtap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cartilage intermediate layer protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842704	Cilp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cartilage intermediate layer protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842789	Cilp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432237	Cilp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433164	Cilp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
casein alpha s2-like A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453795	Csn1s2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
casein alpha s2-like A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453781	Csn1s2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
casein alpha s2-like B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842395	Csn1s2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
casein kappa; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944492	Csn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
casein kinase 1, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364081	Csnk1a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
casein kinase 1, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364081	Csnk1a1<tm1a(KOMP)Wtsi>	25242043	KOMP-CSD
casein kinase 1, alpha 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5762595	Csnk1a1<tm1c(KOMP)Wtsi>	25242043	KOMP-CSD
casein kinase 1, delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842798	Csnk1d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
casein kinase 1, epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363593	Csnk1e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
casein kinase 1, epsilon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362253	Csnk1e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
casein kinase 1, gamma 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014700	Csnk1g2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
casein kinase 1, gamma 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461713	Csnk1g3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
casein kinase 1, gamma 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461732	Csnk1g3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
casein kinase 2, alpha 1 polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434202	Csnk2a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
casein kinase 2, alpha 1 polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431769	Csnk2a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
caseinolytic mitochondrial matrix peptidase proteolytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820264	Clpp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
caseinolytic mitochondrial matrix peptidase proteolytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820371	Clpp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Casitas B-lineage lymphoma b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880973	Cblb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Casitas B-lineage lymphoma b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880975	Cblb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Casitas B-lineage lymphoma c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433780	Cblc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CASK interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947737	Caskin1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CASK interacting protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5583073	Caskin1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
CASK-interacting protein 2; targeted mutation 1.1, Velocigene	MGI:5548764	Caskin2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
CASP8 and FADD-like apoptosis regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433525	Cflar<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CASP8 and FADD-like apoptosis regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434003	Cflar<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
caspase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939736	Casp12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
caspase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939736	Casp12<tm1a(KOMP)Wtsi>	26582949	KOMP-CSD
caspase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939736	Casp12<tm1a(KOMP)Wtsi>	27251234	KOMP-CSD
caspase 12; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5910735	Casp12<tm1d(KOMP)Wtsi>	27251234	KOMP-CSD
caspase 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939738	Casp12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
caspase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4946804	Casp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
caspase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433693	Casp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
caspase 4, apoptosis-related cysteine peptidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363317	Casp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
caspase 4, apoptosis-related cysteine peptidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548377	Casp4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
caspase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419643	Casp7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
caspase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420078	Casp7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
caspase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820268	Casp8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
caspase 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820358	Casp8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
caspase recruitment domain family, member 9; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4841496	Card9<tm1a(EUCOMM)Hmgu>	27032818	EUCOMM
caspase recruitment domain family, member 9; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5806258	Card9<tm1c(EUCOMM)Hmgu>	27032818	EUCOMM
Cas scaffolding protein family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454148	Cass4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Cas scaffolding protein family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454135	Cass4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
castor zinc finger 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4841554	Casz1<tm1a(EUCOMM)Hmgu>	25654255	EUCOMM
castor zinc finger 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636932	Casz1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
catechol-O-methyltransferase domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882027	Comtd1<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
catechol-O-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432657	Comt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
catechol-O-methyltransferase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637202	Comt<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
catenin beta interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441623	Ctnnbip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
catenin beta interacting protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548564	Ctnnbip1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
catenin beta interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442015	Ctnnbip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
catenin (cadherin associated protein), alpha 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319810	Ctnna3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
catenin (cadherin associated protein), alpha 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5002931	Ctnna3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
catenin (cadherin associated protein), alpha 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319830	Ctnna3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
catenin (cadherin associated protein), alpha-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431689	Ctnnal1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
catenin (cadherin associated protein), alpha-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434204	Ctnnal1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
catenin (cadherin associated protein), alpha-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434204	Ctnnal1<tm1e(EUCOMM)Wtsi>	26398943	EUCOMM
catenin (cadherin associated protein), delta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453738	Ctnnd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
catenin (cadherin associated protein), delta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453750	Ctnnd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cathepsin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842600	Cts3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cathepsin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842676	Cts3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cathepsin 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289810	Cts6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5561561	Cts6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cathepsin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287784	Cts7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433100	Ctsd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cathepsin D; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548925	Ctsd<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cathepsin E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441665	Ctse<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cathepsin F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5307088	Ctsf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363323	Ctsh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363844	Ctsh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin K; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605742	Ctsk<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cathepsin M; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431400	Ctsm<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin O; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362502	Ctso<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin O; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841300	Ctso<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin O; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637109	Ctso<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
cathepsin Q; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427183	Ctsq<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin Q; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427129	Ctsq<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cathepsin W; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419338	Ctsw<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cation channel, sperm associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842611	Catsper1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cation channel, sperm associated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842416	Catsper1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cation channel, sperm associated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431865	Catsper2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cation channel, sperm associated 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432145	Catsper2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cation channel, sperm associated 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841330	Catsper3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cation channel, sperm associated 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427131	Catsper3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cation channel, sperm associated 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427156	Catsper4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cation channel sperm associated auxiliary subunit gamma 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362900	Catsperg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cation channel sperm associated auxiliary subunit zeta; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4454032	Catsperz<tm1(KOMP)Mbp>	28226241	KOMP-CSD
caudal type homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009635	Cdx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
caveolae associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434256	Cavin1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
caveolae associated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433603	Cavin1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
caveolae associated 2; targeted mutation 1, Velocigene	MGI:4415387	Cavin2<tm1(KOMP)Vlcg>	23652019	KOMP-Regeneron
caveolae associated 3; targeted mutation 1.1, Velocigene	MGI:5696914	Cavin3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
caveolae associated 3; targeted mutation 1, Velocigene	MGI:3847505	Cavin3<tm1(KOMP)Vlcg>	23652019	KOMP-Regeneron
caveolae associated 3; targeted mutation 1, Velocigene	MGI:3847505	Cavin3<tm1(KOMP)Vlcg>	25036884	KOMP-Regeneron
caveolae associated 3; targeted mutation 1, Velocigene	MGI:3847505	Cavin3<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
caveolin 2; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4950154	Cav2<tm1(KOMP)Mbp>	25269481	KOMP-CSD
caveolin 2; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4950154	Cav2<tm1(KOMP)Mbp>	27317631	KOMP-CSD
caveolin 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364140	Cav2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
caveolin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299545	Cav3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
caveolin 3; targeted mutation 1, Velocigene	MGI:3813029	Cav3<tm1(KOMP)Vlcg>	27033451	KOMP-Regeneron
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293965	Cited2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293927	Cited2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293984	Cited2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4; targeted mutation 1.1, Velocigene	MGI:5469080	Cited4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4; targeted mutation 1.1, Velocigene	MGI:5469080	Cited4<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472767	Cited4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CCAAT/enhancer binding protein (C/EBP), gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451265	Cebpg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CCAAT/enhancer binding protein (C/EBP), gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451675	Cebpg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CCAAT/enhancer binding protein (C/EBP), zeta, opposite strand; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419603	Cebpzos<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CCCTC-binding factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431619	Ctcf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CCCTC-binding factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434277	Ctcf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CCCTC-binding factor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432139	Ctcf<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CCCTC-binding factor (zinc finger protein)-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434452	Ctcfl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CCCTC-binding factor (zinc finger protein)-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434066	Ctcfl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CCR4-NOT transcription complex, subunit 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427240	Cnot11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427230	Cnot11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362409	Cnot2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364224	Cnot2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473082	Cnot2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CCR4-NOT transcription complex, subunit 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472882	Cnot2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
CCR4-NOT transcription complex, subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842581	Cnot4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CCR4-NOT transcription complex, subunit 6-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014723	Cnot6l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CCR4-NOT transcription complex, subunit 6-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014737	Cnot6l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CCR4-NOT transcription complex, subunit 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451305	Cnot6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451633	Cnot6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008781	Cnot8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009570	Cnot8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CCR4-NOT transcription complex, subunit 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431867	Cnot9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CCR4-NOT transcription complex, subunit 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431952	Cnot9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CD109 antigen; targeted mutation 1.1, Velocigene	MGI:5605817	Cd109<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
CD151 antigen; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419572	Cd151<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CD163 antigen; targeted mutation 1.1, Velocigene	MGI:5569066	Cd163<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
CD163 antigen; targeted mutation 1, Velocigene	MGI:3799792	Cd163<tm1(KOMP)Vlcg>	26242746	KOMP-Regeneron
CD163 antigen; targeted mutation 1, Velocigene	MGI:3799792	Cd163<tm1(KOMP)Vlcg>	26376364	KOMP-Regeneron
CD163 antigen; targeted mutation 1, Velocigene	MGI:3799792	Cd163<tm1(KOMP)Vlcg>	27294203	KOMP-Regeneron
CD163 antigen; targeted mutation 1, Velocigene	MGI:3799792	Cd163<tm1(KOMP)Vlcg>	28464519	KOMP-Regeneron
CD164 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052385	Cd164<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD177 antigen; targeted mutation 1, Velocigene	MGI:4415421	Cd177<tm1(KOMP)Vlcg>	25359465	KOMP-Regeneron
CD180 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363642	Cd180<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD180 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362528	Cd180<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD180 antigen; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299634	Cd180<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
CD180 antigen; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299550	Cd180<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CD1d1 antigen; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362363	Cd1d1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CD200 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362965	Cd200<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD200 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362834	Cd200<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD200 receptor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432203	Cd200r3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD200 receptor 4; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5692856	Cd200r4<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
CD200 receptor 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419703	Cd200r4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CD209d antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461659	Cd209d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CD209d antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461708	Cd209d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CD209e antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363909	Cd209e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD209e antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364482	Cd209e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD209g antigen; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420031	Cd209g<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CD226 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456756	Cd226<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CD226 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456852	Cd226<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CD22 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433777	Cd22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CD22 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434358	Cd22<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CD244 natural killer cell receptor 2B4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456660	Cd244<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD244 natural killer cell receptor 2B4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456651	Cd244<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD247 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364912	Cd247<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD247 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364603	Cd247<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD247 antigen; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455535	Cd247<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
CD247 antigen; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455492	Cd247<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CD248 antigen, endosialin; targeted mutation 1.1, Velocigene	MGI:5569050	Cd248<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
CD248 antigen, endosialin; targeted mutation 1, Velocigene	MGI:4399405	Cd248<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
CD274 antigen; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364122	Cd274<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CD28 antigen; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435635	Cd28<tm1a(EUCOMM)Hmgu>	25347065	EUCOMM
CD28 antigen; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435635	Cd28<tm1a(EUCOMM)Hmgu>	25533288	EUCOMM
CD2-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841008	Cd2ap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD2-associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841356	Cd2ap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD300C molecule 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364479	Cd300c2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD300 molecule like family member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363714	Cd300lb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD300 molecule like family member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363088	Cd300lb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD300 molecule like family member B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365135	Cd300lb<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
CD300 molecule like family member B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364466	Cd300lb<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CD300 molecule like family member d; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938564	Cd300ld<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CD300 molecule like family member d; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938579	Cd300ld<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CD300 molecule like family member F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938553	Cd300lf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CD300 molecule like family member G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364847	Cd300lg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD300 molecule like family member G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363731	Cd300lg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD33 antigen; targeted mutation 1.1, Velocigene	MGI:5471218	Cd33<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
CD33 antigen; targeted mutation 1.1, Velocigene	MGI:5471218	Cd33<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
CD34 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365187	Cd34<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD34 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293999	Cd34<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD34 antigen; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5293962	Cd34<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
CD34 antigen; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293922	Cd34<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CD36 molecule; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944546	Cd36<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CD37 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433092	Cd37<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CD37 antigen; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472984	Cd37<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CD3 antigen, delta polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451666	Cd3d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD3 antigen, delta polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451551	Cd3d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD3 antigen, gamma polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431853	Cd3g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CD3E antigen, epsilon polypeptide associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419681	Cd3eap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD3E antigen, epsilon polypeptide associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419357	Cd3eap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD40 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307106	Cd40<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD40 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5308282	Cd40<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD44 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364689	Cd44<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD55 molecule, decay accelerating factor for complement B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868034	Cd55b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD55 molecule, decay accelerating factor for complement B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868031	Cd55b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD5 antigen-like; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5636957	Cd5l<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
CD5 antigen-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293980	Cd5l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD5 antigen; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5583082	Cd5<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
CD63 antigen; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419308	Cd63<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CD68 antigen; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882023	Cd68<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
CD69 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841127	Cd69<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD69 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841223	Cd69<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD6 antigen; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362952	Cd6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CD6 antigen; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365021	Cd6<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CD70 antigen; targeted mutation 1, Velocigene	MGI:3812847	Cd70<tm1(KOMP)Vlcg>	26179759	KOMP-Regeneron
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363485	Cd74<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD79B antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420061	Cd79b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD79B antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419499	Cd79b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD7 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364048	Cd7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD7 antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364717	Cd7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CD83 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286206	Cd83<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CD83 antigen; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548426	Cd83<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
CD84 antigen; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5515779	Cd84<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
CD93 antigen; targeted mutation 1, Velocigene	MGI:4460628	Cd93<tm1(KOMP)Vlcg>	27659228	KOMP-Regeneron
CDC14 cell division cycle 14B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433546	Cdc14b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC14 cell division cycle 14B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432851	Cdc14b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDC14 cell division cycle 14B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472955	Cdc14b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC16 cell division cycle 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434336	Cdc16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC23 cell division cycle 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431711	Cdc23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC23 cell division cycle 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432214	Cdc23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDC28 protein kinase 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140475	Cks1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC42 binding protein kinase alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431983	Cdc42bpa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC42 binding protein kinase alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433470	Cdc42bpa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDC42 binding protein kinase beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289821	Cdc42bpb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CDC42 effector protein (Rho GTPase binding) 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431592	Cdc42ep3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC42 effector protein (Rho GTPase binding) 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432948	Cdc42ep3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDC42 effector protein (Rho GTPase binding) 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293989	Cdc42ep4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CDC42 effector protein (Rho GTPase binding) 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419934	Cdc42ep4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CDC42 effector protein (Rho GTPase binding) 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419249	Cdc42ep5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CDC42 small effector 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433043	Cdc42se1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC42 small effector 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434190	Cdc42se1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDC42 small effector 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299584	Cdc42se2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CDC42 small effector 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458570	Cdc42se2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CDC-like kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432186	Clk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC-like kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432186	Clk1<tm1a(EUCOMM)Wtsi>	27177310	EUCOMM
CDC-like kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434039	Clk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDC-like kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434338	Clk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC like kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944548	Clk4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDC like kinase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944532	Clk4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDGSH iron sulfur domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434148	Cisd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDGSH iron sulfur domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434148	Cisd2<tm1a(EUCOMM)Wtsi>	25422446	EUCOMM
CDGSH iron sulfur domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432001	Cisd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDK5 and Abl enzyme substrate 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365141	Cables1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CDK5 and Abl enzyme substrate 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363186	Cables1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CDK5 and Abl enzyme substrate 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455561	Cables1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
CDK5 and Abl enzyme substrate 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455458	Cables1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842344	Cdkal1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842714	Cdkal1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842388	Cdkal1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842388	Cdkal1<tm2a(EUCOMM)Wtsi>	27626380	EUCOMM
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842388	Cdkal1<tm2a(EUCOMM)Wtsi>	29031721	EUCOMM
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548648	Cdkal1<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:6111542	Cdkal1<tm2c(EUCOMM)Wtsi>	29031721	EUCOMM
CDK5 regulatory subunit associated protein 1-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4842817	Cdkal1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
CDK5 regulatory subunit associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433427	Cdk5rap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDKN1A interacting zinc finger protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427232	Ciz1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CDKN2A interacting protein N-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362329	Cdkn2aipnl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CDKN2A interacting protein N-terminal like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548411	Cdkn2aipnl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
CDKN2A interacting protein N-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365148	Cdkn2aipnl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence AB124611; targeted mutation 1.1, Velocigene	MGI:5695961	AB124611<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cDNA sequence AF529169; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419124	AF529169<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence AF529169; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419958	AF529169<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence AF529169; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452702	AF529169<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence AY761184; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5427190	AY761184<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence AY761184; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5427143	AY761184<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence AY761184; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5444896	AY761184<tm4a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC003331; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433463	BC003331<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC003331; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432775	BC003331<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC005537; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882008	BC005537<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC005624; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363511	BC005624<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC005624; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364910	BC005624<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC017158; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431445	BC017158<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC017158; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431489	BC017158<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC017158; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5303098	BC017158<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC017643; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363837	BC017643<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC017643; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363837	BC017643<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
cDNA sequence BC017643; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363837	BC017643<tm1a(KOMP)Wtsi>	28351984	KOMP-CSD
cDNA sequence BC017643; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365028	BC017643<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC022687; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431622	BC022687<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC022687; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433423	BC022687<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC022687; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473090	BC022687<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC025920; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431556	BC025920<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC025920; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433134	BC025920<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC030499; targeted mutation 1.1, Velocigene	MGI:5571192	BC030499<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cDNA sequence BC030867; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431479	BC030867<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC031181; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842442	BC031181<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC031181; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842538	BC031181<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC048403; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364781	BC048403<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC048403; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363878	BC048403<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC048562; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941501	BC048562<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC048562; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941489	BC048562<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC048671; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427118	BC048671<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC048679; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433357	BC048679<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC048679; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432160	BC048679<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cDNA sequence BC049715; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5696929	BC049715<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
cDNA sequence BC049762; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014591	BC049762<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC049762; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050166	BC049762<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC051665; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451463	BC051665<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC051665; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451287	BC051665<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC053393; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939735	BC053393<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC055324; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548899	BC055324<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cDNA sequence BC067074; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362190	BC067074<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence BC067074; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362440	BC067074<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence CK137956; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947736	CK137956<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cDNA sequence CK137956; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5002937	CK137956<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441646	Cdipt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548363	Cdipt<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441781	Cdipt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363703	Cds2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365117	Cds2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432825	Cadm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cell adhesion molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432825	Cadm1<tm1a(EUCOMM)Wtsi>	22876197	EUCOMM
cell adhesion molecule 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434106	Cadm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cell adhesion molecule 2; targeted mutation 1a, Mouse Biology Program, University of California, Davis	MGI:5553473	Cadm2<tm1a(KOMP)Mbp>	28628102	KOMP-CSD
cell adhesion molecule 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841040	Cadm2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293905	Cadm2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841264	Cadm2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5293981	Cadm2<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296105	Cadm3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363596	Cadm3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364858	Cadm3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cell adhesion molecule L1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006806	Chl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cell cycle associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050262	Caprin1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cell cycle associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433355	Caprin1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cell cycle associated protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511946	Caprin1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
cell cycle progression 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5000356	Ccpg1<tm1a(EUCOMM)Hmgu>	29290589	EUCOMM
cell death-inducing DFFA-like effector c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433521	Cidec<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cell death-inducing DFFA-like effector c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432363	Cidec<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286200	Cideb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 123; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940785	Cdc123<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 123; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548737	Cdc123<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cell division cycle 123; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940766	Cdc123<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 20; targeted mutation 1.1, Velocigene	MGI:5445785	Cdc20<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cell division cycle 20; targeted mutation 1, Velocigene	MGI:4399241	Cdc20<tm1(KOMP)Vlcg>	28700664	KOMP-Regeneron
cell division cycle 26; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548520	Cdc26<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cell division cycle 34; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5532536	Cdc34<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
cell division cycle 37-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363346	Cdc37l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 37; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014563	Cdc37<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 37; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050160	Cdc37<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433348	Cdc45<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle 45; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432180	Cdc45<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle 5-like (S. pombe); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941985	Cdc5l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 5-like (S. pombe); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942019	Cdc5l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454064	Cdc6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454173	Cdc6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 73, Paf1/RNA polymerase II complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939705	Cdc73<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 73, Paf1/RNA polymerase II complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939715	Cdc73<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle 7 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433452	Cdc7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle 7 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432190	Cdc7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle 7 (S. cerevisiae); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434316	Cdc7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle 7 (S. cerevisiae); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434129	Cdc7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle and apoptosis regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452684	Ccar1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle and apoptosis regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840976	Ccar1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle associated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842438	Cdca2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle associated 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842397	Cdca2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cell division cycle associated 5; targeted mutation 1.1, Velocigene	MGI:5576039	Cdca5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cell division cycle associated 7 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364732	Cdca7l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle associated 7 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364661	Cdca7l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle associated 7 like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455526	Cdca7l<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle associated 7 like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455462	Cdca7l<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle associated 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451367	Cdca7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle associated 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451520	Cdca7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cell division cycle associated 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362476	Cdca8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell growth regulator with ring finger domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294970	Cgrrf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cell migration inducing protein, hyaluronan binding; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319889	Cemip<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cellular nucleic acid binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419372	Cnbp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cellular nucleic acid binding protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5645124	Cnbp<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
cellular nucleic acid binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419577	Cnbp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cellular nucleic acid binding protein; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511947	Cnbp<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
cellular retinoic acid binding protein I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432602	Crabp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centlein, centrosomal protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364826	Cntln<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
centlein, centrosomal protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4880963	Cntln<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
centrin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434082	Cetn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centrin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433904	Cetn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842368	Cetn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centrin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842711	Cetn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrobin, centrosomal BRCA2 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363017	Cntrob<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
centrobin, centrosomal BRCA2 interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364150	Cntrob<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
centromere protein A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442037	Cenpa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442037	Cenpa<tm1a(EUCOMM)Wtsi>	28286049	EUCOMM
centromere protein A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5896608	Cenpa<tm1c(EUCOMM)Wtsi>	28286049	EUCOMM
centromere protein A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441989	Cenpa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein E; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548395	Cenpe<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
centromere protein H; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5588273	Cenph<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
centromere protein I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842811	Cenpi<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842727	Cenpi<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432238	Cenpj<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432238	Cenpj<tm1a(EUCOMM)Wtsi>	23166506	EUCOMM
centromere protein J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432238	Cenpj<tm1a(EUCOMM)Wtsi>	23300663	EUCOMM
centromere protein J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432238	Cenpj<tm1a(EUCOMM)Wtsi>	24706806	EUCOMM
centromere protein J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432238	Cenpj<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
centromere protein J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432238	Cenpj<tm1a(EUCOMM)Wtsi>	25282615	EUCOMM
centromere protein J; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5609805	Cenpj<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein J; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5609805	Cenpj<tm1b(EUCOMM)Wtsi>	24706806	EUCOMM
centromere protein J; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5609807	Cenpj<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein J; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5609807	Cenpj<tm1c(EUCOMM)Wtsi>	24706806	EUCOMM
centromere protein J; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5609807	Cenpj<tm1c(EUCOMM)Wtsi>	25282615	EUCOMM
centromere protein J; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5613963	Cenpj<tm1d(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein J; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5613963	Cenpj<tm1d(EUCOMM)Wtsi>	24706806	EUCOMM
centromere protein L; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433140	Cenpl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein L; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433244	Cenpl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein M; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842766	Cenpm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein O; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5463969	Cenpo<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
centromere protein O; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5463969	Cenpo<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
centromere protein P; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365076	Cenpp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
centromere protein P; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458534	Cenpp<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
centromere protein P; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4458572	Cenpp<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
centromere protein S; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432822	Cenps<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein S; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433579	Cenps<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein U; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434264	Cenpu<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein U; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432513	Cenpu<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centromere protein X; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419112	Cenpx<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
centrosomal protein 104; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941564	Cep104<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 104; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950247	Cep104<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 131; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307112	Cep131<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
centrosomal protein 131; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427160	Cep131<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
centrosomal protein 152; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432204	Cep152<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 152; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432204	Cep152<tm1a(EUCOMM)Wtsi>	24706806	EUCOMM
centrosomal protein 152; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432923	Cep152<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 164; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432075	Cep164<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 164; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637128	Cep164<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
centrosomal protein 164; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434035	Cep164<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 250; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431949	Cep250<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 250; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432574	Cep250<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 41; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432442	Cep41<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 41; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434160	Cep41<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 57-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363783	Cep57l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
centrosomal protein 57-like 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5634968	Cep57l1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
centrosomal protein 57-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364334	Cep57l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
centrosomal protein 63; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432689	Cep63<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 63; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5014734	Cep63<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 63; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433659	Cep63<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 76; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5561564	Cep76<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
centrosomal protein 76; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301383	Cep76<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
centrosomal protein 85-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296536	Cep85l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CEP295 N-terminal like; targeted mutation 1.1, Velocigene	MGI:5558038	Cep295nl<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ceramide-1-phosphate transfer protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050847	Cptp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ceramide kinase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881936	Cerkl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ceramide synthase 5; targeted mutation 2b, Mouse Biology Program, University of California, Davis	MGI:5490496	Cers5<tm2b(KOMP)Mbp>	27626380	KOMP-CSD
ceramide synthase 5; targeted mutation 2b, Mouse Biology Program, University of California, Davis	MGI:5490496	Cers5<tm2b(KOMP)Mbp>	28700664	KOMP-CSD
cerebellar degeneration-related 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362978	Cdr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cerebellar degeneration-related 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5293972	Cdr2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cerebellar degeneration-related 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431497	Cdr2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cerebellin 2 precursor protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456070	Cbln2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cerebellin 3 precursor protein; targeted mutation 1.1, Velocigene	MGI:5443924	Cbln3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cerebellin 4 precursor protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296212	Cbln4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cereblon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365185	Crbn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cereblon; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5558154	Crbn<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cereblon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364735	Crbn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cerebral cavernous malformation 2-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293929	Ccm2l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cerebral dopamine neurotrophic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363658	Cdnf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cerebral dopamine neurotrophic factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364180	Cdnf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431676	Cln3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432340	Cln3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ceroid-lipofuscinosis, neuronal 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433397	Cln6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ceroid-lipofuscinosis, neuronal 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513756	Cln6<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ceruloplasmin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362490	Cp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ceruloplasmin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468990	Cp<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
ceruloplasmin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468990	Cp<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ceruloplasmin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468990	Cp<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
CGG triplet repeat binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419579	Cggbp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CGG triplet repeat binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419390	Cggbp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ChaC, cation transport regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286410	Chac1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ChaC, cation transport regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296218	Chac1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chaperonin containing Tcp1, subunit 4 (delta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451467	Cct4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chaperonin containing Tcp1, subunit 5 (epsilon); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820161	Cct5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chaperonin containing Tcp1, subunit 7 (eta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453762	Cct7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chaperonin containing Tcp1, subunit 7 (eta); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453732	Cct7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chaperonin containing Tcp1, subunit 8 (theta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419273	Cct8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chaperonin containing Tcp1, subunit 8 (theta); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420120	Cct8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362486	Chmp1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365218	Chmp1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 1A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473120	Chmp1a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
charged multivesicular body protein 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419331	Chmp2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419277	Chmp2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840968	Chmp2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841394	Chmp2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5581416	Chmp3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
charged multivesicular body protein 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841001	Chmp4b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841068	Chmp4b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431890	Chmp4c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
charged multivesicular body protein 4C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637010	Chmp4c<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
charged multivesicular body protein 4C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432371	Chmp4c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
charged multivesicular body protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944523	Chmp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
charged multivesicular body protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006732	Chmp6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
charged multivesicular body protein 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637182	Chmp6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
charged multivesicular body protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849981	Chmp6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
checkpoint kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286208	Chek1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
checkpoint kinase 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5521536	Chek2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
checkpoint with forkhead and ring finger domains; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364442	Chfr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
checkpoint with forkhead and ring finger domains; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364084	Chfr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451446	Ccl12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451341	Ccl12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426621	Ccl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426555	Ccl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432359	Ccl20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-C motif) ligand 20; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5892150	Ccl20<tm1b(EUCOMM)Hmgu>	26890063	EUCOMM
chemokine (C-C motif) ligand 20; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5892151	Ccl20<tm1c(EUCOMM)Hmgu>	26890063	EUCOMM
chemokine (C-C motif) ligand 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441963	Ccl22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-C motif) ligand 22; targeted mutation 1, Velocigene	MGI:4881184	Ccl22<tm1(KOMP)Vlcg>	27195186	KOMP-Regeneron
chemokine (C-C motif) ligand 26; targeted mutation 1.1, Velocigene	MGI:5529064	Ccl26<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
chemokine (C-C motif) ligand 26; targeted mutation 1.1, Velocigene	MGI:5529064	Ccl26<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
chemokine (C-C motif) ligand 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843856	Ccl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363274	Ccl7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419454	Ccl8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548325	Ccl8<tm1b(KOMP)Wtsi>	27181207	KOMP-CSD
chemokine (C-C motif) ligand 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548325	Ccl8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
chemokine (C-C motif) ligand 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420135	Ccl8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) ligand 9; targeted mutation 1.1, Velocigene	MGI:5548345	Ccl9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
chemokine (C-C motif) ligand 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140476	Ccl9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-C motif) ligand 9; targeted mutation 1, Velocigene	MGI:4452877	Ccl9<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
chemokine (C-C motif) receptor 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008060	Ccr10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-C motif) receptor 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456762	Ccr10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-C motif) receptor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432390	Ccr3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-C motif) receptor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433351	Ccr3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-C motif) receptor 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503351	Ccr5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
chemokine (C-C motif) receptor 6; targeted mutation 1.1, Velocigene	MGI:5696887	Ccr6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
chemokine (C motif) ligand 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840671	Xcl1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X3-C motif) ligand 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433097	Cx3cl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X3-C motif) ligand 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433936	Cx3cl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) ligand 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847870	Cxcl12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) ligand 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847873	Cxcl12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) ligand 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009643	Cxcl17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) ligand 17; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5582438	Cxcl17<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
chemokine (C-X-C motif) ligand 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944537	Cxcl9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) ligand 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636984	Cxcl9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
chemokine (C-X-C motif) receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5497392	Cxcr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) receptor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5692536	Cxcr1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842593	Cxcr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine (C-X-C motif) receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842378	Cxcr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chemokine-like factor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424649	Cklf<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
chibby family member 1, beta catenin antagonist; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419516	Cby1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chimerin 1; targeted mutation 1.1, Velocigene	MGI:5447742	Chn1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
chimerin 1; targeted mutation 1.1, Velocigene	MGI:5447742	Chn1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
chitinase, acidic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363305	Chia1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chitinase, acidic 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363538	Chia1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chitinase, acidic 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841365	Chia1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
chitinase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433371	Chid1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chitinase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432863	Chid1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chitinase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364158	Chil1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chitinase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363579	Chil1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chitinase-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434158	Chil3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chitinase-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452796	Chil4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chitinase-like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842863	Chil4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chitinase-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944382	Chil6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chitobiase, di-N-acetyl-; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432553	Ctbs<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chitobiase, di-N-acetyl-; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432236	Ctbs<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chloride channel accessory 3A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364226	Clca3a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 3A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363176	Clca3a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365042	Clca3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 3B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302293	Clca3b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 3B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5432721	Clca3b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362333	Clca4b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365096	Clca4b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 4B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419890	Clca4b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel accessory 4B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419292	Clca4b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel, voltage-sensitive 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364534	Clcn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel, voltage-sensitive 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364791	Clcn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel, voltage-sensitive 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820312	Clcn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chloride channel, voltage-sensitive 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820218	Clcn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chloride channel, voltage-sensitive 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432722	Clcn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel, voltage-sensitive 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5432717	Clcn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chloride channel, voltage-sensitive 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050846	Clcn7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride intracellular channel 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363612	Clic3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride intracellular channel 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363457	Clic3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chloride intracellular channel 4 (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868078	Clic4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chloride intracellular channel 4 (mitochondrial); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842875	Clic4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chloride intracellular channel 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820216	Clic5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chloride intracellular channel 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820325	Clic5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chloride intracellular channel 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364789	Clic6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chloride intracellular channel 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427204	Clic6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cholecystokinin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432656	Cck<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cholecystokinin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432185	Cck<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cholecystokinin; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5572040	Cck<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
cholesterol 25-hydroxylase; targeted mutation 1.1, Velocigene	MGI:5692613	Ch25h<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
choline acetyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014579	Chat<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
choline acetyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014575	Chat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
choline/ethanolaminephosphotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362663	Cept1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
choline/ethanolaminephosphotransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363198	Cept1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
choline kinase alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419573	Chka<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
choline kinase alpha; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050150	Chka<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
choline phosphotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432100	Chpt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
choline phosphotransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432004	Chpt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, muscarinic 3, cardiac; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014726	Chrm3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, muscarinic 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512004	Chrm5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, muscarinic 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511971	Chrm5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435231	Chrna1<tm1a(EUCOMM)Hmgu>	27098031	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548913	Chrna1<tm1b(EUCOMM)Hmgu>	27098031	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548913	Chrna1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle); targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6101515	Chrna1<tm1c(EUCOMM)Hmgu>	25920679	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle); targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6101515	Chrna1<tm1c(EUCOMM)Hmgu>	27098031	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle); targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:6101516	Chrna1<tm1d(EUCOMM)Hmgu>	27098031	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 7; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637226	Chrna7<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432593	Chrna9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431722	Chrna9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432564	Chrna9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, alpha polypeptide 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433911	Chrna9<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433755	Chrnb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637195	Chrnb2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cholinergic receptor, nicotinic, beta polypeptide 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420149	Chrnb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cholinergic receptor, nicotinic, beta polypeptide 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420067	Chrnb3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cholinergic receptor, nicotinic, beta polypeptide 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452643	Chrnb3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cholinergic receptor, nicotinic, beta polypeptide 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452699	Chrnb3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cholinergic receptor, nicotinic, beta polypeptide 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014708	Chrnb4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, delta polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868082	Chrnd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cholinergic receptor, nicotinic, delta polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868081	Chrnd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chondroitin sulfate N-acetylgalactosaminyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458472	Csgalnact1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate N-acetylgalactosaminyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458562	Csgalnact1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate N-acetylgalactosaminyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362134	Csgalnact2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate N-acetylgalactosaminyltransferase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4362741	Csgalnact2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate N-acetylgalactosaminyltransferase 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4947760	Csgalnact2<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate N-acetylgalactosaminyltransferase 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4941490	Csgalnact2<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate proteoglycan 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419435	Cspg4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate proteoglycan 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548761	Cspg4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
chondroitin sulfate proteoglycan 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419765	Cspg4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chondroitin sulfate proteoglycan 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472965	Cspg4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
chondroitin sulfate proteoglycan 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419567	Cspg5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
chondromodulin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419113	Cnmd<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
chordin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363869	Chrdl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chordin-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299616	Chrdl1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
chordin-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299538	Chrdl1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
chordin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362620	Chrdl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chordin-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362465	Chrdl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chromatin assembly factor 1, subunit A (p150); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052411	Chaf1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chromatin target of PRMT1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842477	Chtop<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromatin target of PRMT1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842477	Chtop<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
chromatin target of PRMT1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842477	Chtop<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
chromatin target of PRMT1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842797	Chtop<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432508	Cbx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432508	Cbx1<tm1a(EUCOMM)Wtsi>	25801166	EUCOMM
chromobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432508	Cbx1<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
chromobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432249	Cbx1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromobox 1; targeted mutation 1, William C Skarnes	MGI:5903509	Cbx1<tm1Wcs>	28981838	null
chromobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420062	Cbx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chromobox 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548919	Cbx2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
chromobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419935	Cbx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chromobox 4; targeted mutation 1.1, Velocigene	MGI:5548407	Cbx4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
chromobox 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441648	Cbx5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromobox 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441775	Cbx5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromobox 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441849	Cbx6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromobox 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441849	Cbx6<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
chromobox 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363230	Cbx7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chromobox 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363230	Cbx7<tm1a(KOMP)Wtsi>	23870131	KOMP-CSD
chromobox 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363230	Cbx7<tm1a(KOMP)Wtsi>	24687849	KOMP-CSD
chromobox 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363230	Cbx7<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
chromobox 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364073	Cbx7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chromobox 8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427216	Cbx8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
chromodomain helicase DNA binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014559	Chd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chromodomain helicase DNA binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513752	Chd1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
chromodomain helicase DNA binding protein 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605818	Chd2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
chromodomain helicase DNA binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433765	Chd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432665	Chd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5561559	Chd4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
chromodomain helicase DNA binding protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433238	Chd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432636	Chd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432636	Chd5<tm1a(EUCOMM)Wtsi>	24818823	EUCOMM
chromodomain helicase DNA binding protein 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5792826	Chd5<tm1b(EUCOMM)Wtsi>	24818823	EUCOMM
chromodomain helicase DNA binding protein 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5792826	Chd5<tm1b(EUCOMM)Wtsi>	28608855	EUCOMM
chromodomain helicase DNA binding protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432010	Chd5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363465	Chd6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chromodomain helicase DNA binding protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363062	Chd6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chromodomain helicase DNA binding protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432630	Chd7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431638	Chd7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	23827709	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	24293546	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	25183173	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	25985275	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	26102480	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	28931573	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5749385	Chd7<tm2c(EUCOMM)Wtsi>	23827709	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5749385	Chd7<tm2c(EUCOMM)Wtsi>	25183173	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5749385	Chd7<tm2c(EUCOMM)Wtsi>	28165338	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5749385	Chd7<tm2c(EUCOMM)Wtsi>	28317875	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2d, Wellcome Trust Sanger Institute	MGI:5749387	Chd7<tm2d(EUCOMM)Wtsi>	25183173	EUCOMM
chromodomain helicase DNA binding protein 7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431686	Chd7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442028	Chd8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820270	Chd9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromodomain helicase DNA binding protein 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820240	Chd9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromogranin A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362232	Chga<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chromogranin A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363605	Chga<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chromosome alignment maintaining phosphoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453714	Champ1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chromosome alignment maintaining phosphoprotein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453705	Champ1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chromosome segregation 1-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362530	Cse1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chromosome segregation 1-like (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364725	Cse1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
churchill domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441753	Churc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
churchill domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441809	Churc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chymase 1, mast cell; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286199	Cma1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chymase 1, mast cell; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427130	Cma1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chymotrypsin-like elastase family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362672	Cela1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
chymotrypsin-like elastase family, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363957	Cela1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
chymotrypsin-like elastase family, member 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432040	Cela3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
chymotrypsin-like elastase family, member 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434441	Cela3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
chymotrypsin-like elastase family, member 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305619	Cela3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 100; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462585	Cfap100<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 100; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299506	Cfap100<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 157; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451805	Cfap157<tm1a(EUCOMM)Hmgu>	27965440	EUCOMM
cilia and flagella associated protein 157; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5907281	Cfap157<tm1b(EUCOMM)Hmgu>	27965440	EUCOMM
cilia and flagella associated protein 157; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5907282	Cfap157<tm1c(EUCOMM)Hmgu>	27965440	EUCOMM
cilia and flagella associated protein 157; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5907283	Cfap157<tm1d(EUCOMM)Hmgu>	27965440	EUCOMM
cilia and flagella associated protein 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433419	Cfap36<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431687	Cfap36<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 36; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456802	Cfap36<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 36; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456846	Cfap36<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431950	Cfap44<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433464	Cfap44<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363469	Cfap45<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 45; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363484	Cfap45<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 46; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434216	Cfap46<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 46; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433522	Cfap46<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 52; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363295	Cfap52<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 52; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363704	Cfap52<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 53; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4818594	Cfap53<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364019	Cfap54<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 54; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365022	Cfap54<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 57; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433338	Cfap57<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 57; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433503	Cfap57<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 57; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434427	Cfap57<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 61; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944551	Cfap61<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 61; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946805	Cfap61<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 61; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527609	Cfap61<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 65; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880965	Cfap65<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 65; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880948	Cfap65<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 69; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887608	Cfap69<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 69; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887608	Cfap69<tm1a(KOMP)Wtsi>	28495971	KOMP-CSD
cilia and flagella associated protein 69; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548820	Cfap69<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cilia and flagella associated protein 69; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5906136	Cfap69<tm1c(KOMP)Wtsi>	28495971	KOMP-CSD
cilia and flagella associated protein 69; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887591	Cfap69<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 70; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432845	Cfap70<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 70; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433276	Cfap70<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 74; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363670	Cfap74<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 74; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362445	Cfap74<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cilia and flagella associated protein 97; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452783	Cfap97<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cilia and flagella associated protein 97; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452759	Cfap97<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ciliary associated calcium binding coiled-coil 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365217	Cabcoco1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ciliary associated calcium binding coiled-coil 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5289830	Cabcoco1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ciliary associated calcium binding coiled-coil 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841095	Cabcoco1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ciliary neurotrophic factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433013	Cntfr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ciliary neurotrophic factor receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432804	Cntfr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ciliary neurotrophic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050856	Cntf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ciliary rootlet coiled-coil, rootletin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431792	Crocc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ciliary rootlet coiled-coil, rootletin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432538	Crocc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ciliogenesis associated TTC17 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362227	Catip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ciliogenesis associated TTC17 interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637170	Catip<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cingulin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362472	Cgn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cingulin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5521541	Cgn<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
cingulin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5521541	Cgn<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cingulin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362991	Cgn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
circadian associated repressor of transcription; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419170	Ciart<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
circadian associated repressor of transcription; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419170	Ciart<tm1a(KOMP)Wtsi>	24737000	KOMP-CSD
circadian associated repressor of transcription; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419228	Ciart<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
circadian associated repressor of transcription; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419228	Ciart<tm1e(KOMP)Wtsi>	24385426	KOMP-CSD
citrate synthase; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5614712	Cs<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
citrate synthase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4843824	Cs<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
citron; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364407	Cit<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CKLF-like MARVEL transmembrane domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441855	Cmtm4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CKLF-like MARVEL transmembrane domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441896	Cmtm4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CKLF-like MARVEL transmembrane domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286201	Cmtm5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CKLF-like MARVEL transmembrane domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441838	Cmtm6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CKLF-like MARVEL transmembrane domain containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441696	Cmtm6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CKLF-like MARVEL transmembrane domain containing 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4442047	Cmtm6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CKLF-like MARVEL transmembrane domain containing 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451959	Cmtm6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
CKLF-like MARVEL transmembrane domain containing 7; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:5511805	Cmtm7<tm2a(EUCOMM)Hmgu>	24080084	EUCOMM
clarin 1; targeted mutation 1.1, Velocigene	MGI:5582439	Clrn1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
claspin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432127	Clspn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
claspin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433287	Clspn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
claspin; targeted mutation 1, Velocigene	MGI:5085611	Clspn<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
clathrin heavy chain linker domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305668	Clhc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
clathrin heavy chain linker domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305660	Clhc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
clathrin, light polypeptide (Lcb); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441802	Cltb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
clathrin, light polypeptide (Lcb); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441839	Cltb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009636	Cldn12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887689	Cldn12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 13; targeted mutation 1.1, Velocigene	MGI:5515777	Cldn13<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
claudin 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473185	Cldn13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472758	Cldn13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364889	Cldn16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364889	Cldn16<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
claudin 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420028	Cldn16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473127	Cldn17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 18; targeted mutation 1.1, Velocigene	MGI:5569064	Cldn18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
claudin 18; targeted mutation 1, Velocigene	MGI:3812813	Cldn18<tm1(KOMP)Vlcg>	24787463	KOMP-Regeneron
claudin 19; targeted mutation 1.1, Velocigene	MGI:5507837	Cldn19<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
claudin 19; targeted mutation 1.1, Velocigene	MGI:5507837	Cldn19<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
claudin 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433798	Cldn19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433383	Cldn19<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 1; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766169	Cldn1<tm1b(NCOM)Mfgc>	27626380	NorCOMM
claudin 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473157	Cldn23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472735	Cldn23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419794	Cldn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419282	Cldn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473050	Cldn2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 34B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939725	Cldn34b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 34B2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939739	Cldn34b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 34C1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050165	Cldn34c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 34D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426622	Cldn34d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 34D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426558	Cldn34d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
claudin 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512001	Cldn4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511969	Cldn4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473167	Cldn5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
claudin 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472741	Cldn9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
claudin domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841383	Cldnd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
claudin domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363083	Cldnd2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
clavesin 1; targeted mutation 1.1, Velocigene	MGI:5554864	Clvs1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
clavesin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364722	Clvs2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
clavesin 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5473209	Clvs2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cleavage and polyadenylation specific factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458537	Cpsf6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cleavage and polyadenylation specific factor 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458645	Cpsf6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cleavage and polyadenylation specificity factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432649	Cpsf3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cleavage and polyadenylation specificity factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432649	Cpsf3<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
cleavage and polyadenylation specificity factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548494	Cpsf3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cleavage and polyadenylation specificity factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431543	Cpsf3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cleavage stimulation factor, 3' pre-RNA, subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841448	Cstf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cleavage stimulation factor, 3' pre-RNA subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432462	Cstf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cleavage stimulation factor, 3' pre-RNA subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432532	Cstf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cleft lip and palate associated transmembrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419487	Clptm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ClpB caseinolytic peptidase B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432713	Clpb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ClpB caseinolytic peptidase B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434026	Clpb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CLPTM1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433336	Clptm1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
clusterin associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363468	Cluap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
clusterin associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363468	Cluap1<tm1a(KOMP)Wtsi>	23351563	KOMP-CSD
clusterin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548920	Clu<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
c-Maf inducing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286409	Cmip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
c-Maf inducing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286409	Cmip<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
cms small ribosomal subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364294	Cmss1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Cnksr family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419528	Cnksr3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Cnksr family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420086	Cnksr3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coactivator-associated arginine methyltransferase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605773	Carm1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coactosin-like 1 (Dictyostelium); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5613651	Cotl1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coagulation factor III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939706	F3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coagulation factor III; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939700	F3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coagulation factor II; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637201	F2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coagulation factor II (thrombin) receptor-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460480	F2rl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coagulation factor II (thrombin) receptor-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460480	F2rl1<tm1a(EUCOMM)Wtsi>	26993035	EUCOMM
coagulation factor II (thrombin) receptor-like 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548326	F2rl1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
coagulation factor II (thrombin) receptor-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461674	F2rl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coagulation factor II (thrombin) receptor-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363620	F2rl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coagulation factor II (thrombin) receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433828	F2r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coagulation factor VII; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636916	F7<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coagulation factor V; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432480	F5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coagulation factor V; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432381	F5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coagulation factor V; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472688	F5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
coagulation factor V; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472855	F5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
coagulation factor XII (Hageman factor); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362841	F12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coagulation factor XII (Hageman factor); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363721	F12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coagulation factor XII (Hageman factor); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299583	F12<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
coagulation factor XII (Hageman factor); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299518	F12<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
coagulation factor XIII, A1 subunit; targeted mutation 1.1, Velocigene	MGI:5569954	F13a1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
coagulation factor X; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548338	F10<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coatomer protein complex, subunit beta 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503353	Copb1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
coatomer protein complex, subunit beta 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5503336	Copb1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
coatomer protein complex, subunit beta 2 (beta prime); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461723	Copb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coatomer protein complex, subunit epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364272	Cope<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coatomer protein complex, subunit gamma 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432009	Copg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coatomer protein complex, subunit gamma 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432774	Copg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coatomer protein complex, subunit gamma 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451290	Copg2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coenzyme Q10A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842287	Coq10a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q10A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842510	Coq10a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q10B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820231	Coq10b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q10B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820332	Coq10b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637057	Coq2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coenzyme Q3 methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433085	Coq3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441729	Coq4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442027	Coq4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q5 methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433684	Coq5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q5 methyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433530	Coq5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coenzyme Q6 monooxygenase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548683	Coq6<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coenzyme Q8A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293983	Coq8a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coenzyme Q9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362815	Coq9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coenzyme Q9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362815	Coq9<tm1a(KOMP)Wtsi>	25802402	KOMP-CSD
coenzyme Q9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364251	Coq9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil and C2 domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362979	Cc2d1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil and C2 domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362979	Cc2d1a<tm1a(KOMP)Wtsi>	22833682	KOMP-CSD
coiled-coil and C2 domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362979	Cc2d1a<tm1a(KOMP)Wtsi>	26826102	KOMP-CSD
coiled-coil and C2 domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362979	Cc2d1a<tm1a(KOMP)Wtsi>	29101244	KOMP-CSD
coiled-coil and C2 domain containing 1A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111286	Cc2d1a<tm1c(KOMP)Wtsi>	26826102	KOMP-CSD
coiled-coil and C2 domain containing 1A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111286	Cc2d1a<tm1c(KOMP)Wtsi>	29101244	KOMP-CSD
coiled-coil and C2 domain containing 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427224	Cc2d1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil and C2 domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362981	Cc2d1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil and C2 domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362981	Cc2d1b<tm1a(KOMP)Wtsi>	26720614	KOMP-CSD
coiled-coil and C2 domain containing 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365169	Cc2d1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil and C2 domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431801	Cc2d2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil and C2 domain containing 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432301	Cc2d2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 102A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840964	Ccdc102a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 102A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841022	Ccdc102a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 106; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433912	Ccdc106<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 106; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433300	Ccdc106<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 114; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840619	Ccdc114<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 114; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840663	Ccdc114<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 116; targeted mutation 1.1, Velocigene	MGI:5695933	Ccdc116<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
coiled-coil domain containing 116; targeted mutation 1, Velocigene	MGI:5292877	Ccdc116<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
coiled-coil domain containing 116; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299559	Ccdc116<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 120; targeted mutation 1.1, Velocigene	MGI:5445789	Ccdc120<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
coiled-coil domain containing 120; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456055	Ccdc120<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 120; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472939	Ccdc120<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 122; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363388	Ccdc122<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 122; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362928	Ccdc122<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 124; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293951	Ccdc124<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 124; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451449	Ccdc124<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 127; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432124	Ccdc127<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 127; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637023	Ccdc127<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
coiled-coil domain containing 127; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432033	Ccdc127<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 129; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364176	Ccdc129<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 129; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364511	Ccdc129<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 129; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472969	Ccdc129<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364834	Ccdc12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364763	Ccdc12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455553	Ccdc12<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 12; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455460	Ccdc12<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 130; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364450	Ccdc130<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 130; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472931	Ccdc130<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 130; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472790	Ccdc130<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 134; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362536	Ccdc134<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 134; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362385	Ccdc134<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 136; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433316	Ccdc136<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 136; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432977	Ccdc136<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 137; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363458	Ccdc137<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 137; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362854	Ccdc137<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458643	Ccdc13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 141; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419651	Ccdc141<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 146; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014744	Ccdc146<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880921	Ccdc14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880935	Ccdc14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 150; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947748	Ccdc150<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 155; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362885	Ccdc155<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 155; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362885	Ccdc155<tm1a(KOMP)Wtsi>	24062341	KOMP-CSD
coiled-coil domain containing 155; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5700363	Ccdc155<tm1b(KOMP)Wtsi>	24062341	KOMP-CSD
coiled-coil domain containing 155; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5700363	Ccdc155<tm1b(KOMP)Wtsi>	25892231	KOMP-CSD
coiled-coil domain containing 155; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363552	Ccdc155<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 157; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013730	Ccdc157<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 159; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419403	Ccdc159<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 159; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419569	Ccdc159<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 160; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453700	Ccdc160<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 160; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453791	Ccdc160<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 163; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419439	Ccdc163<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 173; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456006	Ccdc173<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 175; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365118	Ccdc175<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 177; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948615	Ccdc177<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 177; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948616	Ccdc177<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled coil domain containing 178; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842483	Ccdc178<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 180; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841107	Ccdc180<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 180; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841166	Ccdc180<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 181; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5550595	Ccdc181<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
coiled-coil domain containing 183; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289816	Ccdc183<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 183; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5289803	Ccdc183<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 184; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473123	Ccdc184<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 184; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472707	Ccdc184<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 186; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426628	Ccdc186<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 186; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426563	Ccdc186<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460455	Ccdc18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460525	Ccdc18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 191; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433531	Ccdc191<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 191; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432275	Ccdc191<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455549	Ccdc24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455454	Ccdc24<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441821	Ccdc25<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441773	Ccdc25<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 28A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364651	Ccdc28a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 28A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364414	Ccdc28a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 28A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419991	Ccdc28a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 28A; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473227	Ccdc28a<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 28A; targeted mutation 3b, Wellcome Trust Sanger Institute	MGI:5634966	Ccdc28a<tm3b(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 28A; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5473213	Ccdc28a<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 30; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420147	Ccdc30<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 33; targeted mutation 1.1, Velocigene	MGI:5548652	Ccdc33<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
coiled-coil domain containing 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365032	Ccdc34<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 34; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362803	Ccdc34<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820154	Ccdc36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840913	Ccdc36<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 36; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299626	Ccdc36<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364215	Ccdc39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364215	Ccdc39<tm1a(KOMP)Wtsi>	29317443	KOMP-CSD
coiled-coil domain containing 39; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302288	Ccdc39<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433198	Ccdc40<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433889	Ccdc40<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 42; targeted mutation 1, Velocigene	MGI:3800251	Ccdc42<tm1(KOMP)Vlcg>	26945718	KOMP-Regeneron
coiled-coil domain containing 57; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431914	Ccdc57<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 57; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431786	Ccdc57<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 57; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431864	Ccdc57<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 57; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434166	Ccdc57<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 57; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456787	Ccdc57<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 57; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4456757	Ccdc57<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 61; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434407	Ccdc61<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 61; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434343	Ccdc61<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 69; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364083	Ccdc69<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 69; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636931	Ccdc69<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
coiled-coil domain containing 69; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363452	Ccdc69<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 71; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944333	Ccdc71<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 77; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432801	Ccdc77<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 77; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432451	Ccdc77<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 80; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008808	Ccdc80<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 81; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432586	Ccdc81<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 83; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951141	Ccdc83<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 83; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006812	Ccdc83<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 86; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512005	Ccdc86<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 86; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511972	Ccdc86<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 88C; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548562	Ccdc88c<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
coiled-coil domain containing 88C; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548562	Ccdc88c<tm1.1(KOMP)Mbp>	29229865	KOMP-CSD
coiled-coil domain containing 88C; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:5141808	Ccdc88c<tm1(KOMP)Mbp>	28746879	KOMP-CSD
coiled-coil domain containing 88C; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:5141808	Ccdc88c<tm1(KOMP)Mbp>	29229865	KOMP-CSD
coiled-coil domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473170	Ccdc8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472745	Ccdc8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 90B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441669	Ccdc90b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil domain containing 94; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419269	Ccdc94<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil domain containing 94; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5563210	Ccdc94<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
coiled-coil domain containing 94; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419296	Ccdc94<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil-helix-coiled-coil-helix domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947809	Chchd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil-helix-coiled-coil-helix domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430978	Chchd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil-helix-coiled-coil-helix domain containing 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419215	Chchd5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
coiled-coil-helix-coiled-coil-helix domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842800	Chchd6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil-helix-coiled-coil-helix domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842341	Chchd7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil-helix-coiled-coil-helix domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842749	Chchd7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coiled-coil-helix-coiled-coil-helix domain containing 7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4842475	Chchd7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
COLCA2 homolog; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766180	Colca2<tm1b(NCOM)Mfgc>	27626380	NorCOMM
cold shock domain containing E1, RNA binding; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842375	Csde1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cold shock domain containing E1, RNA binding; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842738	Csde1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
colipase, pancreatic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431774	Clps<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
colipase, pancreatic; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433214	Clps<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen beta(1-O)galactosyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881956	Colgalt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen beta(1-O)galactosyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881946	Colgalt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305611	Colq<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4944375	Colq<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4944421	Colq<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type I, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887693	Col1a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type I, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887713	Col1a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type I, alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452780	Col1a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type I, alpha 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5575901	Col1a2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
collagen, type I, alpha 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452825	Col1a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type II, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434062	Col2a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type II, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433532	Col2a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type III, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820311	Col3a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type III, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820269	Col3a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287775	Col4a3bp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287775	Col4a3bp<tm1a(KOMP)Wtsi>	27996060	KOMP-CSD
collagen, type IV, alpha 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431840	Col4a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type IV, alpha 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548350	Col4a3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
collagen, type IV, alpha 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434362	Col4a3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type IV, alpha 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432414	Col4a5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type IV, alpha 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432414	Col4a5<tm1a(EUCOMM)Wtsi>	25992553	EUCOMM
collagen, type IX, alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950248	Col9a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type IX, alpha 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692882	Col9a2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
collagen, type IX, alpha 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951112	Col9a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type IX, alpha 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364896	Col9a3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type VI, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431802	Col6a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type VI, alpha 2; targeted mutation 1.1, Velocigene	MGI:5548922	Col6a2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
collagen, type VII, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820319	Col7a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type VII, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820212	Col7a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type X, alpha 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419434	Col10a1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XI, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427161	Col11a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XI, alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305616	Col11a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XII, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364647	Col12a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XII, alpha 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841159	Col12a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XII, alpha 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841201	Col12a1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XIII, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441828	Col13a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type XIV, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363804	Col14a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XIV, alpha 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5561558	Col14a1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
collagen, type XIV, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364658	Col14a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XIX, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364486	Col19a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XIX, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364749	Col19a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XIX, alpha 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473019	Col19a1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type XIX, alpha 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472845	Col19a1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type XV, alpha 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427170	Col15a1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XVIII, alpha 1; targeted mutation 1.1, Velocigene	MGI:5445917	Col18a1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
collagen, type XVIII, alpha 1; targeted mutation 1.1, Velocigene	MGI:5445917	Col18a1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
collagen, type XX, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840962	Col20a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XX, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841179	Col20a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XXIII, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432813	Col23a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type XXIII, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434267	Col23a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type XXIV, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433574	Col24a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type XXIV, alpha 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637054	Col24a1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
collagen, type XXIV, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433788	Col24a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
collagen, type XXVI, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365239	Col26a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XXVI, alpha 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5140440	Col26a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XXVII, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948622	Col27a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
collagen, type XXVII, alpha 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286190	Col27a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
collectin sub-family member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000416	Colec10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
colony stimulating factor 1 (macrophage); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947763	Csf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
colony stimulating factor 1 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014580	Csf1r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887701	Csf2rb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435477	Csf2rb<tm1a(EUCOMM)Hmgu>	26341401	EUCOMM
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435477	Csf2rb<tm1a(EUCOMM)Hmgu>	29126797	EUCOMM
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5792881	Csf2rb<tm1c(EUCOMM)Hmgu>	26341401	EUCOMM
colony stimulating factor 3 receptor (granulocyte); targeted mutation 1.1, Velocigene	MGI:5582428	Csf3r<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
COMM domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842273	Commd10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
COMM domain containing 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842767	Commd10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
COMM domain containing 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4842411	Commd2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
COMM domain containing 2; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:5444899	Commd2<tm4e(KOMP)Wtsi>	21677750	KOMP-CSD
COMM domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302346	Commd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
COMM domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302313	Commd3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
COMM domain containing 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419783	Commd4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
COMM domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365175	Commd9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
COMM domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365175	Commd9<tm1a(KOMP)Wtsi>	26553930	KOMP-CSD
COMM domain containing 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692742	Commd9<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
COMM domain containing 9; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5796331	Commd9<tm1c(KOMP)Wtsi>	26553930	KOMP-CSD
COMM domain containing 9; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5796331	Commd9<tm1c(KOMP)Wtsi>	26965651	KOMP-CSD
COMM domain containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427238	Commd9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842602	C1qa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842602	C1qa<tm1a(EUCOMM)Wtsi>	28264694	EUCOMM
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5488784	C1qa<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5488784	C1qa<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5488784	C1qa<tm1b(EUCOMM)Wtsi>	28700664	EUCOMM
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6108260	C1qa<tm1c(EUCOMM)Wtsi>	28264694	EUCOMM
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842576	C1qa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, q subcomponent, beta polypeptide; targeted mutation 1.1, Velocigene	MGI:5471254	C1qb<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
complement component 1, q subcomponent binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432129	C1qbp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, q subcomponent binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434088	C1qbp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, q subcomponent binding protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434461	C1qbp<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, q subcomponent binding protein; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456772	C1qbp<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, q subcomponent-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512009	C1ql1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 1, r subcomponent-like; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548846	C1rl<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
complement component 1, s subcomponent 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362708	C1s2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
complement component 1, s subcomponent 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363235	C1s2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
complement component (3b/4b) receptor 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939691	Cr1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
complement component (3b/4b) receptor 1-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474762	Cr1l<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
complement component (3b/4b) receptor 1-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474762	Cr1l<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
complement component 3; targeted mutation 1.1, Velocigene	MGI:5471398	C3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
complement component 3; targeted mutation 1.1, Velocigene	MGI:5471398	C3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
complement component 4 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363920	C4bp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
complement component 4 binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364021	C4bp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
complement component 5a receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305670	C5ar1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 5a receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842883	C5ar1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 5a receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009654	C5ar2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 5a receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014695	C5ar2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
complement component 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950960	C6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
complement component 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008792	C6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
complement component 8, alpha polypeptide; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605820	C8a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
complement component 8, beta polypeptide; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637199	C8b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
complement component 8, gamma polypeptide; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419778	C8g<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
complement component 9; targeted mutation 1.1, Velocigene	MGI:5494473	C9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
complement component 9; targeted mutation 1, Velocigene	MGI:4951260	C9<tm1(KOMP)Vlcg>	28700664	KOMP-Regeneron
complement component factor h; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434438	Cfh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
complement component factor i; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636899	Cfi<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
complement factor B; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5529069	Cfb<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
complement factor B; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5529069	Cfb<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
complement factor B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419769	Cfb<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
complement factor H-related 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419965	Cfhr1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
complement factor properdin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433789	Cfp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
complement factor properdin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434009	Cfp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
complexin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432322	Cplx4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
complexin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432095	Cplx4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
component of oligomeric golgi complex 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434315	Cog1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
component of oligomeric golgi complex 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431858	Cog1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
component of oligomeric golgi complex 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473089	Cog1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
component of oligomeric golgi complex 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364810	Cog2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
component of oligomeric golgi complex 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362982	Cog2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
component of oligomeric golgi complex 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364115	Cog2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
component of oligomeric golgi complex 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4365225	Cog2<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
component of oligomeric golgi complex 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548843	Cog3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
component of oligomeric golgi complex 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820323	Cog6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
component of oligomeric golgi complex 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434027	Cog8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
component of oligomeric golgi complex 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431877	Cog8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cone-rod homeobox, opposite strand; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431998	Crxos<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cone-rod homeobox, opposite strand; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431626	Crxos<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cone-rod homeobox, opposite strand; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456078	Crxos<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cone-rod homeobox, opposite strand; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456053	Crxos<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
congenital dyserythropoietic anemia, type I (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363789	Cdan1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
congenital dyserythropoietic anemia, type I (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362370	Cdan1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
connector enhancer of kinase suppressor of Ras 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458522	Cnksr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
connector enhancer of kinase suppressor of Ras 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458462	Cnksr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
connector enhancer of kinase suppressor of Ras 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294020	Cnksr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
conserved helix-loop-helix ubiquitous kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419549	Chuk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
conserved helix-loop-helix ubiquitous kinase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5427211	Chuk<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
consortin, connexin sorting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433458	Cnst<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
consortin, connexin sorting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433672	Cnst<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
contactin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420106	Cntn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
contactin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293977	Cntn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
contactin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293944	Cntn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
contactin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362184	Cntn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
contactin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364736	Cntn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
contactin associated protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431603	Cntnap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
contactin associated protein-like 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5584407	Cntnap1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
contactin associated protein-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433799	Cntnap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
contactin associated protein-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842872	Cntnap4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
contactin associated protein-like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842629	Cntnap4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
contactin associated protein-like 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841002	Cntnap5b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
contactin associated protein-like 5B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841224	Cntnap5b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
contactin associated protein-like 5B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473105	Cntnap5b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
contactin associated protein-like 5C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419614	Cntnap5c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
contactin associated protein-like 5C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419792	Cntnap5c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
contactin associated protein-like 5C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293982	Cntnap5c<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
coordinator of PRMT5, differentiation stimulator; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299561	Coprs<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
COP9 signalosome subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454072	Cops2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
COP9 signalosome subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454149	Cops2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
COP9 signalosome subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948624	Cops3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
COP9 signalosome subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948627	Cops3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
COP9 signalosome subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460425	Cops5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
COP9 signalosome subunit 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460528	Cops5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
COP9 signalosome subunit 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820256	Cops8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
COP9 signalosome subunit 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842445	Cops8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
COP9 signalosome subunit 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419433	Cops9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
copine II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362194	Cpne2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
copine II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363556	Cpne2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
copine VIII; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364998	Cpne8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
copine VIII; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5427117	Cpne8<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
copine V; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5572035	Cpne5<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
coproporphyrinogen oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050869	Cpox<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coproporphyrinogen oxidase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293992	Cpox<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cordon-bleu WH2 repeat; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456652	Cobl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cordon-bleu WH2 repeat; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456650	Cobl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433572	C1galt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472937	C1galt1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820233	Cbfa2t2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820309	Cbfa2t2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
core-binding factor, runt domain, alpha subunit 2, translocated to, 3 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363978	Cbfa2t3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
corepressor interacting with RBPJ, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4819200	Cir1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
corepressor interacting with RBPJ, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427227	Cir1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
corepressor interacting with RBPJ, 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503355	Cir1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
corepressor interacting with RBPJ, 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5577261	Cir1<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
corepressor interacting with RBPJ, 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5577261	Cir1<tm3a(KOMP)Wtsi>	27996060	KOMP-CSD
corin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881083	Corin<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
corin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881087	Corin<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cornichon family AMPA receptor auxiliary protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441972	Cnih1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cornichon family AMPA receptor auxiliary protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452016	Cnih1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cornichon family AMPA receptor auxiliary protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942002	Cnih2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cornichon family AMPA receptor auxiliary protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635040	Cnih2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
cornichon family AMPA receptor auxiliary protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941992	Cnih2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cornichon family AMPA receptor auxiliary protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947746	Cnih3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cornifelin; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050900	Cnfn<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
coronin 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000401	Coro6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coronin 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000412	Coro6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coronin 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000412	Coro6<tm1e(EUCOMM)Wtsi>	29078390	EUCOMM
coronin 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4462636	Coro7<tm1a(EUCOMM)Hmgu>	27143109	EUCOMM
coronin, actin binding protein 1A; targeted mutation 1.1, Velocigene	MGI:5548457	Coro1a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
coronin, actin binding protein 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434238	Coro1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
coronin, actin binding protein 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431579	Coro1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coronin, actin binding protein 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419168	Coro1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coronin, actin binding protein 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419168	Coro1c<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
coronin, actin binding protein 1C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419299	Coro1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
coronin, actin binding protein 2A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364905	Coro2a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
coronin, actin binding protein, 2B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419137	Coro2b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cortactin binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455588	Cttnbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cortactin binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636986	Cttnbp2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cortactin binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455625	Cttnbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cortactin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548978	Cttn<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cortexin 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427171	Ctxn1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
corticotropin releasing hormone binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428565	Crhbp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
corticotropin releasing hormone binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428557	Crhbp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
corticotropin releasing hormone receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434250	Crhr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
corticotropin releasing hormone receptor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4948647	Crhr1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
corticotropin releasing hormone receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362898	Crhr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
corticotropin releasing hormone receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362898	Crhr2<tm1a(KOMP)Wtsi>	28550160	KOMP-CSD
corticotropin releasing hormone receptor 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925366	Crhr2<tm1c(KOMP)Wtsi>	28550160	KOMP-CSD
corticotropin releasing hormone receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365104	Crhr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
corticotropin releasing hormone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433213	Crh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
corticotropin releasing hormone; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432042	Crh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
coxsackie virus and adenovirus receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887597	Cxadr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
coxsackie virus and adenovirus receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887611	Cxadr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cramped chromatin regulator homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461684	Cramp1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cramped chromatin regulator homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461743	Cramp1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
creatine kinase, brain; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419576	Ckb<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
creatine kinase, mitochondrial 1, ubiquitous; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503352	Ckmt1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
creatine kinase, mitochondrial 1, ubiquitous; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5503335	Ckmt1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CREB3 regulatory factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050853	Crebrf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CREB regulated transcription coactivator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432872	Crtc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CREB regulated transcription coactivator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433344	Crtc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CREB regulated transcription coactivator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433344	Crtc2<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
CREB regulated transcription coactivator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433344	Crtc2<tm1a(EUCOMM)Wtsi>	24898145	EUCOMM
CREB regulated transcription coactivator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433344	Crtc2<tm1a(EUCOMM)Wtsi>	29192248	EUCOMM
CREB regulated transcription coactivator 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111714	Crtc2<tm1c(EUCOMM)Wtsi>	29192248	EUCOMM
CREB regulated transcription coactivator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434010	Crtc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CREB regulated transcription coactivator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014596	Crtc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CREB regulated transcription coactivator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014596	Crtc3<tm1a(KOMP)Wtsi>	26644581	KOMP-CSD
CREB regulated transcription coactivator 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548599	Crtc3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
crumbs family member 1, photoreceptor morphogenesis associated; endonuclease-mediated revertant 1, Michael Wiles	MGI:5498686	Crb1<rd8+em1Mvw>	24346171	null
crumbs family member 1, photoreceptor morphogenesis associated; retinal degeneration 8	MGI:2676366	Crb1<rd8>	24346171	null
crumbs family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4818586	Crb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
crumbs family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462622	Crb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, beta A1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4951042	Cryba1<tm1a(EUCOMM)Hmgu>	26863613	EUCOMM
crystallin, beta A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452004	Cryba2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, beta A4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433429	Cryba4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, beta B3; targeted mutation 1.1, Velocigene	MGI:5569032	Crybb3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
crystallin, beta B3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4840657	Crybb3<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, beta B3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4840685	Crybb3<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, beta B3; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:4840697	Crybb3<tm4e(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin beta-gamma domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008764	Crybg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin beta-gamma domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605748	Crybg1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
crystallin beta-gamma domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009565	Crybg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, gamma B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141839	Crygb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, gamma C; targeted mutation 1.1, Velocigene	MGI:5695969	Crygc<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
crystallin, gamma D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085476	Crygd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, gamma D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085474	Crygd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, gamma E; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840577	Cryge<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, gamma E; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840654	Cryge<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, gamma N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455953	Crygn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, gamma N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455953	Crygn<tm1a(EUCOMM)Wtsi>	27517863	EUCOMM
crystallin, gamma S; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050868	Crygs<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, gamma S; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635041	Crygs<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, lambda 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451948	Cryl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
crystallin, mu; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365184	Crym<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, mu; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471222	Crym<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, mu; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471222	Crym<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
crystallin, mu; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471222	Crym<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
crystallin, mu; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363320	Crym<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin zeta like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365171	Cryzl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, zeta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363177	Cryz<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, zeta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364114	Cryz<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, zeta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5428587	Cryz<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, zeta; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4462608	Cryz<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
crystallin, zeta; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4462589	Cryz<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881070	Ctdp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868087	Ctdp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008023	Ctdsp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363830	Ctdspl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847675	Ctdspl2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548409	Ctdspl2<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847677	Ctdspl2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548581	Ctdspl<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
C-terminal binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286406	Ctbp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C-terminal binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453790	Ctbp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CTF18, chromosome transmission fidelity factor 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362910	Chtf18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CTF18, chromosome transmission fidelity factor 18; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529071	Chtf18<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
CTF18, chromosome transmission fidelity factor 18; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529071	Chtf18<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
CTF18, chromosome transmission fidelity factor 18; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529071	Chtf18<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
CTF18, chromosome transmission fidelity factor 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363325	Chtf18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CTR9 homolog, Paf1/RNA polymerase II complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433989	Ctr9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CTR9 homolog, Paf1/RNA polymerase II complex component; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548390	Ctr9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
CTR9 homolog, Paf1/RNA polymerase II complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433876	Ctr9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CTS telomere maintenance complex component 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363331	Ctc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CTS telomere maintenance complex component 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364606	Ctc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 12, member a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293971	Clec12a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 12, member a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293932	Clec12a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 12, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944519	Clec12b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 12, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944556	Clec12b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 14, member a; targeted mutation 1, Velocigene	MGI:5292853	Clec14a<tm1(KOMP)Vlcg>	25745997	KOMP-Regeneron
C-type lectin domain family 1, member a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842367	Clec1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 1, member a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842688	Clec1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 1, member b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364416	Clec1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 1, member b; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452712	Clec1b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 2, member d; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427199	Clec2d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 2, member d; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427158	Clec2d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 3, member b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419155	Clec3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 3, member b; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5646134	Clec3b<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 3, member b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420117	Clec3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member a1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841055	Clec4a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member a1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840938	Clec4a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member a1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4887628	Clec4a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member a1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4887613	Clec4a1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member a3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840936	Clec4a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member a3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841272	Clec4a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member a4; targeted mutation 1, Velocigene	MGI:4460578	Clec4a4<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
C-type lectin domain family 4, member b2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427200	Clec4b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member d; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949374	Clec4d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 4, member d; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842568	Clec4d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 4, member e; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887705	Clec4e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 4, member e; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887717	Clec4e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 4, member f; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462617	Clec4f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member f; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462619	Clec4f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member g; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434273	Clec4g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 4, member g; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433003	Clec4g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
C-type lectin domain family 4, member n; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362287	Clec4n<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 4, member n; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431422	Clec4n<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
C-type lectin domain family 9, member a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947751	Clec9a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CUB and Sushi multiple domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5473214	Csmd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CUB and Sushi multiple domains 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527608	Csmd1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CUB and Sushi multiple domains 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5529962	Csmd1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
CUB and Sushi multiple domains 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451314	Csmd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CUB and zona pellucida-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051023	Cuzd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CUB domain containing protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419722	Cdcp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CUE domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419176	Cuedc2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
CUGBP, Elav-like family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942131	Celf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942139	Celf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434482	Celf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433345	Celf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433345	Celf4<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
CUGBP, Elav-like family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432525	Celf4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527605	Celf4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452763	Celf5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452815	Celf5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CUGBP, Elav-like family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843838	Celf6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CUGBP, Elav-like family member 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548665	Celf6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
CUGBP, Elav-like family member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431441	Celf6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cullin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362214	Cul3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cullin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451448	Cul3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cullin 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451668	Cul3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cullin 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432297	Cul4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cullin 5; targeted mutation 1.1, Velocigene	MGI:5569059	Cul5<tm1.1(KOMP)Vlcg>	28522566	KOMP-Regeneron
cullin 5; targeted mutation 1, Velocigene	MGI:4881245	Cul5<tm1(KOMP)Vlcg>	27233966	KOMP-Regeneron
cullin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434069	Cul7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cullin associated and neddylation disassociated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460485	Cand1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cullin associated and neddylation disassociated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460518	Cand1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cullin-associated and neddylation-dissociated 2 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432020	Cand2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cullin-associated and neddylation-dissociated 2 (putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432421	Cand2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cutA divalent cation tolerance homolog-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432816	Cutal<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cutA divalent cation tolerance homolog-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432881	Cutal<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cutC copper transporter; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432504	Cutc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cutC copper transporter; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431649	Cutc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CWC15 spliceosome-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842827	Cwc15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CWC25 spliceosome-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433107	Cwc25<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CWC25 spliceosome-associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433602	Cwc25<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CWC27 spliceosome-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362268	Cwc27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
CWC27 spliceosome-associated protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474764	Cwc27<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
CWC27 spliceosome-associated protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474764	Cwc27<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
CWC27 spliceosome-associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362865	Cwc27<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
CWC27 spliceosome-associated protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473103	Cwc27<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
CWC27 spliceosome-associated protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472899	Cwc27<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
CXADR-like membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302343	Clmp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CXADR-like membrane protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302309	Clmp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
CXXC finger 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433857	Cxxc5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
CXXC finger 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432391	Cxxc5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclic nucleotide binding domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434076	Cnbd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclic nucleotide binding domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548907	Cnbd1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cyclic nucleotide binding domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433056	Cnbd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclic nucleotide gated channel alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362390	Cnga1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclic nucleotide gated channel alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364510	Cnga1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclic nucleotide gated channel alpha 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431414	Cnga1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclic nucleotide gated channel alpha 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431488	Cnga1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclic nucleotide gated channel alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052505	Cnga2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclic nucleotide gated channel alpha 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419871	Cnga4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cyclic nucleotide gated channel beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842291	Cngb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclic nucleotide gated channel beta 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842585	Cngb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293987	Ccna1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419982	Ccna1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin A1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4420146	Ccna1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin A1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4420026	Ccna1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin B1 interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003022	Ccnb1ip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin B1 interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003020	Ccnb1ip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419820	Ccnb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419820	Ccnb1<tm1a(KOMP)Wtsi>	29072697	KOMP-CSD
cyclin B1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637200	Ccnb1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cyclin B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419248	Ccnb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin B3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014608	Ccnb3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5301390	Ccnc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301384	Ccnc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306498	Ccnc<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5301400	Ccnc<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin C; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5306494	Ccnc<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin C; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5301401	Ccnc<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362247	Cdk14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 14; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841451	Cdk14<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 14; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841421	Cdk14<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841234	Cdk15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498771	Cdk15<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498771	Cdk15<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cyclin-dependent kinase 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841271	Cdk15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947810	Cdk16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947803	Cdk16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 17; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451327	Cdk17<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419942	Cdk20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419942	Cdk20<tm1a(KOMP)Wtsi>	28817564	KOMP-CSD
cyclin-dependent kinase 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419502	Cdk20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 2 interacting protein; targeted mutation 1.1, Velocigene	MGI:5471942	Cinp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cyclin-dependent kinase 2 interacting protein; targeted mutation 1.1, Velocigene	MGI:5471942	Cinp<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
cyclin-dependent kinase 2 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434019	Cinp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 2 interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431748	Cinp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 4; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766181	Cdk4<tm1b(NCOM)Mfgc>	27626380	NorCOMM
cyclin-dependent kinase 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363499	Cdk4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin-dependent kinase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847872	Cdk5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847860	Cdk5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842551	Cdk6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842730	Cdk6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452758	Cdk7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452829	Cdk7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548408	Cdk8<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cyclin-dependent kinase 9 (CDC2-related kinase); targeted mutation 1.1, Velocigene	MGI:5695892	Cdk9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cyclin-dependent kinase inhibitor 1A (P21); targeted mutation 1.1, Velocigene	MGI:5695874	Cdkn1a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cyclin-dependent kinase inhibitor 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460436	Cdkn2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase inhibitor 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460451	Cdkn2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434118	Cdkn2c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473093	Cdkn2c<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472889	Cdkn2c<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432667	Cdkn2d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432829	Cdkn2d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473025	Cdkn2d<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin-dependent kinase-like 2 (CDC2-related kinase); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5581415	Cdkl2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cyclin-dependent kinase-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820326	Cdkl4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin E1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431423	Ccne1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin G associated kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842687	Gak<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin G associated kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842771	Gak<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362932	Ccnh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007969	Ccnh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin H; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5007962	Ccnh<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin H; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5007986	Ccnh<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363679	Ccnk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin K; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362822	Ccnk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin L1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434057	Ccnl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin L1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434167	Ccnl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin L2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433301	Ccnl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin M4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432730	Cnnm4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin M4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432730	Cnnm4<tm1a(EUCOMM)Wtsi>	24339795	EUCOMM
cyclin M4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432730	Cnnm4<tm1a(EUCOMM)Wtsi>	25347473	EUCOMM
cyclin M4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432540	Cnnm4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin N-terminal domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363686	Cntd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin N-terminal domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363686	Cntd1<tm1e(KOMP)Wtsi>	24891606	KOMP-CSD
cyclin O; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457561	Ccno<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin O; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457561	Ccno<tm1a(EUCOMM)Wtsi>	25712475	EUCOMM
cyclin O; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5792813	Ccno<tm1b(EUCOMM)Wtsi>	25712475	EUCOMM
cyclin O; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792814	Ccno<tm1c(EUCOMM)Wtsi>	25712475	EUCOMM
cyclin O; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5792815	Ccno<tm1d(EUCOMM)Wtsi>	25712475	EUCOMM
cyclin O; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457570	Ccno<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin T1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363673	Ccnt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cyclin T2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433822	Ccnt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin T2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431674	Ccnt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin Y-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432945	Ccnyl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cyclin Y-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432945	Ccnyl1<tm1a(EUCOMM)Wtsi>	26305884	EUCOMM
cyclin Y-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432945	Ccnyl1<tm1a(EUCOMM)Wtsi>	26590424	EUCOMM
cyclin Y-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432945	Ccnyl1<tm1a(EUCOMM)Wtsi>	27203244	EUCOMM
cylicin, basic protein of sperm head cytoskeleton 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293954	Cylc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cylicin, basic protein of sperm head cytoskeleton 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293909	Cylc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cystatin 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458536	Cst12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cystatin 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458538	Cst12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cystatin A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432400	Csta1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cystatin A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434395	Csta1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cystatin B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451968	Cstb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cystatin B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451985	Cstb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cystatin C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458863	Cst3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cystatin E/M; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840596	Cst6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cystatin E/M; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840675	Cst6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cystatin F (leukocystatin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363668	Cst7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cystatin F (leukocystatin); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452690	Cst7<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cystatin F (leukocystatin); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452703	Cst7<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine and tyrosine-rich protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363885	Cyyr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine and tyrosine-rich protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363973	Cyyr1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine and tyrosine-rich protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363950	Cyyr1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich C-terminal 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940751	Crct1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich C-terminal 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940779	Crct1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine rich, DPF motif domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432122	Cdpf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine rich, DPF motif domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432595	Cdpf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine rich, DPF motif domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472927	Cdpf1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich hydrophobic domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868091	Chic2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich hydrophobic domain 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637077	Chic2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cysteine-rich hydrophobic domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881089	Chic2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich PDZ-binding protein; targeted mutation 1.1, Velocigene	MGI:5523317	Cript<tm1.1(KOMP)Vlcg>	27250922	KOMP-Regeneron
cysteine-rich PDZ-binding protein; targeted mutation 1.1, Velocigene	MGI:5523317	Cript<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cysteine-rich perinuclear theca 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473163	Cypt4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich perinuclear theca 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472739	Cypt4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich protein 1 (intestinal); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286259	Crip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich protein 1 (intestinal); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293938	Crip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine rich protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849417	Crip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine rich protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849423	Crip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365192	Crip3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007985	Crip3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich secretory protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456670	Crisp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich secretory protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456668	Crisp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich secretory protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363007	Crisp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich secretory protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363784	Crisp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich secretory protein 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364014	Crisp4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich secretory protein LCCL domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364779	Crispld1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich secretory protein LCCL domain containing 2; targeted mutation 1.1, Velocigene	MGI:5548696	Crispld2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cysteine-rich secretory protein LCCL domain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431444	Crispld2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cysteine-rich transmembrane module containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548508	Cystm1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cysteine-rich with EGF-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433580	Creld1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich with EGF-like domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432222	Creld1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich with EGF-like domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431889	Creld2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-rich with EGF-like domains 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548672	Creld2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cysteine-rich with EGF-like domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433668	Creld2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-serine-rich nuclear protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842280	Csrnp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cysteine-serine-rich nuclear protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842470	Csrnp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cysteinyl leukotriene receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451682	Cysltr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cystin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293960	Cys1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytidine 5'-triphosphate synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286254	Ctps<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytidine 5'-triphosphate synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293936	Ctps<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytidine and dCMP deaminase domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840647	Cdadc1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cytidine and dCMP deaminase domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840705	Cdadc1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cytidine deaminase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432943	Cda<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytidine deaminase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432628	Cda<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytidine monophosphate (UMP-CMP) kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441825	Cmpk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytidine monophosphate (UMP-CMP) kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441883	Cmpk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840944	Cmpk2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytidine monophospho-N-acetylneuraminic acid hydroxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442043	Cmah<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome b-245, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432216	Cyba<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome b-245, alpha polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433739	Cyba<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome b-245, beta polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365183	Cybb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b-245, beta polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319826	Cybb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b-245, beta polypeptide; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847712	Cybb<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b-245, beta polypeptide; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548926	Cybb<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome b-561 domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051008	Cyb561d2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome b-561 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5051022	Cyb561d2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome b-561; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432734	Cyb561<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome b-561; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636891	Cyb561<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cytochrome b5 domain containing 1; targeted mutation 1.1, Velocigene	MGI:5471394	Cyb5d1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cytochrome b5 domain containing 1; targeted mutation 1.1, Velocigene	MGI:5471394	Cyb5d1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
cytochrome b5 domain containing 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515784	Cyb5d2<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 domain containing 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515784	Cyb5d2<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome b5 domain containing 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515784	Cyb5d2<tm1.1(KOMP)Wtsi>	28700664	KOMP-CSD
cytochrome b5 domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420071	Cyb5d2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420037	Cyb5r1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427214	Cyb5r1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4455692	Cyb5r2<tm1a(EUCOMM)Hmgu>	24391134	EUCOMM
cytochrome b5 reductase 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548826	Cyb5r2<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
cytochrome b5 reductase 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548826	Cyb5r2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cytochrome b5 reductase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362273	Cyb5r3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471295	Cyb5r3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362613	Cyb5rl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364498	Cyb5rl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431397	Cyb5rl<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 reductase-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431512	Cyb5rl<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 type A (microsomal); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363796	Cyb5a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b5 type A (microsomal); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362935	Cyb5a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome b reductase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637161	Cybrd1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cytochrome c oxidase assembly factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419210	Coa4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome c oxidase assembly factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419326	Coa4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome C oxidase assembly factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419860	Coa5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome C oxidase assembly factor 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513757	Coa5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome C oxidase assembly factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419675	Coa5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome C oxidase assembly factor 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473113	Coa5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome c oxidase assembly factor 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456743	Coa7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome c oxidase assembly factor 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456767	Coa7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome c oxidase assembly protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432191	Cox14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome c oxidase assembly protein 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289813	Cox17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome c oxidase assembly protein 19; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513759	Cox19<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cytochrome c oxidase subunit 4I1; targeted mutation 1.1, Velocigene	MGI:5548923	Cox4i1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
cytochrome c oxidase subunit Vb; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5613669	Cox5b<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
cytochrome c oxidase subunit VIa polypeptide 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419915	Cox6a1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome c oxidase subunit VIa polypeptide 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419915	Cox6a1<tm1(KOMP)Wtsi>	25152455	KOMP-CSD
cytochrome c oxidase subunit VIa polypeptide 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431401	Cox6a2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome c oxidase subunit VIIa 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051005	Cox7a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome c oxidase subunit VIIa 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605757	Cox7a1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cytochrome c oxidase subunit VIIc; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5463977	Cox7c<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
cytochrome c oxidase subunit VIIIb; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840975	Cox8b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome c oxidase subunit VIIIb; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841246	Cox8b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 11, subfamily a, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456025	Cyp11a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 11, subfamily b, polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362538	Cyp11b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 11, subfamily b, polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362513	Cyp11b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 17, subfamily a, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433317	Cyp17a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 17, subfamily a, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605834	Cyp17a1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cytochrome P450, family 1, subfamily b, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364859	Cyp1b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 1, subfamily b, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363165	Cyp1b1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 20, subfamily a, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842859	Cyp20a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 20, subfamily a, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452787	Cyp20a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 24, subfamily a, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364118	Cyp24a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 24, subfamily a, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363947	Cyp24a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 24, subfamily a, polypeptide 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302291	Cyp24a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 27, subfamily b, polypeptide 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5588267	Cyp27b1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cytochrome P450, family 2, subfamily ab, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307103	Cyp2ab1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily ab, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572037	Cyp2ab1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome P450, family 2, subfamily a, polypeptide 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363972	Cyp2a5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364945	Cyp2b10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364727	Cyp2b10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431428	Cyp2b13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 13; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637203	Cyp2b13<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431505	Cyp2b13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841433	Cyp2b19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4843853	Cyp2b19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily b, polypeptide 19; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5473210	Cyp2b19<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 2, subfamily c, polypeptide 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364332	Cyp2c29<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363278	Cyp2c29<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820054	Cyp2c39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 39; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820037	Cyp2c39<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 55; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427186	Cyp2c55<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 65; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050170	Cyp2c65<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 65; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427138	Cyp2c65<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 66; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947756	Cyp2c66<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 70; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365186	Cyp2c70<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 70; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364968	Cyp2c70<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily c, polypeptide 70; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419415	Cyp2c70<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily d, polypeptide 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458652	Cyp2d22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily d, polypeptide 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458609	Cyp2d22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily d, polypeptide 37, pseudogene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841322	Cyp2d37-ps<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily e, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419612	Cyp2e1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily e, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548927	Cyp2e1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome P450, family 2, subfamily e, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419125	Cyp2e1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily f, polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4818585	Cyp2f2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily f, polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4818587	Cyp2f2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily g, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880945	Cyp2g1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily g, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880982	Cyp2g1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily j, polypeptide 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286171	Cyp2j6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily j, polypeptide 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293899	Cyp2j6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily j, polypeptide 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363240	Cyp2j9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily j, polypeptide 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363966	Cyp2j9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily j, polypeptide 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363489	Cyp2j9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily j, polypeptide 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365265	Cyp2j9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 2, subfamily r, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456014	Cyp2r1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 2, subfamily r, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548842	Cyp2r1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cytochrome P450, family 2, subfamily r, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456007	Cyp2r1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 2, subfamily r, polypeptide 1; targeted mutation 1, Velocigene	MGI:3808340	Cyp2r1<tm1(KOMP)Vlcg>	24019477	KOMP-Regeneron
cytochrome P450, family 2, subfamily s, polypeptide 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840631	Cyp2s1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 2, subfamily s, polypeptide 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840591	Cyp2s1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 2, subfamily u, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141847	Cyp2u1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 2, subfamily u, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635043	Cyp2u1<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 2, subfamily u, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5285745	Cyp2u1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 3, subfamily a, polypeptide 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841233	Cyp3a11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841155	Cyp3a11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432295	Cyp3a13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 3, subfamily a, polypeptide 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433966	Cyp3a13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 3, subfamily a, polypeptide 13; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473052	Cyp3a13<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 3, subfamily a, polypeptide 13; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472865	Cyp3a13<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 3, subfamily a, polypeptide 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365233	Cyp3a16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 16; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451542	Cyp3a16<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456667	Cyp3a25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455614	Cyp3a25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 41B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841336	Cyp3a41b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 57; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840981	Cyp3a57<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 57; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841456	Cyp3a57<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 3, subfamily a, polypeptide 59; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947752	Cyp3a59<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily a, polypeptide 12a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461766	Cyp4a12a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 4, subfamily a, polypeptide 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432063	Cyp4a14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 4, subfamily a, polypeptide 14; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434440	Cyp4a14<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 4, subfamily a, polypeptide 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841017	Cyp4a32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily a, polypeptide 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841329	Cyp4a32<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily b, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364022	Cyp4b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily b, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548340	Cyp4b1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome P450, family 4, subfamily b, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363698	Cyp4b1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily b, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363698	Cyp4b1<tm1e(KOMP)Wtsi>	23748241	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 14; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5613654	Cyp4f14<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cytochrome P450, family 4, subfamily f, polypeptide 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363438	Cyp4f15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364040	Cyp4f15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364137	Cyp4f16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 16; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637043	Cyp4f16<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363415	Cyp4f16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319851	Cyp4f18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 18; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319899	Cyp4f18<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 41 pseudogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362303	Cyp4f41-ps<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily f, polypeptide 41 pseudogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362311	Cyp4f41-ps<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytochrome P450, family 4, subfamily v, polypeptide 3; targeted mutation 1, Velocigene	MGI:3808361	Cyp4v3<tm1(KOMP)Vlcg>	25118264	KOMP-Regeneron
cytochrome P450, family 4, subfamily x, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938558	Cyp4x1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 4, subfamily x, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433618	Cyp4x1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 51; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009660	Cyp51<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 7, subfamily a, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433062	Cyp7a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 7, subfamily a, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434377	Cyp7a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 7, subfamily b, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461727	Cyp7b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 7, subfamily b, polypeptide 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5607535	Cyp7b1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
cytochrome P450, family 7, subfamily b, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462683	Cyp7b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 8, subfamily b, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473191	Cyp8b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 8, subfamily b, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472765	Cyp8b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytochrome P450, family 8, subfamily b, polypeptide 1; targeted mutation 1, Velocigene	MGI:3813072	Cyp8b1<tm1(KOMP)Vlcg>	25338812	KOMP-Regeneron
cytoglobin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947843	Cygb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytoglobin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944566	Cygb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytohesin 1 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843844	Cytip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytohesin 1 interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548783	Cytip<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytohesin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014683	Cyth1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytohesin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456013	Cyth2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytohesin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456045	Cyth2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytohesin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365063	Cyth3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytohesin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363288	Cyth3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytohesin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365249	Cyth3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cytohesin 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364748	Cyth3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytohesin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009647	Cyth4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytohesin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014689	Cyth4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytokine inducible SH2-containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362236	Cish<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytokine inducible SH2-containing protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363203	Cish<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytokine inducible SH2-containing protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364730	Cish<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cytokine receptor-like factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363171	Crlf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytokine receptor-like factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363171	Crlf3<tm1a(KOMP)Wtsi>	23870131	KOMP-CSD
cytokine receptor-like factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363171	Crlf3<tm1a(KOMP)Wtsi>	24197666	KOMP-CSD
cytokine receptor-like factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548496	Crlf3<tm1b(KOMP)Wtsi>	24197666	KOMP-CSD
cytokine receptor-like factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548496	Crlf3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
cytokine receptor-like factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365173	Crlf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytoplasmic FMR1 interacting protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002986	Cyfip1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
cytoplasmic FMR1 interacting protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002986	Cyfip1<tm2a(EUCOMM)Wtsi>	24667445	EUCOMM
cytoplasmic FMR1 interacting protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5002987	Cyfip1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
cytoplasmic FMR1 interacting protein 2; mutation 1, National Institutes of Health	MGI:5527294	Cyfip2<M1N>	24357318	null
cytoplasmic FMR1 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434196	Cyfip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytoplasmic FMR1 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434196	Cyfip2<tm1a(EUCOMM)Wtsi>	24357318	EUCOMM
cytoplasmic FMR1 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434196	Cyfip2<tm1a(EUCOMM)Wtsi>	27524794	EUCOMM
cytoplasmic FMR1 interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433418	Cyfip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
cytoplasmic FMR1 interacting protein 2; targeted mutation 1, Velocigene	MGI:5085782	Cyfip2<tm1(KOMP)Vlcg>	25432536	KOMP-Regeneron
cytoplasmic FMR1 interacting protein 2; wild type	MGI:3048261	Cyfip2<+>	24357318	null
cytoplasmic polyadenylation element binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364439	Cpeb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytoplasmic polyadenylation element binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293994	Cpeb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytoplasmic polyadenylation element binding protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293995	Cpeb2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytoplasmic polyadenylation element binding protein 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5293996	Cpeb2<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
cytoplasmic polyadenylation element binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434181	Cpeb4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytoplasmic polyadenylation element binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434181	Cpeb4<tm1a(EUCOMM)Wtsi>	25220394	EUCOMM
cytoplasmic polyadenylation element binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434181	Cpeb4<tm1a(EUCOMM)Wtsi>	27381259	EUCOMM
cytoplasmic polyadenylation element binding protein 4; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5805966	Cpeb4<tm1d(EUCOMM)Wtsi>	27381259	EUCOMM
cytoskeleton-associated protein 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5561565	Ckap4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
cytosolic iron-sulfur protein assembly 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432576	Ciao1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
cytosolic thiouridylase subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840914	Ctu1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
cytosolic thiouridylase subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841378	Ctu1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
cytosolic thiouridylase subunit 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294007	Ctu1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
cytosolic thiouridylase subunit 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293993	Ctu1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
cytosolic thiouridylase subunit 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419518	Ctu2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
cytotoxic T lymphocyte-associated protein 2 beta; targeted mutation 1.1, Mammalian Functional Genomics Centre	MGI:5766141	Ctla2b<tm1.1(NCOM)Mfgc>	27626380	NorCOMM
D4, zinc and double PHD fingers, family 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441840	Dpf3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
D4, zinc and double PHD fingers, family 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441992	Dpf3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dachshund family transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427177	Dach1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dachshund family transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427177	Dach1<tm1a(KOMP)Wtsi>	28779009	KOMP-CSD
dachshund family transcription factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529614	Dach1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
dachshund family transcription factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529614	Dach1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dachshund family transcription factor 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925368	Dach1<tm1c(KOMP)Wtsi>	28779009	KOMP-CSD
dachshund family transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427113	Dach1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
damage specific DNA binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363057	Ddb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
damage specific DNA binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286173	Ddb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
damage specific DNA binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293900	Ddb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DAZ associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462677	Dazap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DAZ associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462673	Dazap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DAZ interacting protein 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319839	Dzip1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DAZ interacting protein 1-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319894	Dzip1l<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
DAZ interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419927	Dzip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DBF4 zinc finger; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419542	Dbf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DBF4 zinc finger; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494452	Dbf4<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
DBF4 zinc finger; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494452	Dbf4<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
DBF4 zinc finger; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419491	Dbf4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458463	Dcun1d3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458552	Dcun1d3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dCTP pyrophosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427197	Dctpp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DDB1 and CUL4 associated factor 10; targeted mutation 1.1, Velocigene	MGI:5529061	Dcaf10<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DDB1 and CUL4 associated factor 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888935	Dcaf10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DDB1 and CUL4 associated factor 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888946	Dcaf10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DDB1 and CUL4 associated factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841129	Dcaf11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DDB1 and CUL4 associated factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841129	Dcaf11<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
DDB1 and CUL4 associated factor 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840943	Dcaf11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DDB1 and CUL4 associated factor 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454174	Dcaf13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DDB1 and CUL4 associated factor 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454158	Dcaf13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DDB1 and CUL4 associated factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842256	Dcaf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DDB1 and CUL4 associated factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842495	Dcaf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DDB1 and CUL4 associated factor 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432724	Dcaf7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DDB1 and CUL4 associated factor 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431829	Dcaf7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DDHD domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362938	Ddhd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DDHD domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362901	Ddhd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DDHD domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820273	Ddhd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DDHD domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820373	Ddhd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DDRGK domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4456718	Ddrgk1<tm1a(EUCOMM)Hmgu>	26544067	EUCOMM
DDRGK domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692746	Ddrgk1<tm1b(EUCOMM)Hmgu>	26544067	EUCOMM
DDRGK domain containing 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5896836	Ddrgk1<tm1c(EUCOMM)Hmgu>	26544067	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455468	Ddx19a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455469	Ddx19a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014691	Ddx19b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433262	Ddx20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888925	Ddx21<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888943	Ddx21<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432522	Ddx23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431695	Ddx23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014711	Ddx25<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363861	Ddx27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363861	Ddx27<tm1a(KOMP)Wtsi>	28981838	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364650	Ddx27<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27; targeted mutation 1, William C Skarnes	MGI:5903510	Ddx27<tm1Wcs>	28981838	null
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948645	Ddx39b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944327	Ddx39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944407	Ddx39<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951139	Ddx3y<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5303166	Ddx3y<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364589	Ddx41<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548627	Ddx41<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948648	Ddx42<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433882	Ddx43<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432588	Ddx43<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432596	Ddx49<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432378	Ddx49<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451373	Ddx4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451415	Ddx4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 50; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364059	Ddx50<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 50; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455491	Ddx50<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 50; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455472	Ddx50<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 51; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431446	Ddx51<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 52; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434081	Ddx52<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 52; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432764	Ddx52<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 55; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434030	Ddx55<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 55; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432920	Ddx55<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888928	Ddx56<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888953	Ddx56<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456813	Ddx58<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 59; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441832	Ddx59<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364758	Ddx5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364003	Ddx5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433764	Ddx60<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433764	Ddx60<tm1a(EUCOMM)Wtsi>	25981042	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433764	Ddx60<tm1a(EUCOMM)Wtsi>	26457795	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5792890	Ddx60<tm1b(EUCOMM)Wtsi>	25981042	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5806064	Ddx60<tm1d(EUCOMM)Wtsi>	26457795	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434271	Ddx60<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456033	Ddx6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD (Asp-Glu-Ala-Asp) box polypeptide 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456076	Ddx6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000396	Ddx11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000421	Ddx11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950255	Dhx15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951129	Dhx15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820343	Dhx16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433104	Dhx29<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434276	Dhx29<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 30; targeted mutation 1.1, Velocigene	MGI:5474769	Dhx30<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DEAH (Asp-Glu-Ala-His) box polypeptide 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000320	Dhx33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 33; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637153	Dhx33<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006751	Dhx33<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453709	Dhx35<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 35; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637055	Dhx35<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 35; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453699	Dhx35<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458576	Dhx36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458559	Dhx36<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052503	Dhx38<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419814	Dhx40<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 40; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548542	Dhx40<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419368	Dhx40<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEAH (Asp-Glu-Ala-His) box polypeptide 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432781	Dhx8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEAH (Asp-Glu-Ala-His) box polypeptide 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434477	Dhx8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DEAQ RNA-dependent ATPase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427225	Dqx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
death associated protein kinase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548588	Dapk1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
death associated protein kinase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548588	Dapk1<tm1b(EUCOMM)Hmgu>	28731405	EUCOMM
death-associated protein kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434345	Dapk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
death-associated protein kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434493	Dapk2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
decapping enzyme, scavenger; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5505910	Dcps<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
decapping enzyme, scavenger; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5505910	Dcps<tm1b(EUCOMM)Hmgu>	28700664	EUCOMM
decapping exoribonuclease; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419213	Dxo<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
decapping mRNA 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434245	Dcp1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
decapping mRNA 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362601	Dcp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
decapping mRNA 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5618767	Dcp2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
decapping mRNA 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363732	Dcp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dedicator of cytokinesis 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436497	Dock10<tm1a(EUCOMM)Hmgu>	25729399	EUCOMM
dedicator of cytokinesis 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436497	Dock10<tm1a(EUCOMM)Hmgu>	27502165	EUCOMM
dedicator of cytokinesis 10; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436497	Dock10<tm1a(EUCOMM)Hmgu>	28507547	EUCOMM
dedicator of cytokinesis 10; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5913865	Dock10<tm1c(EUCOMM)Hmgu>	28507547	EUCOMM
dedicator of cytokinesis 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364363	Dock11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dedicator of cytokinesis 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365237	Dock11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dedicator of cytokinesis 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840961	Dock11<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
dedicator of cytokinesis 11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840950	Dock11<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dedicator of cyto-kinesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432433	Dock2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dedicator of cyto-kinesis 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434255	Dock2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dedicator of cyto-kinesis 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363361	Dock3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dedicator of cyto-kinesis 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363689	Dock3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dedicator of cytokinesis 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842372	Dock5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dedicator of cytokinesis 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051017	Dock7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dedicator of cytokinesis 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051017	Dock7<tm1a(EUCOMM)Wtsi>	27175020	EUCOMM
dedicator of cytokinesis 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085472	Dock7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
defender against cell death 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433182	Dad1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defender against cell death 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432212	Dad1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
defender against cell death 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434330	Dad1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000405	Defb11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362993	Defb14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363755	Defb14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286402	Defb15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013752	Defb18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458560	Defb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 20; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5645997	Defb20<tm1b(EUCOMM)Hmgu>	20978075	EUCOMM
defensin beta 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014598	Defb21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319798	Defb21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013746	Defb22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014567	Defb22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419752	Defb25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420148	Defb25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013735	Defb26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 26; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014593	Defb26<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363418	Defb30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 30; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4454128	Defb30<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 30; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637070	Defb30<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
defensin beta 30; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4454112	Defb30<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141845	Defb40<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5141835	Defb40<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364307	Defb43<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 43; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692868	Defb43<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
defensin beta 43; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841438	Defb43<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
defensin beta 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008035	Defb45<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 45; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008940	Defb45<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441630	Defb47<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 47; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441858	Defb47<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 50; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000424	Defb50<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141843	Defb7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
defensin beta 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5285743	Defb7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dehydrodolichyl diphosphate synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362250	Dhdds<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dehydrodolichyl diphosphate synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362430	Dhdds<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dehydrogenase/reductase member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364555	Dhrs2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dehydrogenase/reductase member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364280	Dhrs2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dehydrogenase/reductase member 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511897	Dhrs2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
dehydrogenase/reductase (SDR family) member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947734	Dhrs11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dehydrogenase/reductase (SDR family) member 7B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434269	Dhrs7b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dehydrogenase/reductase (SDR family) member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431973	Dhrs9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dehydrogenase/reductase (SDR family) member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432208	Dhrs9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
deiodinase, iodothyronine, type II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009575	Dio2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
deiodinase, iodothyronine, type II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427116	Dio2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
deiodinase, iodothyronine, type I; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419442	Dio1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
DEK oncogene (DNA binding); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419995	Dek<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEK oncogene (DNA binding); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420017	Dek<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
deleted in azoospermia-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364955	Dazl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
deleted in azoospermia-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458524	Dazl<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
deleted in colorectal carcinoma; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766182	Dcc<tm1b(NCOM)Mfgc>	27626380	NorCOMM
deleted in liver cancer 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000387	Dlc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
deleted in liver cancer 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000395	Dlc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
deleted in liver cancer 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5497031	Dlc1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
deleted in lung and esophageal cancer 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432388	Dlec1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
deleted in lung and esophageal cancer 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548818	Dlec1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
deleted in lung and esophageal cancer 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432926	Dlec1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
deleted in primary ciliary dyskinesia; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820331	Dpcd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
deleted in primary ciliary dyskinesia; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820244	Dpcd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
delta like canonical Notch ligand 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432653	Dll1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
delta like canonical Notch ligand 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431753	Dll3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
delta like canonical Notch ligand 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433584	Dll3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
delta like canonical Notch ligand 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842302	Dll3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
delta like canonical Notch ligand 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473012	Dll3<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
delta like canonical Notch ligand 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432584	Dll4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
delta like canonical Notch ligand 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432907	Dll4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
delta/notch-like EGF repeat containing; targeted mutation 3b, Helmholtz Zentrum Muenchen GmbH	MGI:5637119	Dner<tm3b(EUCOMM)Hmgu>	27626380	EUCOMM
deltex 1, E3 ubiquitin ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432431	Dtx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
deltex 1, E3 ubiquitin ligase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473074	Dtx1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
deltex 3, E3 ubiquitin ligase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419598	Dtx3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
dendrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461670	Ddn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dendrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461710	Ddn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432789	Dennd1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433195	Dennd1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432505	Dennd1c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432505	Dennd1c<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
DENN/MADD domain containing 1C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548604	Dennd1c<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
DENN/MADD domain containing 1C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433506	Dennd1c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 2C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419317	Dennd2c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DENN/MADD domain containing 2C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419463	Dennd2c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DENN/MADD domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841067	Dennd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DENN/MADD domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840933	Dennd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DENN/MADD domain containing 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433553	Dennd4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433830	Dennd4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141837	Dennd4c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 4C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637024	Dennd4c<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
DENN/MADD domain containing 4C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951092	Dennd4c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 5A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051004	Dennd5a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 5A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085479	Dennd5a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431827	Dennd5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DENN/MADD domain containing 5B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433997	Dennd5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
density-regulated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451332	Denr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
density-regulated protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637029	Denr<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
density-regulated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451505	Denr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
denticleless E3 ubiquitin protein ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141844	Dtl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
denticleless E3 ubiquitin protein ligase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692745	Dtl<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
denticleless E3 ubiquitin protein ligase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5285744	Dtl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
denticleless E3 ubiquitin protein ligase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5285744	Dtl<tm1e(EUCOMM)Wtsi>	28818995	EUCOMM
dentin sialophosphoprotein; targeted mutation 1.1, Velocigene	MGI:5695883	Dspp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
deoxycytidine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441631	Dck<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
deoxycytidine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441934	Dck<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
deoxyhypusine hydroxylase/monooxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441723	Dohh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
deoxyhypusine hydroxylase/monooxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441671	Dohh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
deoxyhypusine synthase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419531	Dhps<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
deoxyhypusine synthase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842333	Dhps<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
deoxyhypusine synthase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842333	Dhps<tm2a(EUCOMM)Wtsi>	26037925	EUCOMM
deoxyhypusine synthase; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5812110	Dhps<tm2c(EUCOMM)Wtsi>	26037925	EUCOMM
deoxyhypusine synthase; targeted mutation 2d, Wellcome Trust Sanger Institute	MGI:5812111	Dhps<tm2d(EUCOMM)Wtsi>	26037925	EUCOMM
deoxyhypusine synthase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4842425	Dhps<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
deoxynucleotidyltransferase, terminal, interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362471	Dnttip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
deoxynucleotidyltransferase, terminal, interacting protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635045	Dnttip1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
deoxynucleotidyltransferase, terminal, interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362732	Dnttip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
deoxynucleotidyltransferase, terminal, interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820282	Dnttip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
deoxynucleotidyltransferase, terminal, interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820355	Dnttip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
deoxynucleotidyltransferase, terminal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419891	Dntt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
deoxynucleotidyltransferase, terminal; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296136	Dntt<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
deoxynucleotidyltransferase, terminal; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5505648	Dntt<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
deoxynucleotidyltransferase, terminal; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296134	Dntt<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
deoxyribonuclease 1-like 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5501065	Dnase1l2<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
deoxyribonuclease 1-like 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5501065	Dnase1l2<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
deoxyribonuclease 1-like 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5501065	Dnase1l2<tm1.1(KOMP)Wtsi>	28700664	KOMP-CSD
deoxyribonuclease 1-like 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362265	Dnase1l2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
deoxyribonuclease 1-like 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362265	Dnase1l2<tm1(KOMP)Wtsi>	23870131	KOMP-CSD
deoxyribonuclease 1-like 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362265	Dnase1l2<tm1(KOMP)Wtsi>	27626380	KOMP-CSD
deoxyribonuclease 1-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363717	Dnase1l3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
deoxyribonuclease 1-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363412	Dnase1l3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
deoxyuridine triphosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948652	Dut<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEP domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362734	Depdc1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DEP domain containing 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364009	Depdc1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEP domain containing 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637113	Depdc5<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
DEP domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052484	Depdc7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEP domain containing MTOR-interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457558	Deptor<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEP domain containing MTOR-interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457578	Deptor<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Der1-like domain family, member 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637117	Derl2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
desmin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431655	Des<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
desmin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432380	Des<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
desmocollin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420081	Dsc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
desmocollin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420021	Dsc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
desmocollin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455496	Dsc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
desmocollin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455602	Dsc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
desmocollin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461753	Dsc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
desmocollin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461734	Dsc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
desmoglein 1 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296543	Dsg1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
desmoglein 1 beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364614	Dsg1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
desmoglein 1 beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364397	Dsg1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
desmoglein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432319	Dsg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
desmoglein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432319	Dsg2<tm1a(EUCOMM)Wtsi>	27338829	EUCOMM
desmoglein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433964	Dsg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
desmoglein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364255	Dsg4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
desmoglein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362335	Dsg4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
desmoglein 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365069	Dsg4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
destrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363033	Dstn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
destrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363033	Dstn<tm1a(KOMP)Wtsi>	26275310	KOMP-CSD
destrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363645	Dstn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
desumoylating isopeptidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428596	Desi2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
desumoylating isopeptidase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428586	Desi2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
developing brain homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006788	Dbx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
developmentally regulated GTP binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432942	Drg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
developmentally regulated GTP binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434108	Drg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
developmental pluripotency associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362687	Dppa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
developmental pluripotency associated 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5574608	Dppa1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
developmental pluripotency associated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362522	Dppa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DEXH (Asp-Glu-X-His) box polypeptide 58; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433000	Dhx58<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DEXH (Asp-Glu-X-His) box polypeptide 58; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433950	Dhx58<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
D-glutamate cyclase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362774	Dglucy<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
D-glutamate cyclase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362774	Dglucy<tm1a(KOMP)Wtsi>	28266638	KOMP-CSD
D-glutamate cyclase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5903047	Dglucy<tm1b(KOMP)Wtsi>	28266638	KOMP-CSD
D-glutamate cyclase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364051	Dglucy<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
diablo, IAP-binding mitochondrial protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842340	Diablo<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
diablo, IAP-binding mitochondrial protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842250	Diablo<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol kinase, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433139	Dgka<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol kinase, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432315	Dgka<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol kinase, epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286176	Dgke<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol kinase, gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364996	Dgkg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol kinase, gamma; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451395	Dgkg<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol kinase, gamma; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451674	Dgkg<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol kinase, theta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451408	Dgkq<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol kinase, theta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451408	Dgkq<tm1a(KOMP)Wtsi>	26748701	KOMP-CSD
diacylglycerol kinase, theta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569033	Dgkq<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
diacylglycerol lipase, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432581	Dagla<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol lipase, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434178	Dagla<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol lipase, alpha; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455987	Dagla<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol lipase, alpha; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455971	Dagla<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol lipase, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427196	Daglb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol lipase, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427154	Daglb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol O-acyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431653	Dgat1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol O-acyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432718	Dgat1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
diacylglycerol O-acyltransferase 2-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364866	Dgat2l6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
diacylglycerol O-acyltransferase 2-like 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299567	Dgat2l6<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
diaphanous related formin 3; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5571349	Diaph3<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
diazepam binding inhibitor-like 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419106	Dbil5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
diazepam binding inhibitor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419418	Dbi<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
dicarbonyl L-xylulose reductase; targeted mutation 1.1, Velocigene	MGI:5692681	Dcxr<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
dicarbonyl L-xylulose reductase; targeted mutation 1.1, Velocigene	MGI:5692681	Dcxr<tm1.1(KOMP)Vlcg>	27643531	KOMP-Regeneron
dicarbonyl L-xylulose reductase; targeted mutation 1, Velocigene	MGI:3800082	Dcxr<tm1(KOMP)Vlcg>	27643531	KOMP-Regeneron
dicer 1, ribonuclease type III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461668	Dicer1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dicer 1, ribonuclease type III; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692797	Dicer1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
dickkopf-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363835	Dkkl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dickkopf-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363038	Dkkl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dickkopf WNT signaling pathway inhibitor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427215	Dkk1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
dickkopf WNT signaling pathway inhibitor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008017	Dkk2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dickkopf WNT signaling pathway inhibitor 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050980	Dkk2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
dickkopf WNT signaling pathway inhibitor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841319	Dkk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dickkopf WNT signaling pathway inhibitor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841319	Dkk3<tm1a(KOMP)Wtsi>	27699213	KOMP-CSD
dickkopf WNT signaling pathway inhibitor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840982	Dkk3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dickkopf WNT signaling pathway inhibitor 4; targeted mutation 1.1, Velocigene	MGI:5572034	Dkk4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
differentially expressed in FDCP 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944563	Def6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
differentially expressed in FDCP 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944512	Def6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
differentially expressed in FDCP 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433995	Def8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DiGeorge syndrome critical region gene 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820058	Dgcr14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DiGeorge syndrome critical region gene 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820153	Dgcr14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DiGeorge syndrome critical region gene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432517	Dgcr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DiGeorge syndrome critical region gene 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548928	Dgcr2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
DiGeorge syndrome critical region gene 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433118	Dgcr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DiGeorge syndrome critical region gene 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868083	Dgcr6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DiGeorge syndrome critical region gene 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868092	Dgcr6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
digestive organ expansion factor homolog (zebrafish); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362971	Diexf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
digestive organ expansion factor homolog (zebrafish); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363387	Diexf<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
digestive organ expansion factor homolog (zebrafish); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364121	Diexf<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dihydrofolate reductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441711	Dhfr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrofolate reductase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513765	Dhfr<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
dihydrofolate reductase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441979	Dhfr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrolipoamide branched chain transacylase E2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433927	Dbt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrolipoamide branched chain transacylase E2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434399	Dbt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrolipoamide branched chain transacylase E2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473081	Dbt<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434065	Dlst<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433507	Dlst<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dihydroorotate dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842671	Dhodh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydroorotate dehydrogenase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548703	Dhodh<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
dihydroorotate dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842751	Dhodh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dihydropyrimidinase-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296137	Dpysl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dihydropyrimidinase-like 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296140	Dpysl2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dihydropyrimidinase-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461717	Dpysl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydropyrimidinase-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363781	Dpysl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dihydropyrimidinase-like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363986	Dpysl4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dihydropyrimidinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950254	Dpys<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydropyrimidinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951099	Dpys<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dihydropyrimidine dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365089	Dpyd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dihydropyrimidine dehydrogenase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513767	Dpyd<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dihydrouridine synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452769	Dus2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrouridine synthase 3-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302338	Dus3l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrouridine synthase 3-like (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302304	Dus3l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrouridine synthase 4-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441833	Dus4l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dihydrouridine synthase 4-like (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441915	Dus4l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dimethylarginine dimethylaminohydrolase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432090	Ddah1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dimethylarginine dimethylaminohydrolase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527610	Ddah1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
dimethylglycine dehydrogenase precursor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451237	Dmgdh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dimethylglycine dehydrogenase precursor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451684	Dmgdh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dipeptidase 1 (renal); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362148	Dpep1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dipeptidase 1 (renal); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364290	Dpep1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dipeptidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302364	Dpep2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431997	Dpep2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302327	Dpep2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364519	Dpep3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dipeptidase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362769	Dpep3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dipeptidylpeptidase 10; targeted mutation 1.1, Mammalian Functional Genomics Centre	MGI:5766148	Dpp10<tm1.1(NCOM)Mfgc>	27626380	NorCOMM
dipeptidylpeptidase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433896	Dpp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidylpeptidase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432610	Dpp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidylpeptidase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461728	Dpp7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidylpeptidase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462682	Dpp7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidylpeptidase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432891	Dpp9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidylpeptidase 9; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548821	Dpp9<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
dipeptidylpeptidase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434467	Dpp9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidylpeptidase 9; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511923	Dpp9<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
dipeptidylpeptidase 9; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511896	Dpp9<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
diphosphoinositol pentakisphosphate kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432024	Ppip5k1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
diphosphoinositol pentakisphosphate kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433621	Ppip5k2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
diphosphoinositol pentakisphosphate kinase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635268	Ppip5k2<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
diphosphoinositol pentakisphosphate kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433399	Ppip5k2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
diphosphoinositol pentakisphosphate kinase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433446	Ppip5k2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
diphosphoinositol pentakisphosphate kinase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434174	Ppip5k2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
diphthamide biosynthesis 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431817	Dph1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
diphthamide biosynthesis 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432853	Dph1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
diphthamide biosynthesis 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362206	Dph5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
diphthamide biosynthesis 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362293	Dph5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
diphthamine biosynthesis 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363043	Dph3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
diphthamine biosynthesis 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363516	Dph3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
diphthamine biosynthesis 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5286215	Dph3<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
diphthamine biosynthesis 3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5293913	Dph3<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
diphthamine biosynthesis 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880925	Dph6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
diphthamine biosynthesis 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880990	Dph6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DIRAS family, GTP-binding RAS-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452011	Diras1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DIRAS family, GTP-binding RAS-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452828	Diras1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DIRAS family, GTP-binding RAS-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950253	Diras2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DIRAS family, GTP-binding RAS-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951125	Diras2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease; targeted mutation 1e.1, Helmholtz Zentrum Muenchen GmbH	MGI:5548623	Dis3<tm1e.1(EUCOMM)Hmgu>	27626380	EUCOMM
disabled 2, mitogen-responsive phosphoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427209	Dab2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
discoidin, CUB  and LCCL domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432501	Dcbld1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
discoidin, CUB  and LCCL domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431913	Dcbld1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
discoidin, CUB  and LCCL domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434524	Dcbld1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
discoidin, CUB and LCCL domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363322	Dcbld2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
discoidin, CUB and LCCL domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364250	Dcbld2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
discoidin domain receptor family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820346	Ddr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
discoidin domain receptor family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820346	Ddr2<tm1a(EUCOMM)Wtsi>	27264173	EUCOMM
discoidin domain receptor family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820346	Ddr2<tm1a(EUCOMM)Wtsi>	27640147	EUCOMM
discoidin domain receptor family, member 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5806884	Ddr2<tm1b(EUCOMM)Wtsi>	27264173	EUCOMM
discoidin domain receptor family, member 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806885	Ddr2<tm1c(EUCOMM)Wtsi>	27264173	EUCOMM
discoidin domain receptor family, member 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806885	Ddr2<tm1c(EUCOMM)Wtsi>	27640147	EUCOMM
discoidin domain receptor family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820352	Ddr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
disco interacting protein 2 homolog A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841288	Dip2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
disco interacting protein 2 homolog A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820141	Dip2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
disco interacting protein 2 homolog A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841025	Dip2a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
disco interacting protein 2 homolog A; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548794	Dip2a<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
disco interacting protein 2 homolog A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841442	Dip2a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
disco interacting protein 2 homolog B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431779	Dip2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
disco interacting protein 2 homolog B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432503	Dip2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
disco interacting protein 2 homolog C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453692	Dip2c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454171	Dlg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
discs large MAGUK scaffold protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841070	Dlg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
discs large MAGUK scaffold protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5426633	Dlg1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
discs large MAGUK scaffold protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5426580	Dlg1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
discs large MAGUK scaffold protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842622	Dlg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842820	Dlg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441739	Dlg3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441977	Dlg3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842264	Dlg4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5805884	Dlg4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5805884	Dlg4<tm1e(EUCOMM)Wtsi>	26865945	EUCOMM
discs large MAGUK scaffold protein 4; targeted mutation 1, Seth G N Grant	MGI:2182460	Dlg4<tm1Grnt>	24721909	null
discs large MAGUK scaffold protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052495	Dlg5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
discs large MAGUK scaffold protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140466	Dlg5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dishevelled associated activator of morphogenesis 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637022	Daam1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
dishevelled associated activator of morphogenesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841108	Daam2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled associated activator of morphogenesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841108	Daam2<tm1a(KOMP)Wtsi>	24091014	KOMP-CSD
dishevelled associated activator of morphogenesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841108	Daam2<tm1a(KOMP)Wtsi>	25754822	KOMP-CSD
dishevelled associated activator of morphogenesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841108	Daam2<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
dishevelled associated activator of morphogenesis 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637087	Daam2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dishevelled associated activator of morphogenesis 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841151	Daam2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled-binding antagonist of beta-catenin 1; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:4460401	Dact1<tm2a(EUCOMM)Hmgu>	24681206	EUCOMM
dishevelled-binding antagonist of beta-catenin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451965	Dact2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dishevelled-binding antagonist of beta-catenin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5584408	Dact2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
dishevelled-binding antagonist of beta-catenin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452021	Dact2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dishevelled-binding antagonist of beta-catenin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319818	Dact3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled-binding antagonist of beta-catenin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637190	Dact3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dishevelled-binding antagonist of beta-catenin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841404	Dact3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled-binding antagonist of beta-catenin 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319834	Dact3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled segment polarity protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473039	Dvl1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
dishevelled segment polarity protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472857	Dvl1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
dishevelled segment polarity protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511154	Dvl1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
dishevelled segment polarity protein 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511147	Dvl1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
dishevelled segment polarity protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362583	Dvl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled segment polarity protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363087	Dvl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled segment polarity protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299605	Dvl3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
dishevelled segment polarity protein 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299526	Dvl3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dispatched RND tramsporter family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050843	Disp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dispatched RND tramsporter family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050854	Disp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dispatched RND transporter family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364057	Disp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dispatched RND transporter family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364461	Disp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
disrupted in renal carcinoma 2 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362697	Dirc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
disrupted in renal carcinoma 2 (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365060	Dirc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
distal membrane arm assembly complex 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432355	Dmac2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
distal membrane arm assembly complex 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431793	Dmac2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DIX domain containing 1; targeted mutation 1.1, Velocigene	MGI:5445766	Dixdc1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DIX domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419679	Dixdc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
DLG associated protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296545	Dlgap4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DLG associated protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296529	Dlgap4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DMRT-like family C1a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451707	Dmrtc1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Dmx-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432280	Dmxl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Dmx-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432280	Dmxl2<tm1a(EUCOMM)Wtsi>	25248098	EUCOMM
Dmx-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432280	Dmxl2<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
Dmx-like 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5705577	Dmxl2<tm1c(EUCOMM)Wtsi>	25248098	EUCOMM
Dmx-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433893	Dmxl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA cross-link repair 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433162	Dclre1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA cross-link repair 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432409	Dclre1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA (cytosine-5-)-methyltransferase 3-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302375	Dnmt3l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA (cytosine-5-)-methyltransferase 3-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302374	Dnmt3l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA damage-induced apoptosis suppressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461747	Ddias<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA damage-induced apoptosis suppressor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462670	Ddias<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA-damage inducible transcript 3; targeted mutation 1.1, Velocigene	MGI:5569942	Ddit3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DNA-damage regulated autophagy modulator 1; targeted mutation 1.1, Velocigene	MGI:5692708	Dram1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DNA-damage regulated autophagy modulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938576	Dram1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA-damage regulated autophagy modulator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842579	Dram2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA-damage regulated autophagy modulator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842733	Dram2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA fragmentation factor, beta subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434230	Dffb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA fragmentation factor, beta subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431841	Dffb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member A1; targeted mutation 1.1, Velocigene	MGI:5445777	Dnaja1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member A4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296125	Dnaja4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member A4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5521538	Dnaja4<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member A4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5521538	Dnaja4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member A4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431439	Dnaja4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member A4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4843849	Dnaja4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member A4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4843836	Dnaja4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member B11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050997	Dnajb11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member B11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085481	Dnajb11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member B12; targeted mutation 1.1, Velocigene	MGI:5471844	Dnajb12<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member B12; targeted mutation 1.1, Velocigene	MGI:5471844	Dnajb12<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member B12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433319	Dnajb12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member B12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431591	Dnajb12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947821	Dnajb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member B3; targeted mutation 1.1, Velocigene	MGI:5468983	Dnajb3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member B3; targeted mutation 1.1, Velocigene	MGI:5468983	Dnajb3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member B6; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050917	Dnajb6<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member B7; targeted mutation 1.1, Velocigene	MGI:5445758	Dnajb7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member B7; targeted mutation 1.1, Velocigene	MGI:5445758	Dnajb7<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432496	Dnajc12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member C12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434112	Dnajc12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member C14; targeted mutation 1.1, Velocigene	MGI:5471951	Dnajc14<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C14; targeted mutation 1.1, Velocigene	MGI:5471951	Dnajc14<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362832	Dnajc15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548512	Dnajc15<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364788	Dnajc15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C16; targeted mutation 1.1, Velocigene	MGI:5463938	Dnajc16<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C16; targeted mutation 1.1, Velocigene	MGI:5463938	Dnajc16<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C17; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548585	Dnajc17<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
DnaJ heat shock protein family (Hsp40) member C18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820211	Dnajc18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member C1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427146	Dnajc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C21; targeted mutation 1.1, Mammalian Functional Genomics Centre	MGI:5766144	Dnajc21<tm1.1(NCOM)Mfgc>	27626380	NorCOMM
DnaJ heat shock protein family (Hsp40) member C22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362643	Dnajc22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362758	Dnajc22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432971	Dnajc24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member C24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433547	Dnajc24<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member C25; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5503333	Dnajc25<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C28; targeted mutation 1.1, Velocigene	MGI:5463945	Dnajc28<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C5 beta; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548519	Dnajc5b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
DnaJ heat shock protein family (Hsp40) member C5 gamma; targeted mutation 1.1, Velocigene	MGI:5445923	Dnajc5g<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C5 gamma; targeted mutation 1.1, Velocigene	MGI:5445923	Dnajc5g<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052492	Dnajc5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DnaJ heat shock protein family (Hsp40) member C7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362904	Dnajc7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5476999	Dnajc7<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5476999	Dnajc7<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364754	Dnajc7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050155	Dnajc8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637033	Dnajc8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DnaJ heat shock protein family (Hsp40) member C9; targeted mutation 1.1, Velocigene	MGI:5474770	Dnajc9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DnaJ heat shock protein family (Hsp40) member C9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4881080	Dnajc9<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
DNA methyltransferase 1-associated protein 1; targeted mutation 1.1, Velocigene	MGI:5443931	Dmap1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DNA methyltransferase 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364077	Dnmt3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA methyltransferase 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364077	Dnmt3a<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
DNA methyltransferase 3A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446396	Dnmt3a<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
DNA methyltransferase 3A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446396	Dnmt3a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
DNA methyltransferase 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362743	Dnmt3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DNA methyltransferase (cytosine-5) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362219	Dnmt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA methyltransferase (cytosine-5) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362596	Dnmt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DNA methyltransferase (cytosine-5) 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455481	Dnmt1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA methyltransferase (cytosine-5) 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455509	Dnmt1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
DNA polymerase N; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548853	Poln<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
DNA primase, p49 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431824	Prim1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA primase, p49 subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441632	Prim1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA primase, p49 subunit; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441728	Prim1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA replication and sister chromatid cohesion 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362627	Dscc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA replication helicase/nuclease 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842457	Dna2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA replication helicase/nuclease 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842458	Dna2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA segment, Chr 10, Johns Hopkins University 81 expressed; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431462	D10Jhu81e<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 16, ERATO Doi 472, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842357	D16Ertd472e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA segment, Chr 16, ERATO Doi 472, expressed; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842718	D16Ertd472e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA segment, Chr 17, Wayne State University 92, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944352	D17Wsu92e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 17, Wayne State University 92, expressed; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944409	D17Wsu92e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 1, ERATO Doi 622, expressed; targeted mutation 1.1, Velocigene	MGI:5554912	D1Ertd622e<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DNA segment, Chr 1, ERATO Doi 622, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456040	D1Ertd622e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA segment, Chr 1, ERATO Doi 622, expressed; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455969	D1Ertd622e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DNA segment, Chr 1, Pasteur Institute 1; targeted mutation 1, Velocigene	MGI:4399403	D1Pas1<tm1(KOMP)Vlcg>	27473657	KOMP-Regeneron
DNA segment, Chr 1, Pasteur Institute 1; targeted mutation 1, Velocigene	MGI:4399403	D1Pas1<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
DNA segment, Chr 3, ERATO Doi 751, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887641	D3Ertd751e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 3, ERATO Doi 751, expressed; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887636	D3Ertd751e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 6, Wayne State University 163, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951107	D6Wsu163e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DNA segment, Chr 6, Wayne State University 163, expressed; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636910	D6Wsu163e<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
DNA segment, Chr 7, ERATO Doi 443, expressed; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363958	D7Ertd443e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 7, ERATO Doi 443, expressed; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363529	D7Ertd443e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 7, ERATO Doi 443, expressed; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455573	D7Ertd443e<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
DNA segment, Chr 7, ERATO Doi 443, expressed; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455550	D7Ertd443e<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
DNA topoisomerase 1, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365054	Top1mt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
docking protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299577	Dok2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
docking protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427125	Dok2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
docking protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452785	Dok5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
docking protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452795	Dok5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
docking protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841156	Dok6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
docking protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841466	Dok6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dolichol-phosphate (beta-D) mannosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458473	Dpm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dolichol-phosphate (beta-D) mannosyltransferase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636953	Dpm1<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
dolichol-phosphate (beta-D) mannosyltransferase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636953	Dpm1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dolichol-phosphate (beta-D) mannosyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458513	Dpm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dolichol-phosphate (beta-D) mannosyltransferase 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692609	Dpm2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
dolichyl-di-phosphooligosaccharide-protein glycotransferase; targeted mutation 1.1, Velocigene	MGI:5548405	Ddost<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
dolichyl-di-phosphooligosaccharide-protein glycotransferase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050957	Ddost<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
dolichyl pyrophosphate phosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364612	Dolpp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dolichyl pyrophosphate phosphatase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364501	Dolpp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dopachrome tautomerase; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548330	Dct<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
dopachrome tautomerase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363806	Dct<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dopachrome tautomerase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458526	Dct<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
dopachrome tautomerase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4458590	Dct<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dopa decarboxylase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419393	Ddc<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
dopamine beta hydroxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014701	Dbh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dopamine beta hydroxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842452	Dbh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dopamine receptor D1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451251	Drd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dopamine receptor D1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451251	Drd1<tm1a(KOMP)Wtsi>	29217689	KOMP-CSD
dopamine receptor D1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115794	Drd1<tm1c(KOMP)Wtsi>	29217689	KOMP-CSD
dopamine receptor D1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299494	Drd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dopamine receptor D4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938595	Drd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dopey family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452820	Dopey2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dopey family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452820	Dopey2<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362351	Dot1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362351	Dot1l<tm1a(KOMP)Wtsi>	28627522	KOMP-CSD
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362351	Dot1l<tm1a(KOMP)Wtsi>	28981838	KOMP-CSD
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925348	Dot1l<tm1c(KOMP)Wtsi>	28627522	KOMP-CSD
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363101	Dot1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 1, William C Skarnes	MGI:5903511	Dot1l<tm1Wcs>	28981838	null
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363572	Dot1l<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363182	Dot1l<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
DOT1-like, histone H3 methyltransferase (S. cerevisiae); targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4364227	Dot1l<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
double C2, alpha; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427173	Doc2a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
double C2, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456032	Doc2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
double C2, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455982	Doc2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
doublecortin domain containing 2b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050845	Dcdc2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
doublecortin domain containing 2b; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637175	Dcdc2b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
doublecortin domain containing 2C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458574	Dcdc2c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
doublecortin-like kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5543459	Dclk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
doublecortin-like kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820262	Dclk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
doublecortin-like kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820295	Dclk2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
doublecortin-like kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364079	Dclk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
doublecortin-like kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363888	Dclk3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
doublecortin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441970	Dcx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
double homeobox B-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842725	Duxbl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
double homeobox B-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842661	Duxbl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
doublesex and mab-3 related transcription factor 3; targeted mutation 1, Velocigene	MGI:3812826	Dmrt3<tm1(KOMP)Vlcg>	23056351	KOMP-Regeneron
doublesex and mab-3 related transcription factor like family A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141836	Dmrta1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
doublesex and mab-3 related transcription factor like family A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296107	Dmrta2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
doublesex and mab-3 related transcription factor like family A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363098	Dmrta2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
doublesex and mab-3 related transcription factor like family A2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296108	Dmrta2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
doublesex and mab-3 related transcription factor like family A2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363545	Dmrta2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
doublesex and mab-3 related transcription factor like family A2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5296142	Dmrta2<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
double zinc ribbon and ankyrin repeat domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841203	Dzank1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
double zinc ribbon and ankyrin repeat domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841203	Dzank1<tm1a(KOMP)Wtsi>	27310661	KOMP-CSD
double zinc ribbon and ankyrin repeat domains 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548739	Dzank1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
double zinc ribbon and ankyrin repeat domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426600	Dzank1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
down-regulator of transcription 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434017	Dr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
downstream neighbor of SON; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433969	Donson<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
downstream neighbor of SON; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433969	Donson<tm1a(EUCOMM)Wtsi>	28630177	EUCOMM
DPH2 homolog; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:4840638	Dph2<tm2(EUCOMM)Wtsi>	21677750	EUCOMM
dpy-19-like 3 (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433660	Dpy19l3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dpy-19-like 3 (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434111	Dpy19l3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dpy-19-like 4 (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014694	Dpy19l4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DPY30 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451482	Dydc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DPY30 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451719	Dydc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
DPY30 domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432466	Dydc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DPY30 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434059	Dydc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dpy-30, histone methyltransferase complex regulatory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887610	Dpy30<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dpy-30, histone methyltransferase complex regulatory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887610	Dpy30<tm1a(KOMP)Wtsi>	25805847	KOMP-CSD
dpy-30, histone methyltransferase complex regulatory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887610	Dpy30<tm1a(KOMP)Wtsi>	27647347	KOMP-CSD
dpy-30, histone methyltransferase complex regulatory subunit; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5812161	Dpy30<tm1c(KOMP)Wtsi>	27647347	KOMP-CSD
dpy-30, histone methyltransferase complex regulatory subunit; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5812162	Dpy30<tm1d(KOMP)Wtsi>	27647347	KOMP-CSD
Dr1 associated protein 1 (negative cofactor 2 alpha); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363100	Drap1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
drebrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363390	Dbn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
drebrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363390	Dbn1<tm1a(KOMP)Wtsi>	27013612	KOMP-CSD
drebrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363390	Dbn1<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
drebrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363390	Dbn1<tm1a(KOMP)Wtsi>	28198431	KOMP-CSD
drebrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363390	Dbn1<tm1a(KOMP)Wtsi>	28700664	KOMP-CSD
drebrin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501061	Dbn1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
drebrin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501061	Dbn1<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
drebrin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501061	Dbn1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
drebrin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501061	Dbn1<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
drebrin-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451400	Dbnl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
drebrin-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451292	Dbnl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
drosha, ribonuclease type III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432937	Drosha<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
drosha, ribonuclease type III; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431808	Drosha<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DS cell adhesion molecule; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364755	Dscam<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
DS cell adhesion molecule; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365064	Dscam<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
D site albumin promoter binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051011	Dbp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DSN1 homolog, MIS12 kinetochore complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452782	Dsn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DSN1 homolog, MIS12 kinetochore complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452786	Dsn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DTW domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456063	Dtwd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
DTW domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842701	Dtwd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
DTW domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842512	Dtwd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
D-tyrosyl-tRNA deacylase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363001	Dtd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
D-tyrosyl-tRNA deacylase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364335	Dtd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dual oxidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365232	Duox2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual oxidase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362920	Duox2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dual oxidase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296143	Duox2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
dual oxidase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296141	Duox2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dual oxidase maturation factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141848	Duoxa1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual oxidase maturation factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951090	Duoxa1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dual oxidase maturation factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305622	Duoxa2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual oxidase maturation factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637016	Duoxa2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dual serine/threonine and tyrosine protein kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431807	Dstyk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual serine/threonine and tyrosine protein kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432444	Dstyk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434394	Dusp11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548616	Dusp11<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
dual specificity phosphatase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364576	Dusp12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363923	Dusp13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 13; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548474	Dusp13<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dual specificity phosphatase 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363615	Dusp13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 13; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472847	Dusp13<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460495	Dusp14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460520	Dusp14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461660	Dusp16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461756	Dusp16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364283	Dusp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364283	Dusp1<tm1(KOMP)Wtsi>	24721909	KOMP-CSD
dual specificity phosphatase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364283	Dusp1<tm1(KOMP)Wtsi>	28759036	KOMP-CSD
dual specificity phosphatase 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473168	Dusp21<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472743	Dusp21<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442056	Dusp22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 26 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363735	Dusp26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 26 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363735	Dusp26<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
dual specificity phosphatase 26 (putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363916	Dusp26<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820135	Dusp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820135	Dusp3<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548619	Dusp3<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548619	Dusp3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365004	Dusp3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364870	Dusp3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431999	Dusp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433453	Dusp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456654	Dusp5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456654	Dusp5<tm1a(KOMP)Wtsi>	27936095	KOMP-CSD
dual specificity phosphatase 5; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888994	Dusp5<tm1c(KOMP)Wtsi>	27936095	KOMP-CSD
dual specificity phosphatase 5; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5888995	Dusp5<tm1d(KOMP)Wtsi>	27936095	KOMP-CSD
dual specificity phosphatase 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419457	Dusp7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419457	Dusp7<tm1(KOMP)Wtsi>	27626380	KOMP-CSD
dual specificity phosphatase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296129	Dusp8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296117	Dusp8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dual specificity phosphatase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434499	Dusp9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual specificity phosphatase-like 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880976	Dusp15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951098	Dyrk1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296119	Dyrk2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014560	Dyrk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362895	Dyrk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364464	Dyrk4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432339	Dctn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynactin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433209	Dctn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynactin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433210	Dctn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynactin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431924	Dctn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynactin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451459	Dctn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451464	Dctn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527599	Dctn4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
dynactin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362780	Dctn5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364744	Dctn5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363526	Dctn5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364885	Dctn5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364973	Dynap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynactin associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363143	Dynap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynamin 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364147	Dnm1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynamin 1-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5602830	Dnm1l<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
dynamin 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419336	Dnm1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynamin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455504	Dnm2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynamin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456644	Dnm2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal assembly factor 2; targeted mutation 1.1, Velocigene	MGI:5532530	Dnaaf2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
dynein, axonemal assembly factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364985	Dnaaf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal assembly factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365162	Dnaaf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal assembly factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882018	Dnaaf5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal assembly factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882002	Dnaaf5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, heavy chain 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286255	Dnah11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841242	Dnah12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841168	Dnah12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433130	Dnah14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, heavy chain 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431652	Dnah14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, heavy chain 14; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473033	Dnah14<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, heavy chain 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940780	Dnah17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940768	Dnah17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820171	Dnah2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820159	Dnah2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458626	Dnah5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841402	Dnah5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynein, axonemal, heavy chain 7B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511980	Dnah7b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, light chain 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441730	Dnal4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, light chain 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548493	Dnal4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
dynein, axonemal, light chain 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441974	Dnal4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, light intermediate polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003016	Dnali1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein, axonemal, light intermediate polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003026	Dnali1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynein cytoplasmic 1 heavy chain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362814	Dync1h1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein cytoplasmic 1 intermediate chain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013754	Dync1i1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein cytoplasmic 1 intermediate chain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5013739	Dync1i1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dynein cytoplasmic 1 intermediate chain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441864	Dync1i2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein cytoplasmic 1 intermediate chain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441864	Dync1i2<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
dynein cytoplasmic 1 intermediate chain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433156	Dync1i2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynein cytoplasmic 1 light intermediate chain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051007	Dync1li1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein cytoplasmic 1 light intermediate chain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085485	Dync1li1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynein cytoplasmic 2 heavy chain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434170	Dync2h1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein light chain LC8-type 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419330	Dynll1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
dynein light chain roadblock-type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432163	Dynlrb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dynein light chain roadblock-type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431681	Dynlrb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dynein light chain roadblock-type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052400	Dynlrb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein regulatory complex subunit 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451680	Drc7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
dynein regulatory complex subunit 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451566	Drc7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
dysbindin (dystrobrevin binding protein 1) domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051009	Dbndd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dysbindin (dystrobrevin binding protein 1) domain containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513763	Dbndd2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
dysbindin (dystrobrevin binding protein 1) domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5051002	Dbndd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dysferlin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051021	Dysf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dysferlin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085475	Dysf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dystonin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453730	Dst<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dystonin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453764	Dst<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dystrobrevin, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431982	Dtnb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dystrobrevin, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432739	Dtnb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dystrobrevin binding protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435469	Dtnbp1<tm1a(EUCOMM)Hmgu>	27330059	EUCOMM
dystrobrevin binding protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513769	Dtnbp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
dystrobrevin binding protein 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5513770	Dtnbp1<tm1c(EUCOMM)Hmgu>	27330059	EUCOMM
dystrophia myotonica-containing WD repeat motif; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951109	Dmwd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
dystrophin, muscular dystrophy; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842790	Dmd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
dystrophin related protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363902	Drp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
E1A binding protein p300; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050996	Ep300<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
E1A binding protein p300; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085484	Ep300<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
E26 avian leukemia oncogene 1, 5' domain; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420049	Ets1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
E2F transcription factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364315	E2f3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
E2F transcription factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363031	E2f3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
E2F transcription factor 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431493	E2f4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
E2F transcription factor 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363426	E2f7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
E2F transcription factor 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471144	E2f7<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
E2F transcription factor 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362964	E2f7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
E2F transcription factor 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364747	E2f8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
E74-like factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432951	Elf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
E74-like factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434368	Elf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
E74-like factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868828	Elf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
E74-like factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548404	Elf3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
E74-like factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868830	Elf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
E74-like factor 4 (ets domain transcription factor); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433650	Elf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
E74-like factor 4 (ets domain transcription factor); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433757	Elf4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
early endosome antigen 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302297	Eea1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
early growth response 1; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766183	Egr1<tm1b(NCOM)Mfgc>	27626380	NorCOMM
early growth response 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287781	Egr3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EBNA1 binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842871	Ebna1bp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EBNA1 binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842684	Ebna1bp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
echinoderm microtubule associated protein like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433126	Eml2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
echinoderm microtubule associated protein like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5609351	Eml2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
echinoderm microtubule associated protein like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433786	Eml2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
echinoderm microtubule associated protein like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944499	Eml3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
echinoderm microtubule associated protein like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944509	Eml3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ecotropic viral integration site 5 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820134	Evi5l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ecotropic viral integration site 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458636	Evi5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ecotropic viral integration site 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458605	Evi5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ecotropic viral integration site 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5008801	Evi5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ect2 oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433090	Ect2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ect2 oncogene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548931	Ect2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ect2 oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432660	Ect2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ectodermal-neural cortex 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051006	Enc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ectodysplasin-A receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362448	Edar<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ectodysplasin-A receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548453	Edar<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ectodysplasin-A receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362159	Edar<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ectodysplasin-A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843832	Eda<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ecto-NOX disulfide-thiol exchanger 1; targeted mutation 1.1, Velocigene	MGI:5634704	Enox1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
ecto-NOX disulfide-thiol exchanger 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427168	Enox1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleoside triphosphate diphosphohydrolase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433342	Entpd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ectonucleoside triphosphate diphosphohydrolase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548332	Entpd1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ectonucleoside triphosphate diphosphohydrolase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434492	Entpd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ectonucleoside triphosphate diphosphohydrolase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363439	Entpd5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleoside triphosphate diphosphohydrolase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365264	Entpd5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleoside triphosphate diphosphohydrolase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363445	Entpd6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleoside triphosphate diphosphohydrolase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362533	Entpd6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleoside triphosphate diphosphohydrolase 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365252	Entpd6<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleoside triphosphate diphosphohydrolase 8; targeted mutation 1.1, Velocigene	MGI:5582435	Entpd8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ectonucleotide pyrophosphatase/phosphodiesterase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363476	Enpp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleotide pyrophosphatase/phosphodiesterase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364096	Enpp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleotide pyrophosphatase/phosphodiesterase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427184	Enpp6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ectonucleotide pyrophosphatase/phosphodiesterase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429369	Enpp6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EEF1A alpha lysine methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431797	Eef1akmt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EEF1A alpha lysine methyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431697	Eef1akmt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EEF1A lysine methyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441987	Eef1akmt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EEF1A lysine methyltransferase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5660733	Eef1akmt2<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
EEF1A lysine methyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442018	Eef1akmt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EF-hand calcium binding domain 11; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637094	Efcab11<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
EF-hand calcium binding domain 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286257	Efcab14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EF-hand calcium binding domain 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050982	Efcab1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
EF-hand calcium binding domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820249	Efcab2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EF-hand calcium binding domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820364	Efcab2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EF-hand calcium binding domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454078	Efcab3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EF-hand calcium binding domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454165	Efcab3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EF-hand calcium binding domain 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141840	Efcab9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EF hand domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431804	Efhd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EF hand domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433690	Efhd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EF hand domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362281	Efhd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EF hand domain containing 2; targeted mutation 1, Velocigene	MGI:3800038	Efhd2<tm1(KOMP)Vlcg>	25092375	KOMP-Regeneron
EF hand domain containing 2; targeted mutation 1, Velocigene	MGI:3800038	Efhd2<tm1(KOMP)Vlcg>	25133820	KOMP-Regeneron
EF hand domain containing 2; targeted mutation 1, Velocigene	MGI:3800038	Efhd2<tm1(KOMP)Vlcg>	25243606	KOMP-Regeneron
EF-hand domain (C-terminal) containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362240	Efhc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EF-hand domain (C-terminal) containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881949	Efhc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EF-hand domain (C-terminal) containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881947	Efhc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EFR3 homolog A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363940	Efr3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EFR3 homolog A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364583	Efr3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EFR3 homolog A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364111	Efr3a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
EFR3 homolog B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364027	Efr3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EFR3 homolog B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362153	Efr3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EGF-like and EMI domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307101	Egfem1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EGF-like and EMI domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293918	Egfem1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EGF-like domain 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842319	Egfl7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EGF-like domain 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842428	Egfl7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EGF-like domain 8; targeted mutation 1.1, Velocigene	MGI:5695940	Egfl8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
EGF-like, fibronectin type III and laminin G domains; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013757	Egflam<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EGF-like, fibronectin type III and laminin G domains; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296524	Egflam<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EGF-like repeats and discoidin I-like domains 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840958	Edil3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EGF-like repeats and discoidin I-like domains 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841357	Edil3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
egl-9 family hypoxia-inducible factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433334	Egln2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
egl-9 family hypoxia-inducible factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431773	Egln2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
egl-9 family hypoxia-inducible factor 2; targeted mutation 1, Velocigene	MGI:5051372	Egln2<tm1(KOMP)Vlcg>	22611156	KOMP-Regeneron
egl-9 family hypoxia-inducible factor 2; targeted mutation 1, Velocigene	MGI:5051372	Egln2<tm1(KOMP)Vlcg>	24990963	KOMP-Regeneron
egl-9 family hypoxia-inducible factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432194	Egln3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
egl-9 family hypoxia-inducible factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432762	Egln3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EH domain binding protein 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432707	Ehbp1l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EH domain binding protein 1-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433151	Ehbp1l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EH domain binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433600	Ehbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EH domain binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433987	Ehbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EH-domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432418	Ehd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EH-domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434462	Ehd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EH-domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452776	Ehd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EH-domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452790	Ehd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
elaC ribonuclease Z 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364671	Elac1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
elaC ribonuclease Z 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364952	Elac1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
elaC ribonuclease Z 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456058	Elac2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
elaC ribonuclease Z 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455998	Elac2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
elastin microfibril interfacer 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363237	Emilin1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
elastin microfibril interfacer 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050876	Emilin1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ELAV like RNA binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362652	Elavl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ELAV like RNA binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363459	Elavl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ELAV like RNA binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302311	Elavl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
electron transfer flavoprotein beta subunit lysine methyltransferase; targeted mutation 1.1, Velocigene	MGI:5548817	Etfbkmt<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
electron transfer flavoprotein beta subunit lysine methyltransferase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363123	Etfbkmt<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
electron transferring flavoprotein, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841175	Etfa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
electron transferring flavoprotein, alpha polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841317	Etfa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ELF1 homolog, elongation factor 1; targeted mutation 1.1, Velocigene	MGI:5569949	Elof1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ELF1 homolog, elongation factor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419882	Elof1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ELK1, member of ETS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5529963	Elk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ELK4, member of ETS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432021	Elk4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ELK4, member of ETS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434116	Elk4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ELKS/RAB6-interacting/CAST family member 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419619	Erc2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ELL associated factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433402	Eaf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ELL associated factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548645	Eaf1<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
ELL associated factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548645	Eaf1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ELL associated factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432427	Eaf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ELL associated factor 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4460290	Eaf2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ELM2 and Myb/SANT-like domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432092	Elmsan1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ELM2 and Myb/SANT-like domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432396	Elmsan1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ELMO/CED-12 domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548895	Elmod1<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
ELMO/CED-12 domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548895	Elmod1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
elongation factor RNA polymerase II 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441868	Ell2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
elongation factor RNA polymerase II 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441868	Ell2<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
elongation factor RNA polymerase II 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548782	Ell2<tm1b(EUCOMM)Wtsi>	26398943	EUCOMM
elongation factor RNA polymerase II 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441911	Ell2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
elongation factor Tu GTP binding domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458495	Eftud2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840603	Elovl1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840698	Elovl1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363709	Elovl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362257	Elovl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
elongator acetyltransferase complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419772	Elp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
elongator acetyltransferase complex subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419949	Elp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
elongator acetyltransferase complex subunit 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473018	Elp2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
elongator acetyltransferase complex subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944493	Elp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
elongator acetyltransferase complex subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441691	Elp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
elongator acetyltransferase complex subunit 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441626	Elp5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
elongin B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419377	Elob<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
embigin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880904	Emb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
embigin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880934	Emb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
embryonic ectoderm development; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431778	Eed<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
embryonic ectoderm development; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431778	Eed<tm1a(EUCOMM)Wtsi>	25228648	EUCOMM
embryonic ectoderm development; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431778	Eed<tm1a(EUCOMM)Wtsi>	28468635	EUCOMM
embryonic ectoderm development; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5645938	Eed<tm1c(EUCOMM)Wtsi>	25228648	EUCOMM
embryonic ectoderm development; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5645938	Eed<tm1c(EUCOMM)Wtsi>	26994968	EUCOMM
embryonic ectoderm development; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5645938	Eed<tm1c(EUCOMM)Wtsi>	27414999	EUCOMM
embryonic ectoderm development; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5645938	Eed<tm1c(EUCOMM)Wtsi>	28468635	EUCOMM
embryonic ectoderm development; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433720	Eed<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
emerin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431494	Emd<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
EMG1 N1-specific pseudouridine methyltransferase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419529	Emg1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
EMI domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433468	Emid1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EMI domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433762	Emid1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
empty spiracles homeobox 1; targeted mutation 1.1, Velocigene	MGI:5695972	Emx1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
empty spiracles homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473129	Emx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
empty spiracles homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472710	Emx1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
empty spiracles homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944379	Emx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ENAH actin regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365163	Enah<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ENAH actin regulator; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4454175	Enah<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Ena-vasodilator stimulated phosphoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363092	Evl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ena-vasodilator stimulated phosphoprotein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548406	Evl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Ena-vasodilator stimulated phosphoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362405	Evl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ena-vasodilator stimulated phosphoprotein; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511944	Evl<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
Ena-vasodilator stimulated phosphoprotein; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511907	Evl<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
endo-beta-N-acetylglucosaminidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455533	Engase<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endo-beta-N-acetylglucosaminidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455539	Engase<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endonuclease domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000394	Endod1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
endonuclease domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000419	Endod1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
endonuclease G; targeted mutation 1.1, Velocigene	MGI:5548410	Endog<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
endonuclease V; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432992	Endov<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
endoplasmic reticulum aminopeptidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364432	Erap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum aminopeptidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364693	Erap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum aminopeptidase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472940	Erap1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
endoplasmic reticulum chaperone SIL1 homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942001	Sil1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum chaperone SIL1 homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942014	Sil1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum (ER) to nucleus signalling 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299628	Ern1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363570	Ergic1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820065	Ergic1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820044	Ergic1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum lectin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364543	Erlec1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum lectin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364203	Erlec1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum metallopeptidase 1; targeted mutation 1.1, Velocigene	MGI:5505907	Ermp1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
endoplasmic reticulum metallopeptidase 1; targeted mutation 1.1, Velocigene	MGI:5505907	Ermp1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
endoplasmic reticulum protein 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847858	Erp27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
endoplasmic reticulum protein 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847851	Erp27<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
endoplasmic reticulum protein 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842664	Erp29<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
endoplasmic reticulum protein 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842702	Erp29<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
endoplasmic reticulum protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052408	Erp44<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum protein 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427135	Erp44<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endoplasmic reticulum protein 44; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5427243	Erp44<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
endosulfine alpha; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431483	Ensa<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
endothelial cell surface expressed chemotaxis and apoptosis regulator; targeted mutation 1.1, Velocigene	MGI:5583063	Ecscr<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
endothelial cell surface expressed chemotaxis and apoptosis regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364516	Ecscr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endothelial cell surface expressed chemotaxis and apoptosis regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364516	Ecscr<tm1a(KOMP)Wtsi>	26692198	KOMP-CSD
endothelial cell surface expressed chemotaxis and apoptosis regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362570	Ecscr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endothelial PAS domain protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548386	Epas1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
endothelin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842389	Edn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
endothelin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842804	Edn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
endothelin converting enzyme 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364371	Ece1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endothelin converting enzyme 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364371	Ece1<tm1a(KOMP)Wtsi>	28409408	KOMP-CSD
endothelin converting enzyme 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6100941	Ece1<tm1c(KOMP)Wtsi>	28409408	KOMP-CSD
endothelin converting enzyme 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6100944	Ece1<tm1d(KOMP)Wtsi>	28409408	KOMP-CSD
endothelin converting enzyme 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426670	Ece1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endothelin converting enzyme-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296135	Ecel1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
endothelin converting enzyme-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419340	Ecel1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
endothelin converting enzyme-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451712	Ecel1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
endothelin receptor type B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451517	Ednrb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
engulfment and cell motility 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939780	Elmo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
engulfment and cell motility 3; targeted mutation 1.1, Velocigene	MGI:5548855	Elmo3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
engulfment and cell motility 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882003	Elmo3<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of mRNA decapping 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433903	Edc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of mRNA decapping 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433903	Edc4<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
enhancer of mRNA decapping 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431728	Edc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of polycomb homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842670	Epc1<tm1a(EUCOMM)Wtsi>	20799038	EUCOMM
enhancer of polycomb homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842670	Epc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of polycomb homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5828782	Epc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of polycomb homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431957	Epc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of polycomb homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431957	Epc2<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
enhancer of polycomb homolog 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692601	Epc2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
enhancer of polycomb homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433594	Epc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of polycomb homolog 2; targeted mutation 1, William C Skarnes	MGI:5903512	Epc2<tm1Wcs>	28981838	null
enhancer of polycomb homolog 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5432209	Epc2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of zeste 1 polycomb repressive complex 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432362	Ezh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of zeste 1 polycomb repressive complex 2 subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692587	Ezh1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
enhancer of zeste 1 polycomb repressive complex 2 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434474	Ezh1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer of zeste 2 polycomb repressive complex 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432638	Ezh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enhancer trap locus 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052413	Etl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
enkurin, TRPC channel interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472848	Enkur<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enolase 3, beta muscle; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302360	Eno3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enolase-phosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950250	Enoph1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl-Coenzyme A delta isomerase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441787	Eci3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl-Coenzyme A delta isomerase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548579	Eci3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
enoyl-Coenzyme A delta isomerase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451992	Eci3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl coenzyme A hydratase 1, peroxisomal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433635	Ech1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl coenzyme A hydratase 1, peroxisomal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433879	Ech1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365266	Ehhadh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362462	Ehhadh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299604	Ehhadh<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
enoyl Coenzyme A hydratase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944528	Echdc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl Coenzyme A hydratase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944565	Echdc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl Coenzyme A hydratase domain containing 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511931	Echdc1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
enoyl Coenzyme A hydratase domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364375	Echdc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
enoyl Coenzyme A hydratase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363364	Echdc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364665	Echs1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
envoplakin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363136	Evpl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
envoplakin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363079	Evpl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ENY2 transcription and export complex 2 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296206	Eny2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eomesodermin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014719	Eomes<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eomesodermin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636935	Eomes<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
eosinophil peroxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842301	Epx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eosinophil peroxidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842683	Epx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ependymin related protein 1 (zebrafish); targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766175	Epdr1<tm1b(NCOM)Mfgc>	27626380	NorCOMM
Eph receptor A10; targeted mutation 1.1, Velocigene	MGI:5576040	Epha10<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Eph receptor A10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888957	Epha10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Eph receptor A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842773	Epha1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Eph receptor A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820254	Epha1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Eph receptor A1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511928	Epha1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
Eph receptor A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419214	Epha2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419774	Epha2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor A6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293952	Epha6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor A6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605744	Epha6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Eph receptor A6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950974	Epha6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor A7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363706	Epha7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor A7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365071	Epha7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433703	Ephb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Eph receptor B3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419663	Ephb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor B3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419563	Ephb3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor B6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364465	Ephb6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Eph receptor B6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364263	Ephb6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ephrin A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433482	Efna1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ephrin A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433482	Efna1<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
ephrin A1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434248	Efna1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ephrin A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452009	Efna2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ephrin A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452019	Efna2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ephrin A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286175	Efna3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ephrin A4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430972	Efna4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ephrin A5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441837	Efna5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ephrin A5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441837	Efna5<tm1a(EUCOMM)Wtsi>	25451192	EUCOMM
ephrin A5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548373	Efna5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ephrin A5; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5752597	Efna5<tm1c(EUCOMM)Wtsi>	25451192	EUCOMM
ephrin B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051016	Efnb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ephrin B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085480	Efnb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ephrin B3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364109	Efnb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor-containing fibulin-like extracellular matrix protein 1; targeted mutation 1.1, Velocigene	MGI:5695896	Efemp1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
epidermal growth factor-containing fibulin-like extracellular matrix protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882013	Efemp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
epidermal growth factor-containing fibulin-like extracellular matrix protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882006	Efemp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
epidermal growth factor-containing fibulin-like extracellular matrix protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363432	Efemp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor-containing fibulin-like extracellular matrix protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455568	Efemp2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor-containing fibulin-like extracellular matrix protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455542	Efemp2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor receptor pathway substrate 15-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419853	Eps15l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor receptor pathway substrate 15-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419815	Eps15l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor receptor pathway substrate 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362352	Eps15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor receptor pathway substrate 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362352	Eps15<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
epidermal growth factor receptor pathway substrate 15; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002916	Eps15<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor receptor pathway substrate 15; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5002922	Eps15<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
epidermal growth factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433235	Egfr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
epidermal growth factor receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433185	Egfr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
epididymal protein 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008794	Eddm3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epididymal protein 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008803	Eddm3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
epilepsy, progressive myoclonic epilepsy, type 2 gene alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941497	Epm2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epilepsy, progressive myoclonic epilepsy, type 2 gene alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947762	Epm2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
epiphycan; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362126	Epyc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epiphycan; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363192	Epyc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
epiphycan; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362573	Epyc<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
epiphycan; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363821	Epyc<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
epithelial membrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942155	Emp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
epithelial membrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942142	Emp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
epithelial membrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364013	Emp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epithelial membrane protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363609	Emp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
epithelial membrane protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840963	Emp2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
epithelial membrane protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841280	Emp2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
epithelial mitogen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840924	Epgn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epithelial mitogen; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5577269	Epgn<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
epithelial splicing regulatory protein 2; targeted mutation 1, Velocigene	MGI:4399676	Esrp2<tm1(KOMP)Vlcg>	26371508	KOMP-Regeneron
epithelial splicing regulatory protein 2; targeted mutation 1, Velocigene	MGI:4399676	Esrp2<tm1(KOMP)Vlcg>	26531099	KOMP-Regeneron
epithelial splicing regulatory protein 2; targeted mutation 1, Velocigene	MGI:4399676	Esrp2<tm1(KOMP)Vlcg>	27404344	KOMP-Regeneron
epithelial stromal interaction 1 (breast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362262	Epsti1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epoxide hydrolase 2, cytoplasmic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842436	Ephx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
epoxide hydrolase 2, cytoplasmic; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842391	Ephx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
epoxide hydrolase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427241	Ephx3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epoxide hydrolase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427231	Ephx3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EPS8-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364005	Eps8l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EPS8-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362298	Eps8l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
EPS8-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296126	Eps8l1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
EPS8-like 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548540	Eps8l1<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
EPS8-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452714	Eps8l1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
EPS8-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842782	Eps8l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EPS8-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842816	Eps8l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EPS8-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473097	Eps8l3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EPS8-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472892	Eps8l3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
epsilon-tubulin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433733	Tube1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
epsin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432201	Epn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
epsin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433608	Epn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
epsin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364105	Epn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
epsin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548611	Epn3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
epsin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548611	Epn3<tm1b(KOMP)Wtsi>	28152424	KOMP-CSD
epsin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365207	Epn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
epsin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365002	Epn3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
epsin 3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4462611	Epn3<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
erb-b2 receptor tyrosine kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460457	Erbb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
erb-b2 receptor tyrosine kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460493	Erbb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ERGIC and golgi 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451966	Ergic3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ERGIC and golgi 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452784	Ergic3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ergosterol biosynthesis 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451980	Erg28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ergosterol biosynthesis 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452000	Erg28<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ergosterol biosynthesis 28; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472693	Erg28<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ERH mRNA splicing and mitosis factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451988	Erh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ERH mRNA splicing and mitosis factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451984	Erh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ERH mRNA splicing and mitosis factor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458828	Erh<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ER lipid raft associated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820210	Erlin2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ER lipid raft associated 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820316	Erlin2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ER membrane protein complex subunit 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432030	Emc10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ER membrane protein complex subunit 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548589	Emc10<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
ER membrane protein complex subunit 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548589	Emc10<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ER membrane protein complex subunit 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431595	Emc10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ER membrane protein complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454147	Emc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ER membrane protein complex subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454172	Emc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ER membrane protein complex subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453751	Emc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ER membrane protein complex subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453740	Emc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ER membrane protein complex subunit 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299564	Emc4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ER membrane protein complex subunit 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419837	Emc6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ER membrane protein complex subunit 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364682	Emc9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ERO1-like beta (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441904	Ero1lb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ERO1-like beta (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441724	Ero1lb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ERO1-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451278	Ero1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ERO1-like (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451658	Ero1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
erythrocyte membrane protein band 4.1 like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842300	Epb41l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
erythrocyte membrane protein band 4.1 like 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5661983	Epb41l1<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
erythrocyte membrane protein band 4.1 like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842401	Epb41l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
erythrocyte membrane protein band 4.1 like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842465	Epb41l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
erythrocyte membrane protein band 4.1 like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842569	Epb41l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
erythrocyte membrane protein band 4.1 like 4a; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5468966	Epb41l4a<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
erythrocyte membrane protein band 4.1 like 4b; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5577266	Epb41l4b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
erythrocyte membrane protein band 4.1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363397	Epb41<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
erythrocyte membrane protein band 4.1; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5474773	Epb41<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
erythrocyte membrane protein band 4.1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364843	Epb41<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
erythrocyte membrane protein band 4.2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460272	Epb42<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
erythrocyte membrane protein band 4.2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460310	Epb42<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
erythropoietin receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363628	Epor<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
erythropoietin receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362449	Epor<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ESF1 nucleolar pre-rRNA processing protein homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363349	Esf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
espin-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364314	Espnl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
espin-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554914	Espnl<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
espin-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554914	Espnl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
espin-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554914	Espnl<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
espin-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006733	Espnl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
espin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431731	Espn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
espin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431554	Espn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
espin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434334	Espn<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
espin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433778	Espn<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
essential meiotic structure-specific endonuclease 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5569963	Eme1<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
essential meiotic structure-specific endonuclease 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419554	Eme1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
establishment of sister chromatid cohesion N-acetyltransferase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419798	Esco1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
establishment of sister chromatid cohesion N-acetyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431943	Esco2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
esterase D/formylglutathione hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462595	Esd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
esterase D/formylglutathione hydrolase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462615	Esd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
estrogen receptor 2 (beta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432527	Esr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
estrogen receptor-binding fragment-associated gene 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820046	Ebag9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
estrogen receptor-binding fragment-associated gene 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296133	Ebag9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
estrogen related receptor, alpha; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299551	Esrra<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
estrogen related receptor, beta; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419903	Esrrb<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ethanolamine kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000400	Etnk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ethanolamine kinase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5574604	Etnk1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ethanolamine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000423	Etnk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ethanolamine phosphate phospholyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362706	Etnppl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ethanolamine phosphate phospholyase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362847	Etnppl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ethylmalonic encephalopathy 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432299	Ethe1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ethylmalonic encephalopathy 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692653	Ethe1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ethylmalonic encephalopathy 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434483	Ethe1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ETS transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455490	Erg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ETS transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455490	Erg<tm1a(KOMP)Wtsi>	28536097	KOMP-CSD
ETS transcription factor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548933	Erg<tm1b(KOMP)Wtsi>	28536097	KOMP-CSD
ETS transcription factor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6110598	Erg<tm1c(KOMP)Wtsi>	28536097	KOMP-CSD
ets variant 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287789	Etv1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ets variant 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842574	Etv2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ets variant 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842284	Etv2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ets variant 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427180	Etv3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ets variant 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427120	Etv3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ets variant 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5427217	Etv3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ets variant 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5427206	Etv3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ets variant 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363276	Etv5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ets variant 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362855	Etv5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ets variant 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363238	Etv6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic elongation factor-2 kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364840	Eef2k<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic elongation factor 2 lysine methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431548	Eef2kmt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic elongation factor 2 lysine methyltransferase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5766155	Eef2kmt<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
eukaryotic elongation factor 2 lysine methyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433018	Eef2kmt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363410	Eef1d<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 2 alpha kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842336	Eif2ak3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2 alpha kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842562	Eif2ak3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434008	Eif2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433143	Eif2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2B, subunit 1 (alpha); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473068	Eif2b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2B, subunit 1 (alpha); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472874	Eif2b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2B, subunit 2 beta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364625	Eif2b2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 2B, subunit 2 beta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365129	Eif2b2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 2B, subunit 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636947	Eif2b3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
eukaryotic translation initiation factor 2B, subunit 4 delta; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548932	Eif2b4<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
eukaryotic translation initiation factor 2B, subunit 4 delta; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431418	Eif2b4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 2B, subunit 5 epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432328	Eif2b5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2B, subunit 5 epsilon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433633	Eif2b5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 2, subunit 1 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419677	Eif2s1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 2, subunit 1 alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419379	Eif2s1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 2, subunit 2 (beta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454108	Eif2s2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 2, subunit 2 (beta); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454079	Eif2s2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 3, subunit A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419670	Eif3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 3, subunit A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419717	Eif3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 3, subunit C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5544983	Eif3c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458838	Eif3e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441848	Eif3g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441717	Eif3g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842850	Eif3i<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842317	Eif3i<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit I; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4842876	Eif3i<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit J1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000422	Eif3j1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842412	Eif3k<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit K; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842454	Eif3k<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 3, subunit M; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426652	Eif3m<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 3, subunit M; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426613	Eif3m<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434418	Eif4a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 4A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432349	Eif4a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 4A2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451262	Eif4a2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4E binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453682	Eif4ebp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 4E binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362911	Eif4ebp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4E binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362592	Eif4ebp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4E binding protein 3; targeted mutation 1.1, Velocigene	MGI:5695888	Eif4ebp3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
eukaryotic translation initiation factor 4E member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364967	Eif4e3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4E member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364967	Eif4e3<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
eukaryotic translation initiation factor 4E member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363379	Eif4e3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4E member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302284	Eif4e3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4E nuclear import factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362912	Eif4enif1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4E nuclear import factor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296127	Eif4enif1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4, gamma 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363990	Eif4g2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4, gamma 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498138	Eif4g2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4, gamma 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498138	Eif4g2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
eukaryotic translation initiation factor 4, gamma 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363632	Eif4g2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4, gamma 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452629	Eif4g2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 4 gamma, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000393	Eif4g3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 4H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842523	Eif4h<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 4H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842731	Eif4h<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 5A2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5013787	Eif5a2<tm1a(EUCOMM)Hmgu>	26037925	EUCOMM
eukaryotic translation initiation factor 5A2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5812101	Eif5a2<tm1c(EUCOMM)Hmgu>	26037925	EUCOMM
eukaryotic translation initiation factor 5A2; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5812102	Eif5a2<tm1d(EUCOMM)Hmgu>	26037925	EUCOMM
eukaryotic translation initiation factor 5A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000389	Eif5a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
eukaryotic translation initiation factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362624	Eif5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eukaryotic translation initiation factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363661	Eif5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eva-1 homolog A (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938524	Eva1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
eva-1 homolog A (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938517	Eva1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
eva-1 homolog B (C. elegans); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419444	Eva1b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
EvC ciliary complex subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433590	Evc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
EvC ciliary complex subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432625	Evc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
EvC ciliary complex subunit 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472998	Evc<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
EvC ciliary complex subunit 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472834	Evc<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
EvC ciliary complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840953	Evc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
even-skipped homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420138	Evx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
even-skipped homeobox 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847697	Evx2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Ewing sarcoma breakpoint region 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000399	Ewsr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ewing sarcoma breakpoint region 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513772	Ewsr1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
Ewing tumor-associated antigen 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364503	Etaa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ewing tumor-associated antigen 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296138	Etaa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
excision repair cross-complementing rodent repair deficiency, complementation group 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362172	Ercc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
excision repair cross-complementing rodent repair deficiency, complementation group 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841005	Ercc1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
excision repair cross-complementing rodent repair deficiency, complementation group 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432864	Ercc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
excision repair cross-complementing rodent repair deficiency, complementation group 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432950	Ercc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
excision repair cross-complementing rodent repair deficiency, complementation group 3; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766184	Ercc3<tm1b(NCOM)Mfgc>	27626380	NorCOMM
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944340	Ercc6l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944366	Ercc6l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
excision repair cross-complementing rodent repair deficiency complementation group 6 like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424641	Ercc6l<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
excision repair cross-complementing rodent repair deficiency, complementation group 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841146	Ercc6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
excision repair cross-complementing rodent repair deficiency, complementation group 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841386	Ercc6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exocrine gland secreted peptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364356	Esp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
exocrine gland secreted peptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363829	Esp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4888885	Exoc1<tm1a(EUCOMM)Hmgu>	26346620	EUCOMM
exocyst complex component 3-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363569	Exoc3l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 3-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363569	Exoc3l2<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
exocyst complex component 3-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363569	Exoc3l2<tm1a(KOMP)Wtsi>	27768725	KOMP-CSD
exocyst complex component 3-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548646	Exoc3l2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
exocyst complex component 3-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548646	Exoc3l2<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
exocyst complex component 3-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362877	Exoc3l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 4; endonuclease-mediated mutation 1, Jackson	MGI:5571596	Exoc4<em1(IMPC)J>	28700664	IMPC
exocyst complex component 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362400	Exoc4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451254	Exoc4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451435	Exoc4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 4; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4880922	Exoc4<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 4; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4880930	Exoc4<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
exocyst complex component 5; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4455411	Exoc5<tm1a(KOMP)Mbp>	26040895	KOMP-CSD
exocyst complex component 5; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4455411	Exoc5<tm1a(KOMP)Mbp>	26046524	KOMP-CSD
exocyst complex component 5; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5774863	Exoc5<tm1c(KOMP)Mbp>	26046524	KOMP-CSD
exocyst complex component 5; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5774863	Exoc5<tm1c(KOMP)Mbp>	26582389	KOMP-CSD
exocyst complex component 5; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5774863	Exoc5<tm1c(KOMP)Mbp>	28729419	KOMP-CSD
exocyst complex component 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842493	Exoc6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exocyst complex component 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842278	Exoc6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exocyst complex component 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432080	Exoc7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exocyst complex component 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433077	Exoc7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exocyst complex component 8; targeted mutation 1.1, Velocigene	MGI:5548744	Exoc8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
exonuclease 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141849	Exo5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exophilin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432491	Exph5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exophilin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432903	Exph5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exoribonuclease 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434404	Eri1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exoribonuclease 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432898	Eri1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exoribonuclease 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842736	Eri3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exosome component 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456675	Exosc10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
exosome component 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456675	Exosc10<tm1a(KOMP)Wtsi>	29118343	KOMP-CSD
exosome component 10; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6110581	Exosc10<tm1c(KOMP)Wtsi>	29118343	KOMP-CSD
exosome component 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455591	Exosc10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exosome component 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947828	Exosc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exosome component 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947841	Exosc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exosome component 3; targeted mutation 1.1, Velocigene	MGI:5695911	Exosc3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
exosome component 8; targeted mutation 1.1, Velocigene	MGI:5445928	Exosc8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
exosome component 8; targeted mutation 1.1, Velocigene	MGI:5445928	Exosc8<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
exosome component 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432683	Exosc8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exosome component 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4442050	Exosc8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
exosome component 8; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441681	Exosc8<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
exosome component 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434326	Exosc9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exosome component 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636988	Exosc9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
exosome component 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434099	Exosc9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exostoses (multiple) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433149	Ext2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exostoses (multiple) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434024	Ext2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exostoses (multiple)-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434040	Extl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
exostoses (multiple)-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431596	Extl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
exostoses (multiple)-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299624	Extl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
exportin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940763	Xpo4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
exportin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941494	Xpo4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exportin 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362245	Xpo6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
exportin 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362879	Xpo6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exportin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419929	Xpo7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
exportin 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419224	Xpo7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
exportin 7; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511917	Xpo7<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
exportin, tRNA (nuclear export receptor for tRNAs); targeted mutation 3b, Helmholtz Zentrum Muenchen GmbH	MGI:5576684	Xpot<tm3b(EUCOMM)Hmgu>	27626380	EUCOMM
expressed sequence AI182371; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293897	AI182371<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI182371; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364459	AI182371<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI182371; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286211	AI182371<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI182371; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293912	AI182371<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI464131; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419226	AI464131<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI464131; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471224	AI464131<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI464131; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471224	AI464131<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
expressed sequence AI464131; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419867	AI464131<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI467606; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419464	AI467606<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI467606; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419880	AI467606<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI467606; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473064	AI467606<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AI481877; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442052	AI481877<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AI481877; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302302	AI481877<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AI837181; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451310	AI837181<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AI837181; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451596	AI837181<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AU015836; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939714	AU015836<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AU015836; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939734	AU015836<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AU018091; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460445	AU018091<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AU018091; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460464	AU018091<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AU019823; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419660	AU019823<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AU021092; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363197	AU021092<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AU021092; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5582437	AU021092<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
expressed sequence AU021092; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420075	AU021092<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AU040320; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938560	AU040320<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AU040320; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938560	AU040320<tm1a(EUCOMM)Wtsi>	29045729	EUCOMM
expressed sequence AU040320; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:6111779	AU040320<tm1b(EUCOMM)Wtsi>	29045729	EUCOMM
expressed sequence AU040320; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111780	AU040320<tm1c(EUCOMM)Wtsi>	29045729	EUCOMM
expressed sequence AU040320; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6111781	AU040320<tm1d(EUCOMM)Wtsi>	29045729	EUCOMM
expressed sequence AW112010; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427202	AW112010<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AW112010; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427162	AW112010<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AW146154; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454169	AW146154<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AW146154; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454144	AW146154<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AW549877; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460434	AW549877<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AW549877; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460475	AW549877<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
expressed sequence AW551984; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841339	AW551984<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence AW551984; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841425	AW551984<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence C77080; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419150	C77080<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence C87436; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419770	C87436<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence C87499; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462573	C87499<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
expressed sequence C87499; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462626	C87499<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
extended synaptotagmin-like protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363392	Esyt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
extended synaptotagmin-like protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4843830	Esyt2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
extended synaptotagmin-like protein 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5605752	Esyt2<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
extended synaptotagmin-like protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4458507	Esyt2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
extended synaptotagmin-like protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433605	Esyt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433605	Esyt3<tm1a(EUCOMM)Wtsi>	27348751	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548398	Esyt3<tm1b(EUCOMM)Wtsi>	25486202	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548398	Esyt3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6101166	Esyt3<tm1c(EUCOMM)Wtsi>	27348751	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5792823	Esyt3<tm1d(EUCOMM)Wtsi>	25486202	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5792823	Esyt3<tm1d(EUCOMM)Wtsi>	27348751	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5792823	Esyt3<tm1d(EUCOMM)Wtsi>	27399837	EUCOMM
extended synaptotagmin-like protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433836	Esyt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
extracellular matrix protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692542	Ecm1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
EYA transcriptional coactivator and phosphatase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458610	Eya4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
EYA transcriptional coactivator and phosphatase 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548437	Eya4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
EYA transcriptional coactivator and phosphatase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458649	Eya4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ezrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431535	Ezr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ezrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433428	Ezr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ezrin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431855	Ezr<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ezrin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432771	Ezr<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ezrin; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4433937	Ezr<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
ezrin; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:4842286	Ezr<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
ezrin; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:4842648	Ezr<tm4e(EUCOMM)Wtsi>	21677750	EUCOMM
FAD-dependent oxidoreductase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842740	Foxred1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FAD-dependent oxidoreductase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842792	Foxred1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 102, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362569	Fam102b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 102, member B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4843823	Fam102b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 103, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420063	Fam103a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 103, member A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419692	Fam103a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 104, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431682	Fam104a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 104, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433549	Fam104a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 104, member A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433192	Fam104a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 104, member A; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456773	Fam104a<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 104, member A; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4456851	Fam104a<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 105, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296541	Fam105a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 107, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140431	Fam107a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 107, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140415	Fam107a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 107, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362853	Fam107b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 107, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362853	Fam107b<tm1a(KOMP)Wtsi>	23870131	KOMP-CSD
family with sequence similarity 109, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419449	Fam109a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 109, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419321	Fam109a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 109, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473073	Fam109a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 109, member A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472875	Fam109a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 110, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433953	Fam110b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 110, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432846	Fam110b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 111, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009658	Fam111a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 111, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461652	Fam111a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 114, member A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362768	Fam114a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 114, member A1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451541	Fam114a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 114, member A1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451622	Fam114a1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 117, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432848	Fam117b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 117, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432140	Fam117b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 118, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460418	Fam118b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 118, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460450	Fam118b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 122, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434225	Fam122b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 122, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432565	Fam122c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 122, member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433655	Fam122c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 124, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451577	Fam124b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 124, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451650	Fam124b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 129, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432171	Fam129a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 129, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434165	Fam129a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 129, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433656	Fam129b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 129, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434359	Fam129b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 129, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942152	Fam129c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 129, member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942148	Fam129c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 131, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511983	Fam131a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 131, member A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511957	Fam131a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 131, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363987	Fam131c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 131, member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364542	Fam131c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 136, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944370	Fam136a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 13, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296555	Fam13a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 13, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364167	Fam13a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 13, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4420095	Fam13a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 13, member A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419986	Fam13a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 13, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842400	Fam13b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 13, member B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548837	Fam13b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
family with sequence similarity 13, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842810	Fam13b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 13, member C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431450	Fam13c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 149, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362638	Fam149a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 149, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362510	Fam149a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 151, member B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548636	Fam151b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
family with sequence similarity 159, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432591	Fam159b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 159, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434032	Fam159b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 160, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849420	Fam160a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 160, member A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849426	Fam160a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 160, member B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461661	Fam160b2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 161, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841105	Fam161a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 161, member A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5472171	Fam161a<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 161, member A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5472171	Fam161a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence similarity 161, member A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5472171	Fam161a<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
family with sequence similarity 161, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840959	Fam161a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 161, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363939	Fam161b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 161, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364383	Fam161b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 163, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5141829	Fam163a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 163, member A; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637187	Fam163a<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence similarity 163, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364507	Fam163b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 163, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364563	Fam163b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 163, member B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451342	Fam163b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 163, member B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451590	Fam163b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 166, member B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841123	Fam166b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 167, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456795	Fam167a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 167, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457565	Fam167a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 167, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432401	Fam167b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 167, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433996	Fam167b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 168, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000408	Fam168a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 170, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5285713	Fam170a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 170, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427132	Fam170a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 171, member A1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431503	Fam171a1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 171, member A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461749	Fam171a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 178, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433061	Fam178b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 178, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433955	Fam178b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 184, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362903	Fam184a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 184, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364391	Fam184a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 184, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363336	Fam184b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 184, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364517	Fam184b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 184, member B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472983	Fam184b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 186, member B; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5554938	Fam186b<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
family with sequence similarity 192, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432874	Fam192a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 193, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364179	Fam193b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 193, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364427	Fam193b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 199, X-linked; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849973	Fam199x<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 19, member A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014712	Fam19a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 19, member A5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941495	Fam19a5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 19, member A5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941505	Fam19a5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 205, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944418	Fam205c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 205, member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944389	Fam205c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 206, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441712	Fam206a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 206, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441619	Fam206a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 209; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849975	Fam209<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 209; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572032	Fam209<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence similarity 20, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364000	Fam20a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 20, member A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548797	Fam20a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence similarity 20, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431900	Fam20b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 20, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433280	Fam20b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 20, member C; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5548734	Fam20c<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence similarity 20, member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365182	Fam20c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 210, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847868	Fam210a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 210, member A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605775	Fam210a<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
family with sequence similarity 210, member B; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548530	Fam210b<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
family with sequence similarity 212, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013738	Fam212b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 212, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5013751	Fam212b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 213, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944491	Fam213a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 213, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944506	Fam213a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 213, member A; targeted mutation 1, Velocigene	MGI:4951256	Fam213a<tm1(KOMP)Vlcg>	26629401	KOMP-Regeneron
family with sequence similarity 214, member B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882019	Fam214b<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 216, member A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548573	Fam216a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
family with sequence similarity 216, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364380	Fam216b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 216, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364812	Fam216b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 217, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362940	Fam217a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 217, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364863	Fam217a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 221, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441805	Fam221b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 221, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441929	Fam221b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 222, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289820	Fam222a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 222, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362516	Fam222b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 222, member B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4880913	Fam222b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 222, member B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4880981	Fam222b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 227, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842473	Fam227a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 227, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842529	Fam227a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 227, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455979	Fam227b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 227, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455975	Fam227b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 234, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433517	Fam234a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 234, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432684	Fam234a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 234, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432729	Fam234b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 234, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433331	Fam234b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 241, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293988	Fam241a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 241, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293985	Fam241a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 241, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294010	Fam241a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 241, member A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294002	Fam241a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 241, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460524	Fam241b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 25, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433537	Fam25c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 25, member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433805	Fam25c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 26, member E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431420	Fam26e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 26, member E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431501	Fam26e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 26, member F; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840585	Fam26f<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 26, member F; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840679	Fam26f<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 45, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433688	Fam45a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 45, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432924	Fam45a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 46, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085347	Fam46c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 46, member C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637082	Fam46c<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence similarity 46, member C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637082	Fam46c<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
family with sequence similarity 47, member E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940801	Fam47e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 47, member E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941562	Fam47e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 49, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948605	Fam49b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 49, member B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605796	Fam49b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence similarity 49, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941993	Fam49b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 50, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944369	Fam50b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 50, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944358	Fam50b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 53, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433038	Fam53a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 53, member B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548690	Fam53b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
family with sequence similarity 57, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433723	Fam57a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 69, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5548321	Fam69a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 69, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140489	Fam69b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 69, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427181	Fam69c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 71, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364165	Fam71b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 71, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362894	Fam71b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 71, member D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460510	Fam71d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 71, member D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460483	Fam71d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 71, member E2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362748	Fam71e2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 71, member E2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364553	Fam71e2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 76, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942134	Fam76a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 76, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947812	Fam76a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 76, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460448	Fam76b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 76, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460515	Fam76b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 81, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432343	Fam81a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 83, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503342	Fam83a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 83, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452026	Fam83b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 83, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452003	Fam83b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 83, member B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458825	Fam83b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 83, member F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841349	Fam83f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 83, member F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841417	Fam83f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 83, member G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431981	Fam83g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 83, member G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434095	Fam83g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 83, member G; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456828	Fam83g<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 83, member G; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456856	Fam83g<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 84, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419971	Fam84a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 84, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452693	Fam84a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 84, member A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452674	Fam84a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 8, member A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849977	Fam8a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 8, member A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849980	Fam8a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 90, member A1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362745	Fam90a1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 90, member A1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364225	Fam90a1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 92, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013734	Fam92a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 92, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296611	Fam92b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 92, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296610	Fam92b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 96, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434093	Fam96a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 96, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451949	Fam96a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
family with sequence similarity 98, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363905	Fam98b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 98, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363046	Fam98b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence similarity 98, member C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419766	Fam98c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence simliarity 151, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363407	Fam151a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
family with sequence simliarity 151, member A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5583078	Fam151a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
family with sequence simliarity 151, member A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364917	Fam151a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
FANCD2/FANCI-associated nuclease 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940765	Fan1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FANCD2/FANCI-associated nuclease 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940765	Fan1<tm1a(KOMP)Wtsi>	26980189	KOMP-CSD
FANCD2/FANCI-associated nuclease 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940765	Fan1<tm1a(KOMP)Wtsi>	27026368	KOMP-CSD
FANCD2/FANCI-associated nuclease 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548893	Fan1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
FANCD2/FANCI-associated nuclease 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5796185	Fan1<tm1c(KOMP)Wtsi>	26980189	KOMP-CSD
FANCD2/FANCI-associated nuclease 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5796264	Fan1<tm1d(KOMP)Wtsi>	26980189	KOMP-CSD
FANCD2/FANCI-associated nuclease 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940774	Fan1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Fancd2 opposite strand; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840597	Fancd2os<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Fancd2 opposite strand; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840658	Fancd2os<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
Fanconi anemia, complementation group A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434431	Fanca<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Fanconi anemia, complementation group A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434431	Fanca<tm1a(EUCOMM)Wtsi>	22922648	EUCOMM
Fanconi anemia, complementation group A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434431	Fanca<tm1a(EUCOMM)Wtsi>	25155611	EUCOMM
Fanconi anemia, complementation group B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432402	Fancb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Fanconi anemia, complementation group C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840986	Fancc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fanconi anemia, complementation group C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841314	Fancc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Fanconi anemia, complementation group G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432590	Fancg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Fanconi anemia, complementation group G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431874	Fancg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Fanconi anemia, complementation group I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456047	Fanci<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Fanconi anemia, complementation group L; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605778	Fancl<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Fanconi anemia core complex associated protein 100; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362788	Faap100<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fanconi anemia core complex associated protein 100; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364008	Faap100<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Fanconi anemia core complex associated protein 20; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456552	Faap20<tm1(KOMP)Mbp>	25917546	KOMP-CSD
farnesyl diphosphate farnesyl transferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451370	Fdft1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
farnesyl diphosphate farnesyl transferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451594	Fdft1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
farnesyltransferase, CAAX box, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451392	Fnta<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
farnesyltransferase, CAAX box, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451652	Fnta<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
farnesyltransferase, CAAX box, beta; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605771	Fntb<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
far upstream element (FUSE) binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006797	Fubp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
far upstream element (FUSE) binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052386	Fubp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fas-activated serine/threonine kinase; targeted mutation 1.1, Velocigene	MGI:5548524	Fastk<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Fas-activated serine/threonine kinase; targeted mutation 1, Velocigene	MGI:4452902	Fastk<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
Fas-associated factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942015	Faf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fas-associated factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942032	Faf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fasciculation and elongation protein zeta 1 (zygin I); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842485	Fez1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fasciculation and elongation protein zeta 2 (zygin II); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362350	Fez2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fascin actin-bundling protein 2; targeted mutation 1.1, Velocigene	MGI:5569958	Fscn2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
fascin actin-bundling protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453753	Fscn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fascin actin-bundling protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453766	Fscn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FAST kinase domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432561	Fastkd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FAST kinase domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434487	Fastkd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FAST kinase domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820277	Fastkd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FAST kinase domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820379	Fastkd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Fas (TNF receptor superfamily member 6); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451530	Fas<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fas (TNF receptor superfamily member 6); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451632	Fas<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Fas (TNFRSF6)-associated via death domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364194	Fadd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fas (TNFRSF6)-associated via death domain; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5573271	Fadd<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
Fas (TNFRSF6)-associated via death domain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363337	Fadd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Fas (TNFRSF6) binding factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432655	Fbf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FAT atypical cadherin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843826	Fat4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FAT atypical cadherin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319796	Fat4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fat mass and obesity associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432397	Fto<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fat mass and obesity associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432397	Fto<tm1a(EUCOMM)Wtsi>	23817550	EUCOMM
fat mass and obesity associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432397	Fto<tm1a(EUCOMM)Wtsi>	25782772	EUCOMM
fat mass and obesity associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432397	Fto<tm1a(EUCOMM)Wtsi>	26188089	EUCOMM
fat mass and obesity associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432397	Fto<tm1a(EUCOMM)Wtsi>	26727661	EUCOMM
fat mass and obesity associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432397	Fto<tm1a(EUCOMM)Wtsi>	27827997	EUCOMM
fat mass and obesity associated; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5795627	Fto<tm1b(EUCOMM)Wtsi>	26188089	EUCOMM
fat mass and obesity associated; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5795627	Fto<tm1b(EUCOMM)Wtsi>	26727661	EUCOMM
fat mass and obesity associated; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5529918	Fto<tm1c(EUCOMM)Wtsi>	23817550	EUCOMM
fat mass and obesity associated; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5529920	Fto<tm1d(EUCOMM)Wtsi>	23817550	EUCOMM
fat mass and obesity associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433313	Fto<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fat storage-inducing transmembrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419689	Fitm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fat storage-inducing transmembrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419186	Fitm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fat storage-inducing transmembrane protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419405	Fitm2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid 2-hydroxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364814	Fa2h<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid 2-hydroxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363743	Fa2h<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid 2-hydroxylase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302295	Fa2h<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid 2-hydroxylase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302281	Fa2h<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid binding protein 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433784	Fabp12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fatty acid binding protein 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433951	Fabp12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fatty acid binding protein 1, liver; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548934	Fabp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
fatty acid binding protein 2, intestinal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363674	Fabp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid binding protein 3, muscle and heart; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431873	Fabp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fatty acid binding protein 3, muscle and heart; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432895	Fabp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fatty acid binding protein 4, adipocyte; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419599	Fabp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid binding protein 4, adipocyte; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419753	Fabp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid binding protein 4, adipocyte; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308297	Fabp4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid binding protein 5, epidermal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434397	Fabp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fatty acid binding protein 7, brain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363223	Fabp7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid desaturase 1; targeted mutation 1.1, Velocigene	MGI:5695931	Fads1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
fatty acid desaturase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364316	Fads3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid desaturase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364316	Fads3<tm1a(KOMP)Wtsi>	28838557	KOMP-CSD
fatty acid desaturase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363085	Fads3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid desaturase domain family, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432828	Fads6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fatty acid synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419205	Fasn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acid synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419252	Fasn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acyl CoA reductase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363332	Far2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acyl CoA reductase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050153	Far2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acyl CoA reductase 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5494450	Far2<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
fatty acyl CoA reductase 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5494450	Far2<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
fatty acyl CoA reductase 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5494450	Far2<tm2b(KOMP)Wtsi>	28700664	KOMP-CSD
FBJ osteosarcoma oncogene B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460300	Fosb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FBJ osteosarcoma oncogene B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460300	Fosb<tm1a(KOMP)Wtsi>	29272704	KOMP-CSD
FBJ osteosarcoma oncogene B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5603357	Fosb<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
FBJ osteosarcoma oncogene B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6112640	Fosb<tm1c(KOMP)Wtsi>	29272704	KOMP-CSD
FBJ osteosarcoma oncogene B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460282	Fosb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363055	Fbxl12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363181	Fbxl12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939718	Fbxl13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419167	Fbxl16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 16; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548838	Fbxl16<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
F-box and leucine-rich repeat protein 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419223	Fbxl16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363107	Fbxl17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363587	Fbxl17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461657	Fbxl19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and leucine-rich repeat protein 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461739	Fbxl19<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and leucine-rich repeat protein 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840937	Fbxl20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841122	Fbxl20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948626	Fbxl21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 21; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473110	Fbxl21<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and leucine-rich repeat protein 21; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637143	Fbxl21<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
F-box and leucine-rich repeat protein 22; targeted mutation 1.1, Velocigene	MGI:5548639	Fbxl22<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
F-box and leucine-rich repeat protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944550	Fbxl4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and leucine-rich repeat protein 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431510	Fbxl6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820357	Fbxl7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and leucine-rich repeat protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820298	Fbxl7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and leucine-rich repeat protein 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364643	Fbxl8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and leucine-rich repeat protein 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364265	Fbxl8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363386	Fbxw11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363048	Fbxw11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364822	Fbxw13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419446	Fbxw17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419239	Fbxw17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947764	Fbxw21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007979	Fbxw21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428555	Fbxw24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428524	Fbxw24<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947750	Fbxw26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box and WD-40 domain protein 26; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548906	Fbxw26<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
F-box and WD-40 domain protein 26; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548906	Fbxw26<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
F-box and WD-40 domain protein 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692636	Fbxw2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
F-box and WD-40 domain protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434243	Fbxw7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and WD-40 domain protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847847	Fbxw7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and WD-40 domain protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847847	Fbxw7<tm2a(EUCOMM)Wtsi>	28422719	EUCOMM
F-box and WD-40 domain protein 7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847867	Fbxw7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and WD-40 domain protein 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692737	Fbxw8<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
F-box and WD-40 domain protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441814	Fbxw9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box and WD-40 domain protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441814	Fbxw9<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
F-box and WD-40 domain protein 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548567	Fbxw9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
F-box and WD-40 domain protein 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441968	Fbxw9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880900	Fbxo10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432314	Fbxo11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431755	Fbxo11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434283	Fbxo11<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434283	Fbxo11<tm2a(EUCOMM)Wtsi>	25827072	EUCOMM
F-box protein 11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432960	Fbxo11<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 15; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511977	Fbxo15<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 16; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692639	Fbxo16<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
F-box protein 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456015	Fbxo17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456019	Fbxo17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881960	Fbxo18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881967	Fbxo18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 18; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319888	Fbxo18<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 18; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319874	Fbxo18<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434171	Fbxo22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432563	Fbxo22<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 24; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419687	Fbxo24<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433489	Fbxo2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5694184	Fbxo2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
F-box protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433309	Fbxo2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451451	Fbxo30<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451358	Fbxo30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461726	Fbxo31<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 31; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548486	Fbxo31<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
F-box protein 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461679	Fbxo31<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286195	Fbxo32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432600	Fbxo33<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 33; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548601	Fbxo33<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
F-box protein 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432135	Fbxo33<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881955	Fbxo36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 36; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605754	Fbxo36<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
F-box protein 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362308	Fbxo39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 39; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363833	Fbxo39<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847695	Fbxo3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847707	Fbxo3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 41; targeted mutation 1.1, Velocigene	MGI:5548413	Fbxo41<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
F-box protein 41; targeted mutation 1, Velocigene	MGI:4881288	Fbxo41<tm1(KOMP)Vlcg>	26063905	KOMP-Regeneron
F-box protein 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006785	Fbxo42<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286396	Fbxo43<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362438	Fbxo44<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362438	Fbxo44<tm1a(KOMP)Wtsi>	26839965	KOMP-CSD
F-box protein 44; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569043	Fbxo44<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
F-box protein 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364056	Fbxo44<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433167	Fbxo45<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 45; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433299	Fbxo45<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431644	Fbxo47<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 47; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433930	Fbxo47<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 47; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434261	Fbxo47<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364537	Fbxo4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365073	Fbxo4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
F-box protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527602	Fbxo5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434927	Fbxo7<tm1a(EUCOMM)Hmgu>	21652635	EUCOMM
F-box protein 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434927	Fbxo7<tm1a(EUCOMM)Hmgu>	27497298	EUCOMM
F-box protein 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434927	Fbxo7<tm1a(EUCOMM)Hmgu>	27915416	EUCOMM
F-box protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842259	Fbxo7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842806	Fbxo7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432597	Fbxo8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
F-box protein 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605766	Fbxo8<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
F-box protein 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432182	Fbxo8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
f-box protein 9; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513776	Fbxo9<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
FCF1 rRNA processing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362830	Fcf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FCF1 rRNA processing protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362873	Fcf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Fc fragment of IgG binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432812	Fcgbp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Fc fragment of IgG binding protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548824	Fcgbp<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
Fc fragment of IgG binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432575	Fcgbp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Fc fragment of IgM receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451628	Fcmr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fc fragment of IgM receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513774	Fcmr<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
FCH and double SH3 domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364667	Fchsd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FCH and double SH3 domains 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840939	Fchsd1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
FCH and double SH3 domains 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841220	Fchsd1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Fc receptor, IgA, IgM, high affinity; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365097	Fcamr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fc receptor, IgA, IgM, high affinity; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428589	Fcamr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Fc receptor, IgE, high affinity I, gamma polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286235	Fcer1g<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fc receptor, IgE, high affinity I, gamma polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5583085	Fcer1g<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Fc receptor, IgG, high affinity I; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419257	Fcgr1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Fc receptor, IgG, low affinity IV; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432792	Fcgr4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Fc receptor, IgG, low affinity IV; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432792	Fcgr4<tm1e(EUCOMM)Wtsi>	24523933	EUCOMM
Fc receptor-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013745	Fcrl6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fc receptor-like A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820059	Fcrla<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Fc receptor-like A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5583069	Fcrla<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
feline leukemia virus subgroup C cellular receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434350	Flvcr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
feline leukemia virus subgroup C cellular receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434396	Flvcr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fem-1 homolog c (C.elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881937	Fem1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fer-1-like 6 (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4818591	Fer1l6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fer-1-like 6 (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4818588	Fer1l6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FERM and PDZ domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363855	Frmpd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FERM and PDZ domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365219	Frmpd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FERM and PDZ domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441884	Frmpd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FERM and PDZ domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302315	Frmpd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FERM domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842580	Frmd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FERM domain containing 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433176	Frmd4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FERM domain containing 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433636	Frmd4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FERM domain containing 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548809	Frmd5<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
FERM domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455520	Frmd7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FERM domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455520	Frmd7<tm1a(KOMP)Wtsi>	26711119	KOMP-CSD
FERM domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455520	Frmd7<tm1a(KOMP)Wtsi>	28530661	KOMP-CSD
FERM domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433665	Frmd8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FERM domain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432116	Frmd8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fermitin family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293969	Fermt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fermitin family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294964	Fermt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fermitin family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433009	Fermt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fermitin family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433009	Fermt2<tm1a(EUCOMM)Wtsi>	25724625	EUCOMM
fermitin family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420015	Fermt3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fermitin family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419561	Fermt3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fermitin family member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472797	Fermt3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
FERM, RhoGEF and pleckstrin domain protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363551	Farp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FERM, RhoGEF and pleckstrin domain protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363551	Farp2<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
FERM, RhoGEF and pleckstrin domain protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363551	Farp2<tm1a(KOMP)Wtsi>	25340873	KOMP-CSD
FERM, RhoGEF and pleckstrin domain protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363970	Farp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5588287	Farp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ferredoxin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452014	Fdx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ferredoxin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5588266	Fdx1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ferredoxin-fold anticodon binding domain containing 1; targeted mutation 1.1, Velocigene	MGI:5568483	Fdxacb1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ferric-chelate reductase 1 like; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637141	Frrs1l<tm1b(EUCOMM)Hmgu>	27236917	EUCOMM
ferric-chelate reductase 1 like; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637141	Frrs1l<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ferric-chelate reductase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842283	Frrs1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ferric-chelate reductase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842755	Frrs1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ferritin, heavy polypeptide-like 17, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426620	Fthl17a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ferritin, heavy polypeptide-like 17, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426554	Fthl17a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fetal and adult testis expressed 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319880	Fate1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fetal and adult testis expressed 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319853	Fate1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FGFR1 oncogene partner 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842345	Fgfr1op2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Fgfr1 oncogene partner; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548654	Fgfr1op<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Fgfr1op N-terminal like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419671	Fopnl<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
FGGY carbohydrate kinase domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451404	Fggy<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FGGY carbohydrate kinase domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451438	Fggy<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FH2 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299572	Fhdc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FH2 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299510	Fhdc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibrinogen alpha chain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458505	Fga<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibrinogen alpha chain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458573	Fga<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibrinogen C domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4868032	Fibcd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast activation protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841090	Fap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast activation protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841460	Fap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431585	Fgf10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548400	Fgf10<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
fibroblast growth factor 10; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5692589	Fgf10<tm1c(EUCOMM)Wtsi>	27826253	EUCOMM
fibroblast growth factor 10; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5692589	Fgf10<tm1c(EUCOMM)Wtsi>	28082865	EUCOMM
fibroblast growth factor 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432673	Fgf10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432799	Fgf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455623	Fgf12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434341	Fgf13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451645	Fgf16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451637	Fgf16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286395	Fgf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299878	Fgf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor 21; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4946696	Fgf21<tm1a(EUCOMM)Hmgu>	26947074	EUCOMM
fibroblast growth factor 22; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4455942	Fgf22<tm1a(EUCOMM)Hmgu>	27083047	EUCOMM
fibroblast growth factor 22; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4455942	Fgf22<tm1a(EUCOMM)Hmgu>	29311892	EUCOMM
fibroblast growth factor 22; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548535	Fgf22<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
fibroblast growth factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433040	Fgf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637206	Fgf2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
fibroblast growth factor 3; targeted mutation 4b, Helmholtz Zentrum Muenchen GmbH	MGI:5605838	Fgf3<tm4b(EUCOMM)Hmgu>	27626380	EUCOMM
fibroblast growth factor 7; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548935	Fgf7<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
fibroblast growth factor 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419458	Fgf8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637224	Fgf8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
fibroblast growth factor 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364690	Fgf9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364690	Fgf9<tm1a(KOMP)Wtsi>	25915623	KOMP-CSD
fibroblast growth factor 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5523233	Fgf9<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5523233	Fgf9<tm1b(KOMP)Wtsi>	25915623	KOMP-CSD
fibroblast growth factor 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5523233	Fgf9<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
fibroblast growth factor 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5523233	Fgf9<tm1b(KOMP)Wtsi>	29107558	KOMP-CSD
fibroblast growth factor 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364281	Fgf9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor (acidic) intracellular binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820345	Fibp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor (acidic) intracellular binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820356	Fibp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008044	Fgfbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor binding protein 3; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5573274	Fgfbp3<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
fibroblast growth factor binding protein 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419835	Fgfbp3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fibroblast growth factor receptor 1; targeted mutation 1.1, Velocigene	MGI:5583086	Fgfr1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
fibroblast growth factor receptor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433501	Fgfr4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor receptor 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548936	Fgfr4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
fibroblast growth factor receptor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432207	Fgfr4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor receptor-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008056	Fgfrl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor receptor substrate 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433393	Frs2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor receptor substrate 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548401	Frs2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
fibroblast growth factor receptor substrate 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433159	Frs2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor receptor substrate 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820315	Frs3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibroblast growth factor receptor substrate 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820301	Frs3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibromodulin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820227	Fmod<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000413	Fn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin leucine rich transmembrane protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435978	Flrt1<tm1a(EUCOMM)Hmgu>	28475893	EUCOMM
fibronectin leucine rich transmembrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432699	Flrt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin leucine rich transmembrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432699	Flrt2<tm1a(EUCOMM)Wtsi>	28475893	EUCOMM
fibronectin leucine rich transmembrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432699	Flrt2<tm1a(EUCOMM)Wtsi>	28576770	EUCOMM
fibronectin leucine rich transmembrane protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432471	Flrt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin leucine rich transmembrane protein 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365248	Flrt3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type 3 and SPRY domain-containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451503	Fsd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type 3 and SPRY domain-containing protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451417	Fsd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III and SPRY domain containing 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842594	Fsd1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin type III and SPRY domain containing 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842808	Fsd1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin type III and SPRY domain containing 1-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5014715	Fsd1l<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin type III and SPRY domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461675	Fsd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin type III and SPRY domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461722	Fsd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibronectin type III domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000326	Fndc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III domain containing 3C1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419714	Fndc3c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III domain containing 3C1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419850	Fndc3c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III domain containing 3C1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4950156	Fndc3c1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III domain containing 3C2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363040	Fnd3c2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III domain containing 3C2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456674	Fnd3c2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III domain containing 3C2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4458484	Fnd3c2<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
fibronectin type III domain containing 3C2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4458614	Fnd3c2<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
fibrosin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453685	Fbrsl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fibrosin-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453771	Fbrsl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fibrosin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431427	Fbrs<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fibulin 7; targeted mutation 1.1, Velocigene	MGI:5548596	Fbln7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
fidgetin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419787	Fign<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
filamin A interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013728	Filip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
filamin A interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006739	Filip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
filamin, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441852	Flna<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
filamin, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441914	Flna<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
filamin, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458530	Flnb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
filamin, beta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637156	Flnb<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
filamin, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458601	Flnb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FIP1 like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887691	Fip1l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FK506 binding protein 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433932	Fkbp10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FK506 binding protein 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5432211	Fkbp10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
FK506 binding protein 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5432211	Fkbp10<tm2a(EUCOMM)Wtsi>	24777781	EUCOMM
FK506 binding protein 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5432211	Fkbp10<tm2a(EUCOMM)Wtsi>	28206698	EUCOMM
FK506 binding protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362831	Fkbp14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363080	Fkbp14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363798	Fkbp15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050935	Fkbp3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
FK506 binding protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941990	Fkbp5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548348	Fkbp5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
FK506 binding protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942028	Fkbp5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428597	Fkbp6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635086	Fkbp6<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362582	Fkbp7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364239	Fkbp7<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472966	Fkbp9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FK506 binding protein-like; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5558157	Fkbpl<tm1.1(KOMP)Wtsi>	25767277	KOMP-CSD
FK506 binding protein-like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431442	Fkbpl<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
FK506 binding protein-like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431442	Fkbpl<tm1(KOMP)Wtsi>	25767277	KOMP-CSD
flap structure specific endonuclease 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434275	Fen1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
flavin containing monooxygenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428598	Fmo1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
flavin containing monooxygenase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881962	Fmo2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
flavin containing monooxygenase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880989	Fmo2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
flavin containing monooxygenase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305671	Fmo4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
flavin containing monooxygenase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365272	Fmo5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
flavin containing monooxygenase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296550	Fmo5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
flavin containing monooxygenase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364632	Fmo9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
flightless I actin binding protein; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548451	Flii<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
flotillin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362899	Flot1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
flotillin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362547	Flot1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
flotillin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431860	Flot2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
flotillin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434086	Flot2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
flotillin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432862	Flot2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
flotillin 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433811	Flot2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
FMS-like tyrosine kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842448	Flt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FMS-like tyrosine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842772	Flt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FMS-like tyrosine kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942039	Flt4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
folate hydrolase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000316	Folh1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
folate receptor 1 (adult); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419626	Folr1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
folliculin interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303094	Fnip2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
follistatin-like 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636888	Fstl1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
follistatin-like 3; targeted mutation 1.1, Velocigene	MGI:5692647	Fstl3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
follistatin-like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305680	Fstl4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
follistatin-like 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419925	Fstl5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
follistatin-like 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841344	Fstl5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
follistatin-like 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841177	Fstl5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
follistatin-like 5; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4841396	Fstl5<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
follistatin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948611	Fst<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
follistatin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942029	Fst<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940800	Foxa1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420118	Foxa2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419984	Foxa2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box H1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419104	Foxh1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box I1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840980	Foxi1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box I1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841240	Foxi1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box I2; targeted mutation 1.1, Velocigene	MGI:5569961	Foxi2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
forkhead box J1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949353	Foxj1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box J1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949366	Foxj1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box J3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452760	Foxj3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box J3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452760	Foxj3<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
forkhead box J3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5613664	Foxj3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
forkhead box J3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452802	Foxj3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box M1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842563	Foxm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box M1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842724	Foxm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box N4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362365	Foxn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box N4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362578	Foxn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box O1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458839	Foxo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box O1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458833	Foxo1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box O3; targeted mutation 1.1, Velocigene	MGI:5471395	Foxo3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
forkhead box O3; targeted mutation 1.1, Velocigene	MGI:5471395	Foxo3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
forkhead box O6; targeted mutation 1, Velocigene	MGI:5292882	Foxo6<tm1(KOMP)Vlcg>	25944898	KOMP-Regeneron
forkhead box P1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941988	Foxp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box P1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942033	Foxp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box P4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888955	Foxp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box P4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888940	Foxp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
forkhead box R2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940781	Foxr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
forkhead box R2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946678	Foxr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
formation of mitochondrial complex V assembly factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289892	Fmc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
formation of mitochondrial complex V assembly factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548510	Fmc1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
formation of mitochondrial complex V assembly factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5289891	Fmc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
formiminotransferase cyclodeaminase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441995	Ftcd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
formin binding protein 1-like; targeted mutation 1.1, Velocigene	MGI:5548692	Fnbp1l<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
formin binding protein 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842299	Fnbp1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
formin binding protein 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842571	Fnbp1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
formin binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451351	Fnbp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
formin binding protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451600	Fnbp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
formin homology 2 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432837	Fhod1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
formin homology 2 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433404	Fhod1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
formin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841198	Fmnl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
formin-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840915	Fmnl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
formin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452781	Fmnl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
formin-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364329	Fmnl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
formin-like 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5561555	Fmnl3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
formin-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364607	Fmnl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
formyl peptide receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286231	Fpr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
formyl peptide receptor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548372	Fpr1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
formyl peptide receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451387	Fpr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
formyl peptide receptor 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050977	Fpr2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
formyl peptide receptor 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050991	Fpr2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
formyl peptide receptor 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5584405	Fpr3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
forty-two-three domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424644	Fyttd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fos-like antigen 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4881077	Fosl1<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
four and a half LIM domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433852	Fhl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
four and a half LIM domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050157	Fhl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
four and a half LIM domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428498	Fhl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
four and a half LIM domains 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472992	Fhl2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
four jointed box 1; targeted mutation 1.1, Velocigene	MGI:5692624	Fjx1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
FRA10AC1 homolog (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432196	Fra10ac1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FRA10AC1 homolog (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434398	Fra10ac1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fragile X mental retardation 1 neighbor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452010	Fmr1nb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fragile X mental retardation, autosomal homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458523	Fxr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fragile X mental retardation, autosomal homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458481	Fxr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fragile X mental retardation, autosomal homolog 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472946	Fxr2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
fragile X mental retardation, autosomal homolog 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472799	Fxr2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
fragile X mental retardation gene 1, autosomal homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455947	Fxr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fragile X mental retardation gene 1, autosomal homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455959	Fxr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fragile X mental retardation syndrome 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433349	Fmr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fragile X mental retardation syndrome 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433165	Fmr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
free fatty acid receptor 1; targeted mutation 1.1, Velocigene	MGI:5695958	Ffar1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
free fatty acid receptor 4; targeted mutation 1, Velocigene	MGI:4881214	Ffar4<tm1(KOMP)Vlcg>	27853148	KOMP-Regeneron
free fatty acid receptor 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431463	Ffar4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Friend leukemia integration 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286216	Fli1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Friend virus susceptibility 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473176	Fv1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Friend virus susceptibility 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472750	Fv1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Friend virus susceptibility 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473177	Fv1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Friend virus susceptibility 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472751	Fv1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
frizzled class receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473201	Fzd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
frizzled class receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472774	Fzd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
frizzled class receptor 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692578	Fzd3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
frizzled class receptor 4; targeted mutation 1.1, Velocigene	MGI:5582423	Fzd4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
frizzled class receptor 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460301	Fzd6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
frizzled class receptor 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460280	Fzd6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
frizzled class receptor 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527589	Fzd6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
frizzled-related protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433676	Frzb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
frizzled-related protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432627	Frzb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fructosamine 3 kinase related protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363817	Fn3krp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fructosamine 3 kinase related protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364296	Fn3krp<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
fructosamine 3 kinase related protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363831	Fn3krp<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
fructosamine 3 kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362433	Fn3k<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fructosamine 3 kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363259	Fn3k<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fructose bisphosphatase 2; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5637205	Fbp2<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
FRY like transcription coactivator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454126	Fryl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FRY like transcription coactivator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454153	Fryl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FtsJ RNA methyltransferase homolog 1 (E. coli); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432274	Ftsj1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FtsJ RNA methyltransferase homolog 1 (E. coli); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548495	Ftsj1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
FtsJ RNA methyltransferase homolog 1 (E. coli); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434413	Ftsj1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fucose mutarotase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431466	Fuom<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fucosidase, alpha-L- 1, tissue; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432048	Fuca1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fucosidase, alpha-L- 1, tissue; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432338	Fuca1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
fucosidase, alpha-L- 1, tissue; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4842434	Fuca1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
fucosidase, alpha-L- 1, tissue; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4842471	Fuca1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
fucosidase, alpha-L- 2, plasma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364074	Fuca2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fucosidase, alpha-L- 2, plasma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363993	Fuca2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fucosyltransferase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462593	Fut10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fucosyltransferase 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462627	Fut10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fucosyltransferase 11; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419333	Fut11<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
fucosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050841	Fut1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fucosyltransferase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433900	Fut7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fucosyltransferase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433026	Fut7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fucosyltransferase 7; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511932	Fut7<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
fucosyltransferase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451690	Fut9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fucosyltransferase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451457	Fut9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fukutin related protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286234	Fkrp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fumarate hydratase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365198	Fh1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fumarate hydratase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364103	Fh1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
fumarate hydratase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299608	Fh1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
fumarylacetoacetate hydrolase domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431777	Fahd2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fumarylacetoacetate hydrolase domain containing 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433196	Fahd2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FUN14 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363327	Fundc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FUN14 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363327	Fundc1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
FUN14 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363327	Fundc1<tm1a(KOMP)Wtsi>	27995894	KOMP-CSD
furin (paired basic amino acid cleaving enzyme); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434157	Furin<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
furin (paired basic amino acid cleaving enzyme); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548958	Furin<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
furin (paired basic amino acid cleaving enzyme); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434392	Furin<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fused in sarcoma; targeted mutation 1.1, Velocigene	MGI:5548484	Fus<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
fused in sarcoma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842474	Fus<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
fused in sarcoma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842474	Fus<tm1a(EUCOMM)Wtsi>	26842965	EUCOMM
fused in sarcoma; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5776262	Fus<tm1c(EUCOMM)Wtsi>	26842965	EUCOMM
fused in sarcoma; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5776263	Fus<tm1d(EUCOMM)Wtsi>	26842965	EUCOMM
fused in sarcoma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842555	Fus<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fuzzy planar cell polarity protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362754	Fuz<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
fuzzy planar cell polarity protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363807	Fuz<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FXYD domain-containing ion transport regulator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434155	Fxyd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FXYD domain-containing ion transport regulator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434154	Fxyd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FXYD domain-containing ion transport regulator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362906	Fxyd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FXYD domain-containing ion transport regulator 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363575	Fxyd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FXYD domain-containing ion transport regulator 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050946	Fxyd4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
FXYD domain-containing ion transport regulator 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050916	Fxyd4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
FXYD domain-containing ion transport regulator 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428594	Fxyd5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FXYD domain-containing ion transport regulator 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428583	Fxyd5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FXYD domain-containing ion transport regulator 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286219	Fxyd7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FXYD domain-containing ion transport regulator 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426579	Fxyd7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
FYN binding protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548460	Fyb<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Fyn proto-oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842482	Fyn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Fyn proto-oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842604	Fyn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
fyn-related kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014571	Frk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
FYVE, RhoGEF and PH domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849414	Fgd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
FYVE, RhoGEF and PH domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849406	Fgd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
FYVE, RhoGEF and PH domain containing 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4868080	Fgd4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
FYVE, RhoGEF and PH domain containing 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4868090	Fgd4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
G0/G1 switch gene 2; targeted mutation 1, Velocigene	MGI:3808572	G0s2<tm1(KOMP)Vlcg>	24194501	KOMP-Regeneron
G0/G1 switch gene 2; targeted mutation 1, Velocigene	MGI:3808572	G0s2<tm1(KOMP)Vlcg>	24556704	KOMP-Regeneron
G0/G1 switch gene 2; targeted mutation 1, Velocigene	MGI:3808572	G0s2<tm1(KOMP)Vlcg>	24583640	KOMP-Regeneron
G0/G1 switch gene 2; targeted mutation 1, Velocigene	MGI:3808572	G0s2<tm1(KOMP)Vlcg>	25666096	KOMP-Regeneron
galactosamine (N-acetyl)-6-sulfate sulfatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461663	Galns<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
galactosamine (N-acetyl)-6-sulfate sulfatase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461742	Galns<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
galactose-3-O-sulfotransferase 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419304	Gal3st4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
galactosidase, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433460	Gla<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
galactosidase, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432594	Gla<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
galactosidase, beta 1-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363734	Glb1l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
galactosylceramidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363461	Galc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
galactosylceramidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513778	Galc<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
galactosylceramidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363690	Galc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
galanin-like peptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432166	Galp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
galanin-like peptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548848	Galp<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
galanin receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434429	Galr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
galanin receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433099	Galr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
galanin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841000	Gal<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
galanin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841467	Gal<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
galectin-related inter-fiber protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419254	Grifin<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
gametocyte specific factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432632	Gtsf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gametocyte specific factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431912	Gtsf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gametogenetin binding protein 1; targeted mutation 1.1, Velocigene	MGI:5695962	Ggnbp1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
gametogenetin binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842314	Ggnbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gametogenetin binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454104	Ggnbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gametogenetin binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513782	Ggnbp2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
gametogenetin binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454150	Ggnbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637004	Gabarapl2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
gamma-aminobutyric acid (GABA) A receptor, pi; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434055	Gabrp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364827	Gabra1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363718	Gabra1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4460285	Gabra1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050967	Gabra5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363652	Gabra6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364043	Gabra6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843857	Gabrb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433146	Gabrb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434328	Gabrb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-aminobutyric acid (GABA) A receptor, subunit delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887702	Gabrd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-aminobutyric acid (GABA) A receptor, subunit delta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887719	Gabrd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-aminobutyric acid (GABA) A receptor, subunit epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428538	Gabre<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit epsilon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428485	Gabre<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289809	Gabrg3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) A receptor, subunit theta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451475	Gabrq<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) B receptor, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940748	Gabbr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) B receptor, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940748	Gabbr1<tm1a(KOMP)Wtsi>	28621310	KOMP-CSD
gamma-aminobutyric acid (GABA) B receptor, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940743	Gabbr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) C receptor, subunit rho 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362133	Gabrr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid (GABA) C receptor, subunit rho 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548937	Gabrr2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
gamma-aminobutyric acid (GABA) C receptor, subunit rho 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363210	Gabrr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-aminobutyric acid receptor associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433472	Gabarap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-aminobutyric acid receptor associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434259	Gabarap<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyl carboxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842295	Ggcx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyl carboxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842770	Ggcx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyl cyclotransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441850	Ggct<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyl cyclotransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441930	Ggct<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyl hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362371	Ggh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-glutamyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432621	Ggt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434363	Ggt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyltransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432350	Ggt5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyltransferase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432443	Ggt5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyltransferase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362694	Ggt6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-glutamyltransferase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419496	Ggt6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-glutamyltransferase 6; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511890	Ggt6<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
gamma-glutamyltransferase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363592	Ggt7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-glutamyltransferase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364064	Ggt7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-secretase activating protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420129	Gsap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-secretase activating protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419943	Gsap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gamma-secretase activating protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299655	Gsap<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ganglioside-induced differentiation-associated-protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363773	Gdap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ganglioside-induced differentiation-associated-protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364916	Gdap1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ganglioside-induced differentiation-associated-protein 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5569041	Gdap1<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
ganglioside-induced differentiation-associated-protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364528	Gdap1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ganglioside-induced differentiation-associated-protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4365082	Gdap1<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
ganglioside-induced differentiation-associated-protein 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4364546	Gdap1<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
ganglioside-induced differentiation-associated-protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431884	Gdap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ganglioside-induced differentiation-associated-protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433114	Gdap2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ganglioside-induced differentiation-associated-protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432483	Gdap2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ganglioside-induced differentiation-associated-protein 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4456749	Gdap2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
gap junction protein, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842331	Gja1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gap junction protein, alpha 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419105	Gja4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gap junction protein, alpha 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419723	Gja4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gap junction protein, alpha 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548980	Gja8<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
gap junction protein, beta 4; targeted mutation 1.1, Velocigene	MGI:5572041	Gjb4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
gap junction protein, delta 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841087	Gjd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gap junction protein, delta 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296557	Gjd2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
gap junction protein, delta 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296553	Gjd2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
gap junction protein, delta 4; targeted mutation 1.1, Velocigene	MGI:5574610	Gjd4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
gap junction protein, epsilon 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4455812	Gje1<tm1a(EUCOMM)Hmgu>	27038752	EUCOMM
gap junction protein, epsilon 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5776523	Gje1<tm1b(EUCOMM)Hmgu>	27038752	EUCOMM
gap junction protein, gamma 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009634	Gjc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gap junction protein, gamma 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842414	Gjc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GAR1 ribonucleoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432700	Gar1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GAR1 ribonucleoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432705	Gar1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GA repeat binding protein, beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140443	Gabpb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GA repeat binding protein, beta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140426	Gabpb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GA repeat binding protein, beta 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419510	Gabpb2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
gasdermin A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419575	Gsdma2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gasdermin A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419359	Gsdma2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gasdermin A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820057	Gsdma3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gasdermin A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820108	Gsdma3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gasdermin C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363044	Gsdmc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gasdermin D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842262	Gsdmd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gasdermin D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842616	Gsdmd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gasdermin E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363231	Gsdme<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gasdermin E; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692646	Gsdme<tm1b(KOMP)Wtsi>	28045099	KOMP-CSD
gasdermin E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364695	Gsdme<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gastric inhibitory polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433625	Gip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gastric inhibitory polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432800	Gip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gastric intrinsic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363945	Gif<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gastric intrinsic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363945	Gif<tm1a(KOMP)Wtsi>	24911144	KOMP-CSD
gastric intrinsic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363945	Gif<tm1a(KOMP)Wtsi>	27329747	KOMP-CSD
gastric intrinsic factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364330	Gif<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gastrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432161	Gast<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gastrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433005	Gast<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gastrokine 1; targeted mutation 1.1, Velocigene	MGI:5696902	Gkn1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
gastrokine 2; targeted mutation 1.1, Velocigene	MGI:5548517	Gkn2<tm1.1(KOMP)Vlcg>	26974160	KOMP-Regeneron
gastrokine 2; targeted mutation 1.1, Velocigene	MGI:5548517	Gkn2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
gastrokine 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461750	Gkn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gastrokine 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462686	Gkn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gastrokine 2; targeted mutation 1, Velocigene	MGI:4399717	Gkn2<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
gastrokine 2; targeted mutation 1, Velocigene	MGI:4399717	Gkn2<tm1(KOMP)Vlcg>	26974160	KOMP-Regeneron
gastrokine 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433233	Gkn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gastrulation brain homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944338	Gbx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gastrulation brain homeobox 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548939	Gbx1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
gastrulation brain homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944411	Gbx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gastrulation brain homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419399	Gbx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gastrulation brain homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419812	Gbx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gastrulation brain homeobox 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451489	Gbx2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
gastrulation brain homeobox 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451269	Gbx2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
GATA binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458623	Gata2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GATA binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458502	Gata2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GATA zinc finger domain containing 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050899	Gatad1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
GATS protein-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433861	Gatsl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GATS protein-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433436	Gatsl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GCN1 general control of amino-acid synthesis 1-like 1 (yeast); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419136	Gcn1l1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
GC-rich promoter binding protein 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460432	Gpbp1l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GC-rich promoter binding protein 1-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460428	Gpbp1l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GC-rich promoter binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006774	Gpbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GDP-mannose 4, 6-dehydratase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363597	Gmds<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GDP-mannose 4, 6-dehydratase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362753	Gmds<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GDP-mannose pyrophosphorylase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842860	Gmppa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G elongation factor, mitochondrial 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432285	Gfm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gelsolin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432685	Gsn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gelsolin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432908	Gsn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
geminin coiled-coil domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841069	Gmnc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
geminin coiled-coil domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841069	Gmnc<tm1a(KOMP)Wtsi>	26882546	KOMP-CSD
geminin coiled-coil domain containing; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637172	Gmnc<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
geminin coiled-coil domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841361	Gmnc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
geminin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363191	Gmnn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
geminin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363191	Gmnn<tm1a(KOMP)Wtsi>	24412371	KOMP-CSD
geminin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363191	Gmnn<tm1a(KOMP)Wtsi>	24995796	KOMP-CSD
geminin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363191	Gmnn<tm1a(KOMP)Wtsi>	29234490	KOMP-CSD
geminin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362549	Gmnn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
geminin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308291	Gmnn<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Gem-interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363029	Gmip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Gem-interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364164	Gmip<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gem nuclear organelle associated protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458861	Gemin4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gem nuclear organelle associated protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458836	Gemin4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GEN1, Holliday junction 5' flap endonuclease; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432245	Gen1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor II A, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363802	Gtf2a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor II A, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363692	Gtf2a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor II A, 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364436	Gtf2a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor II A, 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363901	Gtf2a1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor II A, 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085353	Gtf2a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor IIB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000406	Gtf2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor IIB; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513790	Gtf2b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
general transcription factor II E, polypeptide 1 (alpha subunit); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432302	Gtf2e1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor II E, polypeptide 1 (alpha subunit); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432573	Gtf2e1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor II E, polypeptide 2 (beta subunit); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008024	Gtf2e2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor II E, polypeptide 2 (beta subunit); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008050	Gtf2e2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor II H, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362130	Gtf2h1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor II H, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363283	Gtf2h1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor II H, polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432932	Gtf2h2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor II H, polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433381	Gtf2h2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor III A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307107	Gtf3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor IIIC, polypeptide 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511990	Gtf3c4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor IIIC, polypeptide 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362483	Gtf3c5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor IIIC, polypeptide 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419988	Gtf3c5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor IIIC, polypeptide 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362662	Gtf3c5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor IIIC, polypeptide 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364508	Gtf3c5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor IIIC, polypeptide 6, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434292	Gtf3c6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor IIIC, polypeptide 6, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434254	Gtf3c6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
general transcription factor II I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362138	Gtf2i<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
general transcription factor II I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364659	Gtf2i<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gene regulated by estrogen in breast cancer protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363934	Greb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
gene regulated by estrogen in breast cancer protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548756	Greb1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
gene regulated by estrogen in breast cancer protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419623	Greb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gene rich cluster, C10 gene; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050960	Grcc10<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
genetic suppressor element 1, coiled-coil protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455973	Gse1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
genetic suppressor element 1, coiled-coil protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842854	Gse1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gene trap ROSA 26, Philippe Soriano; targeted mutation 14, Hongkui Zeng	MGI:3809524	Gt(ROSA)26Sor<tm14(CAG-tdTomato)Hze>	23169059	null
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Frank Costantini	MGI:2449038	Gt(ROSA)26Sor<tm1(EYFP)Cos>	23169059	null
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Mario R Capecchi	MGI:3618991	Gt(ROSA)26Sor<tm1(DTA)Mrc>	23844102	null
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Philippe Soriano	MGI:1861932	Gt(ROSA)26Sor<tm1Sor>	23169059	null
gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Stuart Orkin	MGI:2136519	Gt(ROSA)26Sor<tm2Sho>	23169059	null
gene trap ROSA 26, Philippe Soriano; targeted mutation 4, Liqun Luo	MGI:3716464	Gt(ROSA)26Sor<tm4(ACTB-tdTomato,-EGFP)Luo>	23169059	null
geranylgeranyl diphosphate synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000392	Ggps1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
geranylgeranyl diphosphate synthase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548447	Ggps1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
GH regulated TBC protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513788	Grtp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
giant axonal neuropathy; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456004	Gan<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
giant axonal neuropathy; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456064	Gan<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GINS complex subunit 2 (Psf2 homolog); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820281	Gins2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GINS complex subunit 2 (Psf2 homolog); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820238	Gins2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GIPC PDZ domain containing family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454127	Gipc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GIPC PDZ domain containing family, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454151	Gipc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GIPC PDZ domain containing family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364017	Gipc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GIPC PDZ domain containing family, member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446012	Gipc3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
GIPC PDZ domain containing family, member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446012	Gipc3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
GIPC PDZ domain containing family, member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446012	Gipc3<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
GIPC PDZ domain containing family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362685	Gipc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GLE1 RNA export mediator (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431602	Gle1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GLE1 RNA export mediator (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432235	Gle1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glial cell line derived neurotrophic factor family receptor alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003032	Gfra1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glial cell line derived neurotrophic factor family receptor alpha 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820299	Gfra3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glial cell line derived neurotrophic factor family receptor alpha 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820251	Gfra3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glial cell line derived neurotrophic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006796	Gdnf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glial fibrillary acidic protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947813	Gfap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glial fibrillary acidic protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003025	Gfap<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glia maturation factor, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441713	Gmfb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glia maturation factor, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441889	Gmfb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GLI-Kruppel family member GLI3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432333	Gli3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GLI-Kruppel family member GLI3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433328	Gli3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gliomedin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085471	Gldn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gliomedin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294230	Gldn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GLI pathogenesis-related 1 (glioma); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362395	Glipr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GLI pathogenesis-related 1 (glioma); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364564	Glipr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GLI pathogenesis-related 1 like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293939	Glipr1l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GLI pathogenesis-related 1 like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841062	Glipr1l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GLI pathogenesis-related 1 like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841345	Glipr1l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GLIS family zinc finger 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432985	Glis1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GLIS family zinc finger 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432917	Glis1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GLIS family zinc finger 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472980	Glis2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GLIS family zinc finger 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472824	Glis2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GLIS family zinc finger 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426668	Glis3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1; targeted mutation 1.1, Velocigene	MGI:5569959	Gbgt1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glomulin, FKBP associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442045	Glmn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glucagon-like peptide 1 receptor; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5637223	Glp1r<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
glucagon receptor; targeted mutation 1.1, Velocigene	MGI:5569085	Gcgr<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glucagon receptor; targeted mutation 1, Velocigene	MGI:4415466	Gcgr<tm1(KOMP)Vlcg>	26166562	KOMP-Regeneron
glucan (1,4-alpha-), branching enzyme 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364560	Gbe1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glucocorticoid modulatory element binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431553	Gmeb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glucokinase regulatory protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841050	Gckr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glucokinase regulatory protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841074	Gckr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glucosamine-6-phosphate deaminase 1; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5513784	Gnpda1<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
glucosamine-6-phosphate deaminase 2; targeted mutation 1.1, Velocigene	MGI:5696907	Gnpda2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glucosamine-6-phosphate deaminase 2; targeted mutation 1, Velocigene	MGI:3813084	Gnpda2<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
glucosamine-6-phosphate deaminase 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420064	Gnpda2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glucosamine (N-acetyl)-6-sulfatase; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH	MGI:4881048	Gns<tm1e(EUCOMM)Hmgu>	28334745	EUCOMM
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441727	Gne<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441975	Gne<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glucosaminyl (N-acetyl) transferase 3, mucin type; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940761	Gcnt3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glucosaminyl (N-acetyl) transferase 3, mucin type; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940784	Gcnt3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glucosaminyl (N-acetyl) transferase family member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842658	Gcnt7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glucosaminyl (N-acetyl) transferase family member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842631	Gcnt7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glucose-6-phosphatase, catalytic, 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364844	G6pc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glucose-6-phosphatase, catalytic, 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363479	G6pc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glucose-6-phosphatase, catalytic, 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451458	G6pc2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
glucose-fructose oxidoreductase domain containing 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637048	Gfod2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
glucosidase, alpha, acid; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419306	Gaa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glucosidase, alpha, acid; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419153	Gaa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glucosidase beta 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433071	Gba2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glucosidase beta 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432312	Gba2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glucosidase, beta, acid; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847876	Gba<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glucosidase, beta, acid; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847849	Gba<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glucoside xylosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939767	Gxylt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glucoside xylosyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363480	Gxylt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glucoside xylosyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364423	Gxylt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glucoside xylosyltransferase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840966	Gxylt2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
glucoside xylosyltransferase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841348	Gxylt2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate-ammonia ligase (glutamine synthetase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820105	Glul<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate-ammonia ligase (glutamine synthetase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820126	Glul<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate-cysteine ligase, catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432329	Gclc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate-cysteine ligase, catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432329	Gclc<tm1a(EUCOMM)Wtsi>	23226398	EUCOMM
glutamate-cysteine ligase, catalytic subunit; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5475270	Gclc<tm1c(EUCOMM)Wtsi>	23226398	EUCOMM
glutamate-cysteine ligase, catalytic subunit; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5475270	Gclc<tm1c(EUCOMM)Wtsi>	28158580	EUCOMM
glutamate-cysteine ligase, catalytic subunit; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5475270	Gclc<tm1c(EUCOMM)Wtsi>	28177569	EUCOMM
glutamate-cysteine ligase, catalytic subunit; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5475270	Gclc<tm1c(EUCOMM)Wtsi>	28525556	EUCOMM
glutamate-cysteine ligase, catalytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432016	Gclc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate decarboxylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009655	Gad1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate decarboxylase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433550	Gadl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate dehydrogenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820102	Glud1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate dehydrogenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820030	Glud1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, ionotropic, AMPA3 (alpha 3); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842384	Gria3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, ionotropic, delta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431684	Grid1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451578	Grid2ip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432313	Grin1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432313	Grin1<tm1a(EUCOMM)Wtsi>	23277569	EUCOMM
glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5431094	Grin1<tm1c(EUCOMM)Wtsi>	23277569	EUCOMM
glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5431094	Grin1<tm1c(EUCOMM)Wtsi>	29163060	EUCOMM
glutamate receptor, ionotropic, NMDA1 (zeta 1); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434240	Grin1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, ionotropic, NMDA2A (epsilon 1); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880909	Grin2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, ionotropic, NMDA2B (epsilon 2); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293931	Grin2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, ionotropic, NMDA2D (epsilon 4); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432794	Grin2d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, ionotropic, NMDA3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462594	Grin3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, ionotropic, NMDA3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462601	Grin3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841169	Grina<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841256	Grina<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363695	Grm2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820049	Grm3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636981	Grm3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
glutamate receptor, metabotropic 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820130	Grm3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293978	Grm3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431613	Grm6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, metabotropic 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548472	Grm6<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
glutamate receptor, metabotropic 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434014	Grm6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, metabotropic 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472820	Grm6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate receptor, metabotropic 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050862	Grm7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364216	Grm8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364705	Grm8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate receptor, metabotropic 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841284	Grm8<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate rich 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419905	Erich4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glutamate rich 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302337	Erich6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamate rich 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951132	Erich6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamic acid decarboxylase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433273	Gad2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamic acid decarboxylase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548938	Gad2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
glutamic-oxaloacetic transaminase 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842717	Got1l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamic-oxaloacetic transaminase 1-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842570	Got1l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamic pyruvate transaminase (alanine aminotransferase) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363039	Gpt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamic pyruvate transaminase (alanine aminotransferase) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363039	Gpt2<tm1a(KOMP)Wtsi>	27601654	KOMP-CSD
glutamic pyruvate transaminase (alanine aminotransferase) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362244	Gpt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutaminase 2 (liver, mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432108	Gls2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutaminase 2 (liver, mitochondrial); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431701	Gls2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutaminase 2 (liver, mitochondrial); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472689	Gls2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamine and serine rich 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840954	Qser1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamine fructose-6-phosphate transaminase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431600	Gfpt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamine fructose-6-phosphate transaminase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637207	Gfpt1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
glutamine fructose-6-phosphate transaminase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431869	Gfpt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamine fructose-6-phosphate transaminase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433591	Gfpt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamine fructose-6-phosphate transaminase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636966	Gfpt2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
glutamine fructose-6-phosphate transaminase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433304	Gfpt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutamine repeat protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868829	Glrp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamine-rich 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431480	Qrich1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glutaminyl-peptide cyclotransferase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840991	Qpctl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363513	Qrsl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364521	Qrsl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamyl aminopeptidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363369	Enpep<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamyl aminopeptidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363933	Enpep<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamyl-prolyl-tRNA synthetase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513771	Eprs<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
glutamyl-tRNA(Gln) amidotransferase, subunit B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362481	Gatb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamyl-tRNA(Gln) amidotransferase, subunit B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4819198	Gatb<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamyl-tRNA(Gln) amidotransferase, subunit C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362453	Gatc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutamyl-tRNA(Gln) amidotransferase, subunit C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362166	Gatc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutamyl-tRNA synthetase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432622	Ears2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutamyl-tRNA synthetase 2, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432703	Ears2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutaredoxin, cysteine rich 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453783	Grxcr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutaredoxin, cysteine rich 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453779	Grxcr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutaredoxin, cysteine rich 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511948	Grxcr1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
glutaredoxin, cysteine rich 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882017	Grxcr2<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
glutaredoxin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432029	Glrx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutaredoxin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432871	Glrx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione peroxidase 1; targeted mutation 1.1, Velocigene	MGI:5548355	Gpx1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glutathione peroxidase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419347	Gpx1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione peroxidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841147	Gpx3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione peroxidase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692559	Gpx3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
glutathione peroxidase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841009	Gpx3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione peroxidase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433194	Gpx6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione peroxidase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434478	Gpx6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione S-transferase, alpha 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473026	Gsta3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione S-transferase, alpha 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5629310	Gsta4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
glutathione S-transferase, C-terminal domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008022	Gstcd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione S-transferase, C-terminal domain containing; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605781	Gstcd<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
glutathione S-transferase kappa 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947816	Gstk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione S-transferase, mu 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842365	Gstm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione S-transferase, mu 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842374	Gstm2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione S-transferase, mu 4; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5603358	Gstm4<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
glutathione S-transferase, mu 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364233	Gstm5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase, mu 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365243	Gstm5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase, mu 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841200	Gstm7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase, mu 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840912	Gstm7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase omega 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364988	Gsto2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase omega 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840928	Gsto2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase omega 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4843827	Gsto2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase, theta 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419154	Gstt2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glutathione S-transferase, theta 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432761	Gstt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glutathione S-transferase, theta 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432790	Gstt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944561	Gapdhs<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944579	Gapdhs<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycerate kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296549	Glyctk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycerate kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296548	Glyctk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycerol-3-phosphate acyltransferase 2, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364393	Gpat2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycerol-3-phosphate acyltransferase 2, mitochondrial; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4881942	Gpat2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
glycerol-3-phosphate acyltransferase 2, mitochondrial; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4881953	Gpat2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
glycerol-3-phosphate dehydrogenase 1 (soluble); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434282	Gpd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycerol-3-phosphate dehydrogenase 1 (soluble); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434089	Gpd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycerol kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451982	Gk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glyceronephosphate O-acyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868077	Gnpat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycerophosphodiester phosphodiesterase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432292	Gdpd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycerophosphodiester phosphodiesterase domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880967	Gdpd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycerophosphodiester phosphodiesterase domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880905	Gdpd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycerophosphodiester phosphodiesterase domain containing 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5607539	Gdpd5<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
glycine amidinotransferase (L-arginine:glycine amidinotransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362557	Gatm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycine amidinotransferase (L-arginine:glycine amidinotransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362557	Gatm<tm1a(KOMP)Wtsi>	28844881	KOMP-CSD
glycine amidinotransferase (L-arginine:glycine amidinotransferase); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548533	Gatm<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
glycine amidinotransferase (L-arginine:glycine amidinotransferase); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6108890	Gatm<tm1c(KOMP)Wtsi>	28844881	KOMP-CSD
glycine amidinotransferase (L-arginine:glycine amidinotransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363555	Gatm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycine C-acetyltransferase (2-amino-3-ketobutyrate-coenzyme A ligase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820257	Gcat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycine cleavage system protein H (aminomethyl carrier); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881079	Gcsh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycine decarboxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820272	Gldc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycine decarboxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820287	Gldc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycine-N-acyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364590	Glyat<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycine-N-acyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426671	Glyat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycine receptor, alpha 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364480	Glra2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycine receptor, alpha 3 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302336	Glra3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycine receptor, alpha 3 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302303	Glra3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycine receptor, alpha 4 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363311	Glra4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycine receptor, alpha 4 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364636	Glra4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycogenin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364071	Gyg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycogenin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364071	Gyg<tm1a(KOMP)Wtsi>	28683291	KOMP-CSD
glycogenin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548475	Gyg<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
glycogenin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419582	Gyg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycogen synthase 1, muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432767	Gys1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycogen synthase 1, muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432767	Gys1<tm1a(EUCOMM)Wtsi>	23281428	EUCOMM
glycogen synthase 1, muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432767	Gys1<tm1a(EUCOMM)Wtsi>	24452334	EUCOMM
glycogen synthase 1, muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432767	Gys1<tm1a(EUCOMM)Wtsi>	25059425	EUCOMM
glycogen synthase 1, muscle; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619172	Gys1<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
glycogen synthase 1, muscle; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619172	Gys1<tm1c(EUCOMM)Wtsi>	23281428	EUCOMM
glycogen synthase 1, muscle; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619172	Gys1<tm1c(EUCOMM)Wtsi>	26825527	EUCOMM
glycogen synthase 1, muscle; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432719	Gys1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycogen synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364592	Gys2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycogen synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364592	Gys2<tm1a(KOMP)Wtsi>	23990365	KOMP-CSD
glycogen synthase kinase 3 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434136	Gsk3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycogen synthase kinase 3 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434136	Gsk3a<tm1a(EUCOMM)Wtsi>	23185619	EUCOMM
glycogen synthase kinase 3 alpha; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5476700	Gsk3a<tm1c(EUCOMM)Wtsi>	23185619	EUCOMM
glycogen synthase kinase 3 beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434198	Gsk3b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycogen synthase kinase 3 beta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820225	Gsk3b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
glycogen synthase kinase 3 beta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820381	Gsk3b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
glycolipid transfer protein domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431490	Gltpd2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glycophorin C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008037	Gypc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycophorin C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008037	Gypc<tm1a(EUCOMM)Wtsi>	27362409	EUCOMM
glycophorin C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938594	Gypc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycoprotein 2 (zymogen granule membrane); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426661	Gp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycoprotein 2 (zymogen granule membrane); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426659	Gp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycoprotein 9 (platelet); targeted mutation 1.1, Velocigene	MGI:5548499	Gp9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glycoprotein A33 (transmembrane); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364116	Gpa33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycoprotein A33 (transmembrane); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5477931	Gpa33<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
glycoprotein Ib, beta polypeptide; targeted mutation 1.1, Velocigene	MGI:5692575	Gp1bb<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glycoprotein integral membrane 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433106	Ginm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycoprotein integral membrane 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434515	Ginm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycoprotein m6a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842652	Gpm6a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycoprotein m6b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363114	Gpm6b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycoprotein m6b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365145	Gpm6b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycoprotein (transmembrane) nmb; targeted mutation 1.1, Velocigene	MGI:5443925	Gpnmb<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glycoprotein (transmembrane) nmb; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296223	Gpnmb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycoprotein (transmembrane) nmb; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296205	Gpnmb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glycosylated lysosomal membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364069	Glmp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycosylated lysosomal membrane protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362429	Glmp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycosylation dependent cell adhesion molecule 1; targeted mutation 1.1, Velocigene	MGI:5501049	Glycam1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glycosylation dependent cell adhesion molecule 1; targeted mutation 1.1, Velocigene	MGI:5501049	Glycam1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
glycosylation dependent cell adhesion molecule 1; targeted mutation 1, Velocigene	MGI:3812774	Glycam1<tm1(KOMP)Vlcg>	28446179	KOMP-Regeneron
glycosylphosphatidylinositol specific phospholipase D1; targeted mutation 1.1, Velocigene	MGI:5695879	Gpld1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glycosyltransferase 8 domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364018	Glt8d2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glycosyltransferase 8 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363184	Glt8d2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glycosyltransferase-like domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419807	Gtdc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
glycyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453710	Gars<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glycyl-tRNA synthetase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453744	Gars<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glyoxalase 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:5285709	Glo1<tm1a(KOMP)Mbp>	28623132	KOMP-CSD
glyoxalase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5285714	Glo1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glyoxalase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5285711	Glo1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glyoxalase domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454138	Glod4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glyoxalase domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454113	Glod4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glyoxylate reductase 1 homolog (Arabidopsis); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941995	Glyr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glyoxylate reductase 1 homolog (Arabidopsis); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941981	Glyr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glypican 2 (cerebroglycan); targeted mutation 1.1, Velocigene	MGI:5548614	Gpc2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
glypican 2 (cerebroglycan); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461671	Gpc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 2 (cerebroglycan); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461685	Gpc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432071	Gpc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434233	Gpc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432514	Gpc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432991	Gpc4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432991	Gpc4<tm2a(EUCOMM)Wtsi>	29024665	EUCOMM
glypican 4; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5635154	Gpc4<tm2b(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 4; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:6115608	Gpc4<tm2c(EUCOMM)Wtsi>	29024665	EUCOMM
glypican 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433939	Gpc4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455511	Gpc5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
glypican 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455511	Gpc5<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
glypican 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455586	Gpc5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
glypican 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432589	Gpc6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4453713	Gpc6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
glypican 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4453713	Gpc6<tm2a(EUCOMM)Wtsi>	28696225	EUCOMM
glypican 6; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:6098731	Gpc6<tm2c(EUCOMM)Wtsi>	28696225	EUCOMM
glypican 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4453726	Gpc6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
GM2 ganglioside activator protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432728	Gm2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GM2 ganglioside activator protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433527	Gm2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
golgi apparatus protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364575	Glg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi associated, gamma adaptin ear containing, ARF binding protein 1; targeted mutation 1.1, Velocigene	MGI:5695948	Gga1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
golgi associated PDZ and coiled-coil motif containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051001	Gopc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
golgi associated PDZ and coiled-coil motif containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051001	Gopc<tm1a(EUCOMM)Wtsi>	25614626	EUCOMM
golgi associated PDZ and coiled-coil motif containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5051020	Gopc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
golgi autoantigen, golgin subfamily a, 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419117	Golga2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
golgi autoantigen, golgin subfamily a, 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692901	Golga3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
golgi autoantigen, golgin subfamily a, 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420083	Golga5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi autoantigen, golgin subfamily a, 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635144	Golga5<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
golgi autoantigen, golgin subfamily a, 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419128	Golga5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
golgi autoantigen, golgin subfamily a, 7B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947765	Golga7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi autoantigen, golgin subfamily a, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452637	Golga7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi autoantigen, golgin subfamily a, 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452650	Golga7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
golgi autoantigen, golgin subfamily b, macrogolgin 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436000	Golgb1<tm1a(EUCOMM)Hmgu>	27226319	EUCOMM
golgi autoantigen, golgin subfamily b, macrogolgin 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436000	Golgb1<tm1a(EUCOMM)Hmgu>	28509431	EUCOMM
golgi integral membrane protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434246	Golim4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
golgi membrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287786	Golm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi phosphoprotein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944482	Golph3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
golgi phosphoprotein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944576	Golph3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
golgi reassembly stacking protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014574	Gorasp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi reassembly stacking protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050168	Gorasp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
golgi SNAP receptor complex member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365242	Gosr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi SNAP receptor complex member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363362	Gosr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
golgi SNAP receptor complex member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451494	Gosr1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi SNAP receptor complex member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451274	Gosr1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
golgi SNAP receptor complex member 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548699	Gosr2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
golgi-specific brefeldin A-resistance factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419544	Gbf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi-specific brefeldin A-resistance factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419544	Gbf1<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
golgi-specific brefeldin A-resistance factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419930	Gbf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
golgi transport 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458461	Golt1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
golgi transport 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458597	Golt1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
golgi transport 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432110	Golt1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
golgi transport 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432446	Golt1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gon-4-like (C.elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009646	Gon4l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
gon-4-like (C.elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014710	Gon4l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
gonadotropin releasing hormone receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008812	Gnrhr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
goosecoid homebox 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419402	Gsc2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
goosecoid homeobox; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286264	Gsc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G patch domain and ankyrin repeats 1; targeted mutation 1.1, Velocigene	MGI:5574607	Gpank1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G patch domain containing 2 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362674	Gpatch2l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G patch domain containing 2 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364584	Gpatch2l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G patch domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842303	Gpatch3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G patch domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842433	Gpatch3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G patch domain containing 4; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050927	Gpatch4<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
G patch domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014717	Gpatch8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GPI anchor attachment protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5447685	Gpaa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GPI anchor attachment protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5447686	Gpaa1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
GPN-loop GTPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433831	Gpn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GPN-loop GTPase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433702	Gpn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GPN-loop GTPase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947823	Gpn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GPN-loop GTPase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947830	Gpn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GPN-loop GTPase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433430	Gpn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GPN-loop GTPase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433794	Gpn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled bile acid receptor 1; targeted mutation 1.1, Velocigene	MGI:5548845	Gpbar1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G protein-coupled bile acid receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473135	Gpbar1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled bile acid receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472715	Gpbar1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled bile acid receptor 1; targeted mutation 1, Velocigene	MGI:4399435	Gpbar1<tm1(KOMP)Vlcg>	27692610	KOMP-Regeneron
G protein-coupled estrogen receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364256	Gper1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled estrogen receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364256	Gper1<tm1a(KOMP)Wtsi>	27725247	KOMP-CSD
G protein-coupled estrogen receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364256	Gper1<tm1a(KOMP)Wtsi>	28054009	KOMP-CSD
G protein-coupled estrogen receptor 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888889	Gper1<tm1c(KOMP)Wtsi>	27725247	KOMP-CSD
G protein-coupled estrogen receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363780	Gper1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 107; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362797	Gpr107<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 107; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473007	Gpr107<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 107; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472840	Gpr107<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
G-protein coupled receptor 119; targeted mutation 1.1, Velocigene	MGI:5569073	Gpr119<tm1.1(KOMP)Vlcg>	27893106	KOMP-Regeneron
G-protein coupled receptor 119; targeted mutation 1.1, Velocigene	MGI:5569073	Gpr119<tm1.1(KOMP)Vlcg>	28593245	KOMP-Regeneron
G protein-coupled receptor 132; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947819	Gpr132<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 132; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947826	Gpr132<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 137B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820052	Gpr137b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 137B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820096	Gpr137b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 139; targeted mutation 1.1, Velocigene	MGI:5605824	Gpr139<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G protein-coupled receptor 143; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420127	Gpr143<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 143; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420043	Gpr143<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 149; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842386	Gpr149<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 152; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008027	Gpr152<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 152; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548871	Gpr152<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
G protein-coupled receptor 153; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286405	Gpr153<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 153; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296214	Gpr153<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 155; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362968	Gpr155<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 155; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364112	Gpr155<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 157; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451330	Gpr157<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 157; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451706	Gpr157<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 158; targeted mutation 1.1, Velocigene	MGI:5548799	Gpr158<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G protein-coupled receptor 158; targeted mutation 1, Velocigene	MGI:3808194	Gpr158<tm1(KOMP)Vlcg>	25792749	KOMP-Regeneron
G protein-coupled receptor 158; targeted mutation 1, Velocigene	MGI:3808194	Gpr158<tm1(KOMP)Vlcg>	28851741	KOMP-Regeneron
G protein-coupled receptor 174; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140429	Gpr174<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 176; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452025	Gpr176<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 17; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4944300	Gpr17<tm1a(KOMP)Mbp>	26180086	KOMP-CSD
G protein-coupled receptor 17; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548896	Gpr17<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
G protein-coupled receptor 17; targeted mutation 1, Velocigene	MGI:4415438	Gpr17<tm1(KOMP)Vlcg>	25624481	KOMP-Regeneron
G protein-coupled receptor 180; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452644	Gpr180<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 180; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452657	Gpr180<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 182; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365168	Gpr182<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 182; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419674	Gpr182<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 182; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419674	Gpr182<tm2a(KOMP)Wtsi>	26839965	KOMP-CSD
G protein-coupled receptor 182; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419674	Gpr182<tm2a(KOMP)Wtsi>	28094771	KOMP-CSD
G protein-coupled receptor 182; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5569038	Gpr182<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
G protein-coupled receptor 182; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5569038	Gpr182<tm2b(KOMP)Wtsi>	28094771	KOMP-CSD
G protein-coupled receptor 182; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419427	Gpr182<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 18; targeted mutation 1.1, Velocigene	MGI:5792901	Gpr18<tm1.1(KOMP)Vlcg>	26197390	KOMP-Regeneron
G protein-coupled receptor 18; targeted mutation 1, Velocigene	MGI:3812675	Gpr18<tm1(KOMP)Vlcg>	26197390	KOMP-Regeneron
G protein-coupled receptor 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548792	Gpr1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
G protein-coupled receptor 20; targeted mutation 1.1, Velocigene	MGI:5548800	Gpr20<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G protein-coupled receptor 20; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840574	Gpr20<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 20; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840667	Gpr20<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362775	Gpr22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 22; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548628	Gpr22<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
G protein-coupled receptor 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363350	Gpr22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949350	Gpr26<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 33; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548418	Gpr33<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
G protein-coupled receptor 33; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548418	Gpr33<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
G protein-coupled receptor 35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5499310	Gpr35<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 35; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5563209	Gpr35<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 35; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4938582	Gpr35<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 37-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441736	Gpr37l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 37-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441903	Gpr37l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820091	Gpr45<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 45; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820166	Gpr45<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433373	Gpr4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433841	Gpr4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G-protein-coupled receptor 50; targeted mutation 1.1, Velocigene	MGI:5696888	Gpr50<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G-protein-coupled receptor 50; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052513	Gpr50<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G-protein-coupled receptor 50; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140462	Gpr50<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 62; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472772	Gpr62<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 63; targeted mutation 1.1, Velocigene	MGI:5569065	Gpr63<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G protein-coupled receptor 63; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140490	Gpr63<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 63; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140467	Gpr63<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G-protein coupled receptor 65; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013741	Gpr65<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G-protein coupled receptor 65; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5582421	Gpr65<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
G protein-coupled receptor 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431621	Gpr6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 75; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008040	Gpr75<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 83; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362988	Gpr83<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 83; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362818	Gpr83<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 84; targeted mutation 1.1, Velocigene	MGI:5695942	Gpr84<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
G protein-coupled receptor 85; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419371	Gpr85<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor 89; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938563	Gpr89<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor 89; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938603	Gpr89<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor associated sorting protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419152	Gprasp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor, family C, group 5, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452803	Gprc5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor, family C, group 5, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452803	Gprc5b<tm1a(EUCOMM)Wtsi>	28621310	EUCOMM
G protein-coupled receptor, family C, group 5, member B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5766162	Gprc5b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
G protein-coupled receptor, family C, group 5, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452771	Gprc5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor, family C, group 5, member D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432516	Gprc5d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor, family C, group 5, member D; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5568482	Gprc5d<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
G protein-coupled receptor, family C, group 5, member D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434502	Gprc5d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor, family C, group 6, member A; targeted mutation 1.1, Velocigene	MGI:5707439	Gprc6a<tm1.1(KOMP)Vlcg>	25958858	KOMP-Regeneron
G protein-coupled receptor, family C, group 6, member A; targeted mutation 1.1, Velocigene	MGI:5707439	Gprc6a<tm1.1(KOMP)Vlcg>	26863991	KOMP-Regeneron
G protein-coupled receptor, family C, group 6, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461735	Gprc6a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841081	Grk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432741	Grk4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G protein-coupled receptor kinase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820076	Grk5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor kinase 5; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5582424	Grk5<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
G protein-coupled receptor kinase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820125	Grk5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G protein-coupled receptor kinase-interactor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419203	Git1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
G protein pathway suppressor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364797	Gps1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G protein pathway suppressor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605814	Gps1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
G protein pathway suppressor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299622	Gps1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
G-protein signalling modulator 1 (AGS3-like, C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363460	Gpsm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
G-protein signalling modulator 1 (AGS3-like, C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363108	Gpsm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
G-protein signalling modulator 1 (AGS3-like, C. elegans); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363654	Gpsm1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
G-protein signalling modulator 1 (AGS3-like, C. elegans); targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5558155	Gpsm1<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
G-protein signalling modulator 1 (AGS3-like, C. elegans); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364936	Gpsm1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441912	Gpsm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441912	Gpsm2<tm1a(EUCOMM)Wtsi>	24135232	EUCOMM
G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441912	Gpsm2<tm1a(EUCOMM)Wtsi>	26755700	EUCOMM
G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441912	Gpsm2<tm1a(EUCOMM)Wtsi>	27660326	EUCOMM
G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441912	Gpsm2<tm1a(EUCOMM)Wtsi>	29229865	EUCOMM
G-protein signalling modulator 2 (AGS3-like, C. elegans); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548664	Gpsm2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
G-protein signalling modulator 3 (AGS3-like, C. elegans); targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5569069	Gpsm3<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
G-protein signalling modulator 3 (AGS3-like, C. elegans); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419301	Gpsm3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
G-protein signalling modulator 3 (AGS3-like, C. elegans); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419301	Gpsm3<tm1(KOMP)Wtsi>	28062526	KOMP-CSD
grainyhead like transcription factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433681	Grhl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
grainyhead like transcription factor 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456786	Grhl3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
grainyhead like transcription factor 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456823	Grhl3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
GRAM domain containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431805	Gramd1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GRAM domain containing 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433315	Gramd1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GRAM domain containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451563	Gramd1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GRAM domain containing 1C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5661974	Gramd1c<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
GRAM domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431568	Gramd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GRAM domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420006	Gramd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GRAM domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420005	Gramd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GRAM domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364999	Gramd4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GRAM domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364646	Gramd4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
granulin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364672	Grn<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
granzyme A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050949	Gzma<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
granzyme B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451630	Gzmb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
granzyme B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451616	Gzmb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
granzyme B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472814	Gzmb<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
granzyme C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008034	Gzmc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
granzyme K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362377	Gzmk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
granzyme K; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692602	Gzmk<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
granzyme K; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363531	Gzmk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
granzyme M (lymphocyte met-ase 1); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363514	Gzmm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
granzyme N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880917	Gzmn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GRB10 interacting GYF protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000390	Gigyf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GRB2 associated regulator of MAPK1 subtype 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820333	Garem1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GRB2 associated regulator of MAPK1 subtype 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820351	Garem1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Grb2-binding adaptor, transmembrane; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008045	Gapt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Grb2-binding adaptor, transmembrane; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940798	Gapt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GRB2-related adaptor protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939779	Grap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GRB2-related adaptor protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362913	Grap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GRB2-related adaptor protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364496	Grap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
gremlin 1, DAN family BMP antagonist; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511961	Grem1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
G-rich RNA sequence binding factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433076	Grsf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
G-rich RNA sequence binding factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432666	Grsf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth arrest-specific 2 like 1; targeted mutation 1.1, Velocigene	MGI:5569062	Gas2l1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
growth arrest-specific 2 like 1; targeted mutation 1, Velocigene	MGI:4460589	Gas2l1<tm1(KOMP)Vlcg>	26564797	KOMP-Regeneron
growth arrest-specific 2 like 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4881081	Gas2l1<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
growth arrest-specific 2 like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841109	Gas2l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth arrest-specific 2 like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840918	Gas2l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth arrest-specific 2 like 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434781	Gas2l3<tm1a(EUCOMM)Hmgu>	28698371	EUCOMM
growth arrest-specific 2 like 3; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5925364	Gas2l3<tm1c(EUCOMM)Hmgu>	28698371	EUCOMM
growth arrest-specific 2 like 3; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5925365	Gas2l3<tm1d(EUCOMM)Hmgu>	28698371	EUCOMM
growth associated protein 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431861	Gap43<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
growth associated protein 43; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433570	Gap43<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth differentiation factor 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456665	Gdf10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth differentiation factor 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455613	Gdf10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth differentiation factor 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286213	Gdf10<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
growth differentiation factor 10; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5569964	Gdf10<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
growth differentiation factor 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5428501	Gdf10<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
growth differentiation factor 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362649	Gdf15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth differentiation factor 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548459	Gdf15<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
growth differentiation factor 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363047	Gdf15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth differentiation factor 15; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472944	Gdf15<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
growth differentiation factor 2; targeted mutation 1.1, Velocigene	MGI:5692607	Gdf2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
growth differentiation factor 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302296	Gdf6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth differentiation factor 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948643	Gdf7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor, augmenter of liver regeneration; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456605	Gfer<tm1(KOMP)Mbp>	25977511	KOMP-CSD
growth factor independent 1B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636937	Gfi1b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
growth factor independent 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007975	Gfi1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth factor receptor bound protein 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431624	Grb10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441881	Grb10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4442020	Grb10<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419691	Grb14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth factor receptor bound protein 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419963	Grb14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth factor receptor bound protein 2-associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842592	Gab1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 2-associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842609	Gab1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 2-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456657	Gab2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth factor receptor bound protein 2-associated protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456677	Gab2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth factor receptor bound protein 2-associated protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419166	Gab3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth factor receptor bound protein 2-associated protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419267	Gab3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth factor receptor bound protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432956	Grb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434340	Grb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453768	Grb7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
growth factor receptor bound protein 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636886	Grb7<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
growth factor receptor bound protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453715	Grb7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth hormone receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364821	Ghr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth hormone receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364821	Ghr<tm1a(KOMP)Wtsi>	23349524	KOMP-CSD
growth hormone receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5472175	Ghr<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
growth hormone receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5472175	Ghr<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
growth hormone receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5472175	Ghr<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
growth hormone receptor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	23349524	KOMP-CSD
growth hormone receptor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	23941873	KOMP-CSD
growth hormone receptor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	24517230	KOMP-CSD
growth hormone receptor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	25456069	KOMP-CSD
growth hormone receptor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	26950202	KOMP-CSD
growth hormone receptor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	27035649	KOMP-CSD
growth hormone receptor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	27732088	KOMP-CSD
growth hormone receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363503	Ghr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
growth hormone releasing hormone receptor; targeted mutation 1.1, Velocigene	MGI:5445807	Ghrhr<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
growth hormone releasing hormone receptor; targeted mutation 1.1, Velocigene	MGI:5445807	Ghrhr<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
growth hormone releasing hormone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000391	Ghrh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
growth hormone releasing hormone; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000407	Ghrh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
growth hormone secretagogue receptor; targeted mutation 1.1, Velocigene	MGI:5445806	Ghsr<tm1.1(KOMP)Vlcg>	22962259	KOMP-Regeneron
growth hormone secretagogue receptor; targeted mutation 1.1, Velocigene	MGI:5445806	Ghsr<tm1.1(KOMP)Vlcg>	26490687	KOMP-Regeneron
growth hormone secretagogue receptor; targeted mutation 1.1, Velocigene	MGI:5445806	Ghsr<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
growth hormone secretagogue receptor; targeted mutation 1.1, Velocigene	MGI:5445806	Ghsr<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
growth hormone secretagogue receptor; targeted mutation 1.1, Velocigene	MGI:5445806	Ghsr<tm1.1(KOMP)Vlcg>	29063591	KOMP-Regeneron
growth hormone; targeted mutation 1.1, Velocigene	MGI:5569080	Gh<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
growth regulation by estrogen in breast cancer-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363095	Greb1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
growth regulation by estrogen in breast cancer-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364449	Greb1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GrpE-like 1, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432720	Grpel1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GS homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364800	Gsx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GS homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363805	Gsx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase activating protein (SH3 domain) binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454122	G3bp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase activating protein (SH3 domain) binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454163	G3bp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase activating protein (SH3 domain) binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461696	G3bp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GTPase activating protein (SH3 domain) binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461696	G3bp2<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
GTPase activating protein (SH3 domain) binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461687	G3bp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GTPase, IMAP family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451625	Gimap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase, IMAP family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5473206	Gimap3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GTPase, IMAP family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363335	Gimap5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase, IMAP family member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364110	Gimap5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase, IMAP family member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299588	Gimap5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase, IMAP family member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299521	Gimap5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase, IMAP family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364125	Gimap6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase, IMAP family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364125	Gimap6<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
GTPase, IMAP family member 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515619	Gimap6<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
GTPase, IMAP family member 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515619	Gimap6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
GTP binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364028	Gtpbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTP binding protein 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548500	Gtpbp2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
GTP binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364640	Gtpbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GTP binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364401	Gtpbp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTP binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365050	Gtpbp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GTP binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888922	Gtpbp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
GTP binding protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888937	Gtpbp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
GTP-binding protein 8 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841012	Gtpbp8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTP-binding protein 8 (putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841202	Gtpbp8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GTP binding protein (gene overexpressed in skeletal muscle); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363422	Gem<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GTP binding protein (gene overexpressed in skeletal muscle); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847685	Gem<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GTP cyclohydrolase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842536	Gch1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
G two S phase expressed protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289806	Gtse1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine deaminase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000323	Gda<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432307	Gna11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein, alpha 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363618	Gna12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362180	Gna12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419704	Gna13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419591	Gna13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433310	Gna15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein, alpha 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432646	Gna15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein, alpha O; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548941	Gnao1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
guanine nucleotide binding protein, alpha q polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451421	Gnaq<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha q polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451635	Gnaq<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha stimulating, olfactory type; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947731	Gnal<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha stimulating, olfactory type; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007978	Gnal<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein, alpha transducing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432695	Gnat2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein, alpha transducing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432984	Gnat2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein, alpha transducing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842586	Gnat3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein, alpha transducing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842840	Gnat3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein, alpha z subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436442	Gnaz<tm1a(EUCOMM)Hmgu>	28419211	EUCOMM
guanine nucleotide binding protein, alpha z subunit; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5925351	Gnaz<tm1c(EUCOMM)Hmgu>	28419211	EUCOMM
guanine nucleotide binding protein (G protein), alpha inhibiting 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842672	Gnai1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), alpha inhibiting 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5606346	Gnai1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
guanine nucleotide binding protein (G protein), alpha inhibiting 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842842	Gnai1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), alpha inhibiting 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363464	Gnai3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), alpha inhibiting 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364457	Gnai3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286241	Gnb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), beta 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364786	Gnb2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868086	Gnb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637208	Gnb3<tm1b(EUCOMM)Wtsi>	29078390	EUCOMM
guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868094	Gnb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1, Velocigene	MGI:3812642	Gnb3<tm1(KOMP)Vlcg>	22895717	KOMP-Regeneron
guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1, Velocigene	MGI:3812642	Gnb3<tm1(KOMP)Vlcg>	23516284	KOMP-Regeneron
guanine nucleotide binding protein (G protein), beta 3; targeted mutation 1, Velocigene	MGI:3812642	Gnb3<tm1(KOMP)Vlcg>	24519419	KOMP-Regeneron
guanine nucleotide binding protein (G protein), beta 5; targeted mutation 1.1, Velocigene	MGI:5516195	Gnb5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
guanine nucleotide binding protein (G protein), beta 5; targeted mutation 1.1, Velocigene	MGI:5516195	Gnb5<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
guanine nucleotide binding protein (G protein), beta polypeptide 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432438	Gnb1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), beta polypeptide 1-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842679	Gnb1l<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364026	Gng11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), gamma 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431623	Gng12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432702	Gng12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma 13; targeted mutation 1.1, Velocigene	MGI:5548691	Gng13<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
guanine nucleotide binding protein (G protein), gamma 13; targeted mutation 1, Velocigene	MGI:4460590	Gng13<tm1(KOMP)Vlcg>	25416620	KOMP-Regeneron
guanine nucleotide binding protein (G protein), gamma 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419507	Gng3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), gamma 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293967	Gng4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), gamma 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294963	Gng4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), gamma 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433252	Gng7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431741	Gng7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472936	Gng7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma 7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472794	Gng7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451993	Gngt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842496	Gngt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362802	Gngt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362806	Gngt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanosine diphosphate (GDP) dissociation inhibitor 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5588293	Gdi2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
guanosine monophosphate reductase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364934	Gmpr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate binding protein 2b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319836	Gbp2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364979	Gbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548331	Gbp2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
guanylate binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363926	Gbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426642	Gbp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426601	Gbp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate binding protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944569	Gbp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanylate cyclase 1, soluble, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820308	Gucy1a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
guanylate cyclase 2c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363659	Gucy2c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364102	Gucy2c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2e; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426624	Gucy2e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2e; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426560	Gucy2e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2f; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365193	Gucy2f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2f; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286247	Gucy2f<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2f; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5297885	Gucy2f<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2g; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420121	Gucy2g<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase 2g; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420136	Gucy2g<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
guanylate cyclase activator 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364849	Guca1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GUF1 homolog, GTPase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841244	Guf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GUF1 homolog, GTPase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841183	Guf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
GULP, engulfment adaptor PTB domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014573	Gulp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
GULP, engulfment adaptor PTB domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014611	Gulp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
H1 histone family, member O, oocyte-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363979	H1foo<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
H1 histone family, member O, oocyte-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363979	H1foo<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
H1 histone family, member O, oocyte-specific; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5426646	H1foo<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
H1 histone family, member O, oocyte-specific; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5426608	H1foo<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
H1 histone family, member X; targeted mutation 1.1, Velocigene	MGI:5445805	H1fx<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
H1 histone family, member X; targeted mutation 1.1, Velocigene	MGI:5445805	H1fx<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
H2A histone family member L1N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473181	H2al1n<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
H2A histone family, member Y; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441744	H2afy<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
H2A histone family, member Y; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441804	H2afy<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
H2A histone family, member Z; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362676	H2afz<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
H3 histone, family 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432886	H3f3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
H3 histone, family 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432032	H3f3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
H6 homeobox 1; targeted mutation 1, Velocigene	MGI:4399227	Hmx1<tm1(KOMP)Vlcg>	23591430	KOMP-Regeneron
hairless; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433620	Hr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hairless; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432365	Hr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hairy and enhancer of split 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364404	Hes6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hairy/enhancer-of-split related with YRPW motif 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887696	Hey2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hairy/enhancer-of-split related with YRPW motif 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887684	Hey2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hairy/enhancer-of-split related with YRPW motif-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362864	Heyl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hairy/enhancer-of-split related with YRPW motif-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5571348	Heyl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
hairy/enhancer-of-split related with YRPW motif-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5571348	Heyl<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
hairy/enhancer-of-split related with YRPW motif-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363258	Heyl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
haloacid dehalogenase like hydrolase domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363161	Hdhd5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
haptoglobin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052500	Hp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
haptoglobin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140472	Hp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Harvey rat sarcoma virus oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433613	Hras<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HAUS augmin-like complex, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460433	Haus2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HAUS augmin-like complex, subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460517	Haus2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HAUS augmin-like complex, subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006767	Haus5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Hbs1-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887599	Hbs1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Hbs1-like (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887614	Hbs1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HD domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841212	Hddc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HD domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841267	Hddc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HD domain containing 3; targeted mutation 1.1, Velocigene	MGI:5695919	Hddc3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
HDGF like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419715	Hdgfl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HDGF like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419367	Hdgfl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HEAT repeat containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364452	Heatr6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HEAT repeat containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460298	Heatr9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HEAT repeat containing 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302285	Heatr9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock 105kDa/110kDa protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431540	Hsph1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock 105kDa/110kDa protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432413	Hsph1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock factor 1; targeted mutation 1.1, Velocigene	MGI:5445761	Hsf1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
heat shock factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947845	Hsf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888924	Hsf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363515	Hsf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471287	Hsf2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471287	Hsf2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
heat shock factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471287	Hsf2<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
heat shock factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363982	Hsf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock factor binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461715	Hsbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 12A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433266	Hspa12a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 12A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432455	Hspa12a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 12A; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511921	Hspa12a<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 12A; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511895	Hspa12a<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 12B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014721	Hspa12b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 1 (chaperonin 10); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419624	Hspe1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433175	Hspa1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 1-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306492	Hspa1l<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 1-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434137	Hspa1l<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 1-like; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4434421	Hspa1l<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 1; targeted mutation 1.1, Velocigene	MGI:5488491	Hspb1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
heat shock protein 1; targeted mutation 1, Velocigene	MGI:4399629	Hspb1<tm1(KOMP)Vlcg>	27512988	KOMP-Regeneron
heat shock protein 1; targeted mutation 1, Velocigene	MGI:4399629	Hspb1<tm1(KOMP)Vlcg>	28700664	KOMP-Regeneron
heat shock protein 2; targeted mutation 1.1, Velocigene	MGI:5445926	Hspb2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
heat shock protein 2; targeted mutation 1.1, Velocigene	MGI:5445926	Hspb2<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
heat shock protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453757	Hspb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453755	Hspb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 3; targeted mutation 1.1, Velocigene	MGI:5445925	Hspb3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
heat shock protein 3; targeted mutation 1.1, Velocigene	MGI:5445925	Hspb3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
heat shock protein 4 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362801	Hspa4l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 4 like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364895	Hspa4l<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 4 like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363174	Hspa4l<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454132	Hspa4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454129	Hspa4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 5; targeted mutation 1.1, Velocigene	MGI:5445740	Hspa5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
heat shock protein 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841326	Hspa8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841286	Hspa8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 90, alpha (cytosolic), class A member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364475	Hsp90aa1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 90 alpha (cytosolic), class B member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433179	Hsp90ab1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 90 alpha (cytosolic), class B member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434188	Hsp90ab1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 90, beta (Grp94), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433112	Hsp90b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362629	Hspa9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362644	Hspa9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein, alpha-crystallin-related, B6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841255	Hspb6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock protein family B (small), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432759	Hspb11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein family B (small), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432759	Hspb11<tm1a(EUCOMM)Wtsi>	22595669	EUCOMM
heat shock protein family B (small), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432759	Hspb11<tm1a(EUCOMM)Wtsi>	28430876	EUCOMM
heat shock protein family B (small), member 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5426875	Hspb11<tm1b(EUCOMM)Wtsi>	22595669	EUCOMM
heat shock protein family B (small), member 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5426875	Hspb11<tm1b(EUCOMM)Wtsi>	26023097	EUCOMM
heat shock protein family B (small), member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432404	Hspb11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock protein nuclear import factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460509	Hikeshi<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heat shock transcription factor 2 binding protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548644	Hsf2bp<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
heat shock transcription factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363921	Hsf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock transcription factor 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468954	Hsf4<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
heat shock transcription factor 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468954	Hsf4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
heat shock transcription factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363030	Hsf4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434504	Herc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432036	Herc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441860	Hecw2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441642	Hecw2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840984	Hace1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548835	Hace1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
hect domain and RLD 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434045	Herc3<tm1a(EUCOMM)Wtsi>	20799038	EUCOMM
hect domain and RLD 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434045	Herc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hect domain and RLD 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434045	Herc3<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
hect domain and RLD 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880940	Herc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hect domain and RLD 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880942	Herc4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hect domain and RLD 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692668	Herc6<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
HECT domain E3 ubiquitin protein ligase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605813	Hectd1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
HECT domain E3 ubiquitin protein ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364585	Hectd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HECT domain E3 ubiquitin protein ligase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548812	Hectd2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
HECT domain E3 ubiquitin protein ligase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363086	Hectd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HECT domain E3 ubiquitin protein ligase 3; targeted mutation 1, Centre for Modeling Human Disease	MGI:4880080	Hectd3<tm1(NCOM)Cmhd>	27626380	NorCOMM
HECT, UBA and WWE domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820380	Huwe1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HECT, UBA and WWE domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820339	Huwe1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hedgehog interacting protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451243	Hhipl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hedgehog interacting protein-like 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637060	Hhipl1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
hedgehog interacting protein-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451715	Hhipl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
helicase (DNA) B; targeted mutation 1, Velocigene	MGI:4881306	Helb<tm1(KOMP)Vlcg>	26774285	KOMP-Regeneron
helicase-like transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364600	Hltf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
helicase-like transcription factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363664	Hltf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
helicase, lymphoid specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431905	Hells<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
helicase, lymphoid specific; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548365	Hells<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
helicase, lymphoid specific; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433286	Hells<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
helicase, lymphoid specific; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434016	Hells<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
helicase with zinc finger domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289823	Helz<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic cell signal transducer; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451366	Hcst<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic cell signal transducer; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451345	Hcst<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic cell specific Lyn substrate 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363481	Hcls1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic cell specific Lyn substrate 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363408	Hcls1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic prostaglandin D synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362237	Hpgds<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic prostaglandin D synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363375	Hpgds<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic SH2 domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880882	Hsh2d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hematopoietic SH2 domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880952	Hsh2d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heme binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006769	Hebp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hemicentin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455950	Hmcn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hemicentin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456069	Hmcn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hemicentin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433540	Hmcn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hemicentin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433695	Hmcn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HemK methyltransferase family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051010	Hemk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hemochromatosis; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460487	Hfe<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hemochromatosis; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461681	Hfe<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hemochromatosis type 2 (juvenile); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052410	Hfe2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hemochromatosis type 2 (juvenile); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554937	Hfe2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
hemochromatosis type 2 (juvenile); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554937	Hfe2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
hemochromatosis type 2 (juvenile); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5554937	Hfe2<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
hemoglobin, beta adult major chain; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5302282	Hbb-b1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hemolytic complement; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842313	Hc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hemolytic complement; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842498	Hc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heparan-alpha-glucosaminide N-acetyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441956	Hgsnat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heparan-alpha-glucosaminide N-acetyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441956	Hgsnat<tm1a(EUCOMM)Wtsi>	27491071	EUCOMM
heparan-alpha-glucosaminide N-acetyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441921	Hgsnat<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heparan-alpha-glucosaminide N-acetyltransferase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5303175	Hgsnat<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
heparanase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605759	Hpse<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
heparan sulfate 2-O-sulfotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434091	Hs2st1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heparan sulfate (glucosamine) 3-O-sulfotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433623	Hs3st1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heparan sulfate (glucosamine) 3-O-sulfotransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432426	Hs3st1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heparan sulfate (glucosamine) 3-O-sulfotransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841241	Hs3st2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heparan sulfate (glucosamine) 3-O-sulfotransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364181	Hs3st5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heparan sulfate (glucosamine) 3-O-sulfotransferase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006748	Hs3st5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heparan sulfate (glucosamine) 3-O-sulfotransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5006746	Hs3st5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
heparan sulfate (glucosamine) 3-O-sulfotransferase 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5006738	Hs3st5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
heparin-binding EGF-like growth factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431937	Hbegf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heparin-binding EGF-like growth factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432049	Hbegf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hepatic leukemia factor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431448	Hlf<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hepatic nuclear factor 4, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441894	Hnf4a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hepatic nuclear factor 4, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441879	Hnf4a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hepatitis A virus cellular receptor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364700	Havcr1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hepatitis A virus cellular receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880953	Havcr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hepatitis A virus cellular receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880959	Havcr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hepatocyte growth factor activator; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050975	Hgfac<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
hepatocyte nuclear factor 4, gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442019	Hnf4g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hephaestin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426641	Hephl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hephaestin-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426598	Hephl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hephaestin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365257	Heph<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hephaestin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297124	Heph<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
hepsin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362145	Hpn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hepsin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362990	Hpn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HERV-H LTR-associating 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431419	Hhla1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hes family bHLH transcription factor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451509	Hes1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hes family bHLH transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008047	Hes2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hes family bHLH transcription factor 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4950959	Hes5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
heterochromatin protein 1, binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432659	Hp1bp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterochromatin protein 1, binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432659	Hp1bp3<tm1a(EUCOMM)Wtsi>	25662603	EUCOMM
heterochromatin protein 1, binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432659	Hp1bp3<tm1a(EUCOMM)Wtsi>	26402843	EUCOMM
heterochromatin protein 1, binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432659	Hp1bp3<tm1a(EUCOMM)Wtsi>	27460150	EUCOMM
heterochromatin protein 1, binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432659	Hp1bp3<tm1a(EUCOMM)Wtsi>	27470444	EUCOMM
heterogeneous nuclear ribonucleoprotein A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458848	Hnrnpa1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458844	Hnrnpa1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein A2/B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938562	Hnrnpa2b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein A2/B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938599	Hnrnpa2b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434529	Hnrnpa3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434339	Hnrnpa3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303172	Hnrnpc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5303168	Hnrnpc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein D-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434036	Hnrnpdl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363776	Hnrnpd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364395	Hnrnpd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein D; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472905	Hnrnpd<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein D; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472775	Hnrnpd<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458565	Hnrnpf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458550	Hnrnpf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein H1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362975	Hnrnph1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein H1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363406	Hnrnph1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein H1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472972	Hnrnph1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein K; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363684	Hnrnpk<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein K; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363684	Hnrnpk<tm1(KOMP)Wtsi>	26412324	KOMP-CSD
heterogeneous nuclear ribonucleoprotein L; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5444897	Hnrnpl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
heterogeneous nuclear ribonucleoprotein M; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441873	Hnrnpm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein M; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441895	Hnrnpm<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein R; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820294	Hnrnpr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein R; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820385	Hnrnpr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein U; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432439	Hnrnpu<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein U; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432165	Hnrnpu<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
heterogeneous nuclear ribonucleoprotein U; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511935	Hnrnpu<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
hexamethylene bis-acetamide inducible 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442036	Hexim2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hexokinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362962	Hk2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hexokinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363913	Hk2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hexokinase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887590	Hkdc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hexokinase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887590	Hkdc1<tm1a(KOMP)Wtsi>	27459389	KOMP-CSD
hexokinase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887632	Hkdc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hexosaminidase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420038	Hexa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hexosaminidase A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419730	Hexa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432827	H6pd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432909	H6pd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HFM1, ATP-dependent DNA helicase homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433753	Hfm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HGF-regulated tyrosine kinase substrate; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431739	Hgs<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HIG1 domain family, member 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842785	Higd1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HIG1 domain family, member 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842892	Higd1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HIG1 domain family, member 1B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5529967	Higd1b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
highly divergent homeobox; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432202	Hdx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
highly divergent homeobox; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434087	Hdx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
high mobility group 20B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009645	Hmg20b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
high mobility group 20B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014687	Hmg20b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
high mobility group 20B; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511916	Hmg20b<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
high mobility group AT-hook 1; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5561566	Hmga1<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
high mobility group box 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432012	Hmgb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
high mobility group box 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433364	Hmgb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
high mobility group nucleosomal binding domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363729	Hmgn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
high mobility group nucleosomal binding domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364238	Hmgn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hippocalcin-like 4; targeted mutation 1.1, Velocigene	MGI:5548765	Hpcal4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
HIRA interacting protein 3; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548743	Hirip3<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
histamine N-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364774	Hnmt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
histamine N-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364774	Hnmt<tm1a(KOMP)Wtsi>	29162912	KOMP-CSD
histamine N-methyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362393	Hnmt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
histamine N-methyltransferase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293920	Hnmt<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
histamine receptor H3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362838	Hrh3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
histamine receptor H3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364242	Hrh3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
histidine-rich glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842618	Hrg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histidine-rich glycoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842723	Hrg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histidine triad nucleotide binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433692	Hint1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histidine triad nucleotide binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433982	Hint1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histidine triad nucleotide binding protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419484	Hint2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
histidine triad nucleotide binding protein 2; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5435073	Hint2<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
histidine triad nucleotide binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363943	Hint3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
histidine triad nucleotide binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364770	Hint3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
histidyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944426	Hars<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
histidyl-tRNA synthetase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950972	Hars<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296546	H13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 13; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637209	H13<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
histocompatibility 2, class II antigen A, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458506	H2-Aa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 2, class II antigen A, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458547	H2-Aa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 2, class II antigen E beta2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006793	H2-Eb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histocompatibility 2, class II antigen E beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297122	H2-Eb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 2, class II antigen E beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297122	H2-Eb1<tm1a(KOMP)Wtsi>	27233670	KOMP-CSD
histocompatibility 2, class II antigen E beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820163	H2-Eb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 2, class II, locus DMa; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944559	H2-DMa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histocompatibility 2, class II, locus Mb1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453695	H2-DMb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histocompatibility 2, M region locus 10.5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431500	H2-M10.5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 2, M region locus 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420089	H2-M5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 2, O region alpha locus; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009657	H2-Oa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histocompatibility 2, O region alpha locus; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009661	H2-Oa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histocompatibility 2, O region beta locus; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420094	H2-Ob<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
histocompatibility 2, T region locus 23; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419817	H2-T23<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
histone aminotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008052	Hat1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	25087892	EUCOMM
histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	26935106	EUCOMM
histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	27518902	EUCOMM
histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	28600325	EUCOMM
histone cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
histone cell cycle regulator; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619355	Hira<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
histone cell cycle regulator; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619355	Hira<tm1c(EUCOMM)Wtsi>	25087892	EUCOMM
histone cell cycle regulator; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619355	Hira<tm1c(EUCOMM)Wtsi>	26935106	EUCOMM
histone cell cycle regulator; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619355	Hira<tm1c(EUCOMM)Wtsi>	28600325	EUCOMM
histone cell cycle regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431966	Hira<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 10; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5463976	Hdac10<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
histone deacetylase 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887699	Hdac11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842824	Hdac11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5529968	Hdac11<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431918	Hdac1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431918	Hdac1<tm1a(EUCOMM)Wtsi>	26776516	EUCOMM
histone deacetylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431918	Hdac1<tm1a(EUCOMM)Wtsi>	27721407	EUCOMM
histone deacetylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431918	Hdac1<tm1a(EUCOMM)Wtsi>	28791750	EUCOMM
histone deacetylase 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6101465	Hdac1<tm1c(EUCOMM)Wtsi>	28791750	EUCOMM
histone deacetylase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434508	Hdac1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433408	Hdac3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433408	Hdac3<tm1a(EUCOMM)Wtsi>	26776516	EUCOMM
histone deacetylase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451974	Hdac6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451974	Hdac6<tm1a(EUCOMM)Wtsi>	24302573	EUCOMM
histone deacetylase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432268	Hdac8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone deacetylase 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432026	Hdac8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
histone H3 associated protein kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473138	Haspin<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
histone H3 associated protein kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472717	Haspin<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HIV-1 Tat interactive protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842282	Htatip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HIV TAT specific factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426677	Htatsf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HIV TAT specific factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426665	Htatsf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HMG box domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460446	Hmgxb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HMG box domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460494	Hmgxb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HMG box domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431616	Hmgxb4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455974	Hoxa2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456037	Hoxa2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364765	Hoxa3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363867	Hoxa3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452662	Hoxa3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452691	Hoxa3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420040	Hoxa5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364723	Hoxa7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365091	Hoxa7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452656	Hoxa7<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452649	Hoxa7<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox A9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511996	Hoxa9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox B13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362504	Hoxb13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364339	Hoxb13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458571	Hoxb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458544	Hoxb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947761	Hoxb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007993	Hoxb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000317	Hoxb6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426551	Hoxb6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363725	Hoxb7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365216	Hoxb7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox B8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420150	Hoxb8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox C10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512008	Hoxc10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox C10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511974	Hoxc10<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox C11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431481	Hoxc11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox C11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431475	Hoxc11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox C12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297871	Hoxc12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox C12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5297867	Hoxc12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox C13; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050930	Hoxc13<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox C13; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050944	Hoxc13<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox C4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363580	Hoxc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox C5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512007	Hoxc5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox C6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947836	Hoxc6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox C6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950259	Hoxc6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433938	Hmbox1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432712	Hmbox1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
homeobox D11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841355	Hoxd11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox D3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944427	Hoxd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox D3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007983	Hoxd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox D9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420143	Hoxd9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeobox D9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452627	Hoxd9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
homeodomain interacting protein kinase 2; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5548422	Hipk2<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
homeodomain leucine zipper-encoding gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944328	Homez<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homeodomain leucine zipper-encoding gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944412	Homez<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homer scaffolding protein 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419309	Homer3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362679	Herpud1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363719	Herpud1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
homogentisate 1, 2-dioxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841281	Hgd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
homogentisate 1, 2-dioxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841461	Hgd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HORMA domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951101	Hormad1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HORMA domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432105	Hormad2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HORMA domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433046	Hormad2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hormonally upregulated Neu-associated kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050999	Hunk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hormonally upregulated Neu-associated kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085465	Hunk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
host cell factor C1 regulator 1 (XPO1-dependent); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419187	Hcfc1r1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364644	Hps1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363291	Hps3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362494	Hps3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308292	Hps3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5426656	Hps3<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
HPS4, biogenesis of lysosomal organelles complex 3 subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362558	Hps4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HPS4, biogenesis of lysosomal organelles complex 3 subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362794	Hps4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HPS4, biogenesis of lysosomal organelles complex 3 subunit 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363971	Hps4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
HPS4, biogenesis of lysosomal organelles complex 3 subunit 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364378	Hps4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
HPS5, biogenesis of lysosomal organelles complex 2 subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434424	Hps5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HPS5, biogenesis of lysosomal organelles complex 2 subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431766	Hps5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HPS6, biogenesis of lysosomal organelles complex 2 subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473148	Hps6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HPS6, biogenesis of lysosomal organelles complex 2 subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472726	Hps6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HRAS-like suppressor family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939690	Hrasls5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HRAS-like suppressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455532	Hrasls<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HRAS-like suppressor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456678	Hrasls<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HscB iron-sulfur cluster co-chaperone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432940	Hscb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
HscB iron-sulfur cluster co-chaperone; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433025	Hscb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HtrA serine peptidase 2; targeted mutation 1.1, Velocigene	MGI:5695938	Htra2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
HtrA serine peptidase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840588	Htra3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
HtrA serine peptidase 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840683	Htra3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
HtrA serine peptidase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362503	Htra4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HtrA serine peptidase 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692854	Htra4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
HtrA serine peptidase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362488	Htra4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
HtrA serine peptidase 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455505	Htra4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
HtrA serine peptidase 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455512	Htra4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
human immunodeficiency virus type I enhancer binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458644	Hivep2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
human immunodeficiency virus type I enhancer binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458556	Hivep2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin-associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841060	Hap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin-associated protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5646001	Hap1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin-associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841346	Hap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin interacting protein 1 related; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364638	Hip1r<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin interacting protein 1 related; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841248	Hip1r<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin interacting protein 1 related; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5574597	Hip1r<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
huntingtin interacting protein 1 related; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841412	Hip1r<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841014	Hip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841302	Hip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
huntingtin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842407	Htt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
huntingtin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842543	Htt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hyaluronan and proteoglycan link protein 1; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5515316	Hapln1<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
hyaluronan and proteoglycan link protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362730	Hapln1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hyaluronan and proteoglycan link protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419382	Hapln2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hyaluronan mediated motility receptor (RHAMM); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5299824	Hmmr<tm1a(EUCOMM)Hmgu>	28994651	EUCOMM
hyaluronan synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419868	Has1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hyaluronan synthase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636903	Has1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
hyaluronan synthase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420126	Has1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hyaluronan synthase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006771	Has3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hyaluronoglucosaminidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473121	Hyal1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hyaluronoglucosaminidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472894	Hyal1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hyaluronoglucosaminidase 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419654	Hyal3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hyaluronoglucosaminidase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364422	Hyal4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hyaluronoglucosaminidase 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473017	Hyal4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
hyaluronoglucosaminidase 4; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5587051	Hyal4<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
hydrogen voltage-gated channel 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362870	Hvcn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hydrogen voltage-gated channel 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362577	Hvcn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxyacid oxidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297121	Hao2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434061	Hadha<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433713	Hadha<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880972	Hadhb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880908	Hadhb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxyacylglutathione hydrolase-like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419114	Haghl<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxyacyl glutathione hydrolase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008800	Hagh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxypyruvate isomerase (putative); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420060	Hyi<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362580	Hsd11b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362580	Hsd11b1<tm1a(KOMP)Wtsi>	24667799	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362580	Hsd11b1<tm1a(KOMP)Wtsi>	27070821	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362580	Hsd11b1<tm1a(KOMP)Wtsi>	27195053	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5819106	Hsd11b1<tm1c(KOMP)Wtsi>	27070821	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5819106	Hsd11b1<tm1c(KOMP)Wtsi>	27195053	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364686	Hsd11b1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302290	Hsd11b1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxysteroid 11-beta dehydrogenase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008030	Hsd11b2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid (17-beta) dehydrogenase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289818	Hsd17b10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxysteroid (17-beta) dehydrogenase 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426599	Hsd17b10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxysteroid (17-beta) dehydrogenase 11; targeted mutation 1.1, Velocigene	MGI:5581418	Hsd17b11<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
hydroxysteroid (17-beta) dehydrogenase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433984	Hsd17b12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid (17-beta) dehydrogenase 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433294	Hsd17b12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid (17-beta) dehydrogenase 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948618	Hsd17b13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hydroxysteroid (17-beta) dehydrogenase 1; targeted mutation 1.1, Velocigene	MGI:5576042	Hsd17b1<tm1.1(KOMP)Vlcg>	26018678	KOMP-Regeneron
hydroxysteroid (17-beta) dehydrogenase 1; targeted mutation 1.1, Velocigene	MGI:5576042	Hsd17b1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
hydroxysteroid (17-beta) dehydrogenase 1; targeted mutation 1, Velocigene	MGI:3799948	Hsd17b1<tm1(KOMP)Vlcg>	26018678	KOMP-Regeneron
hydroxysteroid (17-beta) dehydrogenase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433249	Hsd17b3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid (17-beta) dehydrogenase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433598	Hsd17b3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid (17-beta) dehydrogenase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472956	Hsd17b3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid (17-beta) dehydrogenase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434023	Hsd17b7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid (17-beta) dehydrogenase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434507	Hsd17b7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid dehydrogenase like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003009	Hsdl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hydroxysteroid dehydrogenase like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003011	Hsdl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
HYLS1, centriolar and ciliogenesis associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364346	Hyls1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
HYLS1, centriolar and ciliogenesis associated; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5473003	Hyls1<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
HYLS1, centriolar and ciliogenesis associated; targeted mutation 5a, Wellcome Trust Sanger Institute	MGI:5511159	Hyls1<tm5a(EUCOMM)Wtsi>	21677750	EUCOMM
hypermethylated in cancer 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947755	Hic1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hypermethylated in cancer 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947754	Hic1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hyperpolarization-activated, cyclic nucleotide-gated K+ 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941502	Hcn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hyperpolarization-activated, cyclic nucleotide-gated K+ 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941500	Hcn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hyperpolarization-activated, cyclic nucleotide-gated K+ 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003028	Hcn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
hypocretin (orexin) receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455611	Hcrtr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hypocretin (orexin) receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456664	Hcrtr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
hypocretin; targeted mutation 1.1, Velocigene	MGI:5582427	Hcrt<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
hypoxia-inducible factor 1, alpha subunit inhibitor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364928	Hif1an<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hypoxia inducible lipid droplet associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426634	Hilpda<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
hypoxia inducible lipid droplet associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426583	Hilpda<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IAP promoted placental gene; targeted mutation 1.1, Velocigene	MGI:5532529	Ipp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
icos ligand; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364624	Icosl<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
IGF-like family receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419558	Igflr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IKAROS family zinc finger 3; targeted mutation 1, Velocigene	MGI:5008103	Ikzf3<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
IKAROS family zinc finger 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419517	Ikzf5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
IKAROS family zinc finger 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419517	Ikzf5<tm1(KOMP)Wtsi>	27626380	KOMP-CSD
IK cytokine; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008765	Ik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IK cytokine; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009579	Ik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IL2 inducible T cell kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820217	Itk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
IL2 inducible T cell kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820376	Itk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
immunity-related GTPase family, cinema 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419645	Irgc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
immunity-related GTPase family, cinema 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419346	Irgc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
immunity-related GTPase family, Q; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009642	Irgq<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
immunity-related GTPase family, Q; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014743	Irgq<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
immunoglobulin joining chain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364897	Jchain<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin joining chain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427205	Jchain<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin joining chain; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4420092	Jchain<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin joining chain; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4420022	Jchain<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin lambda-like polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286237	Igll1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin lambda-like polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426593	Igll1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin-like domain containing receptor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419159	Ildr1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin-like domain containing receptor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419159	Ildr1<tm1(KOMP)Wtsi>	25217574	KOMP-CSD
immunoglobulin-like domain containing receptor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419159	Ildr1<tm1(KOMP)Wtsi>	25822906	KOMP-CSD
immunoglobulin superfamily containing leucine-rich repeat; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006757	Islr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
immunoglobulin superfamily, DCC subclass, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433368	Igdcc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
immunoglobulin superfamily, DCC subclass, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433785	Igdcc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
immunoglobulin superfamily, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364956	Igsf11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364956	Igsf11<tm1a(KOMP)Wtsi>	26595655	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5509325	Igsf11<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5509325	Igsf11<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5509325	Igsf11<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5897622	Igsf11<tm1d(KOMP)Wtsi>	26595655	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365035	Igsf11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297875	Igsf11<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5297899	Igsf11<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 11; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5297896	Igsf11<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 21; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:5511724	Igsf21<tm2a(EUCOMM)Hmgu>	28864826	EUCOMM
immunoglobulin superfamily, member 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419314	Igsf3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419956	Igsf5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419656	Igsf5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419307	Igsf8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
immunoglobulin superfamily, member 9B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052488	Igsf9b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
immunoglobulin superfamily, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433206	Igsf9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
immunoglobulin superfamily, member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432209	Igsf9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944339	Immp1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
impact, RWD domain protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365068	Impact<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
impact, RWD domain protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363004	Impact<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
impact, RWD domain protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299617	Impact<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
impact, RWD domain protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299539	Impact<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
importin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433153	Ipo4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
importin 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432979	Ipo9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
importin 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433051	Ipo9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
importin 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473055	Ipo9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
importin 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472866	Ipo9<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
increased sodium tolerance 1 homolog (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451996	Ist1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
increased sodium tolerance 1 homolog (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842761	Ist1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Indian hedgehog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286385	Ihh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
indoleamine 2,3-dioxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432044	Ido1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
indoleamine 2,3-dioxygenase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456785	Ido1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
indoleamine 2,3-dioxygenase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456855	Ido1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
indoleamine 2,3-dioxygenase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364001	Ido2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
indoleamine 2,3-dioxygenase 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5002991	Ido2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
indoleamine 2,3-dioxygenase 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5002998	Ido2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
indolethylamine N-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451486	Inmt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
indolethylamine N-methyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451441	Inmt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inducible T cell co-stimulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431720	Icos<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inducible T cell co-stimulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432921	Icos<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inducible T cell co-stimulator; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473109	Icos<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
influenza virus NS1A binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432106	Ivns1abp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of Bruton agammaglobulinemia tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050995	Ibtk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of Bruton agammaglobulinemia tyrosine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085487	Ibtk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of DNA binding 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511998	Id2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of DNA binding 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511967	Id2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of growth family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432585	Ing3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of growth family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432585	Ing3<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
inhibitor of growth family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431904	Ing3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of growth family, member 3; targeted mutation 1, William C Skarnes	MGI:5903607	Ing3<tm1Wcs>	28981838	null
inhibitor of kappaB kinase beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432305	Ikbkb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of kappaB kinase gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432136	Ikbkg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of kappaB kinase gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432890	Ikbkg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362242	Ikbkap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362242	Ikbkap<tm1a(KOMP)Wtsi>	23717213	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362242	Ikbkap<tm1a(KOMP)Wtsi>	24173031	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362242	Ikbkap<tm1a(KOMP)Wtsi>	27699209	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362242	Ikbkap<tm1a(KOMP)Wtsi>	28167615	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5558022	Ikbkap<tm1c(KOMP)Wtsi>	24173031	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5558022	Ikbkap<tm1c(KOMP)Wtsi>	27699209	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5558022	Ikbkap<tm1c(KOMP)Wtsi>	28167615	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5558022	Ikbkap<tm1c(KOMP)Wtsi>	28439028	KOMP-CSD
inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365267	Ikbkap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
INO80 complex subunit B; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548594	Ino80b<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
INO80 complex subunit D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306504	Ino80d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
INO80 complex subunit D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305678	Ino80d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
INO80 complex subunit E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433084	Ino80e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
INO80 complex subunit E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434400	Ino80e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
INO80 complex subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436542	Ino80<tm1a(EUCOMM)Hmgu>	26607718	EUCOMM
INO80 complex subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436542	Ino80<tm1a(EUCOMM)Hmgu>	27626380	EUCOMM
INO80 complex subunit; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436542	Ino80<tm1a(EUCOMM)Hmgu>	29371594	EUCOMM
INO80 complex subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548559	Ino80<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
INO80 complex subunit; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6100919	Ino80<tm1c(EUCOMM)Hmgu>	26607718	EUCOMM
INO80 complex subunit; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6100919	Ino80<tm1c(EUCOMM)Hmgu>	29371594	EUCOMM
inosine monophosphate dehydrogenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841113	Impdh1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inosine monophosphate dehydrogenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840931	Impdh1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inosine triphosphatase (nucleoside triphosphate pyrophosphatase); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840621	Itpa<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
inositol 1,3,4,5,6-pentakisphosphate 2-kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942043	Ippk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inositol 1,3,4,5,6-pentakisphosphate 2-kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942027	Ippk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inositol 1,4,5-triphosphate receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432696	Itpr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inositol 1,4,5-triphosphate receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431559	Itpr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inositol 1,4,5-triphosphate receptor interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052397	Itprip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inositol 1,4,5-trisphosphate 3-kinase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441770	Itpka<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inositol 1,4,5-trisphosphate 3-kinase A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441999	Itpka<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inositol 1,4,5-trisphosphate 3-kinase B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842545	Itpkb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inositol 1,4,5-trisphosphate 3-kinase B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433948	Itpkb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inositol hexaphosphate kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426636	Ip6k3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inositol hexaphosphate kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426587	Ip6k3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inositol monophosphatase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363750	Impad1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inositol monophosphatase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364611	Impad1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inositol polyphosphate-1-phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363818	Inpp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inositol polyphosphate-1-phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363818	Inpp1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
inositol polyphosphate-1-phosphatase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548354	Inpp1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
inositol polyphosphate-1-phosphatase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364855	Inpp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inositol polyphosphate-5-phosphatase B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820285	Inpp5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inositol polyphosphate-5-phosphatase B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820378	Inpp5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inositol polyphosphate-5-phosphatase E; targeted mutation 1.1, Velocigene	MGI:5548702	Inpp5e<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
inositol polyphosphate 5-phosphatase K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433849	Inpp5k<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inositol polyphosphate 5-phosphatase K; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433136	Inpp5k<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inositol polyphosphate multikinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460439	Ipmk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inositol polyphosphate multikinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460497	Ipmk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin degrading enzyme; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431946	Ide<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
insulin degrading enzyme; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431946	Ide<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
insulin degrading enzyme; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431875	Ide<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433910	Ins2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
insulin II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434013	Ins2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin induced gene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085355	Insig2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin I; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420079	Ins1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460274	Insl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460302	Insl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305618	Insl6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426582	Insl6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like growth factor 2 mRNA binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051000	Igf2bp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor 2 mRNA binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085483	Igf2bp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor 2 mRNA binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434217	Igf2bp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor 2 mRNA binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433216	Igf2bp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5002926	Igf2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like growth factor binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433178	Igfbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433902	Igfbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363852	Igfbp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like growth factor binding protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548945	Igfbp3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
insulin-like growth factor binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363111	Igfbp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like growth factor binding protein 3; targeted mutation 1, Velocigene	MGI:3797719	Igfbp3<tm1(KOMP)Vlcg>	28088287	KOMP-Regeneron
insulin-like growth factor binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307089	Igfbp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like growth factor binding protein 4; targeted mutation 1, Velocigene	MGI:3797524	Igfbp4<tm1(KOMP)Vlcg>	28184001	KOMP-Regeneron
insulin-like growth factor binding protein 4; targeted mutation 1, Velocigene	MGI:3797524	Igfbp4<tm1(KOMP)Vlcg>	28938423	KOMP-Regeneron
insulin-like growth factor binding protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433725	Igfbp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor binding protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433838	Igfbp5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor binding protein 7; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5609347	Igfbp7<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
insulin-like growth factor binding protein, acid labile subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944348	Igfals<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like growth factor binding protein, acid labile subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944362	Igfals<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
insulin-like growth factor I receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842463	Igf1r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
insulin-like growth factor I receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842852	Igf1r<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
insulin receptor-related receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841117	Insrr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin receptor-related receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841352	Insrr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
insulin receptor substrate 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426643	Irs3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin receptor substrate 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426602	Irs3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
insulin related protein 2 (islet 2); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362919	Isl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
insulin related protein 2 (islet 2); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363145	Isl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integral membrane protein 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868084	Itm2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integral membrane protein 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868076	Itm2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integral membrane protein 2C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431661	Itm2c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integral membrane protein 2C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548700	Itm2c<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
integral membrane protein 2C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432855	Itm2c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297862	Ints10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5661967	Ints10<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362475	Ints10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297872	Ints10<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 10; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5303096	Ints10<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432200	Ints11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433395	Ints11<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434374	Ints11<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432308	Ints12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 12; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637056	Ints12<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
integrator complex subunit 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433732	Ints12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441634	Ints13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362455	Ints2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364808	Ints2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419553	Ints4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419452	Ints4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 6 like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363522	Ints6l<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 6 like; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5293908	Ints6l<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820213	Ints7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrator complex subunit 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289822	Ints8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297877	Ints9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362317	Ints9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4454168	Ints9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
integrator complex subunit 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4454102	Ints9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
integrin alpha 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365119	Itga11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrin alpha 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364499	Itga11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrin alpha 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548946	Itga2<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
integrin alpha 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548946	Itga2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
integrin alpha 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431848	Itga4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin alpha 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050936	Itga7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin alpha 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461471	Itga8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrin alpha 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5509056	Itga8<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
integrin alpha 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5509056	Itga8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
integrin alpha 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461472	Itga8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrin alpha 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5284933	Itga9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin alpha 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286380	Itga9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin alpha 9; targeted mutation 1, Velocigene	MGI:4842949	Itga9<tm1(KOMP)Vlcg>	22772469	KOMP-Regeneron
integrin alpha E, epithelial-associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433992	Itgae<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin alpha E, epithelial-associated; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636943	Itgae<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
integrin alpha V; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432406	Itgav<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin alpha V; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433907	Itgav<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 2-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841161	Itgb2l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrin beta 2-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841385	Itgb2l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrin beta 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431718	Itgb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432661	Itgb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363309	Itgb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrin beta 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365224	Itgb3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrin beta 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432791	Itgb4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433968	Itgb4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431871	Itgb5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433020	Itgb5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363142	Itgb6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrin beta 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363884	Itgb6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
integrin beta 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286411	Itgb7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin beta 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364605	Itgb8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
integrin binding sialoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432014	Ibsp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin binding sialoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434523	Ibsp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin-linked kinase-associated serine/threonine phosphatase 2C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006805	Ilkap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
integrin-linked kinase-associated serine/threonine phosphatase 2C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008944	Ilkap<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
integrin linked kinase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5426617	Ilk<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
intelectin 1 (galactofuranose binding); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363840	Itln1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
intelectin 1 (galactofuranose binding); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419339	Itln1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
interaction protein for cytohesin exchange factors 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363199	Ipcef1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interactor of little elongation complex ELL subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938600	Ice2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interactor of little elongation complex ELL subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938557	Ice2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inter-alpha (globulin) inhibitor H5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458467	Itih5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inter-alpha (globulin) inhibitor H5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458475	Itih5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inter-alpha trypsin inhibitor, heavy chain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364529	Itih1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inter-alpha trypsin inhibitor, heavy chain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364941	Itih1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inter-alpha trypsin inhibitor, heavy chain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287792	Itih3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inter-alpha trypsin inhibitor, heavy chain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293916	Itih3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
inter alpha-trypsin inhibitor, heavy chain 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364862	Itih4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
inter alpha-trypsin inhibitor, heavy chain 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452661	Itih4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
inter alpha-trypsin inhibitor, heavy chain 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452705	Itih4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
inter alpha-trypsin inhibitor, heavy chain 4; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4455580	Itih4<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
inter alpha-trypsin inhibitor, heavy chain 4; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4455622	Itih4<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
intercellular adhesion molecule 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363016	Icam2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
intercellular adhesion molecule 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365241	Icam2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon activated gene 204; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050872	Ifi204<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon activated gene 209; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286233	Ifi209<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon activated gene 209; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426592	Ifi209<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon activated gene 211; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503347	Ifi211<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon activated gene 214; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419805	Ifi214<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon activated gene 214; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420105	Ifi214<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon (alpha and beta) receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433658	Ifnar1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon (alpha and beta) receptor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527593	Ifnar1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon (alpha and beta) receptor 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419939	Ifnar2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
interferon, alpha-inducible protein 27 like 2A; targeted mutation 1.1, Velocigene	MGI:5548678	Ifi27l2a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interferon, alpha-inducible protein 27 like 2A; targeted mutation 1, Velocigene	MGI:3808494	Ifi27l2a<tm1(KOMP)Vlcg>	25184786	KOMP-Regeneron
interferon, alpha-inducible protein 27 like 2A; targeted mutation 1, Velocigene	MGI:3808494	Ifi27l2a<tm1(KOMP)Vlcg>	26699642	KOMP-Regeneron
interferon, alpha-inducible protein 27 like 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432502	Ifi27l2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interferon, alpha-inducible protein 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050993	Ifi27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon beta 1, fibroblast; targeted mutation 1, Velocigene	MGI:4399406	Ifnb1<tm1(KOMP)Vlcg>	22771905	KOMP-Regeneron
interferon gamma induced GTPase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362157	Igtp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma induced GTPase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364035	Igtp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma inducible protein 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364616	Ifi47<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma inducible protein 47; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363937	Ifi47<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma inducible protein 47; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299586	Ifi47<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427218	Ifngr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427213	Ifngr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362811	Ifngr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon gamma receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362998	Ifngr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-induced protein 35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456841	Ifi35<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon-induced protein 35; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457576	Ifi35<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interferon-induced protein 44 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880944	Ifi44l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-induced protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364898	Ifi44<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-induced protein 44; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513793	Ifi44<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
interferon-induced protein 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319912	Ifi44<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	21085181	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	21642987	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	22589727	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	22615570	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	24098121	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	24198415	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	24362933	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	24478444	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	24482115	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	25231314	KOMP-Regeneron
interferon-induced protein with tetratricopeptide repeats 1; targeted mutation 1, Velocigene	MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	26157117	KOMP-Regeneron
interferon induced transmembrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432260	Ifitm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon induced transmembrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431593	Ifitm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interferon induced transmembrane protein 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050901	Ifitm2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon induced transmembrane protein 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050974	Ifitm2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
interferon induced transmembrane protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434475	Ifitm5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon induced transmembrane protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433041	Ifitm6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon induced transmembrane protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433981	Ifitm6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interferon induced with helicase C domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365057	Ifih1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon induced with helicase C domain 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286191	Ifih1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon induced with helicase C domain 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293907	Ifih1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon lambda 3; targeted mutation 1.1, Velocigene	MGI:5575899	Ifnl3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interferon lambda receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527612	Ifnlr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon lambda receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527612	Ifnlr1<tm1a(EUCOMM)Wtsi>	28077655	EUCOMM
interferon lambda receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527612	Ifnlr1<tm1a(EUCOMM)Wtsi>	28846084	EUCOMM
interferon lambda receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527612	Ifnlr1<tm1a(EUCOMM)Wtsi>	28966054	EUCOMM
interferon regulatory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431834	Irf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon regulatory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431834	Irf1<tm1a(EUCOMM)Wtsi>	27822537	EUCOMM
interferon regulatory factor 2 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473166	Irf2bp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon regulatory factor 2 binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472742	Irf2bp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interferon regulatory factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460438	Irf5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interferon regulatory factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460527	Irf5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interferon regulatory factor 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419590	Irf7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
interferon regulatory factor 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419590	Irf7<tm1(KOMP)Wtsi>	27822537	KOMP-CSD
interferon regulatory factor 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362518	Irf8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon regulatory factor 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362518	Irf8<tm1a(KOMP)Wtsi>	27637148	KOMP-CSD
interferon regulatory factor 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446132	Irf8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
interferon regulatory factor 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446132	Irf8<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
interferon regulatory factor 8; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5883831	Irf8<tm1c(KOMP)Wtsi>	27637148	KOMP-CSD
interferon regulatory factor 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362868	Irf8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon regulatory factor 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419436	Irf9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-related developmental regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362357	Ifrd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-related developmental regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362506	Ifrd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-stimulated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820118	Isg20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interferon-stimulated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820107	Isg20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 10 receptor, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307099	Il10ra<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 10 receptor, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364200	Il10rb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 10 receptor, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363636	Il10rb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432290	Il10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433081	Il10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 11 receptor, alpha chain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432288	Il11ra1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 11 receptor, alpha chain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432465	Il11ra1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 12b; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840609	Il12b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 12b; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840656	Il12b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 12 receptor, beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286182	Il12rb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 12 receptor, beta 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572025	Il12rb1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
interleukin 12 receptor, beta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293903	Il12rb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 12 receptor, beta 2; targeted mutation 1.1, Velocigene	MGI:5488781	Il12rb2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 12 receptor, beta 2; targeted mutation 1.1, Velocigene	MGI:5488781	Il12rb2<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
interleukin 12 receptor, beta 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307094	Il12rb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 13; targeted mutation 1.1, Velocigene	MGI:5569965	Il13<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 15 receptor, alpha chain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364347	Il15ra<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 15 receptor, alpha chain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364098	Il15ra<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 15; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636890	Il15<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
interleukin 17B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441982	Il17b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 17B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441938	Il17b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 17F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5430970	Il17f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 17 receptor A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455463	Il17ra<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 17 receptor A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455463	Il17ra<tm1a(KOMP)Wtsi>	25526314	KOMP-CSD
interleukin 17 receptor A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455463	Il17ra<tm1a(KOMP)Wtsi>	28733485	KOMP-CSD
interleukin 17 receptor A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792909	Il17ra<tm1c(KOMP)Wtsi>	25526314	KOMP-CSD
interleukin 17 receptor A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455484	Il17ra<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 17 receptor B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820260	Il17rb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 17 receptor B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820377	Il17rb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 17 receptor C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431411	Il17rc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 17 receptor C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431405	Il17rc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 17 receptor D; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548769	Il17rd<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
interleukin 18 binding protein; targeted mutation 1.1, Velocigene	MGI:5569040	Il18bp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 18 binding protein; targeted mutation 1, Velocigene	MGI:4399404	Il18bp<tm1(KOMP)Vlcg>	28900426	KOMP-Regeneron
interleukin 18 receptor accessory protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420007	Il18rap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 18 receptor accessory protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426571	Il18rap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 18 receptor accessory protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4462625	Il18rap<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 18 receptor accessory protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4818584	Il18rap<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006777	Il18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 18; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5582420	Il18<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
interleukin 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006799	Il19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051015	Il1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 alpha; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635224	Il1a<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 family, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008051	Il1f10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 family, member 5 (delta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840973	Il1f5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 1 family, member 5 (delta); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841422	Il1f5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 1 family, member 8; targeted mutation 1, Velocigene	MGI:4415576	Il1f8<tm1(KOMP)Vlcg>	26203636	KOMP-Regeneron
interleukin 1 family, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441719	Il1f9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 family, member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442039	Il1f9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 receptor accessory protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434152	Il1rapl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 receptor accessory protein-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434143	Il1rapl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 receptor accessory protein-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847859	Il1rapl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 receptor accessory protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364484	Il1rap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 1 receptor accessory protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455565	Il1rap<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin-1 receptor-associated kinase 1 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460292	Irak1bp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin-1 receptor-associated kinase 1 binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460284	Irak1bp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin-1 receptor-associated kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842427	Irak1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin-1 receptor-associated kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431835	Irak2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin-1 receptor-associated kinase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637137	Irak2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
interleukin-1 receptor-associated kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433767	Irak2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin-1 receptor-associated kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431953	Irak3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin-1 receptor-associated kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431953	Irak3<tm1a(EUCOMM)Wtsi>	28120642	EUCOMM
interleukin-1 receptor-associated kinase 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115588	Irak3<tm1c(EUCOMM)Wtsi>	28120642	EUCOMM
interleukin 1 receptor-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820170	Il1rl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 1 receptor-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820176	Il1rl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 1 receptor, type II; targeted mutation 1.1, Velocigene	MGI:5695974	Il1r2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 1 receptor, type II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842437	Il1r2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 1 receptor, type II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842437	Il1r2<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
interleukin 1 receptor, type II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842874	Il1r2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 20 receptor, alpha; targeted mutation 1.1, Velocigene	MGI:5548901	Il20ra<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 20 receptor, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460496	Il20ra<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 20 receptor, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460463	Il20ra<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 20 receptor beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363049	Il20rb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 20 receptor beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362957	Il20rb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 22 receptor, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431742	Il22ra1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 22 receptor, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431742	Il22ra1<tm1a(EUCOMM)Wtsi>	22801499	EUCOMM
interleukin 22 receptor, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431742	Il22ra1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
interleukin 22 receptor, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431742	Il22ra1<tm1a(EUCOMM)Wtsi>	25263220	EUCOMM
interleukin 22 receptor, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433859	Il22ra1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 22 receptor, alpha 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050954	Il22ra2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 23 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434130	Il23r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 23 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434130	Il23r<tm1a(EUCOMM)Wtsi>	27524624	EUCOMM
interleukin 23 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433359	Il23r<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 23 receptor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5085468	Il23r<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 23 receptor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5085468	Il23r<tm2a(EUCOMM)Wtsi>	25838550	EUCOMM
interleukin 24; targeted mutation 1.1, Velocigene	MGI:5468967	Il24<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 24; targeted mutation 1.1, Velocigene	MGI:5468967	Il24<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
interleukin 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527617	Il27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 2 receptor, alpha chain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050998	Il2ra<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 2 receptor, alpha chain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5085486	Il2ra<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 31 receptor A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5751157	Il31ra<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
interleukin 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842595	Il31<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842805	Il31<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 33; targeted mutation 1.1, Velocigene	MGI:5548682	Il33<tm1.1(KOMP)Vlcg>	24613091	KOMP-Regeneron
interleukin 33; targeted mutation 1.1, Velocigene	MGI:5548682	Il33<tm1.1(KOMP)Vlcg>	26272855	KOMP-Regeneron
interleukin 33; targeted mutation 1.1, Velocigene	MGI:5548682	Il33<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 33; targeted mutation 1.1, Velocigene	MGI:5548682	Il33<tm1.1(KOMP)Vlcg>	27994070	KOMP-Regeneron
interleukin 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5308290	Il33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5308281	Il33<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 33; targeted mutation 1, Velocigene	MGI:4452857	Il33<tm1(KOMP)Vlcg>	25617473	KOMP-Regeneron
interleukin 33; targeted mutation 1, Velocigene	MGI:4452857	Il33<tm1(KOMP)Vlcg>	26386119	KOMP-Regeneron
interleukin 33; targeted mutation 1, Velocigene	MGI:4452857	Il33<tm1(KOMP)Vlcg>	27120577	KOMP-Regeneron
interleukin 33; targeted mutation 1, Velocigene	MGI:4452857	Il33<tm1(KOMP)Vlcg>	27775548	KOMP-Regeneron
interleukin 33; targeted mutation 1, Velocigene	MGI:4452857	Il33<tm1(KOMP)Vlcg>	28675392	KOMP-Regeneron
interleukin 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431787	Il34<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431787	Il34<tm1a(EUCOMM)Wtsi>	22729249	EUCOMM
interleukin 34; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5438224	Il34<tm1b(EUCOMM)Wtsi>	22729249	EUCOMM
interleukin 34; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5438224	Il34<tm1b(EUCOMM)Wtsi>	23177320	EUCOMM
interleukin 34; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5438224	Il34<tm1b(EUCOMM)Wtsi>	26121749	EUCOMM
interleukin 34; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5438224	Il34<tm1b(EUCOMM)Wtsi>	26634935	EUCOMM
interleukin 34; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5438224	Il34<tm1b(EUCOMM)Wtsi>	27185853	EUCOMM
interleukin 34; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5438225	Il34<tm1c(EUCOMM)Wtsi>	22729249	EUCOMM
interleukin 34; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5438225	Il34<tm1c(EUCOMM)Wtsi>	26634935	EUCOMM
interleukin 34; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431935	Il34<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 4 induced 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432453	Il4i1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 4 induced 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432748	Il4i1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 5 receptor, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013749	Il5ra<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 6 receptor, alpha; targeted mutation 1.1, Velocigene	MGI:5548361	Il6ra<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
interleukin 6 receptor, alpha; targeted mutation 1, Velocigene	MGI:4399482	Il6ra<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
interleukin 6 signal transducer; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5474976	Il6st<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
interleukin 6 signal transducer; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5474976	Il6st<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
interleukin 6 signal transducer; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458486	Il6st<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 6 signal transducer; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5008784	Il6st<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 7 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940746	Il7r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820293	Il7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820293	Il7<tm1a(EUCOMM)Wtsi>	29321277	EUCOMM
interleukin 7; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6116822	Il7<tm1c(EUCOMM)Wtsi>	29321277	EUCOMM
interleukin 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820335	Il7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin 9 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364960	Il9r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 9 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364630	Il9r<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286390	Il9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
interleukin enhancer binding factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841096	Ilf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interleukin enhancer binding factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841470	Ilf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
intermediate filament family orphan 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365259	Iffo1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
intermediate filament family orphan 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426672	Iffo1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
intermediate filament family orphan 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5426645	Iffo1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
intermediate filament family orphan 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5426606	Iffo1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
internexin neuronal intermediate filament protein, alpha; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511965	Ina<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
interphotoreceptor matrix proteoglycan 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841010	Impg2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
interphotoreceptor matrix proteoglycan 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840940	Impg2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
intersectin 1 (SH3 domain protein 1A); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503338	Itsn1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
intersectin 2; targeted mutation 1.1, Velocigene	MGI:5548439	Itsn2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
intersectin 2; targeted mutation 1.1, Velocigene	MGI:5548439	Itsn2<tm1.1(KOMP)Vlcg>	29337666	KOMP-Regeneron
intestinal cell kinase; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4462529	Ick<tm1a(KOMP)Mbp>	24853502	KOMP-CSD
intestinal cell kinase; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4462529	Ick<tm1a(KOMP)Mbp>	27466187	KOMP-CSD
intestinal cell kinase; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548729	Ick<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
intraflagellar transport 122; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432086	Ift122<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 122; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433892	Ift122<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 140; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363217	Ift140<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
intraflagellar transport 140; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363217	Ift140<tm1a(KOMP)Wtsi>	22282595	KOMP-CSD
intraflagellar transport 140; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363217	Ift140<tm1a(KOMP)Wtsi>	24009529	KOMP-CSD
intraflagellar transport 140; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363217	Ift140<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
intraflagellar transport 140; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5311831	Ift140<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
intraflagellar transport 140; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5311831	Ift140<tm1b(KOMP)Wtsi>	22282595	KOMP-CSD
intraflagellar transport 140; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5311831	Ift140<tm1b(KOMP)Wtsi>	23418020	KOMP-CSD
intraflagellar transport 140; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5311831	Ift140<tm1b(KOMP)Wtsi>	24009529	KOMP-CSD
intraflagellar transport 140; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5311831	Ift140<tm1b(KOMP)Wtsi>	24619649	KOMP-CSD
intraflagellar transport 140; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5311828	Ift140<tm1c(KOMP)Wtsi>	21677750	KOMP-CSD
intraflagellar transport 140; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5311828	Ift140<tm1c(KOMP)Wtsi>	22282595	KOMP-CSD
intraflagellar transport 140; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5311828	Ift140<tm1c(KOMP)Wtsi>	24619649	KOMP-CSD
intraflagellar transport 140; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527606	Ift140<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431815	Ift20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434437	Ift20<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 22; targeted mutation 1.1, Velocigene	MGI:5548538	Ift22<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
intraflagellar transport 27; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4461616	Ift27<tm1a(EUCOMM)Hmgu>	25446516	EUCOMM
intraflagellar transport 27; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4461616	Ift27<tm1a(EUCOMM)Hmgu>	25605782	EUCOMM
intraflagellar transport 27; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4461616	Ift27<tm1a(EUCOMM)Hmgu>	26023097	EUCOMM
intraflagellar transport 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944540	Ift27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 27; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605397	Ift27<tm1b(EUCOMM)Hmgu>	25446516	EUCOMM
intraflagellar transport 27; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5605398	Ift27<tm1c(EUCOMM)Hmgu>	25446516	EUCOMM
intraflagellar transport 27; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5605399	Ift27<tm1d(EUCOMM)Hmgu>	25446516	EUCOMM
intraflagellar transport 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944535	Ift27<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 52; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451496	Ift52<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
intraflagellar transport 52; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451586	Ift52<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
intraflagellar transport 80; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419694	Ift80<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
intraflagellar transport 80; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419694	Ift80<tm1a(KOMP)Wtsi>	26053317	KOMP-CSD
intraflagellar transport 80; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419694	Ift80<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
intraflagellar transport 80; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5701373	Ift80<tm1c(KOMP)Wtsi>	26053317	KOMP-CSD
intraflagellar transport 80; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419592	Ift80<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
intraflagellar transport 80; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472948	Ift80<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 80; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472801	Ift80<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 81; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433881	Ift81<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 81; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432498	Ift81<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 81; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434435	Ift81<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
intraflagellar transport 88; targeted mutation 1.1, Velocigene	MGI:5505911	Ift88<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
intraflagellar transport 88; targeted mutation 1.1, Velocigene	MGI:5505911	Ift88<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
inversin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456036	Invs<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
inversin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456017	Invs<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
inversin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4942132	Invs<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
inverted formin, FH2 and WH2 domain containing; targeted mutation 1.1, Velocigene	MGI:5548597	Inf2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
inverted formin, FH2 and WH2 domain containing; targeted mutation 1.1, Velocigene	MGI:5548597	Inf2<tm1.1(KOMP)Vlcg>	29309034	KOMP-Regeneron
inverted formin, FH2 and WH2 domain containing; targeted mutation 1, Velocigene	MGI:4452925	Inf2<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
involucrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940758	Ivl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
involucrin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569966	Ivl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
involucrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941510	Ivl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
iodotyrosine deiodinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364160	Iyd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
iodotyrosine deiodinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362639	Iyd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363772	Iqsec1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362633	Iqsec1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841262	Iqsec2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841301	Iqsec2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841440	Iqsec3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362739	Iqsec3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364264	Iqsec3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5299499	Iqsec3<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and Sec7 domain 3; targeted mutation 3b, Wellcome Trust Sanger Institute	MGI:5563212	Iqsec3<tm3b(KOMP)Wtsi>	27626380	KOMP-CSD
IQ motif and Sec7 domain 3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5297898	Iqsec3<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif and ubiquitin domain containing; targeted mutation 1.1, Velocigene	MGI:5548891	Iqub<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
IQ motif and ubiquitin domain containing; targeted mutation 1, Velocigene	MGI:4415512	Iqub<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
IQ motif and ubiquitin domain containing; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:4840662	Iqub<tm2(EUCOMM)Wtsi>	21677750	EUCOMM
IQ motif containing C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419705	Iqcc<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif containing D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842675	Iqcd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
IQ motif containing D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842830	Iqcd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
IQ motif containing E; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548641	Iqce<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
IQ motif containing F3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299627	Iqcf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif containing F4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050849	Iqcf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif containing G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431654	Iqcg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
IQ motif containing G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431654	Iqcg<tm1a(EUCOMM)Wtsi>	24362311	EUCOMM
IQ motif containing G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431654	Iqcg<tm1a(EUCOMM)Wtsi>	24849454	EUCOMM
IQ motif containing G; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635126	Iqcg<tm1b(EUCOMM)Wtsi>	24362311	EUCOMM
IQ motif containing G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433890	Iqcg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
IQ motif containing GTPase activating protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008016	Iqgap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
IQ motif containing GTPase activating protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008046	Iqgap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
IQ motif containing GTPase activating protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013753	Iqgap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif containing GTPase activating protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5558039	Iqgap2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif containing GTPase activating protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5558039	Iqgap2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
IQ motif containing H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362326	Iqch<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IQ motif containing H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364080	Iqch<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
iron responsive element binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462676	Ireb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
iron responsive element binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462681	Ireb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
iron-sulfur cluster assembly 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287785	Isca1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
iron-sulfur cluster assembly 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5585595	Isca1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
iron-sulfur cluster assembly 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419552	Isca2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
iron-sulfur cluster assembly 2; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5435072	Isca2<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 1; targeted mutation 1, Velocigene	MGI:4399218	Irx1<tm1(KOMP)Vlcg>	28746823	KOMP-Regeneron
Iroquois homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363065	Irx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365087	Irx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841077	Irx4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841208	Irx4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458627	Irx5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458466	Irx5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364451	Irx6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365012	Irx6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Iroquois homeobox 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5007992	Irx6<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ISL1 transcription factor, LIM/homeodomain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455587	Isl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ISL1 transcription factor, LIM/homeodomain; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4950971	Isl1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
islet amyloid polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842371	Iapp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
islet amyloid polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842835	Iapp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
islet cell autoantigen 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5051003	Ica1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
islet cell autoantigen 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432336	Ica1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
islet cell autoantigen 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433564	Ica1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
islet cell autoantigen 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434405	Ica1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
islet cell autoantigen 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432545	Ica1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
isoamyl acetate-hydrolyzing esterase 1 homolog; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5574600	Iah1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
isochorismatase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880933	Isoc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
isochorismatase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880946	Isoc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
isocitrate dehydrogenase 1 (NADP+), soluble; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432188	Idh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
isocitrate dehydrogenase 1 (NADP+), soluble; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513791	Idh1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
isocitrate dehydrogenase 1 (NADP+), soluble; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433520	Idh1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
isocitrate dehydrogenase 1 (NADP+), soluble; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432246	Idh1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
isocitrate dehydrogenase 2 (NADP+), mitochondrial; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548944	Idh2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
isocitrate dehydrogenase 3 (NAD+) alpha; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419863	Idh3a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
isocitrate dehydrogenase 3 (NAD+) beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050842	Idh3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
isocitrate dehydrogenase 3 (NAD+), gamma; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419543	Idh3g<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
isoleucine-tRNA synthetase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434498	Iars2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
isovaleryl coenzyme A dehydrogenase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548705	Ivd<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
IWS1, SUPT6 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944361	Iws1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IWS1, SUPT6 interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944355	Iws1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364095	Izumo1r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364095	Izumo1r<tm1a(KOMP)Wtsi>	24739963	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548704	Izumo1r<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362135	Izumo1r<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363787	Izumo1r<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363787	Izumo1r<tm2a(KOMP)Wtsi>	24739963	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363787	Izumo1r<tm2a(KOMP)Wtsi>	27626380	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5792910	Izumo1r<tm2c(KOMP)Wtsi>	24739963	KOMP-CSD
IZUMO1 receptor, JUNO; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364970	Izumo1r<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
izumo sperm-egg fusion 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842503	Izumo1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
jade family PHD finger 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419316	Jade1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
jade family PHD finger 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420107	Jade1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
jade family PHD finger 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301404	Jade2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
jade family PHD finger 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433284	Jade3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
jade family PHD finger 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432931	Jade3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
jagged 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880880	Jag2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
jagged 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636926	Jag2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
jagged 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880926	Jag2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
jagunal homolog 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451865	Jagn1<tm1a(EUCOMM)Hmgu>	25129145	EUCOMM
jagunal homolog 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5604904	Jagn1<tm1c(EUCOMM)Hmgu>	25129145	EUCOMM
janus kinase and microtubule interacting protein 1; targeted mutation 1, Velocigene	MGI:4415497	Jakmip1<tm1(KOMP)Vlcg>	26627310	KOMP-Regeneron
janus kinase and microtubule interacting protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420130	Jakmip1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
JAZF zinc finger 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842392	Jazf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
JAZF zinc finger 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842392	Jazf1<tm1a(EUCOMM)Wtsi>	26839965	EUCOMM
JAZF zinc finger 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569067	Jazf1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
jerky; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944401	Jrk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
jerky; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944376	Jrk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
JNK1/MAPK8-associated membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460476	Jkamp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
jumonji, AT rich interactive domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362782	Jarid2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362782	Jarid2<tm1a(KOMP)Wtsi>	24856900	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362782	Jarid2<tm1a(KOMP)Wtsi>	27892467	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362782	Jarid2<tm1a(KOMP)Wtsi>	28981838	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5779200	Jarid2<tm1c(KOMP)Wtsi>	24856900	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5779200	Jarid2<tm1c(KOMP)Wtsi>	27892467	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5888989	Jarid2<tm1d(KOMP)Wtsi>	27892467	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363672	Jarid2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
jumonji, AT rich interactive domain 2; targeted mutation 1, William C Skarnes	MGI:5903608	Jarid2<tm1Wcs>	28981838	null
jumonji, AT rich interactive domain 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364982	Jarid2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
jumonji domain containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842320	Jmjd1c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
jumonji domain containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842320	Jmjd1c<tm1a(EUCOMM)Wtsi>	26878175	EUCOMM
jumonji domain containing 1C; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5904450	Jmjd1c<tm1c(EUCOMM)Wtsi>	26494788	EUCOMM
jumonji domain containing 1C; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5904450	Jmjd1c<tm1c(EUCOMM)Wtsi>	26878175	EUCOMM
jumonji domain containing 1C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842697	Jmjd1c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
jumonji domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432271	Jmjd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
jumonji domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433048	Jmjd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
jumonji domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432550	Jmjd6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
jumonji domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432550	Jmjd6<tm1a(EUCOMM)Wtsi>	28546003	EUCOMM
jumonji domain containing 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548491	Jmjd6<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
jumonji domain containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433661	Jmjd6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
jumonji domain containing 8; targeted mutation 1.1, Velocigene	MGI:5603571	Jmjd8<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
jumonji domain containing 8; targeted mutation 1, Velocigene	MGI:4452995	Jmjd8<tm1(KOMP)Vlcg>	27199445	KOMP-Regeneron
jun B proto-oncogene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5472638	Junb<tm1a(EUCOMM)Hmgu>	28555647	EUCOMM
jun B proto-oncogene; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5925356	Junb<tm1c(EUCOMM)Hmgu>	28555647	EUCOMM
junction adhesion molecule 2; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5516071	Jam2<tm1.1(KOMP)Mbp>	27499083	KOMP-CSD
junction adhesion molecule 2; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5516071	Jam2<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
junction adhesion molecule 2; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5516071	Jam2<tm1.1(KOMP)Mbp>	28700664	KOMP-CSD
junction adhesion molecule 3; targeted mutation 1.1, Velocigene	MGI:5471366	Jam3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
junctional cadherin complex regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940753	Jhy<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
junctional cadherin complex regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940782	Jhy<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
junctional sarcoplasmic reticulum protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462621	Jsrp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
junction plakoglobin; targeted mutation 1.1, Velocigene	MGI:5490517	Jup<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
junction plakoglobin; targeted mutation 1.1, Velocigene	MGI:5490517	Jup<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
junctophilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5284931	Jph1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
junctophilin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441694	Jph2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
junctophilin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441683	Jph2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
junctophilin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362755	Jph3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
junctophilin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364354	Jph3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
junctophilin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363590	Jph4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
junctophilin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362517	Jph4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Jupiter microtubule associated homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364139	Jpt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Jupiter microtubule associated homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364034	Jpt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein 1-related pepidase b4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419283	Klk1b4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein 1-related peptidase b16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305614	Klk1b16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein B, plasma 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456034	Klkb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein B, plasma 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455990	Klkb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein related-peptidase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820368	Klk12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein related-peptidase 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820330	Klk12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein related-peptidase 14; targeted mutation 1.1, Velocigene	MGI:5571350	Klk14<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
kallikrein related-peptidase 14; targeted mutation 1.1, Velocigene	MGI:5571350	Klk14<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
kallikrein related-peptidase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362263	Klk14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365037	Klk14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820353	Klk15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein related-peptidase 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820250	Klk15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein related-peptidase 4 (prostase, enamel matrix, prostate); targeted mutation 1.1, Velocigene	MGI:5567109	Klk4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
kallikrein related-peptidase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363208	Klk5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363264	Klk5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364033	Klk5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364903	Klk5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842851	Klk6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein related-peptidase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050994	Klk8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kallikrein related-peptidase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419836	Klk9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419932	Klk9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297890	Klk9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
kallikrein related-peptidase 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297884	Klk9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
kaptin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433701	Kptn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kaptin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433701	Kptn<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
kaptin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432535	Kptn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
karyopherin (importin) alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452660	Kpna1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
karyopherin (importin) alpha 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363115	Kpna3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
karyopherin (importin) alpha 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362539	Kpna3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
karyopherin (importin) alpha 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441878	Kpna4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
karyopherin (importin) alpha 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441933	Kpna4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
karyopherin (importin) alpha 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363655	Kpna6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
karyopherin (importin) alpha 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364184	Kpna6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
karyopherin (importin) beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364975	Kpnb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
karyopherin (importin) beta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362137	Kpnb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
karyopherin (importin) beta 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472778	Kpnb1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
KAT8 regulatory NSL complex subunit 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432674	Kansl1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
KAT8 regulatory NSL complex subunit 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433069	Kansl1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
KAT8 regulatory NSL complex subunit 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5699600	Kansl1<tm1b(EUCOMM)Hmgu>	28704368	EUCOMM
KAT8 regulatory NSL complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433268	Kansl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
KAT8 regulatory NSL complex subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434382	Kansl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
katanin p60 (ATPase-containing) subunit A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458514	Katna1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
katanin p60 (ATPase-containing) subunit A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458618	Katna1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
katanin p60 subunit A-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841132	Katnal1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
katanin p60 subunit A-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841205	Katnal1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
katanin p60 subunit A-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842422	Katnal2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
katanin p80 (WD40-containing) subunit B 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436305	Katnb1<tm1a(EUCOMM)Hmgu>	25521379	EUCOMM
katanin p80 (WD40-containing) subunit B 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436305	Katnb1<tm1a(EUCOMM)Hmgu>	28791777	EUCOMM
katanin p80 (WD40-containing) subunit B 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637074	Katnb1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Kazal-type serine peptidase inhibitor domain 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050939	Kazald1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
Kazal-type serine peptidase inhibitor domain 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050945	Kazald1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
kazrin, periplakin interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432650	Kazn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kazrin, periplakin interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432650	Kazn<tm1a(EUCOMM)Wtsi>	22513779	EUCOMM
kazrin, periplakin interacting protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5703033	Kazn<tm1c(EUCOMM)Wtsi>	22513779	EUCOMM
kazrin, periplakin interacting protein; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5703057	Kazn<tm1d(EUCOMM)Wtsi>	22513779	EUCOMM
kazrin, periplakin interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432183	Kazn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432255	Kdelr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432569	Kdelr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
KDM1 lysine (K)-specific demethylase 6B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365040	Kdm6b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
KDM1 lysine (K)-specific demethylase 6B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365040	Kdm6b<tm1(KOMP)Wtsi>	23584530	KOMP-CSD
kelch domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363808	Klhdc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5297895	Klhdc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch domain containing 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548587	Klhdc2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
kelch domain containing 8A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052401	Klhdc8a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch domain containing 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419861	Klhdc9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364106	Klhl10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5512015	Klhl12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940795	Klhl14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941488	Klhl14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 15; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419559	Klhl15<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362936	Klhl18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362344	Klhl18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014725	Klhl20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363013	Klhl21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362888	Klhl21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433377	Klhl22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085346	Klhl24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842308	Klhl26<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 26; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842421	Klhl26<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 29; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548861	Klhl29<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
kelch-like 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431509	Klhl30<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431482	Klhl30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820138	Klhl31<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820050	Klhl31<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301399	Klhl32<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362500	Klhl35<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 35; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364660	Klhl35<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442040	Klhl36<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 36; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842742	Klhl36<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364798	Klhl38<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 38; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363157	Klhl38<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4946685	Klhl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637154	Klhl3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
kelch-like 40; targeted mutation 1, Velocigene	MGI:4843038	Klhl40<tm1(KOMP)Vlcg>	24960163	KOMP-Regeneron
kelch-like 40; targeted mutation 1, Velocigene	MGI:4843038	Klhl40<tm1(KOMP)Vlcg>	28826497	KOMP-Regeneron
kelch-like 41; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364947	Klhl41<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 41; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364947	Klhl41<tm1a(KOMP)Wtsi>	28826497	KOMP-CSD
kelch-like 41; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5297881	Klhl41<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944420	Klhl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426610	Klhl4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426638	Klhl6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426591	Klhl6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kelch-like 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431651	Klhl8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548775	Klhl8<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
kelch-like ECH-associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432069	Keap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch-like ECH-associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431571	Keap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kelch repeat and BTB (POZ) domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052498	Kbtbd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kelch repeat and BTB (POZ) domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052507	Kbtbd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kelch repeat and BTB (POZ) domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426543	Kbtbd8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 10; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427167	Krt10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434244	Krt13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433552	Krt13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 15; targeted mutation 1, Velocigene	MGI:3847455	Krt15<tm1(KOMP)Vlcg>	28481227	KOMP-Regeneron
keratin 16; targeted mutation 1, Velocigene	MGI:3808273	Krt16<tm1(KOMP)Vlcg>	22336941	KOMP-Regeneron
keratin 16; targeted mutation 1, Velocigene	MGI:3808273	Krt16<tm1(KOMP)Vlcg>	24218583	KOMP-Regeneron
keratin 16; targeted mutation 1, Velocigene	MGI:3808273	Krt16<tm1(KOMP)Vlcg>	27183391	KOMP-Regeneron
keratin 17; targeted mutation 1.1, Velocigene	MGI:5501220	Krt17<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
keratin 17; targeted mutation 1.1, Velocigene	MGI:5501220	Krt17<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
keratin 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431730	Krt17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939727	Krt25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427176	Krt28<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427112	Krt28<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363845	Krt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363845	Krt2<tm1a(KOMP)Wtsi>	24751727	KOMP-CSD
keratin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363845	Krt2<tm1a(KOMP)Wtsi>	26603179	KOMP-CSD
keratin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569081	Krt2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
keratin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364957	Krt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299636	Krt2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881948	Krt31<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881940	Krt31<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365222	Krt34<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 34; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452622	Krt34<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 34; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452721	Krt34<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841103	Krt36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841372	Krt36<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364513	Krt39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 39; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427221	Krt39<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 39; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5427175	Krt39<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 39; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5427111	Krt39<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841307	Krt40<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841371	Krt40<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434511	Krt42<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 42; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434444	Krt42<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 42; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472901	Krt42<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 5; targeted mutation 1.1, Velocigene	MGI:5695976	Krt5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
keratin 71; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364762	Krt71<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 71; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363639	Krt71<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 73; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944486	Krt73<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 74; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461649	Krt74<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 74; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637188	Krt74<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
keratin 74; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461752	Krt74<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
keratin 76; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363117	Krt76<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 76; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363117	Krt76<tm1a(KOMP)Wtsi>	23936238	KOMP-CSD
keratin 76; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363117	Krt76<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
keratin 76; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363117	Krt76<tm1a(KOMP)Wtsi>	25340345	KOMP-CSD
keratin 79; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365238	Krt79<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 79; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419655	Krt79<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 79; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297893	Krt79<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 79; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297893	Krt79<tm2a(KOMP)Wtsi>	28445731	KOMP-CSD
keratin 79; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5708243	Krt79<tm2b(KOMP)Wtsi>	28445731	KOMP-CSD
keratin 79; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297888	Krt79<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840979	Krt7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548947	Krt7<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
keratin 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841211	Krt7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 80; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303099	Krt80<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 80; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427166	Krt80<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 81; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299637	Krt81<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 82; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841093	Krt82<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 82; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840978	Krt82<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 83; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887631	Krt83<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 83; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887625	Krt83<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 84; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942023	Krt84<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 84; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942025	Krt84<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 88; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085345	Krt88<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 88; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293945	Krt88<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratin 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5612829	Krt8<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
keratin 9; targeted mutation 1.1, Velocigene	MGI:5572043	Krt9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
keratin 9; targeted mutation 1.1, Velocigene	MGI:5572043	Krt9<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
keratin 9; targeted mutation 1, Velocigene	MGI:4460538	Krt9<tm1(KOMP)Vlcg>	23962810	KOMP-Regeneron
keratin associated protein 16-1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472705	Krtap16-1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
keratinocyte differentiation associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457573	Krtdap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
keratinocyte differentiation associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457567	Krtdap<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
keratinocyte differentiation factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432990	Kdf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
keratinocyte differentiation factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432990	Kdf1<tm1a(EUCOMM)Wtsi>	24075906	EUCOMM
keratinocyte differentiation factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432838	Kdf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
keratinocyte expressed, proline-rich; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419539	Kprp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
keratinocyte expressed, proline-rich; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419440	Kprp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
keratocan; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941565	Kera<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
keratocan; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941563	Kera<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ketohexokinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364997	Khk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ketohexokinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362383	Khk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
KH and NYN domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297878	Khnyn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
KH and NYN domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5297873	Khnyn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
KH and NYN domain containing; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297889	Khnyn<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
KH and NYN domain containing; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297882	Khnyn<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
KH and NYN domain containing; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5297883	Khnyn<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
KH and NYN domain containing; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5472970	Khnyn<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
KH and NYN domain containing; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:5472816	Khnyn<tm4e(EUCOMM)Wtsi>	21677750	EUCOMM
KH domain containing, RNA binding, signal transduction associated 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420114	Khdrbs2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
KH domain containing, RNA binding, signal transduction associated 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841011	Khdrbs2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
KH domain containing, RNA binding, signal transduction associated 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840998	Khdrbs2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
KH domain containing, RNA binding, signal transduction associated 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636948	Khdrbs3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
KH-type splicing regulatory protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013750	Khsrp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
KIF1 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939684	Kif1bp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
KIF1 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939684	Kif1bp<tm1a(KOMP)Wtsi>	27996060	KOMP-CSD
KIF1 binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944380	Kif1bp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor family E member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420020	Klre1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor family E member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297870	Klre1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor family E member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297865	Klre1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor family I member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452701	Klri1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor family I member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452717	Klri1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor family I member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293970	Klri2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor family I member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426605	Klri2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor, subfamily A, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841474	Klra5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor, subfamily A, member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297891	Klra5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor, subfamily A, member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297886	Klra5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor, subfamily A, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451718	Klra7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor, subfamily A, member 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319822	Klra7<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily B member 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364549	Klrb1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily B member 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362637	Klrb1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily B member 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462618	Klrb1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily B member 1F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419857	Klrb1f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily B member 1F; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4843852	Klrb1f<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily B member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453704	Klrb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
killer cell lectin-like receptor subfamily B member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453701	Klrb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
killer cell lectin-like receptor subfamily C, member 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420082	Klrc3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor, subfamily D, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303173	Klrd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
killer cell lectin-like receptor subfamily G, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365150	Klrg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily G, member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841254	Klrg1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
killer cell lectin-like receptor subfamily G, member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297866	Klrg1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Kin17 DNA and RNA binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5308298	Kin<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinase D-interacting substrate 220; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419606	Kidins220<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinase D-interacting substrate 220; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841030	Kidins220<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
kinase D-interacting substrate 220; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841219	Kidins220<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
kinase non-catalytic C-lobe domain (KIND) containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455986	Kndc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinase non-catalytic C-lobe domain (KIND) containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456005	Kndc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinase suppressor of ras 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431675	Ksr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinase suppressor of ras 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433148	Ksr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinase suppressor of ras 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938516	Ksr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinase suppressor of ras 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938522	Ksr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin-associated protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362297	Kifap3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin-associated protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363771	Kifap3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013732	Kif11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842729	Kif12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842777	Kif12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 13A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363470	Kif13a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 13A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365276	Kif13a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 13B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842489	Kif13b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 13B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842839	Kif13b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 16B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427155	Kif16b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455989	Kif17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455989	Kif17<tm1a(EUCOMM)Wtsi>	28341548	EUCOMM
kinesin family member 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456068	Kif17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 18B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944522	Kif18b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 18B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944578	Kif18b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 19A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419209	Kif19a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 19A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419481	Kif19a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841217	Kif1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 1B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5505909	Kif1b<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 1B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5505909	Kif1b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
kinesin family member 1B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5505909	Kif1b<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
kinesin family member 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841193	Kif1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364473	Kif1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 1C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363376	Kif1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 20A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636934	Kif20a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
kinesin family member 20B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364072	Kif20b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 20B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365045	Kif20b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 21B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364527	Kif21b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 21B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364527	Kif21b<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
kinesin family member 21B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363854	Kif21b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 21B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431403	Kif21b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 21B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431403	Kif21b<tm2a(KOMP)Wtsi>	27117409	KOMP-CSD
kinesin family member 21B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431429	Kif21b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841207	Kif24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 24; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637052	Kif24<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
kinesin family member 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841400	Kif24<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 26B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455604	Kif26b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 26B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456656	Kif26b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 26B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841368	Kif26b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 26B; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5471275	Kif26b<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 26B; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5471275	Kif26b<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
kinesin family member 26B; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5471275	Kif26b<tm2b(KOMP)Wtsi>	28700664	KOMP-CSD
kinesin family member 26B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841468	Kif26b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473126	Kif2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 2C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441766	Kif2c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 2C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441667	Kif2c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441640	Kif3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441815	Kif3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 3A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456834	Kif3a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 3A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456814	Kif3a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820245	Kif3b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 3B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548376	Kif3b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
kinesin family member 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820389	Kif3b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 5A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842431	Kif5a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 5A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635227	Kif5a<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 5A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842846	Kif5a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin family member 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365039	Kif5b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 5B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4460293	Kif5b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 5B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4460291	Kif5b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 5C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364588	Kif5c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940760	Kif6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin light chain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426647	Klc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin light chain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426609	Klc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin light chain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431823	Klc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin light chain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434042	Klc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin light chain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419895	Klc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinesin light chain 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842274	Klc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kinesin light chain 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842346	Klc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kinetochore-localized astrin/SPAG5 binding; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362164	Knstrn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kinetochore-localized astrin/SPAG5 binding; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548420	Knstrn<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
kinetochore-localized astrin/SPAG5 binding; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5544487	Knstrn<tm1d(KOMP)Wtsi>	26667018	KOMP-CSD
kinetochore-localized astrin/SPAG5 binding; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363530	Knstrn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kininogen 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840572	Kng2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
kininogen 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840572	Kng2<tm2a(EUCOMM)Wtsi>	23912999	EUCOMM
kininogen 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840688	Kng2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
kirre like nephrin family adhesion molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432019	Kirrel<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kirre like nephrin family adhesion molecule 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432671	Kirrel<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kirre like nephrin family adhesion molecule 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364980	Kirrel2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kirre like nephrin family adhesion molecule 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362833	Kirrel2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kirre like nephrin family adhesion molecule 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419560	Kirrel2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
kirre like nephrin family adhesion molecule 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419406	Kirrel2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
kirre like nephrin family adhesion molecule 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433710	Kirrel3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kirre like nephrin family adhesion molecule 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432377	Kirrel3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
KISS1 receptor; targeted mutation 1.1, Velocigene	MGI:5696918	Kiss1r<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
kit ligand; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140474	Kitl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kit ligand; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140457	Kitl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
klotho beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951104	Klb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
K(lysine) acetyltransferase 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362849	Kat2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
K(lysine) acetyltransferase 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419896	Kat5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
K(lysine) acetyltransferase 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431597	Kat6a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
K(lysine) acetyltransferase 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431597	Kat6a<tm1a(EUCOMM)Wtsi>	24646517	EUCOMM
K(lysine) acetyltransferase 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431597	Kat6a<tm1a(EUCOMM)Wtsi>	25757017	EUCOMM
K(lysine) acetyltransferase 6A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5705134	Kat6a<tm1b(EUCOMM)Wtsi>	24646517	EUCOMM
K(lysine) acetyltransferase 6A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5763051	Kat6a<tm1c(EUCOMM)Wtsi>	25757017	EUCOMM
K(lysine) acetyltransferase 6A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433006	Kat6a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
KN motif and ankyrin repeat domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944553	Kank1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
KRAB-A domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420113	Krba1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
kringle containing transmembrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432832	Kremen1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
kringle containing transmembrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434234	Kremen1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
kringle containing transmembrane protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363477	Kremen2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
KRIT1, ankyrin repeat containing; targeted mutation 1.1, Velocigene	MGI:5583067	Krit1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Kruppel-like factor 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840967	Klf11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841230	Klf11<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006770	Klf12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Kruppel-like factor 14; targeted mutation 1.1, Velocigene	MGI:5695130	Klf14<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Kruppel-like factor 14; targeted mutation 1.1, Velocigene	MGI:5695130	Klf14<tm1.1(KOMP)Vlcg>	28962896	KOMP-Regeneron
Kruppel-like factor 14; targeted mutation 1, Velocigene	MGI:3812953	Klf14<tm1(KOMP)Vlcg>	24759103	KOMP-Regeneron
Kruppel-like factor 14; targeted mutation 1, Velocigene	MGI:3812953	Klf14<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
Kruppel-like factor 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842856	Klf15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Kruppel-like factor 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362369	Klf17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 17; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548777	Klf17<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Kruppel-like factor 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362612	Klf17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 2 (lung); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419685	Klf2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 4 (gut); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363121	Klf4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948617	Klf5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942013	Klf5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Kruppel-like factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452794	Klf6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Kruppel-like factor 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452826	Klf6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Kruppel-like factor 7 (ubiquitous); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548730	Klf7<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Kruppel-like factor 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305673	Klf8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Kruppel-like factor 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305661	Klf8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Kv channel interacting protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419266	Kcnip4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Kv channel interacting protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419970	Kcnip4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	26130057	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	26752518	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	27020856	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	27693848	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	27754481	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	27889626	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548736	Kmo<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5796292	Kmo<tm1c(KOMP)Wtsi>	26752518	KOMP-CSD
kynurenine aminotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286223	Kyat1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kynurenine aminotransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362175	Kyat3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
kynurenine aminotransferase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364163	Kyat3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
kynurenine aminotransferase 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297897	Kyat3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
L-3-hydroxyproline dehydratase (trans-); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362829	L3hypdh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
L-3-hydroxyproline dehydratase (trans-); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363914	L3hypdh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
L3MBTL1 histone methyl-lysine binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306502	L3mbtl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
L3MBTL1 histone methyl-lysine binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301402	L3mbtl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
L3MBTL1 histone methyl-lysine binding protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5301405	L3mbtl1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
L3MBTL2 polycomb repressive complex 1 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363641	L3mbtl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
L3MBTL2 polycomb repressive complex 1 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363134	L3mbtl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
L3MBTL2 polycomb repressive complex 1 subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472695	L3mbtl2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
L3MBTL2 polycomb repressive complex 1 subunit; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472792	L3mbtl2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
laccase (multicopper oxidoreductase) domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451304	Lacc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
laccase (multicopper oxidoreductase) domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451304	Lacc1<tm1a(KOMP)Wtsi>	27478939	KOMP-CSD
laccase (multicopper oxidoreductase) domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451681	Lacc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lactase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841441	Lct<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lactase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299540	Lct<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lactate dehydrogenase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432392	Ldha<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lactate dehydrogenase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432392	Ldha<tm1a(EUCOMM)Wtsi>	24726384	EUCOMM
lactate dehydrogenase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432392	Ldha<tm1a(EUCOMM)Wtsi>	25215489	EUCOMM
lactate dehydrogenase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432392	Ldha<tm1a(EUCOMM)Wtsi>	25990470	EUCOMM
lactate dehydrogenase A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619796	Ldha<tm1c(EUCOMM)Wtsi>	24726384	EUCOMM
lactate dehydrogenase A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5619796	Ldha<tm1c(EUCOMM)Wtsi>	28446465	EUCOMM
lactate dehydrogenase A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434126	Ldha<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lactate dehydrogenase B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299501	Ldhb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lactate dehydrogenase B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637210	Ldhb<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
lactate dehydrogenase B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637210	Ldhb<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
lactate dehydrogenase B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362947	Ldhb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lactate dehydrogenase D; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882015	Ldhd<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
lactoperoxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432905	Lpo<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lactoperoxidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548663	Lpo<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lactotransferrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841299	Ltf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lactotransferrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841126	Ltf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lactotransferrin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503356	Ltf<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ladybird homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5297864	Lbx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ladybird homeobox 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297879	Lbx1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ladybird homeobox 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297874	Lbx1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
laeverin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887593	Lvrn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
laeverin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887623	Lvrn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lamin A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433534	Lmna<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lamin A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548950	Lmna<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lamin A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431977	Lmna<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lamin B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432859	Lmnb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lamin B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431892	Lmnb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lamin B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362469	Lmnb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lamin B2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364792	Lmnb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lamin B receptor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299558	Lbr<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
laminin, alpha 4; targeted mutation 1.1, Velocigene	MGI:5695884	Lama4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
laminin, alpha 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302344	Lama4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
laminin, alpha 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363608	Lama5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
laminin, alpha 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692561	Lama5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
laminin, alpha 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364413	Lama5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
laminin B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364415	Lamb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
laminin B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364558	Lamb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
laminin, beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364410	Lamb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
laminin, beta 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548979	Lamb3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
laminin, beta 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451320	Lamb3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
laminin, beta 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451437	Lamb3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
laminin, gamma 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820165	Lamc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
laminin, gamma 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820098	Lamc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
laminin gamma 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364864	Lamc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
laminin gamma 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362905	Lamc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LanC (bacterial lantibiotic synthetase component C)-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052504	Lancl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LanC (bacterial lantibiotic synthetase component C)-like 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431468	Lancl2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
LanC (bacterial lantibiotic synthetase component C)-like 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431468	Lancl2<tm2a(KOMP)Wtsi>	26839965	KOMP-CSD
LanC (bacterial lantibiotic synthetase component C)-like 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5569052	Lancl2<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
LanC lantibiotic synthetase component C-like 3 (bacterial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364209	Lancl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LanC lantibiotic synthetase component C-like 3 (bacterial); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365270	Lancl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lanosterol synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362667	Lss<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lanosterol synthase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5561557	Lss<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
lanosterol synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363895	Lss<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
large tumor suppressor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363129	Lats2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
large tumor suppressor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362507	Lats2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LARGE xylosyl- and glucuronyltransferase 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419876	Large2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
LARGE xylosyl- and glucuronyltransferase 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419876	Large2<tm1(KOMP)Wtsi>	25138275	KOMP-CSD
La ribonucleoprotein domain family, member 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842466	Larp4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
La ribonucleoprotein domain family, member 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842541	Larp4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
La ribonucleoprotein domain family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427174	Larp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
La ribonucleoprotein domain family, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427110	Larp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
La ribonucleoprotein domain family, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841226	Larp6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
La ribonucleoprotein domain family, member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841369	Larp6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LAS1-like (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427223	Las1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951120	Lce1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 1B; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511914	Lce1b<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287776	Lce1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 1C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427115	Lce1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 1F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841178	Lce1f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 1F; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637025	Lce1f<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
late cornified envelope 1F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841013	Lce1f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 1H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951095	Lce1h<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 1H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951122	Lce1h<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 1L; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455564	Lce1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 1M; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052501	Lce1m<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 1M; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637007	Lce1m<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
late cornified envelope 1M; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140458	Lce1m<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944353	Lce3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427114	Lce3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363907	Lce3c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 3C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364143	Lce3c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope 3C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472691	Lce3c<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 3C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472783	Lce3c<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope 3F; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362682	Lce3f<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
late cornified envelope-like proline-rich 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820350	Lelp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
late cornified envelope-like proline-rich 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820372	Lelp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944329	Lamtor1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950965	Lamtor1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419581	Lamtor2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5444898	Lamtor4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5614702	Lamtor5<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
latent transforming growth factor beta binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433604	Ltbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
latent transforming growth factor beta binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433604	Ltbp1<tm1a(EUCOMM)Wtsi>	25805620	EUCOMM
latent transforming growth factor beta binding protein 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5763562	Ltbp1<tm1c(EUCOMM)Wtsi>	25805620	EUCOMM
latent transforming growth factor beta binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364104	Ltbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
latent transforming growth factor beta binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364533	Ltbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
latent transforming growth factor beta binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299571	Ltbp2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
latent transforming growth factor beta binding protein 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5635878	Ltbp2<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
Leber congenital amaurosis 5 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433696	Lca5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Leber congenital amaurosis 5 (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433089	Lca5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511993	Lrat<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511962	Lrat<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
lectin, galactose binding, soluble 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319840	Lgals12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, galactose binding, soluble 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319879	Lgals12<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, galactose binding, soluble 12; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319849	Lgals12<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, galactose binding, soluble 12; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319850	Lgals12<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, galactose binding, soluble 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432481	Lgals3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lectin, galactose binding, soluble 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548948	Lgals3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lectin, galactose binding, soluble 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432227	Lgals3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lectin, galactose binding, soluble 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432104	Lgals7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lectin, galactose binding, soluble 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432104	Lgals7<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
lectin, galactose binding, soluble 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548425	Lgals7<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lectin, galactose binding, soluble 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432344	Lgals7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lectin, galactose binding, soluble 8; targeted mutation 1, Velocigene	MGI:4842980	Lgals8<tm1(KOMP)Vlcg>	27066737	KOMP-Regeneron
lectin, galactose binding, soluble 8; targeted mutation 1, Velocigene	MGI:4842980	Lgals8<tm1(KOMP)Vlcg>	28650992	KOMP-Regeneron
lectin, galactoside-binding, soluble, 3 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364753	Lgals3bp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, galactoside-binding, soluble, 3 binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427219	Lgals3bp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, galactoside-binding, soluble, 3 binding protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299623	Lgals3bp<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, mannose-binding 1 like; targeted mutation 1.1, Velocigene	MGI:5585715	Lman1l<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
lectin, mannose-binding 1 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947815	Lman1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lectin, mannose-binding, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014586	Lman1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lectin, mannose-binding, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014586	Lman1<tm1a(KOMP)Wtsi>	24719406	KOMP-CSD
lectin, mannose-binding, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5501339	Lman1<tm1c(KOMP)Wtsi>	24719406	KOMP-CSD
lectin, mannose-binding, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140421	Lman1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
left right determination factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362323	Lefty1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
left right determination factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362677	Lefty1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
legumain; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766170	Lgmn<tm1b(NCOM)Mfgc>	27626380	NorCOMM
leiomodin 2 (cardiac); targeted mutation 1, Velocigene	MGI:3812792	Lmod2<tm1(KOMP)Vlcg>	26487682	KOMP-Regeneron
leiomodin 2 (cardiac); targeted mutation 1, Velocigene	MGI:3812792	Lmod2<tm1(KOMP)Vlcg>	29078393	KOMP-Regeneron
leishmanolysin-like (metallopeptidase M8 family); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014724	Lmln<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LEM domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458622	Lemd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LEM domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434175	Lemd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lemur tyrosine kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297869	Lmtk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lemur tyrosine kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5297863	Lmtk3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Leo1, Paf1/RNA polymerase II complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950249	Leo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leptin; obese	MGI:1856424	Lep<ob>	26696638	null
leptin receptor; diabetes	MGI:1856009	Lepr<db>	26696638	null
leptin receptor overlapping transcript-like 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637030	Leprotl1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
leptin receptor overlapping transcript; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363442	Leprot<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leptin receptor overlapping transcript; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363875	Leprot<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leptin receptor overlapping transcript; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364337	Leprot<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
leptin receptor overlapping transcript; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364337	Leprot<tm2a(KOMP)Wtsi>	27626380	KOMP-CSD
leptin receptor overlapping transcript; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548880	Leprot<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
leptin receptor overlapping transcript; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363874	Leprot<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
leptin receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453725	Lepr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leptin receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453760	Lepr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine, glutamate and lysine rich 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841316	Lekr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine, glutamate and lysine rich 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841197	Lekr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich adaptor protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841194	Lurap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich alpha-2-glycoprotein 1; targeted mutation 1, Velocigene	MGI:3797829	Lrg1<tm1(KOMP)Vlcg>	23868260	KOMP-Regeneron
leucine rich melanocyte differentiation associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951131	Lrmda<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich melanocyte differentiation associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006791	Lrmda<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich PPR-motif containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363281	Lrpprc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich PPR-motif containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363281	Lrpprc<tm1a(KOMP)Wtsi>	28575497	KOMP-CSD
leucine rich repeat and coiled-coil domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473044	Lrrcc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat and coiled-coil domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472861	Lrrcc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat and fibronectin type III domain containing 2; targeted mutation 1.1, Velocigene	MGI:5695920	Lrfn2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
leucine rich repeat and fibronectin type III domain containing 3; targeted mutation 1.1, Velocigene	MGI:5582440	Lrfn3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
leucine rich repeat and fibronectin type III domain containing 3; targeted mutation 1, Velocigene	MGI:4887760	Lrfn3<tm1(KOMP)Vlcg>	27480238	KOMP-Regeneron
leucine rich repeat and fibronectin type III domain containing 4; targeted mutation 1, Velocigene	MGI:3799757	Lrfn4<tm1(KOMP)Vlcg>	26321637	KOMP-Regeneron
leucine rich repeat and fibronectin type III domain containing 4; targeted mutation 1, Velocigene	MGI:3799757	Lrfn4<tm1(KOMP)Vlcg>	26324892	KOMP-Regeneron
leucine rich repeat and fibronectin type III domain containing 4; targeted mutation 1, Velocigene	MGI:3799757	Lrfn4<tm1(KOMP)Vlcg>	27480238	KOMP-Regeneron
leucine rich repeat and fibronectin type III, extracellular 1; targeted mutation 1.1, Velocigene	MGI:5692822	Elfn1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
leucine rich repeat and fibronectin type III, extracellular 1; targeted mutation 1, Velocigene	MGI:3812600	Elfn1<tm1(KOMP)Vlcg>	24312227	KOMP-Regeneron
leucine rich repeat and fibronectin type III, extracellular 1; targeted mutation 1, Velocigene	MGI:3812600	Elfn1<tm1(KOMP)Vlcg>	26402607	KOMP-Regeneron
leucine rich repeat and fibronectin type III, extracellular 1; targeted mutation 1, Velocigene	MGI:3812600	Elfn1<tm1(KOMP)Vlcg>	28262416	KOMP-Regeneron
leucine rich repeat and fibronectin type III, extracellular 2; targeted mutation 1.1, Velocigene	MGI:5548902	Elfn2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
leucine rich repeat and Ig domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052485	Lingo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat and Ig domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052514	Lingo1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat and Ig domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419908	Lingo3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat and Ig domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419693	Lingo3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat and Ig domain containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451374	Lingo3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat and Ig domain containing 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451547	Lingo3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat and sterile alpha motif containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431919	Lrsam1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat and sterile alpha motif containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433382	Lrsam1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461731	Lrrc14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461683	Lrrc14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940790	Lrrc15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5493277	Lrrc15<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5493277	Lrrc15<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
leucine rich repeat containing 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5493277	Lrrc15<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
leucine rich repeat containing 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940762	Lrrc15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944367	Lrrc18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841245	Lrrc18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944543	Lrrc23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944529	Lrrc23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 26; targeted mutation 1.1, Velocigene	MGI:6107883	Lrrc26<tm1.1(KOMP)Vlcg>	28416688	KOMP-Regeneron
leucine rich repeat containing 26; targeted mutation 1, Velocigene	MGI:3799842	Lrrc26<tm1(KOMP)Vlcg>	28416688	KOMP-Regeneron
leucine rich repeat containing 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434465	Lrrc29<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431960	Lrrc29<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014684	Lrrc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513798	Lrrc2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
leucine rich repeat containing 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441622	Lrrc34<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 34; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441819	Lrrc34<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364532	Lrrc36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362191	Lrrc39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 39; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363302	Lrrc39<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427194	Lrrc3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427149	Lrrc3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842546	Lrrc40<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842821	Lrrc40<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433901	Lrrc42<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 42; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432487	Lrrc42<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362416	Lrrc43<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 43; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363880	Lrrc43<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944414	Lrrc47<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 49; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842550	Lrrc49<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 49; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5646003	Lrrc49<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 49; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002929	Lrrc49<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427178	Lrrc4c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 52; targeted mutation 1.1, Velocigene	MGI:5792928	Lrrc52<tm1.1(KOMP)Vlcg>	25675513	KOMP-Regeneron
leucine rich repeat containing 52; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473171	Lrrc52<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 52; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472746	Lrrc52<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 52; targeted mutation 1, Velocigene	MGI:4881116	Lrrc52<tm1(KOMP)Vlcg>	25675513	KOMP-Regeneron
leucine rich repeat containing 56; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362374	Lrrc56<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 56; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364880	Lrrc56<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 58; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431630	Lrrc58<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 58; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432118	Lrrc58<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 59; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433744	Lrrc59<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 59; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433248	Lrrc59<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 61; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363326	Lrrc61<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 61; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364246	Lrrc61<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 63; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363270	Lrrc63<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 66; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451671	Lrrc66<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 66; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299511	Lrrc66<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 69; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456837	Lrrc69<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 6 (testis); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820029	Lrrc6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 71; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458520	Lrrc71<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 71; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458520	Lrrc71<tm1a(KOMP)Wtsi>	26178246	KOMP-CSD
leucine rich repeat containing 71; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458566	Lrrc71<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 72; targeted mutation 1, Velocigene	MGI:4415495	Lrrc72<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
leucine rich repeat containing 8D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849425	Lrrc8d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 8D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849405	Lrrc8d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 8 family, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947732	Lrrc8b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441944	Lrrc9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441633	Lrrc9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat containing G protein coupled receptor 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419865	Lgr5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat (in FLII) interacting protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419839	Lrrfip1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeat kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365212	Lrrk1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeat kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365212	Lrrk1<tm1a(KOMP)Wtsi>	29056298	KOMP-CSD
leucine-rich repeat kinase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692778	Lrrk1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
leucine-rich repeat kinase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692778	Lrrk1<tm1b(KOMP)Wtsi>	29056298	KOMP-CSD
leucine-rich repeat kinase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451620	Lrrk1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeat kinase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451703	Lrrk1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeat kinase 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363891	Lrrk2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeat LGI family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949343	Lgi2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeat LGI family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949383	Lgi2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeat LGI family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947805	Lgi3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeat LGI family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461673	Lgi3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat protein 1, neuronal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427203	Lrrn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat protein 1, neuronal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427164	Lrrn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeat protein 2, neuronal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849424	Lrrn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat protein 2, neuronal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849408	Lrrn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeats and calponin homology (CH) domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454116	Lrch3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeats and calponin homology (CH) domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454094	Lrch3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine rich repeats and death domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451667	Lrrd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeats and guanylate kinase domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432915	Lrguk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeats and guanylate kinase domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434195	Lrguk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeats and immunoglobulin-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431776	Lrig1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeats and immunoglobulin-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431776	Lrig1<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
leucine-rich repeats and immunoglobulin-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431776	Lrig1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
leucine-rich repeats and immunoglobulin-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431776	Lrig1<tm1a(EUCOMM)Wtsi>	25340873	EUCOMM
leucine-rich repeats and IQ motif containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939686	Lrriq1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeats and IQ motif containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841185	Lrriq3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeats and IQ motif containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841328	Lrriq3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich repeats and transmembrane domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432156	Lrtm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeats and transmembrane domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432570	Lrtm2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeats and WD repeat domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432486	Lrwd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich repeats and WD repeat domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432742	Lrwd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine rich repeat transmembrane neuronal 3; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5569956	Lrrtm3<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
leucine-rich single-pass membrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5285746	Lsmem1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine-rich single-pass membrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458529	Lsmem2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-rich single-pass membrane protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458633	Lsmem2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper and CTNNBIP1 domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364619	Lzic<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper and CTNNBIP1 domain containing; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841042	Lzic<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper and CTNNBIP1 domain containing; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840927	Lzic<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine-zipper-like transcriptional regulator, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432946	Lztr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucine zipper protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419394	Luzp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419833	Luzp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939724	Luzp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper, putative tumor suppressor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947834	Lzts2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leucine zipper transcription factor-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363218	Lztfl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper transcription factor-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363232	Lztfl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucine zipper transcription factor-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363232	Lztfl1<tm1e(KOMP)Wtsi>	26216965	KOMP-CSD
leucyl/cystinyl aminopeptidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286232	Lnpep<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leucyl/cystinyl aminopeptidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293923	Lnpep<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leucyl-tRNA synthetase, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000403	Lars2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leucyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052388	Lars<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leukemia inhibitory factor receptor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548949	Lifr<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
leukemia inhibitory factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302308	Lif<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leukocyte-associated Ig-like receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014594	Lair1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leukocyte cell-derived chemotaxin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297868	Lect2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leukocyte cell-derived chemotaxin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451250	Lect2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
leukocyte specific transcript 1; targeted mutation 1.1, Velocigene	MGI:5569039	Lst1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
leukocyte specific transcript 1; targeted mutation 1, Velocigene	MGI:4415420	Lst1<tm1(KOMP)Vlcg>	26817701	KOMP-Regeneron
leukocyte tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842745	Ltk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
leukocyte tyrosine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842307	Ltk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
leukotriene A4 hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820073	Lta4h<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
leukotriene A4 hydrolase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692899	Lta4h<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
leukotriene B4 receptor 2; targeted mutation 1, Velocigene	MGI:3812648	Ltb4r2<tm1(KOMP)Vlcg>	27489284	KOMP-Regeneron
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050871	Lfng<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ligand dependent nuclear receptor corepressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419776	Lcor<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ligand dependent nuclear receptor corepressor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420141	Lcor<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ligand of numb-protein X 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433509	Lnx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ligand of numb-protein X 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434047	Lnx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ligase I, DNA, ATP-dependent; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455972	Lig1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ligase III, DNA, ATP-dependent; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363599	Lig3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LIM and senescent cell antigen like domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052502	Lims2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LIM and SH3 protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842556	Lasp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
limb-bud and heart; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841218	Lbh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
limbic system-associated membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441902	Lsamp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LIM domain and actin binding 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362452	Lima1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LIM domain and actin binding 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5488778	Lima1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
LIM domain and actin binding 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5488778	Lima1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
LIM domain binding 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4458711	Ldb1<tm1a(EUCOMM)Hmgu>	26321200	EUCOMM
LIM domain containing preferred translocation partner in lipoma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289817	Lpp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LIM-domain containing, protein kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052486	Limk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LIM-domain containing, protein kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052511	Limk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
LIM domain only 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433917	Lmo4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
LIM domain only 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441928	Lmo4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
LIM domain only 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4442003	Lmo4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
LIM homeobox protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432952	Lhx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LIM homeobox protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362773	Lhx6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LIM homeobox protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362977	Lhx6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LIM homeobox protein 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841116	Lhx8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LIM homeobox protein 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841423	Lhx8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LIM homeobox protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434450	Lhx9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LIM homeobox protein 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434278	Lhx9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
LIM homeobox transcription factor 1 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847881	Lmx1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LIM homeobox transcription factor 1 beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363084	Lmx1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LIM homeobox transcription factor 1 beta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419450	Lmx1b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
LIM homeobox transcription factor 1 beta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4420024	Lmx1b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
LIM motif-containing protein kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431692	Limk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lin-28 homolog A (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140441	Lin28a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lin-54 homolog (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880924	Lin54<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lin-54 homolog (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881963	Lin54<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lin-7 homolog C (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842289	Lin7c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lin-7 homolog C (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842713	Lin7c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
linker for activation of T cells; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4881071	Lat<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
lipase, endothelial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5295576	Lipg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lipase, family member M; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363989	Lipm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipase, family member M; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841275	Lipm<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
lipase, family member N; targeted mutation 1.1, Velocigene	MGI:5576043	Lipn<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
lipase, family member N; targeted mutation 1.1, Velocigene	MGI:5576043	Lipn<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
lipase, gastric; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363883	Lipf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipase, gastric; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840922	Lipf<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
lipase, gastric; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841176	Lipf<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
lipase, hepatic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842836	Lipc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lipase, hepatic; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842669	Lipc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lipase, hormone sensitive; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419272	Lipe<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lipase, hormone sensitive; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692897	Lipe<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
lipase, hormone sensitive; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419968	Lipe<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipase maturation factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842765	Lmf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lipid droplet associated hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456805	Ldah<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lipid droplet associated hydrolase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637035	Ldah<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lipid droplet associated hydrolase; targeted mutation 1, Velocigene	MGI:4399711	Ldah<tm1(KOMP)Vlcg>	27836991	KOMP-Regeneron
lipin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362949	Lpin2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lipin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513796	Lpin2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
lipin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513796	Lpin2<tm1b(KOMP)Wtsi>	28031477	KOMP-CSD
lipin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364151	Lpin2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362605	Lpin3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lipin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362605	Lpin3<tm1a(KOMP)Wtsi>	26839965	KOMP-CSD
lipin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548504	Lpin3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
lipin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362862	Lpin3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipocalin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302289	Lcn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lipocalin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302278	Lcn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipocalin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427244	Lcn5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipolysis stimulated lipoprotein receptor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420030	Lsr<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
lipoma HMGIC fusion partner-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462597	Lhfpl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lipoma HMGIC fusion partner-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462603	Lhfpl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lipoma HMGIC fusion partner-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052510	Lhfpl5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lipoma HMGIC fusion partner; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452027	Lhfp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lipoma HMGIC fusion partner; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842837	Lhfp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lipopolysaccharide binding protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636928	Lbp<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
lipoprotein lipase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362195	Lpl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lipoyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432763	Lipt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lipoyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431537	Lipt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
liver glycogen phosphorylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362669	Pygl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Lix1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432131	Lix1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Lix1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432641	Lix1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
LLGL2 scribble cell polarity complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362197	Llgl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LLGL2 scribble cell polarity complex component; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635230	Llgl2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
LLGL2 scribble cell polarity complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362825	Llgl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LLLL and CFNLAS motif containing 1; targeted mutation 1.1, Velocigene	MGI:5569060	Llcfc1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
LLP homolog, long-term synaptic facilitation (Aplysia); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052483	Llph<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LMBR1 domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513795	Lmbrd1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
lon peptidase 1, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419741	Lonp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lon peptidase 1, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419383	Lonp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lon peptidase 1, mitochondrial; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472696	Lonp1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
LON peptidase N-terminal domain and ring finger 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363930	Lonrf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LON peptidase N-terminal domain and ring finger 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363930	Lonrf3<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
LON peptidase N-terminal domain and ring finger 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548642	Lonrf3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
loricrin; targeted mutation 1.1, Velocigene	MGI:5605843	Lor<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
low density lipoprotein receptor adaptor protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432607	Ldlrap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
low density lipoprotein receptor class A domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462592	Ldlrad1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein receptor class A domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462579	Ldlrad1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein receptor class A domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820334	Ldlrad4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
low density lipoprotein receptor class A domain containing 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636938	Ldlrad4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
low density lipoprotein receptor class A domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820310	Ldlrad4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
low-density lipoprotein receptor-related protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419788	Lrp10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
low-density lipoprotein receptor-related protein 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419899	Lrp10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein receptor-related protein 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5494466	Lrp1<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein receptor-related protein 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5494466	Lrp1<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
low density lipoprotein receptor-related protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419615	Lrp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein receptor-related protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362279	Lrp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein receptor-related protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364602	Lrp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein receptor-related protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473004	Lrp3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
low density lipoprotein receptor-related protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944515	Lrp6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
low density lipoprotein receptor-related protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944545	Lrp6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
low density lipoprotein receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433768	Ldlr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
low density lipoprotein receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432549	Ldlr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
low density lipoprotein-related protein 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365180	Lrp12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
low density lipoprotein-related protein 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841134	Lrp12<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
LPS-induced TN factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842513	Litaf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Lrp2 binding protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294971	Lrp2bp<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Lrp2 binding protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296113	Lrp2bp<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
LSM12 homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887596	Lsm12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LSM12 homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887605	Lsm12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LSM14A mRNA processing body assembly factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362817	Lsm14a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LSM14A mRNA processing body assembly factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362817	Lsm14a<tm1a(KOMP)Wtsi>	27183626	KOMP-CSD
LSM14A mRNA processing body assembly factor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548532	Lsm14a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
LSM14A mRNA processing body assembly factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362474	Lsm14a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LSM1 homolog, mRNA degradation associated; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548536	Lsm1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419407	Lsm2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419428	Lsm3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451487	Lsm4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451348	Lsm4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LSM family member 14B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363222	Lsm14b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LSM family member 14B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364182	Lsm14b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
L-threonine dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362820	Tdh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
L-threonine dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363492	Tdh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
LUC7-like 3 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362286	Luc7l3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LUC7-like 3 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364701	Luc7l3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Luc7-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454107	Luc7l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Luc7-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454106	Luc7l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lunapark, ER junction formation factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434161	Lnpk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ly6/neurotoxin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940791	Lynx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ly6/Plaur domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050883	Lypd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ly6/Plaur domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427182	Lypd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ly6/Plaur domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426557	Lypd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ly6/Plaur domain containing 3; targeted mutation 1.1, Velocigene	MGI:5548620	Lypd3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Ly6/Plaur domain containing 3; targeted mutation 1, Velocigene	MGI:4399526	Lypd3<tm1(KOMP)Vlcg>	27169360	KOMP-Regeneron
Ly6/Plaur domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944345	Lypd5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LY6/PLAUR domain containing 6B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365126	Lypd6b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LY6/PLAUR domain containing 6B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548612	Lypd6b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
LY6/PLAUR domain containing 6B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5014606	Lypd6b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
LY6/PLAUR domain containing 6B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5014603	Lypd6b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
LY6/PLAUR domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948607	Lypd6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
LY6/PLAUR domain containing 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5583075	Lypd6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
lymphocyte antigen 6 complex, locus D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052402	Ly6d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 6 complex, locus G6E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420033	Ly6g6e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 6 complex, locus G6E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419734	Ly6g6e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 6 complex, locus G6F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462613	Ly6g6f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 6 complex, locus G6F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462604	Ly6g6f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 6 complex, locus H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950246	Ly6h<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lymphocyte antigen 6 complex, locus K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052389	Ly6k<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 6 complex, locus K; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052404	Ly6k<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 86; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287791	Ly86<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte antigen 96; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363963	Ly96<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte cytosolic protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052390	Lcp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte cytosolic protein 1; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5635229	Lcp1<tm1e.1(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte cytosolic protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5632140	Lcp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte cytosolic protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419318	Lcp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte cytosolic protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419445	Lcp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte expansion molecule; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362692	Lexm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lymphocyte expansion molecule; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362692	Lexm<tm1a(KOMP)Wtsi>	25883318	KOMP-CSD
lymphocyte expansion molecule; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362523	Lexm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lymphoid enhancer binding factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052496	Lef1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lymphoid-restricted membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432722	Lrmp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lymphoid-restricted membrane protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432170	Lrmp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lymphotoxin A; targeted mutation 1.1, Velocigene	MGI:5695877	Lta<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
lymphotoxin B receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009664	Ltbr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lymphotoxin B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419103	Ltb<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
LYR motif containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456026	Lyrm7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LYR motif containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456073	Lyrm7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine acetyltransferase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363521	Kat14<tm1a(KOMP)Wtsi>	20808945	KOMP-CSD
lysine acetyltransferase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363521	Kat14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysine acetyltransferase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363521	Kat14<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
lysine acetyltransferase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363521	Kat14<tm1a(KOMP)Wtsi>	27310661	KOMP-CSD
lysine acetyltransferase 14; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5910764	Kat14<tm1d(KOMP)Wtsi>	27310661	KOMP-CSD
lysine (K)-specific demethylase 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881958	Kdm1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysine (K)-specific demethylase 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881944	Kdm1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysine (K)-specific demethylase 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944360	Kdm2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysine (K)-specific demethylase 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014742	Kdm3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455955	Kdm4a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455955	Kdm4a<tm1a(EUCOMM)Wtsi>	27266524	EUCOMM
lysine (K)-specific demethylase 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455955	Kdm4a<tm1a(EUCOMM)Wtsi>	28827393	EUCOMM
lysine (K)-specific demethylase 4A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792924	Kdm4a<tm1c(EUCOMM)Wtsi>	27257215	EUCOMM
lysine (K)-specific demethylase 4A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792924	Kdm4a<tm1c(EUCOMM)Wtsi>	27266524	EUCOMM
lysine (K)-specific demethylase 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433704	Kdm4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433704	Kdm4b<tm1a(EUCOMM)Wtsi>	27266524	EUCOMM
lysine (K)-specific demethylase 4B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792925	Kdm4b<tm1c(EUCOMM)Wtsi>	27257215	EUCOMM
lysine (K)-specific demethylase 4B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792925	Kdm4b<tm1c(EUCOMM)Wtsi>	27266524	EUCOMM
lysine (K)-specific demethylase 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362199	Kdm4c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362199	Kdm4c<tm1a(KOMP)Wtsi>	24396064	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362199	Kdm4c<tm1a(KOMP)Wtsi>	27266524	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362199	Kdm4c<tm1a(KOMP)Wtsi>	28981838	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792835	Kdm4c<tm1c(KOMP)Wtsi>	24396064	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792835	Kdm4c<tm1c(KOMP)Wtsi>	27257215	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792835	Kdm4c<tm1c(KOMP)Wtsi>	27266524	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5792836	Kdm4c<tm1d(KOMP)Wtsi>	24396064	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364136	Kdm4c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysine (K)-specific demethylase 4C; targeted mutation 1, William C Skarnes	MGI:5903609	Kdm4c<tm1Wcs>	28981838	null
lysine (K)-specific demethylase 4D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433324	Kdm4d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 4D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434274	Kdm4d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 4D; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4460459	Kdm4d<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 4D; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4460488	Kdm4d<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 5A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887711	Kdm5a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 5A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887692	Kdm5a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431538	Kdm5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431538	Kdm5b<tm1a(EUCOMM)Wtsi>	22020125	EUCOMM
lysine (K)-specific demethylase 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431538	Kdm5b<tm1a(EUCOMM)Wtsi>	23637629	EUCOMM
lysine (K)-specific demethylase 5B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5308434	Kdm5b<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 5B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5308434	Kdm5b<tm1c(EUCOMM)Wtsi>	22020125	EUCOMM
lysine (K)-specific demethylase 5B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5308434	Kdm5b<tm1c(EUCOMM)Wtsi>	23637629	EUCOMM
lysine (K)-specific demethylase 5B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5308434	Kdm5b<tm1c(EUCOMM)Wtsi>	26023081	EUCOMM
lysine (K)-specific demethylase 5C; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5759977	Kdm5c<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
lysine (K)-specific demethylase 6A; targeted insertion 1c, Wellcome Trust Sanger Institute	MGI:5516010	Kdm6a<tm1c(EUCOMM)Wtsi>	23028370	EUCOMM
lysine (K)-specific demethylase 6A; targeted insertion 1c, Wellcome Trust Sanger Institute	MGI:5516010	Kdm6a<tm1c(EUCOMM)Wtsi>	25101834	EUCOMM
lysine (K)-specific demethylase 6A; targeted insertion 1c, Wellcome Trust Sanger Institute	MGI:5516010	Kdm6a<tm1c(EUCOMM)Wtsi>	29073101	EUCOMM
lysine (K)-specific demethylase 6A; targeted insertion 1c, Wellcome Trust Sanger Institute	MGI:5516010	Kdm6a<tm1c(EUCOMM)Wtsi>	29143738	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434460	Kdm6a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434460	Kdm6a<tm1a(EUCOMM)Wtsi>	23028370	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434460	Kdm6a<tm1a(EUCOMM)Wtsi>	28732206	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434460	Kdm6a<tm1a(EUCOMM)Wtsi>	29143738	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 1b,  Rudolf Jaenisch	MGI:5507843	Kdm6a<tm1b(EUCOMM)Jae>	22826230	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 1b,  Rudolf Jaenisch	MGI:5507843	Kdm6a<tm1b(EUCOMM)Jae>	25132549	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5516011	Kdm6a<tm1b(EUCOMM)Wtsi>	23028370	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441731	Kdm6a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 6A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441969	Kdm6a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 7A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432944	Kdm7a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 7A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432944	Kdm7a<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
lysine (K)-specific demethylase 7A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432611	Kdm7a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431607	Kdm8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific demethylase 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548680	Kdm8<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
lysine (K)-specific demethylase 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548680	Kdm8<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lysine (K)-specific demethylase 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433282	Kdm8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine (K)-specific methyltransferase 2B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419830	Kmt2b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
lysine (K)-specific methyltransferase 2C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286228	Kmt2c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysine (K)-specific methyltransferase 2E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434295	Kmt2e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine methyltransferase 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363450	Kmt5b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysine methyltransferase 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363450	Kmt5b<tm1a(KOMP)Wtsi>	28981838	KOMP-CSD
lysine methyltransferase 5B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362289	Kmt5b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysine methyltransferase 5B; targeted mutation 1, William C Skarnes	MGI:5903615	Kmt5b<tm1Wcs>	28981838	null
lysine methyltransferase 5B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363133	Kmt5b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
lysine methyltransferase 5C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842332	Kmt5c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine methyltransferase 5C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842507	Kmt5c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine-rich coiled-coil 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456768	Krcc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine-rich coiled-coil 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456825	Krcc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysine rich nucleolar protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432697	Knop1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysine rich nucleolar protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5568481	Knop1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lysine rich nucleolar protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432533	Knop1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
LysM, putative peptidoglycan-binding, domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938565	Lysmd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
LysM, putative peptidoglycan-binding, domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938598	Lysmd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
LysM, putative peptidoglycan-binding, domain containing 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840598	Lysmd4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
LysM, putative peptidoglycan-binding, domain containing 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840684	Lysmd4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidic acid receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441643	Lpar1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidic acid receptor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635231	Lpar1<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidic acid receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442002	Lpar1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidic acid receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948653	Lpar2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidic acid receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948646	Lpar2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidic acid receptor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454096	Lpar5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysophosphatidic acid receptor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454121	Lpar5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysophosphatidic acid receptor 6; targeted mutation 1.1, Velocigene	MGI:5471392	Lpar6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
lysophosphatidic acid receptor 6; targeted mutation 1.1, Velocigene	MGI:5471392	Lpar6<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
lysophosphatidic acid receptor 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511994	Lpar6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidic acid receptor 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511963	Lpar6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidylcholine acyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433127	Lpcat3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysophosphatidylcholine acyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433127	Lpcat3<tm1a(EUCOMM)Wtsi>	25806685	EUCOMM
lysophosphatidylcholine acyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433127	Lpcat3<tm1a(EUCOMM)Wtsi>	26833026	EUCOMM
lysophosphatidylcholine acyltransferase 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5822780	Lpcat3<tm1c(EUCOMM)Wtsi>	25806685	EUCOMM
lysophosphatidylcholine acyltransferase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433493	Lpcat3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysophospholipase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940788	Lypla2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysophospholipase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946684	Lypla2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysophospholipase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363255	Lyplal1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysophospholipase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363255	Lyplal1<tm1a(KOMP)Wtsi>	26275310	KOMP-CSD
lysophospholipase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363255	Lyplal1<tm1a(KOMP)Wtsi>	26839965	KOMP-CSD
lysophospholipase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363255	Lyplal1<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
lysophospholipase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363255	Lyplal1<tm1a(KOMP)Wtsi>	29084768	KOMP-CSD
lysophospholipase-like 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548788	Lyplal1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
lysophospholipase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363124	Lyplal1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysosomal-associated membrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441808	Lamp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysosomal-associated membrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441817	Lamp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysosomal-associated membrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433401	Lamp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysosomal-associated membrane protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432870	Lamp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysosomal-associated protein transmembrane 4A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548380	Laptm4a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
lysosomal-associated protein transmembrane 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941998	Laptm4b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysosomal-associated protein transmembrane 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941989	Laptm4b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysosomal-associated protein transmembrane 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433224	Laptm5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysosomal-associated protein transmembrane 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433642	Laptm5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysosomal trafficking regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451971	Lyst<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysosomal trafficking regulator; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513800	Lyst<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
lysosomal trafficking regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451990	Lyst<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysozyme 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296131	Lyz1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysozyme G-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458829	Lyg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysozyme G-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458849	Lyg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysozyme G-like 1; targeted mutation 1, Velocigene	MGI:4415415	Lyg1<tm1(KOMP)Vlcg>	28507796	KOMP-Regeneron
lysozyme-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365098	Lyzl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysozyme-like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363897	Lyzl4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysozyme-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364174	Lyzl6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysozyme-like 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362318	Lyzl6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
lysyl oxidase-like 1; targeted mutation 1.1, Velocigene	MGI:5445673	Loxl1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
lysyl oxidase-like 1; targeted mutation 1.1, Velocigene	MGI:5445673	Loxl1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
lysyl oxidase-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441845	Loxl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysyl oxidase-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442059	Loxl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysyl oxidase-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431542	Loxl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
lysyl oxidase-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431542	Loxl3<tm1a(EUCOMM)Wtsi>	26954549	EUCOMM
lysyl oxidase-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434354	Loxl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
lysyl oxidase-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362851	Loxl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysyl oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050878	Lox<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
lysyl-tRNA synthetase; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5573275	Kars<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	23989956	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	24284630	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	25525875	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	26223655	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	26320659	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	26903602	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	27496731	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	28137885	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	28533362	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	28801234	EUCOMM
Mab-21 domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435548	Mb21d1<tm1a(EUCOMM)Hmgu>	29030458	EUCOMM
Mab-21 domain containing 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5578169	Mb21d1<tm1c(EUCOMM)Hmgu>	24284630	EUCOMM
Mab-21 domain containing 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5578169	Mb21d1<tm1c(EUCOMM)Hmgu>	29030458	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	24284630	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	26590319	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	27076643	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	27462105	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	27565347	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	27830700	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	28704551	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	29030458	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	29106401	EUCOMM
Mab-21 domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5578170	Mb21d1<tm1d(EUCOMM)Hmgu>	29176737	EUCOMM
Mab-21 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842450	Mb21d2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mab-21-like 3 (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840949	Mab21l3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mab-21-like 3 (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841351	Mab21l3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MACRO domain containing 2; targeted mutation 1.1, Velocigene	MGI:5445674	Macrod2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
macrophage erythroblast attacher; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842478	Maea<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
macrophage erythroblast attacher; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5588275	Maea<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
macrophage erythroblast attacher; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842619	Maea<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
macrophage galactose N-acetyl-galactosamine specific lectin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365078	Mgl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
macrophage galactose N-acetyl-galactosamine specific lectin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548793	Mgl2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
macrophage galactose N-acetyl-galactosamine specific lectin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363403	Mgl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
macrophage galactose N-acetyl-galactosamine specific lectin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472945	Mgl2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
macrophage galactose N-acetyl-galactosamine specific lectin 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472798	Mgl2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
macrophage migration inhibitory factor (glycosylation-inhibiting factor); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419329	Mif<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
macrophage scavenger receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420116	Msr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
macrophage stimulating 1 (hepatocyte growth factor-like); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431447	Mst1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
macrophage stimulating 1 receptor (c-met-related tyrosine kinase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938573	Mst1r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
macrophage stimulating 1 receptor (c-met-related tyrosine kinase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938561	Mst1r<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MAD1 mitotic arrest deficient 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362893	Mad1l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MAD1 mitotic arrest deficient 1-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364044	Mad1l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MAD2 mitotic arrest deficient-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432091	Mad2l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MAD2 mitotic arrest deficient-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432091	Mad2l2<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
maelstrom spermatogenic transposon silencer; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363462	Mael<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
maelstrom spermatogenic transposon silencer; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299670	Mael<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
maestro heat-like repeat family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050151	Mroh1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
maestro heat-like repeat family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363764	Mroh4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
maestro heat-like repeat family member 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637041	Mroh4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
maestro heat-like repeat family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364860	Mroh4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
maestro heat-like repeat family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363024	Mroh5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
maestro heat-like repeat family member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434135	Mroh7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
maestro heat-like repeat family member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434000	Mroh7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
maestro heat-like repeat family member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302347	Mroh9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
maestro heat-like repeat family member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302314	Mroh9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MAF1 homolog, negative regulator of RNA polymerase III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420076	Maf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
magnesium-dependent phosphatase 1; targeted mutation 1.1, Velocigene	MGI:5576045	Mdp1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
magnesium-dependent phosphatase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420132	Mdp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mago homolog B, exon junction complex core component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427198	Magohb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mago homolog B, exon junction complex core component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427157	Magohb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mago homolog, exon junction complex core component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365256	Magoh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mago homolog, exon junction complex core component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427237	Magoh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mahogunin, ring finger 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887700	Mgrn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mahogunin, ring finger 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887686	Mgrn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
major facilitator superfamily domain containing 10; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419172	Mfsd10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 13B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433719	Mfsd13b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
major facilitator superfamily domain containing 13B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432199	Mfsd13b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
major facilitator superfamily domain containing 14A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434486	Mfsd14a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
major facilitator superfamily domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939721	Mfsd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939702	Mfsd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287802	Mfsd2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287802	Mfsd2a<tm1a(KOMP)Wtsi>	27008858	KOMP-CSD
major facilitator superfamily domain containing 2A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5583066	Mfsd2a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
major facilitator superfamily domain containing 2A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5805836	Mfsd2a<tm1c(KOMP)Wtsi>	27008858	KOMP-CSD
major facilitator superfamily domain containing 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362372	Mfsd2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362372	Mfsd2b<tm1a(KOMP)Wtsi>	29045386	KOMP-CSD
major facilitator superfamily domain containing 2B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111979	Mfsd2b<tm1c(KOMP)Wtsi>	29045386	KOMP-CSD
major facilitator superfamily domain containing 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362427	Mfsd2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 4A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363688	Mfsd4a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 4B1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503345	Mfsd4b1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 4B5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364816	Mfsd4b5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 4B5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427212	Mfsd4b5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363262	Mfsd5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363614	Mfsd5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 7A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140445	Mfsd7a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 7A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453671	Mfsd7a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4456699	Mfsd8<tm1a(EUCOMM)Hmgu>	24423645	EUCOMM
major facilitator superfamily domain containing 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4456699	Mfsd8<tm1a(EUCOMM)Hmgu>	26681805	EUCOMM
major facilitator superfamily domain containing 8; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4456699	Mfsd8<tm1a(EUCOMM)Hmgu>	26975023	EUCOMM
major facilitator superfamily domain containing 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637063	Mfsd8<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
major facilitator superfamily domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362590	Mfsd9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
major facilitator superfamily domain containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362840	Mfsd9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
makorin, ring finger protein 2, opposite strand; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419909	Mkrn2os<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
makorin, ring finger protein 2, opposite strand; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419384	Mkrn2os<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
makorin, ring finger protein, 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944368	Mkrn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
makorin, ring finger protein, 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548531	Mkrn2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
makorin, ring finger protein, 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944404	Mkrn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
malate dehydrogenase 1B, NAD (soluble); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363318	Mdh1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
malate dehydrogenase 1B, NAD (soluble); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364842	Mdh1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
malate dehydrogenase 1, NAD (soluble); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431531	Mdh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
malate dehydrogenase 1, NAD (soluble); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441788	Mdh1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
malate dehydrogenase 1, NAD (soluble); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441940	Mdh1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
malate dehydrogenase 1, NAD (soluble); targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456827	Mdh1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
malate dehydrogenase 2, NAD (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944501	Mdh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
malate dehydrogenase 2, NAD (mitochondrial); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944508	Mdh2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
malectin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461689	Mlec<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
malectin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461689	Mlec<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
malectin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461714	Mlec<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
malic enzyme 3, NADP(+)-dependent, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362498	Me3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
malic enzyme 3, NADP(+)-dependent, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364010	Me3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
malignant T cell amplified sequence 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433880	Mcts1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
malignant T cell amplified sequence 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431987	Mcts1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
malignant T cell amplified sequence 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511999	Mcts2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
malonyl CoA:ACP acyltransferase (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951108	Mcat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
malonyl-CoA decarboxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362673	Mlycd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
malonyl-CoA decarboxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364060	Mlycd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MALT1 paracaspase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4455782	Malt1<tm1a(EUCOMM)Hmgu>	27551157	EUCOMM
MALT1 paracaspase; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5812177	Malt1<tm1c(EUCOMM)Hmgu>	27551157	EUCOMM
mal, T cell differentiation protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451485	Mal2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mal, T cell differentiation protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451655	Mal2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MAM and LDL receptor class A domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881943	Malrd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mannan-binding lectin serine peptidase 1; targeted mutation 1.1, Velocigene	MGI:5544601	Masp1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
mannose-binding lectin (protein C) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363241	Mbl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannose-binding lectin (protein C) 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455493	Mbl2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mannose-binding lectin (protein C) 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455474	Mbl2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mannose-P-dolichol utilization defect 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365199	Mpdu1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannose-P-dolichol utilization defect 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362141	Mpdu1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mannose phosphate isomerase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432151	Mpi<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mannose phosphate isomerase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432821	Mpi<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mannosidase 2, alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362866	Man2a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase 2, alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364931	Man2a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase 2, alpha B1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511976	Man2b1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mannosidase 2, alpha B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362174	Man2b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase 2, alpha B2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513801	Man2b2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
mannosidase 2, alpha B2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362537	Man2b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, alpha, class 1A, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441758	Man1a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mannosidase, alpha, class 1C, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364355	Man1c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, alpha, class 1C, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364293	Man1c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, alpha, class 2C, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364149	Man2c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, alpha, class 2C, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362249	Man2c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, alpha, class 2C, member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364286	Man2c1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, alpha, class 2C, member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364309	Man2c1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, beta A, lysosomal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362487	Manba<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, endo-alpha-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362994	Maneal<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, endo-alpha-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364539	Maneal<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mannosidase, endo-alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434138	Manea<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mannosyl-oligosaccharide glucosidase; targeted mutation 1, Velocigene	MGI:3808372	Mogs<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
MANSC domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419207	Mansc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
MANSC domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947759	Mansc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MANSC domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5002933	Mansc4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MAP3K12 binding inhibitory protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434191	Mbip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MAP3K12 binding inhibitory protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431635	Mbip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MAP3K12 binding inhibitory protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511922	Mbip<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
MAP kinase-activated protein kinase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4842229	Mapkapk2<tm1a(EUCOMM)Hmgu>	26078274	EUCOMM
MAP kinase-activated protein kinase 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548388	Mapkapk2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
MAP kinase-activated protein kinase 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5822781	Mapkapk2<tm1c(EUCOMM)Hmgu>	26078274	EUCOMM
MAP kinase-activated protein kinase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432027	Mapkapk5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MAP kinase-activated protein kinase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434480	Mapkapk5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MAP kinase-interacting serine/threonine kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432143	Mknk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MAP kinase-interacting serine/threonine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431569	Mknk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MAP kinase-interacting serine/threonine kinase 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419234	Mknk2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
MAP/microtubule affinity regulating kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365077	Mark2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MAP/microtubule affinity regulating kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427207	Mark2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MAP/microtubule affinity regulating kinase 3; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4843657	Mark3<tm1a(KOMP)Mbp>	27866947	KOMP-CSD
MARCKS-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434472	Marcksl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MARCKS-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433109	Marcksl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MARVEL (membrane-associating) domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461651	Marveld2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MARVEL (membrane-associating) domain containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637157	Marveld2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
MARVEL (membrane-associating) domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461658	Marveld2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MAS1 oncogene; targeted mutation 1.1, Velocigene	MGI:5696938	Mas1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
MAS1 oncogene; targeted mutation 1.1, Velocigene	MGI:5696938	Mas1<tm1.1(KOMP)Vlcg>	27856608	KOMP-Regeneron
MAS1 oncogene; targeted mutation 1.1, Velocigene	MGI:5696938	Mas1<tm1.1(KOMP)Vlcg>	27986659	KOMP-Regeneron
MAS1 oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461709	Mas1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MAS1 oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461763	Mas1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MAS-related GPR, member F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427151	Mrgprf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mast cell expressed membrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364324	Mcemp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mast cell expressed membrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362382	Mcemp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mast cell protease 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000402	Mcpt8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mastermind like transcriptional coactivator 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363269	Maml1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mastermind like transcriptional coactivator 1; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5472903	Maml1<tm2(EUCOMM)Wtsi>	21677750	EUCOMM
mastermind like transcriptional coactivator 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948621	Maml3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
maternal embryonic leucine zipper kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362376	Melk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
maternal embryonic leucine zipper kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362376	Melk<tm1a(KOMP)Wtsi>	24844244	KOMP-CSD
maternal embryonic leucine zipper kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364206	Melk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
maternal embryonic leucine zipper kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364206	Melk<tm1e(KOMP)Wtsi>	24844244	KOMP-CSD
matrilin 1, cartilage matrix protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014577	Matn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
matrilin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365188	Matn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
matrilin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365085	Matn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
matrix AAA peptidase interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363777	Maip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
matrix extracellular phosphoglycoprotein with ASARM motif (bone); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302355	Mepe<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
matrix extracellular phosphoglycoprotein with ASARM motif (bone); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302330	Mepe<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362171	Mmp15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362171	Mmp15<tm1a(KOMP)Wtsi>	27633994	KOMP-CSD
matrix metallopeptidase 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605746	Mmp15<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
matrix metallopeptidase 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362889	Mmp15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014693	Mmp16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 16; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548416	Mmp16<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
matrix metallopeptidase 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433469	Mmp16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 16; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434134	Mmp16<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419160	Mmp19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419147	Mmp19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362300	Mmp21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362495	Mmp21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 23; targeted mutation 1.1, Velocigene	MGI:5548468	Mmp23<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
matrix metallopeptidase 23; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419635	Mmp23<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014733	Mmp25<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947735	Mmp27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
matrix metallopeptidase 28 (epilysin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452774	Mmp28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 28 (epilysin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452797	Mmp28<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 8; targeted mutation 1.1, Velocigene	MGI:5471364	Mmp8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
matrix metallopeptidase 8; targeted mutation 1.1, Velocigene	MGI:5471364	Mmp8<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
matrix metallopeptidase 8; targeted mutation 1, Velocigene	MGI:4951232	Mmp8<tm1(KOMP)Vlcg>	28700664	KOMP-Regeneron
matrix metallopeptidase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286404	Mmp9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
matrix metallopeptidase 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548952	Mmp9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
matrix metallopeptidase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296213	Mmp9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
matrix-remodelling associated 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433751	Mxra7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
matrix-remodelling associated 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548547	Mxra7<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
matrix-remodelling associated 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548547	Mxra7<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
matrix-remodelling associated 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432276	Mxra7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
maturin, neural progenitor differentiation regulator homolog (Xenopus); targeted mutation 1.1, Velocigene	MGI:5548560	Mturn<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
MAU2 sister chromatid cohesion factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419101	Mau2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MAU2 sister chromatid cohesion factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419716	Mau2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
max binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420133	Mnt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
max binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420090	Mnt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MAX dimerization protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419473	Mxd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MAX dimerization protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419695	Mxd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Max dimerization protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364262	Mxd4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Max dimerization protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299669	Mxd4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Max dimerization protein 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431440	Mxd4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Max dimerization protein 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431431	Mxd4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
MAX-like protein X; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419763	Mlx<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mbt domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455993	Mbtd1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mbt domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456023	Mbtd1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mcf.2 transforming sequence; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431862	Mcf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mcf.2 transforming sequence; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302361	Mcf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Mdm2, transformed 3T3 cell double minute p53 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363586	Mtbp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Mdm2, transformed 3T3 cell double minute p53 binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362948	Mtbp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Mdm2, transformed 3T3 cell double minute p53 binding protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472817	Mtbp<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mechanistic target of rapamycin kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432158	Mtor<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mechanistic target of rapamycin kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432158	Mtor<tm1a(EUCOMM)Wtsi>	25195104	EUCOMM
Meckel syndrome, type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433029	Mks1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Meckel syndrome, type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433029	Mks1<tm1a(EUCOMM)Wtsi>	23454480	EUCOMM
Meckel syndrome, type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433029	Mks1<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
Meckel syndrome, type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432768	Mks1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 11; targeted mutation 1.1, Velocigene	MGI:5471426	Med11<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
mediator complex subunit 11; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419665	Med11<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434001	Med12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 13-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363207	Med13l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 13-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364343	Med13l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362752	Med13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362338	Med13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364983	Med15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362927	Med15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419216	Med16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419566	Med16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432982	Med18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431814	Med18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432772	Med19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431863	Med19<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362386	Med1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363061	Med1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511911	Med1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511888	Med1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008031	Med22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363962	Med23<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363404	Med23<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 23; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527607	Med23<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431530	Med24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432072	Med24<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362835	Med25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 25; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5615649	Med25<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
mediator complex subunit 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362929	Med25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 28; targeted mutation 1.1, Velocigene	MGI:5548528	Med28<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
mediator complex subunit 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887716	Med28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887714	Med28<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 29; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419550	Med29<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365220	Med4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364523	Med4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451691	Med4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451559	Med4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mediator complex subunit 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441627	Med6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441827	Med6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433102	Med9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator complex subunit 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432109	Med9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mediator of cell motility 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008015	Memo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mediator of cell motility 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008015	Memo1<tm1a(EUCOMM)Wtsi>	26746790	EUCOMM
mediator of cell motility 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008015	Memo1<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
mediator of cell motility 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548676	Memo1<tm1b(EUCOMM)Wtsi>	26746790	EUCOMM
mediator of cell motility 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548676	Memo1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
mediator of cell motility 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5896997	Memo1<tm1c(EUCOMM)Wtsi>	26746790	EUCOMM
MEF2 activating motif and SAP domain containing transcriptional regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942136	Mamstr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MEF2 activating motif and SAP domain containing transcriptional regulator; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637079	Mamstr<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
MEF2 activating motif and SAP domain containing transcriptional regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942135	Mamstr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
megakaryocyte and platelet inhibitory receptor G6b; targeted mutation 1.1, Velocigene	MGI:5569070	Mpig6b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
megakaryocyte and platelet inhibitory receptor G6b; targeted mutation 1, Velocigene	MGI:4415504	Mpig6b<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
megakaryocyte and platelet inhibitory receptor G6b; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362217	Mpig6b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human); targeted mutation 1.1, Velocigene	MGI:5548766	Mlc1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363644	Mlc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
meiosis expressed gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364803	Meig1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
meiosis expressed gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362211	Meig1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
meiosis regulator for oocyte development; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431885	Mios<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
meiosis regulator for oocyte development; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431767	Mios<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
meiosis-specific nuclear structural protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364128	Mns1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
meiosis-specific nuclear structural protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364820	Mns1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
meiosis specific with coiled-coil domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362869	Meioc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
meiosis specific with coiled-coil domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362869	Meioc<tm1a(KOMP)Wtsi>	26742488	KOMP-CSD
meiosis specific with coiled-coil domain; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5796294	Meioc<tm1c(KOMP)Wtsi>	26742488	KOMP-CSD
meiosis specific with OB domains; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820241	Meiob<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
meiosis specific with OB domains; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820366	Meiob<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
meiotic double-stranded break formation protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841174	Mei4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
meiotic double-stranded break formation protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427122	Mei4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MEIR1 treanscription regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431567	Mier1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MEIR1 treanscription regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431567	Mier1<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
MEIR1 treanscription regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432039	Mier1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MEIR1 treanscription regulator; targeted mutation 1, William C Skarnes	MGI:5903610	Mier1<tm1Wcs>	28981838	null
Meis homeobox 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419684	Meis2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Meis homeobox 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419684	Meis2<tm1(KOMP)Wtsi>	27012318	KOMP-CSD
Meis homeobox 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431476	Meis3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
melanocortin 1 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473189	Mc1r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanocortin 1 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472762	Mc1r<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
melanocortin 2 receptor accessory protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434054	Mrap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanocortin 2 receptor accessory protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434054	Mrap2<tm1a(EUCOMM)Wtsi>	26829592	EUCOMM
melanocortin 2 receptor accessory protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434054	Mrap2<tm1a(EUCOMM)Wtsi>	27106110	EUCOMM
melanocortin 3 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473169	Mc3r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanocortin 3 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472744	Mc3r<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
melanocortin 4 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473140	Mc4r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanocortin 4 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472718	Mc4r<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
melanocortin 5 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941997	Mc5r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
melanocortin 5 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942005	Mc5r<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
melanocyte proliferating gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362271	Myg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
melanocyte proliferating gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364453	Myg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
melanoma antigen, family A, 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473139	Magea4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma antigen, family B, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473190	Mageb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma antigen, family B, 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472764	Mageb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma antigen, family B, 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365151	Mageb4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
melanoma antigen, family D, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430961	Maged1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
melanoma antigen, family D, 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364837	Maged2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
melanoma antigen, family H, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473174	Mageh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma antigen, family H, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472749	Mageh1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma associated antigen (mutated) 1-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085469	Mum1l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma associated antigen (mutated) 1-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294232	Mum1l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma associated antigen (mutated) 1-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5140470	Mum1l1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma cell adhesion molecule; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5692763	Mcam<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
melanoma cell adhesion molecule; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419884	Mcam<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
melanoma inhibitory activity 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050965	Mia2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
melanoma inhibitory activity; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419376	Mia<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
melanophilin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362228	Mlph<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
melanotransferrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820034	Meltf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
melanotransferrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820157	Meltf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
melatonin receptor 1B; targeted mutation 1.1, Velocigene	MGI:5548779	Mtnr1b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
melatonin receptor 1B; targeted mutation 1, Velocigene	MGI:4399541	Mtnr1b<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
membrane associated guanylate kinase, WW and PDZ domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458504	Magi1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
membrane associated guanylate kinase, WW and PDZ domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458580	Magi1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-associated ring finger (C3HC4) 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363847	March10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-associated ring finger (C3HC4) 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363448	March10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-associated ring finger (C3HC4) 11; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419894	March11<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-associated ring finger (C3HC4) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006803	March2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453746	March4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453774	March4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433802	March5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433802	March5<tm1a(EUCOMM)Wtsi>	26246171	EUCOMM
membrane-associated ring finger (C3HC4) 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432897	March5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434296	March7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434388	March7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452800	March9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-associated ring finger (C3HC4) 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452824	March9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane bound O-acyltransferase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5301388	Mboat1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane bound O-acyltransferase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442058	Mboat1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane bound O-acyltransferase domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5301398	Mboat1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane bound O-acyltransferase domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363399	Mboat7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
membrane bound O-acyltransferase domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363399	Mboat7<tm1a(KOMP)Wtsi>	23472195	KOMP-CSD
membrane bound O-acyltransferase domain containing 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637092	Mboat7<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
membrane bound O-acyltransferase domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363056	Mboat7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-bound transcription factor peptidase, site 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842880	Mbtps1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-bound transcription factor peptidase, site 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511941	Mbtps1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-bound transcription factor peptidase, site 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511904	Mbtps1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-bound transcription factor peptidase, site 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050884	Mbtps2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-bound transcription factor peptidase, site 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428513	Mbtps2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
membrane frizzled-related protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456645	Mfrp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
membrane frizzled-related protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456679	Mfrp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
membrane magnesium transporter 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433138	Mmgt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane magnesium transporter 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006784	Mmgt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948614	Mpp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442032	Mpp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452012	Mpp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820275	Mpp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441990	Mpp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441991	Mpp5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane protein, palmitoylated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431717	Mpp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
membrane protein, palmitoylated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432159	Mpp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
membrane-spanning 4-domains, subfamily A, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014595	Ms4a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-spanning 4-domains, subfamily A, member 3; targeted mutation 1.1, Velocigene	MGI:5692795	Ms4a3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
membrane-spanning 4-domains, subfamily A, member 4C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419768	Ms4a4c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
membrane-spanning 4-domains, subfamily A, member 4D; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431409	Ms4a4d<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
menage a trois 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458632	Mnat1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
meprin 1 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455495	Mep1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
meprin 1 alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455558	Mep1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
meprin 1 beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947807	Mep1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
meprin 1 beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003029	Mep1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mesencephalic astrocyte-derived neurotrophic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362648	Manf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mesencephalic astrocyte-derived neurotrophic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362648	Manf<tm1a(KOMP)Wtsi>	24726366	KOMP-CSD
mesencephalic astrocyte-derived neurotrophic factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362648	Manf<tm1a(KOMP)Wtsi>	29082311	KOMP-CSD
mesencephalic astrocyte-derived neurotrophic factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364188	Manf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mesenteric estrogen dependent adipogenesis; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362640	Medag<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mesenteric estrogen dependent adipogenesis; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363425	Medag<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mesenteric estrogen dependent adipogenesis; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431426	Medag<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mesenteric estrogen dependent adipogenesis; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548602	Medag<tm2b(KOMP)Wtsi>	26398943	KOMP-CSD
mesenteric estrogen dependent adipogenesis; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548602	Medag<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
mesenteric estrogen dependent adipogenesis; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431416	Medag<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mesothelin-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842712	Mslnl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mesothelin-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842515	Mslnl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mesothelin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419737	Msln<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
metadherin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364954	Mtdh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
metallo-beta-lactamase domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451263	Mblac2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
metallo-beta-lactamase domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451235	Mblac2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
metallophosphoesterase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455609	Mpped1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
metallophosphoesterase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455601	Mpped1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
metallothionein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441913	Mt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
metallothionein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441708	Mt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
metallothionein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419185	Mt2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
metallothionein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842787	Mt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
metallothionein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842794	Mt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
metal response element binding transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362402	Mtf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
metal response element binding transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362402	Mtf1<tm1a(KOMP)Wtsi>	24529376	KOMP-CSD
metal response element binding transcription factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515625	Mtf1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
metal response element binding transcription factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515625	Mtf1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
metal response element binding transcription factor 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5621187	Mtf1<tm1c(KOMP)Wtsi>	24529376	KOMP-CSD
metal response element binding transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363268	Mtf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
metal response element binding transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433808	Mtf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
metastasis associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842891	Mta1<tm1a(EUCOMM)Wtsi>	20799038	EUCOMM
metastasis associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842891	Mta1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
metastasis associated 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5692470	Mta3<tm1a(KOMP)Wtsi>	20799038	KOMP-CSD
metastasis associated 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5692470	Mta3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
metastasis associated 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362296	Mta3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
metastasis associated 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362362	Mta3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
metastasis associated 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363334	Mta3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
metastasis associated 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4419906	Mta3<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
metastasis-associated gene family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432219	Mta2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
metastasis-associated gene family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432374	Mta2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
metastasis-associated gene family, member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472920	Mta2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
metastasis-associated gene family, member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472784	Mta2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
metastasis suppressor 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840989	Mtss1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
metastasis suppressor 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841268	Mtss1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
metaxin 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419364	Mtx1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
meteorin, glial cell differentiation regulator-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362702	Metrnl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
meteorin, glial cell differentiation regulator-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363416	Metrnl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methenyltetrahydrofolate synthetase domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841225	Mthfsd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methionine adenosyltransferase I, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460481	Mat1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methionine adenosyltransferase I, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460466	Mat1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methionine adenosyltransferase II, alpha; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5550596	Mat2a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
methionine sulfoxide reductase A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419699	Msra<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
methionine sulfoxide reductase B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432326	Msrb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methionine sulfoxide reductase B3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453686	Msrb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methionine sulfoxide reductase B3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453739	Msrb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methionine-tRNA synthetase 2 (mitochondrial); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511964	Mars2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
methionyl aminopeptidase type 1D (mitochondrial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362796	Metap1d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methionyl aminopeptidase type 1D (mitochondrial); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364734	Metap1d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methyl-CpG binding domain protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431986	Mbd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methyl-CpG binding domain protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433184	Mbd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methyl-CpG binding domain protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434064	Mbd2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
methyl-CpG binding domain protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434485	Mbd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methyl-CpG binding domain protein 5; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5002989	Mbd5<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
methyl-CpG binding domain protein 5; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5002994	Mbd5<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
methyl-CpG binding domain protein 6; targeted mutation 1.1, Velocigene	MGI:5548367	Mbd6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
methyl-CpG binding domain protein 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363052	Mbd6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
methyl CpG binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434266	Mecp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methylcrotonoyl-Coenzyme A carboxylase 1 (alpha); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841266	Mccc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methylcrotonoyl-Coenzyme A carboxylase 1 (alpha); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841231	Mccc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methylcrotonoyl-Coenzyme A carboxylase 2 (beta); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880896	Mccc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944557	Mthfd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949363	Mthfd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434021	Mthfd1l<tm1a(EUCOMM)Wtsi>	19525957	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434021	Mthfd1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434021	Mthfd1l<tm1a(EUCOMM)Wtsi>	23267094	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5470152	Mthfd1l<tm1b(EUCOMM)Wtsi>	23267094	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431820	Mthfd2l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548566	Mthfd2l<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434012	Mthfd2l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451722	Mthfd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451608	Mthfd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299643	Mthfd1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299639	Mthfd1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
methylenetetrahydrofolate reductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434197	Mthfr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methylenetetrahydrofolate reductase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432989	Mthfr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427133	Mmadhc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5430974	Mmadhc<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
methylmalonic aciduria (cobalamin deficiency) type A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420048	Mmaa<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
methylmalonyl CoA epimerase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841335	Mcee<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methylmalonyl CoA epimerase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841381	Mcee<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methylmalonyl-Coenzyme A mutase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441659	Mut<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methylsterol monoxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432850	Msmo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methylsterol monoxygenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433634	Msmo1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methylthioadenosine phosphorylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880969	Mtap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 11B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432450	Mettl11b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 11B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434173	Mettl11b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006761	Mettl14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006807	Mettl14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 16; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5583061	Mettl16<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
methyltransferase like 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364629	Mettl17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363357	Mettl17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 21A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363353	Mettl21a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 21C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008057	Mettl21c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 21C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008053	Mettl21c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363211	Mettl24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364254	Mettl24<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 25; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503354	Mettl25<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 25; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5503337	Mettl25<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442034	Mettl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442041	Mettl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
methyltransferase like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363451	Mettl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362628	Mettl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
methyltransferase like 7B; targeted mutation 1.1, Velocigene	MGI:5574603	Mettl7b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
mex3 RNA binding family member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427179	Mex3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mex3 RNA binding family member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427119	Mex3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MGAT4 family, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433541	Mgat4c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MGAT4 family, member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840990	Mgat4d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MGAT4 family, member C; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548545	Mgat4d<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
MGAT4 family, member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434307	Mgat4c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MICAL C-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944385	Micalcl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MICAL-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455483	Micall2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MICAL-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455510	Micall2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microcephaly, primary autosomal recessive 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431685	Mcph1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
microcephaly, primary autosomal recessive 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431685	Mcph1<tm1a(EUCOMM)Wtsi>	23516444	EUCOMM
microcephaly, primary autosomal recessive 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431685	Mcph1<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
microfibrillar-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364362	Mfap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microfibrillar-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364362	Mfap2<tm1a(KOMP)Wtsi>	26902431	KOMP-CSD
microfibrillar-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364362	Mfap2<tm1a(KOMP)Wtsi>	27445989	KOMP-CSD
microfibrillar-associated protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363094	Mfap2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microfibrillar-associated protein 3-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362632	Mfap3l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microfibrillar-associated protein 3-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363562	Mfap3l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microfibrillar-associated protein 4; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766171	Mfap4<tm1b(NCOM)Mfgc>	27626380	NorCOMM
microrchidia 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942000	Morc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microrchidia 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941987	Morc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microrchidia 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841083	Morc2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microrchidia 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841387	Morc2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microrchidia 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820110	Morc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microrchidia 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820113	Morc4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microRNA 141; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5320087	Mir141<tm1Wtsi>	27626380	Sanger miRNA knockouts
microRNA 143; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5319992	Mir143<tm1Wtsi>	27626380	Sanger miRNA knockouts
microRNA 145a; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5319993	Mir145a<tm1Wtsi>	27626380	Sanger miRNA knockouts
microRNA 203; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5320098	Mir203<tm1Wtsi>	27626380	Sanger miRNA knockouts
microRNA 320; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5319975	Mir320<tm1Wtsi>	27626380	Sanger miRNA knockouts
microsomal glutathione S-transferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363892	Mgst1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microsomal glutathione S-transferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362930	Mgst3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microsomal glutathione S-transferase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548521	Mgst3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
microspherule protein 1; targeted mutation 1.1, Velocigene	MGI:5581465	Mcrs1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
microtubule associated monooxygenase, calponin and LIM domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050973	Mical1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule associated monooxygenase, calponin and LIM domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050920	Mical1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule associated monooxygenase, calponin and LIM domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362301	Mical2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule associated monooxygenase, calponin and LIM domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362321	Mical2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule-associated protein 1 A; targeted mutation 1.2, Mouse Biology Program, UCDavis	MGI:5774957	Map1a<tm1.2(KOMP)Mbp>	25788676	KOMP-CSD
microtubule-associated protein 1 A; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4454010	Map1a<tm1(KOMP)Mbp>	25788676	KOMP-CSD
microtubule-associated protein 1 light chain 3 beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433412	Map1lc3b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein 1 light chain 3 beta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441777	Map1lc3b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein 1 light chain 3 beta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441973	Map1lc3b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419873	Map2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule-associated protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419873	Map2<tm1(KOMP)Wtsi>	23912999	KOMP-CSD
microtubule-associated protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432192	Map6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432154	Map6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363310	Map7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule-associated protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364248	Map7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule-associated protein 7; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511933	Map7<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein 7; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511902	Map7<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363348	Map9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule-associated protein, RP/EB family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456646	Mapre2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule-associated protein, RP/EB family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456681	Mapre2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule-associated protein, RP/EB family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432919	Mapre3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein, RP/EB family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432919	Mapre3<tm1a(EUCOMM)Wtsi>	26119739	EUCOMM
microtubule-associated protein, RP/EB family, member 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5780100	Mapre3<tm1c(EUCOMM)Wtsi>	26119739	EUCOMM
microtubule-associated protein, RP/EB family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431837	Mapre3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule-associated protein tau; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5615650	Mapt<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
microtubule associated serine/threonine kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432743	Mast1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule associated serine/threonine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433707	Mast1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule associated serine/threonine kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363089	Mast2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule associated serine/threonine kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365244	Mast2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule associated serine/threonine kinase 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511942	Mast2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule associated serine/threonine kinase 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511905	Mast2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule associated serine/threonine kinase 3; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5635248	Mast3<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule associated serine/threonine kinase 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419161	Mast3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
microtubule associated serine/threonine kinase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842598	Mastl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule associated serine/threonine kinase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842453	Mastl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
microtubule crosslinking factor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362872	Mtcl1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)); targeted mutation 1.1, Velocigene	MGI:5548557	Mid1ip1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
midasin AAA ATPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363099	Mdn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
midasin AAA ATPase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364668	Mdn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
midkine; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5493326	Mdk<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
midkine; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5493326	Mdk<tm1.1(KOMP)Mbp>	28700664	KOMP-CSD
midline 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840960	Mid2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
midline 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841449	Mid2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MIER family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842680	Mier2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MIER family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364831	Mier3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MIER family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427236	Mier3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MIF4G domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319824	Mif4gd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
migration and invasion enhancer 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841311	Mien1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
milk fat globule-EGF factor 8 protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431780	Mfge8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
milk fat globule-EGF factor 8 protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432013	Mfge8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
milk fat globule-EGF factor 8 protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432130	Mfge8<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mindbomb E3 ubiquitin protein ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441697	Mib1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mindbomb E3 ubiquitin protein ligase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442026	Mib1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mindbomb E3 ubiquitin protein ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431678	Mib2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mindbomb E3 ubiquitin protein ligase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433985	Mib2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MINDY lysine 48 deubiquitinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433829	Mindy1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MINDY lysine 48 deubiquitinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433829	Mindy1<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
MINDY lysine 48 deubiquitinase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548651	Mindy1<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
MINDY lysine 48 deubiquitinase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548651	Mindy1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
MINDY lysine 48 deubiquitinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432709	Mindy1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MINDY lysine 48 deubiquitinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364376	Mindy2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MINDY lysine 48 deubiquitinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427208	Mindy2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MINDY lysine 48 deubiquitinase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419119	Mindy2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
MINDY lysine 48 deubiquitinase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419799	Mindy2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
minichromosome maintenance 9 homologous recombination repair factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452672	Mcm9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
minichromosome maintenance complex component 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000388	Mcm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 3a, Helmholtz Zentrum Muenchen GmbH	MGI:5511194	Mcmdc2<tm3a(EUCOMM)Hmgu>	27760146	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 3b, Helmholtz Zentrum Muenchen GmbH	MGI:5892145	Mcmdc2<tm3b(EUCOMM)Hmgu>	27760146	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 3c, Helmholtz Zentrum Muenchen GmbH	MGI:5892146	Mcmdc2<tm3c(EUCOMM)Hmgu>	27760146	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 4a, Helmholtz Zentrum Muenchen GmbH	MGI:5511519	Mcmdc2<tm4a(EUCOMM)Hmgu>	27760146	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 4a, Helmholtz Zentrum Muenchen GmbH	MGI:5511519	Mcmdc2<tm4a(EUCOMM)Hmgu>	27986806	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 4b, Helmholtz Zentrum Muenchen GmbH	MGI:5892147	Mcmdc2<tm4b(EUCOMM)Hmgu>	27760146	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 4c, Helmholtz Zentrum Muenchen GmbH	MGI:5892148	Mcmdc2<tm4c(EUCOMM)Hmgu>	27760146	EUCOMM
minichromosome maintenance domain containing 2; targeted mutation 4c, Helmholtz Zentrum Muenchen GmbH	MGI:5892148	Mcmdc2<tm4c(EUCOMM)Hmgu>	27986806	EUCOMM
mirror-image polydactyly 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605791	Mipol1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
MIS12 kinetochore complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451709	Mis12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MIS12 kinetochore complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451552	Mis12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MIS18 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432385	Mis18bp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MIS18 binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433991	Mis18bp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
misato 1, mitochondrial distribution and morphology regulator; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419648	Msto1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitchondrial ribosomal protein S7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419144	Mrps7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial calcium uniporter dominant negative beta subunit; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4840771	Mcub<tm1a(KOMP)Mbp>	26828201	KOMP-CSD
mitochondrial calcium uniporter dominant negative beta subunit; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5637017	Mcub<tm1b(KOMP)Mbp>	26828201	KOMP-CSD
mitochondrial calcium uniporter dominant negative beta subunit; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5637017	Mcub<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
mitochondrial calcium uniporter regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364571	Mcur1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial calcium uniporter regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364571	Mcur1<tm1a(KOMP)Wtsi>	27184846	KOMP-CSD
mitochondrial calcium uniporter regulator 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5910730	Mcur1<tm1c(KOMP)Wtsi>	27184846	KOMP-CSD
mitochondrial calcium uniporter regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362884	Mcur1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial calcium uniporter; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637176	Mcu<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
mitochondrial calcium uptake 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363924	Micu1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial calcium uptake 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472812	Micu1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial calcium uptake 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434182	Micu2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial calcium uptake 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472963	Micu2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial carrier 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362828	Mtch1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial carrier 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363747	Mtch1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial carrier 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431470	Mtch1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial carrier 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431474	Mtch1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial carrier 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548706	Mtch2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
mitochondrial elongation factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140478	Mief1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial elongation factor 2; targeted mutation 1, Velocigene	MGI:3808263	Mief2<tm1(KOMP)Vlcg>	27076521	KOMP-Regeneron
mitochondrial fission process 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419680	Mtfp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial fission regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433187	Mtfr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial fission regulator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948649	Mtfr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial fission regulator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008018	Mtfr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial inner membrane organizing system 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458525	Minos1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial inner membrane organizing system 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458568	Minos1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial methionyl-tRNA formyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362485	Mtfmt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial methionyl-tRNA formyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362485	Mtfmt<tm1a(KOMP)Wtsi>	26331883	KOMP-CSD
mitochondrial methionyl-tRNA formyltransferase; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5904492	Mtfmt<tm1c(KOMP)Wtsi>	26331883	KOMP-CSD
mitochondrial methionyl-tRNA formyltransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363949	Mtfmt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial pyruvate carrier 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433496	Mpc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial pyruvate carrier 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433496	Mpc1<tm1a(EUCOMM)Wtsi>	26344103	EUCOMM
mitochondrial pyruvate carrier 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5903307	Mpc1<tm1c(EUCOMM)Wtsi>	26344103	EUCOMM
mitochondrial pyruvate carrier 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5903307	Mpc1<tm1c(EUCOMM)Wtsi>	28812582	EUCOMM
mitochondrial pyruvate carrier 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431746	Mpc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial pyruvate carrier 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003002	Mpc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial pyruvate carrier 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003002	Mpc2<tm1a(EUCOMM)Wtsi>	26344101	EUCOMM
mitochondrial pyruvate carrier 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816915	Mpc2<tm1c(EUCOMM)Wtsi>	26344101	EUCOMM
mitochondrial pyruvate carrier 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938554	Mpc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456792	Mrpl10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362461	Mrpl13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365234	Mrpl13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451973	Mrpl16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451995	Mrpl16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434342	Mrpl18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947814	Mrpl21<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938584	Mrpl21<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L23; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840687	Mrpl23<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432258	Mrpl27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434146	Mrpl27<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363701	Mrpl28<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362688	Mrpl28<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364908	Mrpl30<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364162	Mrpl30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947749	Mrpl33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L34; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419271	Mrpl34<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L36; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419856	Mrpl36<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L37; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419195	Mrpl37<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L37; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5435078	Mrpl37<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842762	Mrpl38<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L38; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842826	Mrpl38<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363739	Mrpl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365003	Mrpl3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5426675	Mrpl3<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L3; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5426678	Mrpl3<tm4a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L3; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:5426676	Mrpl3<tm4e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L40; targeted mutation 1, Velocigene	MGI:3847513	Mrpl40<tm1(KOMP)Vlcg>	27184122	KOMP-Regeneron
mitochondrial ribosomal protein L41; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419459	Mrpl41<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841408	Mrpl44<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841338	Mrpl44<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L44; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299642	Mrpl44<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L44; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299638	Mrpl44<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456774	Mrpl45<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L46; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363396	Mrpl46<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L51; targeted mutation 1.1, Velocigene	MGI:5565611	Mrpl51<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
mitochondrial ribosomal protein L51; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419196	Mrpl51<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein L54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432901	Mrpl54<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L55; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433228	Mrpl55<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein L55; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433609	Mrpl55<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431907	Mrps11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433647	Mrps11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433490	Mrps11<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S14; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419255	Mrps14<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S18A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365214	Mrps18a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S18A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458516	Mrps18a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S18B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006792	Mrps18b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433083	Mrps21<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433908	Mrps21<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S21; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441749	Mrps21<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S23; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419602	Mrps23<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S24; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419291	Mrps24<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S25; targeted mutation 1.1, Velocigene	MGI:5445931	Mrps25<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
mitochondrial ribosomal protein S25; targeted mutation 1.1, Velocigene	MGI:5445931	Mrps25<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
mitochondrial ribosomal protein S27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008039	Mrps27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942147	Mrps2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942157	Mrps2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451621	Mrps30<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299543	Mrps30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S34; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419628	Mrps34<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial ribosomal protein S35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433487	Mrps35<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S35; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433832	Mrps35<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432560	Mrps5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548689	Mrps5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
mitochondrial ribosomal protein S5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431955	Mrps5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432263	Mrps9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosomal protein S9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434420	Mrps9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosome-associated GTPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432023	Mtg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ribosome-associated GTPase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434335	Mtg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial rRNA methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362647	Mrm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial rRNA methyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364085	Mrm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial rRNA methyltransferase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472694	Mrm1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial rRNA methyltransferase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472789	Mrm1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial rRNA methyltransferase 3; targeted mutation 1.1, Velocigene	MGI:5516076	Mrm3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
mitochondrial rRNA methyltransferase 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419851	Mrm3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial trans-2-enoyl-CoA reductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432643	Mecr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial trans-2-enoyl-CoA reductase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456781	Mecr<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial trans-2-enoyl-CoA reductase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456809	Mecr<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial transcription termination factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432387	Mterf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial transcription termination factor 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432957	Mterf2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial transcription termination factor 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511148	Mterf2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial transcription termination factor 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5512010	Mterf2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial transcription termination factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432559	Mterf3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial transcription termination factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433240	Mterf3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial translational initiation factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431634	Mtif2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial translational initiation factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431551	Mtif2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial translational initiation factor 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433337	Mtif2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial translational initiation factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457571	Mtif3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial translational initiation factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457559	Mtif3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial translational release factor 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363611	Mtrf1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial translational release factor 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362941	Mtrf1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial translational release factor 1-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364618	Mtrf1l<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial translational release factor 1-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365255	Mtrf1l<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mitochondrial tRNA translation optimization 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432793	Mto1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial tRNA translation optimization 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433398	Mto1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitochondrial ubiquitin ligase activator of NFKB 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938593	Mul1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitofusin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434285	Mfn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842613	Mapk10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 11; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636964	Mapk11<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
mitogen-activated protein kinase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441658	Mapk14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441686	Mapk14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 1 interacting protein 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052382	Mapk1ip1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase 1 interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4946689	Mapk1ip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase 1 interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940750	Mapk1ip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432537	Mapk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362691	Mapk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003035	Mapk7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938586	Mapk7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 8 interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847882	Mapk8ip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 8 interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849982	Mapk8ip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 8 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433297	Mapk8ip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 8 interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431979	Mapk8ip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431629	Mapk9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432797	Mapk9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456783	Mapk9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456836	Mapk9<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820336	Mapkap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820336	Mapkap1<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
mitogen-activated protein kinase associated protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548828	Mapkap1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
mitogen-activated protein kinase associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820263	Mapkap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase binding protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548464	Mapkbp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
mitogen-activated protein kinase kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434127	Map2k2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432691	Map2k2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432587	Map2k3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432808	Map2k3<tm2a(EUCOMM)Wtsi>	19525957	EUCOMM
mitogen-activated protein kinase kinase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432808	Map2k3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434459	Map2k3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009641	Map2k5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014706	Map2k5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842504	Map2k7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842318	Map2k7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase kinase 10; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548463	Map3k10<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
mitogen-activated protein kinase kinase kinase 11; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431415	Map3k11<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362915	Map3k13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362915	Map3k13<tm1a(KOMP)Wtsi>	27511108	KOMP-CSD
mitogen-activated protein kinase kinase kinase 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363504	Map3k13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947800	Map3k14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase kinase 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364582	Map3k15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363823	Map3k15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451248	Map3k1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451325	Map3k1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434801	Map3k5<tm1a(EUCOMM)Hmgu>	25298527	EUCOMM
mitogen-activated protein kinase kinase kinase 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434801	Map3k5<tm1a(EUCOMM)Hmgu>	28702328	EUCOMM
mitogen-activated protein kinase kinase kinase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947820	Map3k7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase kinase 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548462	Map3k7<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
mitogen-activated protein kinase kinase kinase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452626	Map3k8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5558152	Map3k8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
mitogen-activated protein kinase kinase kinase 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452676	Map3k8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362846	Map4k2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362327	Map4k2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitogen-activated protein kinase kinase kinase kinase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472958	Map4k2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitogen-activated protein kinase kinase kinase kinase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472807	Map4k2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
mitoguardin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461706	Miga1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mitoguardin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5567110	Miga1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
mitoguardin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461686	Miga1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	22876197	KOMP-CSD
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	25526730	KOMP-CSD
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	26711011	KOMP-CSD
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	26716412	KOMP-CSD
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	28938432	KOMP-CSD
mitoguardin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	29180626	KOMP-CSD
mitoguardin 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6112036	Miga2<tm1c(KOMP)Wtsi>	26716412	KOMP-CSD
mitoguardin 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6112036	Miga2<tm1c(KOMP)Wtsi>	29180626	KOMP-CSD
mitoguardin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364260	Miga2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mitoguardin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362955	Miga2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
mitoguardin 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364554	Miga2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
mitotic spindle organizing protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944365	Mzt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mitotic spindle positioning; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434279	Misp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mitotic spindle positioning; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4442061	Misp<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mitotic spindle positioning; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441836	Misp<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
MLX interacting protein-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473056	Mlxipl<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
MLX interacting protein-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5499312	Mlxipl<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
MLX interacting protein-like; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511155	Mlxipl<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
MMS19 (MET18 S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363935	Mms19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MMS19 (MET18 S. cerevisiae); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419728	Mms19<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
MMS19 (MET18 S. cerevisiae); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419690	Mms19<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
MMS22-like, DNA repair protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433323	Mms22l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MMS22-like, DNA repair protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433323	Mms22l<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
MOB family member 4, phocein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433595	Mob4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MOB kinase activator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286243	Mob2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MOB kinase activator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426597	Mob2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MOB kinase activator 3A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840581	Mob3a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
MOB kinase activator 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052418	Mob3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MOB kinase activator 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140422	Mob3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MOB kinase activator 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842379	Mob3c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MOB kinase activator 3C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842573	Mob3c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
moesin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433818	Msn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Moloney leukemia virus 10-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455556	Mov10l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Moloney leukemia virus 10-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457511	Mov10l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Moloney sarcoma oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473150	Mos<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Moloney sarcoma oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472728	Mos<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
molybdenum cofactor synthesis 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365013	Mocs1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
molybdenum cofactor synthesis 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299585	Mocs1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
molybdenum cofactor synthesis 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299519	Mocs1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
molybdenum cofactor synthesis 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456059	Mocs2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
molybdenum cofactor synthesis 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548433	Mocs2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
molybdenum cofactor synthesis 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456035	Mocs2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
molybdenum cofactor synthesis 2; targeted mutation 1, Velocigene	MGI:4881158	Mocs2<tm1(KOMP)Vlcg>	27138983	KOMP-Regeneron
monoacylglycerol O-acyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363665	Mogat1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
monoacylglycerol O-acyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362408	Mogat1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
monoacylglycerol O-acyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362407	Mogat2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
monoacylglycerol O-acyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362407	Mogat2<tm1a(KOMP)Wtsi>	24784138	KOMP-CSD
monoacylglycerol O-acyltransferase 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5779196	Mogat2<tm1c(KOMP)Wtsi>	24784138	KOMP-CSD
monoacylglycerol O-acyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364291	Mogat2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
monoamine oxidase A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362464	Maoa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
monoamine oxidase A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363265	Maoa<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
monoamine oxidase B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362751	Maob<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
monocyte to macrophage differentiation-associated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950954	Mmd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
monocyte to macrophage differentiation-associated 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950947	Mmd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
monooxygenase, DBH-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363767	Moxd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
monooxygenase, DBH-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841303	Moxd1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
monooxygenase, DBH-like 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5502314	Moxd1<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
monooxygenase, DBH-like 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5502314	Moxd1<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
monooxygenase, DBH-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841409	Moxd1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
monooxygenase, DBH-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842506	Moxd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
monooxygenase, DBH-like 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4951106	Moxd2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
MORN repeat containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842511	Morn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MORN repeat containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842637	Morn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MORN repeat containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4946682	Morn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MORN repeat containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940772	Morn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MORN repeat containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433847	Morn5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MORN repeat containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432955	Morn5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
motile sperm domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362521	Mospd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
motile sperm domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364142	Mospd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
motile sperm domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364178	Mospd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
motile sperm domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364962	Mospd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
M phase phosphoprotein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008036	Mphosph6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
M-phase phosphoprotein 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432287	Mphosph8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
M-phase phosphoprotein 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433644	Mphosph8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
M-phase specific PLK1 intereacting protein; targeted mutation 1.1, Velocigene	MGI:5569045	Mplkip<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
MPN domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431992	Mpnd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MPN domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432456	Mpnd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Mpv17 transgene, kidney disease mutant-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363312	Mpv17l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mRNA turnover 4, ribosome maturation factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432690	Mrto4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mRNA turnover 4, ribosome maturation factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433735	Mrto4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MRN complex interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431715	Mrnip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MRN complex interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432592	Mrnip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MRN complex interacting protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441877	Mrnip<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
MRN complex interacting protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441847	Mrnip<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
MRN complex interacting protein; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456798	Mrnip<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
MRS2 magnesium transporter; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299681	Mrs2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MRS2 magnesium transporter; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299680	Mrs2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
msh homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363610	Msx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
msh homeobox 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5463966	Msx1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
msh homeobox 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5463966	Msx1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
msh homeobox 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008043	Msx3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MSL complex subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364117	Msl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MSL complex subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364169	Msl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MSL complex subunit 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451601	Msl3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
MSS51 mitochondrial translational activator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941996	Mss51<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
MSS51 mitochondrial translational activator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942031	Mss51<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mucin 13, epithelial transmembrane; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881076	Muc13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mucin 1, transmembrane; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433998	Muc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mucin 1, transmembrane; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433333	Muc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mucin 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431931	Muc20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mucin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419115	Muc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mucin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420000	Muc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mucin 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299556	Muc4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
mucolipin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363127	Mcoln2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mucolipin 2; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5881907	Mcoln2<tm1e.1(KOMP)Wtsi>	26432893	KOMP-CSD
mucolipin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364456	Mcoln2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mucolipin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364456	Mcoln2<tm1e(KOMP)Wtsi>	26432893	KOMP-CSD
mucosal pentraxin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419875	Mptx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
mucosal pentraxin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420016	Mptx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
mucosal vascular addressin cell adhesion molecule 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419162	Madcam1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
multimerin 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548605	Mmrn1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
multiple EGF-like-domains 10; targeted mutation 1, Velocigene	MGI:4454190	Megf10<tm1(KOMP)Vlcg>	24270812	KOMP-Regeneron
multiple EGF-like-domains 10; targeted mutation 1, Velocigene	MGI:4454190	Megf10<tm1(KOMP)Vlcg>	27170117	KOMP-Regeneron
multiple EGF-like-domains 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431993	Megf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
multiple EGF-like-domains 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431993	Megf11<tm1a(EUCOMM)Wtsi>	22407321	EUCOMM
multiple EGF-like-domains 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433088	Megf11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
multiple EGF-like-domains 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419193	Megf6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
multiple EGF-like-domains 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365132	Megf9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
multiple EGF-like-domains 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365088	Megf9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
multiple EGF-like-domains 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299512	Megf9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
multiple endocrine neoplasia 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364261	Men1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
multiple endocrine neoplasia 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364289	Men1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
multiple endocrine neoplasia 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472808	Men1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
multivesicular body subunit 12A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441984	Mvb12a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
multivesicular body subunit 12A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441673	Mvb12a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
murinoglobulin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887634	Mug2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
murinoglobulin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887638	Mug2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
MUS81 structure-specific endonuclease subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432337	Mus81<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MUS81 structure-specific endonuclease subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431733	Mus81<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
muscle and microspikes RAS; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433491	Mras<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
muscleblind like splicing factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820383	Mbnl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
muscleblind like splicing factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820394	Mbnl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
muscle glycogen phosphorylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944541	Pygm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
muscle glycogen phosphorylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944513	Pygm<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
musculoskeletal, embryonic nuclear protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473008	Mustn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
musculoskeletal, embryonic nuclear protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472841	Mustn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
muskelin 1, intracellular mediator containing kelch motifs; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432038	Mkln1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mutL homolog 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692538	Mlh1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
mutS homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888951	Msh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mutS homolog 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842260	Msh5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
mutS homolog 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842327	Msh5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
mutY DNA glycosylase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840626	Mutyh<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
mutY DNA glycosylase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840589	Mutyh<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
MX dynamin-like GTPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431734	Mx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MX dynamin-like GTPase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432494	Mx1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MYB binding protein (P160) 1a; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548364	Mybbp1a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	20799038	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	22184403	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	24014243	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	24062447	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	25217698	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	25340873	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	25613381	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	26125289	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	26768662	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	28978033	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5896989	Mysm1<tm1b(KOMP)Wtsi>	22169041	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5896989	Mysm1<tm1b(KOMP)Wtsi>	25710881	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5896989	Mysm1<tm1b(KOMP)Wtsi>	26474655	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5896988	Mysm1<tm1c(KOMP)Wtsi>	26125289	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5896988	Mysm1<tm1c(KOMP)Wtsi>	26768662	KOMP-CSD
myb-like, SWIRM and MPN domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362635	Mysm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Myb/SANT-like DNA-binding domain containing 1; targeted mutation 1.1, Velocigene	MGI:5569075	Msantd1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Myb/SANT-like DNA-binding domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820242	Msantd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Myb/SANT-like DNA-binding domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820341	Msantd3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MYC-associated zinc finger protein (purine-binding transcription factor); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299562	Maz<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
MYC binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458840	Mycbp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MYC binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939712	Mycbp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myc target 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286392	Myct1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myelin-associated glycoprotein; targeted mutation 1.1, Velocigene	MGI:5576044	Mag<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
myelin-associated glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842494	Mag<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myelin basic protein expression factor 2, repressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432692	Myef2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myelin basic protein expression factor 2, repressor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432055	Myef2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myelin protein zero-like 1; targeted mutation 1.1, Velocigene	MGI:5695917	Mpzl1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
myelin protein zero-like 3; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4454034	Mpzl3<tm1(KOMP)Mbp>	24531688	KOMP-CSD
myelin regulatory factor-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441747	Myrfl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myelin regulatory factor-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441666	Myrfl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myelin transcription factor 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842524	Myt1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myelin transcription factor 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842377	Myt1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myelin transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362239	Myt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myelin transcription factor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364557	Myt1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
myeloblastosis oncogene-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431618	Mybl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myeloblastosis oncogene-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432144	Mybl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myeloblastosis oncogene-like 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511912	Mybl1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
myeloblastosis oncogene-like 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511889	Mybl1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
myeloblastosis oncogene-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085464	Mybl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myeloblastosis oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363214	Myb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myeloblastosis oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362226	Myb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myelocytomatosis oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302301	Myc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myeloid differentiation primary response gene 88; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434029	Myd88<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myeloid differentiation primary response gene 88; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432964	Myd88<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myeloid leukemia factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462599	Mlf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myeloid leukemia factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462598	Mlf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myeloid leukemia factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008025	Mlf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363553	Mllt10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299607	Mllt10<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548595	Mllt3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006766	Mllt6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myeloperoxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362976	Mpo<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myeloperoxidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548953	Mpo<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
myeloperoxidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362267	Mpo<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myocardin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433954	Myocd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myocardin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434383	Myocd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myocardin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4942150	Myocd<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
myocyte enhancer factor 2D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432226	Mef2d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myocyte enhancer factor 2D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434224	Mef2d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
MyoD family inhibitor domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286240	Mdfic<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myoglobin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451953	Mb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myoglobin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451956	Mb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myo-inositol 1-phosphate synthase A1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419387	Isyna1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
myo-inositol oxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430973	Miox<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1a, Mouse Biology Program, University of California, Davis	MGI:5444894	Mymk<tm1a(KOMP)Mbp>	25085416	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841277	Mymk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1c, Mouse Biology Program, University of California, Davis	MGI:6116818	Mymk<tm1c(KOMP)Mbp>	25085416	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1c, Mouse Biology Program, University of California, Davis	MGI:6116818	Mymk<tm1c(KOMP)Mbp>	28186492	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841439	Mymk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841439	Mymk<tm1e(KOMP)Wtsi>	23868259	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841439	Mymk<tm1e(KOMP)Wtsi>	25085416	KOMP-CSD
myomaker, myoblast fusion factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841439	Mymk<tm1e(KOMP)Wtsi>	28186492	KOMP-CSD
myomesin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452652	Myom1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myomesin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452671	Myom1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myomesin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013756	Myom2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myomesin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427152	Myom2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myomesin family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432251	Myom3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myomesin family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434521	Myom3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myomixer, myoblast fusion factor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431485	Mymx<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
myosin 1H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462578	Myo1h<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin 1H; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635249	Myo1h<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
myosin 1H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462616	Myo1h<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin binding protein C, cardiac; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435924	Mybpc3<tm1a(EUCOMM)Hmgu>	28239655	EUCOMM
myosin binding protein H-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364468	Mybphl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin binding protein H-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364468	Mybphl<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
myosin binding protein H-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548569	Mybphl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
myosin binding protein H-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548569	Mybphl<tm1b(KOMP)Wtsi>	27996060	KOMP-CSD
myosin binding protein H-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548569	Mybphl<tm1b(KOMP)Wtsi>	28778945	KOMP-CSD
myosin binding protein H-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363102	Mybphl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin binding protein H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362950	Mybph<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin binding protein H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362412	Mybph<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy chain 7B, cardiac muscle, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013737	Myh7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 10, non-muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433275	Myh10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, heavy polypeptide 13, skeletal muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299664	Myh13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 13, skeletal muscle; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299662	Myh13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431529	Myh14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, heavy polypeptide 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432017	Myh14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, heavy polypeptide 1, skeletal muscle, adult; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364447	Myh1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 1, skeletal muscle, adult; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364950	Myh1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 1, skeletal muscle, adult; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299579	Myh1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 1, skeletal muscle, adult; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299514	Myh1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 2, skeletal muscle, adult; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009573	Myh2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 2, skeletal muscle, adult; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009585	Myh2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 2, skeletal muscle, adult; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299676	Myh2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 2, skeletal muscle, adult; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299667	Myh2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 3, skeletal muscle, embryonic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000418	Myh3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, heavy polypeptide 4, skeletal muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420084	Myh4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 4, skeletal muscle; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419854	Myh4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 4, skeletal muscle; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472950	Myh4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, heavy polypeptide 7, cardiac muscle, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363697	Myh7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 7, cardiac muscle, beta; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4365229	Myh7<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 7, cardiac muscle, beta; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5299660	Myh7<tm4a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 7, cardiac muscle, beta; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:5299653	Myh7<tm4e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 8, skeletal muscle, perinatal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428592	Myh8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 8, skeletal muscle, perinatal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365124	Myh8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, heavy polypeptide 9, non-muscle; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432815	Myh9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IA; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000410	Myo1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IC; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433417	Myo1c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IC; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433860	Myo1c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IC; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4949359	Myo1c<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin ID; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5301387	Myo1d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin ID; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301380	Myo1d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin ID; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5301394	Myo1d<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IF; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000414	Myo1f<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IG; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441738	Myo1g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IG; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441829	Myo1g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IIIA; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948630	Myo3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin IIIA; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006741	Myo3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin IXa; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433267	Myo9a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin IXa; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636908	Myo9a<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
myosin IXb; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887586	Myo9b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin IXb; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949334	Myo9b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, light chain 12B, regulatory; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433200	Myl12b<tm1a(EUCOMM)Wtsi>	19525957	EUCOMM
myosin, light chain 12B, regulatory; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433200	Myl12b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, light polypeptide 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431641	Myl4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, light polypeptide 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433078	Myl4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, light polypeptide 6B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431590	Myl6b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin, light polypeptide 9, regulatory; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299665	Myl9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, light polypeptide 9, regulatory; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299663	Myl9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, light polypeptide kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362946	Mylk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin, light polypeptide kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364944	Mylk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin phosphatase Rho interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456831	Mprip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin regulatory light chain interacting protein; targeted mutation 1.1, Velocigene	MGI:5576056	Mylip<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
myosin VA; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5641704	Myo5a<tm1a(KOMP)Wtsi>	24721909	null
myosin VA; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363512	Myo5a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin VA; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363512	Myo5a<tm1e(KOMP)Wtsi>	23349704	KOMP-CSD
myosin VA; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363512	Myo5a<tm1e(KOMP)Wtsi>	25340873	KOMP-CSD
myosin VA; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847692	Myo5a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin VA; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847708	Myo5a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin VB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461468	Myo5b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin VB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461468	Myo5b<tm1a(KOMP)Wtsi>	26201991	KOMP-CSD
myosin VB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461468	Myo5b<tm1a(KOMP)Wtsi>	27019864	KOMP-CSD
myosin VB; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002984	Myo5b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin VB; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5003006	Myo5b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin VIIA; shaker 1, 6 Jackson	MGI:1860092	Myo7a<sh1-6J>	24721909	null
myosin VIIA; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431921	Myo7a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin VIIA; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433030	Myo7a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin VIIB; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5555872	Myo7b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
myosin VIIB; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5555872	Myo7b<tm1b(EUCOMM)Hmgu>	28700664	EUCOMM
myosin VI; Snell's waltzer	MGI:1856555	Myo6<sv>	24721909	null
myosin VI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434306	Myo6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin VI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432958	Myo6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin VI; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842285	Myo6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin VI; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4842650	Myo6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin X; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362586	Myo10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin X; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362586	Myo10<tm1a(KOMP)Wtsi>	29229982	KOMP-CSD
myosin X; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115837	Myo10<tm1c(KOMP)Wtsi>	29229982	KOMP-CSD
myosin X; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6115841	Myo10<tm1d(KOMP)Wtsi>	29229982	KOMP-CSD
myosin X; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364713	Myo10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin X; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:4362966	Myo10<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
myosin X; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:4362966	Myo10<tm2(KOMP)Wtsi>	23912999	KOMP-CSD
myosin X; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:4362966	Myo10<tm2(KOMP)Wtsi>	27932544	KOMP-CSD
myosin X; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:4362966	Myo10<tm2(KOMP)Wtsi>	28289096	KOMP-CSD
myosin XVB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419761	Myo15b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin XVB; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419409	Myo15b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin XVIIIA; gtargeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513803	Myo18a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
myosin XVIIIA; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419827	Myo18a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin XVIIIA; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419396	Myo18a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin XVI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841239	Myo16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myosin XVI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841265	Myo16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myosin XVI; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5473218	Myo16<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
myosin XV; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431637	Myo15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myosin XV; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432811	Myo15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myotrophin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451557	Mtpn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myotrophin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451272	Mtpn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427222	Mtmr11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427201	Mtmr12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 12; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692827	Mtmr12<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
myotubularin related protein 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427159	Mtmr12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362891	Mtmr14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363589	Mtmr14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364801	Mtmr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364766	Mtmr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455465	Mtmr1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455555	Mtmr1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
myotubularin related protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433302	Mtmr4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
myotubularin related protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434147	Mtmr4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
myozenin 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548708	Myoz1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
myristoylated alanine rich protein kinase C substrate; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299646	Marcks<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
myristoylated alanine rich protein kinase C substrate; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362772	Marcks<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
myristoylated alanine rich protein kinase C substrate; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299492	Marcks<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
myristoylated alanine rich protein kinase C substrate; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451337	Marcks<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
MYST/Esa1-associated factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433956	Meaf6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
MYST/Esa1-associated factor 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432410	Meaf6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
N-6 adenine-specific DNA methyltransferase 1 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842699	N6amt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-6 adenine-specific DNA methyltransferase 1 (putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847874	N6amt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NAC alpha domain containing; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362585	Nacad<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
N-acetyl galactosaminidase, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820246	Naga<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842803	Gnptab<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362890	Nagpa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-acetylglucosamine-1-phosphotransferase, gamma subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286226	Gnptg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-acetylglucosamine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441905	Nagk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetylglucosamine kinase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548501	Nagk<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
N-acetylglucosamine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451950	Nagk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetylglutamate synthase; targeted mutation 1, Velocigene	MGI:3847452	Nags<tm1(KOMP)Vlcg>	22503289	KOMP-Regeneron
N-acetylglutamate synthase; targeted mutation 1, Velocigene	MGI:3847452	Nags<tm1(KOMP)Vlcg>	27771289	KOMP-Regeneron
N-acetylneuraminate pyruvate lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433215	Npl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetylneuraminic acid phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939740	Nanp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-acetylneuraminic acid phosphatase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939708	Nanp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-acetyltransferase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050156	Nat10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-acetyl transferase 1; targeted mutation 1.1, Velocigene	MGI:5505902	Nat1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
N-acetyl transferase 1; targeted mutation 1.1, Velocigene	MGI:5505902	Nat1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
N-acetyl transferase 1; targeted mutation 1, Velocigene	MGI:4881104	Nat1<tm1(KOMP)Vlcg>	25798622	KOMP-Regeneron
N-acetyl transferase 1; targeted mutation 1, Velocigene	MGI:4881104	Nat1<tm1(KOMP)Vlcg>	27705799	KOMP-Regeneron
N-acetyltransferase 2 (arylamine N-acetyltransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433145	Nat2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetyltransferase 2 (arylamine N-acetyltransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431781	Nat2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006801	Nat3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetyltransferase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305623	Nat6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-acetyltransferase 8 (GCN5-related) family member 2; targeted mutation 1.1, Velocigene	MGI:5445781	Nat8f2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
N-acetyltransferase 8 (GCN5-related) family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842265	Nat8f4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetyltransferase 8 (GCN5-related) family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842539	Nat8f4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetyltransferase 8 (GCN5-related) family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141838	Nat8f5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetyltransferase 8 (GCN5-related) family member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637037	Nat8f5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
N-acetyltransferase 8-like; targeted mutation 1, Velocigene	MGI:3808552	Nat8l<tm1(KOMP)Vlcg>	28077719	KOMP-Regeneron
N-acetyltransferase 8-like; targeted mutation 1, Velocigene	MGI:3808552	Nat8l<tm1(KOMP)Vlcg>	29116375	KOMP-Regeneron
N-acetyltransferase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432892	Natd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-acetyltransferase domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548455	Natd1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
N-acetyltransferase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433643	Natd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
N-acylethanolamine acid amidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419604	Naaa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-acylethanolamine acid amidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419156	Naaa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-acyl phosphatidylethanolamine phospholipase D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451315	Napepld<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-acyl phosphatidylethanolamine phospholipase D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451572	Napepld<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419408	Ndufa11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420003	Ndufa11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419981	Ndufa2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419583	Ndufa4l2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419365	Ndufa5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842584	Ndufa6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842747	Ndufa6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431433	Ndufa7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548563	Ndufa8<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841337	Ndufa9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939689	Ndufaf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939719	Ndufaf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008054	Ndufaf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex assembly factor 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820288	Ndufaf7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex assembly factor 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820302	Ndufaf7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427192	Ndufb11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427145	Ndufb11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840606	Ndufb3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451549	Ndufb4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451436	Ndufb4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419847	Ndufb7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432457	Ndufb8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434213	Ndufb8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433125	Ndufaf6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456753	Ndufaf6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) Fe-S protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548814	Ndufs1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
NADH dehydrogenase (ubiquinone) Fe-S protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433795	Ndufs3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) Fe-S protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433021	Ndufs3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) Fe-S protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842325	Ndufs4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) Fe-S protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842382	Ndufs4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADH dehydrogenase (ubiquinone) Fe-S protein 7; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5609354	Ndufs7<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
NAD kinase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842252	Nadk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NAD kinase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842252	Nadk2<tm1a(EUCOMM)Wtsi>	28923496	EUCOMM
NAD kinase 2, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842552	Nadk2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NAD kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431680	Nadk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NAD kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433269	Nadk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NAD(P) dependent steroid dehydrogenase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432941	Nsdhl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NAD(P) dependent steroid dehydrogenase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432966	Nsdhl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NAD(P)H dehydrogenase, quinone 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441762	Nqo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NAD(P)H dehydrogenase, quinone 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441676	Nqo1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADPH dependent diflavin oxidoreductase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433787	Ndor1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADPH oxidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433133	Nox1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADPH oxidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434080	Nox1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADPH oxidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431920	Nox3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NADPH oxidase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434200	Nox3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NADPH oxidase organizer 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419707	Noxo1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NAD synthetase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364569	Nadsyn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NAD synthetase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548698	Nadsyn1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
naked cuticle 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841216	Nkd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Na+/K+ transporting ATPase interacting 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841016	Nkain2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Na+/K+ transporting ATPase interacting 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841171	Nkain2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Na+/K+ transporting ATPase interacting 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427191	Nkain3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Na+/K+ transporting ATPase interacting 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430965	Nkain3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 16, NatA auxiliary subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431511	Naa16<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 20, NatB catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420100	Naa20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 20, NatB catalytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419926	Naa20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 35, NatC auxiliary subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362143	Naa35<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 35, NatC auxiliary subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363915	Naa35<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 35, NatC auxiliary subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362589	Naa35<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 35, NatC auxiliary subunit; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363368	Naa35<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 38, NatC auxiliary subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419811	Naa38<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
N(alpha)-acetyltransferase 60, NatF catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460424	Naa60<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N(alpha)-acetyltransferase 60, NatF catalytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461711	Naa60<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Nanog homeobox; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451256	Nanog<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Nanog homeobox; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451378	Nanog<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
natriuretic peptide receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432115	Npr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
natriuretic peptide receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433390	Npr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
natriuretic peptide type A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419319	Nppa<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
natriuretic peptide type B; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456595	Nppb<tm1(KOMP)Mbp>	23704570	KOMP-CSD
natural killer cell group 7 sequence; targeted mutation 1.1, Velocigene	MGI:5548721	Nkg7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
NCK associated protein 1 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841323	Nckap1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NCK associated protein 1 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841049	Nckap1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NCK-associated protein 5-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433150	Nckap5l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NCK-associated protein 5-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432210	Nckap5l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NCK-associated protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299618	Nckap5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NCK-associated protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299541	Nckap5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NDC80 kinetochore complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454070	Ndc80<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NDC80 kinetochore complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454167	Ndc80<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085348	Ndst1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944343	Ndst2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944374	Ndst2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363360	Ndst3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362934	Ndst3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451532	Ndst4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
nebulette; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5603346	Nebl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nebulin-related anchoring protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364617	Nrap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nebulin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050882	Neb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nebulin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5289801	Neb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nectin cell adhesion molecule 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433239	Nectin3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NEDD4 binding protein 2-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419315	N4bp2l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NEDD4 binding protein 2-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419605	N4bp2l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NEDD4 binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433691	N4bp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NEDD4 binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434447	N4bp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NEDD4 binding protein 3; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548805	N4bp3<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
Nedd4 family interacting protein 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436082	Ndfip2<tm1a(EUCOMM)Hmgu>	27048792	EUCOMM
Nedd4 family interacting protein 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548666	Ndfip2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
NEDD8 activating enzyme E1 subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434194	Nae1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NEDD8 activating enzyme E1 subunit 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548785	Nae1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
NEDD8 activating enzyme E1 subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434209	Nae1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
negative elongation factor complex member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433888	Nelfb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
negative elongation factor complex member E, Rdbp; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842623	Nelfe<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
negative elongation factor complex member E, Rdbp; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842266	Nelfe<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
negative regulator of reactive oxygen species; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364197	Nrros<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nei endonuclease VIII-like 1 (E. coli); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842497	Neil1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nei endonuclease VIII-like 1 (E. coli); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842508	Neil1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neighbor of Brca1 gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362162	Nbr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neighbor of Brca1 gene 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548384	Nbr1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
neighbor of Brca1 gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364887	Nbr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neighbor of Brca1 gene 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363954	Nbr1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
neighbor of Brca1 gene 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365086	Nbr1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
nei like 3 (E. coli); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364119	Neil3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nemo like kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363009	Nlk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nemo like kinase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4454071	Nlk<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
nemo like kinase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4454071	Nlk<tm2a(KOMP)Wtsi>	27764156	KOMP-CSD
nemo like kinase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4454071	Nlk<tm2a(KOMP)Wtsi>	27879317	KOMP-CSD
nemo like kinase; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5788454	Nlk<tm2c(KOMP)Wtsi>	27764156	KOMP-CSD
nemo like kinase; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5788454	Nlk<tm2c(KOMP)Wtsi>	27879317	KOMP-CSD
nemo like kinase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4454123	Nlk<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
nephrocan; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840977	Nepn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nephrocan; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841243	Nepn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nephronophthisis 1 (juvenile) homolog (human); targeted mutation 1.1, Velocigene	MGI:5695906	Nphp1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nephrosis 1, nephrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286221	Nphs1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nephrosis 1, nephrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293917	Nphs1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nerve growth factor receptor (TNFR superfamily, member 16); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432054	Ngfr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nerve growth factor receptor (TNFR superfamily, member 16); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637211	Ngfr<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
nerve growth factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847853	Ngf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nerve growth factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847880	Ngf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nescient helix loop helix 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419578	Nhlh1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nescient helix loop helix 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419285	Nhlh1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nescient helix loop helix 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5637212	Nhlh2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
nestin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419143	Nes<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nestin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520173	Nes<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
nestin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520173	Nes<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
nestin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520173	Nes<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
nestin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420051	Nes<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-ethylmaleimide sensitive fusion protein attachment protein gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938592	Napg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-ethylmaleimide sensitive fusion protein; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5446014	Nsf<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
netrin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840942	Ntn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
netrin 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548502	Ntn4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
neugrin, neurite outgrowth associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940742	Ngrn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neugrin, neurite outgrowth associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940787	Ngrn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neural cell adhesion molecule 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511978	Ncam2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
neural cell adhesion molecule 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511953	Ncam2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
neuralized E3 ubiquitin protein ligase 2; targeted mutation 1.1, Velocigene	MGI:5578489	Neurl2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
neuralized E3 ubiquitin protein ligase 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299552	Neurl4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
neural precursor cell expressed, developmentally down-regulated gene 4-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363447	Nedd4l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neural precursor cell expressed, developmentally down-regulated gene 4-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637104	Nedd4l<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
neural precursor cell expressed, developmentally down-regulated gene 4-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362848	Nedd4l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neural precursor cell expressed, developmentally down-regulated gene 8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419469	Nedd8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
neuraminidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441652	Neu1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neuraminidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441652	Neu1<tm1a(EUCOMM)Wtsi>	28442549	EUCOMM
neuraminidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441774	Neu1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neuraminidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363879	Neu2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuraminidase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362861	Neu2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuraminidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287804	Neu3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuraminidase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427165	Neu3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurexin I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008771	Nrxn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurexin I; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636923	Nrxn1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
neurexophilin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461720	Nxph3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurexophilin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461669	Nxph3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurexophilin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363267	Nxph4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurexophilin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364408	Nxph4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurexophilin 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472872	Nxph4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
neurexophilin and PC-esterase domain family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365034	Nxpe2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurexophilin and PC-esterase domain family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363164	Nxpe2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurexophilin and PC-esterase domain family, member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847689	Nxpe2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
neurexophilin and PC-esterase domain family, member 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5293955	Nxpe2<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
neurexophilin and PC-esterase domain family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433447	Nxpe5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurexophilin and PC-esterase domain family, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433305	Nxpe5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurite extension and migration factor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419911	Nexmif<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
neuritin 1-like; targeted mutation 1.1, Velocigene	MGI:5554940	Nrn1l<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
neuritin 1-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840600	Nrn1l<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
neuritin 1-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840701	Nrn1l<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
neuritin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456739	Nrn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neuritin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456853	Nrn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurobeachin like 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419928	Nbeal1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
neurobeachin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461705	Nbeal2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurobeachin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461705	Nbeal2<tm1a(EUCOMM)Wtsi>	25258341	EUCOMM
neurobeachin-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461757	Nbeal2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neuroblastoma, suppression of tumorigenicity 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451955	Nbl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neuroblastoma, suppression of tumorigenicity 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452801	Nbl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurocalcin delta; targeted mutation 1.1, Velocigene	MGI:5468989	Ncald<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
neurocalcin delta; targeted mutation 1.1, Velocigene	MGI:5468989	Ncald<tm1.1(KOMP)Vlcg>	28132687	KOMP-Regeneron
neurocalcin delta; targeted mutation 1.1, Velocigene	MGI:5468989	Ncald<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
neurocan; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432167	Ncan<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurocan; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431893	Ncan<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurochondrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052493	Ncdn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurofibromin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364806	Nf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurofibromin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364806	Nf1<tm1a(KOMP)Wtsi>	25340873	KOMP-CSD
neurofibromin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364806	Nf1<tm1a(KOMP)Wtsi>	27482814	KOMP-CSD
neurofibromin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363507	Nf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurofibromin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363467	Nf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurofibromin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363063	Nf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurofilament, heavy polypeptide; targeted mutation 1.1, Velocigene	MGI:5445744	Nefh<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
neurofilament, heavy polypeptide; targeted mutation 1.1, Velocigene	MGI:5445744	Nefh<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
neurogenic differentiation 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419916	Neurod2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurogenic differentiation 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419948	Neurod2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurogenic differentiation 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940803	Neurod4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurogenic differentiation 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299640	Neurod6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurogenin 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419303	Neurog2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
neuroglobin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431750	Ngb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neuroglobin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431604	Ngb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neuroguidin, EIF4E binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052489	Ngdn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neuroguidin, EIF4E binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052512	Ngdn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neuromedin S; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420091	Nms<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuromedin S; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419920	Nms<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuromedin S; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299645	Nms<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
neuromedin S; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299641	Nms<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
neuromedin S; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5472995	Nms<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
neuromedin U receptor 1; targeted mutation 1.1, Velocigene	MGI:5548449	Nmur1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
neuromedin U receptor 1; targeted mutation 1.1, Velocigene	MGI:5548449	Nmur1<tm1.1(KOMP)Vlcg>	28869965	KOMP-Regeneron
neuromedin U receptor 1; targeted mutation 1.1, Velocigene	MGI:5548449	Nmur1<tm1.1(KOMP)Vlcg>	28869974	KOMP-Regeneron
neuromedin U receptor 1; targeted mutation 1.1, Velocigene	MGI:5548449	Nmur1<tm1.1(KOMP)Vlcg>	28902842	KOMP-Regeneron
neuronal calcium sensor 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548385	Ncs1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
neuronal cell adhesion molecule; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362165	Nrcam<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal cell adhesion molecule; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363437	Nrcam<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal cell adhesion molecule; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431413	Nrcam<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal cell adhesion molecule; targeted mutation 2e.1, Wellcome Trust Sanger Institute	MGI:5488665	Nrcam<tm2e.1(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal cell adhesion molecule; targeted mutation 2e.1, Wellcome Trust Sanger Institute	MGI:5488665	Nrcam<tm2e.1(KOMP)Wtsi>	27626380	KOMP-CSD
neuronal cell adhesion molecule; targeted mutation 2e.1, Wellcome Trust Sanger Institute	MGI:5488665	Nrcam<tm2e.1(KOMP)Wtsi>	28700664	KOMP-CSD
neuronal cell adhesion molecule; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431434	Nrcam<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal growth regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451714	Negr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal growth regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451714	Negr1<tm1a(KOMP)Wtsi>	26839965	KOMP-CSD
neuronal growth regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451714	Negr1<tm1a(KOMP)Wtsi>	27940359	KOMP-CSD
neuronal growth regulator 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692835	Negr1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
neuronal growth regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841398	Negr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal growth regulator 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299671	Negr1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286236	Npas1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050877	Npas2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427137	Npas2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887594	Npas3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887615	Npas3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420023	Npas4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419486	Npas4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal PAS domain protein 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473111	Npas4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
neuronal PAS domain protein 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472821	Npas4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
neuronal pentraxin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052405	Nptx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal pentraxin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473046	Nptx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neuronal pentraxin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472862	Nptx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neuronal pentraxin receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944393	Nptxr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal pentraxin receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944390	Nptxr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal regeneration related protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419642	Nrep<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal regeneration related protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419974	Nrep<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal regeneration related protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473114	Nrep<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888875	Nyap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938521	Nyap2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880893	Nyap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880938	Nyap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuronatin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363800	Nnat<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuronatin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362508	Nnat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuron navigator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014609	Nav3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuron navigator 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427163	Nav3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuron specific gene family member 1; targeted mutation 1.1, Velocigene	MGI:5695882	Nsg1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
neuron specific gene family member 1; targeted mutation 1, Velocigene	MGI:5292862	Nsg1<tm1(KOMP)Vlcg>	28299779	KOMP-Regeneron
neuro-oncological ventral antigen 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4868845	Nova1<tm1a(EUCOMM)Hmgu>	27635635	EUCOMM
neuro-oncological ventral antigen 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5812231	Nova1<tm1c(EUCOMM)Hmgu>	27635635	EUCOMM
neuro-oncological ventral antigen 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419729	Nova2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuro-oncological ventral antigen 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419729	Nova2<tm1a(KOMP)Wtsi>	27635635	KOMP-CSD
neuro-oncological ventral antigen 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5812233	Nova2<tm1c(KOMP)Wtsi>	27635635	KOMP-CSD
neuro-oncological ventral antigen 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419099	Nova2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuropeptide S receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880994	Npsr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuropeptide Y receptor Y1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419412	Npy1r<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
neuropeptide Y receptor Y4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820075	Npy4r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuropeptide Y receptor Y4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820068	Npy4r<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neuropilin (NRP) and tolloid (TLL)-like 1; targeted mutation 1, Velocigene	MGI:3799763	Neto1<tm1(KOMP)Vlcg>	21623363	KOMP-Regeneron
neuropilin (NRP) and tolloid (TLL)-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085351	Neto2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neuroplastin; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4455733	Nptn<tm1a(EUCOMM)Hmgu>	27581460	EUCOMM
neuroplastin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548382	Nptn<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
neuroplastin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548382	Nptn<tm1b(EUCOMM)Hmgu>	26740663	EUCOMM
neuroplastin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548382	Nptn<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
neuroplastin; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548382	Nptn<tm1b(EUCOMM)Hmgu>	29056295	EUCOMM
neurotensin receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888947	Ntsr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurotensin receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888939	Ntsr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurotensin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451664	Nts<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurotensin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451697	Nts<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurotrophic tyrosine kinase, receptor, type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887687	Ntrk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurotrophic tyrosine kinase, receptor, type 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637213	Ntrk1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
neurotrophic tyrosine kinase, receptor, type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887694	Ntrk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurotrophic tyrosine kinase, receptor, type 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511157	Ntrk1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
neurotrophic tyrosine kinase, receptor, type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460486	Ntrk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neurotrophic tyrosine kinase, receptor, type 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637214	Ntrk2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
neurotrophic tyrosine kinase, receptor, type 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460491	Ntrk2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neurotrophin 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548954	Ntf5<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
neurotrophin 5; targeted mutation 1, Velocigene	MGI:5051368	Ntf5<tm1(KOMP)Vlcg>	23224557	KOMP-Regeneron
neurotrophin 5; targeted mutation 1, Velocigene	MGI:5051368	Ntf5<tm1(KOMP)Vlcg>	25525881	KOMP-Regeneron
neurotrophin receptor associated death domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451460	Nradd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neurotrophin receptor associated death domain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451284	Nradd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neurturin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458846	Nrtn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neutrophil cytosolic factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432766	Ncf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
neutrophil cytosolic factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434415	Ncf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
neutrophil cytosolic factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841143	Ncf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
neutrophil cytosolic factor 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692579	Ncf4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
neutrophil cytosolic factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841104	Ncf4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
neutrophilic granule protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451346	Ngp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nexilin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5303176	Nexn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NFKB activating protein-like; targeted mutation 1, Velocigene	MGI:4415546	Nkapl<tm1(KOMP)Vlcg>	25875095	KOMP-Regeneron
NFKB inhibitor interacting Ras-like protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432279	Nkiras2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NFKB inhibitor interacting Ras-like protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433384	Nkiras2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NFU1 iron-sulfur cluster scaffold; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840988	Nfu1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NFU1 iron-sulfur cluster scaffold; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841334	Nfu1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ngfi-A binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364276	Nab1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ngfi-A binding protein 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548375	Nab2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Ngg1 interacting factor 3-like 1 (S. pombe); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432373	Nif3l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ngg1 interacting factor 3-like 1 (S. pombe); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431988	Nif3l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
N-glycanase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362520	Ngly1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-glycanase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363146	Ngly1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-glycanase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362656	Ngly1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
NHL repeat containing 1; targeted mutation 1, Velocigene	MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	20538597	KOMP-Regeneron
NHL repeat containing 1; targeted mutation 1, Velocigene	MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	21882344	KOMP-Regeneron
NHL repeat containing 1; targeted mutation 1, Velocigene	MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	22186021	KOMP-Regeneron
NHL repeat containing 1; targeted mutation 1, Velocigene	MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	24452334	KOMP-Regeneron
NHL repeat containing 1; targeted mutation 1, Velocigene	MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	24914213	KOMP-Regeneron
NHL repeat containing 1; targeted mutation 1, Velocigene	MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	25059425	KOMP-Regeneron
NHL repeat containing 1; targeted mutation 1, Velocigene	MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	25416783	KOMP-Regeneron
NHL repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419640	Nhlrc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NHP2 ribonucleoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362251	Nhp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NHP2 ribonucleoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364446	Nhp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nibrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050860	Nbn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nicastrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452808	Ncstn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nicastrin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452809	Ncstn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nicolin 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419350	Nicn1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nicotinamide N-methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841036	Nnmt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nicotinamide nucleotide adenylyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431754	Nmnat1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nicotinamide nucleotide adenylyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433694	Nmnat1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nicotinamide phosphoribosyltransferase; targeted mutation 1.1, Velocigene	MGI:5548712	Nampt<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nicotinamide phosphoribosyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949358	Nampt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nicotinamide riboside kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419121	Nmrk1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nicotinamide riboside kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419710	Nmrk1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nicotinamide riboside kinase 2; targeted mutation 1.1, Velocigene	MGI:5471953	Nmrk2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nicotinamide riboside kinase 2; targeted mutation 1.1, Velocigene	MGI:5471953	Nmrk2<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
nicotinamide riboside kinase 2; targeted mutation 1, Velocigene	MGI:4842902	Nmrk2<tm1(KOMP)Vlcg>	28842432	KOMP-Regeneron
nidogen 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363401	Nid2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nidogen 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363539	Nid2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nidogen 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511934	Nid2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
nidogen 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511903	Nid2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
Nik related kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364675	Nrk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NIMA (never in mitosis gene a)-related expressed kinase 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362559	Nek11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NIMA (never in mitosis gene a)-related expressed kinase 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5578488	Nek11<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
NIMA (never in mitosis gene a)-related expressed kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362681	Nek2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NIMA (never in mitosis gene a)-related expressed kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432332	Nek3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NIMA (never in mitosis gene a)-related expressed kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431577	Nek3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NIMA (never in mitosis gene a)-related expressed kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140488	Nek4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NIMA (never in mitosis gene a)-related expressed kinase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433670	Nek9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NIMA (never in mitosis gene a)-related expressed kinase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433094	Nek9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NIMA (never in mitosis gene a)-related expressed kinase 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434290	Nek9<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
NIMA (never in mitosis gene a)- related kinase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363663	Nek10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NIMA (never in mitosis gene a)- related kinase 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364055	Nek10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NIN1/RPN12 binding protein 1 homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363463	Nob1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NIN1/RPN12 binding protein 1 homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362717	Nob1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NIN1/RPN12 binding protein 1 homolog; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472895	Nob1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
NIN1/RPN12 binding protein 1 homolog; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5473217	Nob1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
ninein-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432125	Ninl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ninein-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432125	Ninl<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
ninein-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432662	Ninl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ninein-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433740	Ninl<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ninein-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433740	Ninl<tm2a(EUCOMM)Wtsi>	24652767	EUCOMM
ninjurin 1; tarbeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5519238	Ninj1<tm1b(KOMP)Wtsi>	23690620	KOMP-CSD
ninjurin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362260	Ninj1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ninjurin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362260	Ninj1<tm1a(KOMP)Wtsi>	23690620	KOMP-CSD
ninjurin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362260	Ninj1<tm1a(KOMP)Wtsi>	26275310	KOMP-CSD
ninjurin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363428	Ninj1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ninjurin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451377	Ninj2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ninjurin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451406	Ninj2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NIP7, nucleolar pre-rRNA processing protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419536	Nip7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NIPA-like domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455949	Nipal4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NIPA-like domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456043	Nipal4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NIPBL cohesin loading factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842326	Nipbl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NIPBL cohesin loading factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842460	Nipbl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nipsnap homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431806	Nipsnap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nipsnap homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433189	Nipsnap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nipsnap homolog 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944344	Nipsnap3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nipsnap homolog 3A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637068	Nipsnap3a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
nitric oxide associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014581	Noa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nitric oxide synthase 1 (neuronal) adaptor protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013740	Nos1ap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nitric oxide synthase 1 (neuronal) adaptor protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548603	Nos1ap<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
nitric oxide synthase 2, inducible; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947827	Nos2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nitric oxide synthase 2, inducible; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5432210	Nos2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nitrogen fixation gene 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441880	Nfs1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nitrogen fixation gene 1 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441996	Nfs1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nitrogen permease regulator-like 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419370	Nprl2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nitrogen permease regulator-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432440	Nprl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nitrogen permease regulator-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433909	Nprl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NK2 homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009659	Nkx2-2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NK2 homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009662	Nkx2-2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NK2 homeobox 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442010	Nkx2-3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NK2 homeobox 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286400	Nkx2-5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NK2 homeobox 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299879	Nkx2-5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NK2 homeobox 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458554	Nkx2-6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NK2 homeobox 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458519	Nkx2-6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NK3 homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5430969	Nkx3-1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NK3 homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430964	Nkx3-1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NK3 homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363537	Nkx3-2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NK3 homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364421	Nkx3-2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NK3 homeobox 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472994	Nkx3-2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
NK3 homeobox 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472831	Nkx3-2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
NK6 homeobox 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453754	Nkx6-3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NK6 homeobox 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453772	Nkx6-3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NLR family, apoptosis inhibitory protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451502	Naip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, apoptosis inhibitory protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451597	Naip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950976	Nlrp10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 12; C57BL/6J	MGI:5817983	Nlrp12<C57BL/6J>	23902802	null
NLR family, pyrin domain containing 12; C57BL/6N	MGI:5818576	Nlrp12<C57BL/6N>	23902802	null
NLR family, pyrin domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307093	Nlrp1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427126	Nlrp1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880891	Nlrp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294959	Nlrp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050874	Nlrp4c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 4E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364645	Nlrp4e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 4E; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4843834	Nlrp4e<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 4E; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473021	Nlrp4e<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
NLR family, pyrin domain containing 4F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842885	Nlrp4f<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NLR family, pyrin domain containing 4F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842582	Nlrp4f<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NLR family, pyrin domain containing 9A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434500	Nlrp9a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NLR family, pyrin domain containing 9B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841142	Nlrp9b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 9B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841142	Nlrp9b<tm1a(KOMP)Wtsi>	28636595	KOMP-CSD
NLR family, pyrin domain containing 9B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637166	Nlrp9b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
NLR family, pyrin domain containing 9B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5910443	Nlrp9b<tm1c(KOMP)Wtsi>	28636595	KOMP-CSD
NLR family, pyrin domain containing 9B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4843854	Nlrp9b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 9C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362842	Nlrp9c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 9C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840951	Nlrp9c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 9C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841416	Nlrp9c<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 9C; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4841215	Nlrp9c<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
NLR family, pyrin domain containing 9C; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4841414	Nlrp9c<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
NMD3 ribosome export adaptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431636	Nmd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NMDA receptor synaptonuclear signaling and neuronal migration factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363881	Nsmf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NMDA receptor synaptonuclear signaling and neuronal migration factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363881	Nsmf<tm1a(KOMP)Wtsi>	25731822	KOMP-CSD
NME/NM23 family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052499	Nme5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NME/NM23 family member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140465	Nme5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NME/NM23 family member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363548	Nme8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NME/NM23 nucleoside diphosphate kinase 2; targeted mutation 1.1, Velocigene	MGI:5582447	Nme2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
NME/NM23 nucleoside diphosphate kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842269	Nme2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NME/NM23 nucleoside diphosphate kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842399	Nme2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NME/NM23 nucleoside diphosphate kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441641	Nme4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NME/NM23 nucleoside diphosphate kinase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441759	Nme4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NME/NM23 nucleoside diphosphate kinase 6; targeted mutation 1.1, Velocigene	MGI:5565612	Nme6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
NME/NM23 nucleoside diphosphate kinase 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419902	Nme6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
N-methylpurine-DNA glycosylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432493	Mpg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-methylpurine-DNA glycosylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431872	Mpg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NmrA-like family domain containing 1; targeted mutation 1.1, Velocigene	MGI:5695916	Nmral1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
N-myc (and STAT) interactor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432682	Nmi<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-myc (and STAT) interactor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433865	Nmi<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
N-myc downstream regulated gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299515	Ndrg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-myc downstream regulated gene 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299659	Ndrg1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
N-myc downstream regulated gene 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299651	Ndrg1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
N-myc downstream regulated gene 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419206	Ndrg2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
N-myc downstream regulated gene 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362598	Ndrg3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-myc downstream regulated gene 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363475	Ndrg3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-myc downstream regulated gene 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362496	Ndrg4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-myc downstream regulated gene 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637125	Ndrg4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
N-myc downstream regulated gene 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363762	Ndrg4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-myristoyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880902	Nmt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-myristoyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880980	Nmt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NOBOX oogenesis homeobox; targeted mutation 1.1, Velocigene	MGI:5605743	Nobox<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
NOBOX oogenesis homeobox; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842756	Nobox<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NOBOX oogenesis homeobox; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5014562	Nobox<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
NOC3 like DNA replication regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419453	Noc3l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NOC3 like DNA replication regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420072	Noc3l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nocturnin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451514	Noct<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nocturnin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451443	Noct<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nodal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433629	Nodal<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nodal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433959	Nodal<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	22144916	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	23401851	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	25340873	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	28041877	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5310947	Nsun2<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5310947	Nsun2<tm1c(EUCOMM)Wtsi>	22144916	EUCOMM
NOL1/NOP2/Sun domain family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434494	Nsun2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842329	Nsun3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842591	Nsun3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431563	Nsun5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431532	Nsun5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family, member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432758	Nsun5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family, member 5; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5635257	Nsun5<tm2b(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family, member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432599	Nsun5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
NOL1/NOP2/Sun domain family, member 7; targeted mutation 1.1, Velocigene	MGI:5554926	Nsun7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
NOL1/NOP2/Sun domain family, member 7; targeted mutation 1.1, Velocigene	MGI:5554926	Nsun7<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
non-catalytic region of tyrosine kinase adaptor protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140496	Nck1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
non-catalytic region of tyrosine kinase adaptor protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140473	Nck1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
non imprinted in Prader-Willi/Angelman syndrome 1 homolog (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363744	Nipa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
non imprinted in Prader-Willi/Angelman syndrome 1 homolog (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363744	Nipa1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
non imprinted in Prader-Willi/Angelman syndrome 1 homolog (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362823	Nipa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
non imprinted in Prader-Willi/Angelman syndrome 1 homolog (human); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364697	Nipa1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
non imprinted in Prader-Willi/Angelman syndrome 2 homolog (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014692	Nipa2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin I complex, subunit D2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842488	Ncapd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin I complex, subunit D2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842443	Ncapd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin I complex, subunit G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433683	Ncapg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin I complex, subunit G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433967	Ncapg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin I complex, subunit H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431609	Ncaph<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin I complex, subunit H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433057	Ncaph<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin II complex, subunit H2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433039	Ncaph2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
non-SMC condensin II complex, subunit H2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433039	Ncaph2<tm1a(EUCOMM)Wtsi>	25961503	EUCOMM
non-SMC condensin II complex, subunit H2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433869	Ncaph2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NOP10 ribonucleoprotein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424648	Nop10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
NOP14 nucleolar protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441743	Nop14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NOP2 nucleolar protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842662	Nop2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NOP2 nucleolar protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842418	Nop2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NOP9 nucleolar protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426629	Nop9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NOP9 nucleolar protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426565	Nop9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
notch 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441647	Notch1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
notch 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442025	Notch1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
notch 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455984	Notch2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
notch 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456057	Notch2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
notch 3; targeted mutation 1.1, Velocigene	MGI:5695981	Notch3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
notch 4; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766166	Notch4<tm1b(NCOM)Mfgc>	27626380	NorCOMM
notch 4; targeted mutation 1, Velocigene	MGI:4842905	Notch4<tm1(KOMP)Vlcg>	24667410	KOMP-Regeneron
notchless homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363782	Nle1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
notchless homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362756	Nle1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Notch-regulated ankyrin repeat protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473161	Nrarp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
notochord homeobox; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473128	Noto<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
notochord homeobox; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472709	Noto<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
notum palmitoleoyl-protein carboxylesterase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434426	Notum<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
notum palmitoleoyl-protein carboxylesterase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434163	Notum<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NPC1 like intracellular cholesterol transporter 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4842197	Npc1l1<tm1a(EUCOMM)Hmgu>	24336247	EUCOMM
NPC intracellular cholesterol transporter 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636924	Npc1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
NPC intracellular cholesterol transporter 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451994	Npc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NPC intracellular cholesterol transporter 2; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5513806	Npc2<tm1e.1(EUCOMM)Wtsi>	27626380	EUCOMM
NPC intracellular cholesterol transporter 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451979	Npc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NPL4 homolog, ubiquitin recognition factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432939	Nploc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NPL4 homolog, ubiquitin recognition factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433250	Nploc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nrde-2 necessary for RNA interference, domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319845	Nrde2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nrde-2 necessary for RNA interference, domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365254	Nrde2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nrde-2 necessary for RNA interference, domain containing; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4843855	Nrde2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
nrde-2 necessary for RNA interference, domain containing; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4843850	Nrde2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
NSL1, MIS12 kinetochore complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433144	Nsl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-sulfoglucosamine sulfohydrolase (sulfamidase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841056	Sgsh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-sulfoglucosamine sulfohydrolase (sulfamidase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841056	Sgsh<tm1a(KOMP)Wtsi>	28418018	KOMP-CSD
N-terminal EF-hand calcium binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305672	Necab1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-terminal EF-hand calcium binding protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306505	Necab1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
N-terminal EF-hand calcium binding protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5305681	Necab1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
N-terminal EF-hand calcium binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363790	Necab2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
N-terminal EF-hand calcium binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363790	Necab2<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
N-terminal EF-hand calcium binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364234	Necab2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
N-terminal EF-hand calcium binding protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364760	Necab2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
N-terminal Xaa-Pro-Lys N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141841	Ntmt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
N-terminal Xaa-Pro-Lys N-methyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5285742	Ntmt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nth (endonuclease III)-like 1 (E.coli); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433960	Nthl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NUAK family, SNF1-like kinase, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363559	Nuak1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NUAK family, SNF1-like kinase, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363866	Nuak1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NUAK family, SNF1-like kinase, 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433806	Nuak2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NUAK family, SNF1-like kinase, 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433024	Nuak2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear antigen Sp100; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455607	Sp100<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear antigen Sp100; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455618	Sp100<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear antigen Sp100; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5424654	Sp100<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear autoantigenic sperm protein (histone-binding); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006782	Nasp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear cap binding protein subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432509	Ncbp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear cap binding protein subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432425	Ncbp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear cap binding subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433298	Ncbp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear cap binding subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847869	Ncbp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear export mediator factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5488789	Nemf<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
nuclear export mediator factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5488789	Nemf<tm1b(EUCOMM)Hmgu>	28700664	EUCOMM
nuclear factor, erythroid derived 2,-like 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4455823	Nfe2l1<tm1a(EUCOMM)Hmgu>	29149604	EUCOMM
nuclear factor, erythroid derived 2,-like 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6101514	Nfe2l1<tm1c(EUCOMM)Hmgu>	29149604	EUCOMM
nuclear factor, erythroid derived 2, like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451349	Nfe2l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor, erythroid derived 2, like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451349	Nfe2l2<tm1a(KOMP)Wtsi>	29149604	KOMP-CSD
nuclear factor, erythroid derived 2, like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451537	Nfe2l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor I/B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5303179	Nfib<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor, interleukin 3, regulated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453723	Nfil3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor, interleukin 3, regulated; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820258	Nfil3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor of activated T cells 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451440	Nfat5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of activated T cells 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635252	Nfat5<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of activated T cells 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451679	Nfat5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420088	Nfatc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458615	Nfatc1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434272	Nfatc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432888	Nfatc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548344	Nfatc3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4; targeted mutation 1.1, Velocigene	MGI:5554925	Nfatc4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363738	Nfkb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363738	Nfkb1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364321	Nfkb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363753	Nfkb2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289811	Nfkbia<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426564	Nfkbia<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432464	Nfkbid<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432464	Nfkbid<tm1a(EUCOMM)Wtsi>	22761313	EUCOMM
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432823	Nfkbid<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419526	Nfkbie<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452665	Nfkbie<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452680	Nfkbie<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286210	Nfkbil1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286210	Nfkbil1<tm1a(KOMP)Wtsi>	27233670	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293911	Nfkbil1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140482	Nfkbiz<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear factor related to kappa B binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431932	Nfrkb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear fragile X mental retardation protein interacting protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840629	Nufip2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear fragile X mental retardation protein interacting protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840636	Nufip2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear GTPase, germinal center associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432652	Nuggc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear GTPase, germinal center associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433226	Nuggc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear pore membrane protein 121; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944504	Pom121<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear pore membrane protein 121; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944500	Pom121<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear prelamin A recognition factor-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431632	Narfl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear prelamin A recognition factor-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431811	Narfl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear protein in the AT region; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433158	Npat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear protein in the AT region; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636907	Npat<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
nuclear protein in the AT region; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431545	Npat<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434528	Nrbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434297	Nrbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472699	Nrbp1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472839	Nrbp1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511930	Nrbp1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding protein 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511901	Nrbp1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840704	Nrbp2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor binding SET domain protein 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637114	Nsd3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
nuclear receptor coactivator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362683	Ncoa2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear receptor coactivator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008021	Ncoa3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor coactivator 7; targeted mutation 1.1, Velocigene	MGI:5695956	Ncoa7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nuclear receptor co-repressor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286194	Ncor1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear receptor interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364574	Nrip2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear receptor interacting protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457580	Nrip3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor interacting protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457579	Nrip3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 1, group D, member 1; targeted mutation 1.1, Velocigene	MGI:5548823	Nr1d1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nuclear receptor subfamily 1, group D, member 1; targeted mutation 1, Velocigene	MGI:3847528	Nr1d1<tm1(KOMP)Vlcg>	26058812	KOMP-Regeneron
nuclear receptor subfamily 1, group D, member 1; targeted mutation 1, Velocigene	MGI:3847528	Nr1d1<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nuclear receptor subfamily 1, group D, member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419657	Nr1d1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear receptor subfamily 1, group H, member 3; targeted mutation 1.1, Velocigene	MGI:5695902	Nr1h3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nuclear receptor subfamily 1, group H, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432259	Nr1h3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 1, group I, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432300	Nr1i2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 1, group I, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432809	Nr1i2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 1, group I, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432045	Nr1i3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 1, group I, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431972	Nr1i3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 2, group C, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432752	Nr2c1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 2, group C, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431625	Nr2c2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 2, group C, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433045	Nr2c2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 2, group E, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944496	Nr2e1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 2, group F, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441755	Nr2f2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 3, group C, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432469	Nr3c1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 3, group C, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432548	Nr3c1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 3, group C, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433037	Nr3c2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 3, group C, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434228	Nr3c2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 4, group A, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432935	Nr4a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 4, group A, member 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419243	Nr4a2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear receptor subfamily 6, group A, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431821	Nr6a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 6, group A, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431821	Nr6a1<tm1a(EUCOMM)Wtsi>	23762465	EUCOMM
nuclear receptor subfamily 6, group A, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5561560	Nr6a1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
nuclear receptor subfamily 6, group A, member 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5510737	Nr6a1<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear receptor subfamily 6, group A, member 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5510737	Nr6a1<tm1c(EUCOMM)Wtsi>	23762465	EUCOMM
nuclear receptor subfamily 6, group A, member 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5532717	Nr6a1<tm1d(EUCOMM)Wtsi>	23762465	EUCOMM
nuclear receptor subfamily 6, group A, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432580	Nr6a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear respiratory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363206	Nrf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear respiratory factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362373	Nrf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear RNA export factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420056	Nxf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear RNA export factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419846	Nxf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear RNA export factor 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363928	Nxf7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear RNA export factor 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452685	Nxf7<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear RNA export factor 7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452640	Nxf7<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear transcription factor, X-box binding 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362255	Nfx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear transcription factor, X-box binding 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364578	Nfx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear transcription factor, X-box binding-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432670	Nfxl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear transcription factor, X-box binding-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432858	Nfxl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear transcription factor-Y alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364082	Nfya<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear transcription factor-Y alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362551	Nfya<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear transcription factor-Y beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441741	Nfyb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear transcription factor-Y beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441939	Nfyb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear transport factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431438	Nutf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear transport factor 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548558	Nutf2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
nuclear transport factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431436	Nutf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nuclear VCP-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820289	Nvl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nuclear VCP-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820306	Nvl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleic acid binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365166	Nabp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleic acid binding protein 2; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5548593	Nabp2<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
nucleic acid binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363656	Nabp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleobindin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880949	Nucb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleobindin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880960	Nucb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolar and coiled-body phosphoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432873	Nolc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar and coiled-body phosphoprotein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433651	Nolc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar and spindle associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456659	Nusap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolar and spindle associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456676	Nusap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolar protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887629	Nol11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolar protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887622	Nol11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolar protein 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140479	Nol12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar protein 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140461	Nol12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar protein 4-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842312	Nol4l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar protein 4-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842469	Nol4l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar protein 8; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5574602	Nol8<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
nucleolar protein family 6 (RNA-associated); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364191	Nol6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolar protein interacting with the FHA domain of MKI67; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432788	Nifk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar protein interacting with the FHA domain of MKI67; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433455	Nifk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolar protein with MIF4G domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841092	Nom1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolar protein with MIF4G domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841457	Nom1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleolus and neural progenitor protein; targeted mutation 1.1, Velocigene	MGI:5695952	Nepro<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nucleolus and neural progenitor protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433431	Nepro<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleolus and neural progenitor protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434386	Nepro<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoplasmin 3; targeted mutation 1.1, Velocigene	MGI:5577271	Npm3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nucleoplasmin 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420070	Npm3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 133; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462672	Nup133<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 133; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462675	Nup133<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 155; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5308285	Nup155<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 155; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428477	Nup155<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 205; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882004	Nup205<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 205; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882022	Nup205<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 214; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364113	Nup214<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 214; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362432	Nup214<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008019	Nup35<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 35; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014705	Nup35<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 37; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842783	Nup37<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 50; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432830	Nup50<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 62 C-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451639	Nup62cl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 62 C-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451567	Nup62cl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 62; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451352	Nup62<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 62; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451311	Nup62<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 85; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944384	Nup85<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 85; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944331	Nup85<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoporin 88; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431752	Nup88<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 88; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434056	Nup88<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 98; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842385	Nup98<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoporin 98; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842298	Nup98<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoredoxin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364815	Nxnl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoredoxin-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362907	Nxnl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleoredoxin-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472942	Nxnl1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoredoxin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432925	Nxn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoredoxin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548389	Nxn<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
nucleoredoxin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548389	Nxn<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
nucleoredoxin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548389	Nxn<tm1b(EUCOMM)Wtsi>	28700664	EUCOMM
nucleoredoxin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432324	Nxn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoredoxin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432640	Nxn<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleoredoxin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433350	Nxn<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleotide-binding oligomerization domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427229	Nod1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nucleotide binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431633	Nubp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleotide binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431633	Nubp1<tm1a(EUCOMM)Wtsi>	23028652	EUCOMM
nucleotide binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432680	Nubp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleotide binding protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363128	Nubpl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nucleotide binding protein-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548675	Nubpl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433973	Nacc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441947	Nacc2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637027	Nacc2<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441967	Nacc2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
NudC domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432751	Nudcd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NudC domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434068	Nudcd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
NudC domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887616	Nudcd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nudE neurodevelopment protein 1 like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452646	Ndel1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nudE neurodevelopment protein 1 like 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635250	Ndel1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
nudE neurodevelopment protein 1 like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841135	Ndel1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
nudE neurodevelopment protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441892	Nde1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nudE neurodevelopment protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441613	Nde1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
nudix (nucleoside diphosphate linked moiety X)-type motif 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451360	Nudt12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nudix (nucleoside diphosphate linked moiety X)-type motif 14; targeted mutation 1.1, Velocigene	MGI:5548514	Nudt14<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nudix (nucleoside diphosphate linked moiety X)-type motif 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006768	Nudt18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nudix (nucleoside diphosphate linked moiety X)-type motif 19; targeted mutation 1.1, Velocigene	MGI:5569079	Nudt19<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
nudix (nucleoside diphosphate linked moiety X)-type motif 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511985	Nudt1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
nudix (nucleoside diphosphate linked moiety X)-type motif 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511958	Nudt1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
nudix (nucleoside diphosphate linked moiety X)-type motif 22; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419610	Nudt22<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nudix (nucleoside diphosphate linked moiety X)-type motif 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432760	Nudt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
nudix (nucleoside diphosphate linked moiety X)-type motif 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419975	Nudt4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nudix (nucleoside diphosphate linked moiety X)-type motif 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5428531	Nudt7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
nudix (nucleotide diphosphate linked moiety X)-type motif 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362186	Nudt3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
nudix (nucleotide diphosphate linked moiety X)-type motif 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363355	Nudt3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
NUF2, NDC80 kinetochore complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842500	Nuf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
NUT family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840651	Nutm2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
NUT family member 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637173	Nutm2<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
NUT family member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840612	Nutm2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
NUT midline carcinoma, family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363742	Nutm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
NUT midline carcinoma, family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363313	Nutm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
O-6-methylguanine-DNA methyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008058	Mgmt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
O-acyltransferase like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365014	Oacyl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
occludin/ELL domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451598	Ocel1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
occludin/ELL domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451649	Ocel1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
occludin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433791	Ocln<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
occludin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431672	Ocln<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
oculocutaneous albinism II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938519	Oca2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oculocutaneous albinism II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006743	Oca2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
odontogenic, ameloblast asssociated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426553	Odam<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
odorant binding protein 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949352	Obp2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
odorant binding protein 2A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692815	Obp2a<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
odorant binding protein 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949356	Obp2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
odorant binding protein 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299498	Obp2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
OFD1, centriole and centriolar satellite protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431558	Ofd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
OFD1, centriole and centriolar satellite protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434470	Ofd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
OFD1, centriole and centriolar satellite protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431587	Ofd1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
OFD1, centriole and centriolar satellite protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434220	Ofd1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
oleoyl-ACP hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363705	Olah<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oleoyl-ACP hydrolase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548738	Olah<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
olfactomedin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951116	Olfm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
olfactomedin-like 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307104	Olfml2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
olfactomedin-like 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428511	Olfml2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1229; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428566	Olfr1229<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1229; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428558	Olfr1229<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1234; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364145	Olfr1234<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1242; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428571	Olfr1242<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1258; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364144	Olfr1258<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1396; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503343	Olfr1396<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1396; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5503334	Olfr1396<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1443; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362291	Olfr1443<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1443; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364485	Olfr1443<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1508; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363301	Olfr1508<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 1508; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362799	Olfr1508<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363352	Olfr27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365017	Olfr27<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 378; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364719	Olfr378<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 378; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363536	Olfr378<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 398; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299650	Olfr398<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
olfactory receptor 649; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365202	Olfr649<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oligophrenin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365191	Ophn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
OMA1 zinc metallopeptidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365095	Oma1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
OMA1 zinc metallopeptidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299675	Oma1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
OMA1 zinc metallopeptidase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299661	Oma1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
OMA1 zinc metallopeptidase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299657	Oma1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
OMA1 zinc metallopeptidase; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319802	Oma1<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
oncomodulin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431716	Ocm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
oncomodulin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432497	Ocm<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
oncoprotein induced transcript 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462576	Oit1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oncoprotein induced transcript 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462591	Oit1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oncoprotein induced transcript 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363638	Oit3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oncoprotein induced transcript 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364038	Oit3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oncostatin M receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940764	Osmr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oncostatin M; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820047	Osm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oncostatin M; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474774	Osm<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
oncostatin M; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474774	Osm<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
oncostatin M; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5474774	Osm<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
oncostatin M; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820069	Osm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oocyte expressed protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419157	Ooep<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
oocyte secreted protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362716	Oosp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oocyte secreted protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428601	Oosp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oocyte secreted protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841213	Oosp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oocyte specific homeobox 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841424	Obox5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oocyte specific homeobox 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841325	Obox5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oocyte specific homeobox 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842519	Obox6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
oocyte specific homeobox 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842710	Obox6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
oocyte specific homeobox 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841358	Obox7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oogenesin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460430	Oog2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
oogenesin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841257	Oog3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oogenesin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050857	Oog4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
OPA1, mitochondrial dynamin like GTPase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364874	Opa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
OPA1, mitochondrial dynamin like GTPase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365133	Opa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
opioid binding protein/cell adhesion molecule-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363682	Opcml<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
opioid binding protein/cell adhesion molecule-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364435	Opcml<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
opioid growth factor receptor-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451383	Ogfrl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
opioid growth factor receptor-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451699	Ogfrl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
opioid receptor, delta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432412	Oprd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
opioid receptor, delta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432327	Oprd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
opioid receptor, kappa 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434294	Oprk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
opioid receptor, kappa 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434356	Oprk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
opioid receptor, mu 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000325	Oprm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
opsin 1 (cone pigments), medium-wave-sensitive (color blindness, deutan); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006763	Opn1mw<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
opsin 1 (cone pigments), medium-wave-sensitive (color blindness, deutan); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006763	Opn1mw<tm1a(EUCOMM)Wtsi>	28751656	EUCOMM
opsin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434488	Opn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
opsin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434038	Opn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
opsin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434308	Opn3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
opsin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434308	Opn3<tm2a(EUCOMM)Wtsi>	26392540	EUCOMM
opsin 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5897190	Opn3<tm2b(EUCOMM)Wtsi>	26392540	EUCOMM
opsin 4 (melanopsin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841059	Opn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
opsin 4 (melanopsin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841379	Opn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
opticin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363413	Optc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
optineurin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432769	Optn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
optineurin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432769	Optn<tm1a(EUCOMM)Wtsi>	25026213	EUCOMM
optineurin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432769	Optn<tm1a(EUCOMM)Wtsi>	26044960	EUCOMM
optineurin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432769	Optn<tm1a(EUCOMM)Wtsi>	27493188	EUCOMM
optineurin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432352	Optn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ORAI calcium release-activated calcium modulator 2; targeted mutation 1.1, Velocigene	MGI:5908178	Orai2<tm1.1(KOMP)Vlcg>	28294127	KOMP-Regeneron
ORAI calcium release-activated calcium modulator 2; targeted mutation 1, Velocigene	MGI:4843091	Orai2<tm1(KOMP)Vlcg>	27721237	KOMP-Regeneron
ORAI calcium release-activated calcium modulator 2; targeted mutation 1, Velocigene	MGI:4843091	Orai2<tm1(KOMP)Vlcg>	28294127	KOMP-Regeneron
ORAI calcium release-activated calcium modulator 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362761	Orai2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ORAI calcium release-activated calcium modulator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428551	Orai3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
origin recognition complex, subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847686	Orc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
origin recognition complex, subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847686	Orc1<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
origin recognition complex, subunit 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515783	Orc1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
origin recognition complex, subunit 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515783	Orc1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
origin recognition complex, subunit 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515783	Orc1<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
origin recognition complex, subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847676	Orc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
origin recognition complex, subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433411	Orc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
origin recognition complex, subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432064	Orc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
origin recognition complex, subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433141	Orc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
origin recognition complex, subunit 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433769	Orc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
origin recognition complex, subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433614	Orc5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
origin recognition complex, subunit 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433466	Orc5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ORM1-like 3 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527616	Ormdl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ornithine aminotransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461655	Oat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ornithine aminotransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461746	Oat<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ornithine decarboxylase antizyme 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840593	Oaz1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ornithine decarboxylase antizyme 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840706	Oaz1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ornithine transcarbamylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364943	Otc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ornithine transcarbamylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299648	Otc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ornithine transcarbamylase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299502	Otc<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ornithine transcarbamylase; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5299885	Otc<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
ornithine transcarbamylase; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5299874	Otc<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
orthodenticle homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050867	Otx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
orthopedia homeobox; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008941	Otp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
O-sialoglycoprotein endopeptidase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432922	Osgepl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
O-sialoglycoprotein endopeptidase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432003	Osgepl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
O-sialoglycoprotein endopeptidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841039	Osgep<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
O-sialoglycoprotein endopeptidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841459	Osgep<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
osteoclast associated receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820081	Oscar<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
osteoclast associated receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820038	Oscar<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
osteoclast stimulatory transmembrane protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364551	Ocstamp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
osteoclast stimulatory transmembrane protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458541	Ocstamp<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
osteoclast stimulatory transmembrane protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458541	Ocstamp<tm2a(KOMP)Wtsi>	26042409	KOMP-CSD
osteoclast stimulatory transmembrane protein; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5447727	Ocstamp<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
osteoclast stimulatory transmembrane protein; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5447727	Ocstamp<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
osteoglycin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944372	Ogn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
osteoglycin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944408	Ogn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
osteopetrosis associated transmembrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428600	Ostm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
otoancorin; targeted mutation 1.1, Velocigene	MGI:5548754	Otoa<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
otoancorin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363815	Otoa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
otoancorin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364836	Otoa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
otoconin 90; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365142	Oc90<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
otoconin 90; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363917	Oc90<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
otoconin 90; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299580	Oc90<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
otoferlin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363757	Otof<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
otoferlin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362451	Otof<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
otogelin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431484	Otog<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
otogelin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431435	Otog<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
otopetrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431640	Otop3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
otopetrin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434464	Otop3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
otospiralin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432731	Otos<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
otospiralin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434075	Otos<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
OTU deubiquitinase with linear linkage specificity; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436500	Otulin<tm1a(EUCOMM)Hmgu>	27523608	EUCOMM
OTU domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456807	Otud3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
OTU domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456819	Otud3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
OTU domain containing 6A; targeted mutation 1, Velocigene	MGI:4951157	Otud6a<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
OTU domain containing 6B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431669	Otud6b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
OTU domain containing 6B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637064	Otud6b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
OTU domain containing 6B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637064	Otud6b<tm1b(EUCOMM)Wtsi>	28343629	EUCOMM
OTU domain containing 6B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432555	Otud6b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
OTU domain containing 7A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362875	Otud7a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
OTU domain containing 7B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008026	Otud7b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
OTU domain containing 7B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637162	Otud7b<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
OTU domain, ubiquitin aldehyde binding 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692787	Otub1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
OTU domain, ubiquitin aldehyde binding 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433067	Otub2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
OTU domain, ubiquitin aldehyde binding 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433322	Otub2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
out at first homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5284928	Oaf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
out at first homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286376	Oaf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
outer dense fiber of sperm tails 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006794	Odf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
outer dense fiber of sperm tails 3B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419676	Odf3b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
outer dense fiber of sperm tails 3-like 2; targeted mutation 1.1, Velocigene	MGI:5548879	Odf3l2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
outer dense fiber of sperm tails 3-like 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050987	Odf3l2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
outer dense fiber of sperm tails 3-like 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5140460	Odf3l2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
oviductal glycoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362777	Ovgp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oviductal glycoprotein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636904	Ovgp1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
oviductal glycoprotein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365120	Ovgp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ovo like zinc finger 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451508	Ovol1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ovo like zinc finger 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5507829	Ovol1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
ovo like zinc finger 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5507829	Ovol1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ovo like zinc finger 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451255	Ovol1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oxidation resistance 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461745	Oxr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
oxidation resistance 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461745	Oxr1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
oxidation resistance 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461745	Oxr1<tm1a(EUCOMM)Wtsi>	26668325	EUCOMM
oxidation resistance 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461759	Oxr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
oxidative stress induced growth inhibitor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840615	Osgin1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
oxidative stress induced growth inhibitor 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840666	Osgin1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939703	Ogdh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939737	Ogdh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oxoglutarate (alpha-ketoglutarate) receptor 1; targeted mutation 1, Velocigene	MGI:3812671	Oxgr1<tm1(KOMP)Vlcg>	23504326	KOMP-Regeneron
oxoglutarate (alpha-ketoglutarate) receptor 1; targeted mutation 1, Velocigene	MGI:3812671	Oxgr1<tm1(KOMP)Vlcg>	23934124	KOMP-Regeneron
oxoglutarate (alpha-ketoglutarate) receptor 1; targeted mutation 1, Velocigene	MGI:3812671	Oxgr1<tm1(KOMP)Vlcg>	24244016	KOMP-Regeneron
oxoglutarate (alpha-ketoglutarate) receptor 1; targeted mutation 1, Velocigene	MGI:3812671	Oxgr1<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
oxoglutarate (alpha-ketoglutarate) receptor 1; targeted mutation 1, Velocigene	MGI:3812671	Oxgr1<tm1(KOMP)Vlcg>	27693579	KOMP-Regeneron
oxysterol binding protein-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432059	Osbpl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
oxysterol binding protein-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432369	Osbpl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
oxysterol binding protein-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842360	Osbpl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
oxysterol binding protein-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842655	Osbpl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
oxysterol binding protein-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014587	Osbpl5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oxysterol binding protein-like 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434110	Osbpl7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
oxysterol binding protein-like 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362479	Osbpl8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oxysterol binding protein-like 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364058	Osbpl8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oxysterol binding protein-like 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364325	Osbpl9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oxysterol binding protein-like 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363132	Osbpl9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
oxysterol binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362771	Osbp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
oxysterol binding protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473077	Osbp<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
oxysterol binding protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472878	Osbp<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
oxytocin receptor; targeted mutation 1.1, Velocigene	MGI:5766256	Oxtr<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
oxytocin receptor; targeted mutation 1, Velocigene	MGI:4399486	Oxtr<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
oxytocin receptor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512003	Oxtr<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
p21 protein (Cdc42/Rac)-activated kinase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636968	Pak1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
p21 protein (Cdc42/Rac)-activated kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432619	Pak2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
P450 (cytochrome) oxidoreductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362169	Por<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
P450 (cytochrome) oxidoreductase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362591	Por<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
p53 and DNA damage regulated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842799	Pdrg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paired box 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433135	Pax1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
paired box 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286205	Pax2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
paired box 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548955	Pax4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
paired box 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433183	Pax5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paired box 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433758	Pax5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
paired box 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882024	Pax6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paired box 7; targeted mutation 1.1, Velocigene	MGI:5505636	Pax7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
paired box 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842769	Pax7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paired box 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299881	Pax7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
paired box 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428487	Pax9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
paired immunoglobin-like type 2 receptor alpha; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5428530	Pilra<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
paired-like homeobox 2b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286388	Phox2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paired-like homeobox 2b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286375	Phox2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
paired-like homeobox 2b; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511919	Phox2b<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
paired-like homeobox 2b; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511892	Phox2b<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
paired-like homeodomain transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847871	Pitx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paired-like homeodomain transcription factor 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5760000	Pitx2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
paired-like homeodomain transcription factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847856	Pitx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
paired-like homeodomain transcription factor 3; targeted mutation 1.1, Velocigene	MGI:5488783	Pitx3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
paired related homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453703	Prrx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paired related homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453780	Prrx1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PAK1 interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820062	Pak1ip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PAK1 interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820124	Pak1ip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
palmitoyl-protein thioesterase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362678	Ppt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
palmitoyl-protein thioesterase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841007	Ppt2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
palmitoyl-protein thioesterase 2; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5636995	Ppt2<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
PAN2 poly(A) specific ribonuclease subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014572	Pan2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PAN2 poly(A) specific ribonuclease subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605785	Pan2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pancreatic and duodenal homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453759	Pdx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pancreatic and duodenal homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453689	Pdx1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pancreatic lipase-related protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420097	Pnliprp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pancreatic lipase-related protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420008	Pnliprp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pancreatic polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362546	Ppy<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pancreatic polypeptide; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364966	Ppy<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
pancreatic progenitor cell differentiation and proliferation factor; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5582431	Ppdpf<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	21606493	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	21949881	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	21983290	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	22499153	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	22915101	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	22956847	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	23675350	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	23742824	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	23827947	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	23885286	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	24646995	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	24668173	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	24860098	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	25070895	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	25080488	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	25170954	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	26002464	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	26035172	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	26136251	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	26553756	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	26839965	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	27076682	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	27797339	KOMP-CSD
pannexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	27910899	KOMP-CSD
pannexin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5696900	Panx1<tm1b(KOMP)Wtsi>	26136251	KOMP-CSD
pannexin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5696900	Panx1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pannexin 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5515918	Panx1<tm1c(KOMP)Wtsi>	23675350	KOMP-CSD
pannexin 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5515918	Panx1<tm1c(KOMP)Wtsi>	24646995	KOMP-CSD
pannexin 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5515918	Panx1<tm1c(KOMP)Wtsi>	25690012	KOMP-CSD
pannexin 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5515918	Panx1<tm1c(KOMP)Wtsi>	26242575	KOMP-CSD
pannexin 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5515918	Panx1<tm1c(KOMP)Wtsi>	27910899	KOMP-CSD
pannexin 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5616343	Panx1<tm1d(KOMP)Wtsi>	24646995	KOMP-CSD
pannexin 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5616343	Panx1<tm1d(KOMP)Wtsi>	27910899	KOMP-CSD
pannexin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362584	Panx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pannexin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451515	Panx1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
pannexin 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451546	Panx1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
pannexin 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473043	Panx1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
pannexin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451264	Panx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pannexin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451264	Panx2<tm1a(KOMP)Wtsi>	27797339	KOMP-CSD
pannexin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548503	Panx2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pannexin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451244	Panx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pannexin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841195	Panx3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pannexin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841195	Panx3<tm1a(KOMP)Wtsi>	26138248	KOMP-CSD
pannexin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548608	Panx3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pannexin 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5788523	Panx3<tm1c(KOMP)Wtsi>	26138248	KOMP-CSD
pannexin 3; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5788524	Panx3<tm1d(KOMP)Wtsi>	26138248	KOMP-CSD
pannexin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840955	Panx3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PAP associated domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302358	Papd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PAP associated domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302363	Papd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PAP associated domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302359	Papd5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PAP associated domain containing 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306497	Papd5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PAP associated domain containing 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302367	Papd5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
PAP associated domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441935	Papd7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PAP associated domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441699	Papd7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
papilin, proteoglycan-like sulfated glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362282	Papln<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
papilin, proteoglycan-like sulfated glycoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364561	Papln<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
papillary renal cell carcinoma (translocation-associated); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362610	Prcc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
papillary renal cell carcinoma (translocation-associated); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365051	Prcc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pappalysin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299610	Pappa2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pappalysin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299532	Pappa2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
par-3 family cell polarity regulator beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441664	Pard3b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
par-3 family cell polarity regulator beta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5588280	Pard3b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
par-3 family cell polarity regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364353	Pard3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
par-3 family cell polarity regulator; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637107	Pard3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
par-3 family cell polarity regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362543	Pard3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
paralemmin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434121	Palm3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
paralemmin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431606	Palm3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
paraoxonase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419534	Pon1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
paraoxonase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419749	Pon1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
paraoxonase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455567	Pon3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
paraoxonase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455615	Pon3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
paraspeckle protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363541	Pspc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
paraspeckle protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363541	Pspc1<tm1a(KOMP)Wtsi>	28192372	KOMP-CSD
paraspeckle protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363625	Pspc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
parathymosin; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515315	Ptms<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
parathymosin; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515315	Ptms<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
parathymosin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419420	Ptms<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
parathyroid hormone 1 receptor; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5014612	Pth1r<tm1a(EUCOMM)Hmgu>	27996060	EUCOMM
parathyroid hormone 2 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364487	Pth2r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
parathyroid hormone 2 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364868	Pth2r<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
parathyroid hormone 2 receptor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364506	Pth2r<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
parathyroid hormone-like peptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880897	Pthlh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
parathyroid hormone-like peptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880992	Pthlh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
parathyroid hormone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849407	Pth<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
parathyroid hormone; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849413	Pth<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
paroxysmal nonkinesiogenic dyskinesia; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451510	Pnkd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
paroxysmal nonkinesiogenic dyskinesia; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451433	Pnkd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PARP1 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5301386	Parpbp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PARP1 binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301379	Parpbp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
partner and localizer of BRCA2; targeted mutation 1,1, Velocigene	MGI:5471393	Palb2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
partner of NOB1 homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364918	Pno1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
parvin, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432840	Parva<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
parvin, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433260	Parva<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
parvin, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431642	Parvb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
parvin, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433413	Parvb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PAS domain containing serine/threonine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431795	Pask<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PAS domain containing serine/threonine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434317	Pask<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PAS domain containing serine/threonine kinase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433745	Pask<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
patatin-like phospholipase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085354	Pnpla1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
patatin-like phospholipase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085354	Pnpla1<tm1a(KOMP)Wtsi>	28369476	KOMP-CSD
patatin-like phospholipase domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548905	Pnpla1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
patatin-like phospholipase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5300818	Pnpla3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
patched domain containing 1; targeted mutation 1a, Institut de Transgenose	MGI:5755971	Ptchd1<tm1a(KOMP)IcsOrl>	21677750	KOMP-CSD
patched domain containing 1; targeted mutation 1a, Institut de Transgenose	MGI:5755971	Ptchd1<tm1a(KOMP)IcsOrl>	29118110	KOMP-CSD
patched domain containing 1; targeted mutation 1b, Institut de Transgenose	MGI:5763006	Ptchd1<tm1b(KOMP)IcsOrl>	27626380	KOMP-CSD
patched domain containing 1; targeted mutation 1d, Institut de Transgenose	MGI:6111285	Ptchd1<tm1d(KOMP)IcsOrl>	29118110	KOMP-CSD
patched domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364914	Ptchd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
patched domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451466	Ptchd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
patched domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451700	Ptchd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
paternally expressed 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435596	Peg3<tm1a(EUCOMM)Hmgu>	24391757	EUCOMM
paternally expressed 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435596	Peg3<tm1a(EUCOMM)Hmgu>	25774914	EUCOMM
paternally expressed 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435596	Peg3<tm1a(EUCOMM)Hmgu>	26640945	EUCOMM
paternally expressed 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435596	Peg3<tm1a(EUCOMM)Hmgu>	27075691	EUCOMM
paternally expressed 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435596	Peg3<tm1a(EUCOMM)Hmgu>	28609438	EUCOMM
paternally expressed 3; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5806481	Peg3<tm1c(EUCOMM)Hmgu>	25774914	EUCOMM
paternally expressed 3; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5806481	Peg3<tm1c(EUCOMM)Hmgu>	26640945	EUCOMM
paternally expressed 3; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5806481	Peg3<tm1c(EUCOMM)Hmgu>	27075691	EUCOMM
paternally expressed 3; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5806482	Peg3<tm1d(EUCOMM)Hmgu>	25774914	EUCOMM
paternally expressed 3; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5806482	Peg3<tm1d(EUCOMM)Hmgu>	26640945	EUCOMM
paternally expressed 3; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5806482	Peg3<tm1d(EUCOMM)Hmgu>	27075691	EUCOMM
PAX3 and PAX7 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432776	Paxbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PAX3 and PAX7 binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431555	Paxbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PAX3 and PAX7 binding protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432187	Paxbp1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PAX interacting (with transcription-activation domain) protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428506	Paxip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Pbx/knotted 1 homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431989	Pknox2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PC4 and SFRS1 interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456818	Psip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PC-esterase domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842567	Pced1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PC-esterase domain containing 1A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548804	Pced1a<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
PC-esterase domain containing 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842793	Pced1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PCF11 cleavage and polyadenylation factor subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461698	Pcf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PCF11 cleavage and polyadenylation factor subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461768	Pcf11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PCI domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364257	Pcid2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PCNA clamp associated factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461695	Pclaf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PCNA clamp associated factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461738	Pclaf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PDGFA associated protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050934	Pdap1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PDGFA associated protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050988	Pdap1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
PDLIM1 interacting kinase 1 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460469	Pdik1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PDLIM1 interacting kinase 1 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460490	Pdik1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PDS5 cohesin associated factor B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432978	Pds5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PDS5 cohesin associated factor B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432708	Pds5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PDX1 C-terminal inhibiting factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820337	Pcif1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PDX1 C-terminal inhibiting factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820255	Pcif1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ and LIM domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428578	Pdlim3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ and LIM domain 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363646	Pdlim4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ and LIM domain 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364522	Pdlim4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ and LIM domain 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364832	Pdlim4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ and pleckstrin homology domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013742	Pdzph1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ and pleckstrin homology domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014610	Pdzph1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ domain containing 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842362	Pdzd11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842677	Pdzd11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473202	Pdzk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5497391	Pdzk1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5692756	Pdzk1<tm2b(EUCOMM)Wtsi>	27996060	EUCOMM
PDZ domain containing 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5527592	Pdzk1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419952	Pdzd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419493	Pdzd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ domain containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472988	Pdzd3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472827	Pdzd3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433578	Pdzd7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433578	Pdzd7<tm1a(EUCOMM)Wtsi>	24334608	EUCOMM
PDZ domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433578	Pdzd7<tm1a(EUCOMM)Wtsi>	26401052	EUCOMM
PDZ domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433578	Pdzd7<tm1a(EUCOMM)Wtsi>	28031293	EUCOMM
PDZ domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431714	Pdzd7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431887	Pdzd8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PDZ domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880916	Pdzd9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PDZ domain containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880954	Pdzd9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PDZK1 interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286258	Pdzk1ip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PDZK1 interacting protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5430977	Pdzk1ip1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
PEAK1 related kinase activating pseudokinase 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4944311	Prag1<tm1a(KOMP)Mbp>	25038227	KOMP-CSD
PEAK1 related kinase activating pseudokinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362983	Prag1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pecanex homolog 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636997	Pcnx3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
pecanex homolog 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503340	Pcnx4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
pellino 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433689	Peli1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pellino 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434288	Peli1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
penta-EF hand domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5614701	Pef1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
pentatricopeptide repeat domain 1; targeted mutation 1, Velocigene	MGI:4951221	Ptcd1<tm1(KOMP)Vlcg>	28835921	KOMP-Regeneron
pentraxin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286227	Ptx4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peptidase domain containing associated with muscle regeneration 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363683	Pamr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
peptidase domain containing associated with muscle regeneration 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364531	Pamr1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
peptidase domain containing associated with muscle regeneration 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363955	Pamr1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
peptidase D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363495	Pepd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peptidase D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365093	Pepd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
peptidase M20 domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431929	Pm20d2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peptidase M20 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432806	Pm20d2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peptide YY; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363090	Pyy<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
peptidoglycan recognition protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428472	Pglyrp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
peptidyl arginine deiminase, type III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362791	Padi3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peptidyl arginine deiminase, type III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362791	Padi3<tm1a(KOMP)Wtsi>	27866708	KOMP-CSD
peptidyl arginine deiminase, type III; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472863	Padi3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
peptidyl arginine deiminase, type II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431421	Padi2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peptidyl arginine deiminase, type II; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548442	Padi2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
peptidyl arginine deiminase, type I; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511984	Padi1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
peptidyl arginine deiminase, type VI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363066	Padi6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peptidyl arginine deiminase, type VI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364703	Padi6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
peptidylglycine alpha-amidating monooxygenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820276	Pam<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peptidylglycine alpha-amidating monooxygenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820279	Pam<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peptidylprolyl isomerase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940794	Ppia<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peptidylprolyl isomerase A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940759	Ppia<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
peptidylprolyl isomerase (cyclophilin)-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460482	Ppil3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peptidylprolyl isomerase (cyclophilin)-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460426	Ppil3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peptidylprolyl isomerase (cyclophilin)-like 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511955	Ppil6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
peptidylprolyl isomerase F (cyclophilin F); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433443	Ppif<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peptidylprolyl isomerase F (cyclophilin F); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433858	Ppif<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peptidyl prolyl isomerase H; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431561	Ppih<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peptidyl prolyl isomerase H; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433790	Ppih<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peptidyl prolyl isomerase H; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5003013	Ppih<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
peptidyl prolyl isomerase H; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5003023	Ppih<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
pericentrin (kendrin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938581	Pcnt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pericentrin (kendrin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938559	Pcnt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pericentriolar material 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006790	Pcm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
perilipin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432810	Plin2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
perilipin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432810	Plin2<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
perilipin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432810	Plin2<tm1a(EUCOMM)Wtsi>	26968211	EUCOMM
perilipin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433205	Plin2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
perilipin 4; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548711	Plin4<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
perilipin 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363377	Plin4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
perilipin 4; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5472902	Plin4<tm2(EUCOMM)Wtsi>	21677750	EUCOMM
perilipin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364899	Plin5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
perilipin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364899	Plin5<tm1a(KOMP)Wtsi>	27189934	KOMP-CSD
perilipin 5; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5819278	Plin5<tm1c(KOMP)Wtsi>	27189934	KOMP-CSD
perilipin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363886	Plin5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
perilipin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363886	Plin5<tm1e(KOMP)Wtsi>	25161888	KOMP-CSD
perilipin 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455577	Plin5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
perilipin 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455574	Plin5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
period circadian clock 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462583	Per3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
period circadian clock 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462577	Per3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
periostin, osteoblast specific factor; targeted mutation 1.1, Velocigene	MGI:5520181	Postn<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
peripheral myelin protein 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880919	Pmp22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peripheral myelin protein 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880931	Pmp22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
peripheral myelin protein 2; targeted mutation 1, Velocigene	MGI:3812759	Pmp2<tm1(KOMP)Vlcg>	24849898	KOMP-Regeneron
peripheral myelin protein 2; targeted mutation 1, Velocigene	MGI:5803681	Pmp2<tm1.1(KOMP)Vlcg>	24849898	KOMP-Regeneron
periplakin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840929	Ppl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
periplakin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841145	Ppl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
perlecan (heparan sulfate proteoglycan 2); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841031	Hspg2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peroxiredoxin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432626	Prdx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxiredoxin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441644	Prdx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxiredoxin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442033	Prdx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxiredoxin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433070	Prdx4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxiredoxin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456821	Prdx5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxiredoxin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456833	Prdx5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxiredoxin 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431891	Prdx6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxiredoxin 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431891	Prdx6<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
peroxiredoxin 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433737	Prdx6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432787	Pex10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433074	Pex10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 11 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441980	Pex11a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 11 alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441923	Pex11a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 11 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441675	Pex11g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 12; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419325	Pex12<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
peroxisomal biogenesis factor 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434219	Pex13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434448	Pex13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 26; targeted mutation 1.1, Velocigene	MGI:5548637	Pex26<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
peroxisomal biogenesis factor 26; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840633	Pex26<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 26; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840681	Pex26<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431895	Pex3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431895	Pex3<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
peroxisomal biogenesis factor 5-like; targeted mutation 1, Velocigene	MGI:3808533	Pex5l<tm1(KOMP)Vlcg>	21555075	KOMP-Regeneron
peroxisomal biogenesis factor 5-like; targeted mutation 1, Velocigene	MGI:3808533	Pex5l<tm1(KOMP)Vlcg>	22363812	KOMP-Regeneron
peroxisomal biogenesis factor 5-like; targeted mutation 1, Velocigene	MGI:3808533	Pex5l<tm1(KOMP)Vlcg>	24409334	KOMP-Regeneron
peroxisomal biogenesis factor 5-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050911	Pex5l<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 5-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050984	Pex5l<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal biogenesis factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938602	Pex6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisomal membrane protein 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419659	Pxmp4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847879	Ppargc1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847862	Ppargc1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisome proliferative activated receptor, gamma, coactivator 1 beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432077	Ppargc1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisome proliferative activated receptor, gamma, coactivator 1 beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433320	Ppargc1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisome proliferator activated receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432239	Ppara<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisome proliferator activated receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432239	Ppara<tm1a(EUCOMM)Wtsi>	28082284	EUCOMM
peroxisome proliferator activated receptor alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433264	Ppara<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peroxisome proliferator activated receptor gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419888	Pparg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peroxisome proliferator activated receptor gamma; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637216	Pparg<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
peroxisome proliferator activated receptor gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419978	Pparg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
peroxisome proliferator activator receptor delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363286	Ppard<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
peroxisome proliferator activator receptor delta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364876	Ppard<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PERP, TP53 apoptosis effector; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008946	Perp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pescadillo ribosomal biogenesis factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938566	Pes1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pescadillo ribosomal biogenesis factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938587	Pes1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
peter pan homolog; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419426	Ppan<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
PHD finger protein 13; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050929	Phf13<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PHD finger protein 13; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050989	Phf13<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
PHD finger protein 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432264	Phf20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PHD finger protein 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432264	Phf20<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
PHD finger protein 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431783	Phf20<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PHD finger protein 20; targeted mutation 1, William C Skarnes	MGI:5903611	Phf20<tm1Wcs>	28981838	null
PHD finger protein 23; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050908	Phf23<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
PHD finger protein 23; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050941	Phf23<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
PHD finger protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052421	Phf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PHD finger protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880929	Phf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PHD finger protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432234	Phf6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PHD finger protein 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548606	Phf6<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
PHD finger protein 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434367	Phf8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451926	Phlpp2<tm1a(EUCOMM)Hmgu>	25829425	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451926	Phlpp2<tm1a(EUCOMM)Hmgu>	26187040	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451926	Phlpp2<tm1a(EUCOMM)Hmgu>	27481093	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451926	Phlpp2<tm1a(EUCOMM)Hmgu>	28859855	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5763605	Phlpp2<tm1c(EUCOMM)Hmgu>	25829425	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5763605	Phlpp2<tm1c(EUCOMM)Hmgu>	26187040	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5763605	Phlpp2<tm1c(EUCOMM)Hmgu>	28859855	EUCOMM
PH domain and leucine rich repeat protein phosphatase 2; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5795604	Phlpp2<tm1d(EUCOMM)Hmgu>	26187040	EUCOMM
phenazine biosynthesis-like protein domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842632	Pbld2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phenylalanine hydroxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419907	Pah<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phenylalanyl-tRNA synthetase, alpha subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431650	Farsa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phenylalanyl-tRNA synthetase, alpha subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441679	Farsa<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phenylalkylamine Ca2+ antagonist (emopamil) binding protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419664	Ebp<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
phenylethanolamine-N-methyltransferase; targeted mutation 1.1, Velocigene	MGI:5523412	Pnmt<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
phenylethanolamine-N-methyltransferase; targeted mutation 1.1, Velocigene	MGI:5523412	Pnmt<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
phorbol-12-myristate-13-acetate-induced protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140480	Pmaip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosducin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426640	Pdc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosducin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426596	Pdc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatase and actin regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841057	Phactr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatase and actin regulator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434078	Phactr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatase and tensin homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432094	Pten<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatase and tensin homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434476	Pten<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatase domain containing, paladin 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451291	Pald1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatase, orphan 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433804	Phospho2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatase, orphan 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433115	Phospho2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphate cytidylyltransferase 1, choline, alpha isoform; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432485	Pcyt1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphate cytidylyltransferase 1, choline, alpha isoform; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433236	Pcyt1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphate cytidylyltransferase 2, ethanolamine; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419191	Pcyt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphate cytidylyltransferase 2, ethanolamine; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419696	Pcyt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphate regulating endopeptidase homolog, X-linked; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430975	Phex<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylcholine transfer protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460283	Pctp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylcholine transfer protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460296	Pctp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylethanolamine binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003012	Pebp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylglycerophosphate synthase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637078	Pgs1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419102	Prex1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419392	Prex1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433098	Pik3c3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433098	Pik3c3<tm1a(EUCOMM)Wtsi>	22308354	EUCOMM
phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5316387	Pik3c3<tm1c(EUCOMM)Wtsi>	22308354	EUCOMM
phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5316387	Pik3c3<tm1c(EUCOMM)Wtsi>	23596309	EUCOMM
phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5316387	Pik3c3<tm1c(EUCOMM)Wtsi>	27548528	EUCOMM
phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5316387	Pik3c3<tm1c(EUCOMM)Wtsi>	28716903	EUCOMM
phosphatidylinositol 3-kinase catalytic subunit type 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433259	Pik3c3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431745	Pik3ca<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432526	Pik3ca<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434375	Pik3cb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432229	Pik3cg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431610	Pik3cg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol 4-kinase alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820307	Pi4ka<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol 4-kinase alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820221	Pi4ka<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol 4-kinase beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432647	Pi4kb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol 4-kinase type 2 alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000321	Pi4k2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513807	Pik3c2a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433072	Pik3c2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434406	Pik3c2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434381	Pik3c2b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4-phosphate 5-kinase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433510	Pip5kl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4-phosphate 5-kinase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431757	Pip5kl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362880	Pip5k1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5509059	Pip5k1c<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433743	Pip4k2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419885	Pip4k2c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5629320	Pip4k2c<tm1b(KOMP)Wtsi>	27313209	KOMP-CSD
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419345	Pip4k2c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol binding clathrin assembly protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430960	Picalm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456770	Pigc<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456754	Pigc<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class C; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456777	Pigc<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class C; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4457568	Pigc<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class C; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:4840649	Pigc<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class C; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:4840611	Pigc<tm4e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013736	Pigf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431845	Pigg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432521	Pigg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class G; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473096	Pigg<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class G; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472891	Pigg<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class H; targeted mutation 1.1, Velocigene	MGI:5445921	Pigh<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
phosphatidylinositol glycan anchor biosynthesis, class L; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820087	Pigl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class L; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637168	Pigl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class L; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820097	Pigl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050850	Pign<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class O; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456850	Pigo<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class O; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456848	Pigo<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class P; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305664	Pigp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class Q; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451987	Pigq<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class Q; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452001	Pigq<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class Q; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458823	Pigq<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class S; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296123	Pigs<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class S; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296112	Pigs<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol glycan anchor biosynthesis, class U; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548887	Pigu<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phosphatidylinositol glycan anchor biosynthesis, class Z; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428582	Pigz<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-specific phospholipase C, X domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433356	Plcxd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-specific phospholipase C, X domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433975	Plcxd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol-specific phospholipase C, X domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052396	Plcxd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-specific phospholipase C, X domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362419	Plcxd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol-specific phospholipase C, X domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365273	Plcxd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol transfer protein, membrane-associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431584	Pitpnm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol transfer protein, membrane-associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431584	Pitpnm1<tm1a(EUCOMM)Wtsi>	23820044	EUCOMM
phosphatidylinositol transfer protein, membrane-associated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433403	Pitpnm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylinositol transfer protein, membrane-associated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364683	Pitpnm2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylinositol transfer protein, membrane-associated 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299620	Pitpnm2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphatidylserine decarboxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455965	Pisd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphatidylserine synthase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548417	Ptdss1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phosphodiesterase 10A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434145	Pde10a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphodiesterase 10A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456051	Pde10a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphodiesterase 10A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456080	Pde10a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphodiesterase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451347	Pde12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 12; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548813	Pde12<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
phosphodiesterase 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451394	Pde12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 1B, Ca2+-calmodulin dependent; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939778	Pde1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphodiesterase 1B, Ca2+-calmodulin dependent; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614713	Pde1b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
phosphodiesterase 1B, Ca2+-calmodulin dependent; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939772	Pde1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphodiesterase 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363826	Pde1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 1C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428560	Pde1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 3A, cGMP inhibited; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841251	Pde3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 3A, cGMP inhibited; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841455	Pde3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 3B, cGMP-inhibited; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841184	Pde3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 4B, cAMP specific; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364772	Pde4b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 4C, cAMP specific; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5585589	Pde4c<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 4C, cAMP specific; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419834	Pde4c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 4D interacting protein (myomegalin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939723	Pde4dip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 4D interacting protein (myomegalin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939695	Pde4dip<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947742	Pde6b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 6G, cGMP-specific, rod, gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441800	Pde6g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphodiesterase 7B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362264	Pde7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 7B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364704	Pde7b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphodiesterase 8A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5694167	Pde8a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phosphodiesterase 8B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363103	Pde8b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphofructokinase, liver, B-type; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432814	Pfkl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphofructokinase, liver, B-type; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432814	Pfkl<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
phosphofructokinase, liver, B-type; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432814	Pfkl<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
phosphofructokinase, platelet; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433669	Pfkp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphofructokinase, platelet; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432839	Pfkp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphofructokinase, platelet; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472953	Pfkp<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoglucomutase 2-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286262	Pgm2l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoglucomutase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140430	Pgm2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoglucomutase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841189	Pgm5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphogluconate dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431737	Pgd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphogluconate dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434314	Pgd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoglycerate mutase family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432458	Pgam5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoglycerate mutase family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432458	Pgam5<tm1a(EUCOMM)Wtsi>	25222142	EUCOMM
phosphoglycerate mutase family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432458	Pgam5<tm1a(EUCOMM)Wtsi>	26582950	EUCOMM
phosphoglycerate mutase family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432458	Pgam5<tm1a(EUCOMM)Wtsi>	26807733	EUCOMM
phosphoglycerate mutase family member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548621	Pgam5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
phosphoglycerate mutase family member 5; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5882559	Pgam5<tm1c(EUCOMM)Wtsi>	26582950	EUCOMM
phosphoglycerate mutase family member 5; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5882561	Pgam5<tm1d(EUCOMM)Wtsi>	26582950	EUCOMM
phosphohistidine phosphatase 1; targeted mutation 1.1, Velocigene	MGI:5695929	Phpt1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
phosphohistidine phosphatase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362375	Phpt1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoinositide-3-kinase adaptor protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419954	Pik3ap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoinositide-3-kinase adaptor protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419631	Pik3ap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoinositide-3-kinase interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452793	Pik3ip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452817	Pik3ip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase regulatory subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050263	Pik3r1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase regulatory subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302331	Pik3r1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase regulatory subunit 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302332	Pik3r1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase regulatory subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363675	Pik3r2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoinositide-3-kinase regulatory subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363631	Pik3r2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoinositide-3-kinase regulatory subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842818	Pik3r3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase regulatory subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842288	Pik3r3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase regulatory subunit 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432735	Pik3r5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoinositide-3-kinase regulatory subunit 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432711	Pik3r5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A1 member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951127	Pla1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A1 member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951130	Pla1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IIC; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455976	Pla2g2c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IIC; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455957	Pla2g2c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IIE; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432002	Pla2g2e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IIE; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636980	Pla2g2e<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
phospholipase A2, group IIE; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432386	Pla2g2e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IIF; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458478	Pla2g2f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group IIF; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458575	Pla2g2f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group IVB (cytosolic); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432604	Pla2g4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IVB (cytosolic); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432664	Pla2g4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IVB (cytosolic); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473075	Pla2g4b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IVB (cytosolic); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472877	Pla2g4b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group IVC (cytosolic, calcium-independent); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455529	Pla2g4c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group IVC (cytosolic, calcium-independent); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455617	Pla2g4c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group IVD; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363528	Pla2g4d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group IVD; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362306	Pla2g4d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364279	Pla2g7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363307	Pla2g7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group V; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433027	Pla2g5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group XIIB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363178	Pla2g12b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group XIIB; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362355	Pla2g12b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase A2, group X; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473053	Pla2g10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group X; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548469	Pla2g10<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phospholipase A2, group XVI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433367	Pla2g16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2, group XVI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433367	Pla2g16<tm1a(EUCOMM)Wtsi>	28077878	EUCOMM
phospholipase A2, group XVI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431735	Pla2g16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2 inhibitor and LY6/PLAUR domain containing; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4888956	Pinlyp<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase A2 receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433311	Pla2r1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase B domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362953	Plbd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase B domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362953	Plbd1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
phospholipase B domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363304	Plbd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842479	Plcb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase C, beta 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363828	Plcb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, beta 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548374	Plcb2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
phospholipase C, beta 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363383	Plcb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, beta 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460456	Plcb4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase C, beta 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460513	Plcb4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase C, delta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842394	Plcd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase C, delta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842674	Plcd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase C, eta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364604	Plch1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, eta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364784	Plch1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, eta 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364851	Plch2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, eta 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365134	Plch2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, eta 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299677	Plch2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, eta 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299672	Plch2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, zeta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363969	Plcz1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase C, zeta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364702	Plcz1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase D1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363449	Pld1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase D1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363229	Pld1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase D2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461741	Pld2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase D2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461693	Pld2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase D2; targeted mutation 1, Velocigene	MGI:3847515	Pld2<tm1(KOMP)Vlcg>	22974101	KOMP-Regeneron
phospholipase D2; targeted mutation 1, Velocigene	MGI:3847515	Pld2<tm1(KOMP)Vlcg>	24262632	KOMP-Regeneron
phospholipase D2; targeted mutation 1, Velocigene	MGI:3847515	Pld2<tm1(KOMP)Vlcg>	24813107	KOMP-Regeneron
phospholipase D family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842315	Pld3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase D family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842606	Pld3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipase D family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842606	Pld3<tm1e(EUCOMM)Wtsi>	28128235	EUCOMM
phospholipase D family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050858	Pld4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase D family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363433	Pld5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipase D family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363433	Pld5<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
phospholipase D family, member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548802	Pld5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
phospholipid phosphatase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433587	Plpp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipid phosphatase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433479	Plpp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phospholipid phosphatase 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548553	Plpp3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phospholipid phosphatase 6; targeted mutation 1.1, Velocigene	MGI:5692731	Plpp6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
phospholipid phosphatase 6; targeted mutation 1, Velocigene	MGI:3812842	Plpp6<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
phospholipid phosphatase 7 (inactive); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840923	Plpp7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipid phosphatase related 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363299	Plppr3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipid phosphatase related 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365274	Plppr4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipid scramblase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548929	Plscr1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
phospholipid scramblase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363158	Plscr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipid scramblase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636936	Plscr2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
phospholipid scramblase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363263	Plscr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phospholipid scramblase 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363811	Plscr3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
phospholysine phosphohistidine inorganic pyrophosphate phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5297880	Lhpp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phospholysine phosphohistidine inorganic pyrophosphate phosphatase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5297876	Lhpp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphomannomutase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364159	Pmm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphomannomutase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362387	Pmm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphomannomutase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472925	Pmm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphomannomutase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472786	Pmm2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphopantothenoylcysteine synthetase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419588	Ppcs<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoprotein associated with glycosphingolipid microdomains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841136	Pag1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoprotein associated with glycosphingolipid microdomains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841033	Pag1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoribosylformylglycinamidine synthase (FGAR amidotransferase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454066	Pfas<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoribosylformylglycinamidine synthase (FGAR amidotransferase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454180	Pfas<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoribosylglycinamide formyltransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888927	Gart<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoribosylglycinamide formyltransferase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513780	Gart<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
phosphoribosyl pyrophosphate synthetase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434300	Prps1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoribosyl pyrophosphate synthetase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548962	Prps1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
phosphoribosyl pyrophosphate synthetase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432256	Prps1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoribosyl pyrophosphate synthetase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434105	Prps1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoribosyl pyrophosphate synthetase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362501	Prps2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoribosyl pyrophosphate synthetase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362501	Prps2<tm1a(KOMP)Wtsi>	24855946	KOMP-CSD
phosphoribosyl pyrophosphate synthetase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364937	Prps2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoribosyl pyrophosphate synthetase 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364504	Prps2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoribosyl pyrophosphate synthetase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364641	Prps2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoribosyl pyrophosphate synthetase-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432556	Prpsap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphoribosyl pyrophosphate synthetase-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432556	Prpsap2<tm1a(EUCOMM)Wtsi>	22876197	EUCOMM
phosphoribosyl pyrophosphate synthetase-associated protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456748	Prpsap2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphorylase kinase alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849415	Phka1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphorylase kinase alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849418	Phka1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phosphorylase kinase beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888874	Phkb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphorylase kinase beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938523	Phkb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphorylase kinase gamma 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441887	Phkg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phosphorylase kinase, gamma 2 (testis); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430976	Phkg2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoserine aminotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363603	Psat1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoserine aminotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363603	Psat1<tm1a(KOMP)Wtsi>	23870131	KOMP-CSD
phosphoserine aminotransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364172	Psat1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phosphoserine phosphatase; targeted mutation 1.1, Velocigene	MGI:5548963	Psph<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
phosphoserine phosphatase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4950198	Psph<tm1a(EUCOMM)Hmgu>	27626380	EUCOMM
phosphoserine phosphatase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4950198	Psph<tm1a(EUCOMM)Hmgu>	27996060	EUCOMM
phosphotyrosine interaction domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458546	Pid1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
phosphotyrosine interaction domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458637	Pid1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
phytanoyl-CoA hydroxylase interacting protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460503	Phyhipl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phytanoyl-CoA hydroxylase interacting protein-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460526	Phyhipl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
phytanoyl-CoA hydroxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441760	Phyh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
phytanoyl-CoA hydroxylase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605835	Phyh<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
phytanoyl-CoA hydroxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442023	Phyh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
piezo-type mechanosensitive ion channel component 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451539	Piezo1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
piezo-type mechanosensitive ion channel component 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451539	Piezo1<tm1a(KOMP)Wtsi>	25119035	KOMP-CSD
piezo-type mechanosensitive ion channel component 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451539	Piezo1<tm1a(KOMP)Wtsi>	27797339	KOMP-CSD
piezo-type mechanosensitive ion channel component 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5823989	Piezo1<tm1c(KOMP)Wtsi>	25119035	KOMP-CSD
piezo-type mechanosensitive ion channel component 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451654	Piezo1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
piezo-type mechanosensitive ion channel component 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841238	Piezo2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
piezo-type mechanosensitive ion channel component 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841475	Piezo2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PIF1 5'-to-3' DNA helicase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432015	Pif1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PIF1 5'-to-3' DNA helicase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431888	Pif1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
piggyBac transposable element derived 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140437	Pgbd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
piggyBac transposable element derived 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428509	Pgbd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
piggyBac transposable element derived 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364412	Pgbd5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
piggyBac transposable element derived 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364824	Pgbd5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Pigy upstream reading frame; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050875	Pyurf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Pigy upstream reading frame; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451544	Pyurf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PIH1 domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419757	Pih1d1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
PILR alpha associated neural protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419838	Pianp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PILR alpha associated neural protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419793	Pianp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PIN2/TERF1 interacting, telomerase inhibitor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434348	Pinx1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pinin; targeted mutation 1.1, Velocigene	MGI:5695886	Pnn<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
pipecolic acid oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441875	Pipox<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pipecolic acid oxidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513809	Pipox<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
pipecolic acid oxidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441700	Pipox<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pipecolic acid oxidase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456789	Pipox<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
pirin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452645	Pir<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pirin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452663	Pir<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419947	Pithd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419389	Pithd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511938	Pithd1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
pitrilysin metallepetidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085349	Pitrm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pitrilysin metallepetidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085349	Pitrm1<tm1a(KOMP)Wtsi>	26697887	KOMP-CSD
pituitary tumor-transforming gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433833	Pttg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
piwi-like RNA-mediated gene silencing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453789	Piwil1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
piwi-like RNA-mediated gene silencing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428484	Piwil2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
placental growth factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451298	Pgf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
placental growth factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451593	Pgf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
placental specific protein 1; targeted mutation 1, Velocigene	MGI:3808477	Plac1<tm1(KOMP)Vlcg>	22729990	KOMP-Regeneron
placenta specific 9a; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637163	Plac9a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
placenta specific 9a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433053	Plac9a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
placenta specific 9b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419258	Plac9b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
placenta specific 9b; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050152	Plac9b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
plakophilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365048	Pkp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
plakophilin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364666	Pkp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
plakophilin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456649	Pkp1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
plakophilin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456649	Pkp1<tm2a(KOMP)Wtsi>	27033150	KOMP-CSD
plakophilin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456649	Pkp1<tm2a(KOMP)Wtsi>	27375112	KOMP-CSD
plakophilin 1; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5823265	Pkp1<tm2c(KOMP)Wtsi>	27033150	KOMP-CSD
plakophilin 1; targeted mutation 2d, Wellcome Trust Sanger Institute	MGI:5823266	Pkp1<tm2d(KOMP)Wtsi>	27033150	KOMP-CSD
plakophilin 1; targeted mutation 2d, Wellcome Trust Sanger Institute	MGI:5823266	Pkp1<tm2d(KOMP)Wtsi>	27375112	KOMP-CSD
plakophilin 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456642	Pkp1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
plakophilin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013758	Pkp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
plakophilin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428514	Pkp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
plakophilin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432523	Pkp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plakophilin 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5581414	Pkp4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
plasmalemma vesicle associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432043	Plvap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plasmalemma vesicle associated protein; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH	MGI:4434827	Plvap<tm1e(EUCOMM)Hmgu>	22782339	EUCOMM
plasmalemma vesicle associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431528	Plvap<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plasminogen activator, tissue; targeted mutation 1.1, Velocigene	MGI:5582448	Plat<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
plasminogen activator, tissue; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842251	Plat<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plasminogen activator, tissue; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842660	Plat<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plasminogen activator, urokinase receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302362	Plaur<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plasminogen activator, urokinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944525	Plau<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plasminogen activator, urokinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944549	Plau<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plasminogen receptor, C-terminal lysine transmembrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5284930	Plgrkt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plasminogen receptor, C-terminal lysine transmembrane protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286377	Plgrkt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plastin 1 (I-isoform); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431925	Pls1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plastin 1 (I-isoform); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433612	Pls1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
plastin 1 (I-isoform); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434239	Pls1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
plastin 3 (T-isoform); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451991	Pls3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plastin 3 (T-isoform); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951089	Pls3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847687	Pafah1b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847690	Pafah1b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
platelet-activating factor acetylhydrolase, isoform 1b, subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441617	Pafah1b3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
platelet-activating factor receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460278	Ptafr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
platelet-activating factor receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460287	Ptafr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
platelet derived growth factor, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441924	Pdgfa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
platelet derived growth factor, B polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887618	Pdgfb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
platelet derived growth factor, B polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887601	Pdgfb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
platelet-derived growth factor, D polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461758	Pdgfd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
platelet-derived growth factor, D polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461754	Pdgfd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
platelet derived growth factor receptor, beta polypeptide; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692911	Pdgfrb<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
platelet endothelial aggregation receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363617	Pear1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
platelet endothelial aggregation receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363617	Pear1<tm1a(KOMP)Wtsi>	27614188	KOMP-CSD
platelet endothelial aggregation receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364025	Pear1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452639	Plek2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin and Sec7 domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455570	Psd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin and Sec7 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455605	Psd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin and Sec7 domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008062	Psd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin and Sec7 domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008028	Psd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin and Sec7 domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944514	Psd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin and Sec7 domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944518	Psd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4840785	Plekha8<tm1a(KOMP)Mbp>	26839965	KOMP-CSD
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362995	Plekha8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569074	Plekha8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pleckstrin homology domain containing, family F (with FYVE domain) member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286260	Plekhf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin homology domain containing, family F (with FYVE domain) member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293941	Plekhf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin homology domain containing, family G (with RhoGef domain) member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431598	Plekhg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family G (with RhoGef domain) member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434128	Plekhg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family G (with RhoGef domain) member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433405	Plekhg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family G (with RhoGef domain) member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434172	Plekhg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family G (with RhoGef domain) member 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548798	Plekhg3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
pleckstrin homology domain containing, family G (with RhoGef domain) member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432205	Plekhg4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin homology domain containing, family G (with RhoGef domain) member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364053	Plekhg4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin homology domain containing, family M (with RUN domain) member 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513810	Plekhm1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
pleckstrin homology domain containing, family M (with RUN domain) member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432896	Plekhm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family M (with RUN domain) member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432896	Plekhm2<tm1a(EUCOMM)Wtsi>	26268777	EUCOMM
pleckstrin homology domain containing, family M (with RUN domain) member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432896	Plekhm2<tm1a(EUCOMM)Wtsi>	29150602	EUCOMM
pleckstrin homology domain containing, family M (with RUN domain) member 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:6115604	Plekhm2<tm1b(EUCOMM)Wtsi>	29150602	EUCOMM
pleckstrin homology domain containing, family M (with RUN domain) member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434033	Plekhm2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family O member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820386	Plekho1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology domain containing, family O member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820259	Plekho1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology like domain, family A, member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512000	Phlda2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology like domain, family A, member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511968	Phlda2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology like domain, family B, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432282	Phldb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pleckstrin homology like domain, family B, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299590	Phldb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pleckstrin homology like domain, family B, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299522	Phldb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
plectin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362313	Plec<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pleiomorphic adenoma gene-like 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002920	Plagl2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
pleiomorphic adenoma gene-like 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5002921	Plagl2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
plexin A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432861	Plxna2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plexin A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432861	Plxna2<tm1a(EUCOMM)Wtsi>	24179230	EUCOMM
plexin A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432861	Plxna2<tm1a(EUCOMM)Wtsi>	25959730	EUCOMM
plexin A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431846	Plxna2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plexin A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286185	Plxna3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
plexin A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426559	Plxna3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
plexin A4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293915	Plxna4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
plexin B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433461	Plxnb2<tm1a(EUCOMM)Wtsi>	21122816	EUCOMM
plexin B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433461	Plxnb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plexin B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433461	Plxnb2<tm1a(EUCOMM)Wtsi>	26579598	EUCOMM
plexin B2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5706788	Plxnb2<tm1c(EUCOMM)Wtsi>	26579598	EUCOMM
plexin B2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434241	Plxnb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plexin B3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419514	Plxnb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
plexin B3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420027	Plxnb3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
plexin D1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432571	Plxnd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
plexin D1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433502	Plxnd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
plexin domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431881	Plxdc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pluripotency associated transcript 26; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419280	Platr26<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
PML-RAR alpha-regulated adaptor molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461665	Pram1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PML-RAR alpha-regulated adaptor molecule 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637181	Pram1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
PML-RAR alpha-regulated adaptor molecule 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461702	Pram1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PML-RAR alpha-regulated adaptor molecule 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820247	Pram1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PML-RAR alpha-regulated adaptor molecule 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820214	Pram1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
PMS1 homolog 1, mismatch repair system component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842822	Pms1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PMS1 homolog 1, mismatch repair system component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842373	Pms1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PMS1 homolog2, mismatch repair system component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419826	Pms2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PMS1 homolog2, mismatch repair system component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419475	Pms2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PMS1 homolog2, mismatch repair system component; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473047	Pms2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PNMA-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287797	Pnmal1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PNMA-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293925	Pnmal1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PNN interacting serine/arginine-rich; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947829	Pnisr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
POC1 centriolar protein A; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:5287771	Poc1a<tm1(KOMP)Mbp>	26496357	KOMP-CSD
POC1 centriolar protein B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364351	Poc1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
POC1 centriolar protein B; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5572031	Poc1b<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
POC1 centriolar protein B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364785	Poc1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
POC5 centriolar protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843843	Poc5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
POC5 centriolar protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4843831	Poc5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
podocalyxin-like 2; targeted mutation 1.1, Velocigene	MGI:5569957	Podxl2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
podocalyxin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842467	Podxl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
podocalyxin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842467	Podxl2<tm1a(EUCOMM)Wtsi>	27542690	EUCOMM
podocalyxin-like 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5883834	Podxl2<tm1c(EUCOMM)Wtsi>	27542690	EUCOMM
podocalyxin-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363279	Podxl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
podocalyxin-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364738	Podxl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
podocan; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296132	Podn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
podocan; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605822	Podn<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
podocan; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296121	Podn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
podoplanin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842558	Pdpn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
podoplanin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842558	Pdpn<tm1a(EUCOMM)Wtsi>	28222099	EUCOMM
podoplanin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548337	Pdpn<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
podoplanin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548337	Pdpn<tm1b(EUCOMM)Wtsi>	28222099	EUCOMM
podoplanin; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5692543	Pdpn<tm1c(EUCOMM)Wtsi>	28222099	EUCOMM
podoplanin; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5692543	Pdpn<tm1c(EUCOMM)Wtsi>	28488815	EUCOMM
podoplanin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842366	Pdpn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
poliovirus receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365131	Pvr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
poliovirus receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365251	Pvr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
poliovirus receptor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299606	Pvr<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
poliovirus receptor; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299527	Pvr<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
polo like kinase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548960	Plk1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
polo like kinase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548960	Plk1<tm1b(EUCOMM)Hmgu>	27662907	EUCOMM
polo like kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842862	Plk2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polo like kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842858	Plk3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polo like kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458854	Plk3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polo like kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362916	Plk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
poly(A) binding protein, cytoplasmic 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431852	Pabpc1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein, cytoplasmic 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434114	Pabpc1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein, cytoplasmic 1-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432938	Pabpc1l<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein, cytoplasmic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842501	Pabpc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein, cytoplasmic 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4939765	Pabpc1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein, cytoplasmic 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364054	Pabpc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
poly(A) binding protein, cytoplasmic 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364054	Pabpc4<tm1a(KOMP)Wtsi>	23912999	KOMP-CSD
poly(A) binding protein, cytoplasmic 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364130	Pabpc4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
poly(A) binding protein, cytoplasmic 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364130	Pabpc4<tm1e(KOMP)Wtsi>	26398943	KOMP-CSD
poly(A) binding protein, cytoplasmic 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473124	Pabpc6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein, cytoplasmic 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472708	Pabpc6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein interacting protein 2B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419404	Paip2b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
poly(A)binding protein nuclear 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842589	Pabpn1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A)binding protein nuclear 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842305	Pabpn1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A) binding protein, nuclear 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419476	Pabpn1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
polyadenylate binding protein-interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940757	Paip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
poly (ADP-ribose) polymerase family, member 11; targeted mutation 1.1, Velocigene	MGI:5548742	Parp11<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
poly (ADP-ribose) polymerase family, member 11; targeted mutation 1, Velocigene	MGI:4415414	Parp11<tm1(KOMP)Vlcg>	25673562	KOMP-Regeneron
poly (ADP-ribose) polymerase family, member 12; targeted mutation 1.1, Velocigene	MGI:5548746	Parp12<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
poly (ADP-ribose) polymerase family, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426550	Parp12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
poly (ADP-ribose) polymerase family, member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319907	Parp12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
poly (ADP-ribose) polymerase family, member 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319928	Parp12<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
poly (ADP-ribose) polymerase family, member 12; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319923	Parp12<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
poly (ADP-ribose) polymerase family, member 16; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5468969	Parp16<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
poly (ADP-ribose) polymerase family, member 16; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5468969	Parp16<tm1.1(KOMP)Mbp>	28700664	KOMP-CSD
poly (ADP-ribose) polymerase family, member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435467	Parp1<tm1a(EUCOMM)Hmgu>	28107648	EUCOMM
poly (ADP-ribose) polymerase family, member 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692622	Parp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
poly (ADP-ribose) polymerase family, member 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6100929	Parp1<tm1c(EUCOMM)Hmgu>	28107648	EUCOMM
poly (ADP-ribose) polymerase family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433965	Parp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
poly (ADP-ribose) polymerase family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306491	Parp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
poly (ADP-ribose) polymerase family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302329	Parp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
poly (ADP-ribose) polymerase family, member 8; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5494979	Parp8<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
poly (ADP-ribose) polymerase family, member 8; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5494979	Parp8<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
poly (ADP-ribose) polymerase family, member 8; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5494979	Parp8<tm1.1(KOMP)Wtsi>	28700664	KOMP-CSD
poly (ADP-ribose) polymerase family, member 8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419178	Parp8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
poly (ADP-ribose) polymerase family, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433246	Parp9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
poly (ADP-ribose) polymerase family, member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434329	Parp9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polyamine oxidase (exo-N4-amino); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363510	Paox<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
poly (A) polymerase alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363069	Papola<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
poly (A) polymerase beta (testis specific); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473180	Papolb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
poly (A) polymerase beta (testis specific); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472754	Papolb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
poly(A)-specific ribonuclease (PARN)-like domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433711	Pnldc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polybromo 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432389	Pbrm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polybromo 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432389	Pbrm1<tm1a(EUCOMM)Wtsi>	28473526	EUCOMM
polycomb group ring finger 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419937	Pcgf1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
polycomb group ring finger 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458483	Pcgf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polycomb group ring finger 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548974	Pcgf2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
polycomb group ring finger 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458617	Pcgf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polycomb group ring finger 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431813	Pcgf3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polycomb group ring finger 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431580	Pcgf3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polycystic kidney disease 1 like 2; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548849	Pkd1l2<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
polycystic kidney disease 2-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841297	Pkd2l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polycystic kidney disease 2-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841321	Pkd2l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polycystic kidney disease 2-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432894	Pkd2l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polycystic kidney disease 2-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548488	Pkd2l2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
polycystic kidney disease 2-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433872	Pkd2l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polyhomeotic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940786	Phc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polyhomeotic 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940793	Phc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polyhomeotic 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362173	Phc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polyhomeotic 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363527	Phc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polyhomeotic 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362125	Phc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polyhomeotic 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363624	Phc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polyhomeotic 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363371	Phc3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
polyhomeotic 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4362719	Phc3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940776	Pola1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299644	Pola2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), alpha 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364195	Pola2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950969	Polb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950969	Polb<tm1a(KOMP)Wtsi>	27996060	KOMP-CSD
polymerase (DNA directed), beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950973	Polb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), beta; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319865	Polb<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), delta 1, catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431772	Pold1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA directed), delta 1, catalytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431991	Pold1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA directed), delta 2, regulatory subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419171	Pold2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA-directed), delta 3, accessory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441785	Pold3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA-directed), delta 3, accessory subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637026	Pold3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
polymerase (DNA-directed), delta 3, accessory subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441908	Pold3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA directed), epsilon 2 (p59 subunit); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942009	Pole2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA-directed), epsilon 4 (p12 subunit); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433445	Pole4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA-directed), epsilon 4 (p12 subunit); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432757	Pole4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA directed), gamma 2, accessory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432134	Polg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA directed), gamma 2, accessory subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433330	Polg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (DNA directed), kappa; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307090	Polk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), mu; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362457	Polm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (DNA directed), mu; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363173	Polm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882028	Polr2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) II (DNA directed) polypeptide B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887698	Polr2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) II (DNA directed) polypeptide D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942026	Polr2d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941991	Polr2d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide E; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419284	Polr2e<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431562	Polr2f<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) II (DNA directed) polypeptide H; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5498773	Polr2h<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide H; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5498773	Polr2h<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide H; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419380	Polr2h<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide I; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419358	Polr2i<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide J; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451479	Polr2j<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide J; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455519	Polr2j<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide J; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455503	Polr2j<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide L; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451319	Polr2l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) II (DNA directed) polypeptide L; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451556	Polr2l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) III (DNA directed) polypeptide C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431544	Polr3c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) III (DNA directed) polypeptide C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433450	Polr3c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) III (DNA directed) polypeptide E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296226	Polr3e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) III (DNA directed) polypeptide F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431549	Polr3f<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) III (DNA directed) polypeptide F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434409	Polr3f<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) III (DNA directed) polypeptide G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441807	Polr3g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) III (DNA directed) polypeptide G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442030	Polr3g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polymerase (RNA) I polypeptide C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840957	Polr1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) I polypeptide C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841018	Polr1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) I polypeptide E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362193	Polr1e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) I polypeptide E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364773	Polr1e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) mitochondrial (DNA directed); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000327	Polrmt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) mitochondrial (DNA directed); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006742	Polrmt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polymerase (RNA) mitochondrial (DNA directed); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299666	Polrmt<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
polynucleotide kinase 3'- phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842461	Pnkp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polynucleotide kinase 3'- phosphatase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842886	Pnkp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
polypeptide N-acetylgalactosaminyltransferase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456806	Galnt10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polypeptide N-acetylgalactosaminyltransferase 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002996	Galnt12<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
polypeptide N-acetylgalactosaminyltransferase 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947766	Galnt14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polypeptide N-acetylgalactosaminyltransferase 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362514	Galnt15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polypeptide N-acetylgalactosaminyltransferase 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364478	Galnt15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polypeptide N-acetylgalactosaminyltransferase 17; targeted mutation 1.1, Velocigene	MGI:5695943	Galnt17<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
polypeptide N-acetylgalactosaminyltransferase 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085352	Galnt18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polypeptide N-acetylgalactosaminyltransferase 18; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637158	Galnt18<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
polypeptide N-acetylgalactosaminyltransferase 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881970	Galnt18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polypeptide N-acetylgalactosaminyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286188	Galnt3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polypeptide N-acetylgalactosaminyltransferase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441811	Galnt6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
polypyrimidine tract binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362698	Ptbp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polypyrimidine tract binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362698	Ptbp1<tm1a(KOMP)Wtsi>	28296893	KOMP-CSD
polypyrimidine tract binding protein 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5908195	Ptbp1<tm1c(KOMP)Wtsi>	28296893	KOMP-CSD
polypyrimidine tract binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362565	Ptbp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
poly(rC) binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419889	Pcbp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
poly(rC) binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419373	Pcbp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polyribonucleotide nucleotidyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364657	Pnpt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
polyribonucleotide nucleotidyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364904	Pnpt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polyribonucleotide nucleotidyltransferase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364949	Pnpt1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
polysaccharide biosynthesis domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419135	Pbdc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
polysaccharide biosynthesis domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451656	Pbdc1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
popeye domain containing 3; targeted mutation 1.1, Velocigene	MGI:5548717	Popdc3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
post-GPI attachment to proteins 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453763	Pgap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
post-GPI attachment to proteins 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453706	Pgap2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
post-GPI attachment to proteins 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363140	Pgap3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
post-GPI attachment to proteins 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363872	Pgap3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel modulatory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006758	Kcmf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily K, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461751	Kcnk10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily K, member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461712	Kcnk10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily K, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294968	Kcnk12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily K, member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299509	Kcnk12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily K, member 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456074	Kcnk13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily K, member 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455981	Kcnk13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily K, member 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949370	Kcnk15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily K, member 16; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503346	Kcnk16<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily K, member 18; targeted mutation 1.1, Velocigene	MGI:5548875	Kcnk18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
potassium channel, subfamily K, member 18; targeted mutation 1.1, Velocigene	MGI:5548875	Kcnk18<tm1.1(KOMP)Vlcg>	28937579	KOMP-Regeneron
potassium channel, subfamily K, member 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140463	Kcnk18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily K, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942003	Kcnk5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily K, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942008	Kcnk5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily K, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419165	Kcnk7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily K, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419342	Kcnk7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily T, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431703	Kcnt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily T, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433730	Kcnt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily T, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433113	Kcnt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily T, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434156	Kcnt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel, subfamily U, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451258	Kcnu1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily U, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451561	Kcnu1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel, subfamily V, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451607	Kcnv1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel tetramerisation domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008048	Kctd10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 13; targeted mutation 1.1, Velocigene	MGI:6111982	Kctd13<tm1.1(KOMP)Vlcg>	29088697	KOMP-Regeneron
potassium channel tetramerisation domain containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944510	Kctd13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 13; targeted mutation 1, Velocigene	MGI:5292984	Kctd13<tm1(KOMP)Vlcg>	29088697	KOMP-Regeneron
potassium channel tetramerisation domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434119	Kctd14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434510	Kctd14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432583	Kctd15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432583	Kctd15<tm1a(EUCOMM)Wtsi>	26839965	EUCOMM
potassium channel tetramerisation domain containing 15; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548790	Kctd15<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
potassium channel tetramerisation domain containing 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431945	Kctd15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441854	Kctd17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441867	Kctd17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363769	Kctd19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel tetramerisation domain containing 19; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820048	Kctd19<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel tetramerisation domain containing 19; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820175	Kctd19<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel tetramerisation domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052490	Kctd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140446	Kctd21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel tetramerisation domain containing 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140428	Kctd21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel tetramerisation domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433862	Kctd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052494	Kctd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432422	Kctd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432777	Kctd5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433168	Kctd6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433432	Kctd6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium channel tetramerisation domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364042	Kctd7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium channel tetramerisation domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362463	Kctd7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419229	Kcnn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419448	Kcnn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433082	Kcnn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433731	Kcnn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451428	Kcnj10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium inwardly-rectifying channel, subfamily J, member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451403	Kcnj10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium inwardly rectifying channel, subfamily J, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473147	Kcnj11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly rectifying channel, subfamily J, member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472725	Kcnj11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432694	Kcnj12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433562	Kcnj12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 12; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511920	Kcnj12<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 12; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511894	Kcnj12<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362275	Kcnj13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium inwardly-rectifying channel, subfamily J, member 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363508	Kcnj13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium inwardly-rectifying channel, subfamily J, member 13; targeted mutation 1, Velocigene	MGI:5312614	Kcnj13<tm1(KOMP)Vlcg>	26402555	KOMP-Regeneron
potassium inwardly-rectifying channel, subfamily J, member 14; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5637127	Kcnj14<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434371	Kcnj15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433940	Kcnj15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842402	Kcnj16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842440	Kcnj16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426612	Kcnj2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium inwardly-rectifying channel, subfamily J, member 3; targeted mutation 1.1, Velocigene	MGI:5695876	Kcnj3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
potassium inwardly-rectifying channel, subfamily J, member 9; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548379	Kcnj9<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
potassium inwardly-rectifying channel, subfamily J, member 9; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548379	Kcnj9<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
potassium large conductance calcium-activated channel, subfamily M, alpha member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939742	Kcnma1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426648	Kcns3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426611	Kcns3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, Isk-related subfamily, gene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431909	Kcne2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, Isk-related subfamily, gene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431909	Kcne2<tm1a(EUCOMM)Wtsi>	25127743	EUCOMM
potassium voltage-gated channel, Isk-related subfamily, gene 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431828	Kcne2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, Isk-related subfamily, gene 3; targeted mutation 1, Velocigene	MGI:5292850	Kcne3<tm1(KOMP)Vlcg>	24727472	KOMP-Regeneron
potassium voltage gated channel, Shab-related subfamily, member 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5695133	Kcnb1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
potassium voltage-gated channel, shaker-related subfamily, beta member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365209	Kcnab2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, beta member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362675	Kcnab2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, beta member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299534	Kcnab2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, beta member 3; targeted mutation 1.1, Velocigene	MGI:5695894	Kcnab3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
potassium voltage-gated channel, shaker-related subfamily, beta member 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050928	Kcnab3<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, shaker-related subfamily, beta member 3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050972	Kcnab3<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, shaker-related subfamily, member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419638	Kcna10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, member 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5297892	Kcna10<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, member 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5297887	Kcna10<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, member 1; targeted mutation 1.1, Velocigene	MGI:5605842	Kcna1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
potassium voltage-gated channel, shaker-related subfamily, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842666	Kcna2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, shaker-related subfamily, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880985	Kcna4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881941	Kcna4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, shaker-related subfamily, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473188	Kcna5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, shaker-related subfamily, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472761	Kcna5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, shaker-related subfamily, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052509	Kcna7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, Shal-related family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363607	Kcnd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, Shal-related family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362655	Kcnd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage gated channel, Shaw-related subfamily, member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847682	Kcnc1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage gated channel, Shaw-related subfamily, member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847691	Kcnc1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage gated channel, Shaw-related subfamily, member 2; targeted mutation 1.1, Velocigene	MGI:5695975	Kcnc2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
potassium voltage gated channel, Shaw-related subfamily, member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050963	Kcnc2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage gated channel, Shaw-related subfamily, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052506	Kcnc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily G, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888932	Kcng1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily G, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888934	Kcng1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily G, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451584	Kcng3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, subfamily G, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451465	Kcng3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, subfamily G, member 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840575	Kcng4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily H (eag-related), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432138	Kcnh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily H (eag-related), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433884	Kcnh2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily H (eag-related), member 3; targeted mutation 1.1, Velocigene	MGI:5445933	Kcnh3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
potassium voltage-gated channel, subfamily H (eag-related), member 3; targeted mutation 1.1, Velocigene	MGI:5445933	Kcnh3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
potassium voltage-gated channel, subfamily H (eag-related), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460286	Kcnh4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, subfamily H (eag-related), member 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637120	Kcnh4<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
potassium voltage-gated channel, subfamily H (eag-related), member 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637120	Kcnh4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
potassium voltage-gated channel, subfamily H (eag-related), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461476	Kcnh4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, subfamily H (eag-related), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842603	Kcnh5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily H (eag-related), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842624	Kcnh5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily H (eag-related), member 6; targeted mutation 1.1, Velocigene	MGI:5695959	Kcnh6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
potassium voltage-gated channel, subfamily H (eag-related), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456840	Kcnh6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily Q, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432710	Kcnq2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily Q, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432856	Kcnq2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
potassium voltage-gated channel, subfamily Q, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462571	Kcnq5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
potassium voltage-gated channel, subfamily Q, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948609	Kcnq5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
POTE ankyrin domain family, member G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842788	Poteg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
POU domain, class 1, transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938556	Pou1f1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
POU domain, class 1, transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938605	Pou1f1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
POU domain, class 2, associating factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947733	Pou2af1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
POU domain, class 2, transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431770	Pou2f1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
POU domain, class 2, transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431770	Pou2f1<tm1a(EUCOMM)Wtsi>	26481684	EUCOMM
POU domain, class 2, transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432529	Pou2f1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
POU domain, class 2, transcription factor 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472854	Pou2f1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
POU domain, class 2, transcription factor 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4847790	Pou2f2<tm1a(EUCOMM)Hmgu>	26993806	EUCOMM
POU domain, class 2, transcription factor 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5767180	Pou2f2<tm1c(EUCOMM)Hmgu>	26993806	EUCOMM
POU domain, class 2, transcription factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433414	Pou2f3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
POU domain, class 4, transcription factor 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419116	Pou4f3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
POU domain, class 6, transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419381	Pou6f1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
POU domain, class 6, transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419562	Pou6f1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
POU domain, class 6, transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428547	Pou6f2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
POU domain, class 6, transcription factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428510	Pou6f2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
POZ (BTB) and AT hook containing zinc finger 1; targeted mutation 1.1, Velocigene	MGI:5695909	Patz1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
POZ (BTB) and AT hook containing zinc finger 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4868033	Patz1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
PQ loop repeat containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433169	Pqlc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PQ loop repeat containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434403	Pqlc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PQ loop repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947825	Pqlc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PQ loop repeat containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820031	Pqlc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PQ loop repeat containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820088	Pqlc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PRA1 domain family 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457577	Praf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PRA1 domain family 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457557	Praf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
praja ring finger ubiquitin ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006789	Pja1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
praja ring finger ubiquitin ligase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006798	Pja1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
praja ring finger ubiquitin ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432417	Pja2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
praja ring finger ubiquitin ligase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572033	Pja2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
praja ring finger ubiquitin ligase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433746	Pja2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PRAME family member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951123	Pramef12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PRAME family member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951138	Pramef12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PRAME family member 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419212	Pramef17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PRAME family member 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419270	Pramef17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PRAME family member 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940749	Pramef20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PRAME family member 20; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637193	Pramef20<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
PRAME family member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362595	Pramef8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PRAME family member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364328	Pramef8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PR domain containing 10; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5574612	Prdm10<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
PR domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441656	Prdm14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441656	Prdm14<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
PR domain containing 14; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5755614	Prdm14<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
PR domain containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441771	Prdm14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441771	Prdm14<tm1e(EUCOMM)Wtsi>	23670199	EUCOMM
PR domain containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432795	Prdm15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433471	Prdm15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432818	Prdm16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431546	Prdm16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 1, with ZNF domain; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050950	Prdm1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548625	Prdm4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
PR domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299884	Prdm8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434298	Prdm9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PR domain containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432500	Prdm9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pre B cell leukemia homeobox 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433160	Pbx3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pre B cell leukemia homeobox 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548956	Pbx3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
pre-B lymphocyte gene 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299560	Vpreb1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 10058; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841391	Gm10058<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 10058; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841415	Gm10058<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 10439; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841278	Gm10439<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 10486; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841431	Gm10486<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 10486; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841308	Gm10486<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1070; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362541	Gm1070<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1070; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364989	Gm1070<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 10822; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433201	Gm10822<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 10822; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431822	Gm10822<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 10845; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842643	Gm10845<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 11232; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452718	Gm11232<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 11232; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296525	Gm11232<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1123; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842560	Gm1123<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 1141; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364709	Gm1141<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1141; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319900	Gm1141<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1141; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319809	Gm1141<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1141; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4462574	Gm1141<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1141; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5287782	Gm1141<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1141; targeted mutation 4e, Wellcome Trust Sanger Institute	MGI:5319854	Gm1141<tm4e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1141; targeted mutation 5a, Wellcome Trust Sanger Institute	MGI:5426546	Gm1141<tm5a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1141; targeted mutation 5e, Wellcome Trust Sanger Institute	MGI:5319855	Gm1141<tm5e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 11444; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363956	Gm11444<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 11444; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364318	Gm11444<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 11444; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841463	Gm11444<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 11444; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841390	Gm11444<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12169; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419946	Gm12169<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12253; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008795	Gm12253<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12253; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008813	Gm12253<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12258; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456822	Gm12258<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 12258; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548909	Gm12258<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
predicted gene 12258; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456839	Gm12258<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 12394; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364031	Gm12394<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12695; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426618	Gm12695<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12789; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419488	Gm12789<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12790; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419983	Gm12790<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12790; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419746	Gm12790<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12790; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296554	Gm12790<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12886; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286253	Gm12886<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12886; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426607	Gm12886<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12886; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5426673	Gm12886<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12887; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050864	Gm12887<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12887; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419972	Gm12887<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 12888; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820128	Gm12888<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13030; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362604	Gm13030<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13030; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362725	Gm13030<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13078; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868040	Gm13078<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13078; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868030	Gm13078<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13084; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849967	Gm13084<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13084; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849969	Gm13084<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13088; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420112	Gm13088<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13089; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362721	Gm13089<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13090; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362789	Gm13090<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13090; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363266	Gm13090<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13090; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419844	Gm13090<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13090; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473040	Gm13090<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 13090; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5472859	Gm13090<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 13103; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458600	Gm13103<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13103; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458587	Gm13103<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13119; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364277	Gm13119<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13119; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4454060	Gm13119<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13119; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4454124	Gm13119<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13128; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419287	Gm13128<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13128; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419189	Gm13128<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13178; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503348	Gm13178<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13306; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363696	Gm13306<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13306; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5511951	Gm13306<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 13547; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419244	Gm13547<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13547; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419969	Gm13547<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13941; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419780	Gm13941<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 13941; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841158	Gm13941<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14025; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362665	Gm14025<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14025; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419771	Gm14025<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14025; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419849	Gm14025<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14221; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296559	Gm14221<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14221; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296562	Gm14221<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14221; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296560	Gm14221<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14401; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364648	Gm14401<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14401; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363050	Gm14401<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14401; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451386	Gm14401<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14401; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293924	Gm14401<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14632; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364872	Gm14632<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14781; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950944	Gm14781<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14781; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841186	Gm14781<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 14851; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842361	Gm14851<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 14851; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842719	Gm14851<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 15091; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820148	Gm15091<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15091; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820173	Gm15091<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15127; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820164	Gm15127<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15127; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820122	Gm15127<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15155; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841162	Gm15155<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15155; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841353	Gm15155<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15319; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420039	Gm15319<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15319; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420052	Gm15319<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15401; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419585	Gm15401<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15440; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462605	Gm15440<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 15440; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462580	Gm15440<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 156; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451412	Gm156<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 16294; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426631	Gm16294<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 16294; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426572	Gm16294<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 16432; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841221	Gm16432<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 16432; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841173	Gm16432<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 1673; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4882030	Gm1673<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene, 17359; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5568484	Gm17359<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
predicted gene 21976; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939697	Gm21976<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 438; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419726	Gm438<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 454; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362809	Gm454<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 454; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363702	Gm454<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 4567; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140436	Gm4567<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 4832; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460431	Gm4832<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 4832; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460521	Gm4832<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 4847; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4950946	Gm4847<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 4907; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319817	Gm4907<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 4907; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887639	Gm4907<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 4951; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140434	Gm4951<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 4951; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4818590	Gm4951<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 498; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951117	Gm498<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5065; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052422	Gm5065<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5113; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432542	Gm5113<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5113; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433254	Gm5113<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5127; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460308	Gm5127<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5127; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319838	Gm5127<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5416; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432807	Gm5416<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5416; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432953	Gm5416<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5434; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473156	Gm5434<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5434; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472733	Gm5434<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5532; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433817	Gm5532<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5532; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433685	Gm5532<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 5535; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364927	Gm5535<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5544; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364386	Gm5544<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5544; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363712	Gm5544<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5544; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363944	Gm5544<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5546; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363574	Gm5546<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5546; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362202	Gm5546<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5546; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455502	Gm5546<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5546; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455530	Gm5546<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5615; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458479	Gm5615<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5615; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458650	Gm5615<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5640; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458509	Gm5640<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5640; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458539	Gm5640<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5800; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363443	Gm5800<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5800; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451473	Gm5800<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5800; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451501	Gm5800<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5878; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419462	Gm5878<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 5891; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841462	Gm5891<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 595; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006786	Gm595<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 595; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006808	Gm595<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 609; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434097	Gm609<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 6116; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364581	Gm6116<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6268; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050879	Gm6268<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6268; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426577	Gm6268<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6377; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942011	Gm6377<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6377; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5007966	Gm6377<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6471; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452708	Gm6471<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6471; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452720	Gm6471<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 648; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364088	Gm648<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 648; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364134	Gm648<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6498; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299587	Gm6498<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6498; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299520	Gm6498<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6578; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455593	Gm6578<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6578; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456647	Gm6578<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6812; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419423	Gm6812<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6878; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286187	Gm6878<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6878; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427127	Gm6878<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6994; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363856	Gm6994<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 6994; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5472938	Gm6994<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 7173; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006749	Gm7173<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 7173; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940769	Gm7173<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 7247; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841029	Gm7247<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 7247; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841370	Gm7247<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 732; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880979	Gm732<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 7489; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841389	Gm7489<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 7534; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013747	Gm7534<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 773; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939729	Gm773<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 7861; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050172	Gm7861<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 7861; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473024	Gm7861<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 813; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426626	Gm813<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 813; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426561	Gm813<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 8773; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882007	Gm8773<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 8773; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887718	Gm8773<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 9112; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431404	Gm9112<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 94; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000322	Gm94<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 973; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286389	Gm973<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 973; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296203	Gm973<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 9780; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420010	Gm9780<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 9780; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419122	Gm9780<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted gene 9961; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434265	Gm9961<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted gene 9961; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432096	Gm9961<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted pseudogene 10364; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432910	Gm10364<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted pseudogene 10364; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431928	Gm10364<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
predicted pseudogene 16379; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364434	Gm16379<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted pseudogene 16379; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362776	Gm16379<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted pseudogene 5069; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887617	Gm5069<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
predicted pseudogene 5069; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887600	Gm5069<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
predicted pseudogene 5801; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433914	Gm5801<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted pseudogene 9008; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473134	Gm9008<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
predicted pseudogene 9008; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472714	Gm9008<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
preferentially expressed antigen in melanoma like 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287800	Pramel5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
preferentially expressed antigen in melanoma like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457564	Pramel6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
preferentially expressed antigen in melanoma like 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457560	Pramel6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
preferentially expressed antigen in melanoma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880903	Prame<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
preferentially expressed antigen in melanoma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880957	Prame<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prefoldin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888949	Pfdn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prefoldin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888929	Pfdn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prefoldin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432133	Pfdn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prefoldin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431923	Pfdn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prefoldin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433448	Pfdn5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prefoldin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433891	Pfdn5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prefoldin subunit 6; targeted mutation 1.1, Velocigene	MGI:5581419	Pfdn6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
prefoldin subunit 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419471	Pfdn6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
pregnancy-associated plasma protein A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000319	Pappa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pregnancy-associated plasma protein A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299652	Pappa<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
pregnancy upregulated non-ubiquitously expressed CaM kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451259	Pnck<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pregnancy upregulated non-ubiquitously expressed CaM kinase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548467	Pnck<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pregnancy upregulated non-ubiquitously expressed CaM kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451536	Pnck<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PRELI domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842294	Prelid2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PRELI domain containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637093	Prelid2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
PRELI domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842734	Prelid2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
premature ovarian failure 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843846	Pof1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
premature ovarian failure 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4843825	Pof1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
premelanosome protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441778	Pmel<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
premelanosome protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441670	Pmel<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pre-mRNA processing factor 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842537	Prpf19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pre-mRNA processing factor 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842376	Prpf19<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pre-mRNA processing factor 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432954	Prpf31<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pre-mRNA processing factor 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432954	Prpf31<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
pre-mRNA processing factor 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431564	Prpf31<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pre-mRNA processing factor 31; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473000	Prpf31<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
pre-mRNA processing factor 31; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472835	Prpf31<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
pre-mRNA processing factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820067	Prpf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pre-mRNA processing factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820119	Prpf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pre-mRNA processing factor 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299597	Prpf4b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pre-mRNA processing factor 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458654	Prpf4b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pre-mRNA processing factor 4B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299647	Prpf4b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
pre-mRNA processing factor 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050981	Prpf8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
prenylcysteine oxidase 1 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363906	Pcyox1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prenyl (solanesyl) diphosphate synthase, subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014718	Pdss1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
preproenkephalin; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4454042	Penk<tm1(KOMP)Mbp>	27626380	KOMP-CSD
presenilin 1; targeted mutation 1.1, Velocigene	MGI:5515627	Psen1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
presenilin 1; targeted mutation 1.1, Velocigene	MGI:5515627	Psen1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
presenilin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050961	Psen1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
presenilin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286403	Psen2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
presenilin enhancer gamma secretase subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419841	Psenen<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
presequence translocase-asssociated motor 16 homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000409	Pam16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
presequence translocase-asssociated motor 16 homolog (S. cerevisiae); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637011	Pam16<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
prickle planar cell polarity protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003014	Prickle1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prickle planar cell polarity protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003033	Prickle1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prickle planar cell polarity protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455956	Prickle3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prickle planar cell polarity protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455994	Prickle3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prickle planar cell polarity protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426630	Prickle4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prickle planar cell polarity protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426566	Prickle4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
primary cilia formation; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014570	Pifo<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
primary cilia formation; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014607	Pifo<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
primase and polymerase (DNA-directed); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432243	Primpol<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
primase and polymerase (DNA-directed); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548900	Primpol<tm1b(EUCOMM)Wtsi>	25849460	EUCOMM
primase and polymerase (DNA-directed); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548900	Primpol<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
primase and polymerase (DNA-directed); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431663	Primpol<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
primase and polymerase (DNA-directed); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473222	Primpol<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
primase and polymerase (DNA-directed); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5473207	Primpol<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
prion like protein doppel; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431456	Prnd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prion like protein doppel; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431430	Prnd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PRKC, apoptosis, WT1, regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888921	Pawr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PRKC, apoptosis, WT1, regulator; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692789	Pawr<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
PRKC, apoptosis, WT1, regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888938	Pawr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
probasin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299576	Pbsn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
probasin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299658	Pbsn<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
probasin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299649	Pbsn<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
processing of precursor 1, ribonuclease P/MRP family, (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451558	Pop1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
processing of precursor 1, ribonuclease P/MRP family, (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451582	Pop1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
processing of precursor 4, ribonuclease P/MRP family, (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944520	Pop4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
processing of precursor 4, ribonuclease P/MRP family, (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944484	Pop4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
procollagen C-endopeptidase enhancer protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460444	Pcolce<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
procollagen C-endopeptidase enhancer protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461704	Pcolce<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605846	Plod1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419668	Plod3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434527	P4ha1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434423	P4ha2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431899	P4ha2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prodynorphin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820278	Pdyn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prodynorphin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820297	Pdyn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
profilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433191	Pfn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
profilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433191	Pfn1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
profilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433191	Pfn1<tm1a(EUCOMM)Wtsi>	25187265	EUCOMM
profilin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431995	Pfn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
profilin family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451293	Pfn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
profilin family, member 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548626	Pfn4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
profilin family, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451626	Pfn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
profilin family, member 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451599	Pfn4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
profilin family, member 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451615	Pfn4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
progesterone immunomodulatory binding factor 1; targeted mutation 1.1, Velocigene	MGI:5505638	Pibf1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
progesterone receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847854	Pgr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
progestin and adipoQ receptor family member III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362421	Paqr3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member III; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364444	Paqr3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member III; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363196	Paqr3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member III; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364236	Paqr3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member VIII; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451409	Paqr8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member VIII; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451659	Paqr8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member VII; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305620	Paqr7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member VI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451294	Paqr6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member VI; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548574	Paqr6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
progestin and adipoQ receptor family member VI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451321	Paqr6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
progestin and adipoQ receptor family member V; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364959	Paqr5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
programmed cell death 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363532	Pdcd10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
programmed cell death 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364348	Pdcd11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
programmed cell death 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363071	Pdcd11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
programmed cell death 1 ligand 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451521	Pdcd1lg2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
programmed cell death 2-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433760	Pdcd2l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
programmed cell death 2-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433878	Pdcd2l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
programmed cell death 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432528	Pdcd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
programmed cell death 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636894	Pdcd2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
programmed cell death 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5609169	Pdcd2<tm1c(EUCOMM)Wtsi>	25150276	EUCOMM
programmed cell death 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432877	Pdcd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
programmed cell death 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433444	Pdcd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
programmed cell death 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432970	Pdcd6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
programmed cell death 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433807	Pdcd6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
programmed cell death 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840921	Pdcd7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
programmed cell death 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841102	Pdcd7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
progressive ankylosis; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294019	Ank<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prohibitin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306493	Phb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prohibitin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302356	Phb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prohibitin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306499	Phb2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
prohibitin 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302371	Phb2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
prokineticin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939726	Prok1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prokineticin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944423	Prok1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prokineticin receptor 1; targeted mutation 1.1, Velocigene	MGI:5448534	Prokr1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
prolactin family 2, subfamily a, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319910	Prl2a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 2, subfamily b, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299601	Prl2b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 2, subfamily b, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319797	Prl2b1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily a, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426635	Prl3a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily a, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426586	Prl3a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily b, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451524	Prl3b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily b, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451591	Prl3b1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily c, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319842	Prl3c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily c, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319833	Prl3c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily c, member 1; targeted mutation 1, Velocigene	MGI:3808306	Prl3c1<tm1(KOMP)Vlcg>	28576872	KOMP-Regeneron
prolactin family 3, subfamily c, member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319884	Prl3c1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily c, member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319864	Prl3c1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 3, subfamily c, member 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5319931	Prl3c1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
prolactin family 4, subfamily a, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363759	Prl4a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 4, subfamily a, member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458540	Prl4a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 5, subfamily a, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950977	Prl5a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 7, subfamily a, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426584	Prl7a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 7, subfamily b, member 1; targeted mutation 1.1, Velocigene	MGI:5692736	Prl7b1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
prolactin family 7, subfamily b, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286399	Prl7b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prolactin family 7, subfamily b, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296211	Prl7b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prolactin family 7, subfamily b, member 1; targeted mutation 1, Velocigene	MGI:3800059	Prl7b1<tm1(KOMP)Vlcg>	26985002	KOMP-Regeneron
prolactin family 7, subfamily c, member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5140454	Prl7c1<tm1a(EUCOMM)Hmgu>	28448534	EUCOMM
prolactin family 8, subfamily a, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426585	Prl8a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 8, subfamily a, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287793	Prl8a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin family 8, subfamily a, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286224	Prl8a6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin induced protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431396	Pip<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin regulatory element binding; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451579	Preb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin regulatory element binding; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451279	Preb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426637	Prl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5426655	Prl<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
prolactin; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473013	Prl<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
prolactin; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5472842	Prl<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
proliferation-associated 2G4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433339	Pa2g4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proline arginine-rich end leucine-rich repeat; targeted mutation 1.1, Velocigene	MGI:5548757	Prelp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
proline dehydrogenase (oxidase) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841139	Prodh2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline dehydrogenase (oxidase) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841032	Prodh2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939696	Prodh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline dehydrogenase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548961	Prodh<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
proline dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939694	Prodh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 13; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419202	Prr13<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 15-like; targeted mutation 1.1, Velocigene	MGI:5548795	Prr15l<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
proline rich 15-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840592	Prr15l<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
proline rich 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458557	Prr15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458594	Prr15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420036	Prr27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420012	Prr27<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364520	Prr32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426667	Prr32<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 32; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5426568	Prr32<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462587	Prr33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462610	Prr33<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich 7 (synaptic); targeted mutation 1, Velocigene	MGI:4399196	Prr7<tm1(KOMP)Vlcg>	27657535	KOMP-Regeneron
proline rich 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841222	Prr9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline-rich acidic protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840648	Prap1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
proline-rich acidic protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840702	Prap1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
proline-rich coiled-coil 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452631	Prrc2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline-rich coiled-coil 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452700	Prrc2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline-rich coiled-coil 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461729	Prrc2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proline-rich coiled-coil 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461729	Prrc2b<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
proline-rich coiled-coil 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462671	Prrc2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286386	Prrg3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842363	Prrg4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842532	Prrg4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441650	Prrg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451964	Prrg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proline rich membrane anchor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299632	Prima1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich membrane anchor 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299656	Prima1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich membrane anchor 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5299679	Prima1<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
proline rich membrane anchor 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5299674	Prima1<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
proline-rich nuclear receptor coactivator 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944396	Pnrc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline-rich nuclear receptor coactivator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944425	Pnrc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proline-rich transmembrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362325	Prrt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proline-rich transmembrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362325	Prrt2<tm1a(KOMP)Wtsi>	28007585	KOMP-CSD
prolyl 3-hydroxylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5051012	P3h1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prolyl 3-hydroxylase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364924	P3h2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolyl 3-hydroxylase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364924	P3h2<tm1a(KOMP)Wtsi>	25645914	KOMP-CSD
prolyl 3-hydroxylase 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5792810	P3h2<tm1c(KOMP)Wtsi>	25645914	KOMP-CSD
prolyl 3-hydroxylase 2; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5792811	P3h2<tm1d(KOMP)Wtsi>	25645914	KOMP-CSD
prolyl 3-hydroxylase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364173	P3h2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolyl 3-hydroxylase 3; targeted mutation 1, Velocigene	MGI:4399383	P3h3<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
prolyl 3-hydroxylase 3; targeted mutation 1, Velocigene	MGI:4399383	P3h3<tm1(KOMP)Vlcg>	28115524	KOMP-Regeneron
prolyl 4-hydroxylase, beta polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363474	P4hb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolyl 4-hydroxylase, beta polypeptide; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692909	P4hb<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
prolyl 4-hydroxylase, beta polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362511	P4hb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prolyl 4-hydroxylase, beta polypeptide; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472876	P4hb<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
prolylcarboxypeptidase (angiotensinase C); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5301391	Prcp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prolyl endopeptidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050861	Prep<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolyl endopeptidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471425	Prep<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
prolyl endopeptidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471425	Prep<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
prolyl endopeptidase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471425	Prep<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
prolyl-tRNA synthetase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433033	Prorsd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prolyl-tRNA synthetase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432506	Prorsd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prolyl-tRNA synthetase (mitochondrial)(putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460304	Pars2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prolyl-tRNA synthetase (mitochondrial)(putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460288	Pars2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prominin 2; targeted mutation 1.1, Velocigene	MGI:5443933	Prom2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
prominin 2; targeted mutation 1.1, Velocigene	MGI:5443933	Prom2<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
promyelocytic leukemia; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453745	Pml<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
promyelocytic leukemia; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453688	Pml<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pro-opiomelanocortin-alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948623	Pomc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
propionyl-Coenzyme A carboxylase, alpha polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431964	Pcca<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pro-platelet basic protein; targeted mutation 1.1, Velocigene	MGI:5692644	Ppbp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
pro-platelet basic protein; targeted mutation 1, Velocigene	MGI:3797508	Ppbp<tm1(KOMP)Vlcg>	23550035	KOMP-Regeneron
proprotein convertase subtilisin/kexin type 1 inhibitor; targeted mutation 1.1, Velocigene	MGI:5548481	Pcsk1n<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
proprotein convertase subtilisin/kexin type 1 inhibitor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458855	Pcsk1n<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proprotein convertase subtilisin/kexin type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441678	Pcsk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proprotein convertase subtilisin/kexin type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441678	Pcsk1<tm1a(EUCOMM)Wtsi>	28355570	EUCOMM
proprotein convertase subtilisin/kexin type 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548957	Pcsk1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
proprotein convertase subtilisin/kexin type 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111718	Pcsk1<tm1c(EUCOMM)Wtsi>	28355570	EUCOMM
proprotein convertase subtilisin/kexin type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441901	Pcsk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proprotein convertase subtilisin/kexin type 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363010	Pcsk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proprotein convertase subtilisin/kexin type 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498354	Pcsk4<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
proprotein convertase subtilisin/kexin type 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5498354	Pcsk4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
proprotein convertase subtilisin/kexin type 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363657	Pcsk4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proprotein convertase subtilisin/kexin type 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364893	Pcsk4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
proprotein convertase subtilisin/kexin type 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363846	Pcsk4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
proprotein convertase subtilisin/kexin type 5; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5474776	Pcsk5<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
proprotein convertase subtilisin/kexin type 5; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5474776	Pcsk5<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
prospero homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951143	Prox1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prospero homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951143	Prox1<tm1a(EUCOMM)Wtsi>	25737499	EUCOMM
prospero homeobox 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5619617	Prox1<tm1b(EUCOMM)Wtsi>	25737499	EUCOMM
prospero homeobox 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6102940	Prox1<tm1c(EUCOMM)Wtsi>	25737499	EUCOMM
prospero homeobox 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6102941	Prox1<tm1d(EUCOMM)Wtsi>	25737499	EUCOMM
prospero homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006804	Prox1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prostaglandin E receptor 1 (subtype EP1); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364490	Ptger1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prostaglandin E receptor 1 (subtype EP1); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362646	Ptger1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
prostaglandin E synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432215	Ptges2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prostaglandin E synthase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432148	Ptges2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prostaglandin E synthase 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511949	Ptges2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
prostaglandin E synthase 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511909	Ptges2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
prostaglandin F receptor; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5426615	Ptgfr<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
prostaglandin reductase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432266	Ptgr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prostaglandin reductase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548534	Ptgr1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
prostate and testis expressed 2; targeted mutation 1.1, Velocigene	MGI:5548876	Pate2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
prostate and testis expressed 4; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456499	Pate4<tm1(KOMP)Mbp>	26731031	KOMP-CSD
prostate tumor over expressed gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302340	Ptov1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prostate tumor over expressed gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302306	Ptov1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protease-associated domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419759	Pradc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease-associated domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419758	Pradc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419250	Psme3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protease (prosome, macropain) 26S subunit, ATPase 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419698	Psmc5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 16 (thymus); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363836	Prss16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 16 (thymus); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365001	Prss16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 16 (thymus); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364839	Prss16<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 16 (thymus); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364759	Prss16<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 1 (trypsin 1); targeted mutation 1.1, Velocigene	MGI:5692918	Prss1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protease, serine 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364752	Prss21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364867	Prss21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365027	Prss2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362654	Prss2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428562	Prss30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473020	Prss32<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 33; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419808	Prss33<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947730	Prss38<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428544	Prss40<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428502	Prss40<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 41; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362185	Prss41<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 41; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363660	Prss41<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 42; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419960	Prss42<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419992	Prss44<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420102	Prss44<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 44; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452635	Prss44<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 44; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452673	Prss44<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433481	Prss45<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 46; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842334	Prss46<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 46; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842610	Prss46<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 48; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455992	Prss48<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 48; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4840695	Prss48<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 50; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431941	Prss50<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 50; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432403	Prss50<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 52; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364577	Prss52<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 52; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299581	Prss52<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 52; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299516	Prss52<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 53; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433122	Prss53<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 53; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432437	Prss53<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protease, serine 55; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841366	Prss55<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 55; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319829	Prss55<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protease, serine 58; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050966	Prss58<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, ATPase 3, interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842270	Psmc3ip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, ATPase, 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432230	Psmc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, ATPase, 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434428	Psmc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, ATPase, 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868039	Psmc6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, ATPase, 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635269	Psmc6<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, ATPase, 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868029	Psmc6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451407	Psmd12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451527	Psmd12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364631	Psmd13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364266	Psmd13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299614	Psmd13<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299537	Psmd13<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820230	Psmd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, non-ATPase, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050863	Psmd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5692537	Psmd3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460417	Psmd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460478	Psmd5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452687	Psmd6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299535	Psmd6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433068	Psmd9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434025	Psmd9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419107	Psme1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) assembly chaperone 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363402	Psmg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) assembly chaperone 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363765	Psmg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) assembly chaperone 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431965	Psmg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) assembly chaperone 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434162	Psmg2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) inhibitor subunit 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5577264	Psmf1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441812	Psma1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441660	Psma1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942006	Psma2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, alpha type 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5085466	Psma2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452756	Psma3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452806	Psma3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4362713	Psma4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, alpha type 4; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4419310	Psma4<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, alpha type 4; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4419842	Psma4<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, alpha type 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431830	Psma6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432784	Psma6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteasome (prosome, macropain) subunit, alpha type 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365108	Psma7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 10; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419495	Psmb10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454105	Psmb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454154	Psmb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362813	Psmb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419328	Psmb3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419164	Psmb4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419951	Psmb6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868038	Psmb8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364399	Psmb9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363430	Psmb9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protection of telomeres 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364317	Pot1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protection of telomeres 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362661	Pot1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein arginine N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432476	Prmt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432476	Prmt1<tm1a(EUCOMM)Wtsi>	22532369	EUCOMM
protein arginine N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432476	Prmt1<tm1a(EUCOMM)Wtsi>	26637354	EUCOMM
protein arginine N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432476	Prmt1<tm1a(EUCOMM)Wtsi>	27466704	EUCOMM
protein arginine N-methyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432476	Prmt1<tm1a(EUCOMM)Wtsi>	28655788	EUCOMM
protein arginine N-methyltransferase 1; targeted mutation 1c, Welcome Trust Sanger Institute	MGI:5587827	Prmt1<tm1c(EUCOMM)Wtsi>	26637354	EUCOMM
protein arginine N-methyltransferase 1; targeted mutation 1c, Welcome Trust Sanger Institute	MGI:5587827	Prmt1<tm1c(EUCOMM)Wtsi>	28330868	EUCOMM
protein arginine N-methyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433170	Prmt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433170	Prmt2<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
protein arginine N-methyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433128	Prmt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433008	Prmt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433008	Prmt3<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
protein arginine N-methyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433008	Prmt3<tm1a(EUCOMM)Wtsi>	25340873	EUCOMM
protein arginine N-methyltransferase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433454	Prmt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432546	Prmt5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432546	Prmt5<tm1a(EUCOMM)Wtsi>	28238654	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432057	Prmt5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432368	Prmt5<tm2a(EUCOMM)Wtsi>	19525957	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432368	Prmt5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432368	Prmt5<tm2a(EUCOMM)Wtsi>	24013503	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432368	Prmt5<tm2a(EUCOMM)Wtsi>	25519955	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432368	Prmt5<tm2a(EUCOMM)Wtsi>	26072710	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432368	Prmt5<tm2a(EUCOMM)Wtsi>	26258414	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5636983	Prmt5<tm2b(EUCOMM)Wtsi>	26258414	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5546597	Prmt5<tm2c(EUCOMM)Wtsi>	24013503	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5546597	Prmt5<tm2c(EUCOMM)Wtsi>	25519955	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5546597	Prmt5<tm2c(EUCOMM)Wtsi>	25970242	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5546597	Prmt5<tm2c(EUCOMM)Wtsi>	26028225	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5546597	Prmt5<tm2c(EUCOMM)Wtsi>	26258414	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5546597	Prmt5<tm2c(EUCOMM)Wtsi>	27827819	EUCOMM
protein arginine N-methyltransferase 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432834	Prmt5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431677	Prmt7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431677	Prmt7<tm1a(EUCOMM)Wtsi>	26437029	EUCOMM
protein arginine N-methyltransferase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431677	Prmt7<tm1a(EUCOMM)Wtsi>	27207521	EUCOMM
protein arginine N-methyltransferase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433716	Prmt7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434085	Prmt8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434085	Prmt8<tm1a(EUCOMM)Wtsi>	26665171	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434085	Prmt8<tm1a(EUCOMM)Wtsi>	27935040	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434085	Prmt8<tm1a(EUCOMM)Wtsi>	28878098	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806494	Prmt8<tm1c(EUCOMM)Wtsi>	26665171	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806494	Prmt8<tm1c(EUCOMM)Wtsi>	28878098	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5806495	Prmt8<tm1d(EUCOMM)Wtsi>	26665171	EUCOMM
protein arginine N-methyltransferase 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434169	Prmt8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
proteinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441621	Prtn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441726	Prtn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein associated with topoisomerase II homolog 1 (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433073	Patl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein associated with topoisomerase II homolog 1 (yeast); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5574606	Patl1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
protein C receptor, endothelial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441668	Procr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein C receptor, endothelial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441750	Procr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein disulfide isomerase associated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944363	Pdia2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein disulfide isomerase associated 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842358	Pdia4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein disulfide isomerase associated 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636896	Pdia4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
protein disulfide isomerase associated 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842722	Pdia4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein disulfide isomerase associated 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605786	Pdia6<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein glucosylgalactosylhydroxylysine glucosidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364969	Pgghg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein glucosylgalactosylhydroxylysine glucosidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427235	Pgghg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein inhibitor of activated STAT 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880983	Pias1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein inhibitor of activated STAT 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880983	Pias1<tm1a(KOMP)Wtsi>	27155222	KOMP-CSD
protein inhibitor of activated STAT 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419892	Pias2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein inhibitor of activated STAT 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432704	Pias3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein inhibitor of activated STAT 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433705	Pias3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein interacting with cyclin A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363284	Proca1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein interacting with cyclin A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364360	Proca1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, AMP-activated, alpha 2 catalytic subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636958	Prkaa2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362414	Prkab1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362414	Prkab1<tm1a(KOMP)Wtsi>	25195104	KOMP-CSD
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362414	Prkab1<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501071	Prkab1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501071	Prkab1<tm1b(KOMP)Wtsi>	26952277	KOMP-CSD
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501071	Prkab1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5501071	Prkab1<tm1b(KOMP)Wtsi>	27666489	KOMP-CSD
protein kinase, AMP-activated, beta 1 non-catalytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365079	Prkab1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, AMP-activated, beta 2 non-catalytic subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636959	Prkab2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein kinase, AMP-activated, gamma 2 non-catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433539	Prkag2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase, AMP-activated, gamma 2 non-catalytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434490	Prkag2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase, AMP-activated, gamma 3 non-catatlytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426662	Prkag3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, cAMP dependent regulatory, type II beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441910	Prkar2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase, cAMP dependent regulatory, type II beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442012	Prkar2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase C and casein kinase substrate in neurons 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5569946	Pacsin2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein kinase C and casein kinase substrate in neurons 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431643	Pacsin3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase C and casein kinase substrate in neurons 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434006	Pacsin3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase C, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433335	Prkcb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase C, beta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4948651	Prkcb<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase C, epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433814	Prkce<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase C, epsilon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433875	Prkce<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase, cGMP-dependent, type II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841153	Prkg2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, cGMP-dependent, type II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841199	Prkg2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, cGMP-dependent, type I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454120	Prkg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase, cGMP-dependent, type I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454091	Prkg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase C, zeta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433718	Prkcz<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase C, zeta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433718	Prkcz<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
protein kinase C, zeta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433718	Prkcz<tm1a(EUCOMM)Wtsi>	25617472	EUCOMM
protein kinase C, zeta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433718	Prkcz<tm1a(EUCOMM)Wtsi>	25660024	EUCOMM
protein kinase C, zeta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433718	Prkcz<tm1a(EUCOMM)Wtsi>	26868297	EUCOMM
protein kinase C, zeta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432317	Prkcz<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase D1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841187	Prkd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase D1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841253	Prkd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase D2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014741	Prkd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase D3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432250	Prkd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase D3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433101	Prkd3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase inhibitor, alpha; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5616352	Pkia<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein kinase inhibitor beta, cAMP dependent, testis specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362435	Pkib<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase inhibitor beta, cAMP dependent, testis specific; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364929	Pkib<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase inhibitor, gamma; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636975	Pkig<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein kinase inhibitor, gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433223	Pkig<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase N1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365010	Pkn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase N1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365010	Pkn1<tm1a(KOMP)Wtsi>	28875501	KOMP-CSD
protein kinase N1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636911	Pkn1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
protein kinase N1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636911	Pkn1<tm1b(KOMP)Wtsi>	28875501	KOMP-CSD
protein kinase N1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6116286	Pkn1<tm1c(KOMP)Wtsi>	28875501	KOMP-CSD
protein kinase N2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363870	Pkn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase N2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363870	Pkn2<tm1a(KOMP)Wtsi>	26774483	KOMP-CSD
protein kinase N2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363870	Pkn2<tm1a(KOMP)Wtsi>	28875501	KOMP-CSD
protein kinase N2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5613636	Pkn2<tm1b(KOMP)Wtsi>	28875501	KOMP-CSD
protein kinase N2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364861	Pkn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase N2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364861	Pkn2<tm1e(KOMP)Wtsi>	26774483	KOMP-CSD
protein kinase N2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364211	Pkn2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protein kinase N2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473203	Pkn2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase N2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5473216	Pkn2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
protein kinase, X-linked; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009582	Prkx<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433812	Pcmtd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein O-fucosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880915	Pofut1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein O-fucosyltransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880971	Pofut1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein O-fucosyltransferase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319911	Pofut1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protein O-glucosyltransferase 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4887665	Poglut1<tm1a(EUCOMM)Hmgu>	26496195	EUCOMM
protein O-glucosyltransferase 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5792950	Poglut1<tm1c(EUCOMM)Hmgu>	26496195	EUCOMM
protein O-glucosyltransferase 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5792952	Poglut1<tm1d(EUCOMM)Hmgu>	26496195	EUCOMM
protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140438	Pin1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140423	Pin1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050953	Pin4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1A, magnesium dependent, alpha isoform; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637227	Ppm1a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein phosphatase 1B, magnesium dependent, beta isoform; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458511	Ppm1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1B, magnesium dependent, beta isoform; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458553	Ppm1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, catalytic subunit, alpha isoform; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947811	Ppp1ca<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, catalytic subunit, beta isoform; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419848	Ppp1cb<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, catalytic subunit, gamma isoform; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434236	Ppp1cc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, catalytic subunit, gamma isoform; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432356	Ppp1cc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, catalytic subunit, gamma isoform; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433197	Ppp1cc<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1D magnesium-dependent, delta isoform; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362316	Ppm1d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1D magnesium-dependent, delta isoform; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365206	Ppm1d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1E (PP2C domain containing); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441756	Ppm1e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1E (PP2C domain containing); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441951	Ppm1e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1E (PP2C domain containing); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455966	Ppm1e<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1E (PP2C domain containing); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456066	Ppm1e<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1F (PP2C domain containing); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431825	Ppm1f<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1F (PP2C domain containing); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431664	Ppm1f<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1H (PP2C domain containing); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841080	Ppm1h<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1H (PP2C domain containing); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841089	Ppm1h<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1H (PP2C domain containing); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841287	Ppm1h<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363023	Ppm1j<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1J; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605787	Ppm1j<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
protein phosphatase 1J; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364374	Ppm1j<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1K (PP2C domain containing); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841261	Ppm1k<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 12A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364268	Ppp1r12a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 12A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364231	Ppp1r12a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 12B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428515	Ppp1r12b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 13B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434471	Ppp1r13b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 14D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451518	Ppp1r14d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 14D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451390	Ppp1r14d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 16A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441769	Ppp1r16a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 16A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441806	Ppp1r16a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 16B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286239	Ppp1r16b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 16B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426595	Ppp1r16b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362857	Ppp1r1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362807	Ppp1r1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433870	Ppp1r2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461676	Ppp1r3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820280	Ppp1r3c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 3C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820209	Ppp1r3c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431762	Ppp1r7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433588	Ppp1r7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433772	Ppp1r8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434301	Ppp1r8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 1, regulatory (inhibitor) subunit 9A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458482	Ppp1r9a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory (inhibitor) subunit 9A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458658	Ppp1r9a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory subunit 27; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419261	Ppp1r27<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory subunit 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944323	Ppp1r32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory subunit 32; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5582432	Ppp1r32<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
protein phosphatase 1, regulatory subunit 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939733	Ppp1r32<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory subunit 35; targeted mutation 1.1, Velocigene	MGI:5588283	Ppp1r35<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protein phosphatase 1, regulatory subunit 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364817	Ppp1r42<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory subunit 42; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362945	Ppp1r42<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 1, regulatory subunit 9B; targeted mutation 1.1, Velocigene	MGI:5445920	Ppp1r9b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protein phosphatase 1, regulatory subunit 9B; targeted mutation 1.1, Velocigene	MGI:5445920	Ppp1r9b<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
protein phosphatase 2 protein activator; targeted mutation 1.1, Velocigene	MGI:5766257	Ptpa<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protein phosphatase 2, regulatory subunit A, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006756	Ppp2r1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 2, regulatory subunit A, beta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5694177	Ppp2r1b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
protein phosphatase 2, regulatory subunit B, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362883	Ppp2r2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363843	Ppp2r2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B'', alpha; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431449	Ppp2r3a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B, alpha; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364320	Ppp2r2a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B, alpha; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363261	Ppp2r2a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364039	Ppp2r2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364039	Ppp2r2b<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
protein phosphatase 2, regulatory subunit B', beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433974	Ppp2r5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 2, regulatory subunit B, beta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513812	Ppp2r2b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
protein phosphatase 2, regulatory subunit B', beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433754	Ppp2r5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 2, regulatory subunit B', delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299589	Ppp2r5d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B', delta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458542	Ppp2r5d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B', epsilon; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363715	Ppp2r5e<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B', epsilon; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364036	Ppp2r5e<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 2, regulatory subunit B'', gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432868	Ppp2r3c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 2, regulatory subunit B'', gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433456	Ppp2r3c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 2, regulatory subunit B'', gamma; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472971	Ppp2r3c<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431539	Ppp3ca<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431775	Ppp3ca<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431541	Ppp3ca<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432193	Ppp3ca<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432193	Ppp3ca<tm2e(EUCOMM)Wtsi>	23300663	EUCOMM
protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432193	Ppp3ca<tm2e(EUCOMM)Wtsi>	24721909	EUCOMM
protein phosphatase 3, catalytic subunit, alpha isoform; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4434122	Ppp3ca<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II); targeted mutation 1.1, Velocigene	MGI:5548369	Ppp3r2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452779	Ppp3r1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452821	Ppp3r1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 4, regulatory subunit 2; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5548882	Ppp4r2<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
protein phosphatase 4, regulatory subunit 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052414	Ppp4r4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 4, regulatory subunit 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5287807	Ppp4r4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 5, catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431812	Ppp5c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 5, catalytic subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431812	Ppp5c<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
protein phosphatase 5, catalytic subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432309	Ppp5c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase 6, catalytic subunit; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548551	Ppp6c<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein phosphatase 6, regulatory subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458521	Ppp6r3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase 6, regulatory subunit 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458608	Ppp6r3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein phosphatase, EF hand calcium-binding domain 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460452	Ppef2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase, EF hand calcium-binding domain 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460511	Ppef2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein phosphatase with EF hand calcium-binding domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840952	Ppef1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein prenyltransferase alpha subunit repeat containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432780	Ptar1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein prenyltransferase alpha subunit repeat containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433931	Ptar1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein S (alpha); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441898	Pros1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein serine kinase H1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431894	Pskh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein serine kinase H1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5645992	Pskh1<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
protein serine kinase H1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433775	Pskh1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein serine kinase H1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433132	Pskh1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein serine kinase H1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433715	Pskh1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase 4a1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949381	Ptp4a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase 4a1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949382	Ptp4a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase domain containing 1; targeted mutation 1.1, Velocigene	MGI:5695946	Ptpdc1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protein tyrosine phosphatase, mitochondrial 1; targeted mutation 1.1, Velocigene	MGI:5548522	Ptpmt1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protein tyrosine phosphatase, non-receptor type 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432484	Ptpn11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432701	Ptpn11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433270	Ptpn11<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432996	Ptpn11<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 12; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766164	Ptpn12<tm1b(NCOM)Mfgc>	27626380	NorCOMM
protein tyrosine phosphatase, non-receptor type 14; targeted mutation 1.1, Velocigene	MGI:5695871	Ptpn14<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protein tyrosine phosphatase, non-receptor type 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426576	Ptpn18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938525	Ptpn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938526	Ptpn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452623	Ptpn20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 21; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451576	Ptpn21<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 22 (lymphoid); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434268	Ptpn22<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 23; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5567111	Ptpn23<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
protein tyrosine phosphatase, non-receptor type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441737	Ptpn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441737	Ptpn2<tm1a(EUCOMM)Wtsi>	28322331	EUCOMM
protein tyrosine phosphatase, non-receptor type 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5902694	Ptpn2<tm1c(EUCOMM)Wtsi>	28322331	EUCOMM
protein tyrosine phosphatase, non-receptor type 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441918	Ptpn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363613	Ptpn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363154	Ptpn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286202	Ptpn5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, non-receptor type 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947831	Ptpn6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947842	Ptpn6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, non-receptor type 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428488	Ptpn9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840652	Ptprcap<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840650	Ptprcap<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, receptor type, D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362361	Ptprd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, D; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458607	Ptprd<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, D; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458607	Ptprd<tm2a(KOMP)Wtsi>	29024665	KOMP-CSD
protein tyrosine phosphatase, receptor type, D; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:6115609	Ptprd<tm2c(KOMP)Wtsi>	29024665	KOMP-CSD
protein tyrosine phosphatase, receptor type, D; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4458647	Ptprd<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887720	Ptprf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, receptor type, F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842468	Ptprf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein tyrosine phosphatase, receptor type, R; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462582	Ptprr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, S; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4840831	Ptprs<tm1a(KOMP)Mbp>	26231120	KOMP-CSD
protein tyrosine phosphatase, receptor type, T; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364157	Ptprt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, T; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363998	Ptprt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, T; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364425	Ptprt<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
protein tyrosine phosphatase, receptor type, V; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5513815	Ptprv<tm1b(NCOM)Mfgc>	27626380	NorCOMM
protein-tyrosine sulfotransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460522	Tpst1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein-tyrosine sulfotransferase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460440	Tpst1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protein-tyrosine sulfotransferase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511150	Tpst1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protein Z, vitamin K-dependent plasma glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842617	Proz<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protein Z, vitamin K-dependent plasma glycoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842530	Proz<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteoglycan 3; targeted mutation 1.1, Velocigene	MGI:5605767	Prg3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
proteolipid protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453761	Plp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteolipid protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453770	Plp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteolipid protein (myelin) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433111	Plp1<tm1a(EUCOMM)Wtsi>	19525957	EUCOMM
proteolipid protein (myelin) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433111	Plp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
proteolipid protein (myelin) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433111	Plp1<tm1a(EUCOMM)Wtsi>	28836307	EUCOMM
proteolipid protein (myelin) 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115637	Plp1<tm1c(EUCOMM)Wtsi>	28836307	EUCOMM
proteolipid protein (myelin) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431798	Plp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
proteolipid protein (myelin) 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433586	Plp1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
proteolipid protein (myelin) 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434207	Plp1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
prothymosin alpha; targeted mutation 1.1, Velocigene	MGI:5548964	Ptma<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protocadherin 18; targeted mutation 1.1, Velocigene	MGI:5548631	Pcdh18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
protocadherin 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299493	Pcdh20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
protocadherin 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841294	Pcdh20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
protocadherin beta 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473152	Pcdhb17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protocadherin beta 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472730	Pcdhb17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protocadherin beta 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473154	Pcdhb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protocadherin beta 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472732	Pcdhb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
protocadherin beta 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473155	Pcdhb2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
protocadherin beta 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473153	Pcdhb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
protocadherin beta 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472731	Pcdhb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PRP38 pre-mRNA processing factor 38 (yeast) domain containing A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050922	Prpf38a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
prune exopolyphosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431886	Prune1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
prune exopolyphosphatase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432306	Prune1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
prune homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840948	Prune2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
prune homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841026	Prune2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pseudouridine synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949355	Pus1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pseudouridine synthase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949371	Pus1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pseudouridylate synthase 7-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364313	Pus7l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pseudouridylate synthase 7-like; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451717	Pus7l<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
pseudouridylate synthase 7-like; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4841343	Pus7l<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
pseudouridylate synthase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432120	Pus7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pseudouridylate synthase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432746	Pus7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PTEN induced putative kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008020	Pink1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PTEN induced putative kinase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637036	Pink1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432949	Pcbd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434212	Pcbd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PTK2 protein tyrosine kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008768	Ptk2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PTK6 protein tyrosine kinase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433821	Ptk6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PTK6 protein tyrosine kinase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431756	Ptk6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PTPRF interacting protein, binding protein 1 (liprin beta 1); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432432	Ppfibp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pumilio RNA-binding family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363598	Pum2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
purine-nucleoside phosphorylase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050852	Pnp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
purinergic receptor P2X, ligand-gated ion channel, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820292	P2rx3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
purinergic receptor P2X, ligand-gated ion channel 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944573	P2rx4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
purinergic receptor P2X, ligand-gated ion channel 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548440	P2rx4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
purinergic receptor P2X, ligand-gated ion channel, 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050912	P2rx6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
purinergic receptor P2X, ligand-gated ion channel, 6; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548438	P2rx6<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
purinergic receptor P2X, ligand-gated ion channel, 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050937	P2rx6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
purinergic receptor P2X, ligand-gated ion channel, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432150	P2rx7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
purinergic receptor P2X, ligand-gated ion channel, 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432150	P2rx7<tm1a(EUCOMM)Wtsi>	26060214	EUCOMM
purinergic receptor P2X, ligand-gated ion channel, 7; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548444	P2rx7<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
purinergic receptor P2X, ligand-gated ion channel, 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434094	P2rx7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
purinergic receptor P2Y, G-protein coupled 10B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426614	P2ry10b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
purinergic receptor P2Y, G-protein coupled 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436299	P2ry2<tm1a(EUCOMM)Hmgu>	26168216	EUCOMM
purinergic receptor P2Y, G-protein coupled 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5792951	P2ry2<tm1c(EUCOMM)Hmgu>	26168216	EUCOMM
purinergic receptor P2Y, G-protein coupled 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5792951	P2ry2<tm1c(EUCOMM)Hmgu>	27797339	EUCOMM
purine rich element binding protein A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5308288	Pura<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
purine rich element binding protein A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299523	Pura<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
purine-rich element binding protein G; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419914	Purg<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Purkinje cell protein 4-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431464	Pcp4l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Purkinje cell protein 4-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431424	Pcp4l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
putative homeodomain transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365189	Phtf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
putative homeodomain transcription factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548431	Phtf1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
putative homeodomain transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363524	Phtf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
putative homeodomain transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432782	Phtf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
putative homeodomain transcription factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432035	Phtf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
putative homeodomain transcription factor 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433776	Phtf2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
PWP1 homolog, endonuclein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441688	Pwp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PWP1 homolog, endonuclein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441688	Pwp1<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
PWP1 homolog, endonuclein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441966	Pwp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PWP2 periodic tryptophan protein homolog (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299574	Pwp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PWP2 periodic tryptophan protein homolog (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880911	Pwp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PWWP domain containing 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363685	Pwwp2b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PWWP domain containing 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362715	Pwwp2b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PX domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364942	Pxdc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PX domain containing 1; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5637020	Pxdc1<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
PX domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363316	Pxdc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PX domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5141833	Pxdc1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
PX domain containing serine/threonine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842364	Pxk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
PX domain containing serine/threonine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842275	Pxk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pygopus 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363340	Pygo1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pygopus 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364828	Pygo1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pygopus 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947798	Pygo2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pygopus 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947818	Pygo2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
PYM homolog 1, exon junction complex associated factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880984	Pym1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
PYM homolog 1, exon junction complex associated factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880966	Pym1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pyridine nucleotide-disulphide oxidoreductase domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009564	Pyroxd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pyridine nucleotide-disulphide oxidoreductase domain 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5563211	Pyroxd1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pyridine nucleotide-disulphide oxidoreductase domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950964	Pyroxd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pyridoxal phosphate binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842323	Plpbp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyridoxal phosphate binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842403	Plpbp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyridoxal (pyridoxine, vitamin B6) kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441874	Pdxk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyridoxal (pyridoxine, vitamin B6) kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442038	Pdxk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyridoxine 5'-phosphate oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363478	Pnpo<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pyridoxine 5'-phosphate oxidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364402	Pnpo<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pyroglutamylated RFamide peptide receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841363	Qrfpr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pyroglutamyl-peptidase I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944334	Pgpep1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pyroglutamyl-peptidase I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944388	Pgpep1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pyrophosphatase (inorganic) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432616	Ppa1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyrophosphatase (inorganic) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434183	Ppa1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase 1; targeted mutation 1.1, Velocigene	MGI:5507839	Pycr1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
pyrroline-5-carboxylate reductase 1; targeted mutation 1.1, Velocigene	MGI:5507839	Pycr1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
pyrroline-5-carboxylate reductase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5529965	Pycr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434149	Pycr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441735	Pycr1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441672	Pycr1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842705	Pycr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842726	Pycr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460441	Pycrl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyrroline-5-carboxylate reductase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460447	Pycrl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate carboxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432994	Pcx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate carboxylase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548959	Pcx<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
pyruvate dehydrogenase E1 alpha 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455995	Pdha1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate dehydrogenase E1 alpha 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456065	Pdha1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate dehydrogenase E1 alpha 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473182	Pdha2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate dehydrogenase E1 alpha 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472755	Pdha2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate dehydrogenase kinase, isoenzyme 1; targeted mutation 1.1, Velocigene	MGI:5695937	Pdk1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
pyruvate dehydrogenase kinase, isoenzyme 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365208	Pdk3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate dehydrogenase kinase, isoenzyme 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4458498	Pdk3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate dehydrogenase kinase, isoenzyme 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4458604	Pdk3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate dehydrogenase kinase, isoenzyme 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364613	Pdk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate dehydrogenase kinase, isoenzyme 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548473	Pdk4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
pyruvate dehydrogenase kinase, isoenzyme 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364123	Pdk4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate dehydrogenase phosphatase regulatory subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441663	Pdpr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate dehydrogenase phosphatase regulatory subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442016	Pdpr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
pyruvate dehyrogenase phosphatase catalytic subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5430971	Pdp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate dehyrogenase phosphatase catalytic subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430966	Pdp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate kinase liver and red blood cell; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947741	Pklr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
pyruvate kinase liver and red blood cell; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947768	Pklr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
PZP, alpha-2-macroglobulin like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003010	Pzp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
quiescin Q6 sulfhydryl oxidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362310	Qsox1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
quiescin Q6 sulfhydryl oxidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364135	Qsox1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
quinolinate phosphoribosyltransferase; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050903	Qprt<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
quinolinate phosphoribosyltransferase; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050932	Qprt<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
R3H domain and coiled-coil containing 1 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050164	R3hcc1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
R3H domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006764	R3hdm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
R3H domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364062	R3hdm2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
R3H domain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419994	R3hdm2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
R3H domain containing 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419748	R3hdm2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
R3H domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842844	R3hdm4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB10, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419503	Rab10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB10, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420029	Rab10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB11A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364977	Rab11a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB11A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364977	Rab11a<tm1a(KOMP)Wtsi>	25527643	KOMP-CSD
RAB11A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364977	Rab11a<tm1a(KOMP)Wtsi>	27529348	KOMP-CSD
RAB11A, member RAS oncogene family; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5708486	Rab11a<tm1c(KOMP)Wtsi>	25527643	KOMP-CSD
RAB11A, member RAS oncogene family; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5708486	Rab11a<tm1c(KOMP)Wtsi>	27529348	KOMP-CSD
RAB11 family interacting protein 2 (class I); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362254	Rab11fip2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB11 family interacting protein 2 (class I); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364441	Rab11fip2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB11 family interacting protein 4 (class II); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456843	Rab11fip4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB15 effector protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473178	Rep15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB15 effector protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472752	Rep15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB15, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363640	Rab15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB15, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364685	Rab15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB17, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948606	Rab17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB19, member RAS oncogene family; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548343	Rab19<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RAB1A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363435	Rab1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB1A, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362460	Rab1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB20, member RAS oncogene family; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5294223	Rab20<tm1a(EUCOMM)Hmgu>	28494243	EUCOMM
RAB20, member RAS oncogene family; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5520178	Rab20<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RAB21, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458569	Rab21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB21, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458561	Rab21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB22A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364230	Rab22a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB22A, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363792	Rab22a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB23, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460477	Rab23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB23, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5695135	Rab23<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RAB23, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460530	Rab23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB24, member RAS oncogene family; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5474977	Rab24<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
RAB24, member RAS oncogene family; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5474977	Rab24<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
RAB24, member RAS oncogene family; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419337	Rab24<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RAB24, member RAS oncogene family; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419337	Rab24<tm1(KOMP)Wtsi>	28700664	KOMP-CSD
RAB27A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433714	Rab27a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB27A, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433271	Rab27a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB27B, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364199	Rab27b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB27B, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5502310	Rab27b<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAB27B, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5502310	Rab27b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAB27B, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5502310	Rab27b<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
RAB27B, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364829	Rab27b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB28, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847852	Rab28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB29, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432353	Rab29<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB30, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014713	Rab30<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB32, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364488	Rab32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB32, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364488	Rab32<tm1a(KOMP)Wtsi>	26275310	KOMP-CSD
RAB32, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692679	Rab32<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAB32, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364737	Rab32<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB32, member RAS oncogene family; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5141834	Rab32<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB34, member RAS oncogene family; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5520180	Rab34<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RAB34, member RAS oncogene family; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5520180	Rab34<tm1b(EUCOMM)Hmgu>	28700664	EUCOMM
RAB35, member RAS oncogene family; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548685	Rab35<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RAB36, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364152	Rab36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB36, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5507834	Rab36<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAB36, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5507834	Rab36<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAB36, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5507834	Rab36<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
RAB37, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006753	Rab37<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB39, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451281	Rab39<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB39, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5505641	Rab39<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAB39, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5505641	Rab39<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAB39, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451379	Rab39<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB3A interacting protein (rabin3)-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840628	Rab3il1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3A interacting protein (rabin3)-like 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840616	Rab3il1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3A interacting protein; targeted mutation 1.1, Velocigene	MGI:5500804	Rab3ip<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RAB3A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433318	Rab3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3A, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434044	Rab3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3C, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888944	Rab3c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3C, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635270	Rab3c<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3C, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888945	Rab3c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3D, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842641	Rab3d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3D, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842877	Rab3d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3D, member RAS oncogene family; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4944505	Rab3d<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3D, member RAS oncogene family; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4944530	Rab3d<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB3 GTPase activating protein subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939711	Rab3gap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rab40C, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362234	Rab40c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rab40C, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5521537	Rab40c<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
Rab40C, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5521537	Rab40c<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Rab40C, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365153	Rab40c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rab40C, member RAS oncogene family; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472844	Rab40c<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB43, member RAS oncogene family; targeted mutation 1.1, Velocigene	MGI:5494988	Rab43<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RAB43, member RAS oncogene family; targeted mutation 1.1, Velocigene	MGI:5494988	Rab43<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
RAB43, member RAS oncogene family; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419460	Rab43<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RAB4B, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432066	Rab4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB4B, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433657	Rab4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB5A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014589	Rab5a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB5A, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5475013	Rab5a<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAB5A, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5475013	Rab5a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAB5A, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5475013	Rab5a<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
RAB5B, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419478	Rab5b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB5B, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5477000	Rab5b<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAB5B, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420080	Rab5b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAB5C, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432624	Rab5c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB5C, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433365	Rab5c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB6A GEF compex partner 1; targeted mutation 1.1, Velocigene	MGI:5474777	Rgp1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RAB6A GEF compex partner 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419322	Rgp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RAB6A, member RAS oncogene family; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002983	Rab6a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB6A, member RAS oncogene family; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5002999	Rab6a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB7B, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286249	Rab7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB7, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289805	Rab7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB8A, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434351	Rab8a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB8A, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432217	Rab8a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB8B, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432247	Rab8b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB8B, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431897	Rab8b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB8B, member RAS oncogene family; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472952	Rab8b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB8B, member RAS oncogene family; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472804	Rab8b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RAB9B, member RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5284932	Rab9b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAB9B, member RAS oncogene family; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286379	Rab9b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rab9 effector protein with kelch motifs; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419133	Rabepk<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Rab acceptor 1 (prenylated); targeted mutation 1.1, Velocigene	MGI:5635277	Rabac1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
Rab acceptor 1 (prenylated); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419595	Rabac1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Rab acceptor 1 (prenylated); targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5435075	Rabac1<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
rabaptin, RAB GTPase binding effector protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842531	Rabep2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rabaptin, RAB GTPase binding effector protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842878	Rabep2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
rabaptin, RAB GTPase binding effector protein 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511939	Rabep2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
rabenosyn, RAB effector; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441653	Rbsn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rabenosyn, RAB effector; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441981	Rbsn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rab geranylgeranyl transferase, a subunit; targeted mutation 1.1, Velocigene	MGI:5766259	Rabggta<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Rab geranylgeranyl transferase, a subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419410	Rabggta<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RAB interacting factor; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419989	Rabif<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Rab interacting lysosomal protein-like 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548660	Rilpl1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Rab interacting lysosomal protein-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451313	Rilpl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rab interacting lysosomal protein-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468953	Rilpl2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
Rab interacting lysosomal protein-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468953	Rilpl2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Rab interacting lysosomal protein-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468953	Rilpl2<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
Rab interacting lysosomal protein-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451488	Rilpl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rab interacting lysosomal protein; targeted mutation 1.1, Velocigene	MGI:5548749	Rilp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RAB, member RAS oncogene family-like 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548568	Rabl2<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
RAB, member RAS oncogene family-like 2; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548568	Rabl2<tm1.1(KOMP)Wtsi>	28625565	KOMP-CSD
RAB, member RAS oncogene family-like 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431454	Rabl2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RAB, member RAS oncogene family-like 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431454	Rabl2<tm1(KOMP)Wtsi>	27732084	KOMP-CSD
RAB, member RAS oncogene family-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363544	Rabl6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAB, member RAS oncogene family-like 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548811	Rabl6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAB, member RAS oncogene family-like 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364006	Rabl6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
rabphilin 3A-like (without C2 domains); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441625	Rph3al<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rabphilin 3A-like (without C2 domains); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442042	Rph3al<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
rabphilin 3A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5588265	Rph3a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433632	Arhgef6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5140483	Arhgef6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5140464	Arhgef6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5305679	Arhgef6<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
Rac GTPase-activating protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363629	Racgap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAD17 checkpoint clamp loader component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434227	Rad17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAD17 checkpoint clamp loader component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434324	Rad17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAD18 E3 ubiquitin protein ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433190	Rad18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAD18 E3 ubiquitin protein ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433190	Rad18<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
RAD18 E3 ubiquitin protein ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433190	Rad18<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
RAD18 E3 ubiquitin protein ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433190	Rad18<tm1a(EUCOMM)Wtsi>	25340873	EUCOMM
RAD1 checkpoint DNA exonuclease; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364310	Rad1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAD21-like (S. pombe); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419683	Rad21l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAD21-like (S. pombe); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5448653	Rad21l<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAD21-like (S. pombe); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5448653	Rad21l<tm1b(KOMP)Wtsi>	27172213	KOMP-CSD
RAD21-like (S. pombe); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5448653	Rad21l<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAD21-like (S. pombe); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5448653	Rad21l<tm1b(KOMP)Wtsi>	28050734	KOMP-CSD
RAD21-like (S. pombe); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420013	Rad21l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAD23 homolog A, nucleotide excision repair protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432184	Rad23a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAD23 homolog A, nucleotide excision repair protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433920	Rad23a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAD23 homolog B, nucleotide excision repair protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362974	Rad23b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAD23 homolog B, nucleotide excision repair protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362974	Rad23b<tm1a(KOMP)Wtsi>	25901318	KOMP-CSD
RAD50 double strand break repair protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363365	Rad50<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAD50 interactor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451661	Rint1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAD50 interactor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5447050	Rint1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAD50 interactor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5447050	Rint1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RAD50 interactor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451711	Rint1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAD51 associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842757	Rad51ap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAD51 associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842628	Rad51ap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAD51 paralog D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006755	Rad51d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAD51 paralog D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006780	Rad51d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAD51 recombinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951118	Rad51<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAD54 homolog B (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441816	Rad54b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAD54 like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454086	Rad54l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAD54 like (S. cerevisiae); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635283	Rad54l<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
RAD54 like (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454141	Rad54l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAD9 checkpoint clamp component A; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5636951	Rad9a<tm1.1(KOMP)Wtsi>	27671873	KOMP-CSD
RAD9 checkpoint clamp component A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4847699	Rad9a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
rad and gem related GTP binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052412	Rem1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
rad and gem related GTP binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052403	Rem1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
radial spoke 3A homolog (Chlamydomonas); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842309	Rsph3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
radial spoke 3A homolog (Chlamydomonas); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842695	Rsph3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
radial spoke 3B homolog (Chlamydomonas); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364875	Rsph3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
radial spoke 3B homolog (Chlamydomonas); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363496	Rsph3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
radial spoke 3B homolog (Chlamydomonas); targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511918	Rsph3b<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
radial spoke 3B homolog (Chlamydomonas); targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511891	Rsph3b<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
radial spoke head 10 homolog B (Chlamydomonas); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455477	Rsph10b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
radial spoke head 10 homolog B (Chlamydomonas); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455576	Rsph10b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
radial spoke head 9 homolog (Chlamydomonas); targeted mutation 1.1, Velocigene	MGI:5695930	Rsph9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
radial spoke head 9 homolog (Chlamydomonas); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938570	Rsph9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
radial spoke head homolog 14 (Chlamydomonas); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5464317	Rsph14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
radical S-adenosyl methionine domain containing 1; targeted mutation 1.1, Velocigene	MGI:5548890	Rsad1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
radical S-adenosyl methionine domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472690	Rsad1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
radical S-adenosyl methionine domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5499311	Rsad1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
radical S-adenosyl methionine domain containing 1; targeted mutation 1, Velocigene	MGI:3808228	Rsad1<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
radical S-adenosyl methionine domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511160	Rsad1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
radical S-adenosyl methionine domain containing 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511975	Rsad1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
radical S-adenosyl methionine domain containing 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511952	Rsad1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
radical S-adenosyl methionine domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841292	Rsad2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
radical S-adenosyl methionine domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841019	Rsad2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
radixin; targeted mutation 1.1, Velocigene	MGI:5445756	Rdx<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
radixin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050907	Rdx<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
raftlin family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432088	Rftn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
raftlin family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433645	Rftn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ralA binding protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050955	Ralbp1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ralA binding protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050909	Ralbp1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RALBP1 associated Eps domain containing protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434022	Reps2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RALBP1 associated Eps domain containing protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433641	Reps2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RALBP1 associated Eps domain containing protein 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511937	Reps2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
RalBP1 associated Eps domain containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363431	Reps1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RalBP1 associated Eps domain containing protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364076	Reps1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ral GEF with PH domain and SH3 binding motif 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460462	Ralgps2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ral GEF with PH domain and SH3 binding motif 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460479	Ralgps2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Ral GTPase activating protein, alpha subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420099	Ralgapa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ral GTPase activating protein, alpha subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420065	Ralgapa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ral GTPase activating protein, alpha subunit 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455541	Ralgapa1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Ral GTPase activating protein, alpha subunit 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455476	Ralgapa1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Ral GTPase activating protein, beta subunit (non-catalytic); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363602	Ralgapb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ral guanine nucleotide dissociation stimulator-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307102	Rgl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ral guanine nucleotide dissociation stimulator-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948625	Rgl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ral guanine nucleotide dissociation stimulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432366	Ralgds<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ral guanine nucleotide dissociation stimulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432849	Ralgds<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAN binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363006	Ranbp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAN binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364438	Ranbp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAN binding protein 2; targeted mutation 1.1, Velocigene	MGI:5583083	Ranbp2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RAN binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419574	Ranbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAN binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419953	Ranbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAN binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286198	Ranbp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAN binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868035	Ranbp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAN binding protein 9; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5792832	Ranbp9<tm1c(EUCOMM)Hmgu>	24509082	EUCOMM
RAN GTPase activating protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454164	Rangap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAN GTPase activating protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840925	Rangap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAN, member RAS oncogene family; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424646	Ran<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RAP2C, member of RAS oncogene family; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286204	Rap2c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAP2C, member of RAS oncogene family; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319883	Rap2c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RAP2C, member of RAS oncogene family; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319860	Rap2c<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RAP2C, member of RAS oncogene family; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319904	Rap2c<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
Rap guanine nucleotide exchange factor (GEF) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419872	Rapgef1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rap guanine nucleotide exchange factor (GEF) 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635284	Rapgef1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
Rap guanine nucleotide exchange factor (GEF) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419940	Rapgef1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rap guanine nucleotide exchange factor (GEF) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432967	Rapgef2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rap guanine nucleotide exchange factor (GEF) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432321	Rapgef2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rap guanine nucleotide exchange factor (GEF)-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362680	Rapgefl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rap guanine nucleotide exchange factor (GEF)-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364492	Rapgefl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAR-related orphan receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432489	Rora<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAR-related orphan receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432489	Rora<tm1a(EUCOMM)Wtsi>	26523868	EUCOMM
RAR-related orphan receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432489	Rora<tm1a(EUCOMM)Wtsi>	27184849	EUCOMM
RAR-related orphan receptor alpha; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548347	Rora<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RAR-related orphan receptor alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432933	Rora<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAS and EF hand domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428481	Rasef<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ras and Rab interactor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419388	Rin1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Ras and Rab interactor 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362588	Rin3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842387	Raph1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842737	Raph1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Ras association (RalGDS/AF-6) domain family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363411	Rassf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) domain family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364359	Rassf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) domain family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364684	Rassf2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) domain family member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365128	Rassf2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) domain family member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942037	Rassf5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) domain family member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942042	Rassf5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419110	Rassf7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8; targeted mutation 1.1, Velocigene	MGI:5695922	Rassf8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949362	Rassf8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364742	Rassf9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS, dexamethasone-induced 1; targeted mutation 1.1, Velocigene	MGI:5695889	Rasd1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RAS, dexamethasone-induced 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362381	Rasd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RasGEF domain family, member 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363680	Rasgef1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RasGEF domain family, member 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363942	Rasgef1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RasGEF domain family, member 1B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455514	Rasgef1b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RasGEF domain family, member 1B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455546	Rasgef1b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS guanyl releasing protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362161	Rasgrp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS guanyl releasing protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362225	Rasgrp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS guanyl releasing protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365146	Rasgrp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS guanyl releasing protein 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841072	Rasgrp4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS guanyl releasing protein 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841367	Rasgrp4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Ras homolog enriched in brain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434509	Rheb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453690	Rhoa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453743	Rhoa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441790	Rhoc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442009	Rhoc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433583	Rhod<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434124	Rhod<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member F (in filopodia); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363021	Rhof<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member F (in filopodia); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364327	Rhof<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451275	Rhog<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451569	Rhog<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365246	Rhoj<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365246	Rhoj<tm1a(KOMP)Wtsi>	22535667	KOMP-CSD
ras homolog family member J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365246	Rhoj<tm1a(KOMP)Wtsi>	24928894	KOMP-CSD
ras homolog family member J; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365246	Rhoj<tm1a(KOMP)Wtsi>	28753606	KOMP-CSD
ras homolog family member J; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364664	Rhoj<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member T1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432006	Rhot1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ras homolog family member T1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432006	Rhot1<tm1a(EUCOMM)Wtsi>	27705781	EUCOMM
ras homolog family member T2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419477	Rhot2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member T2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419477	Rhot2<tm1(KOMP)Wtsi>	24721909	KOMP-CSD
ras homolog family member T2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419477	Rhot2<tm1(KOMP)Wtsi>	27705781	KOMP-CSD
ras homolog family member U; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363423	Rhou<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member U; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363519	Rhou<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ras homolog family member V; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419177	Rhov<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Ras interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431647	Rasip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433354	Rasip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Ras interacting protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433887	Rasip1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
Ras interacting protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5472982	Rasip1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras interacting protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5472982	Rasip1<tm3a(EUCOMM)Wtsi>	26897025	EUCOMM
RAS-like, estrogen-regulated, growth-inhibitor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364292	Rerg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS-like, estrogen-regulated, growth-inhibitor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428588	Rerg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS-like, family 10, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362132	Rasl10b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS-like, family 10, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362470	Rasl10b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS-like, family 11, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362434	Rasl11a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS-like, family 11, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362364	Rasl11a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS-like, family 11, member B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052406	Rasl11b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS p21 protein activator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362124	Rasa3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS p21 protein activator 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363877	Rasa3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS protein activator like 1 (GAP1 like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364597	Rasal1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RAS protein activator like 1 (GAP1 like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364536	Rasal1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RAS protein activator like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939768	Rasal2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RAS protein activator like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939769	Rasal2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RAS protein-specific guanine nucleotide-releasing factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050162	Rasgrf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ras-related associated with diabetes; targeted mutation 1.1, Velocigene	MGI:5502315	Rrad<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RAS-related C3 botulinum substrate 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286408	Rac3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras-related GTP binding C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433247	Rragc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras-related GTP binding C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433866	Rragc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Ras-related GTP binding C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441942	Rragc<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras-related GTP binding C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441888	Rragc<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RAS related protein 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296228	Rap1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ras responsive element binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441720	Rreb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ras responsive element binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441784	Rreb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Ras suppressor protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511987	Rsu1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Ras suppressor protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511960	Rsu1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RB1-inducible coiled-coil 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842608	Rb1cc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RB-associated KRAB zinc finger; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364920	Rbak<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RB-associated KRAB zinc finger; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364217	Rbak<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RB-associated KRAB zinc finger; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364691	Rbak<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RB-associated KRAB zinc finger; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364221	Rbak<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RBPJ interacting and tubulin associated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841296	Rita1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RBPJ interacting and tubulin associated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841260	Rita1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RB transcriptional corepressor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364364	Rb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RB transcriptional corepressor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362766	Rb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RB transcriptional corepressor like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820253	Rbl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RCC1 domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419878	Rccd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RCSD domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419584	Rcsd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RDH16 family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363554	Rdh16f2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RDH16 family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364377	Rdh16f2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RE1-silencing transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433924	Rest<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RE1-silencing transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433924	Rest<tm1a(EUCOMM)Wtsi>	26119235	EUCOMM
RE1-silencing transcription factor; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5779558	Rest<tm1c(EUCOMM)Wtsi>	26119235	EUCOMM
RE1-silencing transcription factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431747	Rest<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RE1-silencing transcription factor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431796	Rest<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RE1-silencing transcription factor; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5692555	Rest<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
RE1-silencing transcription factor; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432298	Rest<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
reactive intermediate imine deaminase A homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5002935	Rida<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reactive intermediate imine deaminase A homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5002936	Rida<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
rearranged L-myc fusion sequence; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880941	Rlf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
REC114 meiotic recombination protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419253	Rec114<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
REC8 meiotic recombination protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364591	Rec8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
REC8 meiotic recombination protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5694668	Rec8<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
REC8 meiotic recombination protein; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5635285	Rec8<tm1e.1(KOMP)Wtsi>	21677750	KOMP-CSD
REC8 meiotic recombination protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364921	Rec8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
receptor accessory protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419194	Reep2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
receptor accessory protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050848	Reep4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
receptor accessory protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006810	Reep5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
receptor accessory protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362989	Reep6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
receptor accessory protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364933	Reep6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
receptor-associated protein of the synapse; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433819	Rapsn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
receptor-associated protein of the synapse; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637222	Rapsn<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
receptor-associated protein of the synapse; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431985	Rapsn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
receptor (calcitonin) activity modifying protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286381	Ramp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
receptor (calcitonin) activity modifying protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636992	Ramp1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
receptor (calcitonin) activity modifying protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299875	Ramp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
receptor (calcitonin) activity modifying protein 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299565	Ramp2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
receptor for activated C kinase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451318	Rack1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
receptor-interacting serine-threonine kinase 3; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5583070	Ripk3<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
receptor-interacting serine-threonine kinase 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419652	Ripk3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
receptor-interacting serine-threonine kinase 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419652	Ripk3<tm1(KOMP)Wtsi>	28537251	KOMP-CSD
receptor-interacting serine-threonine kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442055	Ripk4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
receptor-interacting serine-threonine kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442055	Ripk4<tm1a(EUCOMM)Wtsi>	28507225	EUCOMM
receptor-interacting serine-threonine kinase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452799	Ripk4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
receptor-like tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296229	Ryk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
receptor (TNFRSF)-interacting serine-threonine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364253	Ripk1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
recombination activating gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451677	Rag1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
recombination activating gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451687	Rag1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
recombination signal binding protein for immunoglobulin kappa J region-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364029	Rbpjl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
recombination signal binding protein for immunoglobulin kappa J region-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636933	Rbpjl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
recombination signal binding protein for immunoglobulin kappa J region-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365016	Rbpjl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
recombination signal binding protein for immunoglobulin kappa J region; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5009600	Rbpj<tm1a(EUCOMM)Hmgu>	26188077	EUCOMM
recombination signal binding protein for immunoglobulin kappa J region; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5614604	Rbpj<tm1b(EUCOMM)Hmgu>	28700664	EUCOMM
RecQ protein-like 4; targeted mutation 1.1, Velocigene	MGI:5548719	Recql4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RecQ protein-like 4; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050948	Recql4<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
reduced expression 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441949	Rex2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
reelin; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4840853	Reln<tm1a(KOMP)Mbp>	26662625	KOMP-CSD
reelin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364398	Reln<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reelin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365080	Reln<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
refilin A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363382	Rflna<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regenerating islet-derived 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014604	Reg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regenerating islet-derived 2; targeted mutation 1.1, Velocigene	MGI:5548968	Reg2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
regenerating islet-derived 2; targeted mutation 1.1, Velocigene	MGI:5548968	Reg2<tm1.1(KOMP)Vlcg>	28009527	KOMP-Regeneron
regenerating islet-derived 3 delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849409	Reg3d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regenerating islet-derived 3 delta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636985	Reg3d<tm1b(EUCOMM)Wtsi>	26398943	EUCOMM
regenerating islet-derived 3 delta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636985	Reg3d<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
regenerating islet-derived 3 delta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849410	Reg3d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regenerating islet-derived 3 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363444	Reg3g<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regenerating islet-derived 3 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363444	Reg3g<tm1a(KOMP)Wtsi>	25263220	KOMP-CSD
regenerating islet-derived 3 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363444	Reg3g<tm1a(KOMP)Wtsi>	26329040	KOMP-CSD
regenerating islet-derived 3 gamma; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451638	Reg3g<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
regucalcin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362406	Rgn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulated endocrine-specific protein 18; targeted mutation 1.1, Velocigene	MGI:5443932	Resp18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
regulated endocrine-specific protein 18; targeted mutation 1.1, Velocigene	MGI:5443932	Resp18<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
regulating synaptic membrane exocytosis 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842248	Rims2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulating synaptic membrane exocytosis 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842590	Rims2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulating synaptic membrane exocytosis 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451369	Rims3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulating synaptic membrane exocytosis 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451369	Rims3<tm1a(KOMP)Wtsi>	28642685	KOMP-CSD
regulating synaptic membrane exocytosis 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548815	Rims3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
regulator of calcineurin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286172	Rcan1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of cell cycle; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5569044	Rgcc<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
regulator of cell cycle; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362711	Rgcc<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of cell cycle; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362711	Rgcc<tm1(KOMP)Wtsi>	23695833	KOMP-CSD
regulator of cell cycle; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362711	Rgcc<tm1(KOMP)Wtsi>	25385871	KOMP-CSD
regulator of cell cycle; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362711	Rgcc<tm1(KOMP)Wtsi>	26134570	KOMP-CSD
regulator of cell cycle; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362711	Rgcc<tm1(KOMP)Wtsi>	26275310	KOMP-CSD
regulator of cell cycle; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362711	Rgcc<tm1(KOMP)Wtsi>	26839965	KOMP-CSD
regulator of chromosome condensation 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453694	Rcc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of chromosome condensation 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692719	Rcc2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
regulator of chromosome condensation 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453778	Rcc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 11; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363130	Rgs11<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signaling 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453718	Rgs12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453681	Rgs12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432074	Rgs14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432473	Rgs14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362810	Rgs17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signaling 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363330	Rgs17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signaling 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841411	Rgs18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signaling 19; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419524	Rgs19<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signaling 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363067	Rgs20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signaling 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363393	Rgs20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signaling 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849427	Rgs2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849422	Rgs2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434451	Rgs3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434018	Rgs3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511893	Rgs3<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432511	Rgs5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548396	Rgs5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
regulator of G-protein signaling 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432737	Rgs5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432928	Rgs9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signaling 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433484	Rgs9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulator of G-protein signalling 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363293	Rgs22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signalling 22; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5608779	Rgs22<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signalling 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364909	Rgs22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signalling 7 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362379	Rgs7bp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of G-protein signalling 7 binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363167	Rgs7bp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of microtubule dynamics 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4819201	Rmdn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulator of microtubule dynamics 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4819199	Rmdn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
regulatory associated protein of MTOR, complex 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432132	Rptor<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory associated protein of MTOR, complex 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441657	Rptor<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory associated protein of MTOR, complex 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548643	Rptor<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
regulatory associated protein of MTOR, complex 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441715	Rptor<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 2 (influences HLA class II expression); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941984	Rfx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulatory factor X, 2 (influences HLA class II expression); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942018	Rfx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
regulatory factor X, 4 (influences HLA class II expression); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431588	Rfx4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 4 (influences HLA class II expression); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433616	Rfx4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 5 (influences HLA class II expression); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842823	Rfx5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 5 (influences HLA class II expression); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840613	Rfx5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 5 (influences HLA class II expression); targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4842732	Rfx5<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 5 (influences HLA class II expression); targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4842337	Rfx5<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050985	Rfx6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050990	Rfx6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
regulatory factor X, 7; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5637140	Rfx7<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451704	Riiad1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428470	Riiad1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
related RAS viral (r-ras) oncogene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842281	Rras2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
related RAS viral (r-ras) oncogene 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842578	Rras2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
relaxin 1; targeted mutation 1.1, Velocigene	MGI:5766260	Rln1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
relaxin 3; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456517	Rln3<tm1(KOMP)Mbp>	27626380	KOMP-CSD
relaxin/insulin-like family peptide receptor 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4820189	Rxfp1<tm1a(EUCOMM)Hmgu>	25715795	EUCOMM
relaxin/insulin-like family peptide receptor 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5792956	Rxfp1<tm1c(EUCOMM)Hmgu>	25715795	EUCOMM
relaxin/insulin-like family peptide receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433327	Rxfp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
relaxin/insulin-like family peptide receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433327	Rxfp2<tm1a(EUCOMM)Wtsi>	23100620	EUCOMM
relaxin/insulin-like family peptide receptor 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548762	Rxfp2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
relaxin/insulin-like family peptide receptor 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5473310	Rxfp2<tm1c(EUCOMM)Wtsi>	23100620	EUCOMM
RELT-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140486	Rell2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
REM2 and RAB-like small GTPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363961	Rsg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
REM2 and RAB-like small GTPase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362918	Rsg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
remodeling and spacing factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431882	Rsf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
remodeling and spacing factor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605823	Rsf1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
remodeling and spacing factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433933	Rsf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
renalase, FAD-dependent amine oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847877	Rnls<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
renalase, FAD-dependent amine oxidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847855	Rnls<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
renin 1 structural; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432098	Ren1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
renin 1 structural; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432128	Ren1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
renin binding protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419441	Renbp<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
replication factor C (activator 1) 1; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5495286	Rfc1<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
replication factor C (activator 1) 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442035	Rfc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
replication initiator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008938	Repin1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
replication initiator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938589	Repin1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
replication protein A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419697	Rpa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
replication protein A1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446173	Rpa1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
replication protein A1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446173	Rpa1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
replication protein A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419818	Rpa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
replication protein A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428572	Rpa3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
replication termination factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365094	Rtf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
replication termination factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427234	Rtf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
replication timing regulatory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453697	Rif1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
replication timing regulatory factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453785	Rif1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
reproductive homeobox 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428568	Rhox11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reproductive homeobox 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820151	Rhox13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reproductive homeobox 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820151	Rhox13<tm1a(KOMP)Wtsi>	27486269	KOMP-CSD
reproductive homeobox 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820151	Rhox13<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
reproductive homeobox 13; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548634	Rhox13<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
reproductive homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363455	Rhox1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reproductive homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364411	Rhox1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
required for meiotic nuclear division 1 homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433835	Rmnd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
required for meiotic nuclear division 1 homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432918	Rmnd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
REST corepressor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820223	Rcor1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
REST corepressor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820390	Rcor1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
REST corepressor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431639	Rcor2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
REST corepressor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431639	Rcor2<tm1a(EUCOMM)Wtsi>	26795843	EUCOMM
REST corepressor 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806455	Rcor2<tm1c(EUCOMM)Wtsi>	26795843	EUCOMM
REST corepressor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432520	Rcor2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
retbindin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433926	Rtbdn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retbindin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432783	Rtbdn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
reticulocalbin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363546	Rcn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reticuloendotheliosis oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441649	Rel<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
reticuloendotheliosis oncogene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637218	Rel<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
reticulon 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880888	Rtn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reticulon 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548728	Rtn1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
reticulon 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050159	Rtn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reticulon 4 interacting protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363509	Rtn4ip1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
reticulon 4 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363908	Rtn4r<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
reticulon 4 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428585	Rtn4r<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
reticulophagy regulator family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431557	Retreg3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
reticulophagy regulator family member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433416	Retreg3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
reticulophagy regulator family member 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548555	Retreg3<tm2b(EUCOMM)Wtsi>	25849460	EUCOMM
reticulophagy regulator family member 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548555	Retreg3<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
reticulophagy regulator family member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433002	Retreg3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
reticulophagy regulator family member 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456761	Retreg3<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
retina and anterior neural fold homeobox; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419211	Rax<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
retinaldehyde binding protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548969	Rlbp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
retinal G protein coupled receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454134	Rgr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinal G protein coupled receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454161	Rgr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinal pigment epithelium derived rhodopsin homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085344	Rrh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinitis pigmentosa 1 homolog like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880907	Rp1l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinitis pigmentosa 2 homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052419	Rp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinitis pigmentosa 2 homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140424	Rp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinitis pigmentosa 9 (human); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473022	Rp9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retinitis pigmentosa 9 (human); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472846	Rp9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
retinoblastoma binding protein 4, chromatin remodeling factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432168	Rbbp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retinoblastoma binding protein 4, chromatin remodeling factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433016	Rbbp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
retinoblastoma binding protein 6, ubiquitin ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948641	Rbbp6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retinoblastoma binding protein 7, chromatin remodeling factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455962	Rbbp7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retinoblastoma binding protein 7, chromatin remodeling factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455962	Rbbp7<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
retinoic acid early transcript gamma; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548391	Raet1c<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
retinoic acid receptor, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947770	Rarb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinoic acid receptor responder (tazarotene induced) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362170	Rarres1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinoic acid receptor responder (tazarotene induced) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362129	Rarres1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinoic acid receptor responder (tazarotene induced) 2; targeted mutation 1, Velocigene	MGI:3800007	Rarres2<tm1(KOMP)Vlcg>	25659101	KOMP-Regeneron
retinol binding protein 4, plasma; targeted mutation 1.1, Velocigene	MGI:5548967	Rbp4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
retinol dehydrogenase 10 (all-trans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362599	Rdh10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362599	Rdh10<tm1a(KOMP)Wtsi>	22319578	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362599	Rdh10<tm1a(KOMP)Wtsi>	23765990	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362599	Rdh10<tm1a(KOMP)Wtsi>	26278034	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362599	Rdh10<tm1a(KOMP)Wtsi>	27214556	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5429723	Rdh10<tm1c(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5429723	Rdh10<tm1c(KOMP)Wtsi>	22319578	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5429723	Rdh10<tm1c(KOMP)Wtsi>	23267101	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5429723	Rdh10<tm1c(KOMP)Wtsi>	26391396	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5429723	Rdh10<tm1c(KOMP)Wtsi>	27214556	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5429723	Rdh10<tm1c(KOMP)Wtsi>	28169399	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5429724	Rdh10<tm1d(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5429724	Rdh10<tm1d(KOMP)Wtsi>	22319578	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5429724	Rdh10<tm1d(KOMP)Wtsi>	23765990	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5429724	Rdh10<tm1d(KOMP)Wtsi>	25809880	KOMP-CSD
retinol dehydrogenase 10 (all-trans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363812	Rdh10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442060	Rdh11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retinol dehydrogenase 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441986	Rdh11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
retinol dehydrogenase 14 (all-trans and 9-cis); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452681	Rdh14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 14 (all-trans and 9-cis); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452677	Rdh14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362960	Rdh16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362422	Rdh16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362330	Rdh19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365102	Rdh19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363834	Rdh7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950252	Rdh8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retinol dehydrogenase 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458476	Rdh9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinol dehydrogenase 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458616	Rdh9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retinol saturase (all trans retinol 13,14 reductase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362328	Retsat<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
retinol saturase (all trans retinol 13,14 reductase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363347	Retsat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
retrotransposon Gag like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006811	Rtl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
retrotransposon Gag like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362339	Rtl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
REV1, DNA directed polymerase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296224	Rev1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
REV1, DNA directed polymerase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296207	Rev1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
reversion-inducing-cysteine-rich protein with kazal motifs; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456737	Reck<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
reversion-inducing-cysteine-rich protein with kazal motifs; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456800	Reck<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
REX4, 3'-5' exonuclease; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364795	Rexo4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
REX4, 3'-5' exonuclease; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364024	Rexo4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RFT1 homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881951	Rft1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RFT1 homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881964	Rft1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rh blood group, D antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431572	Rhd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rh blood group, D antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433877	Rhd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rhesus blood group-associated A glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949330	Rhag<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rhesus blood group-associated A glycoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949331	Rhag<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rhesus blood group-associated B glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362617	Rhbg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rhesus blood group-associated B glycoprotein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472921	Rhbg<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Rhesus blood group-associated C glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451474	Rhcg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rhesus blood group-associated C glycoprotein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451534	Rhcg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho-associated coiled-coil containing protein kinase 1; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766167	Rock1<tm1b(NCOM)Mfgc>	27626380	NorCOMM
Rho-associated coiled-coil containing protein kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451368	Rock2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho-associated coiled-coil containing protein kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451470	Rock2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho family GTPase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458858	Rnd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho family GTPase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458857	Rnd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho family GTPase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305674	Rnd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho family GTPase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305663	Rnd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho family GTPase 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637075	Rnd3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RHO family interacting cell polarization regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820229	Ripor1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RHO family interacting cell polarization regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820340	Ripor1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RHO family interacting cell polarization regulator 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296551	Ripor2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RHO family interacting cell polarization regulator 2; targeted mutation 1, Velocigene	MGI:5085529	Ripor2<tm1(KOMP)Vlcg>	27269051	KOMP-Regeneron
RHO family interacting cell polarization regulator 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296556	Ripor2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GDP dissociation inhibitor (GDI) alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940755	Arhgdia<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GDP dissociation inhibitor (GDI) alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940778	Arhgdia<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GDP dissociation inhibitor (GDI) gamma; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5427172	Arhgdig<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363201	Arhgap15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364565	Arhgap15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842587	Arhgap17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842596	Arhgap17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363220	Arhgap18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363220	Arhgap18<tm1a(KOMP)Wtsi>	25425145	KOMP-CSD
Rho GTPase activating protein 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364573	Arhgap18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419959	Arhgap19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 19; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569051	Arhgap19<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Rho GTPase activating protein 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420011	Arhgap19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881971	Arhgap20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881969	Arhgap20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 20; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294023	Arhgap20<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363166	Arhgap22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364229	Arhgap22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 22; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364295	Arhgap22<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433512	Arhgap23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 23; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605828	Arhgap23<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
Rho GTPase activating protein 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434489	Arhgap23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948613	Arhgap24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362243	Arhgap25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362243	Arhgap25<tm1a(KOMP)Wtsi>	27365422	KOMP-CSD
Rho GTPase activating protein 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362243	Arhgap25<tm1a(KOMP)Wtsi>	27566826	KOMP-CSD
Rho GTPase activating protein 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363860	Arhgap25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 25; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364193	Arhgap25<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419662	Arhgap27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431425	Arhgap28<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 28; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5750967	Arhgap28<tm2b(KOMP)Wtsi>	25211221	KOMP-CSD
Rho GTPase activating protein 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431499	Arhgap28<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 28; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451570	Arhgap28<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 28; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451570	Arhgap28<tm2a(KOMP)Wtsi>	25211221	KOMP-CSD
Rho GTPase activating protein 28; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451380	Arhgap28<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433173	Arhgap30<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431721	Arhgap30<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008806	Arhgap31<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009562	Arhgap31<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419297	Arhgap33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 33; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5582443	Arhgap33<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Rho GTPase activating protein 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419311	Arhgap33<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 35; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4460279	Arhgap35<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427185	Arhgap36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427136	Arhgap36<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014696	Arhgap39<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 39; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432248	Arhgap39<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 39; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433761	Arhgap39<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820072	Arhgap40<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820060	Arhgap40<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho GTPase activating protein 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432447	Arhgap45<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 45; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433415	Arhgap45<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho GTPase activating protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364907	Arhgap6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 10-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305662	Arhgef10l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho guanine nucleotide exchange factor (GEF) 10; targeted mutation 1.1, Velocigene	MGI:5488782	Arhgef10<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Rho guanine nucleotide exchange factor (GEF) 10; targeted mutation 1.1, Velocigene	MGI:5488782	Arhgef10<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
Rho guanine nucleotide exchange factor (GEF) 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014576	Arhgef11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548801	Arhgef11<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293957	Arhgef12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 15; targeted mutation 1.1, Velocigene	MGI:5583080	Arhgef15<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
Rho guanine nucleotide exchange factor (GEF) 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420034	Arhgef15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419667	Arhgef15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 15; targeted mutation 1, Velocigene	MGI:3812708	Arhgef15<tm1(KOMP)Vlcg>	22535667	KOMP-Regeneron
Rho guanine nucleotide exchange factor (GEF) 15; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294006	Arhgef15<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 15; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293991	Arhgef15<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434048	Arhgef1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho guanine nucleotide exchange factor (GEF) 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365277	Arhgef26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 26; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427210	Arhgef26<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842257	Arhgef28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho guanine nucleotide exchange factor (GEF) 28; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548458	Arhgef28<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
Rho guanine nucleotide exchange factor (GEF) 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842565	Arhgef28<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho guanine nucleotide exchange factor (GEF) 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949326	Arhgef38<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 38; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4939699	Arhgef38<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 38; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4939743	Arhgef38<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419295	Arhgef3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419295	Arhgef3<tm1(KOMP)Wtsi>	28542600	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364388	Arhgef4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299598	Arhgef4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho guanine nucleotide exchange factor (GEF) 5; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766172	Arhgef5<tm1b(NCOM)Mfgc>	27626380	NorCOMM
Rho guanine nucleotide exchange factor (GEF7); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009652	Arhgef7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho guanine nucleotide exchange factor (GEF7); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009652	Arhgef7<tm1a(EUCOMM)Wtsi>	25512563	EUCOMM
rhomboid 5 homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458860	Rhbdf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rhomboid 5 homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458860	Rhbdf1<tm1a(EUCOMM)Wtsi>	24078251	EUCOMM
rhomboid 5 homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458860	Rhbdf1<tm1a(EUCOMM)Wtsi>	25918388	EUCOMM
rhomboid 5 homolog 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5792831	Rhbdf1<tm1b(EUCOMM)Wtsi>	25918388	EUCOMM
rhomboid 5 homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458832	Rhbdf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
rhomboid 5 homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362881	Rhbdf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
rhomboid 5 homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362881	Rhbdf2<tm1a(KOMP)Wtsi>	22550345	KOMP-CSD
rhomboid 5 homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362881	Rhbdf2<tm1a(KOMP)Wtsi>	24825892	KOMP-CSD
rhomboid 5 homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362881	Rhbdf2<tm1a(KOMP)Wtsi>	29155878	KOMP-CSD
rhomboid 5 homolog 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548807	Rhbdf2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
rhomboid 5 homolog 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548807	Rhbdf2<tm1b(KOMP)Wtsi>	29155878	KOMP-CSD
rhomboid 5 homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362378	Rhbdf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
rhomboid domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433378	Rhbdd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rhomboid domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432987	Rhbdd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rhomboid domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433771	Rhbdd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
rhomboid like 1; targeted mutation 1.1, Velocigene	MGI:5548786	Rhbdl1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
rhomboid like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287801	Rhbdl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
rhomboid like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572036	Rhbdl2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
rhomboid like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5572036	Rhbdl2<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
rhomboid like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433810	Rhbdl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rhomboid like 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548774	Rhbdl3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
rhomboid like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433837	Rhbdl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
rhophilin, Rho GTPase binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363446	Rhpn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
rhophilin, Rho GTPase binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5582426	Rhpn1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
rhophilin, Rho GTPase binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363053	Rhpn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
rhophilin, Rho GTPase binding protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363827	Rhpn1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
rhophilin, Rho GTPase binding protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364345	Rhpn1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
rhophilin, Rho GTPase binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305667	Rhpn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rhophilin, Rho GTPase binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305659	Rhpn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho-related BTB domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364100	Rhobtb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho-related BTB domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363367	Rhobtb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rho-related BTB domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303170	Rhobtb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rho-related BTB domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5303165	Rhobtb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rho-related BTB domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362349	Rhobtb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Rho-related BTB domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362349	Rhobtb3<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
Rho-related BTB domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362349	Rhobtb3<tm1a(KOMP)Wtsi>	24923387	KOMP-CSD
Rho-related BTB domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362349	Rhobtb3<tm1a(KOMP)Wtsi>	26215701	KOMP-CSD
Rho-related BTB domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364305	Rhobtb3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIB43A domain with coiled-coils 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434458	Ribc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
riboflavin kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363483	Rfk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
riboflavin kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362144	Rfk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
riboflavin kinase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363494	Rfk<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
riboflavin kinase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363020	Rfk<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ribokinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431575	Rbks<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribokinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433674	Rbks<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribonuclease/angiogenin inhibitor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941493	Rnh1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease/angiogenin inhibitor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947767	Rnh1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease H2, large subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362394	Rnaseh2a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease H2, subunit B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432164	Rnaseh2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribonuclease H2, subunit B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432164	Rnaseh2b<tm1a(EUCOMM)Wtsi>	22579044	EUCOMM
ribonuclease H2, subunit B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432164	Rnaseh2b<tm1a(EUCOMM)Wtsi>	22802351	EUCOMM
ribonuclease H2, subunit B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432164	Rnaseh2b<tm1a(EUCOMM)Wtsi>	26903602	EUCOMM
ribonuclease H2, subunit B; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5911393	Rnaseh2b<tm1c(EUCOMM)Wtsi>	22802351	EUCOMM
ribonuclease H2, subunit B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432913	Rnaseh2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribonuclease H2, subunit C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364620	Rnaseh2c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease P 14 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451469	Rpp14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease P 14 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451624	Rpp14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease P/MRP 25 subunit-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434133	Rpp25l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribonuclease P/MRP 25 subunit-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431732	Rpp25l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribonuclease P/MRP 38 subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420025	Rpp38<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease, RNase K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849411	Rnasek<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribonuclease, RNase K; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849416	Rnasek<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribonuclease T2A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419869	Rnaset2a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribonuclease T2B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637192	Rnaset2b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ribonucleic acid export 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431498	Rae1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribonucleoprotein, PTB-binding 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140491	Raver1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribonucleoprotein, PTB-binding 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140468	Raver1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribonucleoprotein, PTB-binding 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941980	Raver2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribonucleoprotein, PTB-binding 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948620	Raver2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribonucleotide reductase M2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841063	Rrm2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribonucleotide reductase M2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548970	Rrm2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ribonucleotide reductase M2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841023	Rrm2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribophorin II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432779	Rpn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribophorin II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432824	Rpn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribose 5-phosphate isomerase A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364474	Rpia<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribose 5-phosphate isomerase A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365115	Rpia<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal L24 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296220	Rsl24d1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal modification protein rimK-like family member B; targeted mutation 1.1, Velocigene	MGI:5474780	Rimklb<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ribosomal oxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473130	Riox1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal oxygenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472711	Riox1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal oxygenase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432346	Riox2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L10A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419174	Rpl10a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L10; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420009	Rpl10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L13A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432578	Rpl13a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L18A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419199	Rpl18a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L22; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419522	Rpl22<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008945	Rpl24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441936	Rpl26<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L27A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428552	Rpl27a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L27A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428519	Rpl27a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L27A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527615	Rpl27a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458657	Rpl35<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L36A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5308294	Rpl36a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L36A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428516	Rpl36a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L37a; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419142	Rpl37a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L37; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458831	Rpl37<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L37; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458850	Rpl37<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L38; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840607	Rpl38<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842774	Rpl39<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L7A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420140	Rpl7a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein L7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432833	Rpl7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein L8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419416	Rpl8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein, large, P1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419472	Rplp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein, large P2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456673	Rplp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050158	Rps11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428493	Rps11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456747	Rps14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456784	Rps14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944494	Rps15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S16; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419182	Rps16<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S17; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419727	Rps17<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S18; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419557	Rps18<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S19 binding protein 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5617789	Rps19bp1<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
ribosomal protein S19 binding protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419305	Rps19bp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451322	Rps19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451692	Rps19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S20; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4460270	Rps20<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S21; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419400	Rps21<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S23; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419933	Rps23<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441638	Rps25<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441801	Rps25<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S27A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420142	Rps27a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S27-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433990	Rps27l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S28; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431399	Rps28<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S29; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419822	Rps29<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419961	Rps2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S3A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419622	Rps3a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S3A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419735	Rps3a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433592	Rps3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319847	Rps5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365228	Rps5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4843848	Rps5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4843847	Rps5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase-like 1; targeted mutation 1.1, Velocigene	MGI:5614610	Rps6kl1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
ribosomal protein S6 kinase polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433516	Rps6kc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S6 kinase polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451331	Rps6ka1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451420	Rps6ka1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase polypeptide 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302294	Rps6ka1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase, polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363882	Rps6kb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase, polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362315	Rps6kb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase polypeptide 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431785	Rps6ka3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S6 kinase, polypeptide 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362337	Rps6ka4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase, polypeptide 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419111	Rps6ka5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase, polypeptide 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419760	Rps6ka5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S6 kinase polypeptide 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364570	Rps6ka6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal protein S9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433597	Rps9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal protein S9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433054	Rps9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal RNA adenine dimethylase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419755	Rrnad1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal RNA adenine dimethylase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419512	Rrnad1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal RNA processing 15 homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419938	Rrp15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal RNA processing 15 homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419976	Rrp15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal RNA processing 1 homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842779	Rrp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ribosomal RNA processing 7 homolog A (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944330	Rrp7a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal RNA processing 7 homolog A (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950948	Rrp7a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ribosomal RNA processing 8, methyltransferase, homolog (yeast); targeted mutation 1.1, Velocigene	MGI:5581417	Rrp8<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ribosomal RNA processing 8, methyltransferase, homolog (yeast); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4888952	Rrp8<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
ribulose-5-phosphate-3-epimerase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431768	Rpe<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIC8 guanine nucleotide exchange factor A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420046	Ric8a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIC8 guanine nucleotide exchange factor A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420046	Ric8a<tm1a(KOMP)Wtsi>	27348266	KOMP-CSD
RIC8 guanine nucleotide exchange factor A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5882612	Ric8a<tm1c(KOMP)Wtsi>	27348266	KOMP-CSD
RIC8 guanine nucleotide exchange factor A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420057	Ric8a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIC8 guanine nucleotide exchange factor B; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434606	Ric8b<tm1a(EUCOMM)Hmgu>	29118104	EUCOMM
RIC8 guanine nucleotide exchange factor B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441684	Ric8b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIC8 guanine nucleotide exchange factor B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548860	Ric8b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RIC8 guanine nucleotide exchange factor B; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5692848	Ric8b<tm1c(EUCOMM)Hmgu>	29118104	EUCOMM
RIC8 guanine nucleotide exchange factor B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441624	Ric8b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 0610009L18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433425	0610009L18Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 0610009L18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433721	0610009L18Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 0610010F05 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419208	0610010F05Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 0610010F05 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419293	0610010F05Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 0610037L13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431771	0610037L13Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 0610037L13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432142	0610037L13Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110004E09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431743	1110004E09Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110004E09 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527594	1110004E09Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110004F10 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431971	1110004F10Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110004F10 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433700	1110004F10Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110004F10 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473086	1110004F10Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110004F10 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472885	1110004F10Rik<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110008P14 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419262	1110008P14Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1110034G24 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880991	1110034G24Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1110034G24 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880970	1110034G24Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1110051M20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431671	1110051M20Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110051M20 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431744	1110051M20Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110051M20 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472917	1110051M20Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110059G10 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419470	1110059G10Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1110059G10 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419881	1110059G10Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1110059G10 gene; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511940	1110059G10Rik<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1110065P20 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362621	1110065P20Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1190002N15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419862	1190002N15Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1190002N15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419289	1190002N15Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1190002N15 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5289828	1190002N15Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1190002N15 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5289824	1190002N15Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1300017J02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820099	1300017J02Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1300017J02 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820063	1300017J02Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1500011B03 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419221	1500011B03Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1500011B03 gene; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:4419497	1500011B03Rik<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1600029I14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451242	1600029I14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700001C02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432273	1700001C02Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700001K19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460499	1700001K19Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700001K19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460449	1700001K19Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700001L19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008793	1700001L19Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700003F12 gene; targeted mutation 1.1, Velocigene	MGI:5548659	1700003F12Rik<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RIKEN cDNA 1700006A11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820283	1700006A11Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700006A11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820397	1700006A11Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700006E09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947739	1700006E09Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700006E09 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548656	1700006E09Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 1700007G11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453712	1700007G11Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700007G11 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548582	1700007G11Rik<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RIKEN cDNA 1700007K13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419779	1700007K13Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700007K13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419286	1700007K13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700007K13 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472700	1700007K13Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700008O03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451336	1700008O03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700008O03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451589	1700008O03Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700010I14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363118	1700010I14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700010I14 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5289825	1700010I14Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700010I14 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364729	1700010I14Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700010I14 gene; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548527	1700010I14Rik<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 1700011H14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363567	1700011H14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700011H14 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362762	1700011H14Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700011I03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441826	1700011I03Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700011M02 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420047	1700011M02Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700012B09 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4843840	1700012B09Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700013H16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363635	1700013H16Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700013H16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426666	1700013H16Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700013H16 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296537	1700013H16Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700013H16 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296526	1700013H16Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700015F17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451716	1700015F17Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700015F17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451333	1700015F17Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700016C15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362574	1700016C15Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700016C15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363339	1700016C15Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700016D06 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419630	1700016D06Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700016H13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434289	1700016H13Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700017D01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364609	1700017D01Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700017D01 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364288	1700017D01Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700017D01 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473092	1700017D01Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700018B08 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462680	1700018B08Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700018B08 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462684	1700018B08Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700019D03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5284927	1700019D03Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700019N19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363584	1700019N19Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700019N19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364696	1700019N19Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700020A23 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365240	1700020A23Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700020N15 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420087	1700020N15Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700021F07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820139	1700021F07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700021F07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820132	1700021F07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700021P04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364132	1700021P04Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700022A21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461653	1700022A21Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700023F06 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364587	1700023F06Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700024P04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473122	1700024P04Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700024P04 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637040	1700024P04Rik<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RIKEN cDNA 1700024P04 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472706	1700024P04Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700025G04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432681	1700025G04Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700028J19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452762	1700028J19Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700028J19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452818	1700028J19Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700028K03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451587	1700028K03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700028K03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451713	1700028K03Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700029H14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365122	1700029H14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700029H14 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364688	1700029H14Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700029H14 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419600	1700029H14Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700029H14 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419245	1700029H14Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700029J07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363022	1700029J07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700029J07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364341	1700029J07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700030K09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451453	1700030K09Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700030K09 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451299	1700030K09Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700034E13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365033	1700034E13Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700034E13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363254	1700034E13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700034E13 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5141832	1700034E13Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700034J05 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849971	1700034J05Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700034J05 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849979	1700034J05Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700066B19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820382	1700066B19Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700066B19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820348	1700066B19Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700067K01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841065	1700067K01Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700067K01 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841413	1700067K01Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700067K01 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5289829	1700067K01Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700067K01 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5289829	1700067K01Rik<tm2a(KOMP)Wtsi>	27996060	KOMP-CSD
RIKEN cDNA 1700067K01 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5289826	1700067K01Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700074P13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426570	1700074P13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700080O16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050880	1700080O16Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700080O16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5289802	1700080O16Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700080O16 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5289827	1700080O16Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700086L19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842476	1700086L19Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700086L19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842253	1700086L19Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700093J21 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434034	1700093J21Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700094D03 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451288	1700094D03Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1700123O20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434270	1700123O20Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700123O20 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434505	1700123O20Rik<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700125H20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441950	1700125H20Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1700125H20 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548635	1700125H20Rik<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RIKEN cDNA 1700125H20 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441765	1700125H20Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1810024B03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455616	1810024B03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1810024B03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455467	1810024B03Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1810030O07 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364654	1810030O07Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 1810043G02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432613	1810043G02Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1810043G02 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434101	1810043G02Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 1810043G02 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434113	1810043G02Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2010106E10 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293898	2010106E10Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2010106E10 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5289832	2010106E10Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2010107E04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432645	2010107E04Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2010107E04 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434422	2010107E04Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2010109A12 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842561	2010109A12Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2010109A12 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842321	2010109A12Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2010111I01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941982	2010111I01Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2010111I01 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942020	2010111I01Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2010300C02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364312	2010300C02Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2010300C02 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637062	2010300C02Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 2010300C02 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365008	2010300C02Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2200002D01 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431459	2200002D01Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2210010C04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888876	2210010C04Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2210010C04 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548539	2210010C04Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 2210016L21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419127	2210016L21Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2210016L21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419127	2210016L21Rik<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
RIKEN cDNA 2210016L21 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419483	2210016L21Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2210016L21 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419363	2210016L21Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2210016L21 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419204	2210016L21Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2210408I21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434390	2210408I21Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2300002M23 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431455	2300002M23Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2310007B03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362992	2310007B03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2310011J03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451323	2310011J03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2310011J03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451516	2310011J03Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2310033P09 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841082	2310033P09Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2310057J18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364593	2310057J18Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2310057J18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364731	2310057J18Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2310061I04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432283	2310061I04Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2410002F23 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419904	2410002F23Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2410004B18 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420032	2410004B18Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2410131K14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299889	2410131K14Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2410137M14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452807	2410137M14Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2510002D24 gene; targeted mutation 1.1, Velocigene	MGI:5583064	2510002D24Rik<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RIKEN cDNA 2510002D24 gene; targeted mutation 1, Velocigene	MGI:4842943	2510002D24Rik<tm1(KOMP)Vlcg>	27184122	KOMP-Regeneron
RIKEN cDNA 2610002M06 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420098	2610002M06Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2610318N02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451963	2610318N02Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2610318N02 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548598	2610318N02Rik<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RIKEN cDNA 2610318N02 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452792	2610318N02Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2610507B11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842462	2610507B11Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2610507B11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842838	2610507B11Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2700049A03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432606	2700049A03Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2700049A03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433433	2700049A03Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2700097O09 gene; targeted mutation 1.1, Velocigene	MGI:5569054	2700097O09Rik<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RIKEN cDNA 2700097O09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842634	2700097O09Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2700097O09 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842369	2700097O09Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2700097O09 gene; targeted mutation 1, Velocigene	MGI:4399527	2700097O09Rik<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
RIKEN cDNA 2810408A11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431683	2810408A11Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2810408A11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432205	2810408A11Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 2810474O19 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420059	2810474O19Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 2900092C05 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939776	2900092C05Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 3110001I22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434304	3110001I22Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 3110035E14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843828	3110035E14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 3110035E14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843828	3110035E14Rik<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
RIKEN cDNA 3110035E14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843828	3110035E14Rik<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 3110035E14 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548679	3110035E14Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 3110040N11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434455	3110040N11Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 3110043O21 gene; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548633	3110043O21Rik<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
RIKEN cDNA 3110043O21 gene; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548633	3110043O21Rik<tm1.1(KOMP)Mbp>	27875531	KOMP-CSD
RIKEN cDNA 3110043O21 gene; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548633	3110043O21Rik<tm1.1(KOMP)Mbp>	28720882	KOMP-CSD
RIKEN cDNA 3110043O21 gene; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4950129	3110043O21Rik<tm1(KOMP)Mbp>	26989253	KOMP-CSD
RIKEN cDNA 3110062M04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842521	3110062M04Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 3110079O15 gene; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436063	3110079O15Rik<tm1a(EUCOMM)Hmgu>	28323137	EUCOMM
RIKEN cDNA 3110079O15 gene; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637067	3110079O15Rik<tm1b(EUCOMM)Hmgu>	28323137	EUCOMM
RIKEN cDNA 3110082I17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453698	3110082I17Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 3110082I17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453765	3110082I17Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 3300002A11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887592	3300002A11Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 3300002A11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887621	3300002A11Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 3830406C13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286250	3830406C13Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 3830406C13 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637049	3830406C13Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 3830406C13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302280	3830406C13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 3830417A13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841046	3830417A13Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 3830417A13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841046	3830417A13Rik<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
RIKEN cDNA 4430402I18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868036	4430402I18Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4833427G06 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420058	4833427G06Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4833427G06 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841397	4833427G06Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4921501E09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473159	4921501E09Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4921501E09 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472737	4921501E09Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4921509C19 gene; targeted mutation 1.1, Velocigene	MGI:5523316	4921509C19Rik<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RIKEN cDNA 4921530L21 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431458	4921530L21Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4921536K21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363036	4921536K21Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4921536K21 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363667	4921536K21Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4922502D21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008796	4922502D21Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4922502D21 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009577	4922502D21Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930402F06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364243	4930402F06Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930402F06 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293998	4930402F06Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930402F06 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294012	4930402F06Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930402H24 gene; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605794	4930402H24Rik<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RIKEN cDNA 4930404H24 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050148	4930404H24Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930404H24 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419500	4930404H24Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930404H24 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5294009	4930404H24Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930404H24 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294001	4930404H24Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930430A15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431437	4930430A15Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930430A15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293940	4930430A15Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930430F08 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842864	4930430F08Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4930449E01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841164	4930449E01Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930449E01 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841232	4930449E01Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930451I11 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431410	4930451I11Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930453N24 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841085	4930453N24Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930453N24 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841094	4930453N24Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930470P17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841340	4930470P17Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930470P17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841110	4930470P17Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930502E18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363297	4930502E18Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930505A04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458497	4930505A04Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930505A04 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5581734	4930505A04Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 4930505A04 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458527	4930505A04Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930510E17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820093	4930510E17Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930510E17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820032	4930510E17Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930519G04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431402	4930519G04Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930522H14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363500	4930522H14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930522H14 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363005	4930522H14Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930544G11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472719	4930544G11Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4930555F03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842577	4930555F03Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4930563D23 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511991	4930563D23Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4930568D16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363959	4930568D16Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930568D16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362123	4930568D16Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930579F01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365031	4930579F01Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930583I09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364802	4930583I09Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930590J08 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882021	4930590J08Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4930590J08 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882016	4930590J08Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4930591A17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944391	4930591A17Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4930591A17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944383	4930591A17Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4931400O07 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420074	4931400O07Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4931406B18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363314	4931406B18Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4931406B18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363520	4931406B18Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4931406C07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461694	4931406C07Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4931406C07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461672	4931406C07Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4931422A03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842456	4931422A03Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4931422A03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842464	4931422A03Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4931429L15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460419	4931429L15Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4931429L15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460473	4931429L15Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4932414N04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364741	4932414N04Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4932415D10 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473133	4932415D10Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4932415D10 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472713	4932415D10Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4932438H23 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433980	4932438H23Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4932438H23 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434141	4932438H23Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933400A11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426639	4933400A11Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933400A11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426594	4933400A11Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402D24 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363606	4933402D24Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402E13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947745	4933402E13Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402E13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941499	4933402E13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402J07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841120	4933402J07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402J07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841282	4933402J07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402N03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363748	4933402N03Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402N03 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820121	4933402N03Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933402N03 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820129	4933402N03Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933403O08 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050171	4933403O08Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933406M09 gene; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5609361	4933406M09Rik<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RIKEN cDNA 4933407L21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451425	4933407L21Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933408B17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286212	4933408B17Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933408B17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426575	4933408B17Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933409G03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364177	4933409G03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933409G03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294016	4933409G03Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933409G03 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451646	4933409G03Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933411K16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473149	4933411K16Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933411K16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472727	4933411K16Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933413J09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5304864	4933413J09Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933414I15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451477	4933414I15Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933414I15 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451698	4933414I15Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933417A18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888942	4933417A18Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933417A18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888948	4933417A18Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933425L06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363980	4933425L06Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933425L06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363980	4933425L06Rik<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
RIKEN cDNA 4933427D06 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451669	4933427D06Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933427D06 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4938529	4933427D06Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933427D06 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4938528	4933427D06Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 4933427D14 gene; targeted mutation 1.1, Velocigene	MGI:5515778	4933427D14Rik<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
RIKEN cDNA 4933427D14 gene; targeted mutation 1.1, Velocigene	MGI:5515778	4933427D14Rik<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
RIKEN cDNA 4933428M09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473183	4933428M09Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933428M09 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472756	4933428M09Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933430I17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432117	4933430I17Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933430I17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432117	4933430I17Rik<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
RIKEN cDNA 4933430I17 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548894	4933430I17Rik<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RIKEN cDNA 4933430I17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433332	4933430I17Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933434E20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432969	4933434E20Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 4933434E20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432969	4933434E20Rik<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
RIKEN cDNA 4933434E20 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434211	4933434E20Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 5031439G07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362824	5031439G07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5031439G07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363289	5031439G07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5330417C22 gene; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548671	5330417C22Rik<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RIKEN cDNA 5430427O19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940775	5430427O19Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5430427O19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941506	5430427O19Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5530401A14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362179	5530401A14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5530401A14 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364418	5530401A14Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5730507C01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427193	5730507C01Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5730559C18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433555	5730559C18Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 5730559C18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433379	5730559C18Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 5730559C18 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527587	5730559C18Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 5830411N06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419525	5830411N06Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 5830411N06 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548819	5830411N06Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA 5830411N06 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419608	5830411N06Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6030468B19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840994	6030468B19Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6030468B19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840994	6030468B19Rik<tm1a(KOMP)Wtsi>	28978694	KOMP-CSD
RIKEN cDNA 6030468B19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841191	6030468B19Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6030498E09 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294008	6030498E09Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6330549D23 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432334	6330549D23Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 6330549D23 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432605	6330549D23Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 6430531B16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457566	6430531B16Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 6430531B16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457563	6430531B16Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 6430548M08 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364300	6430548M08Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6430548M08 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364445	6430548M08Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6430573F11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462572	6430573F11Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6430573F11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462629	6430573F11Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6530409C15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363523	6530409C15Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6530409C15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363170	6530409C15Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 6820408C15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451961	6820408C15Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 6820408C15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452767	6820408C15Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 8030411F24 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840668	8030411F24Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 8030411F24 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840674	8030411F24Rik<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 9130011E15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455980	9130011E15Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 9130011E15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456075	9130011E15Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA 9130409I23 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944322	9130409I23Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9130409I23 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462628	9130409I23Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9230110F15 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458619	9230110F15Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9230110F15 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458579	9230110F15Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9230112D13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364220	9230112D13Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9230112D13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362342	9230112D13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9330182L06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841114	9330182L06Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9630041A04 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820146	9630041A04Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9630041A04 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299635	9630041A04Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9930012K11 gene; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5613660	9930012K11Rik<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
RIKEN cDNA 9930022D16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364392	9930022D16Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA 9930022D16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364714	9930022D16Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A230083G16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842825	A230083G16Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA A330008L17 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362128	A330008L17Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A330008L17 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364615	A330008L17Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A330070K13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426604	A330070K13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A430005L14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419175	A430005L14Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A430005L14 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419564	A430005L14Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A430005L14 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473118	A430005L14Rik<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA A430078G23 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426632	A430078G23Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A430078G23 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426578	A430078G23Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A430089I19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951133	A430089I19Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA A430089I19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462678	A430089I19Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA A430105I19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472880	A430105I19Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA A530099J19 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426657	A530099J19Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A630010A05 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841464	A630010A05Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A630012P03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289812	A630012P03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A630095E13 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419829	A630095E13Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A630095E13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419993	A630095E13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A630095E13 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452630	A630095E13Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A630095E13 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452697	A630095E13Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A730017C20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000328	A730017C20Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A730017C20 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637144	A730017C20Rik<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
RIKEN cDNA A730017C20 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637144	A730017C20Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA A730017C20 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006750	A730017C20Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A730017C20 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319882	A730017C20Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A730017C20 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319857	A730017C20Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A730020M07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880943	A730020M07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A730020M07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880898	A730020M07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A730049H05 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362738	A730049H05Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A830005F24 gene; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5569077	A830005F24Rik<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
RIKEN cDNA A830019P07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820036	A830019P07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A830019P07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5447688	A830019P07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A830019P07 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299595	A830019P07Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A830019P07 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5447689	A830019P07Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A830031A19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841190	A830031A19Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A930004D18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441782	A930004D18Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA A930004D18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441718	A930004D18Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA A930017K11 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419706	A930017K11Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA A930017K11 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419447	A930017K11Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B020004J07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451303	B020004J07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B020004J07 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548898	B020004J07Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA B020004J07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451592	B020004J07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B130024G19 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944378	B130024G19Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B230118H07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362302	B230118H07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B230118H07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362302	B230118H07Rik<tm1a(KOMP)Wtsi>	26703212	KOMP-CSD
RIKEN cDNA B230118H07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362563	B230118H07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B230118H07 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363162	B230118H07Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B230219D22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842644	B230219D22Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA B230219D22 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842575	B230219D22Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA B430306N03 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363728	B430306N03Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA B430306N03 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364888	B430306N03Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C030017K20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419910	C030017K20Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C030017K20 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419492	C030017K20Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C030048H21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419912	C030048H21Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C030048H21 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419312	C030048H21Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C130050O18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419465	C130050O18Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C130050O18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419225	C130050O18Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C130073F10 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362343	C130073F10Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C130073F10 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362837	C130073F10Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C130073F10 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451468	C130073F10Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C130073F10 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451456	C130073F10Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C330007P06 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451416	C330007P06Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C330007P06 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451575	C330007P06Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA C330018D20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433677	C330018D20Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA C330018D20 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433664	C330018D20Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA D130040H23 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286183	D130040H23Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362922	D130043K22Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362922	D130043K22Rik<tm1a(KOMP)Wtsi>	27510895	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362922	D130043K22Rik<tm1a(KOMP)Wtsi>	28334068	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362922	D130043K22Rik<tm1a(KOMP)Wtsi>	29045729	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5696928	D130043K22Rik<tm1b(KOMP)Wtsi>	27510895	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5696928	D130043K22Rik<tm1b(KOMP)Wtsi>	29045729	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111776	D130043K22Rik<tm1c(KOMP)Wtsi>	27510895	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111776	D130043K22Rik<tm1c(KOMP)Wtsi>	28334068	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111776	D130043K22Rik<tm1c(KOMP)Wtsi>	29045729	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6111777	D130043K22Rik<tm1d(KOMP)Wtsi>	27510895	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6111777	D130043K22Rik<tm1d(KOMP)Wtsi>	29045729	KOMP-CSD
RIKEN cDNA D130043K22 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299500	D130043K22Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D230025D16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431938	D230025D16Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA D230025D16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433773	D230025D16Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA D330045A20 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364228	D330045A20Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D330045A20 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364986	D330045A20Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D330045A20 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452641	D330045A20Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D330045A20 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452668	D330045A20Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D630003M21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364911	D630003M21Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D630003M21 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362515	D630003M21Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D630003M21 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452675	D630003M21Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D630023F18 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949325	D630023F18Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D630023F18 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637108	D630023F18Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA D630023F18 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5002930	D630023F18Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D630045J12 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880912	D630045J12Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA D630045J12 gene; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513761	D630045J12Rik<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RIKEN cDNA D830044D21 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432490	D830044D21Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA D930028M14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432198	D930028M14Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA D930028M14 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432198	D930028M14Rik<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
RIKEN cDNA D930028M14 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432678	D930028M14Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA E030025P04 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419520	E030025P04Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E130309D02 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363676	E130309D02Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E130311K13 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364045	E130311K13Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E130311K13 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841382	E130311K13Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E130311K13 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841312	E130311K13Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Riken cDNA E230025N22 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365000	E230025N22Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Riken cDNA E230025N22 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364326	E230025N22Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330009J07 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364733	E330009J07Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330009J07 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365072	E330009J07Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330009J07 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5009574	E330009J07Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330009J07 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294961	E330009J07Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330017A01 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363282	E330017A01Rik<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330017A01 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362767	E330017A01Rik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330017A01 gene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299582	E330017A01Rik<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA E330017A01 gene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299517	E330017A01Rik<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIKEN cDNA F830045P16 gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299888	F830045P16Rik<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA F830045P16 gene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299882	F830045P16Rik<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIKEN cDNA K230010J24 gene; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419129	K230010J24Rik<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RING1 and YY1 binding protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5319806	Rybp<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring-box 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052423	Rbx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger and CCCH-type zinc finger domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364357	Rc3h2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger and CCCH-type zinc finger domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364357	Rc3h2<tm1a(KOMP)Wtsi>	23583643	KOMP-CSD
ring finger and CCCH-type zinc finger domains 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5509140	Rc3h2<tm1c(KOMP)Wtsi>	23583643	KOMP-CSD
ring finger and CCCH-type zinc finger domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362783	Rc3h2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger and CHY zinc finger domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365056	Rchy1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger and CHY zinc finger domain containing 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5002982	Rchy1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger and SPRY domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419609	Rspry1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 103; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441818	Rnf103<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 103; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441997	Rnf103<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362564	Rnf10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548492	Rnf10<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ring finger protein 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548492	Rnf10<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
ring finger protein 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364108	Rnf10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 112; targeted mutation 1, Velocigene	MGI:3812654	Rnf112<tm1(KOMP)Vlcg>	26212327	KOMP-Regeneron
ring finger protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434446	Rnf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433137	Rnf11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 122; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363525	Rnf122<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 122; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363960	Rnf122<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 126; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431705	Rnf126<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 126; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434060	Rnf126<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 130; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432601	Rnf130<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 130; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434384	Rnf130<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 139; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419541	Rnf139<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 139; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419541	Rnf139<tm1(KOMP)Wtsi>	26319415	KOMP-CSD
ring finger protein 13; targeted mutation 1.1, Velocigene	MGI:5608781	Rnf13<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ring finger protein 144A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944321	Rnf144a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 144A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4940771	Rnf144a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 144B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5574609	Rnf144b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ring finger protein 145; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887607	Rnf145<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 145; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949336	Rnf145<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820347	Rnf14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820266	Rnf14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 151; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419279	Rnf151<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 157; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432623	Rnf157<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 157; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637139	Rnf157<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ring finger protein 157; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431758	Rnf157<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455964	Rnf17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456003	Rnf17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 180; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419964	Rnf180<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 181; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5428528	Rnf181<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 182; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003003	Rnf182<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 183; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419200	Rnf183<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 183; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548662	Rnf183<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ring finger protein 183; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419351	Rnf183<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 185; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432081	Rnf185<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 185; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433783	Rnf185<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 185; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433034	Rnf185<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 185; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433905	Rnf185<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 207; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363766	Rnf207<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 207; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362524	Rnf207<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 20; targeted mutation 1.1, Velocigene	MGI:5605801	Rnf20<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ring finger protein 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868089	Rnf20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868093	Rnf20<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 216; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006752	Rnf216<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 216; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605760	Rnf216<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ring finger protein 217; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4847705	Rnf217<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 219; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442057	Rnf219<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 220; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362450	Rnf220<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 220; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362689	Rnf220<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 222; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419712	Rnf222<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 222; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419485	Rnf222<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 222; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472949	Rnf222<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 222; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472802	Rnf222<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433237	Rnf24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433671	Rnf24<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 25; targeted mutation 1.1, Velocigene	MGI:5569948	Rnf25<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ring finger protein 25; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419790	Rnf25<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363859	Rnf31<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362664	Rnf31<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 31; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364871	Rnf31<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 31; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364871	Rnf31<tm2a(KOMP)Wtsi>	25284787	KOMP-CSD
ring finger protein 31; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5825498	Rnf31<tm2c(KOMP)Wtsi>	25284787	KOMP-CSD
ring finger protein 31; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5825498	Rnf31<tm2c(KOMP)Wtsi>	27810922	KOMP-CSD
ring finger protein 31; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5825498	Rnf31<tm2c(KOMP)Wtsi>	28120397	KOMP-CSD
ring finger protein 31; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363183	Rnf31<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940783	Rnf32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941498	Rnf32<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362477	Rnf38<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 38; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569953	Rnf38<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ring finger protein 38; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362189	Rnf38<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 44; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419985	Rnf44<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419190	Rnf5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432053	Rnf7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432053	Rnf7<tm1a(EUCOMM)Wtsi>	24210661	EUCOMM
ring finger protein 7; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5545787	Rnf7<tm1c(EUCOMM)Wtsi>	24210661	EUCOMM
ring finger protein 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432842	Rnf7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ring finger protein (C3H2C3 type) 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365158	Rnf6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein (C3H2C3 type) 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364210	Rnf6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein (C3H2C3 type) 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286244	Rnf6<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein, LIM domain interacting; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319825	Rlim<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein, LIM domain interacting; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451602	Rlim<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein, LIM domain interacting; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4947738	Rlim<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ring finger protein, LIM domain interacting; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319803	Rlim<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RIO kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299609	Riok2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIO kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299531	Riok2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIO kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842404	Riok3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RIO kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842276	Riok3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RIPOR family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364923	Ripor3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RIPOR family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296552	Ripor3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RIPOR family member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296561	Ripor3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RIPOR family member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5296558	Ripor3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ripply transcriptional repressor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451307	Ripply1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ripply transcriptional repressor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451688	Ripply1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ripply transcriptional repressor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433779	Ripply3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ripply transcriptional repressor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431660	Ripply3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA 2',3'-cyclic phosphate and 5'-OH ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362526	Rtcb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA 2',3'-cyclic phosphate and 5'-OH ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362526	Rtcb<tm1a(KOMP)Wtsi>	25378478	KOMP-CSD
RNA 2',3'-cyclic phosphate and 5'-OH ligase; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5688394	Rtcb<tm1c(KOMP)Wtsi>	25378478	KOMP-CSD
RNA 2',3'-cyclic phosphate and 5'-OH ligase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363964	Rtcb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA 2',3'-cyclic phosphate and 5'-OH ligase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364467	Rtcb<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA 2',3'-cyclic phosphate and 5'-OH ligase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5006747	Rtcb<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA 3'-terminal phosphate cyclase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4841792	Rtca<tm1a(EUCOMM)Hmgu>	25961792	EUCOMM
RNA binding motif protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364331	Rbm10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301381	Rbm11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362139	Rbm14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363453	Rbm14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 17; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434757	Rbm17<tm1a(EUCOMM)Hmgu>	28007900	EUCOMM
RNA binding motif protein 17; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5903132	Rbm17<tm1c(EUCOMM)Hmgu>	28007900	EUCOMM
RNA binding motif protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842703	Rbm18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842857	Rbm18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454092	Rbm27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454085	Rbm27<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887695	Rbm33<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 38; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4455352	Rbm38<tm1a(KOMP)Mbp>	28850611	KOMP-CSD
RNA binding motif protein 38; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:6115586	Rbm38<tm1c(KOMP)Mbp>	28850611	KOMP-CSD
RNA binding motif protein 38; targeted mutation 1d, Mouse Biology Program, UCDavis	MGI:6115587	Rbm38<tm1d(KOMP)Mbp>	28850611	KOMP-CSD
RNA binding motif protein 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362480	Rbm43<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 43; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365161	Rbm43<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363002	Rbm44<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363242	Rbm44<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008038	Rbm45<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432904	Rbm47<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 47; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433058	Rbm47<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 47; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472954	Rbm47<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 47; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472805	Rbm47<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif protein 8a; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419320	Rbm8a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein, X chromosome; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364273	Rbmx<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein, X chromosome; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363716	Rbmx<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein, X chromosome; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363716	Rbmx<tm2a(KOMP)Wtsi>	27626380	KOMP-CSD
RNA binding motif protein, X chromosome; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5558151	Rbmx<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
RNA binding motif protein, X chromosome; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5428577	Rbmx<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein, X chromosome; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5284905	Rbmx<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif protein, X chromosome; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5428489	Rbmx<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif (RNP1, RRM) protein 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419547	Rbm3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif, single stranded interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433622	Rbms1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif, single stranded interacting protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636998	Rbms1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RNA binding motif, single stranded interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432079	Rbms1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA binding motif, single stranded interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364443	Rbms3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding motif, single stranded interacting protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455534	Rbms3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding protein, fox-1 homolog (C. elegans) 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428536	Rbfox1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding protein, fox-1 homolog (C. elegans) 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428482	Rbfox1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding protein, fox-1 homolog (C. elegans) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362686	Rbfox2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding protein, fox-1 homolog (C. elegans) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364535	Rbfox2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding protein, fox-1 homolog (C. elegans) 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299575	Rbfox2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA binding protein, fox-1 homolog (C. elegans) 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434907	Rbfox3<tm1a(EUCOMM)Hmgu>	26619789	EUCOMM
RNA binding protein, fox-1 homolog (C. elegans) 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434907	Rbfox3<tm1a(EUCOMM)Hmgu>	27701470	EUCOMM
RNA-binding region (RNP1, RRM) containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433222	Rnpc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA-binding region (RNP1, RRM) containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434201	Rnpc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA exonuclease 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433994	Rexo2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA exonuclease 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636999	Rexo2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RNA exonuclease 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432558	Rexo2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RNA guanylyltransferase and 5'-phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454082	Rngtt<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA guanylyltransferase and 5'-phosphatase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454178	Rngtt<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA polymerase II associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362158	Rpap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA polymerase II associated protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362626	Rpap2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA polymerase II associated protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364396	Rpap2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA polymerase II associated protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364642	Rpap3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA pseudouridylate synthase domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455537	Rpusd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA pseudouridylate synthase domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455466	Rpusd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RNA pseudouridylate synthase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451634	Rpusd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RNA pseudouridylate synthase domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433640	Rpusd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RNA pseudouridylate synthase domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431910	Rpusd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ropporin 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842420	Ropn1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ropporin 1-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548780	Ropn1l<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ropporin 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842698	Ropn1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Ros1 proto-oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456658	Ros1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Ros1 proto-oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457516	Ros1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
rosbin, round spermatid basic protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433850	Rsbn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
rosbin, round spermatid basic protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548833	Rsbn1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
rosbin, round spermatid basic protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434325	Rsbn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
rosbin, round spermatid basic protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434479	Rsbn1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
rosbin, round spermatid basic protein 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5472900	Rsbn1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
rotatin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363026	Rttn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
rotatin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365279	Rttn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
roundabout guidance receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428537	Robo1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
roundabout guidance receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428483	Robo1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Rous sarcoma oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433474	Src<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rous sarcoma oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431573	Src<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Rous sarcoma oncogene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431843	Src<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Rous sarcoma oncogene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431843	Src<tm2a(EUCOMM)Wtsi>	26398943	EUCOMM
Rous sarcoma oncogene; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432534	Src<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
Rpgrip1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432510	Rpgrip1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Rpgrip1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432510	Rpgrip1l<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
Rpgrip1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432510	Rpgrip1l<tm1a(EUCOMM)Wtsi>	24807221	EUCOMM
Rpgrip1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432510	Rpgrip1l<tm1a(EUCOMM)Wtsi>	27064284	EUCOMM
Rpgrip1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432341	Rpgrip1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RRP9, small subunit (SSU) processome component, homolog (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434107	Rrp9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
R-spondin 1; targeted mutation 1.1, Velocigene	MGI:5583071	Rspo1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
R-spondin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5141830	Rspo1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
R-spondin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364711	Rspo4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
R-spondin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365053	Rspo4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
R-spondin 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299678	Rspo4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
R-spondin 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299673	Rspo4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
RTF1, Paf1/RNA polymerase II complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363925	Rtf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RTF1, Paf1/RNA polymerase II complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363622	Rtf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RUN and cysteine rich domain containing beclin 1 interacting protein like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941508	Rubcnl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RUN and FYVE domain-containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434385	Rufy2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RUN and FYVE domain-containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432113	Rufy2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RUN and FYVE domain containing 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5581413	Rufy3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302345	Rubcn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842752	Rubcn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RUN domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441618	Rundc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RUN domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441618	Rundc1<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
RUN domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548750	Rundc1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
RUN domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548750	Rundc1<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
RUN domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442044	Rundc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RUN domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456830	Rundc1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
RUN domain containing 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008049	Rundc3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RUN domain containing 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364409	Rundc3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RUN domain containing 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365167	Rundc3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
runt related transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364090	Runx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
runt related transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362860	Runx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
runt related transcription factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319812	Runx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
runt related transcription factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319793	Runx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
runt related transcription factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840992	Runx3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
runt related transcription factor 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635287	Runx3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
runt related transcription factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841429	Runx3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RuvB-like protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432034	Ruvbl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RuvB-like protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432034	Ruvbl1<tm1a(EUCOMM)Wtsi>	25428364	EUCOMM
RuvB-like protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432034	Ruvbl1<tm1a(EUCOMM)Wtsi>	29113992	EUCOMM
RWD domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362724	Rwdd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RWD domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637013	Rwdd1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RWD domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363585	Rwdd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
RWD domain containing 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433511	Rwdd2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
RWD domain containing 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433979	Rwdd2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
RWD domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419570	Rwdd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
RWD domain containing 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548630	Rwdd3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
RWD domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419247	Rwdd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ryanodine receptor 2, cardiac; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458493	Ryr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ryanodine receptor 2, cardiac; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637225	Ryr2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ryanodine receptor 2, cardiac; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458592	Ryr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
S100 calcium binding protein A11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296219	S100a11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
S100 calcium binding protein A14; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513816	S100a14<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
S100 calcium binding protein A16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940767	S100a16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
S100 calcium binding protein A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842413	S100a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
S100 calcium binding protein A6 (calcyclin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451462	S100a6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
S100 calcium binding protein A6 (calcyclin); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692619	S100a6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
S100 calcium binding protein A6 (calcyclin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451528	S100a6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
S100 calcium binding protein A9 (calgranulin B); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949360	S100a9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
S100 calcium binding protein A9 (calgranulin B); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949384	S100a9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
S100 calcium binding protein A9 (calgranulin B); targeted mutation 1, Velocigene	MGI:4415430	S100a9<tm1(KOMP)Vlcg>	28137827	KOMP-Regeneron
S100 calcium binding protein A9 (calgranulin B); targeted mutation 1, Velocigene	MGI:4415430	S100a9<tm1(KOMP)Vlcg>	29204146	KOMP-Regeneron
S100 protein, beta polypeptide, neural; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432844	S100b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
S100 protein, beta polypeptide, neural; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432844	S100b<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
S1 RNA binding domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454100	Srbd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
S1 RNA binding domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454061	Srbd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SAC1 suppressor of actin mutations 1-like (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000315	Sacm1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SAC1 suppressor of actin mutations 1-like (yeast); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605807	Sacm1l<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
SAC3 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307095	Sac3d1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SAC3 domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5307096	Sac3d1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
Sad1 and UNC84 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433047	Sun1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Sad1 and UNC84 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432415	Sun1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Sad1 and UNC84 domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473051	Sun1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
S-adenosylhomocysteine hydrolase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431930	Ahcyl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
S-adenosylhomocysteine hydrolase-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4434352	Ahcyl1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
S-adenosylhomocysteine hydrolase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605830	Ahcy<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
salt inducible kinase 1; targeted mutation 1.1, Velocigene	MGI:5548353	Sik1<tm1.1(KOMP)Vlcg>	25918234	KOMP-Regeneron
salt inducible kinase 1; targeted mutation 1.1, Velocigene	MGI:5548353	Sik1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
salt inducible kinase 1; targeted mutation 1, Velocigene	MGI:4454182	Sik1<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
salt inducible kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433243	Sik2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
salt inducible kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434176	Sik2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
salt inducible kinase 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472819	Sik2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
salvador family WW domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451736	Sav1<tm1a(EUCOMM)Hmgu>	26913567	EUCOMM
salvador family WW domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434120	Sav1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
salvador family WW domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434411	Sav1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SAM and SH3 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451401	Sash1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SAM and SH3 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451672	Sash1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SAM domain and HD domain, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431751	Samhd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SAM domain and HD domain, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431751	Samhd1<tm1a(EUCOMM)Wtsi>	23972988	EUCOMM
SAM domain and HD domain, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5551757	Samhd1<tm1c(EUCOMM)Wtsi>	23972988	EUCOMM
SAM domain and HD domain, 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5551758	Samhd1<tm1d(EUCOMM)Wtsi>	23972988	EUCOMM
SAM domain and HD domain, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433662	Samhd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SAM pointed domain containing ets transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363247	Spdef<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SAM pointed domain containing ets transcription factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362295	Spdef<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
S-antigen, retina and pineal gland (arrestin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433619	Sag<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
S-antigen, retina and pineal gland (arrestin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431581	Sag<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SAP30 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947802	Sap30bp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sarcoglycan, delta (dystrophin-associated glycoprotein); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944517	Sgcd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sarcoglycan, delta (dystrophin-associated glycoprotein); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842429	Sgcd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sarcolipin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433928	Sln<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sarcolipin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434393	Sln<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sarcosine dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364771	Sardh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sarcosine dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363054	Sardh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SAYSVFN motif domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432676	Saysd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SAYSVFN motif domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431550	Saysd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SAYSVFN motif domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473030	Saysd1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
SAYSVFN motif domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472851	Saysd1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
SBDS ribosome maturation factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433022	Sbds<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SBDS ribosome maturation factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433581	Sbds<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
scavenger receptor class A, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296221	Scara3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
scavenger receptor class B, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453752	Scarb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
scavenger receptor class B, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548930	Scarb1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
scavenger receptor class B, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453721	Scarb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
scavenger receptor class B, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453749	Scarb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
scavenger receptor class F, member 2; targeted mutation 1.1, Velocigene	MGI:5548490	Scarf2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
scavenger receptor cysteine rich family, 4 domains; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431842	Ssc4d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
scavenger receptor cysteine rich family, 4 domains; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432765	Ssc4d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
schlafen 1; targeted mutation 1.1, Velocigene	MGI:5766261	Slfn1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
schlafen 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008779	Slfn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
schlafen 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008780	Slfn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
schlafen 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944570	Slfn4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
schlafen 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636952	Slfn4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
schlafen 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944555	Slfn4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
schlafen 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286383	Slfn9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
schlafen 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299876	Slfn9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
schlafen like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453731	Slfnl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
schlafen like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453796	Slfnl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
scinderin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299592	Scin<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
scinderin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841377	Scin<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sclerostin domain containing 1; targeted mutation 1.1, Velocigene	MGI:5695910	Sostdc1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
sclerostin domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432738	Sostdc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sclerostin domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432644	Sostdc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sclerostin domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473001	Sostdc1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sclerostin domain containing 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472836	Sostdc1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sclerostin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842396	Sost<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sclerostin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319925	Sost<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	20952383	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	22434688	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	22886088	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	23530237	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	23918385	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	24211207	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	24780398	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	25757567	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	27759007	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	29229807	KOMP-Regeneron
sclerostin; targeted mutation 1, Velocigene	MGI:3797839	Sost<tm1(KOMP)Vlcg>	29349060	KOMP-Regeneron
sclerostin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319932	Sost<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sclerostin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319926	Sost<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
Scl/Tal1 interrupting locus; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432291	Stil<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Scl/Tal1 interrupting locus; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432460	Stil<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Scm-like with four mbt domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451233	Sfmbt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Scm-like with four mbt domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432530	Sfmbt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Scm-like with four mbt domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433988	Sfmbt2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Scm polycomb group protein like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842393	Scml2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Scm polycomb group protein like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842741	Scml2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SCO1 cytochrome c oxidase assembly protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363778	Sco1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SCO1 cytochrome c oxidase assembly protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363778	Sco1<tm1a(KOMP)Wtsi>	25683716	KOMP-CSD
SCO1 cytochrome c oxidase assembly protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5758867	Sco1<tm1c(KOMP)Wtsi>	25683716	KOMP-CSD
SCO1 cytochrome c oxidase assembly protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5758867	Sco1<tm1c(KOMP)Wtsi>	28973536	KOMP-CSD
scrapie responsive gene 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5428529	Scrg1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
scratch family zinc finger 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428478	Scrt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
scratch family zinc finger 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319892	Scrt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
scribbled planar cell polarity; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766176	Scrib<tm1b(NCOM)Mfgc>	27626380	NorCOMM
SCY1-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451611	Scyl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SCY1-like 1 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451385	Scyl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SCY1-like 2 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286174	Scyl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SCY1-like 2 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428473	Scyl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SEC11 homolog A, signal peptidase complex subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419621	Sec11a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SEC11 homolog C, signal peptidase complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456039	Sec11c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SEC11 homolog C, signal peptidase complex subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456009	Sec11c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SEC14-like lipid binding 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441674	Sec14l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SEC14-like lipid binding 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441897	Sec14l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SEC14-like lipid binding 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362178	Sec14l3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SEC14-like lipid binding 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362324	Sec14l3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SEC14-like lipid binding 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433028	Sec14l4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SEC14-like lipid binding 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433675	Sec14l4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SEC16 homolog A, endoplasmic reticulum export factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362312	Sec16a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SEC16 homolog A, endoplasmic reticulum export factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363260	Sec16a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SEC16 homolog B (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365061	Sec16b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SEC16 homolog B (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363138	Sec16b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SEC22 homolog B, vesicle trafficking protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433526	Sec22b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SEC22 homolog B, vesicle trafficking protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115369	Sec22b<tm1c(EUCOMM)Wtsi>	28658614	EUCOMM
SEC23 homolog A, COPII coat complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362215	Sec23a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SEC23 homolog A, COPII coat complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362215	Sec23a<tm1a(KOMP)Wtsi>	27297878	KOMP-CSD
SEC23 homolog A, COPII coat complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428574	Sec23a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SEC23 homolog B, COPII coat complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432981	Sec23b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432981	Sec23b<tm1a(EUCOMM)Wtsi>	22745161	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432981	Sec23b<tm1a(EUCOMM)Wtsi>	25071156	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432981	Sec23b<tm1a(EUCOMM)Wtsi>	27297878	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5433325	Sec23b<tm1b(EUCOMM)Wtsi>	22745161	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5583844	Sec23b<tm1c(EUCOMM)Wtsi>	25071156	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5583844	Sec23b<tm1c(EUCOMM)Wtsi>	27297878	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5583845	Sec23b<tm1d(EUCOMM)Wtsi>	25071156	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5583845	Sec23b<tm1d(EUCOMM)Wtsi>	27297878	EUCOMM
SEC23 homolog B, COPII coat complex component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433649	Sec23b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Sec24 related gene family, member A (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362779	Sec24a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Sec24 related gene family, member A (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362779	Sec24a<tm1a(KOMP)Wtsi>	23580231	KOMP-CSD
Sec24 related gene family, member A (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362779	Sec24a<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
Sec24 related gene family, member A (S. cerevisiae); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:6093442	Sec24a<tm1b(KOMP)Wtsi>	23580231	KOMP-CSD
Sec24 related gene family, member A (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6093443	Sec24a<tm1c(KOMP)Wtsi>	23580231	KOMP-CSD
Sec24 related gene family, member A (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364237	Sec24a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Sec24 related gene family, member B (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364342	Sec24b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Sec24 related gene family, member C (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431706	Sec24c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Sec24 related gene family, member C (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431706	Sec24c<tm1a(EUCOMM)Wtsi>	24876386	EUCOMM
Sec24 related gene family, member C (S. cerevisiae); targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5501469	Sec24c<tm1c(EUCOMM)Wtsi>	24876386	EUCOMM
Sec24 related gene family, member C (S. cerevisiae); targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5501471	Sec24c<tm1d(EUCOMM)Wtsi>	24876386	EUCOMM
Sec24 related gene family, member C (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434501	Sec24c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Sec31 homolog B (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364185	Sec31b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Sec61 alpha 1 subunit (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441978	Sec61a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Sec61 alpha 1 subunit (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441823	Sec61a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Sec61, alpha subunit 2 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456071	Sec61a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Sec61, alpha subunit 2 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456001	Sec61a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SEC61, gamma subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940745	Sec61g<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SEC61, gamma subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941507	Sec61g<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
secernin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003008	Scrn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secernin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5003015	Scrn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secernin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452778	Scrn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SECIS binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433050	Secisbp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SECIS binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433050	Secisbp2<tm1a(EUCOMM)Wtsi>	24274065	EUCOMM
SECIS binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433050	Secisbp2<tm1a(EUCOMM)Wtsi>	24844465	EUCOMM
SECIS binding protein 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5583885	Secisbp2<tm1c(EUCOMM)Wtsi>	24274065	EUCOMM
SECIS binding protein 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5583885	Secisbp2<tm1c(EUCOMM)Wtsi>	24844465	EUCOMM
SECIS binding protein 2; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5583886	Secisbp2<tm1d(EUCOMM)Wtsi>	24274065	EUCOMM
secretagogin, EF-hand calcium binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287795	Scgn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
secreted acidic cysteine rich glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432869	Sparc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secreted acidic cysteine rich glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432869	Sparc<tm1a(EUCOMM)Wtsi>	22876197	EUCOMM
secreted acidic cysteine rich glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432869	Sparc<tm1a(EUCOMM)Wtsi>	23300663	EUCOMM
secreted acidic cysteine rich glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432869	Sparc<tm1a(EUCOMM)Wtsi>	24833352	EUCOMM
secreted acidic cysteine rich glycoprotein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432869	Sparc<tm1a(EUCOMM)Wtsi>	25340873	EUCOMM
secreted acidic cysteine rich glycoprotein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456815	Sparc<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
secreted and transmembrane 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296227	Sectm1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secreted and transmembrane 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296217	Sectm1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secreted frizzled-related protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511992	Sfrp2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
secreted frizzled-related sequence protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433824	Sfrp5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secreted frizzled-related sequence protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434313	Sfrp5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secreted Ly6/Plaur domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431407	Slurp2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
secreted phosphoprotein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456012	Spp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secreted phosphoprotein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456042	Spp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secretin; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050926	Sct<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
secretion associated Ras related GTPase 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451271	Sar1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
secretion associated Ras related GTPase 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451545	Sar1a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
secretion associated Ras related GTPase 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432515	Sar1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secretion associated Ras related GTPase 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432213	Sar1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secretoglobin, family 1A, member 1 (uteroglobin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363637	Scgb1a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
secretoglobin, family 1A, member 1 (uteroglobin); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050873	Scgb1a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
secretoglobin, family 1A, member 1 (uteroglobin); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299504	Scgb1a1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
secretoglobin, family 1B, member 27; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362466	Scgb1b27<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
secretoglobin, family 1C, member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419893	Scgb1c1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
secretoglobin, family 3A, member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419298	Scgb3a1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
secretory blood group 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842255	Sec1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secretory blood group 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842645	Sec1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secretory carrier membrane protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433352	Scamp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secretory carrier membrane protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433637	Scamp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secretory carrier membrane protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842693	Scamp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
secretory carrier membrane protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842691	Scamp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
secretory leukocyte peptidase inhibitor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363215	Slpi<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
secretory leukocyte peptidase inhibitor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362258	Slpi<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sedoheptulokinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455978	Shpk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sedoheptulokinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456077	Shpk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SEH1-like (S. cerevisiae; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453708	Seh1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SEH1-like (S. cerevisiae; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453708	Seh1l<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
SEH1-like (S. cerevisiae; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453747	Seh1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
seizure related 6 homolog like 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692809	Sez6l2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
seizure related 6 homolog like; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637106	Sez6l<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
seizure threshold 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841079	Szt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
seizure threshold 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841118	Szt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sel-1 suppressor of lin-12-like (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364141	Sel1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sel-1 suppressor of lin-12-like (C. elegans); targeted mutation 1c, Welcome Trust Sanger Institute	MGI:5576558	Sel1l<tm1c(KOMP)Wtsi>	24453213	KOMP-CSD
sel-1 suppressor of lin-12-like (C. elegans); targeted mutation 1c, Welcome Trust Sanger Institute	MGI:5576558	Sel1l<tm1c(KOMP)Wtsi>	25066055	KOMP-CSD
sel-1 suppressor of lin-12-like (C. elegans); targeted mutation 1c, Welcome Trust Sanger Institute	MGI:5576558	Sel1l<tm1c(KOMP)Wtsi>	26551274	KOMP-CSD
sel-1 suppressor of lin-12-like (C. elegans); targeted mutation 1c, Welcome Trust Sanger Institute	MGI:5576558	Sel1l<tm1c(KOMP)Wtsi>	27568564	KOMP-CSD
sel-1 suppressor of lin-12-like (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364219	Sel1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
selectin, endothelial cell; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432448	Sele<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
selectin, endothelial cell; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431939	Sele<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
selectin, endothelial cell; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511950	Sele<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
selectin, platelet; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527618	Selp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
selection and upkeep of intraepithelial T cells 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454069	Skint10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selection and upkeep of intraepithelial T cells 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462631	Skint3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selection and upkeep of intraepithelial T cells 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428520	Skint3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
selection and upkeep of intraepithelial T cells 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009580	Skint4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selection and upkeep of intraepithelial T cells 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419917	Skint5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selenium binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364881	Selenbp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selenium binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548951	Selenbp1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
selenium binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548951	Selenbp1<tm1b(KOMP)Wtsi>	29255262	KOMP-CSD
selenium binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365113	Selenbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selenium binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364775	Selenbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
selenocysteine lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362224	Scly<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selenocysteine lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362224	Scly<tm1a(KOMP)Wtsi>	22487427	KOMP-CSD
selenocysteine lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362224	Scly<tm1a(KOMP)Wtsi>	22890841	KOMP-CSD
selenocysteine lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362224	Scly<tm1a(KOMP)Wtsi>	24519931	KOMP-CSD
selenocysteine lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362224	Scly<tm1a(KOMP)Wtsi>	26192035	KOMP-CSD
selenocysteine lyase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362224	Scly<tm1a(KOMP)Wtsi>	26586820	KOMP-CSD
selenocysteine lyase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362204	Scly<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
selenocysteine lyase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363649	Scly<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
selenoprotein F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451344	Selenof<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selenoprotein H; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419151	Selenoh<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
selenoprotein K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431818	Selenok<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
selenoprotein K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431818	Selenok<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
selenoprotein K; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548722	Selenok<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
selenoprotein K; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433451	Selenok<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
selenoprotein M; targeted mutation 1, Velocigene	MGI:3812975	Selenom<tm1(KOMP)Vlcg>	23880772	KOMP-Regeneron
selenoprotein N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363081	Selenon<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
selenoprotein N; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364879	Selenon<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
selenoprotein P; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451960	Selenop<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
selenoprotein P; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452002	Selenop<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
selenoprotein S; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441824	Selenos<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
selenoprotein S; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442001	Selenos<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
selenoprotein W; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458843	Selenow<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
selenoprotein W; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458842	Selenow<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433844	Sema3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456030	Sema3a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456052	Sema3a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428549	Sema3c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428549	Sema3c<tm1a(KOMP)Wtsi>	26053665	KOMP-CSD
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D; targeted mutation 1a, Bin Zhou	MGI:5638222	Sema3d<tm1a(KOMP)Bz>	23797856	KOMP-CSD
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820051	Sema3d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434481	Sema3e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636922	Sema3f<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G; targeted mutation 1, Velocigene	MGI:3797882	Sema3g<tm1(KOMP)Vlcg>	26319580	KOMP-Regeneron
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432304	Sema4f<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434366	Sema4f<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456021	Sema4f<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455997	Sema4f<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432866	Sema4a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432866	Sema4a<tm1a(EUCOMM)Wtsi>	25892012	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5807134	Sema4a<tm1b(EUCOMM)Wtsi>	25892012	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5807134	Sema4a<tm1b(EUCOMM)Wtsi>	28007914	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433208	Sema4a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432357	Sema4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434041	Sema4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433556	Sema4b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432911	Sema4b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4434513	Sema4b<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433529	Sema4d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636915	Sema4d<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432798	Sema4d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302342	Sema4g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441943	Sema4g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302341	Sema4g<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4842884	Sema4g<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364545	Sema5a<tm1a(KOMP)Wtsi21677750	KOMP-CSD
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420145	Sema5a<tm1e(KOMP)Wtsi21677750	KOMP-CSD
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432860	Sema5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432732	Sema5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431948	Sema6c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842690	Sema6d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842849	Sema6d<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
seminal vesicle antigen-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364297	Sval1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319814	Sval1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947844	Sval2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
seminal vesicle antigen-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947804	Sval2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
seminal vesicle antigen-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431492	Sval3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319795	Sval3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen-like 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319906	Sval3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen-like 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5319920	Sval3<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen-like 3; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319919	Sval3<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319813	Sva<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319794	Sva<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle antigen; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319905	Sva<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
seminal vesicle secretory protein 2; targeted mutation 1.1, Velocigene	MGI:5548489	Svs2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
seminal vesicle secretory protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949347	Svs4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
senataxin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014716	Setx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
senataxin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5584409	Setx<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
sentan, cilia apical structure protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841437	Sntn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sentan, cilia apical structure protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841119	Sntn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sepiapterin reductase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503339	Spr<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
sepiapterin reductase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5503332	Spr<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434098	Sepsecs<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434514	Sepsecs<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
septin 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014599	Sept10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
septin 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050163	Sept10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
septin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433544	Sept1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
septin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432579	Sept1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
septin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433809	Sept2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
septin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363384	Sept3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
septin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363419	Sept3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
septin 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433986	Sept8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
septin 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433986	Sept8<tm1a(EUCOMM)Wtsi>	27504968	EUCOMM
septin 8; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5806071	Sept8<tm1c(EUCOMM)Wtsi>	27504968	EUCOMM
septin 8; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5806073	Sept8<tm1d(EUCOMM)Wtsi>	27504968	EUCOMM
septin 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433441	Sept8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
septin 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451282	Sept9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
septin 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451398	Sept9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sequestosome 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364926	Sqstm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sequestosome 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364926	Sqstm1<tm1a(KOMP)Wtsi>	29311767	KOMP-CSD
sequestosome 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364853	Sqstm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine active site containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363650	Serac1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine active site containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363918	Serac1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine active site containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363681	Serac1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/arginine repetitive matrix 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882011	Srrm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine repetitive matrix 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882020	Srrm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine repetitive matrix 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302319	Srrm3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine repetitive matrix 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451978	Srrm4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine repetitive matrix 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451978	Srrm4<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
serine/arginine repetitive matrix 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451978	Srrm4<tm1a(EUCOMM)Wtsi>	25838543	EUCOMM
serine/arginine repetitive matrix 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5752029	Srrm4<tm1b(EUCOMM)Wtsi>	25838543	EUCOMM
serine/arginine repetitive matrix 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5752029	Srrm4<tm1b(EUCOMM)Wtsi>	27984743	EUCOMM
serine/arginine repetitive matrix 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451952	Srrm4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich protein specific kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009561	Srpk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/arginine-rich splicing factor 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286248	Srsf10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/arginine-rich splicing factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433120	Srsf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431944	Srsf11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840643	Srsf12<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 12; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840642	Srsf12<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419571	Srsf1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
serine/arginine-rich splicing factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431961	Srsf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433498	Srsf4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419754	Srsf6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
serine/arginine-rich splicing factor 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433826	Srsf7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432286	Srsf7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/arginine-rich splicing factor 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419181	Srsf9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
serine carboxypeptidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419596	Scpep1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine dehydratase-like; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548781	Sdsl<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
serine dehydratase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456060	Sds<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine dehydratase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456048	Sds<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine hydrolase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362550	Serhl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine hydrolase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362587	Serhl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine hydroxymethyltransferase 1 (soluble); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454114	Shmt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine hydroxymethyltransferase 1 (soluble); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692916	Shmt1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
serine hydroxymethyltransferase 1 (soluble); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454177	Shmt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine incorporator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365127	Serinc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine incorporator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428559	Serinc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine incorporator 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363849	Serinc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine incorporator 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364218	Serinc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine incorporator 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887584	Serinc5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine incorporator 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887626	Serinc5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939688	Serpina10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364047	Serpina12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362923	Serpina12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 1F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299631	Serpina1f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 1F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949329	Serpina1f<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009640	Serpina3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade A, member 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841452	Serpina3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299549	Serpina3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363850	Serpina3c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 3C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363710	Serpina3c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 3N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299630	Serpina3n<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 3N; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299548	Serpina3n<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade A, member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511989	Serpina5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade B, member 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286214	Serpinb1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 1b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428503	Serpinb1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302353	Serpinb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade B, member 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5706979	Serpinb2<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade B, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302326	Serpinb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade B, member 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428556	Serpinb3c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 3C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428526	Serpinb3c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880936	Serpinb5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5575897	Serpinb5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881938	Serpinb5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 6b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363091	Serpinb6b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 6b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363125	Serpinb6b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 6c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849963	Serpinb6c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 6d; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840974	Serpinb6d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 6d; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841376	Serpinb6d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 6e; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841003	Serpinb6e<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 9b; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840686	Serpinb9b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade B, member 9b; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840632	Serpinb9b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade B, member 9c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849970	Serpinb9c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 9c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849976	Serpinb9c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B, member 9d; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428581	Serpinb9d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362484	Serpinb11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452628	Serpinb11<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362859	Serpinb12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287803	Serpinb13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428527	Serpinb13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820101	Serpinb3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820053	Serpinb3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841247	Serpinb3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363938	Serpinb3d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433624	Serpinc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432296	Serpinc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade F, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364222	Serpinf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade F, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299496	Serpinf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade F, member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419796	Serpinf1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade F, member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365020	Serpinf1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade F, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842764	Serpinf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade G, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432436	Serping1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade G, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434053	Serping1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade I, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433374	Serpini1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade I, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433475	Serpini1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine (or cysteine) peptidase inhibitor, clade I, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5308286	Serpini2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine (or cysteine) peptidase inhibitor, clade I, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428480	Serpini2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, long chain base subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363381	Sptlc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, long chain base subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363540	Sptlc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, long chain base subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843842	Sptlc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, small subunit A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419731	Sptssa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, small subunit A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471307	Sptssa<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, small subunit A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471307	Sptssa<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
serine palmitoyltransferase, small subunit A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5471307	Sptssa<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
serine palmitoyltransferase, small subunit A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420050	Sptssa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, small subunit B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820035	Sptssb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine palmitoyltransferase, small subunit B; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5502305	Sptssb<tm1b(KOMP)Mbp>	26438849	KOMP-CSD
serine palmitoyltransferase, small subunit B; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5502305	Sptssb<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
serine palmitoyltransferase, small subunit B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820084	Sptssb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841128	Spink10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841454	Spink10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841327	Spink12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841035	Spink14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841420	Spink14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458492	Spink1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458606	Spink1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 2; targeted mutation 1.1, Velocigene	MGI:5573273	Spink2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
serine peptidase inhibitor, Kazal type 2; targeted mutation 1.1, Velocigene	MGI:5573273	Spink2<tm1.1(KOMP)Vlcg>	28554943	KOMP-Regeneron
serine peptidase inhibitor, Kazal type 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428496	Spink6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841148	Spink8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kazal type 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841393	Spink8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine peptidase inhibitor, Kunitz type, 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460474	Spint3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kazal type-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461707	Spinkl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kazal type-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461719	Spinkl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kunitz type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432018	Spint1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kunitz type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432878	Spint1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kunitz type 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433155	Spint2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kunitz type 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432620	Spint2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kunitz type 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431582	Spint4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine protease inhibitor, Kunitz type 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433945	Spint4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432046	Stk10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433272	Stk10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 16; targeted mutation 1.1, Velocigene	MGI:5443938	Stk16<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
serine/threonine kinase 16; targeted mutation 1.1, Velocigene	MGI:5443938	Stk16<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
serine/threonine kinase 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428535	Stk16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428479	Stk16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 17b (apoptosis-inducing); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432749	Stk17b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 17b (apoptosis-inducing); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433554	Stk17b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine threonine kinase 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365025	Stk31<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine threonine kinase 31; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841276	Stk31<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
serine threonine kinase 31; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841276	Stk31<tm2a(KOMP)Wtsi>	23929668	KOMP-CSD
serine threonine kinase 31; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5605799	Stk31<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
serine threonine kinase 31; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841064	Stk31<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 32A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433325	Stk32a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 32A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433566	Stk32a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 32C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362693	Stk32c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 32C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5307108	Stk32c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433970	Stk33<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 38 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419791	Stk38l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 38 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419802	Stk38l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307100	Stk38<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 38; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635370	Stk38<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 39; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433935	Stk39<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363911	Stk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362997	Stk4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine kinase 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473037	Stk4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472856	Stk4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine kinase receptor associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140494	Strap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serine/threonine/tyrosine interacting-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363737	Styxl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine/tyrosine interacting-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362896	Styxl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine/tyrosine kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364259	Styk1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serine/threonine/tyrosine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428590	Styk1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serologically defined colon cancer antigen 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363563	Sdccag3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serologically defined colon cancer antigen 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362917	Sdccag3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serologically defined colon cancer antigen 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473014	Sdccag3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
serologically defined colon cancer antigen 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458862	Sdccag8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serologically defined colon cancer antigen 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458830	Sdccag8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
serologically defined colon cancer antigen 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458830	Sdccag8<tm1e(EUCOMM)Wtsi>	25088364	EUCOMM
SERTA domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820392	Sertad1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SERTA domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319930	Sertad1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
SERTA domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842784	Sertad3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SERTA domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362411	Sertad4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SERTA domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362149	Sertad4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serum amyloid A 3; targeted mutation 1.1, Velocigene	MGI:5569083	Saa3<tm1.1(KOMP)Vlcg>	26838764	KOMP-Regeneron
serum amyloid A 3; targeted mutation 1.1, Velocigene	MGI:5569083	Saa3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
serum amyloid A 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428540	Saa3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serum amyloid A 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428490	Saa3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
serum amyloid A 3; targeted mutation 1, Velocigene	MGI:4452947	Saa3<tm1(KOMP)Vlcg>	25251243	KOMP-Regeneron
serum amyloid A 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299886	Saa4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serum/glucocorticoid regulated kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299887	Sgk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
serum response factor binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364448	Srfbp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
serum response factor binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363999	Srfbp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sestrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306501	Sesn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sestrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306501	Sesn1<tm1a(EUCOMM)Wtsi>	28114291	EUCOMM
sestrin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635289	Sesn1<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
sestrin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451612	Sesn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sestrin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451612	Sesn2<tm1a(KOMP)Wtsi>	25259925	KOMP-CSD
sestrin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451270	Sesn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sestrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432370	Sesn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sestrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432370	Sesn3<tm1a(EUCOMM)Wtsi>	22958918	EUCOMM
sestrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432370	Sesn3<tm1a(EUCOMM)Wtsi>	24055102	EUCOMM
sestrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432370	Sesn3<tm1a(EUCOMM)Wtsi>	25259925	EUCOMM
sestrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432370	Sesn3<tm1a(EUCOMM)Wtsi>	25377878	EUCOMM
sestrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432370	Sesn3<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
SET and MYND domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362468	Smyd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362468	Smyd2<tm1a(KOMP)Wtsi>	26988419	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362468	Smyd2<tm1a(KOMP)Wtsi>	27655694	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362468	Smyd2<tm1a(KOMP)Wtsi>	28604386	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5883839	Smyd2<tm1b(KOMP)Wtsi>	26988419	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5883837	Smyd2<tm1c(KOMP)Wtsi>	27655694	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5883838	Smyd2<tm1d(KOMP)Wtsi>	27655694	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362695	Smyd2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5432206	Smyd2<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362710	Smyd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362710	Smyd3<tm1a(KOMP)Wtsi>	24847881	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362710	Smyd3<tm1a(KOMP)Wtsi>	25669152	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362710	Smyd3<tm1a(KOMP)Wtsi>	27655694	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5883840	Smyd3<tm1b(KOMP)Wtsi>	24847881	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5883835	Smyd3<tm1c(KOMP)Wtsi>	25669152	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5883835	Smyd3<tm1c(KOMP)Wtsi>	27655694	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5883836	Smyd3<tm1d(KOMP)Wtsi>	27655694	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363760	Smyd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363150	Smyd3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363150	Smyd3<tm2a(KOMP)Wtsi>	24652767	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363517	Smyd3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 3; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4364633	Smyd3<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
SET and MYND domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432884	Smyd4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET and MYND domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432884	Smyd4<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
SET and MYND domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433667	Smyd4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SET and MYND domain containing 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456746	Smyd4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
SET and MYND domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431696	Smyd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET and MYND domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431696	Smyd5<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
SET and MYND domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431696	Smyd5<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
SET and MYND domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433561	Smyd5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SET and MYND domain containing 5; targeted mutation 1, William C Skarnes	MGI:5903613	Smyd5<tm1Wcs>	28981838	null
SET binding factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363566	Sbf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SET binding factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362203	Sbf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SET binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442011	Setbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548727	Setbp1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
SET binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442007	Setbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SET domain, bifurcated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432424	Setdb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET domain, bifurcated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432424	Setdb1<tm1a(EUCOMM)Wtsi>	22876197	EUCOMM
SET domain, bifurcated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432424	Setdb1<tm1a(EUCOMM)Wtsi>	27013243	EUCOMM
SET domain, bifurcated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432424	Setdb1<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
SET domain, bifurcated 1; targeted mutation 1, William C Skarnes	MGI:5903612	Setdb1<tm1Wcs>	28981838	null
SET domain, bifurcated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364322	Setdb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SET domain, bifurcated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364322	Setdb2<tm1a(KOMP)Wtsi>	26709698	KOMP-CSD
SET domain, bifurcated 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364322	Setdb2<tm1a(KOMP)Wtsi>	27568546	KOMP-CSD
SET domain, bifurcated 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816257	Setdb2<tm1c(KOMP)Wtsi>	26709698	KOMP-CSD
SET domain, bifurcated 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816257	Setdb2<tm1c(KOMP)Wtsi>	27568546	KOMP-CSD
SET domain, bifurcated 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362798	Setdb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SET domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432882	Setd1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432882	Setd1a<tm1a(EUCOMM)Wtsi>	25550471	EUCOMM
SET domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432882	Setd1a<tm1a(EUCOMM)Wtsi>	26785054	EUCOMM
SET domain containing 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432882	Setd1a<tm1a(EUCOMM)Wtsi>	27141965	EUCOMM
SET domain containing 1A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5910691	Setd1a<tm1c(EUCOMM)Wtsi>	25550471	EUCOMM
SET domain containing 1A; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5910691	Setd1a<tm1c(EUCOMM)Wtsi>	27141965	EUCOMM
SET domain containing 1B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431469	Setd1b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SET domain containing 2; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766174	Setd2<tm1b(NCOM)Mfgc>	27626380	NorCOMM
SET domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364212	Setd4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SET domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432631	Setd5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432631	Setd5<tm1a(EUCOMM)Wtsi>	29180574	EUCOMM
SET domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432961	Setd5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SET domain containing 6; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5446143	Setd6<tm1.1(KOMP)Mbp>	21677750	KOMP-CSD
SET domain containing 6; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5446143	Setd6<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
SET domain without mariner transposase fusion; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432061	Setmar<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET nuclear oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432240	Set<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SET nuclear oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432157	Set<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sex comb on midleg homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441791	Scmh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sex hormone binding globulin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419222	Shbg<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841318	Sugt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841269	Sugt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH2B adaptor protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820092	Sh2b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH2B adaptor protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820149	Sh2b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH2B adaptor protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014685	Sh2b3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH2B adaptor protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842654	Sh2b3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH2 domain containing 1B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364476	Sh2d1b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH2 domain containing 1B2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363793	Sh2d1b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH2 domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451399	Sh2d2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH2 domain containing 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451454	Sh2d2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH2 domain containing 3C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362623	Sh2d3c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH2 domain containing 3C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364976	Sh2d3c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH2 domain containing 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362954	Sh2d4a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH2 domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432348	Sh2d5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH2 domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431856	Sh2d5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3 and cysteine rich domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365152	Stac3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 and cysteine rich domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365152	Stac3<tm1a(KOMP)Wtsi>	23626854	KOMP-CSD
SH3 and cysteine rich domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365152	Stac3<tm1a(KOMP)Wtsi>	23818578	KOMP-CSD
SH3 and cysteine rich domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365152	Stac3<tm1a(KOMP)Wtsi>	27621462	KOMP-CSD
SH3 and cysteine rich domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362127	Stac3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 and cysteine rich domain 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299619	Stac3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 and multiple ankyrin repeat domains 3; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4454002	Shank3<tm1a(KOMP)Mbp>	25852484	KOMP-CSD
SH3 and multiple ankyrin repeat domains 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364384	Shank3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 and multiple ankyrin repeat domains 3; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5792940	Shank3<tm1c(KOMP)Mbp>	25852484	KOMP-CSD
SH3 and multiple ankyrin repeat domains 3; targeted mutation 1d, Mouse Biology Program, UCDavis	MGI:5792941	Shank3<tm1d(KOMP)Mbp>	25852484	KOMP-CSD
SH3 and multiple ankyrin repeat domains 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363619	Shank3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 and PX domains 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842409	Sh3pxd2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3 and PX domains 2A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636944	Sh3pxd2a<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
SH3 and PX domains 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842324	Sh3pxd2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3 and PX domains 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302376	Sh3pxd2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3 binding domain protein 5 like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419242	Sh3bp5l<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SH3-binding kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842348	Sbk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-binding kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842656	Sbk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3 domain and tetratricopeptide repeats 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362230	Sh3tc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 domain and tetratricopeptide repeats 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5447051	Sh3tc2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 domain and tetratricopeptide repeats 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5447051	Sh3tc2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
SH3 domain and tetratricopeptide repeats 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5447051	Sh3tc2<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
SH3 domain and tetratricopeptide repeats 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364244	Sh3tc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH3 domain binding glutamic acid-rich protein-like 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840634	Sh3bgrl3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3 domain binding glutamic acid-rich protein-like 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840605	Sh3bgrl3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458852	Sh3bp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458826	Sh3bp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362963	Sh3bp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH3-domain binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548461	Sh3bp2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
SH3-domain binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364092	Sh3bp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SH3-domain binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433523	Sh3bp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain binding protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434522	Sh3bp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain binding protein 5 (BTK-associated); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050859	Sh3bp5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SH3-domain binding protein 5 (BTK-associated); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050859	Sh3bp5<tm1a(KOMP)Wtsi>	26845758	KOMP-CSD
SH3-domain binding protein 5 (BTK-associated); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050859	Sh3bp5<tm1a(KOMP)Wtsi>	28661486	KOMP-CSD
SH3-domain binding protein 5 (BTK-associated); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605761	Sh3bp5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
SH3-domain GRB2-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433389	Sh3gl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain GRB2-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433386	Sh3gl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain GRB2-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433494	Sh3gl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain GRB2-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513818	Sh3gl2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
SH3-domain GRB2-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433438	Sh3gl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain GRB2-like endophilin B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006754	Sh3glb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SH3-domain GRB2-like (endophilin) interacting protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548629	Sgip1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Sh3 domain YSC-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840935	Sh3yl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Sh3kbp1 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842417	Shkbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Sh3kbp1 binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842889	Shkbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SHANK-associated RH domain interacting protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419709	Sharpin<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Shc SH2-domain binding protein 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364718	Shcbp1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Shc SH2-domain binding protein 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364718	Shcbp1l<tm1a(KOMP)Wtsi>	24557841	KOMP-CSD
Shc SH2-domain binding protein 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363385	Shcbp1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Shc SH2-domain binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461664	Shcbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Shc SH2-domain binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461664	Shcbp1<tm1a(EUCOMM)Wtsi>	25153088	EUCOMM
Shc SH2-domain binding protein 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5582589	Shcbp1<tm1c(EUCOMM)Wtsi>	25153088	EUCOMM
Shc SH2-domain binding protein 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5582592	Shcbp1<tm1d(EUCOMM)Wtsi>	25153088	EUCOMM
Shc SH2-domain binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461677	Shcbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SHC (Src homology 2 domain containing) transforming protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451504	Shc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SHC (Src homology 2 domain containing) transforming protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451267	Shc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364694	Shisa3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364994	Shisa3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452638	Shisa3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452647	Shisa3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451389	Shisa4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451245	Shisa4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880914	Shisa7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
shisa family member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880956	Shisa7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
shootin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881084	Shtn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
shootin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302286	Shtn1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
shootin 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050971	Shtn1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
short chain dehydrogenase/reductase family 16C, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299593	Sdr16c5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
short chain dehydrogenase/reductase family 16C, member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299668	Sdr16c5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
short chain dehydrogenase/reductase family 16C, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458464	Sdr16c6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
short chain dehydrogenase/reductase family 16C, member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458583	Sdr16c6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
short chain dehydrogenase/reductase family 39U, member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451329	Sdr39u1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
short chain dehydrogenase/reductase family 42E, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419616	Sdr42e1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
short chain dehydrogenase/reductase family 42E, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419146	Sdr42e1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
short coiled-coil protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050149	Scoc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
short stature homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841021	Shox2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
short stature homeobox 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841362	Shox2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
SHQ1 homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434090	Shq1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SHQ1 homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433007	Shq1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
shroom family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432577	Shroom2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
shroom family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433012	Shroom2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
shroom family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428533	Shroom3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
shroom family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428471	Shroom3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
shugoshin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433385	Sgo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
shugoshin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433385	Sgo1<tm1a(EUCOMM)Wtsi>	28465207	EUCOMM
shugoshin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432721	Sgo1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
shugoshin 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432361	Sgo2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
shugoshin 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432361	Sgo2a<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
shugoshin 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432007	Sgo2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
siah E3 ubiquitin protein ligase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842444	Siah2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sialic acid acetylesterase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842607	Siae<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sialic acid acetylesterase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842607	Siae<tm1a(EUCOMM)Wtsi>	27210752	EUCOMM
sialic acid acetylesterase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842557	Siae<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sialic acid binding Ig-like lectin H; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299553	Siglech<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sialidase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006772	Neu4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sialophorin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419361	Spn<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SID1 transmembrane family, member 1; targeted mutation 1.1, Velocigene	MGI:5695953	Sidt1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SID1 transmembrane family, member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365101	Sidt1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SID1 transmembrane family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841027	Sidt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SID1 transmembrane family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841395	Sidt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sidekick cell adhesion molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014732	Sdk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sideroflexin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434144	Sfxn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sideroflexin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5660778	Sfxn1<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
sideroflexin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434327	Sfxn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sideroflexin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419546	Sfxn2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sideroflexin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419131	Sfxn2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sideroflexin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431412	Sfxn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sideroflexin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548735	Sfxn3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
sideroflexin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548735	Sfxn3<tm1b(KOMP)Wtsi>	28049716	KOMP-CSD
sideroflexin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431406	Sfxn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sideroflexin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363839	Sfxn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sideroflexin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363271	Sfxn4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sigma non-opioid intracellular receptor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419417	Sigmar1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
signal-induced proliferation-associated 1 like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419620	Sipa1l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
signal-induced proliferation-associated 1 like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419845	Sipa1l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
signaling lymphocytic activation molecule family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363648	Slamf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
signal peptidase complex subunit 1 homolog (S. cerevisiae); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299557	Spcs1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
signal peptide, CUB domain, EGF-like 3; targeted mutation 1, Velocigene	MGI:4415473	Scube3<tm1(KOMP)Vlcg>	23383134	KOMP-Regeneron
signal peptide peptidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441701	Sppl3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
signal peptide peptidase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441926	Sppl3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
signal peptide peptidase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5529966	Sppl3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
signal recognition particle 14; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420069	Srp14<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
signal recognition particle 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319816	Srp19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
signal recognition particle 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4843835	Srp19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
signal recognition particle 19; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319861	Srp19<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
signal recognition particle 68; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428553	Srp68<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
signal recognition particle 9; targeted mutation 1.1, Velocigene	MGI:5571347	Srp9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
signal-regulatory protein alpha; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5614693	Sirpa<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
signal sequence receptor, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842268	Ssr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
signal sequence receptor, beta; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637009	Ssr2<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
signal sequence receptor, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842526	Ssr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441705	Stat1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442046	Stat1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820224	Stat1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820396	Stat1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319804	Stat3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
signal transducer and activator of transcription 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319876	Stat3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
signal transducer and activator of transcription 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286391	Stat4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296204	Stat4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 5A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050947	Stat5a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 5B; targeted mutation 1.1, Velocigene	MGI:5529631	Stat5b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
signal transducer and activator of transcription 5B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306503	Stat5b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducer and activator of transcription 5B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301403	Stat5b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducing adaptor family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458470	Stap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
signal transducing adaptor family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458489	Stap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
signal transducing adaptor molecule (SH3 domain and ITAM motif) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460461	Stam2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
signal transducing adaptor molecule (SH3 domain and ITAM motif) 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460529	Stam2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SIK family kinase 3; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5085429	Sik3<tm1a(EUCOMM)Hmgu>	27009967	EUCOMM
SIK family kinase 3; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5904827	Sik3<tm1c(EUCOMM)Hmgu>	27009967	EUCOMM
Sin3A associated protein; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:5141821	Sap130<tm1a(KOMP)Mbp>	28530678	KOMP-CSD
Sin3A associated protein; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:5141821	Sap130<tm1a(KOMP)Mbp>	29078390	KOMP-CSD
sine oculis binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462584	Sobp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sine oculis binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462609	Sobp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419756	Sigirr<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
single-pass membrane protein with aspartate rich tail 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441734	Smdt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
single-pass membrane protein with aspartate rich tail 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548576	Smdt1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
single-pass membrane protein with aspartate rich tail 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441722	Smdt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
single-pass membrane protein with coiled-coil domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419743	Smco1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
single-pass membrane protein with coiled-coil domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419551	Smco1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
single-pass membrane protein with coiled-coil domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431574	Smco2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
single-pass membrane protein with coiled-coil domains 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548583	Smco2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
single-pass membrane protein with coiled-coil domains 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420125	Smco3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
single-pass membrane protein with coiled-coil domains 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433435	Smco4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
single-pass membrane protein with coiled-coil domains 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432474	Smco4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
single-stranded DNA binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938520	Ssbp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
single-stranded DNA binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938527	Ssbp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
single-stranded DNA binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426549	Ssbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
single-stranded DNA binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605777	Ssbp2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
single-stranded DNA binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364204	Ssbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
single-strand selective monofunctional uracil DNA glycosylase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435952	Smug1<tm1a(EUCOMM)Hmgu>	22447450	EUCOMM
single-strand selective monofunctional uracil DNA glycosylase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435952	Smug1<tm1a(EUCOMM)Hmgu>	28775312	EUCOMM
sirtuin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432175	Sirt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548731	Sirt1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
sirtuin 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5692765	Sirt1<tm1c(EUCOMM)Wtsi>	28445726	EUCOMM
sirtuin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433396	Sirt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431586	Sirt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431586	Sirt2<tm1a(EUCOMM)Wtsi>	23908241	EUCOMM
sirtuin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431586	Sirt2<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
sirtuin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441628	Sirt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441628	Sirt3<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
sirtuin 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548701	Sirt3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
sirtuin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441998	Sirt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5529969	Sirt4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548655	Sirt4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
sirtuin 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432093	Sirt6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432740	Sirt6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sirtuin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950957	Sirt7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sirtuin 7; targeted mutation 2c, Eva Bober	MGI:5637421	Sirt7<tm2c(KOMP)Evbo>	24703702	KOMP-CSD
SIVA1, apoptosis-inducing factor; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605765	Siva1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
six transmembrane epithelial antigen of the prostate 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432102	Steap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
six transmembrane epithelial antigen of the prostate 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432796	Steap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Sjogren syndrome/scleroderma autoantigen 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419275	Sssca1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SKI/DACH domain containing 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548624	Skida1<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
SKI/DACH domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841167	Skida1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SKI/DACH domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4841167	Skida1<tm1(KOMP)Wtsi>	27626380	KOMP-CSD
SLAM family member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820089	Slamf7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SLAM family member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820078	Slamf7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SLAM family member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433560	Slamf9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SLAM family member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434139	Slamf9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
slingshot protein phosphatase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939685	Ssh3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
slingshot protein phosphatase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939687	Ssh3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SLIT and NTRK-like family, member 1; targeted mutation 1.1, Velocigene	MGI:5583079	Slitrk1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SLIT and NTRK-like family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305613	Slitrk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SLIT and NTRK-like family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460289	Slitrk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SLIT and NTRK-like family, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460307	Slitrk4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
slit guidance ligand 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363887	Slit1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
slit guidance ligand 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636949	Slit1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
slit guidance ligand 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362360	Slit1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SLIT-ROBO Rho GTPase activating protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432204	Srgap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SLIT-ROBO Rho GTPase activating protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432204	Srgap1<tm1a(KOMP)Wtsi>	27882344	KOMP-CSD
SLIT-ROBO Rho GTPase activating protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420110	Srgap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SLP adaptor and CSK interacting membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362812	Scimp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SLP adaptor and CSK interacting membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362812	Scimp<tm1a(KOMP)Wtsi>	27288407	KOMP-CSD
SLU7 splicing factor homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363740	Slu7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SLU7 splicing factor homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362622	Slu7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SLX4 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433347	Slx4ip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SLX4 interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433589	Slx4ip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	21240276	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	21655083	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	22922648	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	23468651	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	24726326	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	26980189	EUCOMM
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434506	Slx4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SMAD family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451555	Smad2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SMAD family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451363	Smad2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SMAD family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433375	Smad4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SMAD family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431724	Smad4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SMAD family member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286189	Smad6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SMAD family member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293906	Smad6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SMAD family member 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419535	Smad7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Smad nuclear interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431749	Snip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Smad nuclear interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431749	Snip1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
Smad nuclear interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433999	Snip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SMAD specific E3 ubiquitin protein ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433314	Smurf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SMAD specific E3 ubiquitin protein ligase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637086	Smurf1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
SMAD specific E3 ubiquitin protein ligase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433894	Smurf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SMAD specific E3 ubiquitin protein ligase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431726	Smurf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SMAD specific E3 ubiquitin protein ligase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548518	Smurf2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
SMAD specific E3 ubiquitin protein ligase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433457	Smurf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small ArfGAP 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432420	Smap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small ArfGAP 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433285	Smap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small ArfGAP 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433846	Smap2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small ArfGAP 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434425	Smap2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small EDRK-rich factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363693	Serf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5515781	Sgta<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5515781	Sgta<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
small G protein signaling modulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949373	Sgsm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small G protein signaling modulator 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636905	Sgsm1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
small G protein signaling modulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006779	Sgsm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small integral membrane protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434092	Smim11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small integral membrane protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433291	Smim11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small integral membrane protein 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433011	Smim15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small integral membrane protein 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432668	Smim15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small integral membrane protein 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365236	Smim23<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small integral membrane protein 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365100	Smim23<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small integral membrane protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441886	Smim3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small integral membrane protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362996	Smim6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small integral membrane protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362241	Smim6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small integral membrane protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364306	Smim7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small integral membrane protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433573	Smim9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein 200 (U5); targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548825	Snrnp200<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
small nuclear ribonucleoprotein 27 (U4/U6.U5); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842426	Snrnp27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein 27 (U4/U6.U5); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548525	Snrnp27<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
small nuclear ribonucleoprotein 27 (U4/U6.U5); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842549	Snrnp27<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein 35 (U11/U12); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433558	Snrnp35<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein 35 (U11/U12); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433426	Snrnp35<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein 40 (U5); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453728	Snrnp40<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein 40 (U5); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453773	Snrnp40<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein 48 (U11/U12); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434193	Snrnp48<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365114	Snrpb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364556	Snrpb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365262	Snrpb<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein B; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4452715	Snrpb<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein D2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451480	Snrpd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein D2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451442	Snrpd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein N; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299513	Snrpn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein polypeptide A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432428	Snrpa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein polypeptide A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433306	Snrpa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small nuclear ribonucleoprotein polypeptide F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319790	Snrpf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein polypeptide G; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458586	Snrpg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear ribonucleoprotein polypeptide G; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458642	Snrpg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear RNA activating complex, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458500	Snapc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear RNA activating complex, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458630	Snapc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear RNA activating complex, polypeptide 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305615	Snapc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear RNA activating complex, polypeptide 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305610	Snapc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear RNA activating complex, polypeptide 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362491	Snapc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small nuclear RNA activating complex, polypeptide 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364284	Snapc4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small proline-rich protein 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052384	Sprr1a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small proline-rich protein 2D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363296	Sprr2d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small proline-rich protein 2F; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951105	Sprr2f<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small proline-rich protein 2F; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847861	Sprr2f<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
small proline-rich protein 2I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363768	Sprr2i<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small proline-rich protein 2I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364559	Sprr2i<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
small proline-rich protein 2I; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472915	Sprr2i<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
small proline-rich protein 2J, pseudogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887642	Sprr2j-ps<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small proline-rich protein 2K; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455610	Sprr2k<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
small ubiquitin-like modifier 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432062	Sumo2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
small ubiquitin-like modifier 3; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5002918	Sumo3<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
SMC5-SMC6 complex localization factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820219	Slf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472702	Smg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511988	Smg1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433646	Smg9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692712	Smg9<tm1b(EUCOMM)Wtsi>	27996060	EUCOMM
smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433407	Smg9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Smith-Magenis syndrome chromosome region, candidate 8 homolog (human); targeted mutation 1.1, Velocigene	MGI:5812680	Smcr8<tm1.1(KOMP)Vlcg>	27617292	KOMP-Regeneron
Smith-Magenis syndrome chromosome region, candidate 8 homolog (human); targeted mutation 1, Velocigene	MGI:4452950	Smcr8<tm1(KOMP)Vlcg>	27617292	KOMP-Regeneron
smoothelin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419738	Smtn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
smoothelin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419900	Smtn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
smoothened, frizzled class receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841150	Smo<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
smoothened, frizzled class receptor; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5573269	Smo<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
smoothened, frizzled class receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841306	Smo<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
snail family zinc finger 1; targeted mutation 1, Velocigene	MGI:4399469	Snai1<tm1(KOMP)Vlcg>	24401905	KOMP-Regeneron
snail family zinc finger 1; targeted mutation 1, Velocigene	MGI:4399469	Snai1<tm1(KOMP)Vlcg>	24894949	KOMP-Regeneron
snail family zinc finger 1; targeted mutation 1, Velocigene	MGI:4399469	Snai1<tm1(KOMP)Vlcg>	27479603	KOMP-Regeneron
snail family zinc finger 1; targeted mutation 1, Velocigene	MGI:4399469	Snai1<tm1(KOMP)Vlcg>	27749822	KOMP-Regeneron
snail family zinc finger 2; targeted mutation 1.1, Velocigene	MGI:5582425	Snai2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SNAP-associated protein; targeted mutation 1.1, Velocigene	MGI:5571346	Snapin<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SNAP-associated protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419158	Snapin<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433763	Snf8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431589	Snf8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456788	Snf8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
SNF related kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363321	Snrk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SNF related kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363851	Snrk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SNU13 homolog, small nuclear ribonucleoprotein (U4/U6.U5); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052497	Snu13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
soc-2 (suppressor of clear) homolog (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419810	Shoc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
soc-2 (suppressor of clear) homolog (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420131	Shoc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sodium channel, nonvoltage-gated 1 beta; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548351	Scnn1b<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
sodium channel, nonvoltage-gated 1 gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008942	Scnn1g<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sodium channel, nonvoltage-gated 1 gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299883	Scnn1g<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sodium channel, voltage-gated, type III, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363292	Scn3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sodium channel, voltage-gated, type III, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4819197	Scn3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sodium channel, voltage-gated, type IV, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299629	Scn4a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sodium channel, voltage-gated, type IV, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419801	Scn4a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sodium channel, voltage-gated, type IV, alpha; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5284906	Scn4a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
sodium channel, voltage-gated, type IV, alpha; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548971	Scn4a<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
sodium channel, voltage-gated, type IV, alpha; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4847696	Scn4a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
sodium channel, voltage-gated, type VII, alpha; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428486	Scn7a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sodium leak channel, non-selective; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419858	Nalcn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sodium leak channel, non-selective; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419858	Nalcn<tm1a(KOMP)Wtsi>	26276633	KOMP-CSD
sodium leak channel, non-selective; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5823777	Nalcn<tm1c(KOMP)Wtsi>	26276633	KOMP-CSD
sodium leak channel, non-selective; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5823777	Nalcn<tm1c(KOMP)Wtsi>	27177420	KOMP-CSD
sodium leak channel, non-selective; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5823777	Nalcn<tm1c(KOMP)Wtsi>	28392070	KOMP-CSD
sodium leak channel, non-selective; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419877	Nalcn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 10 (sodium/bile acid cotransporter family), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840926	Slc10a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434417	Slc11a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433925	Slc11a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 12, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363722	Slc12a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 12, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362973	Slc12a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 12, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461654	Slc12a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 12, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461690	Slc12a3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 12, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441960	Slc12a6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 12, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362401	Slc12a7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 12, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363294	Slc12a7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 12 (potassium/chloride transporters), member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433292	Slc12a9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 12 (potassium/chloride transporters), member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432617	Slc12a9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364146	Slc13a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548755	Slc13a3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 13 (sodium/sulfate symporters), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441655	Slc13a4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 13 (sodium/sulfate symporters), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441655	Slc13a4<tm1a(EUCOMM)Wtsi>	26292834	EUCOMM
solute carrier family 13 (sodium/sulfate symporters), member 4; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5881936	Slc13a4<tm1c(EUCOMM)Wtsi>	26292834	EUCOMM
solute carrier family 13 (sodium/sulfate symporters), member 4; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5881938	Slc13a4<tm1d(EUCOMM)Wtsi>	26292834	EUCOMM
solute carrier family 13 (sodium/sulfate symporters), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441891	Slc13a4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 14 (urea transporter), member 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431486	Slc14a2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 15 (H+/peptide transporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363871	Slc15a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 15, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363498	Slc15a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 15, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363498	Slc15a3<tm1a(KOMP)Wtsi>	24695226	KOMP-CSD
solute carrier family 15, member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637100	Slc15a3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 15, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362800	Slc15a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 15, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363256	Slc15a5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 15 (oligopeptide transporter), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419126	Slc15a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 15 (oligopeptide transporter), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419140	Slc15a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 16 (monocarboxylic acid transporters), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052415	Slc16a10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 16 (monocarboxylic acid transporters), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363035	Slc16a12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 16 (monocarboxylic acid transporters), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364794	Slc16a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 16 (monocarboxylic acid transporters), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364794	Slc16a2<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
solute carrier family 16 (monocarboxylic acid transporters), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453792	Slc16a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637103	Slc16a3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453724	Slc16a3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840700	Slc16a4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840599	Slc16a4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431916	Slc16a6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434070	Slc16a6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433188	Slc16a6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 6; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456764	Slc16a6<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 6; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4456803	Slc16a6<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 16 (monocarboxylic acid transporters), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451614	Slc16a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 16 (monocarboxylic acid transporters), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451629	Slc16a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (anion/sugar transporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452764	Slc17a5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 17 (anion/sugar transporter), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452770	Slc17a5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 17, member 9; targeted mutation 1.1, Velocigene	MGI:5695923	Slc17a9<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 17, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431727	Slc17a9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 17, member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431700	Slc17a9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881966	Slc17a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887643	Slc17a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (sodium phosphate), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363096	Slc17a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (sodium phosphate), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364987	Slc17a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (sodium phosphate), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364892	Slc17a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (sodium phosphate), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362707	Slc17a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (sodium phosphate), member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362759	Slc17a3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 17 (sodium phosphate), member 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637136	Slc17a3<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 17 (sodium phosphate), member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363041	Slc17a3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 18 (vesicular monoamine), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944416	Slc18a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 18 (vesicular monoamine), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432865	Slc18a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 19 (folate transporter), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434050	Slc19a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 19 (folate transporter), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433913	Slc19a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 19, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948657	Slc19a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 19 (thiamine transporter), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364552	Slc19a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 19 (thiamine transporter), member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841188	Slc19a2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 19 (thiamine transporter), member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841061	Slc19a2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 1 (glial high affinity glutamate transporter), member 3; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5443926	Slc1a3<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
solute carrier family 1 (glial high affinity glutamate transporter), member 3; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456561	Slc1a3<tm1(KOMP)Mbp>	26839965	KOMP-CSD
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362597	Slc1a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841006	Slc1a6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950955	Slc1a6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841333	Slc1a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529617	Slc1a1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529617	Slc1a1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428505	Slc1a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	23934451	EUCOMM
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	26660102	EUCOMM
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	26822507	EUCOMM
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	26952749	EUCOMM
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	27943094	EUCOMM
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	29133259	EUCOMM
solute carrier family 20, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	29259219	EUCOMM
solute carrier family 20, member 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548966	Slc20a2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 20, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433495	Slc20a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 22, member 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458558	Slc22a28<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22, member 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458634	Slc22a28<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22. member 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363487	Slc22a29<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic anion transporter), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364493	Slc22a6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic anion transporter), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362529	Slc22a6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic anion transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419220	Slc22a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic anion transporter), member 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636960	Slc22a8<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 22 (organic anion transporter), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419720	Slc22a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic anion transporter), member 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472926	Slc22a8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 22 (organic cation transporter), member 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365258	Slc22a14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428591	Slc22a14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363774	Slc22a16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362305	Slc22a16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948655	Slc22a18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 22 (organic cation transporter), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364715	Slc22a21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364715	Slc22a21<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363213	Slc22a22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 26; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4951087	Slc22a26<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 22 (organic cation transporter), member 26; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840622	Slc22a26<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 22 (organic cation transporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452655	Slc22a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319801	Slc22a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286252	Slc22a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293933	Slc22a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 22 (organic cation transporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842338	Slc22a5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 22 (organic cation transporter), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842614	Slc22a5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 23 member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363429	Slc23a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 23 member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363838	Slc23a4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 23 (nucleobase transporters), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841196	Slc23a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 23 (nucleobase transporters), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841121	Slc23a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 23 (nucleobase transporters), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842855	Slc23a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 24, member 5; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5554824	Slc24a5<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009569	Slc24a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319791	Slc24a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944392	Slc24a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637159	Slc24a4<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 25, member 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452777	Slc25a28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 28; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637123	Slc25a28<tm1b(EUCOMM)Wtsi>	26398943	EUCOMM
solute carrier family 25, member 28; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637123	Slc25a28<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 25, member 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452798	Slc25a28<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842343	Slc25a30<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842625	Slc25a30<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433678	Slc25a33<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432318	Slc25a33<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 35; targeted mutation 1.1, Velocigene	MGI:5505637	Slc25a35<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 25, member 35; targeted mutation 1.1, Velocigene	MGI:5505637	Slc25a35<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
solute carrier family 25, member 35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453719	Slc25a35<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 35; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453742	Slc25a35<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431760	Slc25a38<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431760	Slc25a38<tm1a(EUCOMM)Wtsi>	26335643	EUCOMM
solute carrier family 25, member 38; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433108	Slc25a38<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 39; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419944	Slc25a39<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25, member 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431810	Slc25a42<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 42; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432980	Slc25a42<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431833	Slc25a43<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 43; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434318	Slc25a43<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 46; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842272	Slc25a46<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 46; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842258	Slc25a46<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25, member 47; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5319805	Slc25a47<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25, member 48; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363359	Slc25a48<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25, member 48; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364046	Slc25a48<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25, member 51; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363328	Slc25a51<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25, member 51; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365203	Slc25a51<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25, member 54; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5464324	Slc25a54<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431570	Slc25a20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431570	Slc25a20<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432747	Slc25a20<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009583	Slc25a31<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432177	Slc25a4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433883	Slc25a4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431658	Slc25a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434310	Slc25a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472853	Slc25a1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460471	Slc25a10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460498	Slc25a10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, glutamate), member 22; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363137	Slc25a22<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier), member 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4946683	Slc25a18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier), member 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946679	Slc25a18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362397	Slc25a29<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362781	Slc25a29<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, peroxisomal membrane protein), member 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363582	Slc25a17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, peroxisomal membrane protein), member 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364953	Slc25a17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363122	Slc25a23<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363345	Slc25a23<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286261	Slc25a24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293942	Slc25a24<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362142	Slc25a25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362778	Slc25a25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842310	Slc25a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548483	Slc25a3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364913	Slc25a21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364913	Slc25a21<tm1a(KOMP)Wtsi>	23300663	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364913	Slc25a21<tm1a(KOMP)Wtsi>	23912999	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364913	Slc25a21<tm1a(KOMP)Wtsi>	24642684	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548834	Slc25a21<tm1b(KOMP)Wtsi>	24642684	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5629861	Slc25a21<tm1c(KOMP)Wtsi>	24642684	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5629856	Slc25a21<tm1d(KOMP)Wtsi>	24642684	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5629856	Slc25a21<tm1d(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5426548	Slc25a21<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319902	Slc25a21<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 26, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364681	Slc26a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 26, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365066	Slc26a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 26, member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299599	Slc26a3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 26, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286218	Slc26a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 26, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441909	Slc26a5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 26, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442024	Slc26a5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 26, member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842356	Slc26a8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 26, member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842455	Slc26a8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 27 (fatty acid transporter), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433915	Slc27a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 27 (fatty acid transporter), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431665	Slc27a3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 27 (fatty acid transporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458856	Slc27a5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 27 (fatty acid transporter), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458835	Slc27a5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 27 (fatty acid transporter), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843851	Slc27a6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365190	Slc28a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364460	Slc28a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 29 (nucleoside transporters), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364067	Slc29a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 29 (nucleoside transporters), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462570	Slc29a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 29 (nucleoside transporters), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462602	Slc29a4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948612	Slc2a13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008809	Slc2a13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364349	Slc2a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5575896	Slc2a2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299497	Slc2a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364678	Slc2a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6116230	Slc2a3<tm1c(KOMP)Wtsi>	28663252	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428564	Slc2a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363303	Slc2a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363338	Slc2a4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 2 (facilitated glucose transporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842480	Slc2a5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 2 (facilitated glucose transporter), member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5613655	Slc2a5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 2 (facilitated glucose transporter), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842750	Slc2a5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 2 (facilitated glucose transporter), member 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840640	Slc2a9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 2 (facilitated glucose transporter), member 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840630	Slc2a9<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 30, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294972	Slc30a10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30, member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299529	Slc30a10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365106	Slc30a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363662	Slc30a4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451253	Slc30a4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451249	Slc30a4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363152	Slc30a5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364745	Slc30a5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140420	Slc30a6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363904	Slc30a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364958	Slc30a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364526	Slc30a9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 30 (zinc transporter), member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364477	Slc30a9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 31, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881952	Slc31a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 31, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881959	Slc31a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 31, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432041	Slc31a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 32 (GABA vesicular transporter), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363011	Slc32a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 32 (GABA vesicular transporter), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364687	Slc32a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 33 (acetyl-CoA transporter), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362340	Slc33a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 33 (acetyl-CoA transporter), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364830	Slc33a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 34 (sodium phosphate), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419120	Slc34a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 34 (sodium phosphate), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419236	Slc34a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 34 (sodium phosphate), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364311	Slc34a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 34 (sodium phosphate), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363308	Slc34a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 35, member B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301392	Slc35b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member B1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5306495	Slc35b1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member B1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5301393	Slc35b1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member B3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434337	Slc35b3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member E1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433885	Slc35e1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member E1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441851	Slc35e1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member E1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441954	Slc35e1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member F1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363454	Slc35f1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 35, member F1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363454	Slc35f1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
solute carrier family 35, member F1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363751	Slc35f1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 35, member F2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441953	Slc35f2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member F2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441752	Slc35f2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member F3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362322	Slc35f3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 35, member F3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363501	Slc35f3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 35, member F6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432047	Slc35f6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 35, member F6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432050	Slc35f6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 36 (proton/amino acid symporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5002932	Slc36a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 36 (proton/amino acid symporter), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293966	Slc36a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 36 (proton/amino acid symporter), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293928	Slc36a4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 37 (glucose-6-phosphate transporter), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460429	Slc37a4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 37 (glucose-6-phosphate transporter), member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460492	Slc37a4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 37 (glycerol-3-phosphate transporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840917	Slc37a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 37 (glycerol-3-phosphate transporter), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841320	Slc37a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 37 (glycerol-3-phosphate transporter), member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841053	Slc37a2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 37 (glycerol-3-phosphate transporter), member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841332	Slc37a2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 38, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431702	Slc38a10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431702	Slc38a10<tm1a(EUCOMM)Wtsi>	22876197	EUCOMM
solute carrier family 38, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431702	Slc38a10<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
solute carrier family 38, member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432112	Slc38a10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441779	Slc38a10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 10; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456820	Slc38a10<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050978	Slc38a1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319921	Slc38a1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293947	Slc38a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 38, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294957	Slc38a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 38, member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527588	Slc38a2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419922	Slc38a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 38, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419607	Slc38a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 38, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431996	Slc38a4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432277	Slc38a4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433747	Slc38a5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 5; targeted mutation 1, Velocigene	MGI:4843107	Slc38a5<tm1(KOMP)Vlcg>v	28591637	KOMP-Regeneron
solute carrier family 38, member 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511979	Slc38a6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433874	Slc38a7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 38, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433947	Slc38a7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 39 (metal ion transporter), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433505	Slc39a11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 39 (metal ion transporter), member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432582	Slc39a11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 39 (metal ion transporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419233	Slc39a5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 39 (metal ion transporter), member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692713	Slc39a5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 39 (metal ion transporter), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419887	Slc39a5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 39 (metal ion transporter), member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472871	Slc39a5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 39 (metal ion transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432011	Slc39a8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 39 (metal ion transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432011	Slc39a8<tm1a(EUCOMM)Wtsi>	24529376	EUCOMM
solute carrier family 39 (metal ion transporter), member 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548544	Slc39a8<tm1b(EUCOMM)Wtsi>	24529376	EUCOMM
solute carrier family 39 (metal ion transporter), member 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548544	Slc39a8<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 39 (metal ion transporter), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432993	Slc39a8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 39 (zinc transporter), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441872	Slc39a10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 39 (zinc transporter), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364525	Slc39a12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 39 (zinc transporter), member 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451405	Slc39a12<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 39 (zinc transporter), member 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419633	Slc39a4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 39 (zinc transporter), member 7; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548942	Slc39a7<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5430967	Slc3a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5430962	Slc3a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 3, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938601	Slc3a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 3, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938555	Slc3a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 40 (iron-regulated transporter), member 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435780	Slc40a1<tm1a(EUCOMM)Hmgu>	25713362	EUCOMM
solute carrier family 40 (iron-regulated transporter), member 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548423	Slc40a1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
solute carrier family 40 (iron-regulated transporter), member 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5648258	Slc40a1<tm1c(EUCOMM)Hmgu>	25713362	EUCOMM
solute carrier family 41, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365235	Slc41a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 41, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365235	Slc41a3<tm1a(KOMP)Wtsi>	27349617	KOMP-CSD
solute carrier family 41, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363922	Slc41a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 43, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460311	Slc43a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 43, member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635290	Slc43a3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 44, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319916	Slc44a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 44, member 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637111	Slc44a1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
solute carrier family 44, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319903	Slc44a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 44, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434043	Slc44a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 44, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433626	Slc44a3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 44, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364041	Slc44a5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 44, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364740	Slc44a5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 45, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364267	Slc45a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 45, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364340	Slc45a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 45, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362216	Slc45a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 45, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364107	Slc45a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 45, member 3; targeted mutation 1.1, Velocigene	MGI:5548649	Slc45a3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 46, member 3; targeted mutation 1.1, Velocigene	MGI:5565613	Slc46a3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 47, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432174	Slc47a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 47, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548541	Slc47a1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 47, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434232	Slc47a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 47, member 2; targeted mutation 1.1, Velocigene	MGI:5548897	Slc47a2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 47, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364124	Slc47a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 48 (heme transporter), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847704	Slc48a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 48 (heme transporter), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847701	Slc48a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 4 (anion exchanger), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432178	Slc4a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 4 (anion exchanger), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434079	Slc4a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 4 (anion exchanger), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431560	Slc4a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 4 (anion exchanger), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432176	Slc4a2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 4 (anion exchanger), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433929	Slc4a8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451535	Slc4a10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 4, sodium bicarbonate cotransporter, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305657	Slc4a5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 4, sodium bicarbonate cotransporter, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419538	Slc4a7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 4, sodium bicarbonate cotransporter, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420042	Slc4a7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 4, sodium bicarbonate transporter-like, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473060	Slc4a11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 4, sodium bicarbonate transporter-like, member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472869	Slc4a11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 50 (sugar transporter), member 1; targeted mutation 3, Wellcome Trust Sanger Institute	MGI:5050913	Slc50a1<tm3(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 5 (choline transporter), member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942035	Slc5a7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (choline transporter), member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942035	Slc5a7<tm1a(KOMP)Wtsi>	27996060	KOMP-CSD
solute carrier family 5 (choline transporter), member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942007	Slc5a7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (inositol transporters), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887609	Slc5a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (iodide transporter), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820061	Slc5a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (iodide transporter), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820120	Slc5a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (neutral amino acid transporters, system A), member 4b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433221	Slc5a4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 5 (neutral amino acid transporters, system A), member 4b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431615	Slc5a4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 5 (sodium-dependent vitamin transporter), member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432225	Slc5a6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 5 (sodium-dependent vitamin transporter), member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434067	Slc5a6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 5 (sodium/glucose cotransporter), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364454	Slc5a10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363803	Slc5a10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364382	Slc5a12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308296	Slc5a12<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 12; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5428522	Slc5a12<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363573	Slc5a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363573	Slc5a2<tm1a(KOMP)Wtsi>	22262063	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363573	Slc5a2<tm1a(KOMP)Wtsi>	25268124	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363573	Slc5a2<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
solute carrier family 5 (sodium/glucose cotransporter), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363561	Slc5a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium iodide symporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294969	Slc5a5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium iodide symporter), member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294969	Slc5a5<tm1a(KOMP)Wtsi>	28706256	KOMP-CSD
solute carrier family 5 (sodium iodide symporter), member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614611	Slc5a5<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 5 (sodium iodide symporter), member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614611	Slc5a5<tm1b(KOMP)Wtsi>	28706256	KOMP-CSD
solute carrier family 5 (sodium iodide symporter), member 5; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111966	Slc5a5<tm1c(KOMP)Wtsi>	28706256	KOMP-CSD
solute carrier family 5 (sodium iodide symporter), member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294958	Slc5a5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363985	Slc6a12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363074	Slc6a12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, creatine), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363533	Slc6a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, creatine), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363493	Slc6a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363577	Slc6a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5488785	Slc6a3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5488785	Slc6a3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362850	Slc6a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, GABA), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453794	Slc6a11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 6 (neurotransmitter transporter, GABA), member 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363785	Slc6a13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, GABA), member 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364639	Slc6a13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, GABA), member 13; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364505	Slc6a13<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, GABA), member 13; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4364655	Slc6a13<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, GABA), member 13; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4364854	Slc6a13<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter, glycine), member 5; targeted mutation 1.1, Velocigene	MGI:5548359	Slc6a5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 6 (neurotransmitter transporter), member 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363148	Slc6a14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 14; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6115852	Slc6a14<tm1d(KOMP)Wtsi>	29259090	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364627	Slc6a14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052395	Slc6a15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 15; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286267	Slc6a15<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363890	Slc6a17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364235	Slc6a17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363535	Slc6a19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362579	Slc6a19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 20A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362653	Slc6a20a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 20A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363505	Slc6a20a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 20B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420018	Slc6a20b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 6 (neurotransmitter transporter), member 20B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299542	Slc6a20b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362261	Slc7a10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364530	Slc7a10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441748	Slc7a11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548466	Slc7a11<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364430	Slc7a12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363927	Slc7a12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319819	Slc7a12<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452636	Slc7a12<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7, (cationic amino acid transporter, y+ system) member 13; targeted mutation 1.1, Velocigene	MGI:5569057	Slc7a13<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 7, (cationic amino acid transporter, y+ system) member 13; targeted mutation 1, Velocigene	MGI:3800041	Slc7a13<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
solute carrier family 7, (cationic amino acid transporter, y+ system) member 13; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840587	Slc7a13<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 7, (cationic amino acid transporter, y+ system) member 13; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840689	Slc7a13<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 7 (cationic amino acid transporter, y+ system), member 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363858	Slc7a15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362136	Slc7a15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009637	Slc7a7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944577	Slc7a7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 8 (sodium/calcium exchanger), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944417	Slc8a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 8 (sodium/calcium exchanger), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944415	Slc8a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 8 (sodium/calcium exchanger), member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458535	Slc8a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 8 (sodium/calcium exchanger), member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458577	Slc8a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 8 (sodium/calcium exchanger), member 3; targeted mutation 1.1, Velocigene	MGI:5554913	Slc8a3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433823	Slc8b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433823	Slc8b1<tm1a(EUCOMM)Wtsi>	28445457	EUCOMM
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5909410	Slc8b1<tm1c(EUCOMM)Wtsi>	28445457	EUCOMM
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434071	Slc8b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441834	Slc9a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441971	Slc9a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362641	Slc9a3r1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363014	Slc9a3r1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527591	Slc9a3r1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 3; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766165	Slc9a3<tm1b(NCOM)Mfgc>	27626380	NorCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842748	Slc9a4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636898	Slc9a4<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841418	Slc9a7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841052	Slc9a7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472701	Slc9a7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363224	Slc9a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363224	Slc9a8<tm1a(KOMP)Wtsi>	25736793	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363224	Slc9a8<tm1a(KOMP)Wtsi>	25791178	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363224	Slc9a8<tm1a(KOMP)Wtsi>	28476888	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925353	Slc9a8<tm1c(KOMP)Wtsi>	28476888	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5925354	Slc9a8<tm1d(KOMP)Wtsi>	28476888	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364901	Slc9a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365159	Slc9a9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299568	Slc9a9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9 (sodium/hydrogen exchanger), member 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299503	Slc9a9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433225	Slc9b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2; targeted mutation 1.1, Velocigene	MGI:5695944	Slc9b2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier family 9, subfamily C (Na+-transporting carboxylic acid decarboxylase), member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948610	Slc9c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier family 9, subfamily C (Na+-transporting carboxylic acid decarboxylase), member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948631	Slc9c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1a1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363994	Slco1a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1a4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364405	Slco1a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1a4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365261	Slco1a4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1a4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455563	Slco1a4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1a6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008762	Slco1a6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1b2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363995	Slco1b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1b2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5426547	Slco1b2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 1c1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433281	Slco1c1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier organic anion transporter family, member 2a1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942030	Slco2a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 2b1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363700	Slco2b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 2b1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363700	Slco2b1<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
solute carrier organic anion transporter family, member 3a1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319786	Slco3a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 3a1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458584	Slco3a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 3a1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319915	Slco3a1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 3a1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319897	Slco3a1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 3a1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319898	Slco3a1<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 4C1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820086	Slco4c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 4C1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820158	Slco4c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 5A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009576	Slco5a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 5A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319800	Slco5a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 6b1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365271	Slco6b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 6b1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5013729	Slco6b1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 6b1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5006734	Slco6b1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier organic anion transporter family, member 6c1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472908	Slco6c1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier organic anion transporter family, member 6c1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472779	Slco6c1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
solute carrier protein 52, member 2; targeted mutation 1.1, Velocigene	MGI:5548419	Slc52a2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
solute carrier protein 52, member 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419501	Slc52a2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier protein family 52, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362403	Slc52a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier protein family 52, member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363008	Slc52a3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
solute carrier protein family 52, member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363008	Slc52a3<tm2a(KOMP)Wtsi>	26976849	KOMP-CSD
solute carrier protein family 52, member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363008	Slc52a3<tm2a(KOMP)Wtsi>	27272163	KOMP-CSD
solute carrier protein family 52, member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363405	Slc52a3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
somatostatin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286229	Sst<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
somatostatin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5568485	Sst<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
somatostatin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426590	Sst<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sonic hedgehog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433366	Shh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sonic hedgehog; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637219	Shh<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
sorbin and SH3 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419921	Sorbs1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorbin and SH3 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420144	Sorbs1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sorbin and SH3 domain containing 2; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5494474	Sorbs2<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
sorbin and SH3 domain containing 2; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5494474	Sorbs2<tm1.1(KOMP)Mbp>	28700664	KOMP-CSD
sorbin and SH3 domain containing 2; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456607	Sorbs2<tm1(KOMP)Mbp>	28700664	KOMP-CSD
sorbitol dehydrogenase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880964	Sord<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorbitol dehydrogenase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880951	Sord<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sorcin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944524	Sri<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sortilin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842306	Sort1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sortilin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636963	Sort1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
sortilin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842525	Sort1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sortilin-related receptor, LDLR class A repeats-containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451976	Sorl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sortilin-related receptor, LDLR class A repeats-containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452005	Sorl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sortilin-related VPS10 domain containing receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434518	Sorcs2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sortilin-related VPS10 domain containing receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434516	Sorcs2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sortilin-related VPS10 domain containing receptor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841444	Sorcs3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842709	Snx10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sorting nexin 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363761	Snx11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363246	Snx11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319807	Snx11<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319788	Snx11<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 11; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5511886	Snx11<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
sorting nexin 15; targeted mutation 1.1, Velocigene	MGI:5585592	Snx15<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
sorting nexin 22; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5605826	Snx22<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
sorting nexin 22; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419474	Snx22<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841331	Snx25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841426	Snx25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 29; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548647	Snx29<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
sorting nexin 31; targeted mutation 1a, Mouse Biology Program, University of California, Davis	MGI:5497029	Snx31<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887690	Snx4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sorting nexin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887709	Snx4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sorting nexin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362512	Snx5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362512	Snx5<tm1a(KOMP)Wtsi>	26459636	KOMP-CSD
sorting nexin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363472	Snx5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473080	Snx7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sorting nexin 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472881	Snx7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sorting nexin family member 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363873	Snx21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin family member 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364016	Snx21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin family member 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362389	Snx27<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexin family member 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362389	Snx27<tm1a(KOMP)Wtsi>	24811384	KOMP-CSD
sorting nexin family member 27; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548673	Snx27<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
sorting nexin family member 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363003	Snx27<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sorting nexing 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302339	Snx24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sorting nexing 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302305	Snx24<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SOS Ras/Rac guanine nucleotide exchange factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289807	Sos1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spalt like transcription factor 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5473311	Sall1<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
spalt like transcription factor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431504	Sall1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spalt like transcription factor 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419632	Sall2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spalt like transcription factor 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431443	Sall4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SPANX family, member N4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473142	Spanxn4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SPANX family, member N4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472720	Spanxn4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SPARC related  modular calcium binding 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431709	Smoc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SPARC related  modular calcium binding 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431709	Smoc1<tm1a(EUCOMM)Wtsi>	21750680	EUCOMM
SPARC related  modular calcium binding 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431709	Smoc1<tm1a(EUCOMM)Wtsi>	22005280	EUCOMM
SPARC related  modular calcium binding 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548713	Smoc1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
SPARC related  modular calcium binding 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433559	Smoc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SPARC related modular calcium binding 2; targeted mutation 1.1, Velocigene	MGI:5529632	Smoc2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SPARC related modular calcium binding 2; targeted mutation 1.1, Velocigene	MGI:5529632	Smoc2<tm1.1(KOMP)Vlcg>	28422762	KOMP-Regeneron
SPARC related modular calcium binding 2; targeted mutation 1.1, Velocigene	MGI:5529632	Smoc2<tm1.1(KOMP)Vlcg>	28552356	KOMP-Regeneron
spastic paraplegia 20, spartin (Troyer syndrome) homolog (human); targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5548741	Spg20<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
spastin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014568	Spast<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spastin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014568	Spast<tm1a(KOMP)Wtsi>	27773584	KOMP-CSD
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820291	Spc24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944516	Spc25<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944533	Spc25<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
special AT-rich sequence binding protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436287	Satb1<tm1a(EUCOMM)Hmgu>	23142661	EUCOMM
special AT-rich sequence binding protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436287	Satb1<tm1a(EUCOMM)Hmgu>	28781169	EUCOMM
special AT-rich sequence binding protein 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548358	Satb1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
special AT-rich sequence binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364679	Satb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
special AT-rich sequence binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364679	Satb2<tm1a(KOMP)Wtsi>	26324926	KOMP-CSD
special AT-rich sequence binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364679	Satb2<tm1a(KOMP)Wtsi>	27897969	KOMP-CSD
special AT-rich sequence binding protein 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548857	Satb2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
special AT-rich sequence binding protein 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888867	Satb2<tm1c(KOMP)Wtsi>	26324926	KOMP-CSD
special AT-rich sequence binding protein 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888867	Satb2<tm1c(KOMP)Wtsi>	27897969	KOMP-CSD
special AT-rich sequence binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364303	Satb2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
special AT-rich sequence binding protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365139	Satb2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
speckle-type POZ protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455963	Spopl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
speckle-type POZ protein-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433803	Spopl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
speckle-type POZ protein-like; targeted mutation 1, Velocigene	MGI:5051359	Spopl<tm1(KOMP)Vlcg>	27930311	KOMP-Regeneron
speckle-type POZ protein-like; targeted mutation 1, Velocigene	MGI:5051359	Spopl<tm1(KOMP)Vlcg>	28412462	KOMP-Regeneron
speckle-type POZ protein; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4840778	Spop<tm1a(KOMP)Mbp>	27930311	KOMP-CSD
speckle-type POZ protein; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4840778	Spop<tm1a(KOMP)Mbp>	28412462	KOMP-CSD
speckle-type POZ protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365103	Spop<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
speckle-type POZ protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365103	Spop<tm1a(KOMP)Wtsi>	28414305	KOMP-CSD
speckle-type POZ protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513824	Spop<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
speckle-type POZ protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5513825	Spop<tm1c(KOMP)Wtsi>	28414305	KOMP-CSD
speckle-type POZ protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363896	Spop<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spectrin alpha, erythrocytic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364676	Spta1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spectrin beta, erythrocytic; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363097	Sptb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spectrin beta, erythrocytic; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363471	Sptb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spectrin beta, non-erythrocytic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432393	Sptbn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spectrin beta, non-erythrocytic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432393	Sptbn1<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
spectrin beta, non-erythrocytic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432393	Sptbn1<tm1a(EUCOMM)Wtsi>	24064296	EUCOMM
spectrin beta, non-erythrocytic 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5635107	Sptbn1<tm1c(EUCOMM)Wtsi>	24064296	EUCOMM
spectrin beta, non-erythrocytic 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431927	Sptbn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
spectrin beta, non-erythrocytic 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636946	Sptbn2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
spectrin repeat containing, nuclear envelope 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428494	Syne1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spectrin repeat containing, nuclear envelope family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419997	Syne3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spectrin repeat containing, nuclear envelope family member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548806	Syne3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
spectrin repeat containing, nuclear envelope family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419455	Syne4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spectrin repeat containing, nuclear envelope family member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419188	Syne4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
speedy/RINGO cell cycle regulator family, member E4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849974	Spdye4a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
speedy/RINGO cell cycle regulator family, member E4A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849962	Spdye4a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
speedy/RINGO cell cycle regulator family, member E4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887723	Spdye4b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
speedy/RINGO cell cycle regulator family, member E4B; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5050924	Spdye4b<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
speedy/RINGO cell cycle regulator family, member E4B; targeted mutation 3b, Wellcome Trust Sanger Institute	MGI:5548903	Spdye4b<tm3b(EUCOMM)Wtsi>	27626380	EUCOMM
speedy/RINGO cell cycle regulator family, member E4B; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5050918	Spdye4b<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
speedy/RINGO cell cycle regulator family, member E4C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140442	Spdye4c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
speedy/RINGO cell cycle regulator family, member E4C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140425	Spdye4c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SPEG complex locus; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363677	Speg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SPEG complex locus; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363677	Speg<tm1a(KOMP)Wtsi>	27729468	KOMP-CSD
SPEG complex locus; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605745	Speg<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
SPEG complex locus; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888899	Speg<tm1c(KOMP)Wtsi>	27729468	KOMP-CSD
SPEG complex locus; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363822	Speg<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sperm acrosome associated 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820239	Spaca6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sperm acrosome associated 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820222	Spaca6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sperm acrosome associated 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363025	Spaca9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sperm acrosome associated 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364148	Spaca9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 11B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009568	Spag11b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 11B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881935	Spag11b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364991	Spag17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364991	Spag17<tm1a(KOMP)Wtsi>	23418344	KOMP-CSD
sperm associated antigen 17; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635302	Spag17<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 17; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5636738	Spag17<tm1c(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 17; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5636738	Spag17<tm1c(KOMP)Wtsi>	23418344	KOMP-CSD
sperm associated antigen 17; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5636740	Spag17<tm1d(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 17; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5636740	Spag17<tm1d(KOMP)Wtsi>	23418344	KOMP-CSD
sperm associated antigen 17; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5636740	Spag17<tm1d(KOMP)Wtsi>	26017218	KOMP-CSD
sperm associated antigen 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428569	Spag17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431465	Spag1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 4; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5603354	Spag4<tm1.1(KOMP)Mbp>	28700664	KOMP-CSD
sperm associated antigen 4; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:4456603	Spag4<tm1(KOMP)Mbp>	26621829	KOMP-CSD
sperm associated antigen 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364915	Spag6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 8; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362619	Spag8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sperm associated antigen 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5301385	Spag9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spermatogenesis and centriole associated 1 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434103	Spatc1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spermatogenesis and centriole associated 1 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434249	Spatc1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
spermatogenesis and oogenesis specific basic helix-loop-helix 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887722	Sohlh1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spermatogenesis and oogenesis specific basic helix-loop-helix 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887706	Sohlh1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
spermatogenesis and oogenesis specific basic helix-loop-helix 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362980	Sohlh2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis and oogenesis specific basic helix-loop-helix 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362714	Sohlh2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 20; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363195	Spata20<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365083	Spata22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365083	Spata22<tm1a(KOMP)Wtsi>	28297563	KOMP-CSD
spermatogenesis associated 22; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569960	Spata22<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
spermatogenesis associated 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365149	Spata22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820322	Spata24<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spermatogenesis associated 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820365	Spata24<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
spermatogenesis associated 25; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451280	Spata25<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 2-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289819	Spata2l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 2; targeted mutation 1.1, Velocigene	MGI:5575898	Spata2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
spermatogenesis associated 2; targeted mutation 1, Velocigene	MGI:3800001	Spata2<tm1(KOMP)Vlcg>	28701375	KOMP-Regeneron
spermatogenesis associated 48; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364352	Spata48<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841453	Spata4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841097	Spata4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308287	Spata4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454125	Spata5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605804	Spata5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
spermatogenesis associated 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454156	Spata5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364547	Spata6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364547	Spata6<tm1a(KOMP)Wtsi>	25605924	KOMP-CSD
spermatogenesis associated 6; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548554	Spata6<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
spermatogenesis associated 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362208	Spata6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated glutamate (E)-rich protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363997	Speer2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated glutamate (E)-rich protein 4B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364964	Speer4b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated glutamate (E)-rich protein 4B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363078	Speer4b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated multipass transmembrane protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363068	Samt3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermatogenesis associated, serine-rich 2-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362740	Spats2l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sperm flagellar 1; targeted mutation 1.1, Velocigene	MGI:5695963	Spef1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
spermidine/spermine N1-acetyl transferase 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419421	Sat2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spermidine/spermine N1-acetyl transferase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939720	Satl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spermidine/spermine N1-acetyl transferase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428525	Satl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spermidine synthase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419432	Srm<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spermine oxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842834	Smox<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spermine oxidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842861	Smox<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
spermine synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431547	Sms<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spermine synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431547	Sms<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
spermine synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431547	Sms<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
spermine synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433001	Sms<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sperm maturation 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363992	Spem1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sperm mitochondria-associated cysteine-rich protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453729	Smcp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sperm mitochondria-associated cysteine-rich protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453748	Smcp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sperm specific antigen 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841304	Ssfa2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sperm tail PG rich repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293968	Stpg2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sperm tail PG rich repeat containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293930	Stpg2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sperm tail PG rich repeat containing 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294021	Stpg2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
sperm tail PG rich repeat containing 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362892	Stpg3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sperm tail PG rich repeat containing 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419593	Stpg4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SPG7, paraplegin matrix AAA peptidase subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820267	Spg7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SPG7, paraplegin matrix AAA peptidase subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4887703	Spg7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
SPG7, paraplegin matrix AAA peptidase subunit; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4887712	Spg7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sphingomyelin phosphodiesterase 1, acid lysosomal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949378	Smpd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sphingomyelin phosphodiesterase 2, neutral; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419711	Smpd2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sphingomyelin phosphodiesterase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362744	Smpd4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sphingomyelin phosphodiesterase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365181	Smpd4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sphingomyelin phosphodiesterase 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841172	Smpd4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
sphingomyelin phosphodiesterase 4; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548688	Smpd4<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
sphingomyelin phosphodiesterase 4; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548688	Smpd4<tm2b(KOMP)Wtsi>	27996060	KOMP-CSD
sphingomyelin phosphodiesterase 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841141	Smpd4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
sphingomyelin phosphodiesterase, acid-like 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433288	Smpdl3b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sphingomyelin phosphodiesterase, acid-like 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433288	Smpdl3b<tm1a(EUCOMM)Wtsi>	26095358	EUCOMM
sphingomyelin synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950245	Sgms1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sphingomyelin synthase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820056	Sgms2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sphingomyelin synthase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820055	Sgms2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sphingosine-1-phosphate phosphatase 1; targeted mutation 1, Velocigene	MGI:3808500	Sgpp1<tm1(KOMP)Vlcg>	23637227	KOMP-Regeneron
sphingosine-1-phosphate phosphatase 1; targeted mutation 1, Velocigene	MGI:3808500	Sgpp1<tm1(KOMP)Vlcg>	27059959	KOMP-Regeneron
sphingosine-1-phosphate receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306490	S1pr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sphingosine-1-phosphate receptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302312	S1pr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sphingosine-1-phosphate receptor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820359	S1pr3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sphingosine-1-phosphate receptor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820261	S1pr3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sphingosine-1-phosphate receptor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432902	S1pr5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sphingosine kinase 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4460299	Sphk2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sphingosine phosphate lyase 1; targeted mutation 1.1, Velocigene	MGI:5695887	Sgpl1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SPHK1 interactor, AKAP domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820150	Sphkap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SPHK1 interactor, AKAP domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820074	Sphkap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Spi-B transcription factor (Spi-1/PU.1 related); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939707	Spib<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Spi-B transcription factor (Spi-1/PU.1 related); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939731	Spib<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spindle and kinetochore associated complex subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451365	Ska2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spindle and kinetochore associated complex subunit 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5503136	Ska2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
spindle and kinetochore associated complex subunit 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5503136	Ska2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
spindle and kinetochore associated complex subunit 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5503136	Ska2<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
spindle and kinetochore associated complex subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451339	Ska2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spindle and kinetochore associated complex subunit 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434526	Ska3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spindle apparatus coiled-coil protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419789	Spdl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spindle apparatus coiled-coil protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419521	Spdl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spinster homolog 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432137	Spns1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
spinster homolog 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434332	Spns1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	22664872	KOMP-CSD
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	22876197	KOMP-CSD
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	23180825	KOMP-CSD
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	23870131	KOMP-CSD
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	25356849	KOMP-CSD
spinster homolog 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	28052056	KOMP-CSD
spinster homolog 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5442804	Spns2<tm1b(KOMP)Wtsi>	22664872	KOMP-CSD
spinster homolog 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5442804	Spns2<tm1b(KOMP)Wtsi>	25356849	KOMP-CSD
spinster homolog 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5442804	Spns2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
spinster homolog 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5442806	Spns2<tm1c(KOMP)Wtsi>	22664872	KOMP-CSD
spinster homolog 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5442806	Spns2<tm1c(KOMP)Wtsi>	25356849	KOMP-CSD
spinster homolog 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5442806	Spns2<tm1c(KOMP)Wtsi>	28052056	KOMP-CSD
spinster homolog 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461478	Spns2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
splA/ryanodine receptor domain and SOCS box containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433283	Spsb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
splA/ryanodine receptor domain and SOCS box containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434379	Spsb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
splA/ryanodine receptor domain and SOCS box containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419523	Spsb2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
splA/ryanodine receptor domain and SOCS box containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364437	Spsb4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spleen focus forming virus (SFFV) proviral integration oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363236	Spi1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spleen focus forming virus (SFFV) proviral integration oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364974	Spi1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
spleen focus forming virus (SFFV) proviral integration oncogene; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472918	Spi1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363626	Sf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
splicing factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362492	Sf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
splicing factor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472957	Sf1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472806	Sf1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3a, subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432817	Sf3a1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3a, subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433362	Sf3a1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3a, subunit 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432959	Sf3a1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3a, subunit 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432900	Sf3a1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3a, subunit 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456769	Sf3a1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3a, subunit 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4456832	Sf3a1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3a, subunit 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363434	Sf3a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
splicing factor 3a, subunit 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362897	Sf3a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
splicing factor 3B, subunit 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434302	Sf3b6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor 3B, subunit 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434159	Sf3b6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847863	Sfpq<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847875	Sfpq<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
splicing regulatory glutamine/lysine-rich protein 1interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433218	Srek1ip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
splicing regulatory glutamine/lysine-rich protein 1interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433873	Srek1ip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SPO11 meiotic protein covalently bound to DSB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319843	Spo11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SPO11 meiotic protein covalently bound to DSB; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319835	Spo11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SPO11 meiotic protein covalently bound to DSB; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319885	Spo11<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
SPO11 meiotic protein covalently bound to DSB; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5605762	Spo11<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
SPO11 meiotic protein covalently bound to DSB; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319866	Spo11<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
SPOC domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299563	Spocd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
spondin 1, (f-spondin) extracellular matrix protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363746	Spon1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
spondin 1, (f-spondin) extracellular matrix protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363169	Spon1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sprouty protein with EVH-1 domain 1, related sequence; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363075	Spred1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sprouty protein with EVH-1 domain 1, related sequence; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365278	Spred1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sprouty-related, EVH1 domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441704	Spred3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sprouty-related, EVH1 domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441866	Spred3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SPRY domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419967	Spryd7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SPRY domain containing 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841263	Spryd7<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050915	Spty2d1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
squalene epoxidase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431854	Sqle<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
squalene epoxidase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432568	Sqle<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
squamous cell carcinoma antigen recognized by T cells 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939732	Sart3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
squamous cell carcinoma antigen recognized by T cells 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939709	Sart3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
src homology 2 domain-containing transforming protein C1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432037	Shc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
src homology 2 domain-containing transforming protein E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434257	She<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
src homology 2 domain-containing transforming protein E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434496	She<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
src homology three (SH3) and cysteine rich domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364823	Stac<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
src homology three (SH3) and cysteine rich domain; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299625	Stac<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
src homology three (SH3) and cysteine rich domain; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5299546	Stac<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Src-like-adaptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840941	Sla2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Src-like-adaptor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841181	Sla2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362944	Srms<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364078	Srms<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SRR1 domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434389	Srrd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SRR1 domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433796	Srrd<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SR-related CTD-associated factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433923	Scaf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SR-related CTD-associated factor 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431901	Scaf11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SRY (sex determining region Y)-box 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511997	Sox11<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
SRY (sex determining region Y)-box 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433017	Sox13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SRY (sex determining region Y)-box 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433017	Sox13<tm1a(EUCOMM)Wtsi>	26525805	EUCOMM
SRY (sex determining region Y)-box 13; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5818675	Sox13<tm1c(EUCOMM)Wtsi>	26525805	EUCOMM
SRY (sex determining region Y)-box 13; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5818676	Sox13<tm1d(EUCOMM)Wtsi>	26525805	EUCOMM
SRY (sex determining region Y)-box 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434203	Sox13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SRY (sex determining region Y)-box 18; targeted mutation 1.1, Velocigene	MGI:5493275	Sox18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SRY (sex determining region Y)-box 18; targeted mutation 1.1, Velocigene	MGI:5493275	Sox18<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
SRY (sex determining region Y)-box 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451538	Sox30<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SRY (sex determining region Y)-box 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451538	Sox30<tm1a(KOMP)Wtsi>	29247201	KOMP-CSD
SRY (sex determining region Y)-box 30; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636969	Sox30<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
SRY (sex determining region Y)-box 30; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6114792	Sox30<tm1c(KOMP)Wtsi>	29247201	KOMP-CSD
SRY (sex determining region Y)-box 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451491	Sox30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SRY (sex determining region Y)-box 7; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4842209	Sox7<tm1a(EUCOMM)Hmgu>	28577909	EUCOMM
SRY (sex determining region Y)-box 7; targeted mutation 1, Velocigene	MGI:3808417	Sox7<tm1(KOMP)Vlcg>	28512199	KOMP-Regeneron
SRY (sex determining region Y)-box 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842649	Sox8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SS18, nBAF chromatin remodeling complex subunit like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363109	Ss18l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SS18, nBAF chromatin remodeling complex subunit like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365036	Ss18l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SS18, nBAF chromatin remodeling complex subunit like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308293	Ss18l1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
SS18, nBAF chromatin remodeling complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452804	Ss18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SS nuclear autoantigen 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419618	Ssna1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SS nuclear autoantigen 1; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5435074	Ssna1<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
ssu-2 homolog (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451236	Ssu2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ST3 beta-galactoside alpha-2,3-sialyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014582	St3gal1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ST3 beta-galactoside alpha-2,3-sialyltransferase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840993	St3gal6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ST3 beta-galactoside alpha-2,3-sialyltransferase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841384	St3gal6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ST3 beta-galactoside alpha-2,3-sialyltransferase 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841084	St3gal6<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441957	St6galnac2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455970	St6galnac5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842829	St8sia3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319922	St8sia3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stabilin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362272	Stab1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
stabilin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841044	Stab1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
stabilin 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841258	Stab1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
stabilizer of axonemal microtubules 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434235	Saxo1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
stabilizer of axonemal microtubules 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434361	Saxo1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stabilizer of axonemal microtubules 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364426	Saxo2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stabilizer of axonemal microtubules 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363275	Saxo2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
STAM binding protein like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363647	Stambpl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
STAM binding protein like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365140	Stambpl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
STAM binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887630	Stambp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
starch binding domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050870	Stbd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
starch binding domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050881	Stbd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
STARD3 N-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433420	Stard3nl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
STARD3 N-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431648	Stard3nl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
StAR-related lipid transfer (START) domain containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363733	Stard13<tm1a(KOMP)Wtsi>	20208559	KOMP-CSD
StAR-related lipid transfer (START) domain containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363733	Stard13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
StAR-related lipid transfer (START) domain containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363733	Stard13<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
StAR-related lipid transfer (START) domain containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363733	Stard13<tm1a(KOMP)Wtsi>	26398943	KOMP-CSD
StAR-related lipid transfer (START) domain containing 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363106	Stard13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
StAR-related lipid transfer (START) domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363394	Stard4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
StAR-related lipid transfer (START) domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362630	Stard4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
StAR-related lipid transfer (START) domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363550	Stard5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
StAR-related lipid transfer (START) domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363550	Stard5<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
StAR-related lipid transfer (START) domain containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363996	Stard5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
StAR-related lipid transfer (START) domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362248	Stard6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
START domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419294	Stard10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
START domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419294	Stard10<tm1a(KOMP)Wtsi>	28132686	KOMP-CSD
START domain containing 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548497	Stard10<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
START domain containing 10; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5692642	Stard10<tm1c(KOMP)Wtsi>	28132686	KOMP-CSD
START domain containing 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419533	Stard10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
START domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458612	Stard3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
START domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458651	Stard3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
START domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433666	Stard7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
START domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433666	Stard7<tm1a(EUCOMM)Wtsi>	23620107	EUCOMM
START domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433666	Stard7<tm1a(EUCOMM)Wtsi>	25980009	EUCOMM
START domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433042	Stard7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
START domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434109	Stard8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
START domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434109	Stard8<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
START domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434109	Stard8<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
START domain containing 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548840	Stard8<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
START domain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433369	Stard8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stathmin domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462581	Stmnd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stathmin domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462606	Stmnd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
stathmin-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949335	Stmn4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stathmin-like 4; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635383	Stmn4<tm1b(KOMP)Wtsi>	18478032	KOMP-CSD
staufen double-stranded RNA binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431690	Stau2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
staufen double-stranded RNA binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434495	Stau2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
STE20-like kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419251	Slk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
STE20-like kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420096	Slk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
STE20-related kinase adaptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951088	Strada<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
STE20-related kinase adaptor beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887620	Stradb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
STE20-related kinase adaptor beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887587	Stradb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
STEAP family member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451498	Steap4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stearoyl-Coenzyme A desaturase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434380	Scd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stearoyl-coenzyme A desaturase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362826	Scd4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stearoyl-coenzyme A desaturase 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362285	Scd4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
stefin A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014597	Stfa2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sterile alpha and HEAT/Armadillo motif containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362931	Sarm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sterile alpha and HEAT/Armadillo motif containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451695	Sarm1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
sterile alpha and HEAT/Armadillo motif containing 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5286180	Sarm1<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
sterile alpha motif domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433653	Samd8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sterile alpha motif domain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434189	Samd8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sterile alpha motif domain containing 9-like; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548452	Samd9l<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
sterile alpha motif domain containing 9-like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362671	Samd9l<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
steroid 5 alpha-reductase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362787	Srd5a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
steroid 5 alpha-reductase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362700	Srd5a1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
steroid 5 alpha-reductase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456804	Srd5a3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
steroid 5 alpha-reductase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520177	Srd5a3<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
steroid 5 alpha-reductase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520177	Srd5a3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
steroid 5 alpha-reductase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5520177	Srd5a3<tm1b(EUCOMM)Wtsi>	28700664	EUCOMM
steroid 5 alpha-reductase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456755	Srd5a3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
steroid receptor associated and regulated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419998	Srarp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
steroid receptor associated and regulated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419494	Srarp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
steroid receptor RNA activator 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434735	Sra1<tm1a(EUCOMM)Hmgu>	24675075	EUCOMM
steroid receptor RNA activator 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513826	Sra1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
sterol-C5-desaturase; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451883	Sc5d<tm1a(EUCOMM)Hmgu>	28330720	EUCOMM
sterol-C5-desaturase; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5909263	Sc5d<tm1c(EUCOMM)Hmgu>	28330720	EUCOMM
sterol-C5-desaturase; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5909263	Sc5d<tm1c(EUCOMM)Hmgu>	28774592	EUCOMM
sterol carrier protein 2, liver; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458551	Scp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sterol carrier protein 2, liver; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458613	Scp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
stimulated by retinoic acid gene 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431838	Stra6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
stimulated by retinoic acid gene 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432005	Stra6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stomatin (Epb7.2)-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452682	Stoml3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stomatin (Epb7.2)-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841347	Stoml3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
stomatin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842339	Stoml1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
stomatin-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842815	Stoml1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stomatin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296539	Stom<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stonin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451623	Ston2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stonin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451493	Ston2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
store-operated calcium entry-associated regulatory factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820172	Saraf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
store-operated calcium entry-associated regulatory factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820167	Saraf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
store-operated calcium entry-associated regulatory factor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299596	Saraf<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
store-operated calcium entry-associated regulatory factor; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5428500	Saraf<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
STRA6-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362447	Stra6l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
STRA6-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362447	Stra6l<tm1a(KOMP)Wtsi>	23105095	KOMP-CSD
STRA6-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548638	Stra6l<tm1b(KOMP)Wtsi>	23105095	KOMP-CSD
STRA6-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548638	Stra6l<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
STRA6-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365062	Stra6l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
stratifin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473186	Sfn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
stratifin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472759	Sfn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stress-associated endoplasmic reticulum protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433227	Serp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
stress-associated endoplasmic reticulum protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433473	Serp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stress-induced phosphoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841341	Stip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stress-induced phosphoprotein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841406	Stip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
striatin, calmodulin binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454130	Strn3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
striatin, calmodulin binding protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468974	Strn3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
striatin, calmodulin binding protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5468974	Strn3<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
striatin, calmodulin binding protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454155	Strn3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
striatin, calmodulin binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363225	Strn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
striatin, calmodulin binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363225	Strn<tm1a(KOMP)Wtsi>	25368024	KOMP-CSD
striatin, calmodulin binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363225	Strn<tm1a(KOMP)Wtsi>	26169051	KOMP-CSD
striatin interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362804	Strip1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
striatin interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364580	Strip1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
striatin interacting protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473098	Strip1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
striatin interacting protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472893	Strip1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
stromal antigen 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431940	Stag2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
stromal antigen 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5909046	Stag2<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
stromal antigen 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433063	Stag2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
stromal antigen 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527604	Stag2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
stromal antigen 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451585	Stag3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
stromal antigen 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451585	Stag3<tm1a(KOMP)Wtsi>	24797474	KOMP-CSD
stromal antigen 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446234	Stag3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
stromal antigen 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446234	Stag3<tm1b(KOMP)Wtsi>	24992337	KOMP-CSD
stromal antigen 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5446234	Stag3<tm1b(KOMP)Wtsi>	27172213	KOMP-CSD
stromal antigen 3; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5565201	Stag3<tm1e.1(KOMP)Wtsi>	21677750	KOMP-CSD
stromal antigen 3; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5565201	Stag3<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
stromal antigen 3; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5565201	Stag3<tm1e.1(KOMP)Wtsi>	28700664	KOMP-CSD
stromal antigen 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451647	Stag3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
stromal cell-derived factor 2-like 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419479	Sdf2l1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
structural maintenance of chromosomes 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302317	Smc1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
structural maintenance of chromosomes 1A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302369	Smc1a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	26438361	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	26903600	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	27135601	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	28424523	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5896795	Smc3<tm1c(EUCOMM)Wtsi>	26438361	EUCOMM
structural maintenance of chromosomes 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5896795	Smc3<tm1c(EUCOMM)Wtsi>	28424523	EUCOMM
structural maintenance of chromosomes 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419231	Smc5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
structural maintenance of chromosomes 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419231	Smc5<tm1a(KOMP)Wtsi>	26919979	KOMP-CSD
structural maintenance of chromosomes 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5602831	Smc5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
structural maintenance of chromosomes 5; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5882565	Smc5<tm1c(KOMP)Wtsi>	26919979	KOMP-CSD
structural maintenance of chromosomes 5; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5882565	Smc5<tm1c(KOMP)Wtsi>	28302748	KOMP-CSD
structural maintenance of chromosomes 5; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5882566	Smc5<tm1d(KOMP)Wtsi>	26919979	KOMP-CSD
structural maintenance of chromosomes 5; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5882566	Smc5<tm1d(KOMP)Wtsi>	28302748	KOMP-CSD
structural maintenance of chromosomes 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420054	Smc5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
structure specific recognition protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461716	Ssrp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
structure specific recognition protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461656	Ssrp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SUB1 homolog (S. cerevisiae); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419641	Sub1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
submandibular gland protein C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419702	Smgc<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
succinate-CoA ligase, GDP-forming, alpha subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431883	Suclg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
succinate-CoA ligase, GDP-forming, alpha subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433049	Suclg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
succinate-Coenzyme A ligase, ADP-forming, beta subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5300814	Sucla2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
succinate-Coenzyme A ligase, ADP-forming, beta subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432841	Sucla2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
succinate dehydrogenase complex assembly factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451977	Sdhaf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
succinate dehydrogenase complex assembly factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452020	Sdhaf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
succinate dehydrogenase complex assembly factor 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473102	Sdhaf2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
succinate dehydrogenase complex assembly factor 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472898	Sdhaf2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
succinate dehydrogenase complex, subunit A, flavoprotein (Fp); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362659	Sdha<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
succinate dehydrogenase complex, subunit A, flavoprotein (Fp); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841058	Sdha<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
succinate dehydrogenase complex, subunit A, flavoprotein (Fp); targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5498775	Sdha<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
succinate dehydrogenase complex, subunit A, flavoprotein (Fp); targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5498775	Sdha<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
succinate dehydrogenase complex, subunit A, flavoprotein (Fp); targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5498775	Sdha<tm2b(KOMP)Wtsi>	28700664	KOMP-CSD
succinate dehydrogenase complex, subunit A, flavoprotein (Fp); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841144	Sdha<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
succinate dehydrogenase complex, subunit B, iron sulfur (Ip); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548548	Sdhb<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
succinate dehydrogenase complex, subunit C, integral membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433079	Sdhc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
succinate dehydrogenase complex, subunit C, integral membrane protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433079	Sdhc<tm1a(EUCOMM)Wtsi>	25985299	EUCOMM
succinate dehydrogenase complex, subunit C, integral membrane protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5694171	Sdhc<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
succinate dehydrogenase complex, subunit C, integral membrane protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5805498	Sdhc<tm1c(EUCOMM)Wtsi>	25985299	EUCOMM
succinate dehydrogenase complex, subunit C, integral membrane protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431761	Sdhc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
succinate receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432434	Sucnr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
succinate receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432434	Sucnr1<tm1a(EUCOMM)Wtsi>	25352636	EUCOMM
succinate receptor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5910687	Sucnr1<tm1b(EUCOMM)Wtsi>	25352636	EUCOMM
succinate receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433312	Sucnr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sucrase isomaltase (alpha-glucosidase); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319808	Sis<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SUFU negative regulator of hedgehog signaling; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880885	Sufu<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SUFU negative regulator of hedgehog signaling; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569947	Sufu<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
SUFU negative regulator of hedgehog signaling; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880918	Sufu<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sulfatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868833	Sulf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfatase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868831	Sulf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sulfatase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847693	Sulf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfatase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847694	Sulf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sulfatase modifying factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362283	Sumf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 1A, phenol-preferring, member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419356	Sult1a1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 1B, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363093	Sult1b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 1D, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364850	Sult1d1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 1E, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014602	Sult1e1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950963	Sult2a4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287799	Sult2a6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362821	Sult2a8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362731	Sult2a8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5289831	Sult2a8<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family, cytosolic, 1C, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841111	Sult1c1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family, cytosolic, 1C, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636889	Sult1c1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
sulfotransferase family, cytosolic, 1C, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841270	Sult1c1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family, cytosolic, 1C, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841360	Sult1c2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sulfotransferase family, cytosolic, 2B, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460470	Sult2b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sulfotransferase family, cytosolic, 6B, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431844	Sult6b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sulfotransferase family, cytosolic, 6B, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433055	Sult6b1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SUMO-interacting motifs containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363931	Simc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
SUMO/sentrin specific peptidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868085	Senp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SUMO/sentrin specific peptidase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868079	Senp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SUMO/sentrin specific peptidase 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473221	Senp3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
superkiller viralicidic activity 2-like 2 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939692	Skiv2l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
superkiller viralicidic activity 2-like 2 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939722	Skiv2l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
superkiller viralicidic activity 2-like (S. cerevisiae); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050942	Skiv2l<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
superoxide dismutase 1, soluble; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419149	Sod1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
superoxide dismutase 1, soluble; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419511	Sod1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
superoxide dismutase 3, extracellular; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419855	Sod3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
superoxide dismutase 3, extracellular; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420101	Sod3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
supervillin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455983	Svil<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
supervillin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456020	Svil<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
suppression of tumorigenicity 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362871	St13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
suppression of tumorigenicity 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363363	St18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of cancer cell invasion; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435163	Scai<tm1a(EUCOMM)Hmgu>	27820601	EUCOMM
suppressor of cancer cell invasion; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5898410	Scai<tm1b(EUCOMM)Hmgu>	27820601	EUCOMM
suppressor of cytokine signaling 1; targeted mutation 1.1, Velocigene	MGI:5584406	Socs1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
suppressor of cytokine signaling 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942133	Socs2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942144	Socs2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419278	Socs3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of cytokine signaling 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434370	Socs4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472976	Socs4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451986	Socs6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432554	Socs7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432554	Socs7<tm1a(EUCOMM)Wtsi>	24210661	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432554	Socs7<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5545789	Socs7<tm1c(EUCOMM)Wtsi>	24210661	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434028	Socs7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433687	Socs7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434072	Socs7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of cytokine signaling 7; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456738	Socs7<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of Ty 4A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605739	Supt4a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
suppressor of Ty 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363736	Supt5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of Ty 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428561	Supt5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of Ty 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840996	Supt5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of Ty 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841149	Supt5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of Ty 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419666	Supt6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of Ty 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419411	Supt6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
suppressor of Ty 7-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432224	Supt7l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of Ty 7-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433972	Supt7l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of var1, 3-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434293	Supv3l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
suppressor of var1, 3-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434293	Supv3l1<tm1a(EUCOMM)Wtsi>	28981838	EUCOMM
suppressor of var1, 3-like 1 (S. cerevisiae); targeted mutation 1, William C Skarnes	MGI:5903614	Supv3l1<tm1Wcs>	28981838	null
suppressor of variegation 3-9 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420002	Suv39h2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
surfactant associated protein A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363216	Sftpa1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
surfactant associated protein A1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362542	Sftpa1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
surfactant associated protein D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451353	Sftpd<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
surfactant associated protein D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451506	Sftpd<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
surfeit gene 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433387	Surf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
surfeit gene 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433946	Surf4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SURP and G patch domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944335	Sugp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SURP and G patch domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944373	Sugp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SURP and G patch domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451447	Sugp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
survival motor neuron domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432000	Smndc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
survival motor neuron domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433611	Smndc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sushi domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842781	Susd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sushi domain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050979	Susd2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sushi domain containing 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5050904	Susd2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sushi domain containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840646	Susd3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
sushi domain containing 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840584	Susd3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
sushi domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296544	Susd4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sushi domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299573	Susd6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sushi, nidogen and EGF-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362972	Sned1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
sushi, nidogen and EGF-like domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365197	Sned1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
sushi-repeat-containing protein, X-linked 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085482	Srpx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
sushi-repeat-containing protein, X-linked 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294233	Srpx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5286317	Svep1<tm1a(EUCOMM)Hmgu>	27892606	EUCOMM
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5286317	Svep1<tm1a(EUCOMM)Hmgu>	28179432	EUCOMM
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5509058	Svep1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5509058	Svep1<tm1b(EUCOMM)Hmgu>	27892606	EUCOMM
SUZ12 polycomb repressive complex 2 subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432499	Suz12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SUZ12 polycomb repressive complex 2 subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434319	Suz12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SUZ RNA binding domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286246	Szrd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SV2 related protein homolog (rat)-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362844	Svopl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SV2 related protein homolog (rat)-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362331	Svopl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SWI5 dependent recombination repair 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419767	Sfr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SWI5 dependent recombination repair 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419866	Sfr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SWI5 recombination repair homolog (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432232	Swi5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SWI/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433467	Smarcal1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456643	Smarca1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286225	Smarca2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426588	Smarca2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431662	Smarca5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434262	Smarca5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433095	Smarcc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2; targeted mutation 1.1, Velocigene	MGI:5558158	Smarcd2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2; targeted mutation 1.1, Velocigene	MGI:5558158	Smarcd2<tm1.1(KOMP)Vlcg>	28303890	KOMP-Regeneron
SYF2 homolog, RNA splicing factor (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432411	Syf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SYF2 homolog, RNA splicing factor (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431791	Syf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
symplekin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434309	Sympk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
symplekin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434309	Sympk<tm1a(EUCOMM)Wtsi>	28535374	EUCOMM
synapse associated protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4841544	Syap1<tm1a(EUCOMM)Hmgu>	27344443	EUCOMM
synapse defective 1, Rho GTPase, homolog 1 (C. elegans); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4841821	Syde1<tm1a(EUCOMM)Hmgu>	23791195	EUCOMM
synapse defective 1, Rho GTPase, homolog 2 (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951103	Syde2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synapse differentiation inducing 1 like; targeted mutation 1.1, Velocigene	MGI:5548866	Syndig1l<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
synapse differentiation inducing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455603	Syndig1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synapse differentiation inducing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455559	Syndig1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synapsin III; targeted mutation 1.1, Velocigene	MGI:5507835	Syn3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
synapsin III; targeted mutation 1.1, Velocigene	MGI:5507835	Syn3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
synapsin III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820354	Syn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synapsin III; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820300	Syn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptic vesicle glycoprotein 2 a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456038	Sv2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptic vesicle glycoprotein 2 a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456031	Sv2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptic vesicle glycoprotein 2c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441757	Sv2c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptic vesicle glycoprotein 2c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847866	Sv2c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptogyrin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842518	Syngr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptogyrin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842635	Syngr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptogyrin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364282	Syngr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptogyrin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362334	Syngr2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptogyrin 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527614	Syngr2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptogyrin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364856	Syngr3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptojanin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432121	Synj1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptojanin 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636987	Synj1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
synaptojanin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432146	Synj1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptojanin 2 binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287778	Synj2bp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptojanin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432435	Synj2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptonemal complex central element protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419504	Syce1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptonemal complex central element protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614613	Syce1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
synaptonemal complex central element protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419719	Syce1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptonemal complex central element protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434251	Syce2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptonemal complex central element protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433617	Syce2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptonemal complex protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453767	Sycp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptonemal complex protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453775	Sycp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptonemal complex protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428548	Sycp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptonemal complex protein 3; targeted mutation 1.1, Velocigene	MGI:5494477	Sycp3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
synaptonemal complex protein 3; targeted mutation 1.1, Velocigene	MGI:5494477	Sycp3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
synaptonemal complex protein 3; targeted mutation 1, Velocigene	MGI:3812992	Sycp3<tm1(KOMP)Vlcg>	28700664	KOMP-Regeneron
synaptophysin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014585	Sypl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptophysin-like protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363848	Sypl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptophysin-like protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513828	Sypl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
synaptopodin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441661	Synpo2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptopodin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548760	Synpo2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
synaptopodin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442006	Synpo2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptopodin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441946	Synpo<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptopodin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441780	Synpo<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptoporin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319820	Synpr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptoporin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841473	Synpr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptosomal-associated protein 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460454	Snap23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptosomal-associated protein 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461699	Snap23<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptosomal-associated protein 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433565	Snap29<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptosomal-associated protein 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433565	Snap29<tm1a(EUCOMM)Wtsi>	26747696	EUCOMM
synaptosomal-associated protein 29; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5812298	Snap29<tm1b(EUCOMM)Wtsi>	26747696	EUCOMM
synaptosomal-associated protein 29; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5812297	Snap29<tm1c(EUCOMM)Wtsi>	26747696	EUCOMM
synaptosomal-associated protein 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431534	Snap29<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptosomal-associated protein, 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433792	Snap47<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptosomal-associated protein, 47; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431917	Snap47<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433916	Syt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin III; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434419	Syt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin III; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511927	Syt3<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432835	Syt2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433781	Syt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433781	Syt1<tm1a(EUCOMM)Wtsi>	26280336	EUCOMM
synaptotagmin I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433781	Syt1<tm1a(EUCOMM)Wtsi>	27210552	EUCOMM
synaptotagmin I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433781	Syt1<tm1a(EUCOMM)Wtsi>	28363983	EUCOMM
synaptotagmin I; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5908401	Syt1<tm1c(EUCOMM)Wtsi>	28363983	EUCOMM
synaptotagmin I; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4942154	Syt1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin I; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4942151	Syt1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin IX; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362843	Syt9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin IX; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364540	Syt9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin IX; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308295	Syt9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin IX; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5308283	Syt9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363391	Sytl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363391	Sytl1<tm1a(KOMP)Wtsi>	22438581	KOMP-CSD
synaptotagmin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363391	Sytl1<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
synaptotagmin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363391	Sytl1<tm1a(KOMP)Wtsi>	27701149	KOMP-CSD
synaptotagmin-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365195	Sytl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin-like 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455523	Sytl2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin-like 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455566	Sytl2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin-like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841273	Sytl4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462624	Sytl5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin VIII; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362410	Syt8<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin VII; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287806	Syt7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin VI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362319	Syt6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin VI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364369	Syt6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin XII; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363185	Syt12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin XII; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363797	Syt12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin XIV; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4868088	Syt14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin XIV; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881075	Syt14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin XVII; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841237	Syt17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin XVII; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548356	Syt17<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
synaptotagmin XVII; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841125	Syt17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin XVI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842316	Syt16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin XVI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842887	Syt16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synaptotagmin XV; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363601	Syt15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
synaptotagmin XV; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364764	Syt15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syncoilin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5306506	Sync<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
syncoilin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301406	Sync<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
syndecan 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363506	Sdc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364677	Sdc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364777	Sdc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548470	Sdc2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
syndecan 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364628	Sdc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364884	Sdc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364063	Sdc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451381	Sdc4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451554	Sdc4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363272	Sdcbp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syndecan binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363272	Sdcbp<tm1a(KOMP)Wtsi>	25880340	KOMP-CSD
syndecan binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363272	Sdcbp<tm1a(KOMP)Wtsi>	27341128	KOMP-CSD
syndecan binding protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5766222	Sdcbp<tm1c(KOMP)Wtsi>	25880340	KOMP-CSD
syndecan binding protein; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5766222	Sdcbp<tm1c(KOMP)Wtsi>	27341128	KOMP-CSD
synemin, intermediate filament protein; targeted mutation 1.1, Velocigene	MGI:5548847	Synm<tm1.1(KOMP)Vlcg>	25567810	KOMP-Regeneron
synemin, intermediate filament protein; targeted mutation 1.1, Velocigene	MGI:5548847	Synm<tm1.1(KOMP)Vlcg>	27605453	KOMP-Regeneron
synemin, intermediate filament protein; targeted mutation 1.1, Velocigene	MGI:5548847	Synm<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
synergin, gamma; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460472	Synrg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synergin, gamma; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461724	Synrg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
syntaphilin; targeted mutation 1.1, Velocigene	MGI:5548740	Snph<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
syntaxin 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949328	Stx11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887644	Stx11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362792	Stx16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 16; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494475	Stx16<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 16; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494475	Stx16<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
syntaxin 16; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494475	Stx16<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
syntaxin 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362784	Stx16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880958	Stx17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362933	Stx18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364385	Stx18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 18; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362959	Stx18<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 18; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5529067	Stx18<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 18; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364087	Stx18<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin 19; targeted mutation 1.1, Velocigene	MGI:5603918	Stx19<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
syntaxin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887685	Stx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5694786	Stx2<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887707	Stx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin 3; targeted mutation 1.1, Velocigene	MGI:5529499	Stx3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
syntaxin 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432265	Stx8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432715	Stx8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432376	Stx8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432376	Stx8<tm2a(EUCOMM)Wtsi>	24652767	EUCOMM
syntaxin 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432376	Stx8<tm2a(EUCOMM)Wtsi>	25404741	EUCOMM
syntaxin 8; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433825	Stx8<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin 8; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456771	Stx8<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin binding protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434674	Stxbp1<tm1a(EUCOMM)Hmgu>	28821673	EUCOMM
syntaxin binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286209	Stxbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426574	Stxbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5428593	Stxbp2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin binding protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5428580	Stxbp2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
syntaxin binding protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441932	Stxbp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin binding protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441745	Stxbp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin binding protein 5-like; targeted mutation 1.1, Velocigene	MGI:5695954	Stxbp5l<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
syntaxin binding protein 5-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948654	Stxbp5l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
syntaxin binding protein 6 (amisyn); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841192	Stxbp6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syntrophin, basic 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441687	Sntb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
syntrophin, gamma 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431870	Sntg1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
syntrophin, gamma 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433258	Sntg1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
syntrophin, gamma 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319787	Sntg2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
syntrophin, gamma 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364728	Sntg2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
syntrophin, gamma 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365019	Sntg2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
syntrophin, gamma 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319863	Sntg2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
syntrophin, gamma 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4365111	Sntg2<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
syntrophin, gamma 2; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319909	Sntg2<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
synuclein, alpha interacting protein (synphilin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938575	Sncaip<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
synuclein, alpha interacting protein (synphilin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938569	Sncaip<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
synuclein, beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842505	Sncb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434005	Sys1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432254	Sys1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tachykinin receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008936	Tacr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tachykinin receptor 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420122	Tacr2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
talin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433023	Tln1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
talin 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456794	Tln1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
talin 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456824	Tln1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
TAM41 mitochondrial translocator assembly and maintenance homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820070	Tamm41<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TAM41 mitochondrial translocator assembly and maintenance homolog; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820082	Tamm41<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tandem C2 domains, nuclear; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841131	Tc2n<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TANK-binding kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140427	Tbk1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363205	Tnks2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5473325	Tnks2<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362151	Tnks2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TAP binding protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364196	Tapbpl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TAP binding protein-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428563	Tapbpl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
taperin; targeted mutation 1.1, Velocigene	MGI:5445918	Tprn<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
taperin; targeted mutation 1.1, Velocigene	MGI:5445918	Tprn<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
TAR DNA binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140493	Tardbp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TAR DNA binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140469	Tardbp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
target of EGR1, member 1 (nuclear); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419721	Toe1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
target of myb1-like 1 (chicken); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458496	Tom1l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
target of myb1-like 1 (chicken); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458631	Tom1l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
taspase, threonine aspartase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363420	Tasp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
taspase, threonine aspartase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363799	Tasp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
taste receptor, type 1, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441871	Tas1r1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
taste receptor, type 1, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441959	Tas1r1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
taste receptor, type 1, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363912	Tas1r2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
taste receptor, type 1, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362140	Tas1r2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
taste receptor, type 1, member 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431452	Tas1r3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
TATA-box binding protein associated factor 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842481	Taf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842735	Taf11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287777	Taf15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TATA-box binding protein associated factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432973	Taf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433708	Taf4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 5 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451969	Taf5l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 5 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452013	Taf5l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 6 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944381	Taf6l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TATA-box binding protein associated factor 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432067	Taf6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434131	Taf6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050906	Taf8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
TATA-box binding protein associated factor 9B; targeted mutation 1, Velocigene	MGI:4415411	Taf9b<tm1(KOMP)Vlcg>	25006164	KOMP-Regeneron
TATA box binding protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841133	Tbpl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TATA box binding protein-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841430	Tbpl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TATA box binding protein like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5464328	Tbpl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TATA box binding protein like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5464321	Tbpl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TATA box binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5085467	Tbp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TATA element modulatory factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364489	Tmf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TATA element modulatory factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365009	Tmf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TatD DNase domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431974	Tatdn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TatD DNase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432974	Tatdn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TatD DNase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431994	Tatdn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TatD DNase domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431994	Tatdn3<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
TatD DNase domain containing 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548575	Tatdn3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
TatD DNase domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433864	Tatdn3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tau tubulin kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454073	Ttbk1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tau tubulin kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454103	Ttbk1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1D12: TBC1 domain family, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5300815	Tbc1d12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432028	Tbc1d10a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434031	Tbc1d10a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10a; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432519	Tbc1d10a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10a; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432519	Tbc1d10a<tm2a(EUCOMM)Wtsi>	24652767	EUCOMM
TBC1 domain family, member 10a; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432519	Tbc1d10a<tm2a(EUCOMM)Wtsi>	26398943	EUCOMM
TBC1 domain family, member 10a; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433087	Tbc1d10a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10a; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456741	Tbc1d10a<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10a; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4456751	Tbc1d10a<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432531	Tbc1d10c<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 10c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434305	Tbc1d10c<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460514	Tbc1d13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460443	Tbc1d13<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050865	Tbc1d14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363466	Tbc1d15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362562	Tbc1d15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 15; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511943	Tbc1d15<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 15; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511906	Tbc1d15<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362233	Tbc1d17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363245	Tbc1d17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 17; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364420	Tbc1d17<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849375	Tbc1d1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5013748	Tbc1d1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 22a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014583	Tbc1d22a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 22a; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636942	Tbc1d22a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
TBC1 domain family, member 22a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140417	Tbc1d22a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950953	Tbc1d23<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 23; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4950956	Tbc1d23<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5299621	Tbc1d30<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428518	Tbc1d30<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBC1 domain family, member 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303171	Tbc1d31<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5303167	Tbc1d31<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TBC1 domain family, member 4; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451780	Tbc1d4<tm1a(EUCOMM)Hmgu>	27554475	EUCOMM
TBC1 domain family, member 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5585586	Tbc1d4<tm1b(EUCOMM)Hmgu>	27554475	EUCOMM
TBC1 domain family, member 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5585586	Tbc1d4<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
TBC1 domain family, member 4; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6111786	Tbc1d4<tm1c(EUCOMM)Hmgu>	27554475	EUCOMM
TBCC domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5581733	Tbccd1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
TBC/LysM associated domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849978	Tldc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TBC/LysM associated domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849961	Tldc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TBK1 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842322	Tbkbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TBK1 binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548632	Tbkbp1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
TBK1 binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842627	Tbkbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
T-box 10; targeted mutation 2b, Helmholtz Zentrum Muenchen GmbH	MGI:5561556	Tbx10<tm2b(EUCOMM)Hmgu>	27626380	EUCOMM
T-box 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462685	Tbx20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
T-box 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461736	Tbx20<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
T-box 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364367	Tbx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
T-box 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319828	Tbx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
T-box 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431502	Tbx4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
T-box 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456663	Tbx4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
T-box 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456653	Tbx4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
T-box 4; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5002990	Tbx4<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
T-box 4; targeted mutation 4b, Wellcome Trust Sanger Institute	MGI:5548329	Tbx4<tm4b(EUCOMM)Wtsi>	27626380	EUCOMM
TCDD-inducible poly(ADP-ribose) polymerase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842535	Tiparp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TCDD-inducible poly(ADP-ribose) polymerase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842832	Tiparp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
T cell activation inhibitor, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433698	Tcaim<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
T cell activation inhibitor, mitochondrial; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5577263	Tcaim<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
T cell activation inhibitor, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434432	Tcaim<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
T cell activation Rho GTPase activating protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428573	Tagap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
T cell immunoglobulin and mucin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462600	Timd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
T cell immunoglobulin and mucin domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462590	Timd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
T cell leukemia, homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428541	Tlx1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
T cell leukemia, homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428495	Tlx1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
T cell leukemia/lymphoma 1B, 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5013743	Tcl1b5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
T cell leukemia/lymphoma 1B, 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014584	Tcl1b5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
T cell receptor alpha variable 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841214	Trav1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
T cell receptor alpha variable 7-4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420103	Trav7-4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
TCF3 (E2A) fusion partner; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433742	Tfpt<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TCF3 (E2A) fusion partner; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432172	Tfpt<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
t-complex 11 family, X-linked 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950958	Tcp11x2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
t-complex 11 like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365011	Tcp11l1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
t-complex 11 like 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286265	Tcp11l1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
t-complex-associated testis expressed 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820083	Tcte1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
t-complex-associated testis expressed 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820083	Tcte1<tm1a(KOMP)Wtsi>	28630322	KOMP-CSD
t-complex-associated testis expressed 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820117	Tcte1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
t-complex protein 10b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362611	Tcp10b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
t-complex protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842472	Tcp11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
t-complex protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842517	Tcp11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Tctex1 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455988	Tctex1d1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Tctex1 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456072	Tctex1d1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Tctex1 domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432459	Tctex1d2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Tctex1 domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431764	Tctex1d2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Tctex1 domain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472698	Tctex1d2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
Tctex1 domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457574	Tctex1d4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Tctex1 domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457572	Tctex1d4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TDP-glucose 4,6-dehydratase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454075	Tgds<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TEA domain family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364091	Tead1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TEA domain family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364091	Tead1<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
TEA domain family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364091	Tead1<tm1a(KOMP)Wtsi>	29193599	KOMP-CSD
TEA domain family member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548324	Tead1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
TEA domain family member 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111824	Tead1<tm1c(KOMP)Wtsi>	28878117	KOMP-CSD
TEA domain family member 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6111824	Tead1<tm1c(KOMP)Wtsi>	29193599	KOMP-CSD
TEA domain family member 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6115825	Tead1<tm1d(KOMP)Wtsi>	29193599	KOMP-CSD
TEA domain family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431809	Tead3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
teashirt zinc finger family member 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431477	Tshz3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tec protein tyrosine kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441893	Tec<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tec protein tyrosine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441793	Tec<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tectonic family member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431646	Tctn1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tectonic family member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431763	Tctn1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tectonic family member 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473072	Tctn1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tectonin beta-propeller repeat containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432736	Tecpr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tectonin beta-propeller repeat containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431617	Tecpr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tectonin beta-propeller repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363351	Tecpr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tectorin beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362819	Tectb<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tectorin beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363257	Tectb<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tektin 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419230	Tekt2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tektin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362209	Tekt4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tektin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362544	Tekt4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TELO2 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286217	Tti2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TELO2 interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293914	Tti2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
telomerase associated protein 1; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766168	Tep1<tm1b(NCOM)Mfgc>	27626380	NorCOMM
telomerase reverse transcriptase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882026	Tert<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
telomere repeat binding bouquet formation protein 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4843634	Terb1<tm1a(KOMP)Mbp>	24413433	KOMP-CSD
telomere repeat binding bouquet formation protein 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4843634	Terb1<tm1a(KOMP)Mbp>	26548954	KOMP-CSD
telomere repeat binding bouquet formation protein 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4843634	Terb1<tm1a(KOMP)Mbp>	29083414	KOMP-CSD
telomere repeat binding bouquet formation protein 1; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5583074	Terb1<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
telomere repeat binding bouquet formation protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363273	Terb2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
telomeric repeat binding factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432857	Terf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
telomeric repeat binding factor 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432733	Terf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tenascin C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434208	Tnc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tenascin C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434402	Tnc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tenascin N; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887585	Tnn<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tenascin N; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887640	Tnn<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tenascin R; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428550	Tnr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tenascin R; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428512	Tnr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
teneurin transmembrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434497	Tenm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
teneurin transmembrane protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4456002	Tenm1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
teneurin transmembrane protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456050	Tenm1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
teneurin transmembrane protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434073	Tenm3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
teneurin transmembrane protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4944564	Tenm3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
teneurin transmembrane protein 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4944539	Tenm3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
teneurin transmembrane protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441916	Tenm4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
teneurin transmembrane protein 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452024	Tenm4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tensin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840987	Tns2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tensin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840945	Tns2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tensin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296122	Tns3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tensin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362454	Tns4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tensin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364623	Tns4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tensin 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363300	Tns4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
TEPSIN, adaptor related protein complex 4 accessory protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840947	Tepsin<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TEPSIN, adaptor related protein complex 4 accessory protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637095	Tepsin<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
TEPSIN, adaptor related protein complex 4 accessory protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841047	Tepsin<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
terminal uridylyl transferase 1, U6 snRNA-specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944495	Tut1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
terminal uridylyl transferase 1, U6 snRNA-specific; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944527	Tut1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tescalcin-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473164	Tescl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tescalcin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434512	Tesc<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tescalcin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431947	Tesc<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testicular cell adhesion molecule 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434376	Tcam1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testicular cell adhesion molecule 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441899	Tcam1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
testicular cell adhesion molecule 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441725	Tcam1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
testicular haploid expressed gene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052416	Theg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis derived transcript; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433251	Tes<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis derived transcript; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431565	Tes<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testis development related protein; targeted mutation 1.1, Velocigene	MGI:5569053	Tdrp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
testis expressed 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842630	Tex26<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed 30; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951096	Tex30<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed 30; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951136	Tex30<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed 35; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424645	Tex35<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed 37; targeted mutation 1.1, Velocigene	MGI:5548640	Tex37<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
testis expressed 37; targeted mutation 1, Velocigene	MGI:4399277	Tex37<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
testis expressed 37; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840635	Tex37<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed 38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363110	Tex38<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed 38; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363200	Tex38<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938588	Tex43<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed 45; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364716	Tex45<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed 45; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4841088	Tex45<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed 45; targeted mutation 3b, Wellcome Trust Sanger Institute	MGI:5548667	Tex45<tm3b(KOMP)Wtsi>	27626380	KOMP-CSD
testis expressed 45; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4841298	Tex45<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed 47; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364470	Tex47<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed gene 101; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428545	Tex101<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed gene 101; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428507	Tex101<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed gene 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431736	Tex10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed gene 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432244	Tex10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed gene 10; targeted mutation 1, Velocigene	MGI:5312404	Tex10<tm1(KOMP)Vlcg>	25936917	KOMP-Regeneron
testis expressed gene 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456056	Tex14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed gene 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456016	Tex14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed gene 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419713	Tex15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed gene 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419864	Tex15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed gene 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140444	Tex16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed gene 19.1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419401	Tex19.1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
testis expressed gene 261; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441776	Tex261<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed gene 261; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441994	Tex261<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed metallothionein like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441799	Tesmin<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis expressed metallothionein like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441862	Tesmin<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testis, prostate and placenta expressed; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365006	Tepp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis specific 10 interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307097	Tsga10ip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis specific 10 interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428491	Tsga10ip<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
testis specific 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451375	Tsga10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
testis specific 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451636	Tsga10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
testis specific protein kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842633	Tesk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis specific protein kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842667	Tesk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
testis specific protein-Y encoded, pseudogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842304	Tspy-ps<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis-specific serine kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014697	Tssk3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
testis-specific serine kinase 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424642	Tssk4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tet methylcytosine dioxygenase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286193	Tet1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tet methylcytosine dioxygenase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286169	Tet1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tet methylcytosine dioxygenase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286192	Tet1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tet methylcytosine dioxygenase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527613	Tet2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362531	Tspan10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetraspanin 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364601	Tspan10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetraspanin 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840644	Tspan11<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 11; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840578	Tspan11<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433797	Tspan13<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365043	Tspan17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetraspanin 18; targeted mutation 1.1, Velocigene	MGI:5471282	Tspan18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tetraspanin 18; targeted mutation 1.1, Velocigene	MGI:5471282	Tspan18<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
tetraspanin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887715	Tspan1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887688	Tspan1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 31; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419240	Tspan31<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tetraspanin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433840	Tspan4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842807	Tspan7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tetraspanin 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842739	Tspan7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363724	Tanc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841447	Tanc2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841446	Tanc2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362525	Ttc12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472697	Ttc14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tetratricopeptide repeat domain 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363581	Ttc16<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 16; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308289	Ttc16<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 21A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363699	Ttc21a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 21A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362805	Ttc21a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 21B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362733	Ttc21b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 21B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363395	Ttc21b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 21B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364168	Ttc21b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 21B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364168	Ttc21b<tm2a(KOMP)Wtsi>	24700869	KOMP-CSD
tetratricopeptide repeat domain 21B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364168	Ttc21b<tm2a(KOMP)Wtsi>	28291836	KOMP-CSD
tetratricopeptide repeat domain 21B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363952	Ttc21b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 23-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887602	Ttc23l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 23-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887603	Ttc23l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 28; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513829	Ttc28<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
tetratricopeptide repeat domain 30A2; targeted mutation 1.1, Velocigene	MGI:5548910	Ttc30a2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tetratricopeptide repeat domain 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363027	Ttc34<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 34; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365160	Ttc34<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419821	Ttc36<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419540	Ttc36<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 36; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472826	Ttc36<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tetratricopeptide repeat domain 38; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420119	Ttc38<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 39B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432562	Ttc39b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tetratricopeptide repeat domain 39B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431723	Ttc39b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tetratricopeptide repeat domain 39C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362392	Ttc39c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 39C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363571	Ttc39c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 39C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364706	Ttc39c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 39C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365074	Ttc39c<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364890	Ttc5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455569	Ttc5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456669	Ttc5<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364550	Ttc7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364428	Ttc7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363595	Ttc8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363595	Ttc8<tm1a(KOMP)Wtsi>	29049287	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363595	Ttc8<tm1a(KOMP)Wtsi>	29126234	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925339	Ttc8<tm1c(KOMP)Wtsi>	29049287	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925339	Ttc8<tm1c(KOMP)Wtsi>	29126234	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5925340	Ttc8<tm1d(KOMP)Wtsi>	29049287	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362614	Ttc8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tetratricopeptide repeat domain 8; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4362808	Ttc8<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
TGF-beta activated kinase 1/MAP3K7 binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362763	Tab1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TGF-beta activated kinase 1/MAP3K7 binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365174	Tab1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TGF-beta activated kinase 1/MAP3K7 binding protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432639	Tab3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TGFB-induced factor homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433717	Tgif2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TGFB-induced factor homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433717	Tgif2<tm1a(EUCOMM)Wtsi>	28193997	EUCOMM
TGFB-induced factor homeobox 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692682	Tgif2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
TGFB-induced factor homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433576	Tgif2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
THAP domain containing 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433528	Thap12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
THAP domain containing 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433515	Thap12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
THAP domain containing 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419431	Thap7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
THAP domain containing 7; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5435077	Thap7<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
THAP domain containing, apoptosis associated protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433848	Thap3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
THAP domain containing, apoptosis associated protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434434	Thap3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
theg spermatid protein like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880886	Thegl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
theg spermatid protein like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548609	Thegl<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
theg spermatid protein like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880987	Thegl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thimet oligopeptidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362845	Thop1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thioesterase superfamily member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432717	Them4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thioesterase superfamily member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434430	Them4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thioesterase superfamily member 4; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511913	Them4<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
thioesterase superfamily member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887604	Them5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thioesterase superfamily member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887612	Them5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thioredoxin domain containing 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433983	Txndc15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thioredoxin domain containing 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434519	Txndc15<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thioredoxin domain containing 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305609	Txndc17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thioredoxin domain containing 5; targeted mutation 1.1, Velocigene	MGI:5695945	Txndc5<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
thioredoxin domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364247	Txndc9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thioredoxin domain containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428579	Txndc9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thioredoxin domain containing 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5293958	Txndc9<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
thioredoxin domain containing 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5294962	Txndc9<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
thioredoxin interacting protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5637001	Txnip<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
thioredoxin reductase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433202	Txnrd3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thioredoxin reductase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432893	Txnrd3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thioredoxin-related transmembrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442051	Tmx1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thioredoxin-related transmembrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441682	Tmx1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thioredoxin-related transmembrane protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843833	Tmx4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thiosulfate sulfurtransferase, mitochondrial; targeted mutation 1.1, Velocigene	MGI:5569084	Tst<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
thiosulfate sulfurtransferase, mitochondrial; targeted mutation 1, Velocigene	MGI:4452974	Tst<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
thiosulfate sulfurtransferase, mitochondrial; targeted mutation 1, Velocigene	MGI:4452974	Tst<tm1(KOMP)Vlcg>	27270587	KOMP-Regeneron
thiosulfate sulfurtransferase (rhodanese)-like domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431839	Tstd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thiosulfate sulfurtransferase (rhodanese)-like domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433957	Tstd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thiosulfate sulfurtransferase (rhodanese)-like domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458582	Tstd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thiosulfate sulfurtransferase (rhodanese)-like domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458564	Tstd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
THO complex 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362747	Thoc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
THO complex 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362712	Thoc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
THO complex 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511910	Thoc1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
THO complex 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511887	Thoc1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
THO complex 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362602	Thoc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
THO complex 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840934	Thoc2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
THO complex 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841099	Thoc2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
THO complex 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456790	Thoc5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
THO complex 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456829	Thoc5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
three prime repair exonuclease 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362876	Trex1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
three prime repair exonuclease 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362876	Trex1<tm1(KOMP)Wtsi>	27233670	KOMP-CSD
threonine aldolase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050938	Tha1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
threonyl-tRNA synthetase-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441637	Tarsl2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
threonyl-tRNA synthetase-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442062	Tarsl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thrombopoietin; targeted mutation 1.1, Velocigene	MGI:5548323	Thpo<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
thrombopoietin; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419386	Thpo<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
thrombopoietin; targeted mutation 2, Wellcome Trust Sanger Institute	MGI:5435076	Thpo<tm2(KOMP)Wtsi>	21677750	KOMP-CSD
thrombospondin 1; targeted mutation 1.1, Velocigene	MGI:5582449	Thbs1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
thrombospondin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008758	Thbs2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thrombospondin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454145	Thbs4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thrombospondin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454099	Thbs4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thrombospondin, type I, domain 1; targeted mutation 1.1, Velocigene	MGI:5505900	Thsd1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
thrombospondin, type I, domain 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362790	Thsd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
thrombospondin, type I, domain containing 7B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364126	Thsd7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
THUMP domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451261	Thumpd2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
THUMP domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451644	Thumpd2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thymic stromal lymphopoietin; targeted mutation 1.1, Velocigene	MGI:5695905	Tslp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
thymic stromal lymphopoietin; targeted mutation 1, Velocigene	MGI:5292857	Tslp<tm1(KOMP)Vlcg>	22585305	KOMP-Regeneron
thymic stromal lymphopoietin; targeted mutation 1, Velocigene	MGI:5292857	Tslp<tm1(KOMP)Vlcg>	24751726	KOMP-Regeneron
thymidine kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433171	Tk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thymidine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433031	Tk1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thymidine kinase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820324	Tk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thymocyte selection associated family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364708	Themis2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thymocyte selection associated family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364708	Themis2<tm1a(KOMP)Wtsi>	24907343	KOMP-CSD
thymocyte selection associated family member 2; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5779207	Themis2<tm1d(KOMP)Wtsi>	24907343	KOMP-CSD
thymocyte selection associated family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364202	Themis2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thymocyte selection associated family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364370	Themis3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thymocyte selection associated family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362212	Themis3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thymocyte selection-associated high mobility group box; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451297	Tox<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thymocyte selection-associated high mobility group box; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451648	Tox<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thymoma viral proto-oncogene 1 interacting protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513742	Aktip<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
thymoma viral proto-oncogene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433712	Akt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thymoma viral proto-oncogene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433060	Akt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thymoma viral proto-oncogene 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363824	Akt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thymoma viral proto-oncogene 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365210	Akt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thymoma viral proto-oncogene 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365210	Akt2<tm1e(KOMP)Wtsi>	26865945	KOMP-CSD
thymoma viral proto-oncogene 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944483	Akt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thymoma viral proto-oncogene 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944497	Akt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thymosin beta 15a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432354	Tmsb15a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thymosin beta 15a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433103	Tmsb15a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thymosin, beta 4, X chromosome; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050923	Tmsb4x<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
thyroglobulin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820127	Tg<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid adenoma associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887588	Thada<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid adenoma associated; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548889	Thada<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
thyroid adenoma associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887633	Thada<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid hormone receptor alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455948	Thra<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thyroid hormone receptor alpha; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614615	Thra<tm1b(EUCOMM)Wtsi>	21677750	EUCOMM
thyroid hormone receptor alpha; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614615	Thra<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
thyroid hormone receptor associated protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050844	Thrap3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid hormone receptor beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432316	Thrb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thyroid hormone receptor beta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432802	Thrb<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
thyroid hormone receptor interactor 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944387	Trip12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid hormone receptor interactor 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946681	Trip12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid hormone receptor interactor 13; targeted mutation 1.1, Velocigene	MGI:5443928	Trip13<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
thyroid hormone receptor interactor 13; targeted mutation 1.1, Velocigene	MGI:5443928	Trip13<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
thyroid peroxidase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451276	Tpo<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid peroxidase; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451604	Tpo<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
thyroid stimulating hormone, beta subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949349	Tshb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
thyroid stimulating hormone, beta subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949369	Tshb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
thyrotropin releasing hormone receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287788	Trhr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Tia1 cytotoxic granule-associated RNA binding protein-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432495	Tial1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tight junction associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363623	Tjap1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tight junction associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364971	Tjap1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tight junction protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451268	Tjp1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tight junction protein 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293904	Tjp1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tight junction protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052387	Tjp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tight junction protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419555	Tjp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tight junction protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419804	Tjp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TIP41, TOR signalling pathway regulator-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842812	Tiprl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tissue inhibitor of metalloproteinase 3; targeted mutation 1.1, Velocigene	MGI:5445932	Timp3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tissue inhibitor of metalloproteinase 3; targeted mutation 1.1, Velocigene	MGI:5445932	Timp3<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
tissue specific transplantation antigen P35B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420041	Tsta3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
titin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433906	Ttn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
titin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432688	Ttn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TLC domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419235	Tlcd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
TLC domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364208	Tlcd2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
TM2 domain containing 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419509	Tm2d2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
TMEM9 domain family, member B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140471	Tmem9b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TNFAIP3 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433868	Tnip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TNFAIP3 interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433449	Tnip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TNF receptor-associated factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842639	Traf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TNF receptor-associated factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842261	Traf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TNF receptor-associated factor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452008	Traf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TNF receptor-associated factor 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840586	Traf6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
TNF receptor-associated factor 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840586	Traf6<tm2a(EUCOMM)Wtsi>	27249171	EUCOMM
TNF receptor-associated factor 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840586	Traf6<tm2a(EUCOMM)Wtsi>	27996060	EUCOMM
TNF receptor-associated factor 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840586	Traf6<tm2a(EUCOMM)Wtsi>	28739881	EUCOMM
TNF receptor-associated factor 6; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:6111757	Traf6<tm2c(EUCOMM)Wtsi>	28739881	EUCOMM
TNF receptor-associated factor 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840669	Traf6<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
TNNI3 interacting kinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362404	Tnni3k<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TNNI3 interacting kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363502	Tnni3k<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tocopherol (alpha) transfer protein-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319886	Ttpal<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tocopherol (alpha) transfer protein-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365247	Ttpal<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tocopherol (alpha) transfer protein-like; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4460305	Ttpal<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tocopherol (alpha) transfer protein-like; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5319893	Ttpal<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
tocopherol (alpha) transfer protein-like; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5319891	Ttpal<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
tocopherol (alpha) transfer protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433492	Ttpa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tocopherol (alpha) transfer protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473031	Ttpa<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
TOG array regulator of axonemal microtubules 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944351	Togaram1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TOG array regulator of axonemal microtubules 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944337	Togaram1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
toll-like receptor 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473146	Tlr11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
toll-like receptor 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472723	Tlr11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
toll-like receptor 13; targeted mutation 1.1, Velocigene	MGI:5692860	Tlr13<tm1.1(KOMP)Vlcg>	27509078	KOMP-Regeneron
toll-like receptor 13; targeted mutation 1, Velocigene	MGI:4415366	Tlr13<tm1(KOMP)Vlcg>	28400473	KOMP-Regeneron
toll-like receptor 13; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5302283	Tlr13<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
toll-like receptor adaptor molecule 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362473	Ticam1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
toll-like receptor adaptor molecule 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319832	Ticam1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
toll-like receptor adaptor molecule 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319811	Ticam1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
toll-like receptor adaptor molecule 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319792	Ticam1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tolloid-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420053	Tll2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tolloid-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419806	Tll2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tolloid-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842415	Tll1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tolloid-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842370	Tll1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TOPBP1-interacting checkpoint and replication regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462674	Ticrr<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TOPBP1-interacting checkpoint and replication regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461762	Ticrr<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
topoisomerase (DNA) II alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947744	Top2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
topoisomerase (DNA) III beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452624	Top3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
topoisomerase (DNA) III beta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452686	Top3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
topoisomerase (DNA) I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362276	Top1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
topoisomerase (DNA) I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362276	Top1<tm1a(KOMP)Wtsi>	27231886	KOMP-CSD
topoisomerase (DNA) I; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5509060	Top1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
topoisomerase (DNA) I; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5805889	Top1<tm1c(KOMP)Wtsi>	27231886	KOMP-CSD
topoisomerase (DNA) I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362606	Top1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
topoisomerase I binding, arginine/serine-rich like; targeted mutation 1.1, Velocigene	MGI:5574601	Toporsl<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
torsin family 1, member A (torsin A); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433601	Tor1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
torsin family 1, member A (torsin A); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433577	Tor1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
torsin family 2, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364635	Tor2a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
torsin family 2, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362545	Tor2a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
torsin family 3, member A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820314	Tor3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
torsin family 3, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820235	Tor3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
torsin family 4, member A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951102	Tor4a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tousled-like kinase 2 (Arabidopsis); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009563	Tlk2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TOX high mobility group box family member 3; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5548886	Tox3<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
TOX high mobility group box family member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419686	Tox3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TOX high mobility group box family member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452704	Tox3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
TOX high mobility group box family member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452719	Tox3<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Tp53rk binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820387	Tprkb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Tp53rk binding protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820228	Tprkb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
trace amine-associated receptor 1; targeted mutation 1, Velocigene	MGI:3797798	Taar1<tm1(KOMP)Vlcg>	25740289	KOMP-Regeneron
trace amine-associated receptor 1; targeted mutation 1, Velocigene	MGI:3797798	Taar1<tm1(KOMP)Vlcg>	26601071	KOMP-Regeneron
trace amine-associated receptor 1; targeted mutation 1, Velocigene	MGI:3797798	Taar1<tm1(KOMP)Vlcg>	28919515	KOMP-Regeneron
trace amine-associated receptor 2; targeted mutation 1.1, Velocigene	MGI:5548863	Taar2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
trace amine-associated receptor 5; targeted mutation 1.1, Velocigene	MGI:5548864	Taar5<tm1.1(KOMP)Vlcg>	25897022	KOMP-Regeneron
trace amine-associated receptor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473165	Taar5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
trace amine-associated receptor 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472740	Taar5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
trace amine-associated receptor 5; targeted mutation 1, Velocigene	MGI:3847468	Taar5<tm1(KOMP)Vlcg>	22837392	KOMP-Regeneron
trace amine-associated receptor 5; targeted mutation 1, Velocigene	MGI:3847468	Taar5<tm1(KOMP)Vlcg>	23177478	KOMP-Regeneron
trace amine-associated receptor 5; targeted mutation 1, Velocigene	MGI:3847468	Taar5<tm1(KOMP)Vlcg>	25897022	KOMP-Regeneron
trace amine-associated receptor 5; targeted mutation 1, Velocigene	MGI:3847468	Taar5<tm1(KOMP)Vlcg>	27208093	KOMP-Regeneron
trace amine-associated receptor 6; targeted mutation 1.1, Velocigene	MGI:5548865	Taar6<tm1.1(KOMP)Vlcg>	25897022	KOMP-Regeneron
trace amine-associated receptor 6; targeted mutation 1.1, Velocigene	MGI:5548865	Taar6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
trace amine-associated receptor 6; targeted mutation 1, Velocigene	MGI:4399178	Taar6<tm1(KOMP)Vlcg>	25897022	KOMP-Regeneron
TRAF2 and NCK interacting kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365041	Tnik<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TRAF2 and NCK interacting kinase; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5002995	Tnik<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
TRAF2 and NCK interacting kinase; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5002993	Tnik<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
TRAF3 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432269	Traf3ip2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TRAF3 interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434037	Traf3ip2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TRAF3 interacting protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363678	Traf3ip3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TRAF3 interacting protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363678	Traf3ip3<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
TRAF3 interacting protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363678	Traf3ip3<tm1a(KOMP)Wtsi>	26011558	KOMP-CSD
TRAF3 interacting protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363678	Traf3ip3<tm1a(KOMP)Wtsi>	26195727	KOMP-CSD
TRAF3 interacting protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5795737	Traf3ip3<tm1b(KOMP)Wtsi>	26011558	KOMP-CSD
TRAF3 interacting protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5795737	Traf3ip3<tm1b(KOMP)Wtsi>	26195727	KOMP-CSD
TRAF3 interacting protein 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5795738	Traf3ip3<tm1c(KOMP)Wtsi>	26195727	KOMP-CSD
TRAF3 interacting protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364596	Traf3ip3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
trafficking protein particle complex 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419611	Trappc10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trafficking protein particle complex 10; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636961	Trappc10<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
trafficking protein particle complex 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363557	Trappc12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trafficking protein particle complex 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362441	Trappc12<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
trafficking protein particle complex 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419238	Trappc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
trafficking protein particle complex 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461737	Trappc9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
trafficking protein particle complex 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461760	Trappc9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TRAF-interacting protein with forkhead-associated domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365231	Tifa<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TRAF-interacting protein with forkhead-associated domain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363082	Tifa<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TRAF type zinc finger domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432441	Trafd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TRAF type zinc finger domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432726	Trafd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
trans-2,3-enoyl-CoA reductase-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319914	Tecrl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trans-2,3-enoyl-CoA reductase-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319896	Tecrl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
trans-2,3-enoyl-CoA reductase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419879	Tecr<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
trans-acting transcription factor 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363354	Sp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
trans-acting transcription factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841101	Sp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
trans-acting transcription factor 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5424640	Sp4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
trans-acting transcription factor 4; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5426544	Sp4<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
trans-acting transcription factor 4; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5424653	Sp4<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
trans-acting transcription factor 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820039	Sp5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trans-acting transcription factor 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635299	Sp5<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
transaldolase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363116	Taldo1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transaldolase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363209	Taldo1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcriptional adaptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364783	Tada1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcriptional adaptor 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635385	Tada1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
transcriptional adaptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319867	Tada1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcriptional regulating factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433607	Trerf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription elongation factor A like 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455578	Tceal9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription elongation factor A like 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455594	Tceal9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription elongation factor A (SII), 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433199	Tcea3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription elongation factor A (SII), 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433899	Tcea3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription elongation factor A (SII), 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433599	Tcea3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription elongation factor A (SII), 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433722	Tcea3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription elongation factor A (SII)-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451413	Tceal5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription elongation factor A (SII)-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451413	Tceal5<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
transcription elongation factor A (SII)-like 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548883	Tceal5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
transcription elongation factor A (SII)-like 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451574	Tceal5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription elongation factor A (SII)-like 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457569	Tceal8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription elongation factor A (SII)-like 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4457562	Tceal8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription elongation factor A (SII) N-terminal and central domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363248	Tceanc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription elongation factor A (SII) N-terminal and central domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363248	Tceanc2<tm1a(KOMP)Wtsi>	23912999	KOMP-CSD
transcription elongation factor A (SII) N-terminal and central domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364186	Tceanc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription elongation regulator 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820071	Tcerg1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription elongation regulator 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820143	Tcerg1l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor 19; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605734	Tcf19<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
transcription factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362384	Tcf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365112	Tcf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432303	Tcf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432303	Tcf4<tm1a(EUCOMM)Wtsi>	27986456	EUCOMM
transcription factor 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433897	Tcf4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7 like 1 (T cell specific, HMG box); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432867	Tcf7l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7 like 1 (T cell specific, HMG box); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432867	Tcf7l1<tm1a(EUCOMM)Wtsi>	27302397	EUCOMM
transcription factor 7 like 1 (T cell specific, HMG box); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433172	Tcf7l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431951	Tcf7l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431951	Tcf7l2<tm1a(EUCOMM)Wtsi>	23028378	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431951	Tcf7l2<tm1a(EUCOMM)Wtsi>	27996060	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432382	Tcf7l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433709	Tcf7l2<tm2a(EUCOMM)Wtsi>	19525957	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433709	Tcf7l2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433709	Tcf7l2<tm2a(EUCOMM)Wtsi>	23912999	EUCOMM
transcription factor 7 like 2, T cell specific, HMG box; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432745	Tcf7l2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441645	Tcf7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441645	Tcf7<tm1a(EUCOMM)Wtsi>	24836425	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441645	Tcf7<tm1a(EUCOMM)Wtsi>	26214740	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441645	Tcf7<tm1a(EUCOMM)Wtsi>	26365183	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816259	Tcf7<tm1c(EUCOMM)Wtsi>	24836425	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816259	Tcf7<tm1c(EUCOMM)Wtsi>	26214740	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816259	Tcf7<tm1c(EUCOMM)Wtsi>	26365183	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816259	Tcf7<tm1c(EUCOMM)Wtsi>	26490636	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5816259	Tcf7<tm1c(EUCOMM)Wtsi>	27501248	EUCOMM
transcription factor 7, T cell specific; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441937	Tcf7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor 7, T cell specific; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456791	Tcf7<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor A, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434349	Tfam<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor AP-2 beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948640	Tfap2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor AP-2, delta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362742	Tfap2d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor AP-2, delta; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363141	Tfap2d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor AP-2, delta; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847698	Tfap2d<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor AP4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942149	Tfap4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor AP4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882010	Tfap4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor B2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363126	Tfb2m<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor B2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363126	Tfb2m<tm1a(KOMP)Wtsi>	28702322	KOMP-CSD
transcription factor B2, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363786	Tfb2m<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor Dp 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014714	Tfdp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor Dp 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452827	Tfdp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	21885532	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	22343943	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	23599343	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	28011087	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	28619945	EUCOMM
transcription factor EB; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	29066772	EUCOMM
transcription factor EB; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548342	Tfeb<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
transcription factor EB; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433706	Tfeb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transcription factor EC; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841443	Tfec<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor EC; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548432	Tfec<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
transcription factor EC; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841163	Tfec<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transcription factor-like 5 (basic helix-loop-helix); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009557	Tcfl5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transcription termination factor, RNA polymerase II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441689	Ttf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transducin-like enhancer of split 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052391	Tle4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transducin-like enhancer of split 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433842	Tle6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transferrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363863	Trf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transformation related protein 53 binding protein 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5694181	Trp53bp2<tm1b(EUCOMM)Hmgu>	27447114	EUCOMM
transformation related protein 53 inducible protein 11; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419901	Trp53i11<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transformation related protein 53 inducible protein 13; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419634	Trp53i13<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transformation related protein 53 regulating kinase B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820320	Trp53rkb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transformation related protein 53 regulating kinase B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820304	Trp53rkb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transformation related protein 53 target 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363427	Trp53tg5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transformation related protein 53 target 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362168	Trp53tg5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transformation related protein 63 regulated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938591	Tprg<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transformation related protein 63 regulated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938596	Tprg<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transformation related protein 73; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286242	Trp73<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transformation/transcription domain-associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433230	Trrap<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transformation/transcription domain-associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431627	Trrap<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transformed mouse 3T3 cell double minute 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451970	Mdm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transformed mouse 3T3 cell double minute 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452006	Mdm2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transforming, acidic coiled-coil containing protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363542	Tacc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transforming, acidic coiled-coil containing protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362167	Tacc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transforming growth factor beta 1 induced transcript 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050851	Tgfb1i1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transforming growth factor beta 1 induced transcript 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050851	Tgfb1i1<tm1a(KOMP)Wtsi>	26172113	KOMP-CSD
transforming growth factor beta 1 induced transcript 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636887	Tgfb1i1<tm1b(KOMP)Wtsi>	26398943	KOMP-CSD
transforming growth factor, beta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362566	Tgfb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transforming growth factor, beta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363841	Tgfb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transforming growth factor, beta 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473015	Tgfb1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transforming growth factor, beta 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4841661	Tgfb2<tm1a(EUCOMM)Hmgu>	24895296	EUCOMM
transforming growth factor, beta 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5638758	Tgfb2<tm1c(EUCOMM)Hmgu>	24895296	EUCOMM
transforming growth factor, beta 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431472	Tgfb3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transforming growth factor, beta induced; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293953	Tgfbi<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transforming growth factor beta regulated gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365070	Tbrg1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transforming growth factor beta regulated gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365070	Tbrg1<tm1a(KOMP)Wtsi>	25393878	KOMP-CSD
transforming growth factor beta regulated gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365070	Tbrg1<tm1a(KOMP)Wtsi>	28811661	KOMP-CSD
transforming growth factor beta regulated gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364568	Tbrg1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transgene insertion 12, Richard A Flavell	MGI:2136412	Tg(Tek-cre)12Flv	23169059	null
transgene insertion 1, Andras Nagy	MGI:3697095	Tg(CAG-Bgeo,-DsRed*MST)1Nagy	23169059	null
transgene insertion 1, Diego H Castrillon	MGI:3757577	Tg(Ddx4-cre)1Dcas	23844102	null
transgene insertion 1, Ed Lein	MGI:3838493	Tg(Cyp39a1-cre)1Aibs	23169059	null
transgene insertion 1, Fred Van Leuven	MGI:2684620	Tg(Thy1-cre)1Vln	23169059	null
transgene insertion 1, Ronald M Evans	MGI:2386686	Tg(Fabp4-cre)1Rev	23169059	null
transgene insertion 1, University of Cologne	MGI:2176180	Tg(CMV-cre)1Cgn	26175717	null
transgene insertion 21, Corrinne Lobe	MGI:3046177	Tg(CAG-Bgeo/GFP)21Lbe	23169059	null
transgene insertion 25, Albee Messing	MGI:2179048	Tg(GFAP-cre)25Mes	23169059	null
transgene insertion 35, Volkhard Lindner	MGI:5291826	Tg(Pdgfrb-cre)35Vli	28552963	null
transgene insertion 7, M Luisa Iruela-Arispe	MGI:3620560	Tg(Cdh5-cre)7Mlia	28552963	null
transgene insertion 9205, Susan Dymecki	MGI:2448985	Tg(ACTFLPe)9205Dym	26175717	null
transgene insertion C5379, Laboratory of Mammalian Genes and Development, Heiner Westphal	MGI:2137691	Tg(EIIa-cre)C5379Lmgd	23169059	null
transgene insertion G32-4, Susumu Tonegawa	MGI:2387441	Tg(Grik4-cre)G32-4Stl	23169059	null
transglutaminase 2, C polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365221	Tgm2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transglutaminase 2, C polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364502	Tgm2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transglutaminase 2, C polypeptide; targeted mutation 1, Robert M Graham	MGI:3525256	Tgm2<tm1Rmgr>	28700664	null
transglutaminase 3, E polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5294973	Tgm3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transglutaminase 4 (prostate); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362984	Tgm4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transglutaminase 4 (prostate); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362984	Tgm4<tm1a(KOMP)Wtsi>	23341775	KOMP-CSD
transglutaminase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451573	Tgm5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transglutaminase 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451573	Tgm5<tm2a(KOMP)Wtsi>	26975724	KOMP-CSD
transglutaminase 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841076	Tgm6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transglutaminase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841106	Tgm6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
trans-golgi network vesicle protein 23A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419354	Tvp23a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trans-golgi network vesicle protein 23A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419274	Tvp23a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453716	Trpc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transient receptor potential cation channel, subfamily C, member 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5550592	Trpc3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
transient receptor potential cation channel, subfamily C, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453787	Trpc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transient receptor potential cation channel, subfamily C, member 4 associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362238	Trpc4ap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 4 associated protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362238	Trpc4ap<tm1a(KOMP)Wtsi>	25340873	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 4 associated protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364433	Trpc4ap<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428539	Trpc4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364838	Trpc5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5568480	Trpc5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319868	Trpc5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299615	Trpc5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 6; targeted mutation 1.1, Mammalian Functional Genomics Centre	MGI:5766207	Trpc6<tm1.1(NCOM)Mfgc>	27626380	NorCOMM
transient receptor potential cation channel, subfamily C, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364653	Trpc7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily C, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364877	Trpc7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily M, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287780	Trpm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily M, member 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636954	Trpm1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
transient receptor potential cation channel, subfamily M, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434372	Trpm2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transient receptor potential cation channel, subfamily M, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942012	Trpm6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily M, member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942034	Trpm6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily M, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841295	Trpm7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily M, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4840971	Trpm7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily M, member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433921	Trpm8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transient receptor potential cation channel, subfamily M, member 8; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4842673	Trpm8<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transient receptor potential cation channel, subfamily V, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428567	Trpv1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily V, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431656	Trpv2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transient receptor potential cation channel, subfamily V, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302368	Trpv2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transient receptor potential cation channel, subfamily V, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460277	Trpv4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transient receptor potential cation channel, subfamily V, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460306	Trpv4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transketolase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363060	Tktl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transketolase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362722	Tktl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
translation machinery associated 16; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433748	Tma16<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translation machinery associated 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433813	Tma16<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translin-associated factor X; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433392	Tsnax<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translin-associated factor X; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434457	Tsnax<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014729	Tsn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane 17b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363941	Timm17b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 17b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363951	Timm17b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364458	Timm21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364891	Timm21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 21; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451257	Timm21<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 21; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451296	Timm21<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363988	Timm22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 22; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529629	Timm22<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 22; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529629	Timm22<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
translocase of inner mitochondrial membrane 22; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5529629	Timm22<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
translocase of inner mitochondrial membrane 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364245	Timm22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of inner mitochondrial membrane 23; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014707	Timm23<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431980	Timm44<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431708	Timm44<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane 50; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433575	Timm50<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane 50; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548523	Timm50<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
translocase of inner mitochondrial membrane 50; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434468	Timm50<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820271	Timm9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820362	Timm9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441702	Timmdc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of inner mitochondrial membrane domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441813	Timmdc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of outer mitochondrial membrane 20 homolog (yeast)-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441690	Tomm20l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of outer mitochondrial membrane 20 homolog (yeast)-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441690	Tomm20l<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
translocase of outer mitochondrial membrane 20 homolog (yeast)-like; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548653	Tomm20l<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
translocase of outer mitochondrial membrane 20 homolog (yeast)-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451957	Tomm20l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of outer mitochondrial membrane 6 homolog (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940754	Tomm6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of outer mitochondrial membrane 6 homolog (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941491	Tomm6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
translocase of outer mitochondrial membrane 70 homolog A (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4882025	Tomm70a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocase of outer mitochondrial membrane 70 homolog A (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882012	Tomm70a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
translocated promoter region, nuclear basket protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364065	Tpr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
translocated promoter region, nuclear basket protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364518	Tpr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
translocated promoter region, nuclear basket protein; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473042	Tpr<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
translocating chain-associating membrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949327	Tram2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
translocating chain-associating membrane protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949333	Tram2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
translocator protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009653	Tspo<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
translocator protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614711	Tspo<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
translocator protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949346	Tspo<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane 4 L six family member 20; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419138	Tm4sf20<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 4 superfamily member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052392	Tm4sf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 4 superfamily member 4; targeted mutation 1.1, Velocigene	MGI:5548789	Tm4sf4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane 4 superfamily member 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050970	Tm4sf4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane 4 superfamily member 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419183	Tm4sf5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 6 superfamily member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364066	Tm6sf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 6 superfamily member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362886	Tm6sf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 6 superfamily member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362886	Tm6sf2<tm1a(KOMP)Wtsi>	27013658	KOMP-CSD
transmembrane 6 superfamily member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363976	Tm6sf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 7 superfamily member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319841	Tm7sf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 7 superfamily member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319831	Tm7sf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 7 superfamily member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319881	Tm7sf2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 7 superfamily member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319856	Tm7sf2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 9 superfamily member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363634	Tm9sf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 9 superfamily member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363160	Tm9sf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 9 superfamily member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365084	Tm9sf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 9 superfamily member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4419800	Tm9sf2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 9 superfamily member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4419966	Tm9sf2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 9 superfamily protein member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363779	Tm9sf4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane 9 superfamily protein member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363779	Tm9sf4<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
transmembrane 9 superfamily protein member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363720	Tm9sf4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled coil domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286256	Tmcc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled coil domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293937	Tmcc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364972	Tmcc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419673	Tmco2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364469	Tmcc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420035	Tmco2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419343	Tmco3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635417	Tmco3<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419385	Tmco3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473057	Tmco3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane and coiled-coil domains 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458490	Tmco5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458602	Tmco5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428543	Tmco6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and coiled-coil domains 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428499	Tmco6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and tetratricopeptide repeat containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319875	Tmtc2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and tetratricopeptide repeat containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319918	Tmtc2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and tetratricopeptide repeat containing 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5319913	Tmtc2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and tetratricopeptide repeat containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441761	Tmtc3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane and tetratricopeptide repeat containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442031	Tmtc3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane and ubiquitin-like domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451478	Tmub2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane and ubiquitin-like domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451361	Tmub2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane anterior posterior transformation 1; targeted mutation 1, Velocigene	MGI:3799889	Tapt1<tm1(KOMP)Vlcg>	21118569	KOMP-Regeneron
transmembrane BAX inhibitor motif containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5284926	Tmbim1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane BAX inhibitor motif containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286374	Tmbim1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane BAX inhibitor motif containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5300816	Tmbim4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane BAX inhibitor motif containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5300813	Tmbim4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane BAX inhibitor motif containing 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5300817	Tmbim4<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane BAX inhibitor motif containing 7; targeted mutation 1.1, Velocigene	MGI:5695928	Tmbim7<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane channel-like gene family 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363366	Tmc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane channel-like gene family 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455516	Tmc3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane channel-like gene family 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455516	Tmc3<tm2a(KOMP)Wtsi>	24981230	KOMP-CSD
transmembrane channel-like gene family 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548850	Tmc3<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
transmembrane channel-like gene family 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434247	Tmc6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane channel-like gene family 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434247	Tmc6<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
transmembrane channel-like gene family 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432152	Tmc8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane channel-like gene family 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431926	Tmc8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane epididymal protein 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473173	Teddm1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane epididymal protein 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472748	Teddm1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane inner ear; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419467	Tmie<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane p24 trafficking protein 10; targeted mutation 1.1, Velocigene	MGI:5695918	Tmed10<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane p24 trafficking protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364512	Tmed11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane p24 trafficking protein 11; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451384	Tmed11<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane p24 trafficking protein 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419625	Tmed4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane p24 trafficking protein 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419506	Tmed9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 11B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820080	Tmprss11b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 11B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820162	Tmprss11b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 11c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365038	Tmprss11c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 11c; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364984	Tmprss11c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 11c; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299570	Tmprss11c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 11f; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365137	Tmprss11f<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 11f; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472785	Tmprss11f<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protease, serine 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364308	Tmprss15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 15; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451461	Tmprss15<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 2; targeted mutation 1, Velocigene	MGI:4399580	Tmprss2<tm1(KOMP)Vlcg>	24600012	KOMP-Regeneron
transmembrane protease, serine 2; targeted mutation 1, Velocigene	MGI:4399580	Tmprss2<tm1(KOMP)Vlcg>	27389476	KOMP-Regeneron
transmembrane protease, serine 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434187	Tmprss3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protease, serine 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432512	Tmprss3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protease, serine 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365177	Tmprss4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820040	Tmprss4<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 4; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820114	Tmprss4<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 5 (spinesin); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362290	Tmprss5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protease, serine 5 (spinesin); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364483	Tmprss5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 100; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451678	Tmem100<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 100; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5548552	Tmem100<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
transmembrane protein 100; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451603	Tmem100<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 106B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881961	Tmem106b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 106B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881968	Tmem106b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 106B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319917	Tmem106b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 106B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5319917	Tmem106b<tm2a(KOMP)Wtsi>	28728022	KOMP-CSD
transmembrane protein 106B; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548613	Tmem106b<tm2b(KOMP)Wtsi>	27626380	KOMP-CSD
transmembrane protein 108; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441635	Tmem108<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 108; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548724	Tmem108<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
transmembrane protein 109; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840595	Tmem109<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 109; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840670	Tmem109<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 110; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363285	Tmem110<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 110; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451382	Tmem110<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 110; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451531	Tmem110<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 119; targeted mutation 1.1, Velocigene	MGI:5583072	Tmem119<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane protein 119; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944488	Tmem119<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 119; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944552	Tmem119<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 120A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433682	Tmem120a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 120A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433422	Tmem120a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 123; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434132	Tmem123<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 123; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434215	Tmem123<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 125; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419816	Tmem125<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 126A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432149	Tmem126a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 126A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432149	Tmem126a<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
transmembrane protein 126A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431954	Tmem126a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 126B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820265	Tmem126b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 126B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820395	Tmem126b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 127; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419725	Tmem127<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 128; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363329	Tmem128<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362366	Tmem132a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548753	Tmem132a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
transmembrane protein 132A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362786	Tmem132a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363936	Tmem132a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363984	Tmem132a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362320	Tmem132d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132D; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820140	Tmem132d<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132D; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820160	Tmem132d<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 132E; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003034	Tmem132e<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 132E; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452023	Tmem132e<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 135; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456079	Tmem135<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 136; targeted mutation 1.1, Velocigene	MGI:5468987	Tmem136<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane protein 136; targeted mutation 1.1, Velocigene	MGI:5468987	Tmem136<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
transmembrane protein 136; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434011	Tmem136<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 136; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441844	Tmem136<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 136; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441680	Tmem136<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 138; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888931	Tmem138<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 138; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4888941	Tmem138<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 141; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4363810	Tmem141<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 143; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951115	Tmem143<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 144; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461718	Tmem144<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 147; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305617	Tmem147<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 147; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428504	Tmem147<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 14A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4950943	Tmem14a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 14A; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5635437	Tmem14a<tm2b(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 14A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4950945	Tmem14a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 150A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419587	Tmem150a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 150C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455583	Tmem150c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 150C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455522	Tmem150c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 150C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455522	Tmem150c<tm1e(KOMP)Wtsi>	27321926	KOMP-CSD
transmembrane protein 151A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456782	Tmem151a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 151A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456849	Tmem151a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 151B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431467	Tmem151b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 151B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494963	Tmem151b<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 151B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494963	Tmem151b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
transmembrane protein 151B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5494963	Tmem151b<tm1b(KOMP)Wtsi>	28700664	KOMP-CSD
transmembrane protein 151B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431487	Tmem151b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 154; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432203	Tmem154<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 154; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433941	Tmem154<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 158; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472763	Tmem158<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 159; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363825	Tmem159<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 159; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365156	Tmem159<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 163; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820115	Tmem163<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 163; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841236	Tmem163<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 165; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431713	Tmem165<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 165; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432756	Tmem165<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 167B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433442	Tmem167b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 167B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432330	Tmem167b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 169; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364494	Tmem169<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 169; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365230	Tmem169<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 171; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362914	Tmem171<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 171; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364799	Tmem171<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 175; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431451	Tmem175<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 175; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431491	Tmem175<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 177; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433738	Tmem177<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 177; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473076	Tmem177<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 178; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419108	Tmem178<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 179; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949372	Tmem179<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 179; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949377	Tmem179<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 181A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319927	Tmem181a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 182; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420109	Tmem182<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 184a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840983	Tmem184a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 184a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841283	Tmem184a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 184b; targeted mutation 1.1, Velocigene	MGI:5583076	Tmem184b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane protein 184C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843821	Tmem184c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 185A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431478	Tmem185a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 185A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431506	Tmem185a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 189; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363077	Tmem189<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 189; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363788	Tmem189<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842746	Tmem18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842746	Tmem18<tm1a(EUCOMM)Wtsi>	28811369	EUCOMM
transmembrane protein 18; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925358	Tmem18<tm1c(EUCOMM)Wtsi>	28811369	EUCOMM
transmembrane protein 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842441	Tmem18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 191C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419163	Tmem191c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 192; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:5303143	Tmem192<tm2a(EUCOMM)Hmgu>	28504966	EUCOMM
transmembrane protein 192; targeted mutation 2d, Helmholtz Zentrum Muenchen GmbH	MGI:6115602	Tmem192<tm2d(EUCOMM)Hmgu>	28504966	EUCOMM
transmembrane protein 198; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880928	Tmem198<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 198; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881945	Tmem198<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 199; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364381	Tmem199<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303177	Tmem19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456041	Tmem19<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 19; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302352	Tmem19<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 19; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302325	Tmem19<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 200A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426589	Tmem200a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 202; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419733	Tmem202<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 211; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4888873	Tmem211<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 214; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431956	Tmem214<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 215; targeted mutation 1, Velocigene	MGI:4842901	Tmem215<tm1(KOMP)Vlcg>	28199486	KOMP-Regeneron
transmembrane protein 218; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431536	Tmem218<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 218; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431857	Tmem218<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 219; targeted mutation 1, Velocigene	MGI:4399704	Tmem219<tm1(KOMP)Vlcg>	27629921	KOMP-Regeneron
transmembrane protein 223; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419438	Tmem223<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 233; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419688	Tmem233<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 233; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419425	Tmem233<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 234; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286251	Tmem234<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 235; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363903	Tmem235<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 235; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362636	Tmem235<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 236; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4843841	Tmem236<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 236; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4843837	Tmem236<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 241; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948650	Tmem241<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 241; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820342	Tmem241<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 242; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419613	Tmem242<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 245; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296110	Tmem245<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 245; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294027	Tmem245<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 248; targeted mutation 1.1, Velocigene	MGI:5569952	Tmem248<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane protein 248; targeted mutation 1, Velocigene	MGI:4399524	Tmem248<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
transmembrane protein 252; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427189	Tmem252<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 252; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427142	Tmem252<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 253; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428492	Tmem253<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 254a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451359	Tmem254a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 254a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451424	Tmem254a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 254b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944325	Tmem254b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 256; targeted mutation 1.1, Velocigene	MGI:5573272	Tmem256<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane protein 256; targeted mutation 1, Velocigene	MGI:3847534	Tmem256<tm1(KOMP)Vlcg>	26839965	KOMP-Regeneron
transmembrane protein 258; targeted mutation 1.1, Velocigene	MGI:5892142	Tmem258<tm1.1(KOMP)Vlcg>	27974209	KOMP-Regeneron
transmembrane protein 258; targeted mutation 1, Velocigene	MGI:5312593	Tmem258<tm1(KOMP)Vlcg>	27974209	KOMP-Regeneron
transmembrane protein 259; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419332	Tmem259<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 260; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365196	Tmem260<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 260; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364258	Tmem260<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 260; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302287	Tmem260<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 266; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008939	Tmem266<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 266; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5009649	Tmem266<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 268; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880881	Tmem268<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 268; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880986	Tmem268<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432408	Tmem27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432488	Tmem27<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451526	Tmem28<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451340	Tmem28<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451300	Tmem29<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 29; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451720	Tmem29<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441917	Tmem2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441869	Tmem2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 30A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286179	Tmem30a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 30B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473136	Tmem30b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 35A; targeted mutation 1.1, Velocigene	MGI:6113597	Tmem35a<tm1.1(KOMP)Vlcg>	27170659	KOMP-Regeneron
transmembrane protein 35A; targeted mutation 1, Velocigene	MGI:4399235	Tmem35a<tm1(KOMP)Vlcg>	27170659	KOMP-Regeneron
transmembrane protein 37; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441685	Tmem37<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 37; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4442021	Tmem37<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 38B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431666	Tmem38b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 38B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433770	Tmem38b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 39a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365092	Tmem39a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 39a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364004	Tmem39a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 39b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362356	Tmem39b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 39b; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362749	Tmem39b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 39b; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363749	Tmem39b<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 41B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362660	Tmem41b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052383	Tmem42<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 43; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453727	Tmem43<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 43; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5550594	Tmem43<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
transmembrane protein 43; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453707	Tmem43<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 44; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842492	Tmem44<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 45A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456029	Tmem45a2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 50B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433648	Tmem50b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 50B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432345	Tmem50b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 52; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944395	Tmem52<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 53; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363358	Tmem53<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362446	Tmem54<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 54; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362210	Tmem54<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 54; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364978	Tmem54<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 55b; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419980	Tmem55b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 57; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432930	Tmem57<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 59-like; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419290	Tmem59l<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 59; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307114	Tmem59<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363708	Tmem5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362760	Tmem5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 63b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433726	Tmem63b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 63b; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548796	Tmem63b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
transmembrane protein 63c; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362439	Tmem63c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 68; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431978	Tmem68<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 68; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433963	Tmem68<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 70; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455478	Tmem70<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 70; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455478	Tmem70<tm1a(KOMP)Wtsi>	28173120	KOMP-CSD
transmembrane protein 70; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5897275	Tmem70<tm1b(KOMP)Wtsi>	28173120	KOMP-CSD
transmembrane protein 70; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455485	Tmem70<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 71; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849968	Tmem71<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 71; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849964	Tmem71<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 72; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880962	Tmem72<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 72; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5006736	Tmem72<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 74B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455459	Tmem74b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 74B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455528	Tmem74b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 74; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428542	Tmem74<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 74; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428497	Tmem74<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 79; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419184	Tmem79<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 87B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426545	Tmem87b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 87B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5424652	Tmem87b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 87B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473062	Tmem87b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 87B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472870	Tmem87b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 8B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363578	Tmem8b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 8B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362222	Tmem8b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 8 (five membrane-spanning domains); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820375	Tmem8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 8 (five membrane-spanning domains); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820286	Tmem8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 91; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455482	Tmem91<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 91; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455544	Tmem91<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein 94; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432189	Tmem94<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 97; targeted mutation 1.1, Velocigene	MGI:5548577	Tmem97<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
transmembrane protein 98; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432615	Tmem98<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 98; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432615	Tmem98<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
transmembrane protein 98; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433434	Tmem98<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433014	Tmem9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein, adipocyte asscociated 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944485	Tpra1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein, adipocyte asscociated 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944526	Tpra1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane protein with EGF-like and two follistatin-like domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362213	Tmeff2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein with EGF-like and two follistatin-like domains 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362534	Tmeff2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane protein with EGF-like and two follistatin-like domains 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364138	Tmeff2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane serine protease 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433394	Tmprss6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane serine protease 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433697	Tmprss6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
transmembrane serine protease 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364390	Tmprss7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transmembrane serine protease 7; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472981	Tmprss7<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
transport and golgi organization 6; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548745	Tango6<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
transportin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293946	Tnpo1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transportin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364809	Tnpo3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
transportin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364809	Tnpo3<tm1a(KOMP)Wtsi>	27880902	KOMP-CSD
transportin 3; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888905	Tnpo3<tm1c(KOMP)Wtsi>	27880902	KOMP-CSD
transportin 3; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5888906	Tnpo3<tm1d(KOMP)Wtsi>	27880902	KOMP-CSD
transportin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362925	Tnpo3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
transportin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473009	Tnpo3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
treacle ribosome biogenesis factor 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5002911	Tcof1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
trefoil factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433486	Tff1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
trefoil factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433486	Tff1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
trefoil factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433596	Tff1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
trefoil factor 3, intestinal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432405	Tff3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
trehalase (brush-border membrane glycoprotein); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451364	Treh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trehalase (brush-border membrane glycoprotein); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451553	Treh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TRH-degrading enzyme; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452688	Trhde<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tribbles pseudokinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363713	Trib1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tribbles pseudokinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363621	Trib1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tribbles pseudokinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363219	Trib2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tribbles pseudokinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363560	Trib2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
trichoplein, keratin filament binding; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433203	Tchp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
trichoplein, keratin filament binding; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432257	Tchp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
triggering receptor expressed on myeloid cells 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364133	Trem1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
triggering receptor expressed on myeloid cells 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364070	Trem1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
triggering receptor expressed on myeloid cells 1; targeted mutation 1, Velocigene	MGI:4415423	Trem1<tm1(KOMP)Vlcg>	27328755	KOMP-Regeneron
triggering receptor expressed on myeloid cells 1; targeted mutation 1, Velocigene	MGI:4415423	Trem1<tm1(KOMP)Vlcg>	28824642	KOMP-Regeneron
triggering receptor expressed on myeloid cells 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4420134	Trem1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
triggering receptor expressed on myeloid cells 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4364995	Trem1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
triggering receptor expressed on myeloid cells 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5527603	Trem1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
triggering receptor expressed on myeloid cells 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460512	Trem2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
triggering receptor expressed on myeloid cells 2; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5897643	Trem2<tm1c(EUCOMM)Wtsi>	21677750	EUCOMM
triggering receptor expressed on myeloid cells 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460421	Trem2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
triggering receptor expressed on myeloid cells 2; targeted mutation 1, Velocigene	MGI:3797897	Trem2<tm1(KOMP)Vlcg>	25732305	KOMP-Regeneron
triggering receptor expressed on myeloid cells 2; targeted mutation 1, Velocigene	MGI:3797897	Trem2<tm1(KOMP)Vlcg>	26374899	KOMP-Regeneron
triggering receptor expressed on myeloid cells 2; targeted mutation 1, Velocigene	MGI:3797897	Trem2<tm1(KOMP)Vlcg>	27143430	KOMP-Regeneron
triggering receptor expressed on myeloid cells 2; targeted mutation 1, Velocigene	MGI:3797897	Trem2<tm1(KOMP)Vlcg>	28077724	KOMP-Regeneron
triggering receptor expressed on myeloid cells 2; targeted mutation 1, Velocigene	MGI:3797897	Trem2<tm1(KOMP)Vlcg>	28100745	KOMP-Regeneron
triggering receptor expressed on myeloid cells 2; targeted mutation 1, Velocigene	MGI:3797897	Trem2<tm1(KOMP)Vlcg>	28680398	KOMP-Regeneron
triggering receptor expressed on myeloid cells 2; targeted mutation 1, Velocigene	MGI:3797897	Trem2<tm1(KOMP)Vlcg>	29040522	KOMP-Regeneron
triggering receptor expressed on myeloid cells-like 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692706	Treml1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
triggering receptor expressed on myeloid cells-like 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419374	Treml4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
triggering receptor expressed on myeloid cells-like 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419374	Treml4<tm1(KOMP)Wtsi>	25848864	KOMP-CSD
trimethylguanosine synthase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842833	Tgs1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
triosephosphate isomerase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432885	Tpi1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
triosephosphate isomerase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433274	Tpi1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4948608	Trim14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451951	Trim17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452788	Trim17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428523	Trim21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364796	Trim24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 24; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299594	Trim24<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434355	Trim27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434284	Trim27<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434517	Trim29<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 29; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434517	Trim29<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
tripartite motif-containing 29; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548617	Trim29<tm1b(EUCOMM)Wtsi>	26398943	EUCOMM
tripartite motif-containing 29; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548617	Trim29<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
tripartite motif-containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842847	Trim2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433563	Trim2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 30B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451525	Trim30b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 30B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451388	Trim30b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 30D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452695	Trim30d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 30D; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452707	Trim30d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434104	Trim32<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 32; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5009638	Trim32<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293976	Trim33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294965	Trim33<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842405	Trim36<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842848	Trim36<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 38; targeted mutation 1, Velocigene	MGI:4415381	Trim38<tm1(KOMP)Vlcg>	26392463	KOMP-Regeneron
tripartite motif-containing 38; targeted mutation 1, Velocigene	MGI:4415381	Trim38<tm1(KOMP)Vlcg>	28250012	KOMP-Regeneron
tripartite motif-containing 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364344	Trim42<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 42; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428570	Trim42<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 42; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5428532	Trim42<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 43A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841428	Trim43a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 43A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841375	Trim43a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363243	Trim45<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363243	Trim45<tm1a(KOMP)Wtsi>	22876197	KOMP-CSD
tripartite motif-containing 45; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363534	Trim45<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 45; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363651	Trim45<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 45; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5002917	Trim45<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 45; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5002909	Trim45<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 50; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362939	Trim50<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 50; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364833	Trim50<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 56; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5527611	Trim56<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 62; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5464329	Trim62<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 62; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5464322	Trim62<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 65; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363168	Trim65<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 65; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637142	Trim65<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
tripartite motif-containing 66; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431799	Trim66<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 66; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431799	Trim66<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
tripartite motif-containing 66; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434051	Trim66<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 66; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433485	Trim66<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 66; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433485	Trim66<tm2a(EUCOMM)Wtsi>	23912999	EUCOMM
tripartite motif-containing 68; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820085	Trim68<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 68; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820077	Trim68<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 6; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419300	Trim6<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 72; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842659	Trim72<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 72; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842721	Trim72<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460507	Trim7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461701	Trim7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tripartite motif-containing 80; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362246	Trim80<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tripartite motif-containing 9; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:5141815	Trim9<tm1a(KOMP)Mbp>	26702829	KOMP-CSD
TRM2 tRNA methyltransferase 2A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840625	Trmt2a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
TRM2 tRNA methyltransferase 2A; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548943	Trmt2a<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
TRM2 tRNA methyltransferase 2A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840614	Trmt2a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA-histidine guanylyltransferase 1-like (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431657	Thg1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltranferase 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473143	Trmt12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltranferase 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472721	Trmt12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 10A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432852	Trmt10a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 10A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432852	Trmt10a<tm1a(EUCOMM)Wtsi>	23870131	EUCOMM
tRNA methyltransferase 10A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434214	Trmt10a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 1 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461650	Trmt1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 1 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461721	Trmt1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5634291	Trmt1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
tRNA methyltransferase 61A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451989	Trmt61a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 61A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452811	Trmt61a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 61A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473091	Trmt61a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 61A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472888	Trmt61a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362540	Trmt6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tRNA methyltransferase O; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432566	Trmo<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA methyltransferase O; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434205	Trmo<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA phosphotransferase 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419246	Trpt1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tRNA splicing endonuclease subunit 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820147	Tsen15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tRNA splicing endonuclease subunit 15; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820145	Tsen15<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tRNA splicing endonuclease subunit 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432097	Tsen34<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA splicing endonuclease subunit 34; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433827	Tsen34<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA splicing endonuclease subunit 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434416	Tsen54<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA splicing endonuclease subunit 54; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432197	Tsen54<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA splicing endonuclease subunit 54; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5308332	Tsen54<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tRNA-yW synthesizing protein 1 homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307110	Tyw1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tRNA-yW synthesizing protein 1 homolog (S. cerevisiae); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635453	Tyw1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
tRNA-yW synthesizing protein 1 homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428517	Tyw1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tRNA-yW synthesizing protein 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286197	Tyw5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trophinin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363409	Tro<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trophinin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362205	Tro<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
trophinin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363072	Tro<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
trophinin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363604	Tro<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tropomodulin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942004	Tmod2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tropomodulin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942017	Tmod2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tropomodulin 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419118	Tmod4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tropomodulin 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419118	Tmod4<tm1(KOMP)Wtsi>	26586224	KOMP-CSD
tropomyosin 1, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842867	Tpm1<tm1a(EUCOMM)Wtsi>	20799038	EUCOMM
tropomyosin 1, alpha; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842867	Tpm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tropomyosin 1, alpha; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5014728	Tpm1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tropomyosin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432629	Tpm4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tropomyosin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432107	Tpm4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
troponin C2, fast; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840579	Tnnc2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
troponin C2, fast; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840573	Tnnc2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
troponin C, cardiac/slow skeletal; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364368	Tnnc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
troponin C, cardiac/slow skeletal; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362967	Tnnc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
troponin I, cardiac 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842882	Tnni3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
troponin T1, skeletal, slow; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364919	Tnnt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
troponin T1, skeletal, slow; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365250	Tnnt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
troponin T3, skeletal, fast; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362201	Tnnt3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
troponin T3, skeletal, fast; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363228	Tnnt3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
troponin T3, skeletal, fast; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363809	Tnnt3<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
troponin T3, skeletal, fast; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363809	Tnnt3<tm2a(KOMP)Wtsi>	23775847	KOMP-CSD
TROVE domain family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452789	Trove2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TROVE domain family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452765	Trove2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Trp53 induced glycolysis repulatory phosphatase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441746	Tigar<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TRPM8 channel-associated factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365007	Tcaf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TRPM8 channel-associated factor 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5285710	Tcaf1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
TRPM8 channel-associated factor 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5427220	Tcaf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TruB pseudouridine (psi) synthase family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840623	Trub2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
TruB pseudouridine (psi) synthase family member 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840623	Trub2<tm2a(EUCOMM)Wtsi>	27233670	EUCOMM
TruB pseudouridine (psi) synthase family member 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840677	Trub2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
trypsin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841098	Try5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
trypsin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841182	Try5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tryptophan hydroxylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362581	Tph1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tryptophan hydroxylase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363983	Tph1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tryptophanyl tRNA synthetase 2 (mitochondrial); targeted mutation 1.1, Velocigene	MGI:5468955	Wars2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tryptophanyl-tRNA synthetase; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548346	Wars<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
TSPY-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880895	Tspyl2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
TSPY-like 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548366	Tspyl2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
TSPY-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881939	Tspyl2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
TSR1 20S rRNA accumulation; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432716	Tsr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
TSR1 20S rRNA accumulation; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432609	Tsr1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
TSR2 20S rRNA accumulation; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433066	Tsr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ts translation elongation factor, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432572	Tsfm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Ts translation elongation factor, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431789	Tsfm<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubby like protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296225	Tulp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubby like protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296210	Tulp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubby-like protein 3; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548429	Tulp3<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
tubby like protein 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365109	Tulp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, alpha 1A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453736	Tuba1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, alpha 1A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453777	Tuba1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, alpha 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052393	Tuba3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, alpha 3A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636920	Tuba3a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
tubulin, alpha 3B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286245	Tuba3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, alpha-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363893	Tubal3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, alpha-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364097	Tubal3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, beta 1 class VI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462607	Tubb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, beta 1 class VI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462632	Tubb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, beta 2B class IIB; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840665	Tubb2b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, beta 2B class IIB; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840624	Tubb2b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, beta 3 class III; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840932	Tubb3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, beta 4A class IVA; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5634810	Tubb4a<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, beta 4A class IVA; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419785	Tubb4a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, beta 4B class IVB; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432906	Tubb4b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, beta 4B class IVB; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441955	Tubb4b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, beta 4B class IVB; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4442000	Tubb4b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, beta 5 class I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820090	Tubb5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, beta 5 class I; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5140487	Tubb5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, delta 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431738	Tubd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, delta 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433978	Tubd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin epsilon and delta complex 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842801	Tedc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin epsilon and delta complex 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460453	Tedc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin folding cofactor B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432725	Tbcb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin folding cofactor B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434151	Tbcb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin folding cofactor E-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434436	Tbcel<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, gamma 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441962	Tubg2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, gamma complex associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420019	Tubgcp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, gamma complex associated protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420093	Tubgcp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, gamma complex associated protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362723	Tubgcp3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, gamma complex associated protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364166	Tubgcp3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, gamma complex associated protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473065	Tubgcp3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin, gamma complex associated protein 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365049	Tubgcp6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin, gamma complex associated protein 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362651	Tubgcp6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin polyglutamylase complex subunit 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432598	Tpgs1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin polyglutamylase complex subunit 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432947	Tpgs1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin polyglutamylase complex subunit 2; targeted mutation 1.1, Velocigene	MGI:5468968	Tpgs2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tubulin polyglutamylase complex subunit 2; targeted mutation 1.1, Velocigene	MGI:5468968	Tpgs2<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
tubulin polymerization-promoting protein family member 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419424	Tppp3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin polymerization promoting protein; targeted mutation 1.1, Velocigene	MGI:5554931	Tppp<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tubulin polymerization promoting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881072	Tppp<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin polymerization promoting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881082	Tppp<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432051	Ttll1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433421	Ttll1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 10; endonuclease-mediated mutation 1, Jackson	MGI:5607785	Ttll10<em1(IMPC)J>	28700664	IMPC
tubulin tyrosine ligase-like family, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820338	Ttll11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820329	Ttll11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432429	Ttll12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433627	Ttll12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433856	Ttll3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433856	Ttll3<tm1a(EUCOMM)Wtsi>	23897886	EUCOMM
tubulin tyrosine ligase-like family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433856	Ttll3<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
tubulin tyrosine ligase-like family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433856	Ttll3<tm1a(EUCOMM)Wtsi>	25180231	EUCOMM
tubulin tyrosine ligase-like family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433856	Ttll3<tm1a(EUCOMM)Wtsi>	28104815	EUCOMM
tubulin tyrosine ligase-like family, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433211	Ttll4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432976	Ttll4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432997	Ttll5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433388	Ttll5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433774	Ttll5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 5; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5472692	Ttll5<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 5; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5472787	Ttll5<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 6; targeted mutation 1.1, Velocigene	MGI:5605489	Ttll6<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tubulin tyrosine ligase-like family, member 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432399	Ttll6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842486	Ttll8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase-like family, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362867	Ttll9<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin tyrosine ligase-like family, member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362256	Ttll9<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tubulin tyrosine ligase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432423	Ttl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tubulin tyrosine ligase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433922	Ttl<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tudor and KH domain containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849959	Tdrkh<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tudor and KH domain containing protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515780	Tdrkh<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
tudor and KH domain containing protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5515780	Tdrkh<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
tudor and KH domain containing protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849966	Tdrkh<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tudor domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363012	Tdrd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tudor domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363857	Tdrd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tudor domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293949	Tdrd3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tudor domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428474	Tdrd3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tudor domain containing 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435844	Tdrd5<tm1a(EUCOMM)Hmgu>	29317670	EUCOMM
tudor domain containing 5; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6115347	Tdrd5<tm1c(EUCOMM)Hmgu>	29317670	EUCOMM
tudor domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5464327	Tdrd7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tudor domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5464320	Tdrd7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tuftelin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419443	Tuft1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tuftelin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419803	Tuft1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tuftelin interacting protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842601	Tfip11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tuftelin interacting protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842626	Tfip11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor, alpha-induced protein 1 (endothelial); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433727	Tnfaip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor, alpha-induced protein 1 (endothelial); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433075	Tnfaip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor, alpha-induced protein 1 (endothelial); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4434442	Tnfaip1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor, alpha-induced protein 8-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428576	Tnfaip8l1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor, alpha-induced protein 8-like 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840691	Tnfaip8l2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor, alpha-induced protein 8-like 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840570	Tnfaip8l2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor, alpha-induced protein 8-like 3; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4462563	Tnfaip8l3<tm1a(KOMP)Mbp>	25242044	KOMP-CSD
tumor necrosis factor, alpha-induced protein 8-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940789	Tnfaip8l3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428595	Tnfsf10<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428584	Tnfsf10<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938567	Tnfsf11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor (ligand) superfamily, member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4938574	Tnfsf11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor (ligand) superfamily, member 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5302335	Tnfsf12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor (ligand) superfamily, member 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302300	Tnfsf12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor (ligand) superfamily, member 12; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5302373	Tnfsf12<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor (ligand) superfamily, member 12; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5302365	Tnfsf12<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor (ligand) superfamily, member 13; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419527	Tnfsf13<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5426627	Tnfsf14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426562	Tnfsf14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 14; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5428575	Tnfsf14<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950975	Tnfsf15<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor (ligand) superfamily, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949354	Tnfsf9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 10b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461662	Tnfrsf10b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 10b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461755	Tnfrsf10b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364882	Tnfrsf14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363076	Tnfrsf14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4452634	Tnfrsf14<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor receptor superfamily, member 18; targeted mutation 1.1, Velocigene	MGI:5583084	Tnfrsf18<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
tumor necrosis factor receptor superfamily, member 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820303	Tnfrsf18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820344	Tnfrsf18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431880	Tnfrsf1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432461	Tnfrsf1a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473067	Tnfrsf1a<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472873	Tnfrsf1a<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433096	Tnfrsf1b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433096	Tnfrsf1b<tm1a(EUCOMM)Wtsi>	27147664	EUCOMM
tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433096	Tnfrsf1b<tm1a(EUCOMM)Wtsi>	28052249	EUCOMM
tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433096	Tnfrsf1b<tm1a(EUCOMM)Wtsi>	28890718	EUCOMM
tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433096	Tnfrsf1b<tm1a(EUCOMM)Wtsi>	29163535	EUCOMM
tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115544	Tnfrsf1b<tm1c(EUCOMM)Wtsi>	29163535	EUCOMM
tumor necrosis factor receptor superfamily, member 1b; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432289	Tnfrsf1b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849960	Tnfrsf26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor receptor superfamily, member 26; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868834	Tnfrsf26<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tumor necrosis factor receptor superfamily, member 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942140	Tnfrsf4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948639	Tnfrsf4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432147	Tnfrsf9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor receptor superfamily, member 9; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548402	Tnfrsf9<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
tumor necrosis factor receptor superfamily, member 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433557	Tnfrsf9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286397	Tnf<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tumor necrosis factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296208	Tnf<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor protein D52-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363000	Tpd52l2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor protein D52-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363000	Tpd52l2<tm1a(KOMP)Wtsi>	24652767	KOMP-CSD
tumor protein D52-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364981	Tpd52l2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tumor protein, translationally-controlled 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5305675	Tpt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tumor suppressor candidate 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009560	Tusc3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor suppressor candidate 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944413	Tusc5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tumor suppressor candidate 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944413	Tusc5<tm1a(KOMP)Wtsi>	26629404	KOMP-CSD
tumor suppressor candidate 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944349	Tusc5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Tu translation elongation factor, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842271	Tufm<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Tu translation elongation factor, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842760	Tufm<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Tu translation elongation factor, mitochondrial; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4951128	Tufm<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
twinfilin actin binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434218	Twf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
twinfilin actin binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434218	Twf1<tm1a(EUCOMM)Wtsi>	23912999	EUCOMM
twinfilin actin binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434218	Twf1<tm1a(EUCOMM)Wtsi>	28743718	EUCOMM
twinfilin actin binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434346	Twf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
twinfilin actin binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842267	Twf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
twinfilin actin binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842715	Twf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
twist basic helix-loop-helix transcription factor 1 neighbor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451958	Twistnb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
twist basic helix-loop-helix transcription factor 1 neighbor; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473005	Twistnb<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
twist basic helix-loop-helix transcription factor 2; targeted mutation 1.1, Velocigene	MGI:5548349	Twist2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
two pore channel 1; targeted mutation 1.1, Velocigene	MGI:5614621	Tpcn1<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
two pore segment channel 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548791	Tpcn2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
two pore segment channel 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5692810	Tpcn2<tm1c(EUCOMM)Hmgu>	26769314	EUCOMM
TXK tyrosine kinase; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050919	Txk<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosinase; albino 2 Jackson	MGI:1855985	Tyr<c-2J>	23844102	null
tyrosinase; albino Wellcome Trust Sanger Institute	MGI:5442732	Tyr<c-Wtsi>	23620107	null
tyrosinase-related protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842612	Tyrp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosinase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4941504	Tyr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942010	Tyr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432936	Ywhae<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432379	Ywhae<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432379	Ywhae<tm1e(EUCOMM)Wtsi>	24721909	EUCOMM
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433121	Ywhae<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433372	Ywhae<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4433424	Ywhae<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosine aminotransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362229	Tat<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosine aminotransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364365	Tat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosine hydroxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363070	Th<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosine hydroxylase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363070	Th<tm1a(KOMP)Wtsi>	28660243	KOMP-CSD
tyrosine hydroxylase; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6115504	Th<tm1c(KOMP)Wtsi>	28660243	KOMP-CSD
tyrosine hydroxylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364567	Th<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosine kinase, non-receptor, 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431790	Tnk2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosine kinase, non-receptor, 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433289	Tnk2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
tyrosine kinase with immunoglobulin-like and EGF-like domains 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940770	Tie1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosine kinase with immunoglobulin-like and EGF-like domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941492	Tie1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosyl-DNA phosphodiesterase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428546	Tdp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosyl-DNA phosphodiesterase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428508	Tdp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosyl-tRNA synthetase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364562	Yars<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
tyrosyl-tRNA synthetase; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513836	Yars<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296222	U2af2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
U6 snRNA biogenesis 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433816	Usb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
U6 snRNA biogenesis 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434260	Usb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
U7 snRNP-specific Sm-like protein LSM10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840576	Lsm10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
U7 snRNP-specific Sm-like protein LSM10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840664	Lsm10<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
U7 snRNP-specific Sm-like protein LSM11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362146	Lsm11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
U7 snRNP-specific Sm-like protein LSM11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364093	Lsm11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UBA-like domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840997	Ubald1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UBA-like domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841209	Ubald1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquilin 3; targeted mutation 1, Velocigene	MGI:4951160	Ubqln3<tm1(KOMP)Vlcg>	25776854	KOMP-Regeneron
ubiquilin 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363234	Ubqln4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquilin 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364373	Ubqln4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquilin-like; targeted mutation 1, Velocigene	MGI:3808576	Ubqlnl<tm1(KOMP)Vlcg>	26043068	KOMP-Regeneron
ubiquinol-cytochrome c reductase binding protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006762	Uqcrb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquinol-cytochrome c reductase binding protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548543	Uqcrb<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquinol-cytochrome c reductase, complex III subunit VII; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419859	Uqcrq<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquinol-cytochrome c reductase, complex III subunit XI; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434286	Uqcr11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquinol-cytochrome c reductase, complex III subunit XI; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433093	Uqcr11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquinol-cytochrome c reductase hinge protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431969	Uqcrh<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquinol-cytochrome c reductase hinge protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433263	Uqcrh<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin A-52 residue ribosomal protein fusion product 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451972	Uba52<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin A-52 residue ribosomal protein fusion product 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451972	Uba52<tm1a(EUCOMM)Wtsi>	27829658	EUCOMM
ubiquitin A-52 residue ribosomal protein fusion product 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451999	Uba52<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-activating enzyme, Chr Y; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881950	Uba1y<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin associated and SH3 domain containing, A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940752	Ubash3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin associated and SH3 domain containing, A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605803	Ubash3a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin associated and SH3 domain containing, A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946687	Ubash3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin associated and SH3 domain containing, B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364462	Ubash3b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin associated and SH3 domain containing, B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364400	Ubash3b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin associated domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441919	Ubac1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin associated domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441876	Ubac1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-associated protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433059	Ubap1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-associated protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433741	Ubap1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-associated protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363018	Ubap2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-associated protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362221	Ubap2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitination factor E4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432477	Ube4a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitination factor E4A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433934	Ube4a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419198	Ubb<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419341	Uchl3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin carboxyl-terminal esterase L5; targeted mutation 1, Mammalian Functional Genomics Centre	MGI:4880413	Uchl5<tm1(NCOM)Mfgc>	27626380	NorCOMM
ubiquitin-conjugating enzyme E2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431903	Ube2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548336	Ube2b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquitin-conjugating enzyme E2C; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5490487	Ube2c<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2C; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5490487	Ube2c<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin-conjugating enzyme E2C; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5490487	Ube2c<tm1.1(KOMP)Wtsi>	28700664	KOMP-CSD
ubiquitin-conjugating enzyme E2C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419169	Ube2c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2D 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434408	Ube2d1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2D 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441882	Ube2d1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2D 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441983	Ube2d1<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2D 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5527597	Ube2d1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2D 2B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5512006	Ube2d2b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2D 2B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511973	Ube2d2b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2E 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364712	Ube2e2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2E 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364712	Ube2e2<tm1a(KOMP)Wtsi>	26839965	KOMP-CSD
ubiquitin-conjugating enzyme E2E 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548787	Ube2e2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin-conjugating enzyme E2G 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5577267	Ube2g1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin-conjugating enzyme E2G 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460484	Ube2g1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2G 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419352	Ube2g2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2G 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419201	Ube2g2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2H; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692550	Ube2h<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin-conjugating enzyme E2J 1; targeted mutation 1.1, Mammalian Functional Genomics Centre	MGI:5766208	Ube2j1<tm1.1(NCOM)Mfgc>	27626380	NorCOMM
ubiquitin-conjugating enzyme E2M; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515621	Ube2m<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2M; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515621	Ube2m<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin-conjugating enzyme E2M; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5515621	Ube2m<tm1.1(KOMP)Wtsi>	28700664	KOMP-CSD
ubiquitin-conjugating enzyme E2M; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419505	Ube2m<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2N; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319789	Ube2n<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2O; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:5014541	Ube2o<tm1(KOMP)Mbp>	28162974	KOMP-CSD
ubiquitin-conjugating enzyme E2O; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:5477804	Ube2o<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
ubiquitin-conjugating enzyme E2O; targeted mutation 1, Mouse Biology Program, UCDavis	MGI:5477804	Ube2o<tm1.1(KOMP)Mbp>	28162974	KOMP-CSD
ubiquitin-conjugating enzyme E2Q family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363280	Ube2q2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2Q family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365226	Ube2q2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2R 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419532	Ube2r2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2U (putative); targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5637184	Ube2u<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin-conjugating enzyme E2U (putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363149	Ube2u<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2U (putative); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4363894	Ube2u<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2U (putative); targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363977	Ube2u<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-conjugating enzyme E2W (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432686	Ube2w<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-conjugating enzyme E2W (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432686	Ube2w<tm1a(EUCOMM)Wtsi>	26601958	EUCOMM
ubiquitin-conjugating enzyme E2W (putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432714	Ube2w<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451997	Ubtd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451981	Ubtd1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441931	Ubtd2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441797	Ubtd2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008947	Ubd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-fold modifier conjugating enzyme 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419369	Ufc1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419795	Ubl3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419419	Ubl3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434100	Uhrf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434100	Uhrf1<tm1a(EUCOMM)Wtsi>	27050515	EUCOMM
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434100	Uhrf1<tm1a(EUCOMM)Wtsi>	27798843	EUCOMM
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434100	Uhrf1<tm1a(EUCOMM)Wtsi>	29180567	EUCOMM
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888866	Uhrf1<tm1c(EUCOMM)Wtsi>	27050515	EUCOMM
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888866	Uhrf1<tm1c(EUCOMM)Wtsi>	27956603	EUCOMM
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888866	Uhrf1<tm1c(EUCOMM)Wtsi>	29180567	EUCOMM
ubiquitin-like, containing PHD and RING finger domains, 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433630	Uhrf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-like, containing PHD and RING finger domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431698	Uhrf2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-like, containing PHD and RING finger domains 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605797	Uhrf2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquitin-like, containing PHD and RING finger domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431906	Uhrf2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-like domain containing CTD phosphatase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841309	Ublcp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like domain containing CTD phosphatase 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548725	Ublcp1<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin-like modifier activating enzyme 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362341	Uba2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like modifier activating enzyme 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364939	Uba2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like modifier activating enzyme 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452773	Uba3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-like modifier activating enzyme 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452791	Uba3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-like modifier activating enzyme 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365099	Uba5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like modifier activating enzyme 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5299633	Uba5<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin-like modifier activating enzyme 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433242	Uba6<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin-like modifier activating enzyme 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434321	Uba6<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin protein ligase E3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419739	Ube3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419413	Ube3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5296535	Ube3a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3A; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5424651	Ube3a<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3 component n-recognin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362908	Ubr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3 component n-recognin 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364205	Ubr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3 component n-recognin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362720	Ubr3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3 component n-recognin 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362176	Ubr3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin protein ligase E3 component n-recognin 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455996	Ubr5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin protein ligase E3 component n-recognin 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456046	Ubr5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin protein ligase E3 component n-recognin 7 (putative); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842447	Ubr7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin protein ligase E3 component n-recognin 7 (putative); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842559	Ubr7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin protein ligase E3C; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5565262	Ube3c<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin recognition factor in ER-associated degradation 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365123	Ufd1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin recognition factor in ER-associated degradation 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364007	Ufd1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin related modifier 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820232	Urm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin related modifier 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820234	Urm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 10; targeted mutation 1, Mammalian Functional Genomics Centre	MGI:4880482	Usp10<tm1(NCOM)Mfgc>	27626380	NorCOMM
ubiquitin specific peptidase 11; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419682	Usp11<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 12; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548414	Usp12<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin specific peptidase 13 (isopeptidase T-3); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364333	Usp13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433699	Usp14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 14; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4460420	Usp14<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 14; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5637099	Usp14<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquitin specific peptidase 15; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008042	Usp15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 16; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5618768	Usp16<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin specific peptidase 17-like C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428554	Usp17lc<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 17-like C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428521	Usp17lc<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947799	Usp18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947824	Usp18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365157	Usp19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364190	Usp19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363583	Usp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363583	Usp1<tm1a(KOMP)Wtsi>	21925315	KOMP-CSD
ubiquitin specific peptidase 1; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:5556385	Usp1<tm1d(KOMP)Wtsi>	21925315	KOMP-CSD
ubiquitin specific peptidase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364746	Usp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887724	Usp21<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887724	Usp21<tm1a(EUCOMM)Wtsi>	25680095	EUCOMM
ubiquitin specific peptidase 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887724	Usp21<tm1a(EUCOMM)Wtsi>	27857073	EUCOMM
ubiquitin specific peptidase 21; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888903	Usp21<tm1c(EUCOMM)Wtsi>	27857073	EUCOMM
ubiquitin specific peptidase 21; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5888903	Usp21<tm1c(EUCOMM)Wtsi>	27886188	EUCOMM
ubiquitin specific peptidase 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887697	Usp21<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364127	Usp22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364127	Usp22<tm1a(KOMP)Wtsi>	26431380	KOMP-CSD
ubiquitin specific peptidase 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364127	Usp22<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin specific peptidase 22; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548748	Usp22<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin specific peptidase 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364419	Usp22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847688	Usp24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847702	Usp24<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 25; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140433	Usp25<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140419	Usp25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 25; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527596	Usp25<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286393	Usp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636991	Usp2<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquitin specific peptidase 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365018	Usp32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364767	Usp32<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433766	Usp33<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431599	Usp33<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453711	Usp34<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 34; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453741	Usp34<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944347	Usp35<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 36; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605789	Usp36<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin specific peptidase 38; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548650	Usp38<tm1b(EUCOMM)Hmgu>	25849460	EUCOMM
ubiquitin specific peptidase 38; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548650	Usp38<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin specific peptidase 39; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605740	Usp39<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
ubiquitin specific peptidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432395	Usp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432395	Usp3<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquitin specific peptidase 3; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548759	Usp3<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquitin specific peptidase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434140	Usp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 42; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433229	Usp42<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 42; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431659	Usp42<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 42; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432706	Usp42<tm2a(EUCOMM)Wtsi>	19525957	EUCOMM
ubiquitin specific peptidase 42; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432706	Usp42<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 42; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432706	Usp42<tm2a(EUCOMM)Wtsi>	24652767	EUCOMM
ubiquitin specific peptidase 42; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4434453	Usp42<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 46; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419580	Usp46<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842809	Usp47<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 47; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605792	Usp47<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
ubiquitin specific peptidase 47; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842451	Usp47<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 49; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4882005	Usp49<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 4 (proto-oncogene); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431578	Usp4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 4 (proto-oncogene); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431578	Usp4<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
ubiquitin specific peptidase 4 (proto-oncogene); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433548	Usp4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ubiquitin specific peptidase 50; targeted mutation 1, Velocigene	MGI:5293035	Usp50<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
ubiquitin specific peptidase 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286230	Usp54<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286230	Usp54<tm1a(KOMP)Wtsi>	27769071	KOMP-CSD
ubiquitin specific peptidase 54; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5694179	Usp54<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
ubiquitin specific peptidase 7; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419327	Usp7<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 9, Y chromosome; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5429381	Usp9y<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase 9, Y chromosome; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429365	Usp9y<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ubiquitin specific peptidase like 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420128	Uspl1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
U box domain containing 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5513832	Ubox5<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
UBX domain protein 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458847	Ubxn10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UBX domain protein 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458851	Ubxn10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UBX domain protein 2A; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419132	Ubxn2a<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
UBX domain protein 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456838	Ubxn2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UBX domain protein 2B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456799	Ubxn2b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UBX domain protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008059	Ubxn7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UDP galactosyltransferase 8A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453684	Ugt8a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420085	B3galt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419840	B3galt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473158	B3galt4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472736	B3galt4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431688	B4galt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434063	B4galt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419597	B4galt4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5052420	B3galnt1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451683	B3gnt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427144	B3gnt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949379	B3gnt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419701	B3gnt5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420055	B3gnt5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5293943	B3gnt6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5548784	B3gnt7<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4887627	B3gnt7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433815	B3gntl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433086	B3gntl1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UDP-glucose glycoprotein glucosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841374	Uggt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-glucose glycoprotein glucosyltransferase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841374	Uggt1<tm1a(KOMP)Wtsi>	28545059	KOMP-CSD
UDP-glucose glycoprotein glucosyltransferase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451533	Uggt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-glucose glycoprotein glucosyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451580	Uggt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-glucuronate decarboxylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362426	Uxs1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-glucuronate decarboxylase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364652	Uxs1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841130	Ugt2a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide A2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841313	Ugt2a2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide A3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286177	Ugt2a3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide A3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428475	Ugt2a3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362666	Ugt2b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B35; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365065	Ugt2b35<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B35; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472923	Ugt2b35<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
UDP glucuronosyltransferase 2 family, polypeptide B36; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428599	Ugt2b36<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B37; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5428476	Ugt2b37<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B38; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363666	Ugt2b38<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B38; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363163	Ugt2b38<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362467	Ugt2b5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glucuronosyltransferase 2 family, polypeptide B5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363756	Ugt2b5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glycosyltransferases 3 family, polypeptide A1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5428534	Ugt3a1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP glycosyltransferases 3 family, polypeptide A2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009559	Ugt3a2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363889	Galntl5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5577268	Galntl5<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363421	Galntl5<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841450	Galntl6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841359	Galntl6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UEV and lactate/malate dehyrogenase domains; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434449	Uevld<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UEV and lactate/malate dehyrogenase domains; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433296	Uevld<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UFM1 specific ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432479	Ufl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UFM1 specific ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432479	Ufl1<tm1a(EUCOMM)Wtsi>	25952549	EUCOMM
UFM1 specific ligase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432479	Ufl1<tm1a(EUCOMM)Wtsi>	28104585	EUCOMM
UFM1-specific peptidase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293956	Ufsp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UFM1-specific peptidase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5294960	Ufsp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UHRF1 (ICBP90) binding protein 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307091	Uhrf1bp1l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UHRF1 (ICBP90) binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461700	Uhrf1bp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UHRF1 (ICBP90) binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461764	Uhrf1bp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
unc-119 lipid binding chaperone B; targeted mutation 1.1, Velocigene	MGI:5695949	Unc119b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
unc-119 lipid binding chaperone; targeted mutation 1.1, Velocigene	MGI:5548428	Unc119<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
unc-13 homolog B (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363745	Unc13b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-13 homolog B (C. elegans); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548450	Unc13b<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
unc-13 homolog B (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365090	Unc13b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
unc-13 homolog D (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363373	Unc13d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-13 homolog D (C. elegans); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362489	Unc13d<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
unc-13 homolog D (C. elegans); targeted mutation 1, Velocigene	MGI:4399208	Unc13d<tm1(KOMP)Vlcg>	23659589	KOMP-Regeneron
unc-13 homolog D (C. elegans); targeted mutation 1, Velocigene	MGI:4399208	Unc13d<tm1(KOMP)Vlcg>	25908104	KOMP-Regeneron
unc-13 homolog D (C. elegans); targeted mutation 1, Velocigene	MGI:4399208	Unc13d<tm1(KOMP)Vlcg>	28077416	KOMP-Regeneron
unc-45 myosin chaperone A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5759982	Unc45a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
unc-45 myosin chaperone B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5305676	Unc45b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
unc-51 like kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006775	Ulk1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
unc-51-like kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362969	Ulk4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-51-like kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362969	Ulk4<tm1a(KOMP)Wtsi>	24284070	KOMP-CSD
unc-51-like kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362969	Ulk4<tm1a(KOMP)Wtsi>	27300315	KOMP-CSD
unc-51-like kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362969	Ulk4<tm1a(KOMP)Wtsi>	27445138	KOMP-CSD
unc-51-like kinase 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362969	Ulk4<tm1a(KOMP)Wtsi>	29034508	KOMP-CSD
unc-5 family C-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364807	Unc5cl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-5 netrin receptor C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365138	Unc5c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-5 netrin receptor C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362567	Unc5c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
unc-5 netrin receptor C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451673	Unc5c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-5 netrin receptor C; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451529	Unc5c<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
unc-5 netrin receptor D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842297	Unc5d<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
unc-79 homolog (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286266	Unc79<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-80, NALCN activator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841354	Unc80<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unc-80, NALCN activator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841373	Unc80<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
unc-93 homolog B1 (C. elegans); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947801	Unc93b1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
unc-93 homolog B1 (C. elegans); targeted mutation 1, Velocigene	MGI:3797728	Unc93b1<tm1(KOMP)Vlcg>	24778236	KOMP-Regeneron
uncoupling protein 1 (mitochondrial, proton carrier); targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5692920	Ucp1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
unkempt family zinc finger; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880910	Unk<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
unkempt family zinc finger; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880910	Unk<tm1a(KOMP)Wtsi>	27996060	KOMP-CSD
unkempt family zinc finger; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880899	Unk<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UPF3 regulator of nonsense transcripts homolog B (yeast); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431819	Upf3b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UPF3 regulator of nonsense transcripts homolog B (yeast); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431967	Upf3b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UPF3 regulator of nonsense transcripts homolog B (yeast); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472999	Upf3b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
upregulated during skeletal muscle growth 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820248	Usmg5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
upregulated during skeletal muscle growth 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5692650	Usmg5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
upregulated during skeletal muscle growth 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820360	Usmg5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
upstream binding transcription factor, RNA polymerase I; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365165	Ubtf<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
upstream binding transcription factor, RNA polymerase I; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363910	Ubtf<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
upstream transcription factor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419941	Usf1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
upstream transcription factor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362527	Usf1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
upstream transcription factor family member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472989	Usf3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
upstream transcription factor family member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5514590	Usf3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
upstream transcription factor family member 3; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5766209	Usf3<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
upstream transcription factor family member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472828	Usf3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
uracil DNA glycosylase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362163	Ung<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
urate (5-hydroxyiso-) hydrolase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431645	Urah<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
urate (5-hydroxyiso-) hydrolase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433123	Urah<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
ureidopropionase, beta; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441733	Upb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
URI1, prefoldin-like chaperone; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942141	Uri1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
URI1, prefoldin-like chaperone; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942145	Uri1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
uridine-cytidine kinase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362156	Uck1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
uridine-cytidine kinase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364680	Uck1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
uridine-cytidine kinase 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4362314	Uck1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
uridine-cytidine kinase 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363975	Uck1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
uridine-cytidine kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432099	Uck2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
uridine-cytidine kinase 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433750	Uck2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
uridine phosphorylase 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363244	Upp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
uridine phosphorylase 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362196	Upp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
urocanase domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5424650	Uroc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
urocanase domain containing 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472919	Uroc1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
urocortin 3; targeted mutation 1.1, Velocigene	MGI:5695941	Ucn3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
uromodulin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289814	Umodl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
uronyl-2-sulfotransferase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363981	Ust<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
uronyl-2-sulfotransferase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363378	Ust<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
uroplakin 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287790	Upk1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
uroplakin 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5427139	Upk1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
uroplakin 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456027	Upk3a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
uroplakin 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455961	Upk3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
uroporphyrinogen III synthase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433834	Uros<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
uroporphyrinogen III synthase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431710	Uros<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
urotensin 2B; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548854	Uts2b<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
urotensin 2 receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473192	Uts2r<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
urotensin 2 receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472766	Uts2r<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
urotensin 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419276	Uts2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
urotensin 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420068	Uts2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
USH1 protein network component harmonin binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460519	Ushbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
USH1 protein network component harmonin binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460465	Ushbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
USH1 protein network component harmonin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363497	Ush1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
USH1 protein network component harmonin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363497	Ush1c<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
USH1 protein network component harmonin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364780	Ush1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
usherin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433567	Ush2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
usherin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433253	Ush2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UTP14A small subunit processome component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433207	Utp14a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UTP14A small subunit processome component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433977	Utp14a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
UTP14B small subunit processome component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944428	Utp14b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UTP14B small subunit processome component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008776	Utp14b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
UTP15 small subunit processome component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006783	Utp15<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
UTP4 small subunit processome component; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458555	Utp4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
UTP4 small subunit processome component; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458595	Utp4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5444979	Abl2<tm1a(EUCOMM)Hmgu>	1648219	EUCOMM
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene); targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:5444979	Abl2<tm1a(EUCOMM)Hmgu>	29231808	EUCOMM
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene); targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6111513	Abl2<tm1c(EUCOMM)Hmgu>	29231808	EUCOMM
vaccinia related kinase 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451701	Vrk2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vaccinia related kinase 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364198	Vrk3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vaccinia related kinase 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363380	Vrk3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vacuolar protein sorting 13A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842502	Vps13a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 13A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637150	Vps13a<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
vacuolar protein sorting 13A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842293	Vps13a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 13C; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548822	Vps13c<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
vacuolar protein sorting 13D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451376	Vps13d<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vacuolar protein sorting 25; targeted mutation 1.1, Velocigene	MGI:5695878	Vps25<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
vacuolar protein sorting 25; targeted mutation 1, Velocigene	MGI:4951319	Vps25<tm1(KOMP)Vlcg>	25373905	KOMP-Regeneron
vacuolar protein sorting 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949345	Vps28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949375	Vps28<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 33B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431968	Vps33b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 33B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432836	Vps33b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 37D; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840582	Vps37d<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 37D; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548767	Vps37d<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
vacuolar protein sorting 37D; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840676	Vps37d<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
vacuolar protein sorting 4A; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5561562	Vps4a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
vacuolar protein sorting 72; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008033	Vps72<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vacuole membrane protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887606	Vmp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vacuole membrane protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5286168	Vmp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
valosin containing protein lysine (K) methyltransferase; targeted mutation 1.1, Velocigene	MGI:5575900	Vcpkmt<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
valosin containing protein lysine (K) methyltransferase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419744	Vcpkmt<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
valosin containing protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880883	Vcp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
valosin containing protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880906	Vcp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
valyl-tRNA synthetase 2, mitochondrial; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363876	Vars2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
valyl-tRNA synthetase 2, mitochondrial; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362958	Vars2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
VANGL planar cell polarity 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362618	Vangl1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
VANGL planar cell polarity 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365105	Vangl1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
VANGL planar cell polarity 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365105	Vangl1<tm1e(KOMP)Wtsi>	25340873	KOMP-CSD
VANGL planar cell polarity 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4364621	Vangl1<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
VANGL planar cell polarity 1; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4363226	Vangl1<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
VANGL planar cell polarity 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431936	Vangl2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
VANGL planar cell polarity 2; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511936	Vangl2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
vanin 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441927	Vnn3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vanin 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473225	Vnn3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
vanin 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5473211	Vnn3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
vascular endothelial growth factor B; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5529627	Vegfb<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
vascular endothelial growth factor D; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434439	Vegfd<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vasoactive intestinal peptide receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364068	Vipr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vasoactive intestinal peptide receptor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364509	Vipr1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vasoactive intestinal peptide receptor 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364726	Vipr2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vasoactive intestinal peptide receptor 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473087	Vipr2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
vasoactive intestinal polypeptide; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307098	Vip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vasohibin 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363202	Vash1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vav 1 oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944399	Vav1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vav 1 oncogene; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944359	Vav1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vav 2 oncogene; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287794	Vav2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
v-crk avian sarcoma virus CT10 oncogene homolog-like; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435697	Crkl<tm1a(EUCOMM)Hmgu>	28439006	EUCOMM
v-crk avian sarcoma virus CT10 oncogene homolog-like; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5825167	Crkl<tm1c(EUCOMM)Hmgu>	28121514	EUCOMM
v-crk avian sarcoma virus CT10 oncogene homolog-like; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5825167	Crkl<tm1c(EUCOMM)Hmgu>	28439006	EUCOMM
v-crk avian sarcoma virus CT10 oncogene homolog-like; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5904959	Crkl<tm1d(EUCOMM)Hmgu>	28439006	EUCOMM
ventral anterior homeobox 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:5014550	Vax1<tm1a(KOMP)Mbp>	27013679	KOMP-CSD
ventral anterior homeobox 1; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5796178	Vax1<tm1c(KOMP)Mbp>	27013679	KOMP-CSD
ventral anterior homeobox 1; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5796178	Vax1<tm1c(KOMP)Mbp>	28164172	KOMP-CSD
ventral anterior homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820363	Vax2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
ventral anterior homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820290	Vax2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
very low density lipoprotein receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364417	Vldlr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
very low density lipoprotein receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429385	Vldlr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vesicle amine transport 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432876	Vat1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle amine transport 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431984	Vat1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle-associated membrane protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5473041	Vamp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle-associated membrane protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5472860	Vamp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle-associated membrane protein 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527590	Vamp3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle-associated membrane protein, associated protein A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842890	Vapa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle-associated membrane protein, associated protein A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462679	Vapa<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle (multivesicular body) trafficking 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434252	Vta1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vesicle transport through interaction with t-SNAREs 1A; targeted mutation 1.1, Velocigene	MGI:5548487	Vti1a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
vesicle transport through interaction with t-SNAREs 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365121	Vti1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vesicle transport through interaction with t-SNAREs 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364865	Vti1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vesicular, overexpressed in cancer, prosurvival protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472964	Vopp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vestigial like family member 1; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5635474	Vgll1<tm1.1(KOMP)Wtsi>	21677750	KOMP-CSD
vestigial like family member 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419644	Vgll1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
vestigial like family member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365024	Vgll2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vestigial like family member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429388	Vgll2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vezatin, adherens junctions transmembrane protein; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5585593	Vezt<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
vimentin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014739	Vim<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
vimentin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434320	Vim<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vimentin; targeted mutation 1, Velocigene	MGI:5051378	Vim<tm1(KOMP)Vlcg>	27480130	KOMP-Regeneron
vinculin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840995	Vcl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vir like m6A methyltransferase associated; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880937	Virma<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vir like m6A methyltransferase associated; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880932	Virma<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
visinin-like 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006773	Vsnl1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
visual system homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453691	Vsx2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
visual system homeobox 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453769	Vsx2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
vitamin D (1,25-dihydroxyvitamin D3) receptor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949332	Vdr<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vitamin D (1,25-dihydroxyvitamin D3) receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5002934	Vdr<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vitamin D binding protein; targeted mutation 1.1, Velocigene	MGI:5577272	Gc<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
vitrin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434015	Vit<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949351	Maff<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4949367	Maff<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432052	Mafk<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432880	Mafk<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4888950	Mycn<tm1(EUCOMM)Wtsi>	21677750	EUCOMM
voltage-dependent anion channel 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432270	Vdac1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
voltage-dependent anion channel 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433871	Vdac1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
voltage-dependent anion channel 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451617	Vdac2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
voltage-dependent anion channel 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451289	Vdac2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 1 receptor 235; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364052	Vmn1r235<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 1 receptor 235; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841154	Vmn1r235<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 1 receptor 235; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841289	Vmn1r235<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 1 receptor 32; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458515	Vmn1r32<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 1 receptor 32; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458567	Vmn1r32<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 1 receptor 45; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451694	Vmn1r45<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 2, receptor 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841471	Vmn2r26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 2, receptor 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363153	Vmn2r28<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
vomeronasal 2, receptor 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4420108	Vmn2r7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
von Hippel-Lindau tumor suppressor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006787	Vhl<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
von Willebrand factor A domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364598	Vwa2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364161	Vwa2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363306	Vwa3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 3A; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637178	Vwa3a<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
von Willebrand factor A domain containing 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362380	Vwa3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 3B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842423	Vwa3b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
von Willebrand factor A domain containing 5A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841458	Vwa5a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 5A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841445	Vwa5a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 5B1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460271	Vwa5b1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 5B2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419897	Vwa5b2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 5B2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419281	Vwa5b2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor A domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441772	Vwa8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
von Willebrand factor A domain containing 8; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5614704	Vwa8<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
von Willebrand factor A domain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441863	Vwa8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
von Willebrand factor C domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944487	Vwc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
von Willebrand factor C domain-containing protein 2-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841403	Vwc2l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
von Willebrand factor C domain-containing protein 2-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841210	Vwc2l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
VPS11, CORVET/HOPS core subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433091	Vps11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
VPS11, CORVET/HOPS core subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434433	Vps11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
VPS18 CORVET/HOPS core subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432211	Vps18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
VPS18 CORVET/HOPS core subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434242	Vps18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
VPS18 CORVET/HOPS core subunit; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473079	Vps18<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
VPS26 retromer complex component B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434491	Vps26b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
VPS26 retromer complex component B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434222	Vps26b<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4840775	Vipas39<tm1a(KOMP)Mbp>	27435297	KOMP-CSD
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5816979	Vipas39<tm1c(KOMP)Mbp>	27435297	KOMP-CSD
VPS50 EARP/GARPII complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319815	Vps50<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
VPS51 GARP complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458528	Vps51<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
VPS53 GARP complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451513	Vps53<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
VPS53 GARP complex subunit; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451643	Vps53<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
VPS8 CORVET complex subunit; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433895	Vps8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
VPS9 domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419519	Vps9d1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
VPS9 domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419784	Vps9d1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
v-raf-leukemia viral oncogene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433410	Raf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
v-raf-leukemia viral oncogene 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548965	Raf1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
v-ral simian leukemia viral oncogene A (ras related); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451975	Rala<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
v-ral simian leukemia viral oncogene A (ras related); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452017	Rala<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
v-ral simian leukemia viral oncogene A (ras related); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473034	Rala<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
v-ral simian leukemia viral oncogene B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433898	Ralb<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
v-ral simian leukemia viral oncogene B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433217	Ralb<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
v-rel reticuloendotheliosis viral oncogene homolog A (avian); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140481	Rela<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
V-set and immunoglobulin domain containing 10 like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5303097	Vsig10l<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
V-set and immunoglobulin domain containing 10 like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429367	Vsig10l<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
V-set and immunoglobulin domain containing 10; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5424647	Vsig10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
V-set and immunoglobulin domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363864	Vsig1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
V-set and immunoglobulin domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365029	Vsig1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
V-set and immunoglobulin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434117	Vsig2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
V-set and immunoglobulin domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433519	Vsig2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
V-set and immunoglobulin domain containing 4; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5529618	Vsig4<tm1b(EUCOMM)Hmgu>	21677750	EUCOMM
V-set and immunoglobulin domain containing 8; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5493273	Vsig8<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
V-set and immunoglobulin domain containing 8; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5493273	Vsig8<tm1.1(KOMP)Mbp>	28700664	KOMP-CSD
V-set and transmembrane domain containing 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433568	Vstm2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
V-set and transmembrane domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364951	Vstm4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
V-set and transmembrane domain containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362603	Vstm5<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
V-set and transmembrane domain containing 5; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473119	Vstm5<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
V-set and transmembrane domain containing 5; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472858	Vstm5<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
V-set domain containing T cell activation inhibitor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364626	Vtcn1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
V-set domain containing T cell activation inhibitor 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362961	Vtcn1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
V-set immunoregulatory receptor; targeted mutation 1.1, Velocigene	MGI:5558156	Vsir<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
V-set immunoregulatory receptor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5426664	Vsir<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
VSP16 CORVET/HOPS core subunit; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362631	Vps16<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455985	Wfikkn2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456000	Wfikkn2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WAP four-disulfide core domain 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286238	Wfdc11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419762	Wfdc11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 13; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840682	Wfdc13<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
WAP four-disulfide core domain 13; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840659	Wfdc13<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
WAP four-disulfide core domain 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296532	Wfdc17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296523	Wfdc17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363398	Wfdc18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363398	Wfdc18<tm1a(KOMP)Wtsi>	25343444	KOMP-CSD
WAP four-disulfide core domain 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364278	Wfdc18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 18; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4365116	Wfdc18<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 1; targeted mutation 1.1, Velocigene	MGI:5692680	Wfdc1<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
WAP four-disulfide core domain 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362270	Wfdc21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362299	Wfdc21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 21; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472932	Wfdc21<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
WAP four-disulfide core domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5296116	Wfdc3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WAP four-disulfide core domain 6A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5141846	Wfdc6a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WASH complex subunit 2`; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364932	Washc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WASH complex subunit 2`; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455547	Washc2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
WASH complex subunit 2`; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5473085	Washc2<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
WASH complex subunit 2`; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5472884	Washc2<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
WASH complex subunit 2`; targeted mutation 4a, Wellcome Trust Sanger Institute	MGI:5511885	Washc2<tm4a(EUCOMM)Wtsi>	21677750	EUCOMM
WASH complex subunit 5; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435153	Washc5<tm1a(EUCOMM)Hmgu>	27390154	EUCOMM
WASH complex subunit 5; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5910638	Washc5<tm1c(EUCOMM)Hmgu>	27390154	EUCOMM
WAS protein homolog associated with actin, golgi membranes and microtubules; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296531	Whamm<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WAS protein homolog associated with actin, golgi membranes and microtubules; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635487	Whamm<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
WAS protein homolog associated with actin, golgi membranes and microtubules; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429364	Whamm<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WAS/WASL interacting protein family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014704	Wipf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WAS/WASL interacting protein family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4818589	Wipf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WAS/WASL interacting protein family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4818593	Wipf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WBP2 N-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944397	Wbp2nl<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WBP2 N-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944398	Wbp2nl<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD and tetratricopeptide repeats 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362336	Wdtc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD and tetratricopeptide repeats 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362336	Wdtc1<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
WD and tetratricopeptide repeats 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362431	Wdtc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat and FYVE domain containing 3; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4455365	Wdfy3<tm1a(KOMP)Mbp>	25198012	KOMP-CSD
WD repeat and FYVE domain containing 3; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4455365	Wdfy3<tm1a(KOMP)Mbp>	27330028	KOMP-CSD
WD repeat and FYVE domain containing 3; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5795593	Wdfy3<tm1c(KOMP)Mbp>	25198012	KOMP-CSD
WD repeat and FYVE domain containing 3; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5795593	Wdfy3<tm1c(KOMP)Mbp>	27330028	KOMP-CSD
WD repeat and HMG-box DNA binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433867	Wdhd1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat and SOCS box-containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458588	Wsb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat and SOCS box-containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458629	Wsb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat and SOCS box-containing 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548747	Wsb2<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
WD repeat containing, antisense to Trp53; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842597	Wrap53<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat containing, antisense to Trp53; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637129	Wrap53<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
WD repeat containing, antisense to Trp53; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637129	Wrap53<tm1b(EUCOMM)Wtsi>	29078390	EUCOMM
WD repeat containing, antisense to Trp53; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842528	Wrap53<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat containing, antisense to Trp73; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365263	Wrap73<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat containing, antisense to Trp73; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4462614	Wrap73<tm3a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat containing, antisense to Trp73; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4462588	Wrap73<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 12; targeted mutation 1.1, Velocigene	MGI:5445742	Wdr12<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
WD repeat domain 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433536	Wdr12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434445	Wdr12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458563	Wdr17<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458488	Wdr17<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014740	Wdr18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432986	Wdr26<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 26; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433497	Wdr26<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 31; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432445	Wdr31<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 31; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431831	Wdr31<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 31; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472959	Wdr31<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 33; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944341	Wdr33<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 33; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944346	Wdr33<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 34; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432567	Wdr34<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 35; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH	MGI:4436424	Wdr35<tm2a(EUCOMM)Hmgu>	21473986	EUCOMM
WD repeat domain 36; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008943	Wdr36<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 37; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452651	Wdr37<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 37; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452651	Wdr37<tm1a(KOMP)Wtsi>	24721909	KOMP-CSD
WD repeat domain 37; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452651	Wdr37<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
WD repeat domain 38; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5299555	Wdr38<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362309	Wdr3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364776	Wdr3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 45; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419996	Wdr45<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 46; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432723	Wdr46<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 46; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5432718	Wdr46<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433065	Wdr47<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 47; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433065	Wdr47<tm1a(EUCOMM)Wtsi>	29078390	EUCOMM
WD repeat domain 47; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:6102912	Wdr47<tm1b(EUCOMM)Wtsi>	29078390	EUCOMM
WD repeat domain 47; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6102913	Wdr47<tm1c(EUCOMM)Wtsi>	29078390	EUCOMM
WD repeat domain 47; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431866	Wdr47<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419852	Wdr4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419180	Wdr4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 4; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473006	Wdr4<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 53; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441841	Wdr53<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 53; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441865	Wdr53<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455517	Wdr54<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 54; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455525	Wdr54<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 55; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420004	Wdr55<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 59; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461692	Wdr59<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 59; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548803	Wdr59<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
WD repeat domain 59; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461691	Wdr59<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 5B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511966	Wdr5b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 60; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473084	Wdr60<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 60; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511152	Wdr60<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 62; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302310	Wdr62<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 72; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363147	Wdr72<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 72; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363147	Wdr72<tm1a(KOMP)Wtsi>	25008349	KOMP-CSD
WD repeat domain 72; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364566	Wdr72<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 77; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014727	Wdr77<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 77; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511945	Wdr77<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 77; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5511908	Wdr77<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 89; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944354	Wdr89<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 89; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944354	Wdr89<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
WD repeat domain 89; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4946686	Wdr89<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 92; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5307105	Wdr92<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 92; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429372	Wdr92<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain 93; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434525	Wdr93<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain 93; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434179	Wdr93<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat domain containing 82; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364050	Wdr82<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain containing 82; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364656	Wdr82<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain containing 82; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455499	Wdr82<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain containing 82; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4455524	Wdr82<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat domain containing 83; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4365200	Wdr83<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
WD repeat, SAM and U-box domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453693	Wdsub1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WD repeat, SAM and U-box domain containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5588281	Wdsub1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
WEE 1 homolog 1 (S. pombe); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842516	Wee1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WEE 1 homolog 1 (S. pombe); targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5513834	Wee1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
Werner helicase interacting protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432335	Wrnip1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Werner helicase interacting protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433729	Wrnip1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
whey acidic protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880892	Wap<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
whirlin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432119	Whrn<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
whirlin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432119	Whrn<tm1a(EUCOMM)Wtsi>	26307081	EUCOMM
whirlin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432119	Whrn<tm1a(EUCOMM)Wtsi>	26420843	EUCOMM
whirlin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432119	Whrn<tm1a(EUCOMM)Wtsi>	27117407	EUCOMM
whirlin; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5796356	Whrn<tm1b(EUCOMM)Wtsi>	27117407	EUCOMM
whirlin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434520	Whrn<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
whirlin; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433400	Whrn<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
whirlin; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433161	Whrn<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
whirlin; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4433476	Whrn<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
whirlin; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4433820	Whrn<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
widely-interspaced zinc finger motifs; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431508	Wiz<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Wilms tumor 1 homolog; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009581	Wt1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 10A; targeted mutation 1.1, Velocigene	MGI:5548381	Wnt10a<tm1.1(KOMP)Vlcg>	25629078	KOMP-Regeneron
wingless-type MMTV integration site family, member 10A; targeted mutation 1.1, Velocigene	MGI:5548381	Wnt10a<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
wingless-type MMTV integration site family, member 10A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433361	Wnt10a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 10B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364848	Wnt10b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 10B; targeted mutation 1e.1, Wellcome Trust Sanger Institute	MGI:5582422	Wnt10b<tm1e.1(KOMP)Wtsi>	27626380	KOMP-CSD
wingless-type MMTV integration site family, member 10B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363034	Wnt10b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 11; targeted mutation 1.1, Velocigene	MGI:5583056	Wnt11<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
wingless-type MMTV integration site family, member 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364720	Wnt11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363929	Wnt11<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 16; targeted mutation 1, Velocigene	MGI:4399182	Wnt16<tm1(KOMP)Vlcg>	25306233	KOMP-Regeneron
wingless-type MMTV integration site family, member 16; targeted mutation 1, Velocigene	MGI:4399182	Wnt16<tm1(KOMP)Vlcg>	26627248	KOMP-Regeneron
wingless-type MMTV integration site family, member 16; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840661	Wnt16<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 16; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5548733	Wnt16<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
wingless-type MMTV integration site family, member 16; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840699	Wnt16<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453782	Wnt1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453782	Wnt1<tm1a(EUCOMM)Wtsi>	28628032	EUCOMM
wingless-type MMTV integration site family, member 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5925361	Wnt1<tm1c(EUCOMM)Wtsi>	28628032	EUCOMM
wingless-type MMTV integration site family, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453737	Wnt1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 2B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951126	Wnt2b<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 2B; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548412	Wnt2b<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
wingless-type MMTV integration site family, member 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363344	Wnt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364930	Wnt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5301395	Wnt3a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433919	Wnt3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434311	Wnt3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455951	Wnt3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456008	Wnt3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 5A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5301389	Wnt5a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 5B; targeted mutation 1.1, Velocigene	MGI:5548972	Wnt5b<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
wingless-type MMTV integration site family, member 5B; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4455999	Wnt5b<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 5B; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4456054	Wnt5b<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 5B; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4840655	Wnt5b<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 5B; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4840637	Wnt5b<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
wingless-type MMTV integration site family, member 6; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5766185	Wnt6<tm1b(NCOM)Mfgc>	27626380	NorCOMM
wingless-type MMTV integration site family, member 7B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364301	Wnt7b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 8A; targeted mutation 1, Velocigene	MGI:4399164	Wnt8a<tm1(KOMP)Vlcg>	23041177	KOMP-Regeneron
wingless-type MMTV integration site family, member 8A; targeted mutation 1, Velocigene	MGI:4399164	Wnt8a<tm1(KOMP)Vlcg>	25809880	KOMP-Regeneron
wingless-type MMTV integration site family, member 9A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419777	Wnt9a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
wingless-type MMTV integration site family, member 9A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419586	Wnt9a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WNT1 inducible signaling pathway protein 2; targeted mutation 1.1, Velocigene	MGI:5548427	Wisp2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
WNT1 inducible signaling pathway protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947808	Wisp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WNT1 inducible signaling pathway protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4947840	Wisp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WT1-interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364240	Wtip<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WT1-interacting protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364240	Wtip<tm1a(KOMP)Wtsi>	26839965	KOMP-CSD
WT1-interacting protein; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5569955	Wtip<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
WT1-interacting protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364023	Wtip<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WW domain binding protein 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5429375	Wbp1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
WW domain binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441789	Wbp2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WW domain binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441789	Wbp2<tm1a(EUCOMM)Wtsi>	26398943	EUCOMM
WW domain binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452018	Wbp2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
WW domain binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847848	Wbp2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
WW domain binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847848	Wbp2<tm2a(EUCOMM)Wtsi>	26881968	EUCOMM
WW domain binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4847848	Wbp2<tm2a(EUCOMM)Wtsi>	28332498	EUCOMM
WW domain containing adaptor with coiled-coil; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362353	Wac<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WW domain containing adaptor with coiled-coil; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364595	Wac<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
WW domain containing adaptor with coiled-coil; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527595	Wac<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
WW domain containing adaptor with coiled-coil; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5527595	Wac<tm2a(EUCOMM)Wtsi>	28319090	EUCOMM
WW domain containing adaptor with coiled-coil; targeted mutation 2c, Wellcome Trust Sanger Institute	MGI:5925355	Wac<tm2c(EUCOMM)Wtsi>	28319090	EUCOMM
WW domain-containing oxidoreductase; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841066	Wwox<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
WW domain containing transcription regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431719	Wwtr1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
WW domain containing transcription regulator 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431719	Wwtr1<tm1a(EUCOMM)Wtsi>	27215660	EUCOMM
WW domain containing transcription regulator 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5603602	Wwtr1<tm1c(EUCOMM)Wtsi>	26989177	EUCOMM
WW domain containing transcription regulator 1; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5603602	Wwtr1<tm1c(EUCOMM)Wtsi>	27215660	EUCOMM
xanthine dehydrogenase; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4451357	Xdh<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
X-box binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432347	Xbp1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
X-box binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432347	Xbp1<tm1a(EUCOMM)Wtsi>	24721909	EUCOMM
X-box binding protein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432347	Xbp1<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
X-box binding protein 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548973	Xbp1<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
X-box binding protein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433488	Xbp1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
X-box binding protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4432995	Xbp1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
X-box binding protein 1; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:4456775	Xbp1<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
X-box binding protein 1; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4456842	Xbp1<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
xenotropic and polytropic retrovirus receptor 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362650	Xpr1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
xeroderma pigmentosum, complementation group A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140484	Xpa<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
xin actin-binding repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458624	Xirp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
xin actin-binding repeat containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458624	Xirp2<tm1a(KOMP)Wtsi>	29306897	KOMP-CSD
xin actin-binding repeat containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:6115345	Xirp2<tm1b(KOMP)Wtsi>	29306897	KOMP-CSD
xin actin-binding repeat containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458656	Xirp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked inhibitor of apoptosis; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435758	Xiap<tm1a(EUCOMM)Hmgu>	25056906	EUCOMM
X-linked Kx blood group related 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950968	Xkr4<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked Kx blood group related 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5008804	Xkr4<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked Kx blood group related 6; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840601	Xkr6<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
X-linked Kx blood group related, X-linked; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453683	Xkrx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
X-linked Kx blood group related, X-linked; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637183	Xkrx<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
X-linked Kx blood group related, X-linked; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453717	Xkrx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
X-linked lymphocyte-regulated 3A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840946	Xlr3a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 3A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841465	Xlr3a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 3A; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4841310	Xlr3a<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 3A; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4841028	Xlr3a<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 3A; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:4841051	Xlr3a<tm3e(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 4A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451562	Xlr4a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 4A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451657	Xlr4a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 5C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847683	Xlr5c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked lymphocyte-regulated 5C; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5286186	Xlr5c<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
X-linked myotubular myopathy gene 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441988	Mtm1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
X-linked myotubular myopathy gene 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441795	Mtm1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
XPA binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432875	Xab2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
XPA binding protein 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441920	Xab2<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
XPA binding protein 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441792	Xab2<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419636	Xpnpep1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419742	Xpnpep1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
X-ray repair complementing defective repair in Chinese hamster cells 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433943	Xrcc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
X-ray repair complementing defective repair in Chinese hamster cells 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432364	Xrcc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
X-ray repair complementing defective repair in Chinese hamster cells 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451285	Xrcc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
X-ray repair complementing defective repair in Chinese hamster cells 3; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5529638	Xrcc3<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
X-ray repair complementing defective repair in Chinese hamster cells 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433839	Xrcc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
X-ray repair complementing defective repair in Chinese hamster cells 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364269	Xrcc6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
X-ray repair complementing defective repair in Chinese hamster cells 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364472	Xrcc6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Xrcc1 N-terminal domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441710	Xndc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
xylosylprotein beta1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362793	B4galt7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
xylosylprotein beta1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362288	B4galt7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
xylosyltransferase II; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841071	Xylt2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
xylosyltransferase II; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841410	Xylt2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Yae1 domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548529	Yae1d1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Y box protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363758	Ybx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
YdjC homolog (bacterial); targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419362	Ydjc<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
YEATS domain containing 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419265	Yeats4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
yes-associated protein 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4455424	Yap1<tm1a(KOMP)Mbp>	27215660	KOMP-CSD
yes-associated protein 1; targeted mutation 1a, Mouse Biology Program, UCDavis	MGI:4455424	Yap1<tm1a(KOMP)Mbp>	28346423	KOMP-CSD
yes-associated protein 1; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5603606	Yap1<tm1c(KOMP)Mbp>	26699479	KOMP-CSD
yes-associated protein 1; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5603606	Yap1<tm1c(KOMP)Mbp>	26989177	KOMP-CSD
yes-associated protein 1; targeted mutation 1c, Mouse Biology Program, UCDavis	MGI:5603606	Yap1<tm1c(KOMP)Mbp>	27215660	KOMP-CSD
YES proto-oncogene 1, Src family tyrosine kinase; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5014601	Yes1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 domain family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432914	Yipf1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
Yip1 domain family, member 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432914	Yipf1<tm1a(EUCOMM)Wtsi>	24652767	EUCOMM
Yip1 domain family, member 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433459	Yipf1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
Yip1 domain family, member 2; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419649	Yipf2<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 domain family, member 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009578	Yipf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 domain family, member 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429370	Yipf3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 domain family, member 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5574599	Yipf5<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
Yip1 domain family, member 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362668	Yipf6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 domain family, member 6; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4452689	Yipf6<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 domain family, member 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4452625	Yipf7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 domain family, member 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4452709	Yipf7<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
Yip1 interacting factor homolog A (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950256	Yif1a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
yippee like 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5429377	Ypel1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
yippee like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433376	Ypel2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
yippee like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433391	Ypel2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
yippee like 3; targeted mutation 1.1, Velocigene	MGI:5548509	Ypel3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
yippee like 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4456736	Ypel4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
yippee like 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4456793	Ypel4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
YKT6 v-SNARE homolog (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5464326	Ykt6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
YKT6 v-SNARE homolog (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5464319	Ykt6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
YLP motif containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362532	Ylpm1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
YLP motif containing 1; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5661980	Ylpm1<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
YLP motif containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362332	Ylpm1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
YME1-like 1 (S. cerevisiae); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4950251	Yme1l1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
YME1-like 1 (S. cerevisiae); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951135	Yme1l1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
yrdC domain containing (E.coli); targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050943	Yrdc<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
YTH domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432642	Ythdc1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
YTH domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432325	Ythdc1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
YTH domain containing 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4436324	Ythdc2<tm1a(EUCOMM)Hmgu>	29087293	EUCOMM
YTH domain containing 2; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:6110119	Ythdc2<tm1b(EUCOMM)Hmgu>	29087293	EUCOMM
YTH domain family 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364431	Ythdf2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
YTH domain family 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363343	Ythdf2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
YY1 transcription factor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431729	Yy1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
YY1 transcription factor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431911	Yy1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc and ring finger 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363204	Znrf3<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc binding alcohol dehydrogenase, domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000385	Zadh2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, AN1-type domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842279	Zfand1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, AN1-type domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842359	Zfand1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, AN1-type domain 2A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460508	Zfand2a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, AN1-type domain 2A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461733	Zfand2a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, AN1 type domain 2B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5429376	Zfand2b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and AT hook domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944350	Zfat<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and AT hook domain containing; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944405	Zfat<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and BTB domain containing 10; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419498	Zbtb10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and BTB domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441698	Zbtb1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441870	Zbtb1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432912	Zbtb20<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433015	Zbtb20<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 24; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548888	Zbtb24<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger and BTB domain containing 32; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5505908	Zbtb32<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
zinc finger and BTB domain containing 44; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432887	Zbtb44<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 44; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441629	Zbtb44<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 44; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4441751	Zbtb44<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 46; targeted mutation 1.1, Velocigene	MGI:5695925	Zbtb46<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger and BTB domain containing 4; targeted mutation 1.1, Velocigene	MGI:5507825	Zbtb4<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger and BTB domain containing 4; targeted mutation 1.1, Velocigene	MGI:5507825	Zbtb4<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
zinc finger and BTB domain containing 4; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419334	Zbtb4<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and BTB domain containing 7a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431836	Zbtb7a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 7a; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432541	Zbtb7a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 8a; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5008032	Zbtb8a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 8b; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5503350	Zbtb8b<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and BTB domain containing 8 opposite strand; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432899	Zbtb8os<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 8 opposite strand; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432927	Zbtb8os<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and BTB domain containing 9; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419237	Zbtb9<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431583	Zscan10<tm1a(EUCOMM)Wtsi>	19525957	EUCOMM
zinc finger and SCAN domain containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431583	Zscan10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432651	Zscan10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 10; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4431612	Zscan10<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 10; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432675	Zscan10<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431691	Zscan21<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433962	Zscan21<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 21; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4433380	Zscan21<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 21; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4432384	Zscan21<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 22; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841350	Zscan22<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domain containing 22; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429373	Zscan22<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domain containing 25; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429386	Zscan25<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domain containing 25; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473045	Zscan25<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger and SCAN domain containing 26; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4947729	Zscan26<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363795	Zscan2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domain containing 2; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4365130	Zscan2<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domains 20; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362368	Zscan20<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger and SCAN domains 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364120	Zscan20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, B-box domain containing; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364514	Zbbx<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, BED type containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942138	Zbed3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, BED type containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4942143	Zbed3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, BED type containing 4; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5548859	Zbed4<tm1.1(KOMP)Mbp>	27626380	KOMP-CSD
zinc finger, BED type containing 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460500	Zbed5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, BED type containing 5; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637059	Zbed5<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger, BED type containing 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461682	Zbed5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, C2HC-type containing 1B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4847679	Zc2hc1b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, C2HC-type containing 1B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4847684	Zc2hc1b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, C2HC-type containing 1C; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364739	Zc2hc1c<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, C2HC-type containing 1C; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362147	Zc2hc1c<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, C3HC type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362278	Zc3hc1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, C3HC type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364743	Zc3hc1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH-type, antiviral 1-like; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319929	Zc3hav1l<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger CCCH-type, antiviral 1-like; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319924	Zc3hav1l<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger CCCH type containing 10; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458859	Zc3h10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger CCCH type containing 10; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458834	Zc3h10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger CCCH type containing 12A; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4434879	Zc3h12a<tm1a(EUCOMM)Hmgu>	29263935	EUCOMM
zinc finger CCCH type containing 12A; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:6115370	Zc3h12a<tm1c(EUCOMM)Hmgu>	29263935	EUCOMM
zinc finger CCCH-type containing 12B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363727	Zc3h12b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH-type containing 12B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364673	Zc3h12b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH type containing 13; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362294	Zc3h13<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH type containing 13; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362703	Zc3h13<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH type containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419828	Zc3h14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH type containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419828	Zc3h14<tm1a(KOMP)Wtsi>	28666327	KOMP-CSD
zinc finger CCCH type containing 14; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:6107560	Zc3h14<tm1c(KOMP)Wtsi>	28666327	KOMP-CSD
zinc finger CCCH type containing 14; targeted mutation 1d, Wellcome Trust Sanger Institute	MGI:6107561	Zc3h14<tm1d(KOMP)Wtsi>	28666327	KOMP-CSD
zinc finger CCCH type containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419781	Zc3h14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH-type containing 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419732	Zc3h18<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH-type containing 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419241	Zc3h18<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH-type containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006760	Zc3h4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger CCCH type containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5319823	Zc3h8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger CCCH type containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880977	Zc3h8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, CCCH-type with G patch domain; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5605819	Zgpat<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger, CCHC domain containing 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296547	Zcchc11<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, CCHC domain containing 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006759	Zcchc12<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CCHC domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362839	Zcchc14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, CCHC domain containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363549	Zcchc14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, CCHC domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433290	Zcchc2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CCHC domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431608	Zcchc2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CCHC domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433180	Zcchc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CCHC domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434443	Zcchc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CCHC domain containing 7; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432539	Zcchc7<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CCHC domain containing 9; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441945	Zcchc9<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CW type with PWWP domain 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432603	Zcwpw1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, CW type with PWWP domain 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434180	Zcwpw1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, DHHC domain containing 11; targeted mutation 1.1, Velocigene	MGI:5445927	Zdhhc11<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger, DHHC domain containing 11; targeted mutation 1.1, Velocigene	MGI:5445927	Zdhhc11<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
zinc finger, DHHC domain containing 12; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5429383	Zdhhc12<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841204	Zdhhc14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841034	Zdhhc14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 18; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944542	Zdhhc18<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, DHHC domain containing 18; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944503	Zdhhc18<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, DHHC domain containing 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462623	Zdhhc19<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 19; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4818592	Zdhhc19<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 20; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429366	Zdhhc20<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 21; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461473	Zdhhc21<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 21; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461474	Zdhhc21<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 23; targeted mutation 1.1, Velocigene	MGI:5548874	Zdhhc23<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger, DHHC domain containing 24; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548600	Zdhhc24<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger, DHHC domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362764	Zdhhc2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 2; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605795	Zdhhc2<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger, DHHC domain containing 4; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432253	Zdhhc4<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, DHHC domain containing 4; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432351	Zdhhc4<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, DHHC domain containing 6; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419745	Zdhhc6<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 6; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419141	Zdhhc6<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432073	Zdhhc7<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, DHHC domain containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5293963	Zdhhc8<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, DHHC domain containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299530	Zdhhc8<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger E-box binding homeobox 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820064	Zeb1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger E-box binding homeobox 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820156	Zeb1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger E-box binding homeobox 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5472985	Zeb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, FYVE domain containing 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362902	Zfyve16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, FYVE domain containing 16; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451610	Zfyve16<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, FYVE domain containing 16; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451631	Zfyve16<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, FYVE domain containing 21; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050959	Zfyve21<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, FYVE domain containing 27; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460458	Zfyve27<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, FYVE domain containing 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460506	Zfyve27<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, FYVE domain containing 28; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432231	Zfyve28<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, FYVE domain containing 28; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637169	Zfyve28<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger, FYVE domain containing 28; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433961	Zfyve28<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, FYVE domain containing 9; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842342	Zfyve9<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, HIT type 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419145	Znhit3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger homeobox 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4948632	Zfhx3<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger like protein 1; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050962	Zfpl1<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger like protein 1; targeted mutation 2b, Wellcome Trust Sanger Institute	MGI:5572028	Zfpl1<tm2b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger, matrin type 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880890	Zmat1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, matrin type 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880939	Zmat1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, MIZ-type containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4451804	Zmiz1<tm1a(EUCOMM)Hmgu>	26522984	EUCOMM
zinc finger, MIZ-type containing 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5795595	Zmiz1<tm1c(EUCOMM)Hmgu>	26522984	EUCOMM
zinc finger, MIZ-type containing 2; targeted mutation 1.1, Velocigene	MGI:5445796	Zmiz2<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger, MYM domain containing 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820327	Zmym1<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYM domain containing 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820313	Zmym1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYM-type 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000398	Zmym5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYM-type 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5000425	Zmym5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYND domain containing 10; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419323	Zmynd10<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, MYND domain containing 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442017	Zmynd11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYND domain containing 12; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5302372	Zmynd12<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYND domain containing 19; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944534	Zmynd19<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYND-type containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433147	Zmynd8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, MYND-type containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433851	Zmynd8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 105; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4819222	Zfp105<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 105; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4819221	Zfp105<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 106; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362535	Zfp106<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 106; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362535	Zfp106<tm1a(KOMP)Wtsi>	23912999	KOMP-CSD
zinc finger protein 106; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362535	Zfp106<tm1a(KOMP)Wtsi>	25594701	KOMP-CSD
zinc finger protein 106; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362535	Zfp106<tm1a(KOMP)Wtsi>	26604141	KOMP-CSD
zinc finger protein 106; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362535	Zfp106<tm1a(KOMP)Wtsi>	27418600	KOMP-CSD
zinc finger protein 106; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362535	Zfp106<tm1a(KOMP)Wtsi>	29078390	KOMP-CSD
zinc finger protein 106; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363600	Zfp106<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 109; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052409	Zfp109<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 110; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432242	Zfp110<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 110; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432750	Zfp110<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 110; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433686	Zfp110<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 111; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462575	Zfp111<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 111; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5605805	Zfp111<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger protein 111; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462620	Zfp111<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 113; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419594	Zfp113<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 114; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454067	Zfp114<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 114; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454115	Zfp114<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 119a; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548456	Zfp119a<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger protein 11; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849428	Zfp11<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 11; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849419	Zfp11<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 128; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441721	Zfp128<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 128; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441890	Zfp128<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 142; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460442	Zfp142<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 142; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460504	Zfp142<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 148; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5636955	Zfp148<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger protein 148; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431408	Zfp148<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944403	Zfp14<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4868832	Zfp14<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 157; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4420139	Zfp157<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 157; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429387	Zfp157<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 160; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842277	Zfp160<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 160; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842380	Zfp160<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 169; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5050885	Zfp169<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 174; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364086	Zfp174<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 180; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5432724	Zfp180<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 180; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5432720	Zfp180<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 182; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841252	Zfp182<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 182; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841252	Zfp182<tm1a(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger protein 182; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5552020	Zfp182<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger protein 184 (Kruppel-like); targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362182	Zfp184<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 184 (Kruppel-like); targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362926	Zfp184<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 189; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880950	Zfp189<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 189; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5287787	Zfp189<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 207; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548446	Zfp207<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger protein 219; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419344	Zfp219<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 235; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4849965	Zfp235<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 235; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4849972	Zfp235<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 239; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5050161	Zfp239<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 239; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636945	Zfp239<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger protein 24; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419919	Zfp24<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 260; targeted mutation 1b, Mammalian Functional Genomics Centre	MGI:5513839	Zfp260<tm1b(NCOM)Mfgc>	27626380	NorCOMM
zinc finger protein 266; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441662	Zfp266<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 266; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637091	Zfp266<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger protein 266; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441754	Zfp266<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 27; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5432719	Zfp27<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 281; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432360	Zfp281<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 281; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431975	Zfp281<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 282; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433119	Zfp282<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 282; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431933	Zfp282<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 282; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511151	Zfp282<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 282; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511156	Zfp282<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 287; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433358	Zfp287<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 287; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548771	Zfp287<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger protein 287; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434469	Zfp287<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 296; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5140439	Zfp296<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 296; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944424	Zfp296<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 300; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419391	Zfp300<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 316; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363490	Zfp316<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 316; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364524	Zfp316<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 318; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364275	Zfp318<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 318; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362188	Zfp318<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 319; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4949368	Zfp319<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 322A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431495	Zfp322a<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 322A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431457	Zfp322a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 324; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431631	Zfp324<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 324; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4431976	Zfp324<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 324; targeted mutation 3e, Wellcome Trust Sanger Institute	MGI:5302320	Zfp324<tm3e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 329; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940792	Zfp329<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 329; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451606	Zfp329<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 334; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419708	Zfp334<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 335; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820243	Zfp335<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 335; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4820367	Zfp335<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 341; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362726	Zfp341<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 341; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363564	Zfp341<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 345; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880968	Zfp345<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 346; targeted mutation 1.1, Velocigene	MGI:5521539	Zfp346<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger protein 346; targeted mutation 1.1, Velocigene	MGI:5521539	Zfp346<tm1.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
zinc finger protein 352; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5299508	Zfp352<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 354B; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362183	Zfp354b<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 354B; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364751	Zfp354b<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 354C; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419764	Zfp354c<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 362; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432677	Zfp362<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 362; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433952	Zfp362<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 365; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364171	Zfp365<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 365; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365179	Zfp365<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 366; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362207	Zfp366<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 366; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362423	Zfp366<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 367; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363813	Zfp367<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 367; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362388	Zfp367<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 369; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431670	Zfp369<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 369; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433363	Zfp369<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 369; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4433232	Zfp369<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 36, C3H type-like 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433277	Zfp36l2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 36, C3H type-like 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432755	Zfp36l2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 36; targeted mutation 1, Velocigene	MGI:3847518	Zfp36<tm1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger protein 382; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362785	Zfp382<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 382; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364187	Zfp382<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 383; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286222	Zfp383<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 385A; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842708	Zfp385a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 385A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842689	Zfp385a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 395; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5009644	Zfp395<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 397; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003017	Zfp397<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 398; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433181	Zfp398<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 398; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432162	Zfp398<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441961	Zfp3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441906	Zfp3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 408; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433343	Zfp408<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 408; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5637174	Zfp408<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger protein 408; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433462	Zfp408<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 408; targeted mutation 3a, Wellcome Trust Sanger Institute	MGI:5511915	Zfp408<tm3a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 40; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296542	Zfp40<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 40; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5635490	Zfp40<tm1b(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 40; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429371	Zfp40<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 414; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363372	Zfp414<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 414; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364634	Zfp414<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 418; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363436	Zfp418<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 418; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363139	Zfp418<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 41; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4362887	Zfp41<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 41; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363298	Zfp41<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 422; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820094	Zfp422<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 426; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363568	Zfp426<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 426; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362709	Zfp426<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 426; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473226	Zfp426<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 426; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5473212	Zfp426<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 428; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5000386	Zfp428<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 429; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840916	Zfp429<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 429; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841024	Zfp429<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 42; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5493322	Zfp42<tm1b(KOMP)Mbp>	27626380	KOMP-CSD
zinc finger protein 42; targeted mutation 1b, Mouse Biology Program, UCDavis	MGI:5493322	Zfp42<tm1b(KOMP)Mbp>	28700664	KOMP-CSD
zinc finger protein 444; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419508	Zfp444<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 446; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842534	Zfp446<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 446; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842381	Zfp446<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 455; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4462586	Zfp455<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 455; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4462630	Zfp455<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 459; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842484	Zfp459<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 459; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842647	Zfp459<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 46; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419192	Zfp46<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 503; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364241	Zfp503<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 503; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362396	Zfp503<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 507; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434186	Zfp507<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 513; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420077	Zfp513<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 518B; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419179	Zfp518b<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 521; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431471	Zfp521<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 523; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432173	Zfp523<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 523; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432252	Zfp523<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 52; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4940799	Zfp52<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 52; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4941561	Zfp52<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 52; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5287796	Zfp52<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 536; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5548695	Zfp536<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger protein 536; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419823	Zfp536<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 541; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840919	Zfp541<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 541; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841435	Zfp541<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 54; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363189	Zfp54<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 54; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364338	Zfp54<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 553; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944521	Zfp553<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 553; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434077	Zfp553<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 563; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419456	Zfp563<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 579; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5429382	Zfp579<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 579; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429368	Zfp579<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 57; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419824	Zfp57<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 580; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433663	Zfp580<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 580; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433010	Zfp580<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 583; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842296	Zfp583<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 592; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5052487	Zfp592<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 592; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5140459	Zfp592<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 595; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4455464	Zfp595<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 595; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4455471	Zfp595<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 597; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419530	Zfp597<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 599; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419650	Zfp599<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 600; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4942146	Zfp600<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 606; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365211	Zfp606<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 606; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319870	Zfp606<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 616; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944324	Zfp616<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 616; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548908	Zfp616<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger protein 616; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944386	Zfp616<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 617; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431707	Zfp617<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 618; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4841054	Zfp618<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 618; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841342	Zfp618<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 622; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842845	Zfp622<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 622; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842753	Zfp622<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 62; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419773	Zfp62<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 637; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453687	Zfp637<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 637; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453702	Zfp637<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 644; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419957	Zfp644<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 646; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419870	Zfp646<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 651; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431473	Zfp651<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 658; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433212	Zfp658<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 658; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432068	Zfp658<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 664; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4887721	Zfp664<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 667; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441714	Zfp667<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 667; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4441900	Zfp667<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 668; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419809	Zfp668<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 672; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433406	Zfp672<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 672; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431803	Zfp672<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 683; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014578	Zfp683<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 687; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419397	Zfp687<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 689; targeted mutation 1.1, Velocigene	MGI:5603580	Zfp689<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger protein 68; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419990	Zfp68<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 704; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431765	Zfp704<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 704; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432025	Zfp704<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 710; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5006781	Zfp710<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 711; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5429384	Zfp711<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 711; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5429374	Zfp711<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 719; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431958	Zfp719<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 719; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431958	Zfp719<tm1a(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger protein 719; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548829	Zfp719<tm1b(EUCOMM)Wtsi>	26398943	EUCOMM
zinc finger protein 719; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548829	Zfp719<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger protein 719; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432524	Zfp719<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 719; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5472991	Zfp719<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 719; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5472830	Zfp719<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 750; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4457575	Zfp750<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 750; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458824	Zfp750<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 758; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842744	Zfp758<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 759; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4460505	Zfp759<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 759; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4460468	Zfp759<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 768; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5429378	Zfp768<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 770; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840604	Zfp770<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 770; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840653	Zfp770<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 775; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4951091	Zfp775<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 775; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4951121	Zfp775<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 786; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5003021	Zfp786<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 788; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458845	Zfp788<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 790; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5289815	Zfp790<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 791; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4939698	Zfp791<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5296534	Zfp7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 800; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454133	Zfp800<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 800; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454119	Zfp800<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 804A; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4363188	Zfp804a<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 809; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944342	Zfp809<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 809; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944342	Zfp809<tm1a(KOMP)Wtsi>	25737282	KOMP-CSD
zinc finger protein 809; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5749229	Zfp809<tm1c(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 809; targeted mutation 1c, Wellcome Trust Sanger Institute	MGI:5749229	Zfp809<tm1c(KOMP)Wtsi>	25737282	KOMP-CSD
zinc finger protein 810; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4433131	Zfp810<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 810; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5473023	Zfp810<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 819; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432294	Zfp819<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 819; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432375	Zfp819<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 82; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4431460	Zfp82<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 831; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944326	Zfp831<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 831; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4944394	Zfp831<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 846; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050952	Zfp846<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 84; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4944422	Zfp84<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 84; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5636909	Zfp84<tm1b(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger protein 84; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4939716	Zfp84<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 85; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419568	Zfp85<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 865; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4434049	Zfp865<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 867; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362701	Zfp867<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 871; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014690	Zfp871<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 879; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4451426	Zfp879<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 879; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4451565	Zfp879<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 882; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4451308	Zfp882<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 882; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4451588	Zfp882<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 92; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4364214	Zfp92<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 930; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5286184	Zfp930<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 935; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4820136	Zfp935<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 93; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419775	Zfp93<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 940; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5050902	Zfp940<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 941; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441958	Zfp941<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 941; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5303178	Zfp941<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 946; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442005	Zfp946<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 954; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4461666	Zfp954<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 954; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461740	Zfp954<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 956; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4840569	Zfp956<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 956; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4840608	Zfp956<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 959; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4442048	Zfp959<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 961; targeted mutation 1.1, Mouse Biology Program, UCDavis	MGI:5516079	Zfp961<tm1.1(KOMP)Mbp>	28700664	KOMP-CSD
zinc finger protein 974; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364302	Zfp974<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 974; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4365107	Zfp974<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 979; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4938571	Zfp979<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein 981; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4458508	Zfp981<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 981; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4458578	Zfp981<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 992; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4365046	Zfp992<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein 992; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364094	Zfp992<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein of the cerebellum 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4461479	Zic1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein of the cerebellum 2; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5293935	Zic2<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger protein of the cerebellum 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4441654	Zic3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger protein of the cerebellum 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4441763	Zic3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, RAN-binding domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435532	Zranb1<tm1a(EUCOMM)Hmgu>	26808229	EUCOMM
zinc finger, RAN-binding domain containing 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH	MGI:4435532	Zranb1<tm1a(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger, RAN-binding domain containing 1; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH	MGI:5548368	Zranb1<tm1b(EUCOMM)Hmgu>	27626380	EUCOMM
zinc finger, RAN-binding domain containing 1; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH	MGI:5806462	Zranb1<tm1c(EUCOMM)Hmgu>	26808229	EUCOMM
zinc finger, RAN-binding domain containing 1; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH	MGI:5806463	Zranb1<tm1d(EUCOMM)Hmgu>	26808229	EUCOMM
zinc finger, RAN-binding domain containing 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432383	Zranb2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, RAN-binding domain containing 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432169	Zranb2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, RAN-binding domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431667	Zranb3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, RAN-binding domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434401	Zranb3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, RAN-binding domain containing 3; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4460437	Zranb3<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, RAN-binding domain containing 3; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4460435	Zranb3<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger RNA binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432078	Zfr2<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger RNA binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433542	Zfr2<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc fingers and homeoboxes 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363591	Zhx2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc fingers and homeoboxes 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4363591	Zhx2<tm1a(KOMP)Wtsi>	27197076	KOMP-CSD
zinc fingers and homeoboxes 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4362284	Zhx2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc fingers and homeoboxes 3; targeted mutation 1.1, Velocigene	MGI:5548830	Zhx3<tm1.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger SCAN domains 29; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4362750	Zscan29<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger SWIM-type containing 3; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4419490	Zswim3<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger SWIM-type containing 5; targeted mutation 1.1, Wellcome Trust Sanger Institute	MGI:5582436	Zswim5<tm1.1(KOMP)Wtsi>	27626380	KOMP-CSD
zinc finger SWIM-type containing 5; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5429379	Zswim5<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger SWIM-type containing 7; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5287783	Zswim7<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger SWIM-type containing 8; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4453722	Zswim8<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger SWIM-type containing 8; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4453696	Zswim8<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger SWIM-type containing 9; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:5511986	Zswim9<tm2a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger SWIM-type containing 9; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:5511959	Zswim9<tm2e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with KRAB and SCAN domains 14; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432778	Zkscan14<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with KRAB and SCAN domains 14; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432407	Zkscan14<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with KRAB and SCAN domains 16; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364622	Zkscan16<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger with KRAB and SCAN domains 16; targeted mutation 2a, Wellcome Trust Sanger Institute	MGI:4820104	Zkscan16<tm2a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger with KRAB and SCAN domains 16; targeted mutation 2e, Wellcome Trust Sanger Institute	MGI:4820100	Zkscan16<tm2e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger with KRAB and SCAN domains 17; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4431816	Zkscan17<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with KRAB and SCAN domains 17; targeted mutation 1b, Wellcome Trust Sanger Institute	MGI:5548856	Zkscan17<tm1b(EUCOMM)Wtsi>	27626380	EUCOMM
zinc finger with KRAB and SCAN domains 17; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4432179	Zkscan17<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with KRAB and SCAN domains 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434096	Zkscan1<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with KRAB and SCAN domains 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4840985	Zkscan2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger with KRAB and SCAN domains 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4841436	Zkscan2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger with KRAB and SCAN domains 5; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432155	Zkscan5<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with KRAB and SCAN domains 5; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4434357	Zkscan5<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger with UFM1-specific peptidase domain; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4419378	Zufsp<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger with UFM1-specific peptidase domain; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4419173	Zufsp<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc finger, ZZ domain containing 3; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4432089	Zzz3<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, ZZ domain containing 3; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4433638	Zzz3<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zinc finger, ZZ-type with EF hand domain 1; targeted mutation 2.1, Velocigene	MGI:5474781	Zzef1<tm2.1(KOMP)Vlcg>	27626380	KOMP-Regeneron
zinc finger, ZZ-type with EF hand domain 1; targeted mutation 2.1, Velocigene	MGI:5474781	Zzef1<tm2.1(KOMP)Vlcg>	28700664	KOMP-Regeneron
zinc finger, ZZ-type with EF hand domain 1; targeted mutation 2, Velocigene	MGI:5085828	Zzef1<tm2(KOMP)Vlcg>	28700664	KOMP-Regeneron
zinc metallopeptidase, STE24; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4880923	Zmpste24<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zinc metallopeptidase, STE24; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4880974	Zmpste24<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zinc ribbon domain containing, 1; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:4420124	Znrd1<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zona pellucida binding protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364993	Zpbp2<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zona pellucida binding protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4364455	Zpbp2<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zona pellucida binding protein; targeted mutation 1, Wellcome Trust Sanger Institute	MGI:5429380	Zpbp<tm1(KOMP)Wtsi>	21677750	KOMP-CSD
zona pellucida glycoprotein 1; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4454080	Zp1<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
zona pellucida glycoprotein 1; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4454088	Zp1<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
ZW10 interactor; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4364608	Zwint<tm1a(KOMP)Wtsi>	21677750	KOMP-CSD
ZW10 interactor; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:5319852	Zwint<tm1e(KOMP)Wtsi>	21677750	KOMP-CSD
zw10 kinetochore protein; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:5014722	Zw10<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zw10 kinetochore protein; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4431794	Zw10<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zyg-11 family member A, cell cycle regulator; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4842353	Zyg11a<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zyg-11 family member A, cell cycle regulator; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4842682	Zyg11a<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
zyxin; targeted mutation 1a, Wellcome Trust Sanger Institute	MGI:4881085	Zyx<tm1a(EUCOMM)Wtsi>	21677750	EUCOMM
zyxin; targeted mutation 1e, Wellcome Trust Sanger Institute	MGI:4881086	Zyx<tm1e(EUCOMM)Wtsi>	21677750	EUCOMM
[mi_adm@ves-ebi-d9 mousemine]$ 
